data_6rzc_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6rzc _Structure_validation_residue.Date_analyzed 2020-07-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 11' ' ' HIS . 56.6 ttt180 . . . . . 0 N--CA 1.459 -0.015 0 CA-C-O 121.132 0.491 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.7 t60 -153.68 144.62 22.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.054 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.15 -31.78 0.23 Allowed 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 125.786 1.929 . . . . 0.0 109.901 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.64 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.67 0.3 Allowed 'General case' 0 N--CA 1.411 -2.378 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.054 ' H ' ' C ' ' A' ' 12' ' ' ALA . 29.5 tttt -115.26 -169.19 1.52 Allowed 'General case' 0 C--N 1.395 2.559 0 CA-C-N 109.446 -3.524 . . . . 0.0 111.826 177.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.695 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 9.5 m-70 32.96 21.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.84 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 173.52 -47.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.63 0 CA-C-O 122.191 0.996 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.74 -14.8 77.99 Favored Glycine 0 C--N 1.271 -3.073 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.446 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.96 -45.92 9.81 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 114.264 -0.968 . . . . 0.0 109.531 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.27 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.941 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.7 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.223 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.2 t -151.01 -29.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.528 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 18.8 t30 136.12 -39.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.63 1.206 . . . . 0.0 109.096 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.528 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 85.5 m-70 -151.93 -131.37 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.31 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.453 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.7 t80 55.53 13.94 1.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.921 0.391 . . . . 0.0 110.311 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.5 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.298 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HE ' ' CA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.049 0.452 . . . . 0.0 109.923 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.645 ' C ' ' H ' ' A' ' 13' ' ' ALA . 18.1 p80 -152.19 145.58 24.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.418 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.099 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.99 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 125.742 1.901 . . . . 0.0 109.917 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.645 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.311 1 N-CA-C 95.42 -5.771 . . . . 0.0 95.42 165.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.099 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -116.18 -168.26 1.41 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.47 -3.514 . . . . 0.0 111.55 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.2 m-70 34.27 19.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.915 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.33 -45.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 122.253 1.025 . . . . 0.0 109.364 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.39 -13.68 81.44 Favored Glycine 0 C--N 1.273 -2.95 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.432 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -92.09 -43.15 9.55 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.82 178.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.621 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.96 41.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.241 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.75 -17.97 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.5 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.621 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.2 t -148.63 -34.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 154.89 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.833 0.708 . . . . 0.0 109.115 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -160.9 45.32 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.28 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -66.59 -19.16 65.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.6 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 88.7 mtt180 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.972 0.415 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.654 ' C ' ' H ' ' A' ' 13' ' ' ALA . 46.5 m80 -151.85 143.83 23.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.291 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.86 -31.58 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.675 1.859 . . . . 0.0 109.497 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.654 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.34 0.28 Allowed 'General case' 0 N--CA 1.413 -2.324 1 N-CA-C 95.467 -5.753 . . . . 0.0 95.467 164.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.97 -169.04 1.52 Allowed 'General case' 0 C--N 1.394 2.5 0 CA-C-N 109.454 -3.521 . . . . 0.0 111.642 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.8 m-70 33.84 19.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.848 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.677 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.69 -45.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.226 1.012 . . . . 0.0 109.382 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.28 -13.95 81.06 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 105.489 -3.044 . . . . 0.0 105.489 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.431 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -91.38 -43.72 9.58 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.806 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.22 41.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.255 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.94 -19.29 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.497 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.8 t -148.78 -32.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 155.44 -47.88 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -172.49 96.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.263 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 55.4 t80 -164.0 1.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.314 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.408 ' H ' ' H ' ' A' ' 24' ' ' TYR . 2.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.18 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 64.5 t-80 -146.57 144.38 29.53 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.181 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.59 -31.41 0.22 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.641 1.838 . . . . 0.0 109.544 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.28 0.28 Allowed 'General case' 0 N--CA 1.412 -2.355 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.048 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttm -116.34 -169.49 1.63 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 109.493 -3.503 . . . . 0.0 111.71 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.672 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 23.5 m-70 34.82 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.851 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.4 tt 175.22 -41.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 CA-C-O 122.027 0.917 . . . . 0.0 109.679 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.37 -12.94 84.09 Favored Glycine 0 C--N 1.275 -2.82 0 N-CA-C 105.622 -2.991 . . . . 0.0 105.622 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.438 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.55 -42.75 8.27 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.639 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.37 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.768 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.63 8.62 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -149.41 -9.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.804 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -37.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.468 1.105 . . . . 0.0 110.563 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.648 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 18.9 t60 -171.86 178.1 3.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.792 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.648 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 23.9 p90 41.9 26.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.485 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.833 0.349 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.654 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.2 t-80 -159.29 143.64 15.27 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.669 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.037 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.5 -31.71 0.23 Allowed 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 125.854 1.971 . . . . 0.0 109.723 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.654 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.29 0.27 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.532 -5.729 . . . . 0.0 95.532 165.118 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.037 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.8 tttm -116.61 -169.28 1.6 Allowed 'General case' 0 C--N 1.392 2.421 0 CA-C-N 109.452 -3.522 . . . . 0.0 111.822 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.693 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.3 m-70 33.11 22.26 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.789 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.4 tt 169.52 -37.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-O 122.258 1.028 . . . . 0.0 109.186 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.32 -11.81 79.88 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 104.753 -3.339 . . . . 0.0 104.753 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.463 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.2 -36.2 13.4 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 114.397 -0.901 . . . . 0.0 109.879 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.35 26.18 0.6 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.66 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.41 -4.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.279 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.573 ' H ' ' C ' ' A' ' 19' ' ' ALA . 47.4 t -151.3 -27.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.047 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -174.24 -92.26 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.131 0.491 . . . . 0.0 110.978 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.3 t60 -159.62 27.37 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 53.3 t80 -74.92 17.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.685 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 23' ' ' HIS . 9.2 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.421 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.652 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t60 -164.18 146.51 9.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.127 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.61 -32.0 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.88 1.988 . . . . 0.0 110.087 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.652 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.85 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.383 -5.784 . . . . 0.0 95.383 165.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.127 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.7 tttm -115.61 -169.83 1.66 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.9 t-80 34.34 18.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.961 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tt 175.65 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.137 0.97 . . . . 0.0 109.583 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.62 -13.34 83.29 Favored Glycine 0 C--N 1.277 -2.697 0 N-CA-C 105.14 -3.184 . . . . 0.0 105.14 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -91.95 -45.54 8.29 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 114.394 -0.903 . . . . 0.0 109.242 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.18 13.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.47 8.48 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.8 t -144.26 -9.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER 105.44 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.581 1.175 . . . . 0.0 110.322 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.629 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 17.0 t-80 -169.83 -134.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.629 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 85.9 m-85 54.06 20.0 2.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.992 0.425 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.644 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.6 t-80 -90.4 145.55 24.85 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.251 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.54 -32.43 0.23 Allowed 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 125.751 1.907 . . . . 0.0 110.302 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.644 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.96 0.48 0.38 Allowed 'General case' 0 N--CA 1.412 -2.338 1 N-CA-C 95.324 -5.806 . . . . 0.0 95.324 165.071 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttm -113.53 -169.36 1.49 Allowed 'General case' 0 C--N 1.393 2.477 0 CA-C-N 109.24 -3.618 . . . . 0.0 112.046 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.695 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 30.2 t-80 34.7 18.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.95 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.68 -46.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.257 1.027 . . . . 0.0 109.121 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.28 78.93 Favored Glycine 0 C--N 1.27 -3.108 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -91.1 -47.04 7.77 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.091 177.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.89 13.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.11 8.27 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' H ' ' C ' ' A' ' 19' ' ' ALA . 59.0 t -144.35 -9.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.432 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.1 t30 103.89 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.521 1.138 . . . . 0.0 109.921 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -178.14 92.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.92 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 88.0 t80 -143.3 9.18 1.63 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.195 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 15.1 ptm180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.701 0.286 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.65 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.9 m-70 -157.37 146.31 19.8 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.089 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.52 -31.52 0.22 Allowed 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 125.797 1.935 . . . . 0.0 110.01 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 1.94 0.31 Allowed 'General case' 0 N--CA 1.412 -2.329 1 N-CA-C 95.299 -5.815 . . . . 0.0 95.299 165.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.089 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.04 -169.46 1.61 Allowed 'General case' 0 C--N 1.392 2.447 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.8 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.689 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.5 m80 34.78 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.865 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 174.96 -42.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.116 0.96 . . . . 0.0 109.669 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.48 83.45 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.09 -44.77 7.86 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 114.591 -0.805 . . . . 0.0 109.565 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.5 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.444 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.89 8.4 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 49.4 t -148.28 -9.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.241 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.43 1.081 . . . . 0.0 109.874 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.553 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -174.95 176.4 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.423 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 53.58 31.59 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 67.6 mtp180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.664 ' C ' ' H ' ' A' ' 13' ' ' ALA . 70.3 m80 -153.12 145.66 24.16 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.104 0.478 . . . . 0.0 110.818 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.082 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.55 -31.52 0.23 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.83 1.956 . . . . 0.0 109.586 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.664 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.72 3.12 0.23 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.477 -5.749 . . . . 0.0 95.477 164.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.082 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.0 tttp -117.68 -169.37 1.66 Allowed 'General case' 0 C--N 1.392 2.443 0 CA-C-N 109.487 -3.506 . . . . 0.0 111.925 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.683 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.2 m-70 31.81 25.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.625 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.1 tt 168.08 -35.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.026 0.917 . . . . 0.0 109.029 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.34 -13.3 74.02 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.516 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.5 t60 -86.79 -39.79 15.59 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 114.181 -1.009 . . . . 0.0 110.154 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -149.16 23.51 0.94 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.152 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.91 5.48 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.551 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.1 t -150.59 -31.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.551 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' VAL . 3.9 m-20 167.82 -74.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.424 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -163.59 24.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.386 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -50.11 -26.96 5.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.0 m80 -153.16 144.08 22.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.254 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.098 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.36 -31.11 0.22 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.678 1.862 . . . . 0.0 109.564 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.32 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.098 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -116.56 -168.9 1.53 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.393 -3.548 . . . . 0.0 111.667 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.1 m80 34.23 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.814 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.08 -43.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 CA-C-O 122.109 0.957 . . . . 0.0 109.734 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.44 -13.13 83.7 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.403 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -95.42 -44.09 7.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 114.589 -0.806 . . . . 0.0 109.624 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.64 8.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.569 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.02 8.74 1.54 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.2 t -148.44 -8.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.647 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 20.5 m-20 97.13 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.555 1.159 . . . . 0.0 110.275 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.9 t60 -170.76 -162.63 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.074 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.661 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.1 t80 56.0 12.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.201 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 99.4 mtt180 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.665 ' C ' ' H ' ' A' ' 13' ' ' ALA . 21.7 m80 -152.69 146.41 25.11 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.21 -31.03 0.21 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.814 1.946 . . . . 0.0 110.095 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.665 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 1.98 0.31 Allowed 'General case' 0 N--CA 1.411 -2.388 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 10.6 ttpt -116.22 -168.86 1.5 Allowed 'General case' 0 C--N 1.395 2.565 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.691 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.681 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 83.2 t60 35.02 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.992 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.3 tt 175.65 -44.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.193 0.997 . . . . 0.0 109.507 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.81 -13.77 82.06 Favored Glycine 0 C--N 1.274 -2.877 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.428 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.25 -45.39 8.65 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.46 -0.87 . . . . 0.0 108.838 177.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 162.36 12.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.89 11.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 19' ' ' ALA . 95.4 t -145.12 -7.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.11 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.1 m120 100.6 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.89 1.369 . . . . 0.0 110.103 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.65 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.8 t-80 -167.42 -136.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.219 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.65 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.5 m-85 46.47 31.6 1.36 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 14.9 ptm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.632 ' C ' ' H ' ' A' ' 13' ' ' ALA . 27.4 m-70 -144.0 146.99 33.27 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.612 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.098 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.13 -31.51 0.23 Allowed 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 125.61 1.818 . . . . 0.0 109.812 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.632 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.61 2.4 0.29 Allowed 'General case' 0 N--CA 1.411 -2.397 1 N-CA-C 95.339 -5.8 . . . . 0.0 95.339 165.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.098 ' H ' ' C ' ' A' ' 12' ' ' ALA . 17.8 tttp -116.19 -168.81 1.49 Allowed 'General case' 0 C--N 1.394 2.504 0 CA-C-N 109.479 -3.509 . . . . 0.0 111.561 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m-70 34.1 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.946 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.38 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.55 -14.05 81.41 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 105.486 -3.046 . . . . 0.0 105.486 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.449 ' CE1' ' HZ2' ' A' ' 14' ' ' LYS . 1.2 m170 -93.78 -48.48 6.29 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 114.398 -0.901 . . . . 0.0 109.77 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 171.69 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.66 9.32 1.1 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 19' ' ' ALA . 98.2 t -146.95 -8.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.784 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 25.6 m-20 97.94 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.702 1.251 . . . . 0.0 110.334 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 55.7 m80 -157.48 -160.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.448 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 55.21 22.75 4.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.572 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.289 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 121.115 0.483 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.643 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.6 t-80 -156.58 145.39 20.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.139 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.41 -31.38 0.22 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.825 1.953 . . . . 0.0 109.629 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.1 0.3 Allowed 'General case' 0 N--CA 1.411 -2.399 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.139 ' H ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.2 -169.3 1.58 Allowed 'General case' 0 C--N 1.393 2.475 0 CA-C-N 109.423 -3.535 . . . . 0.0 111.737 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.696 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.23 19.64 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.791 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 173.87 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 CA-C-O 122.054 0.93 . . . . 0.0 109.567 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.17 -12.87 84.21 Favored Glycine 0 C--N 1.274 -2.89 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.441 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.78 -44.49 8.11 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.075 177.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 162.3 13.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.12 9.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 19' ' ' ALA . 59.8 t -144.76 -9.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.324 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t30 104.38 -36.79 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.628 1.205 . . . . 0.0 110.214 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.633 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 20.8 t-80 -170.38 -126.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.379 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.633 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 97.1 m-85 53.44 11.99 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.559 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.2 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.956 0.407 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.65 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.1 t60 -157.3 147.3 20.69 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.54 -31.6 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.758 1.912 . . . . 0.0 110.048 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 2.1 0.3 Allowed 'General case' 0 N--CA 1.412 -2.349 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 165.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.3 tttt -116.08 -168.79 1.49 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.696 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.677 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.4 t-80 34.23 19.31 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.847 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 174.57 -46.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 CA-C-O 122.308 1.052 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.54 -14.23 77.57 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.411 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.33 -46.88 7.16 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.523 -0.839 . . . . 0.0 109.559 178.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.88 14.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.93 5.65 1.03 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.9 t -144.6 -8.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.343 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 15.5 t30 105.35 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.578 1.174 . . . . 0.0 109.958 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.549 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 2.2 p-80 -170.58 107.74 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -59.92 -9.54 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.453 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.659 ' C ' ' H ' ' A' ' 13' ' ' ALA . 48.2 t-80 -156.75 145.65 20.12 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.047 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.74 -31.65 0.23 Allowed 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 125.835 1.959 . . . . 0.0 109.889 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.46 2.14 0.29 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.047 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttp -116.24 -169.09 1.54 Allowed 'General case' 0 C--N 1.393 2.497 0 CA-C-N 109.435 -3.53 . . . . 0.0 111.68 177.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.686 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.36 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.961 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.12 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.61 0 CA-C-O 122.015 0.912 . . . . 0.0 109.524 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.35 -13.29 83.42 Favored Glycine 0 C--N 1.276 -2.781 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.426 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.5 m170 -94.66 -47.52 6.47 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.709 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 171.0 12.85 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.26 7.45 1.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.373 0.606 . . . . 0.0 109.388 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.3 t -148.31 -9.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.106 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 39.8 t-20 101.66 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.463 1.102 . . . . 0.0 110.084 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' LEU . 76.4 m80 -150.48 112.85 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.383 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 61.8 t80 -53.8 -10.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' HIS . 14.9 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.446 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 11' ' ' HIS . 51.2 mtt-85 . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.659 ' C ' ' H ' ' A' ' 13' ' ' ALA . 39.7 m80 60.08 136.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.544 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.69 -32.43 0.24 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.631 1.832 . . . . 0.0 109.637 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.18 1.32 0.32 Allowed 'General case' 0 N--CA 1.41 -2.431 1 N-CA-C 95.34 -5.8 . . . . 0.0 95.34 164.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.1 tttt -114.62 -169.05 1.47 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.592 -3.458 . . . . 0.0 111.843 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 56.8 m-70 34.44 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.763 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 174.61 -46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-O 122.2 1.0 . . . . 0.0 109.422 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -13.69 80.06 Favored Glycine 0 C--N 1.271 -3.071 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.431 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.27 -43.14 9.45 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.643 -0.778 . . . . 0.0 109.853 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.226 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.93 -17.89 0.16 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.55 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.613 ' H ' ' C ' ' A' ' 19' ' ' ALA . 24.0 t -149.24 -32.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.759 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 156.87 -47.7 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -166.98 68.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.556 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -58.22 -21.66 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.566 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.481 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.1 t-80 -158.85 146.8 17.96 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.72 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.991 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.97 0.24 Allowed 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 125.791 1.932 . . . . 0.0 109.991 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.92 0.29 Allowed 'General case' 0 N--CA 1.412 -2.35 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 165.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.991 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttp -115.59 -169.68 1.63 Allowed 'General case' 0 C--N 1.393 2.465 0 CA-C-N 109.323 -3.58 . . . . 0.0 111.623 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.681 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.5 t60 34.47 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.033 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 176.07 -43.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 CA-C-O 122.093 0.949 . . . . 0.0 109.477 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.55 -14.48 81.99 Favored Glycine 0 C--N 1.274 -2.863 0 N-CA-C 105.197 -3.161 . . . . 0.0 105.197 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.438 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -90.29 -49.38 6.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.179 177.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.57 13.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.16 0.288 . . . . 0.0 110.309 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.48 7.85 1.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.9 t -141.71 -9.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t-20 105.17 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.607 1.192 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.0 t-80 84.71 26.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.008 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.38 -13.66 62.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.277 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.837 0.351 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 98.5 m-70 -136.48 92.02 2.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.318 0.58 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 138.74 -32.86 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -0.39 0.58 Allowed 'General case' 0 N--CA 1.414 -2.25 1 N-CA-C 95.398 -5.779 . . . . 0.0 95.398 164.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.029 ' H ' ' C ' ' A' ' 12' ' ' ALA . 31.9 tttt -114.59 -168.78 1.42 Allowed 'General case' 0 C--N 1.391 2.378 0 CA-C-N 109.441 -3.527 . . . . 0.0 112.001 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.717 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 81.4 m-70 33.45 21.7 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.833 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.75 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.237 1.018 . . . . 0.0 109.452 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.37 -11.5 80.32 Favored Glycine 0 C--N 1.276 -2.751 0 N-CA-C 104.848 -3.301 . . . . 0.0 104.848 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.499 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -91.76 -36.75 13.39 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.843 178.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.45 26.22 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.707 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.13 0.15 0.05 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.269 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.582 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.5 t -151.47 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.266 0.079 . . . . 0.0 110.823 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.64 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -178.87 -89.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.64 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 1.7 t60 -166.51 50.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.428 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 48.4 t80 -74.58 -15.81 60.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.585 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.501 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.658 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.6 t60 -157.52 146.25 19.54 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.632 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.99 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 125.71 1.881 . . . . 0.0 109.898 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.27 1.95 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.044 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.061 ' H ' ' C ' ' A' ' 12' ' ' ALA . 31.4 tttt -115.69 -169.26 1.55 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.744 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 33.89 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.792 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.4 tt 174.37 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-O 122.202 1.001 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.0 -13.86 80.66 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.495 -3.042 . . . . 0.0 105.495 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -91.05 -43.53 9.87 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.674 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.37 41.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.221 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.7 -16.99 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.587 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.7 t -148.95 -34.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t30 155.28 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.827 0.704 . . . . 0.0 109.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.581 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 29.4 t60 -162.89 -117.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.581 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 59.6 t80 54.62 18.0 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.336 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.85 0.357 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.639 ' C ' ' H ' ' A' ' 13' ' ' ALA . 91.8 m-70 -152.8 145.39 24.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.55 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.073 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.36 -31.25 0.22 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.701 1.876 . . . . 0.0 109.726 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.639 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 2.02 0.31 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.353 -5.795 . . . . 0.0 95.353 164.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.073 ' H ' ' C ' ' A' ' 12' ' ' ALA . 13.2 ttpt -115.9 -169.28 1.56 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.424 -3.535 . . . . 0.0 111.577 176.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.2 t-80 34.45 17.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.001 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.7 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.123 0.964 . . . . 0.0 109.565 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -13.68 83.17 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 105.386 -3.086 . . . . 0.0 105.386 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.18 -47.42 7.53 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.211 -0.995 . . . . 0.0 109.251 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.45 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.273 0.358 . . . . 0.0 110.135 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.07 10.2 1.54 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 92.5 t -142.63 -9.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 22.7 t-20 101.89 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.464 1.102 . . . . 0.0 110.813 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.622 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.5 t60 81.63 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.237 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.622 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.1 m-85 50.36 31.95 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.244 -179.923 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 61.9 mtp180 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.647 ' C ' ' H ' ' A' ' 13' ' ' ALA . 90.6 m-70 -156.38 144.85 19.94 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.098 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.96 -31.93 0.23 Allowed 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 125.737 1.898 . . . . 0.0 109.892 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.647 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.91 0.31 Allowed 'General case' 0 N--CA 1.412 -2.37 1 N-CA-C 95.406 -5.776 . . . . 0.0 95.406 165.057 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.098 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.3 tttm -115.15 -169.78 1.63 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.5 -3.5 . . . . 0.0 111.803 176.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.0 t60 34.39 17.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.108 178.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 176.38 -44.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.224 1.011 . . . . 0.0 109.078 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.35 -13.93 82.4 Favored Glycine 0 C--N 1.274 -2.905 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 174.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.434 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.1 m170 -92.28 -47.91 6.96 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.465 -0.867 . . . . 0.0 109.457 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.38 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.641 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.54 7.83 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.411 0.624 . . . . 0.0 109.46 -179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.9 t -146.22 -8.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.958 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.0 t-20 102.52 -37.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.631 1.207 . . . . 0.0 110.031 -179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -173.93 104.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.618 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 48.2 t80 -171.68 -4.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.13 180.0 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 11' ' ' HIS . 13.9 ptm180 . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.816 0.341 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.659 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.9 m170 -135.82 146.75 47.84 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.278 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.101 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.23 -31.62 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.734 1.896 . . . . 0.0 109.851 -177.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 1.99 0.31 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.443 -5.762 . . . . 0.0 95.443 165.051 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.101 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.7 tttp -115.57 -169.12 1.52 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.406 -3.543 . . . . 0.0 111.737 176.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.692 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.8 t60 33.72 19.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.89 178.044 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.31 -45.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.125 0.964 . . . . 0.0 109.551 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.05 -14.33 80.44 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 105.402 -3.079 . . . . 0.0 105.402 174.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.446 ' HD1' ' HZ3' ' A' ' 14' ' ' LYS . 1.1 m170 -91.67 -48.96 6.54 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.325 -0.937 . . . . 0.0 109.182 177.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.08 14.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.29 9.63 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.5 t -144.63 -10.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.845 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.2 t-20 105.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.542 1.151 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 4.9 t-160 83.98 28.02 0.08 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.372 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.61 -19.37 25.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.685 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.4 t-80 -157.22 143.6 18.02 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.324 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.85 -30.73 0.21 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.37 -177.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.685 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.87 3.29 0.24 Allowed 'General case' 0 N--CA 1.41 -2.46 1 N-CA-C 95.332 -5.803 . . . . 0.0 95.332 164.741 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.051 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.8 tttp -119.05 -168.13 1.51 Allowed 'General case' 0 C--N 1.392 2.428 0 CA-C-N 109.457 -3.52 . . . . 0.0 111.684 177.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.4 m80 33.5 23.27 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.556 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.63 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.3 tt 167.41 -34.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.166 0.984 . . . . 0.0 109.256 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.63 -12.37 77.99 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 104.902 -3.279 . . . . 0.0 104.902 174.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 18' ' ' HIS . 18.4 t-160 -92.56 -36.04 13.25 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 114.425 -0.887 . . . . 0.0 110.013 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -146.91 22.88 1.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.96 -2.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.3 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.9 -30.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.738 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -176.63 -90.16 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.011 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.497 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.1 p80 -149.75 25.99 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.48 ' N ' ' CB ' ' A' ' 19' ' ' ALA . 45.5 t80 -72.46 12.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.4 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.253 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.662 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.1 t60 -157.49 145.24 18.82 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.114 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.81 -31.72 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.706 1.879 . . . . 0.0 109.805 -178.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.86 0.3 Allowed 'General case' 0 N--CA 1.412 -2.361 1 N-CA-C 95.303 -5.814 . . . . 0.0 95.303 164.95 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.114 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.556 -3.474 . . . . 0.0 111.876 177.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.678 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 49.3 t-80 33.91 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.787 178.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.14 -46.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 122.234 1.016 . . . . 0.0 109.319 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -13.63 80.57 Favored Glycine 0 C--N 1.271 -3.076 0 N-CA-C 105.571 -3.011 . . . . 0.0 105.571 174.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.436 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.21 -43.09 10.05 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.533 178.181 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.42 41.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.181 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.41 -15.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.612 -179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.615 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.17 -35.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.2 t30 155.53 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.806 0.691 . . . . 0.0 109.19 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -166.11 65.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.6 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 65.1 t80 -70.12 -13.59 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.451 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.005 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.661 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.0 t60 -157.25 145.2 19.12 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.075 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.03 -31.57 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.702 1.876 . . . . 0.0 109.75 -177.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.661 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.85 0.31 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.416 -5.772 . . . . 0.0 95.416 164.914 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.075 ' H ' ' C ' ' A' ' 12' ' ' ALA . 31.8 tttt -115.35 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.45 -3.523 . . . . 0.0 111.759 176.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.691 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 11.7 t-80 34.51 18.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.985 177.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.668 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.88 -46.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.307 1.051 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.16 -14.49 79.0 Favored Glycine 0 C--N 1.271 -3.035 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.433 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.3 -48.63 6.58 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.471 -0.865 . . . . 0.0 109.539 178.113 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 170.26 12.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.433 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.1 8.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 19' ' ' ALA . 89.5 t -145.78 -7.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.783 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.6 m-20 98.57 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.764 1.29 . . . . 0.0 110.19 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.61 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -176.76 87.15 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.352 -179.927 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -66.82 -21.38 66.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.984 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.652 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 t-80 -160.82 144.05 13.16 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.463 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.133 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.58 -31.11 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.568 1.792 . . . . 0.0 109.458 -177.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.652 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.34 0.3 Allowed 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 95.317 -5.808 . . . . 0.0 95.317 164.758 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.133 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.1 tttm -116.33 -169.29 1.59 Allowed 'General case' 0 C--N 1.393 2.468 0 CA-C-N 109.525 -3.489 . . . . 0.0 111.556 177.063 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 34.77 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.99 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 175.83 -41.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.58 0 CA-C-O 122.042 0.925 . . . . 0.0 109.471 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.1 -13.01 83.8 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 105.331 -3.108 . . . . 0.0 105.331 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.431 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.4 m170 -94.38 -46.29 7.09 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.541 178.17 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.63 13.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.772 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.55 5.92 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 20.7 t -148.13 -10.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.391 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 58.2 t-20 110.53 -42.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.632 1.208 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' C ' ' H ' ' A' ' 25' ' ' LEU . 63.2 t-80 -173.9 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.649 0.262 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.05 39.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.477 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.2 tp . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.264 0.554 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.5 t60 -150.16 144.73 25.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.42 -31.4 0.22 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 125.75 1.906 . . . . 0.0 109.648 -177.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.4 0.27 Allowed 'General case' 0 N--CA 1.413 -2.308 1 N-CA-C 95.363 -5.791 . . . . 0.0 95.363 164.952 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.057 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.2 tttt -116.63 -168.63 1.48 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.485 -3.507 . . . . 0.0 111.669 177.096 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.678 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.1 m-70 33.82 20.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.825 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 173.76 -43.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 122.108 0.956 . . . . 0.0 109.61 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.22 -13.24 83.48 Favored Glycine 0 C--N 1.274 -2.911 0 N-CA-C 105.57 -3.012 . . . . 0.0 105.57 174.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -94.77 -45.51 7.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.483 178.117 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.62 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.34 7.16 1.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' H ' ' C ' ' A' ' 19' ' ' ALA . 42.4 t -146.59 -9.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.369 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 37.7 t-20 103.46 -35.93 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.514 1.134 . . . . 0.0 110.058 -179.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.595 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -171.58 112.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.346 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -64.17 -1.03 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.634 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.977 0.418 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.66 ' C ' ' H ' ' A' ' 13' ' ' ALA . 5.7 p80 -155.04 143.77 20.68 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.63 -31.07 0.22 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.694 1.871 . . . . 0.0 109.523 -177.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.02 0.29 Allowed 'General case' 0 N--CA 1.411 -2.391 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 165.078 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.039 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.9 ttpt -116.96 -168.18 1.42 Allowed 'General case' 0 C--N 1.393 2.498 0 CA-C-N 109.398 -3.546 . . . . 0.0 111.498 177.331 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.4 t-80 34.11 20.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.631 177.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 171.36 -46.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 CA-C-O 122.303 1.049 . . . . 0.0 109.254 -179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.69 -13.12 80.6 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.975 -2.85 . . . . 0.0 105.975 175.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -32.21 18.27 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.84 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.795 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.56 -20.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CD2' ' A' ' 15' ' ' HIS . 59.9 t -152.0 -17.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.562 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 164.58 -38.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.958 0.409 . . . . 0.0 110.017 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 31.4 t60 -171.34 26.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.352 -178.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -47.62 -18.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.303 179.935 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.821 0.344 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.651 ' C ' ' H ' ' A' ' 13' ' ' ALA . 74.9 t60 -158.48 146.4 18.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.073 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.05 -31.31 0.22 Allowed 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 125.821 1.951 . . . . 0.0 109.738 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.651 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.79 0.26 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.313 -5.81 . . . . 0.0 95.313 164.957 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.073 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -117.37 -168.62 1.52 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.462 -3.517 . . . . 0.0 111.859 177.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.1 t60 33.86 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.331 178.124 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 172.13 -45.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 CA-C-O 122.058 0.933 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.13 76.34 Favored Glycine 0 C--N 1.272 -3.026 0 N-CA-C 105.812 -2.915 . . . . 0.0 105.812 175.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' C ' ' HD1' ' A' ' 18' ' ' HIS . 7.9 t-80 -93.29 -41.95 9.59 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.31 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.635 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.39 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.621 -179.379 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.62 -12.51 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.016 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.635 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.0 t -148.94 -36.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 121.284 -0.166 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.3 t-20 157.52 -46.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.79 95.8 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.713 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.432 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.4 t80 -170.32 1.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.71 179.965 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.417 ' C ' ' HD1' ' A' ' 11' ' ' HIS . 68.0 mtt-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.653 ' C ' ' H ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -90.14 146.28 24.41 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.201 -179.543 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.65 -32.47 0.23 Allowed 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 125.582 1.801 . . . . 0.0 110.18 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.86 0.39 0.38 Allowed 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 95.382 -5.784 . . . . 0.0 95.382 165.031 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.2 tttt -113.39 -169.93 1.59 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.138 -3.665 . . . . 0.0 112.169 176.546 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.682 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.0 m80 34.47 18.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.896 177.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.83 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 CA-C-O 122.284 1.04 . . . . 0.0 109.169 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.19 -14.62 78.98 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 105.516 -3.033 . . . . 0.0 105.516 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.439 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.72 -47.99 6.8 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.686 -0.757 . . . . 0.0 109.654 177.996 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 171.38 11.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.37 8.73 1.23 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 19' ' ' ALA . 57.7 t -148.04 -7.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.872 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 6.3 m-20 97.61 -36.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.605 1.191 . . . . 0.0 110.087 -179.452 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 75.4 m80 -158.43 -166.15 1.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.221 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 55.94 27.01 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 8.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.118 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.45 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 74.9 m80 -145.06 93.37 2.38 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.414 0.626 . . . . 0.0 109.638 178.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.072 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 137.45 -31.46 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -178.161 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.69 0.54 0.49 Allowed 'General case' 0 N--CA 1.413 -2.3 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 163.9 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.072 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.5 tttm -116.76 -167.89 1.37 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.383 -3.553 . . . . 0.0 111.703 177.024 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.719 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 58.1 m80 33.9 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.955 178.076 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.655 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.8 tt 171.5 -37.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.265 1.031 . . . . 0.0 109.166 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.13 -11.35 81.18 Favored Glycine 0 C--N 1.275 -2.808 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 174.119 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.444 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.3 m170 -95.86 -34.16 11.95 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.078 178.385 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.05 26.6 0.62 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.437 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.22 -11.71 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.581 ' H ' ' C ' ' A' ' 19' ' ' ALA . 90.3 t -152.96 -23.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.322 -179.31 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 38.0 t30 -170.45 -96.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.374 -179.003 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 33.4 m80 -145.51 127.2 15.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.724 -178.616 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 67.4 t80 -75.64 -4.38 39.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.124 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 10' ' ' ARG . 32.8 m80 -146.6 75.01 1.38 Allowed 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 178.642 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' H ' ' A' ' 14' ' ' LYS 0.278 . . 172.2 -32.19 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.513 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.73 -1.73 0.67 Allowed 'General case' 0 N--CA 1.416 -2.126 1 N-CA-C 95.548 -5.723 . . . . 0.0 95.548 164.827 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.029 ' H ' ' C ' ' A' ' 12' ' ' ALA 0.259 20.8 tttm -114.01 -167.74 1.25 Allowed 'General case' 0 C--N 1.387 2.217 0 CA-C-N 109.179 -3.646 . . . . 0.0 111.705 176.648 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.88 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.978 177.697 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.2 tt 174.22 -44.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.142 0.973 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.45 -13.43 81.72 Favored Glycine 0 C--N 1.273 -2.955 0 N-CA-C 105.843 -2.903 . . . . 0.0 105.843 174.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.46 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.7 -42.79 10.52 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.682 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 18' ' ' HIS . . . 156.33 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 61.68 7.56 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.053 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.6 t -144.88 -11.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -179.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 49.4 t30 119.13 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.607 1.192 . . . . 0.0 110.091 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.503 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.8 t60 -172.47 -8.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.643 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -76.06 32.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.9 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.206 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.641 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.6 t-80 -149.52 145.94 27.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.579 179.513 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.34 -31.3 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.668 1.855 . . . . 0.0 109.719 -177.859 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.641 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.64 2.24 0.3 Allowed 'General case' 0 N--CA 1.412 -2.335 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 164.896 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.04 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.2 ttpt -115.95 -168.92 1.5 Allowed 'General case' 0 C--N 1.395 2.554 0 CA-C-N 109.448 -3.524 . . . . 0.0 111.546 176.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.4 m80 34.72 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.013 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 176.06 -44.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.204 1.002 . . . . 0.0 109.46 -179.822 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.76 -14.0 81.8 Favored Glycine 0 C--N 1.273 -2.954 0 N-CA-C 105.449 -3.061 . . . . 0.0 105.449 174.43 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.408 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.43 -47.27 7.54 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.407 177.948 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.75 11.61 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.26 8.85 1.19 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.749 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 77.4 t -144.03 -9.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.113 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.7 t-20 100.15 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.525 1.141 . . . . 0.0 110.252 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.6 t60 89.4 -38.97 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.893 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -76.58 13.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.462 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.3 tt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.128 0.489 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.666 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 m170 -84.63 144.44 28.6 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.279 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.21 -32.05 0.24 Allowed 'General case' 0 CA--C 1.501 -0.922 0 O-C-N 125.403 1.689 . . . . 0.0 109.613 -177.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.666 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.07 0.5 0.4 Allowed 'General case' 0 N--CA 1.413 -2.285 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 164.855 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.031 ' H ' ' C ' ' A' ' 12' ' ' ALA . 29.4 tttt -113.87 -169.66 1.56 Allowed 'General case' 0 C--N 1.39 2.369 0 CA-C-N 109.083 -3.69 . . . . 0.0 111.974 176.432 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.9 t-80 35.16 17.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.977 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 176.19 -43.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.031 0.919 . . . . 0.0 109.465 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 -14.27 82.18 Favored Glycine 0 C--N 1.272 -3.02 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 174.336 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.418 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.94 -47.83 7.09 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.464 -0.868 . . . . 0.0 109.55 177.938 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.77 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.92 10.44 1.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.682 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 19' ' ' ALA . 98.2 t -146.57 -7.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.764 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.3 m120 97.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.567 1.167 . . . . 0.0 110.228 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 96.1 m-70 -159.34 101.78 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -55.14 -14.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.04 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 16.2 ptm180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.668 0.27 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.65 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 m-70 -155.52 145.54 21.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.932 0.396 . . . . 0.0 110.554 179.291 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.09 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.92 -31.85 0.23 Allowed 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 125.689 1.868 . . . . 0.0 109.657 -177.831 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.35 2.06 0.29 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 165.063 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.09 ' H ' ' C ' ' A' ' 12' ' ' ALA . 33.1 tttt -115.63 -169.69 1.63 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.821 177.098 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.692 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 34.3 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.792 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.62 -45.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.142 0.972 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.37 -13.94 81.21 Favored Glycine 0 C--N 1.273 -2.956 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.488 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.426 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.28 -43.91 9.52 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.85 178.159 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.617 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.24 -179.131 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.23 -17.05 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.535 -179.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.617 ' H ' ' C ' ' A' ' 19' ' ' ALA . 15.8 t -148.21 -34.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.4 t-20 154.22 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.501 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.1 t60 -168.67 113.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -56.42 -7.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.428 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.353 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.689 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.7 t-80 -111.4 146.27 37.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.662 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -30.37 0.21 Allowed 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 125.663 1.852 . . . . 0.0 109.391 -177.376 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.689 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.05 3.47 0.24 Allowed 'General case' 0 N--CA 1.41 -2.444 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.602 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 26.8 tttt -119.46 -167.49 1.42 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.605 177.424 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.3 m-70 34.31 22.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 177.705 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.8 tt 169.0 -35.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.239 1.018 . . . . 0.0 109.22 -179.293 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.91 -12.12 80.27 Favored Glycine 0 C--N 1.275 -2.814 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 174.114 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.509 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.2 t60 -93.66 -37.18 11.97 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.938 177.898 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -147.8 25.98 1.03 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.895 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 63.63 -9.25 0.14 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' H ' ' C ' ' A' ' 19' ' ' ALA . 61.4 t -151.23 -26.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.263 -179.346 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 34.3 t30 -171.18 -94.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.277 -179.173 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.557 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 0.6 OUTLIER -152.65 28.55 0.54 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.857 -179.662 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 95.8 m-85 -77.53 19.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.477 179.787 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.6 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.26 179.913 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 93.4 mtt180 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.656 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 m80 -156.52 144.52 19.52 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.504 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.86 -31.7 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.77 1.919 . . . . 0.0 109.803 -178.073 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.656 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.63 0.31 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 95.39 -5.781 . . . . 0.0 95.39 164.961 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.025 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttm -115.04 -169.22 1.51 Allowed 'General case' 0 C--N 1.395 2.553 0 CA-C-N 109.484 -3.507 . . . . 0.0 111.802 176.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.691 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 33.98 19.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.847 178.062 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.7 -46.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 CA-C-O 122.23 1.014 . . . . 0.0 109.247 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 -13.97 79.7 Favored Glycine 0 C--N 1.271 -3.042 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 174.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -90.83 -43.86 9.79 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.582 178.177 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.249 -179.178 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.33 -17.82 0.14 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.705 -179.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.6 t -149.29 -31.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 122.493 -0.13 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t-20 155.69 -47.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.804 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.645 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 9.0 t60 -163.91 -130.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.645 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.7 m-85 54.23 22.43 3.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.486 -179.854 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.543 179.96 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 CA--C 1.518 -0.271 0 CA-C-O 121.257 0.551 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.646 ' C ' ' H ' ' A' ' 13' ' ' ALA . 6.1 p-80 -169.62 143.43 2.73 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.07 179.441 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.102 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 72.0 -31.31 0.22 Allowed 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 125.632 1.833 . . . . 0.0 109.287 -177.566 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 2.65 0.25 Allowed 'General case' 0 N--CA 1.411 -2.415 1 N-CA-C 95.39 -5.782 . . . . 0.0 95.39 164.975 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.102 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.5 ttpp -116.19 -169.6 1.64 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.679 177.008 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.1 m-70 34.11 18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.904 178.154 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 175.07 -43.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.118 0.961 . . . . 0.0 109.477 179.838 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.4 83.49 Favored Glycine 0 C--N 1.274 -2.888 0 N-CA-C 105.411 -3.075 . . . . 0.0 105.411 174.425 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.427 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.37 -45.92 7.59 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 114.537 -0.832 . . . . 0.0 109.44 178.049 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.34 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.061 0.226 . . . . 0.0 110.444 -179.803 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.68 10.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.914 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ALA . 61.1 t -147.75 -8.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.981 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.4 m-20 99.47 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.609 1.193 . . . . 0.0 110.265 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 42.8 p-80 -171.94 97.91 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.803 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -76.25 9.61 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' HIS . 14.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.539 179.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.658 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.9 m80 -162.12 145.25 11.75 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.064 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.2 -31.35 0.22 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.621 1.826 . . . . 0.0 109.538 -177.752 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.45 0.26 Allowed 'General case' 0 N--CA 1.412 -2.356 1 N-CA-C 95.29 -5.818 . . . . 0.0 95.29 165.033 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.064 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.1 tttt -116.35 -169.24 1.58 Allowed 'General case' 0 C--N 1.394 2.51 0 CA-C-N 109.547 -3.478 . . . . 0.0 111.795 177.074 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.683 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.7 t60 34.65 17.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.975 178.094 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 175.43 -41.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.043 0.925 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.62 -13.02 83.94 Favored Glycine 0 C--N 1.276 -2.783 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 174.412 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.433 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.01 -43.78 8.74 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 114.439 -0.88 . . . . 0.0 109.209 178.046 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.27 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.55 10.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.06 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.1 t -145.81 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.02 -179.828 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.8 t-20 102.46 -36.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.585 1.178 . . . . 0.0 110.189 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.455 ' HD1' ' C ' ' A' ' 23' ' ' HIS . 5.4 t-80 -170.48 102.95 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.649 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 51.9 t80 -167.68 -4.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.216 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.428 ' H ' ' H ' ' A' ' 24' ' ' TYR . 2.3 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.668 ' C ' ' H ' ' A' ' 13' ' ' ALA . 51.2 t-80 -170.06 143.75 2.55 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.453 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.037 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.44 -31.45 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.596 1.81 . . . . 0.0 109.547 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.668 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.34 1.74 0.31 Allowed 'General case' 0 N--CA 1.41 -2.433 1 N-CA-C 95.386 -5.783 . . . . 0.0 95.386 164.899 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.037 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.6 tttm -115.47 -169.53 1.59 Allowed 'General case' 0 C--N 1.393 2.492 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.711 177.014 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.8 m-70 34.48 17.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.97 178.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.05 -44.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.135 0.969 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.06 -14.26 81.97 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 174.335 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -89.89 -48.12 7.43 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.246 -0.977 . . . . 0.0 109.102 177.87 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.89 13.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.49 10.85 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 94.1 t -140.23 -9.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 44.9 t-20 107.56 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.65 1.219 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 19.1 t60 80.64 34.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.035 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.47 -31.71 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.249 -179.887 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 53.8 t-80 -164.51 145.0 7.83 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.868 179.407 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -31.71 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.706 1.879 . . . . 0.0 109.99 -178.087 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 1.88 0.32 Allowed 'General case' 0 N--CA 1.413 -2.32 1 N-CA-C 95.389 -5.782 . . . . 0.0 95.389 164.922 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.515 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.71 176.895 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 41.5 m80 33.94 18.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.995 178.094 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.6 tt 175.29 -43.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-O 122.011 0.91 . . . . 0.0 109.483 179.842 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -13.89 82.68 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.325 -3.11 . . . . 0.0 105.325 174.34 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.434 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -91.25 -47.58 7.42 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 114.368 -0.916 . . . . 0.0 109.23 177.95 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.6 14.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 56.82 11.29 0.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.873 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 97.1 t -140.85 -9.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 17.8 t-20 106.85 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.603 1.19 . . . . 0.0 110.427 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 1.2 t-80 83.05 -1.09 1.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.216 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -76.38 -7.85 55.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.501 -179.99 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.443 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 77.6 mtp180 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.356 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.628 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.0 m80 -151.68 147.01 26.21 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 179.636 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.017 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.89 0.23 Allowed 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 125.678 1.861 . . . . 0.0 110.018 -178.227 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.628 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 95.426 -5.768 . . . . 0.0 95.426 165.158 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.017 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.9 tttm -115.51 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 109.409 -3.541 . . . . 0.0 111.818 177.058 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.2 t60 33.99 19.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.86 177.842 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.48 -45.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.363 -179.982 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.43 -13.99 81.28 Favored Glycine 0 C--N 1.273 -2.971 0 N-CA-C 105.406 -3.078 . . . . 0.0 105.406 174.317 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.431 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.52 9.65 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 114.495 -0.853 . . . . 0.0 109.677 178.111 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.67 41.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.176 -179.076 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.92 -19.73 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.471 -179.361 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.609 ' H ' ' C ' ' A' ' 19' ' ' ALA . 39.4 t -149.05 -31.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 156.09 -48.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 25.4 t60 -171.54 5.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 50.5 t80 -73.62 10.53 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.475 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.464 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.6 tt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.122 -179.969 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.9 mtp-105 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.914 0.387 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.653 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.8 t-80 -158.88 143.64 15.88 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.427 179.537 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.06 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.37 -31.58 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.641 1.838 . . . . 0.0 109.673 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.84 0.31 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.387 -5.782 . . . . 0.0 95.387 164.838 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.06 ' H ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.6 -169.22 1.54 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.432 -3.531 . . . . 0.0 111.658 176.936 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.695 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.7 t-80 34.98 17.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.903 177.902 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.87 -46.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.413 1.101 . . . . 0.0 109.231 -179.875 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.76 79.82 Favored Glycine 0 C--N 1.272 -3.003 0 N-CA-C 105.825 -2.91 . . . . 0.0 105.825 174.627 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.82 -44.48 8.92 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.655 -0.772 . . . . 0.0 109.128 177.917 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 162.02 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.63 8.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.165 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' ALA . 74.4 t -144.06 -9.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.386 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.0 t30 105.31 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.662 1.226 . . . . 0.0 110.14 -179.837 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.636 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 16.8 t-80 -169.38 -127.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.636 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 69.7 m-85 50.18 23.54 1.2 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.799 0.333 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.989 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.97 0.414 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.645 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.6 t-80 -169.11 145.7 3.48 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.954 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.084 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.84 -31.79 0.23 Allowed 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 125.811 1.944 . . . . 0.0 109.974 -178.306 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.645 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.74 0.3 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.327 -5.805 . . . . 0.0 95.327 165.206 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.084 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -115.94 -169.55 1.62 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.942 177.152 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.7 18.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.787 178.103 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.93 -44.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.169 0.985 . . . . 0.0 109.605 -179.871 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.91 -13.62 82.35 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 174.854 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.41 -43.19 9.35 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.831 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 160.36 11.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 11.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.697 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' H ' ' C ' ' A' ' 19' ' ' ALA . 91.4 t -145.41 -8.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.018 -179.596 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.5 m120 100.16 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.737 1.273 . . . . 0.0 110.398 -179.597 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.644 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.7 t60 -165.14 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.2 m-85 49.13 21.45 0.5 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.756 0.313 . . . . 0.0 110.671 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.466 -179.987 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.672 ' C ' ' H ' ' A' ' 13' ' ' ALA . 40.0 t60 -162.85 144.91 10.36 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 179.378 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -30.8 0.21 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.866 1.978 . . . . 0.0 109.75 -177.819 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.83 3.05 0.25 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 164.808 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.4 tttp -118.2 -168.31 1.5 Allowed 'General case' 0 C--N 1.394 2.517 0 CA-C-N 109.606 -3.452 . . . . 0.0 111.687 177.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.69 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.3 m-70 33.71 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.418 178.186 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 172.87 -43.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 179.84 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.41 78.64 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 174.703 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 22' ' ' ASN . 6.9 t-80 -92.85 -43.45 8.98 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.344 178.099 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.641 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 46.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.468 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 64.17 -18.69 0.07 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.961 -179.589 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.641 ' H ' ' C ' ' A' ' 19' ' ' ALA . 25.7 t -148.76 -32.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.03 -179.834 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.6 t-20 158.34 -49.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.607 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -171.81 62.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.394 -179.784 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -56.63 -24.33 47.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.491 -179.889 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.828 0.347 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.662 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.3 t60 -160.08 144.53 14.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.412 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.078 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.78 -29.18 0.19 Allowed 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 125.521 1.763 . . . . 0.0 109.798 -177.934 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.13 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 1 N-CA-C 94.819 -5.993 . . . . 0.0 94.819 164.293 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.078 ' H ' ' C ' ' A' ' 12' ' ' ALA . 11.6 tttt -116.96 -160.28 0.76 Allowed 'General case' 0 C--N 1.397 2.657 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.637 176.967 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.609 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.7 t60 30.62 20.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.448 0.699 . . . . 0.0 112.199 178.59 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 173.14 -48.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-O 122.435 1.112 . . . . 0.0 109.228 -179.27 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.6 -13.67 71.61 Favored Glycine 0 C--N 1.27 -3.09 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 175.297 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.403 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.95 -44.5 7.33 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 114.546 -0.827 . . . . 0.0 109.455 178.216 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.46 10.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -179.943 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.61 7.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.981 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.5 t -144.75 -8.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.919 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 61.5 t30 102.18 -37.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.525 1.141 . . . . 0.0 110.4 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -173.8 78.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 54.3 t80 -72.88 -19.08 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.502 179.828 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.433 179.947 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.08 0.467 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.672 ' C ' ' H ' ' A' ' 13' ' ' ALA . 38.8 t-80 -165.71 143.02 5.59 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.702 179.454 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.043 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 72.01 -30.92 0.22 Allowed 'General case' 0 CA--C 1.497 -1.069 0 O-C-N 125.632 1.833 . . . . 0.0 109.212 -177.513 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.3 0.29 Allowed 'General case' 0 N--CA 1.41 -2.467 1 N-CA-C 95.273 -5.825 . . . . 0.0 95.273 164.848 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.043 ' H ' ' C ' ' A' ' 12' ' ' ALA . 2.3 ttpm? -116.86 -169.43 1.64 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.497 -3.502 . . . . 0.0 111.621 177.056 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.698 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 48.6 t-80 33.97 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.82 177.702 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.85 -37.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.256 1.027 . . . . 0.0 109.423 -179.363 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.33 -11.29 80.8 Favored Glycine 0 C--N 1.275 -2.853 0 N-CA-C 105.029 -3.228 . . . . 0.0 105.029 174.074 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.439 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.47 -35.87 12.74 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.776 178.212 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.42 26.76 0.59 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.641 -179.619 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 62.27 -8.18 0.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.567 179.025 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 19' ' ' ALA . 60.5 t -151.48 -25.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.254 -179.355 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -171.45 -94.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.312 -179.272 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' C ' ' H ' ' A' ' 25' ' ' LEU . 13.8 t-160 -158.86 17.98 0.19 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.448 -179.589 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -70.96 8.33 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 23' ' ' HIS . 16.3 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.217 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.842 0.353 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.655 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 t60 -151.64 145.44 25.08 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.659 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.082 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.93 -31.71 0.23 Allowed 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.734 1.896 . . . . 0.0 109.848 -178.008 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.91 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.422 -5.77 . . . . 0.0 95.422 165.085 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.082 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.51 -169.18 1.53 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.424 -3.534 . . . . 0.0 111.744 177.081 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.7 t60 33.92 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.816 177.966 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.24 -46.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.288 1.042 . . . . 0.0 109.306 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.61 -14.01 79.94 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 174.517 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.452 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.02 9.99 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.624 178.21 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.28 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.251 -179.054 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.48 -18.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.523 -179.435 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.606 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.9 t -148.29 -32.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.908 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 155.19 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.982 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.437 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -164.2 65.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.621 -179.866 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.42 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 62.0 t80 -50.84 -14.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.849 0.356 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.654 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.2 t60 -163.61 146.15 9.77 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.376 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.092 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.83 -31.62 0.23 Allowed 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 125.775 1.922 . . . . 0.0 109.956 -178.072 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.654 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.13 0.29 Allowed 'General case' 0 N--CA 1.411 -2.385 1 N-CA-C 95.341 -5.8 . . . . 0.0 95.341 164.995 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.092 ' H ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.96 -169.33 1.58 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.825 177.012 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.0 t60 33.95 18.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.991 178.169 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.18 -42.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 CA-C-O 122.093 0.949 . . . . 0.0 109.459 179.817 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.39 -13.29 83.72 Favored Glycine 0 C--N 1.276 -2.77 0 N-CA-C 105.355 -3.098 . . . . 0.0 105.355 174.168 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.425 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -94.01 -46.46 7.14 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.615 178.15 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 170.4 10.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.63 -179.764 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.426 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.15 10.36 1.21 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.722 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 66.0 t -148.87 -8.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.628 -179.723 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.0 m120 96.48 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.545 1.153 . . . . 0.0 110.169 -179.555 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -172.54 93.15 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.524 179.969 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.47 11.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.836 -179.812 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.697 0.284 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -79.13 72.93 5.7 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.986 0.898 . . . . 0.0 110.056 -179.915 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.975 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.276 . . 174.81 -32.06 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 112.635 -2.075 . . . . 0.0 106.782 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -2.62 0.79 Allowed 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 164.663 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.975 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.252 20.5 tttm -112.75 -168.13 1.28 Allowed 'General case' 0 C--N 1.389 2.314 0 CA-C-N 109.206 -3.634 . . . . 0.0 112.13 176.515 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.707 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 44.9 m80 34.23 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.812 177.879 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 175.47 -47.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.855 0 CA-C-O 122.269 1.033 . . . . 0.0 109.158 -179.749 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.88 -14.15 78.56 Favored Glycine 0 C--N 1.274 -2.903 0 N-CA-C 105.636 -2.985 . . . . 0.0 105.636 174.736 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.451 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.92 -44.02 9.63 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.673 178.059 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.14 42.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.321 -179.084 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.81 -15.9 0.11 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.602 -179.435 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.631 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.4 t -148.79 -35.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.9 t30 154.78 -44.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.911 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.6 t60 -168.83 50.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.519 -179.88 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -64.52 -28.34 69.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.228 -179.924 . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 79.4 mtt-85 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.662 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.8 m80 -157.53 144.04 17.92 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.369 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.096 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.5 -31.23 0.22 Allowed 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 125.603 1.814 . . . . 0.0 109.485 -177.823 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.41 1.87 0.31 Allowed 'General case' 0 N--CA 1.41 -2.428 1 N-CA-C 95.35 -5.796 . . . . 0.0 95.35 164.981 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.096 ' H ' ' C ' ' A' ' 12' ' ' ALA . 13.9 ttpt -115.54 -169.58 1.61 Allowed 'General case' 0 C--N 1.394 2.519 0 CA-C-N 109.399 -3.546 . . . . 0.0 111.655 177.012 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.677 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.7 t-80 34.44 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.079 178.092 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tp 176.33 -46.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.643 0 CA-C-O 122.371 1.082 . . . . 0.0 109.074 -179.924 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.55 -14.69 77.53 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 174.409 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -89.62 -48.71 7.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.325 -0.938 . . . . 0.0 108.885 177.823 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.4 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.995 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.18 9.99 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.938 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.3 t -139.07 -10.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.774 -179.698 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.0 t-20 108.44 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.63 1.206 . . . . 0.0 110.586 179.855 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 8.8 t60 80.08 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.171 -179.61 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -79.54 -15.76 57.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.746 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.401 -179.683 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' H ' ' H ' ' A' ' 11' ' ' HIS . 9.3 ptm180 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.955 0.407 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.652 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 t-80 -102.91 147.49 26.85 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.289 179.454 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.119 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.52 -31.57 0.22 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.716 1.885 . . . . 0.0 110.099 -178.085 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.652 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.89 0.31 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.318 -5.808 . . . . 0.0 95.318 165.052 . . . . . . . . 3 3 . 1 . 052 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.119 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.6 tttm -116.23 -169.0 1.53 Allowed 'General case' 0 C--N 1.393 2.473 0 CA-C-N 109.315 -3.584 . . . . 0.0 111.773 176.971 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 75.0 t60 35.02 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.784 177.96 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 174.64 -42.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.044 0.926 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.52 -13.36 83.52 Favored Glycine 0 C--N 1.275 -2.859 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.645 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.79 -44.2 7.88 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 114.634 -0.783 . . . . 0.0 109.738 178.189 . . . . . . . . 3 3 . 1 . 052 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.26 12.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.501 -179.878 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.17 9.15 0.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.098 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ALA . 54.4 t -147.91 -9.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.142 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.5 t-20 101.79 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.544 1.152 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 35.6 m80 -160.58 109.67 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.466 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 77.8 t80 -74.13 11.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.295 179.64 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.1 tp . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.652 ' C ' ' H ' ' A' ' 13' ' ' ALA . 31.1 m-70 -90.96 145.02 25.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.933 179.996 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.12 -31.9 0.23 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.635 1.834 . . . . 0.0 109.99 -178.138 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.652 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.19 0.93 0.36 Allowed 'General case' 0 N--CA 1.412 -2.33 1 N-CA-C 95.297 -5.816 . . . . 0.0 95.297 164.978 . . . . . . . . 3 3 . 1 . 053 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.8 tttt -114.47 -169.4 1.53 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.24 -3.618 . . . . 0.0 111.87 176.621 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.6 m80 34.92 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.922 177.999 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 175.58 -43.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.114 0.959 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.72 -13.41 83.06 Favored Glycine 0 C--N 1.272 -2.977 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 174.668 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.33 -43.64 9.15 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.062 177.944 . . . . . . . . 3 3 . 1 . 053 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.23 12.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.958 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.13 8.29 1.02 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.7 t -145.83 -8.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.128 -179.844 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.7 t30 103.99 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.502 1.126 . . . . 0.0 109.996 -179.739 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -173.26 103.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.479 179.743 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.438 ' H ' ' H ' ' A' ' 25' ' ' LEU . 84.1 t80 -171.58 -7.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.938 179.897 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' H ' ' A' ' 24' ' ' TYR . 34.4 mt . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 179.812 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.988 0.423 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.664 ' C ' ' H ' ' A' ' 13' ' ' ALA . 92.6 m-70 -140.62 145.41 36.61 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.449 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.67 -31.54 0.23 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.584 1.803 . . . . 0.0 109.571 -177.786 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.664 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.1 0.28 Allowed 'General case' 0 N--CA 1.412 -2.334 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 164.951 . . . . . . . . 3 3 . 1 . 054 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.061 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.14 -169.24 1.57 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.395 -3.548 . . . . 0.0 111.585 177.062 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.9 t-80 34.67 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.028 178.066 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 175.78 -42.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.159 0.98 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.41 -13.57 83.25 Favored Glycine 0 C--N 1.275 -2.824 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 174.278 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.1 -46.01 8.36 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.299 -0.95 . . . . 0.0 109.066 177.957 . . . . . . . . 3 3 . 1 . 054 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.49 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.845 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.11 9.32 0.94 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.103 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 89.5 t -142.83 -9.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.367 -179.843 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 25.7 t30 105.44 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.581 1.176 . . . . 0.0 110.104 -179.954 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.581 ' ND1' ' N ' ' A' ' 24' ' ' TYR . 49.8 t-80 -162.19 -100.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.581 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 62.3 t80 51.97 14.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' HIS . 13.0 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -179.989 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.736 0.303 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.642 ' C ' ' H ' ' A' ' 13' ' ' ALA . 37.5 m80 -135.42 146.29 48.13 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.518 179.663 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.104 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.65 -31.1 0.21 Allowed 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.691 1.869 . . . . 0.0 109.761 -177.985 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.642 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.59 2.07 0.31 Allowed 'General case' 0 N--CA 1.411 -2.384 1 N-CA-C 95.381 -5.785 . . . . 0.0 95.381 164.85 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.104 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.8 tttp -116.11 -168.95 1.51 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.486 -3.506 . . . . 0.0 111.627 176.941 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.679 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.2 m80 34.56 18.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.945 178.079 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.89 -42.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.096 0.95 . . . . 0.0 109.628 179.923 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.51 -12.74 84.24 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.545 -3.022 . . . . 0.0 105.545 174.457 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.482 ' CE1' ' HZ3' ' A' ' 14' ' ' LYS . 1.2 m170 -93.63 -44.19 8.31 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.258 177.969 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.99 10.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.31 10.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.829 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ALA . 97.5 t -147.78 -8.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.046 -179.58 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.6 m120 98.13 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.581 1.175 . . . . 0.0 110.192 -179.512 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 84.3 m-70 -157.84 107.67 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.436 -179.925 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -61.25 -13.63 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.994 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.001 -179.969 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.341 0.115 . . . . 0.0 110.811 . . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -115.96 71.69 0.79 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.922 0.868 . . . . 0.0 110.333 179.388 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.02 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 168.73 -31.9 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.503 -2.135 . . . . 0.0 105.85 -179.655 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.75 -2.29 0.8 Allowed 'General case' 0 N--CA 1.414 -2.256 1 N-CA-C 95.458 -5.756 . . . . 0.0 95.458 164.313 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.02 ' N ' ' C ' ' A' ' 12' ' ' ALA . 35.0 tttt -112.84 -168.56 1.34 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 109.277 -3.601 . . . . 0.0 111.83 176.408 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.718 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.6 t-80 34.52 17.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.004 178.04 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.52 -44.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-O 122.124 0.964 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.19 -13.63 82.6 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 174.56 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.55 -44.79 9.34 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.683 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 162.44 11.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.786 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.31 11.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.684 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ALA . 97.9 t -144.73 -8.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.9 m120 100.68 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.768 1.293 . . . . 0.0 110.698 -179.837 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 90.8 m-70 -158.09 -94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 62.2 t80 57.25 8.52 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.652 -179.822 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 23' ' ' HIS . 16.2 tp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.336 179.876 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.94 0.4 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.676 ' H ' ' HD1' ' A' ' 11' ' ' HIS . 1.2 p-80 -140.12 145.19 37.28 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 179.812 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.56 -29.6 0.19 Allowed 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 125.513 1.758 . . . . 0.0 110.117 -178.336 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.43 1.15 0.57 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 94.73 -6.026 . . . . 0.0 94.73 164.382 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 7.5 ttmt -114.71 -158.51 0.67 Allowed 'General case' 0 C--N 1.397 2.644 0 CA-C-N 109.286 -3.597 . . . . 0.0 110.106 176.268 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.0 t60 28.41 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 112.262 177.955 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 168.33 -52.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-O 122.463 1.125 . . . . 0.0 109.224 -179.143 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.05 -12.8 63.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 176.034 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -32.85 16.87 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.375 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.457 ' CB ' ' N ' ' A' ' 24' ' ' TYR . . . -167.56 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.51 -21.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.878 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.445 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 60.2 t -151.98 -18.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.025 179.905 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 166.35 -39.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.547 0.529 . . . . 0.0 110.045 -179.785 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.652 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -160.95 126.58 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 111.291 -178.616 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 75.2 t80 -66.92 -5.1 11.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.06 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 23' ' ' HIS . 20.2 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.469 179.91 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 12.7 ptm180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.844 0.354 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.671 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.5 m80 -158.48 145.22 17.45 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 179.412 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.09 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -30.94 0.22 Allowed 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 125.698 1.874 . . . . 0.0 109.535 -177.729 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.8 2.82 0.26 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.78 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.09 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -117.52 -168.5 1.5 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.562 -3.472 . . . . 0.0 111.689 177.159 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.691 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 37.8 m80 34.09 20.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.917 178.09 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.663 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 174.35 -42.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 122.339 1.066 . . . . 0.0 108.831 179.713 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.31 -13.05 83.99 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 105.687 -2.965 . . . . 0.0 105.687 174.398 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 22' ' ' ASN . 4.5 m170 -103.02 -7.66 21.24 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.023 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 82.53 22.04 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.239 -179.123 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.65 14.19 0.16 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.874 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.2 t -151.58 -11.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.623 -179.119 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.605 HD21 ' HD1' ' A' ' 23' ' ' HIS . 0.9 OUTLIER 104.79 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.282 0.989 . . . . 0.0 110.473 -179.657 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.605 ' HD1' HD21 ' A' ' 22' ' ' ASN . 34.2 p-80 -169.79 117.51 0.59 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -67.6 -0.99 4.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.225 179.65 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' HIS . 33.9 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.378 179.892 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.44 ' H ' ' H ' ' A' ' 11' ' ' HIS . 59.3 ttt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.033 0.445 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.666 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.2 t-80 -151.2 143.67 24.24 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.232 179.264 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.9 -31.34 0.22 Allowed 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.624 1.828 . . . . 0.0 109.436 -177.583 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.666 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.69 2.49 0.29 Allowed 'General case' 0 N--CA 1.412 -2.374 1 N-CA-C 95.431 -5.766 . . . . 0.0 95.431 164.844 . . . . . . . . 3 3 . 1 . 059 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.025 ' H ' ' C ' ' A' ' 12' ' ' ALA . 15.3 ttpt -116.65 -169.01 1.55 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.455 -3.52 . . . . 0.0 111.456 176.97 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.699 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.2 m80 34.25 20.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.79 177.9 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.659 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.21 -37.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-O 122.364 1.078 . . . . 0.0 109.316 -179.311 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.51 -11.1 80.74 Favored Glycine 0 C--N 1.277 -2.745 0 N-CA-C 105.088 -3.205 . . . . 0.0 105.088 174.082 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.461 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -94.99 -33.94 12.55 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.407 -0.896 . . . . 0.0 109.973 178.275 . . . . . . . . 3 3 . 1 . 059 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.47 23.74 0.71 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.834 -178.968 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.01 -0.34 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.244 179.322 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.589 ' H ' ' C ' ' A' ' 19' ' ' ALA . 45.0 t -152.48 -27.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 121.5 -0.08 . . . . 0.0 110.952 -179.41 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER 176.17 -85.94 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 111.554 -179.354 . . . . . . . . 3 3 . 1 . 059 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.659 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 35.2 m80 -146.95 126.05 12.9 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 -178.837 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 75.4 t80 -73.72 -3.92 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.187 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.332 -0.196 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.495 179.903 . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.372 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.632 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t-80 -161.9 146.81 12.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.565 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.092 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.72 -31.82 0.23 Allowed 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 125.775 1.922 . . . . 0.0 110.043 -178.271 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.632 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.1 0.29 Allowed 'General case' 0 N--CA 1.413 -2.302 1 N-CA-C 95.342 -5.799 . . . . 0.0 95.342 165.157 . . . . . . . . 3 3 . 1 . 060 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.092 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.5 tttt -116.17 -168.95 1.52 Allowed 'General case' 0 C--N 1.393 2.46 0 CA-C-N 109.502 -3.499 . . . . 0.0 111.648 177.018 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 34.33 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.885 177.983 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 174.6 -43.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.137 0.97 . . . . 0.0 109.547 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.36 -13.22 83.58 Favored Glycine 0 C--N 1.274 -2.862 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 174.47 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.423 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.2 m170 -93.25 -45.06 8.02 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.176 177.964 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.18 13.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.86 9.54 0.91 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.131 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 19' ' ' ALA . 83.3 t -146.37 -9.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.332 -179.762 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 40.9 t-20 103.2 -36.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.511 1.132 . . . . 0.0 110.066 -179.784 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 91.1 m-70 -160.43 106.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 67.6 t80 -59.72 -15.09 17.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 10.2 mpt_? . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.726 0.298 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.476 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 79.2 m-70 -153.28 94.82 1.87 Allowed 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.239 0.543 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.032 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 132.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.03 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 0.23 0.55 Allowed 'General case' 0 N--CA 1.413 -2.297 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.649 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.032 ' H ' ' C ' ' A' ' 12' ' ' ALA . 28.6 tttt -115.89 -168.34 1.41 Allowed 'General case' 0 C--N 1.393 2.479 0 CA-C-N 109.504 -3.498 . . . . 0.0 111.641 176.885 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.705 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 94.3 m-70 33.73 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.836 178.257 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.78 -43.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.089 0.947 . . . . 0.0 109.596 179.88 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.35 -13.29 83.5 Favored Glycine 0 C--N 1.274 -2.893 0 N-CA-C 105.582 -3.007 . . . . 0.0 105.582 174.67 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.41 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.97 -44.76 7.91 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-N 114.538 -0.831 . . . . 0.0 109.335 177.947 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.22 10.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.899 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.75 10.7 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.839 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' ALA . 77.3 t -146.94 -8.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.848 -179.682 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.8 m-20 98.61 -36.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.729 1.268 . . . . 0.0 110.104 -179.539 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.6 p-80 -173.18 101.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 74.9 t80 -62.41 -10.13 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.485 179.996 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.061 -179.941 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.033 0.444 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 67.6 m-70 -143.53 146.1 33.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.767 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.062 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.5 -29.88 0.19 Allowed 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 125.59 1.806 . . . . 0.0 110.237 -178.506 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.26 1.08 0.54 Allowed 'General case' 0 N--CA 1.411 -2.412 1 N-CA-C 94.814 -5.995 . . . . 0.0 94.814 164.541 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.062 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.9 tttm -115.11 -158.86 0.69 Allowed 'General case' 0 C--N 1.394 2.527 0 CA-C-N 109.149 -3.659 . . . . 0.0 110.175 176.397 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.7 t60 29.04 23.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 112.187 177.692 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 167.43 -52.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 CA-C-O 122.369 1.081 . . . . 0.0 109.194 -179.067 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.73 63.3 Favored Glycine 0 C--N 1.269 -3.14 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.185 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.92 -33.05 16.57 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.36 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.85 -65.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.788 179.529 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.29 -22.33 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.878 -179.693 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 t -150.6 -18.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 170.03 -38.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.237 0.336 . . . . 0.0 110.274 -179.687 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 27.3 t60 -171.72 -136.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.109 -178.99 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.62 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 76.5 m-85 53.14 27.11 5.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.0 110.765 179.773 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.036 179.993 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.04 0.448 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.627 ' C ' ' H ' ' A' ' 13' ' ' ALA . 54.0 t-80 -153.52 147.84 25.9 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.135 0.493 . . . . 0.0 110.909 179.583 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.054 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.34 -31.71 0.22 Allowed 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.905 2.003 . . . . 0.0 110.211 -178.25 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.316 1 N-CA-C 95.344 -5.799 . . . . 0.0 95.344 165.152 . . . . . . . . 3 3 . 1 . 063 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.054 ' N ' ' C ' ' A' ' 12' ' ' ALA . 19.6 tttm -116.49 -168.73 1.49 Allowed 'General case' 0 C--N 1.392 2.423 0 CA-C-N 109.44 -3.527 . . . . 0.0 111.592 177.124 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.6 t60 34.75 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.834 177.881 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 174.25 -44.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 122.116 0.96 . . . . 0.0 109.633 -179.84 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.89 -13.68 82.27 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.681 -2.968 . . . . 0.0 105.681 174.718 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.67 -45.58 7.64 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 114.515 -0.843 . . . . 0.0 109.309 178.089 . . . . . . . . 3 3 . 1 . 063 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.71 13.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.79 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.69 7.16 0.99 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.272 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 61.2 t -145.41 -9.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.493 -179.868 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 10.4 t-20 105.37 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.479 1.112 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.612 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 1.8 t60 -171.49 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.313 179.903 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.612 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.4 m-85 49.24 18.76 0.27 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 110.597 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.192 -179.973 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.966 0.412 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -148.14 72.76 1.23 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.289 1.042 . . . . 0.0 110.173 178.987 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.043 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.274 . . 172.98 -30.82 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 112.133 -2.303 . . . . 0.0 106.179 179.966 . . . . . . . . 3 3 . 1 . 064 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -0.73 0.55 Allowed 'General case' 0 N--CA 1.415 -2.192 1 N-CA-C 95.502 -5.74 . . . . 0.0 95.502 164.354 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.043 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.255 19.6 tttp -116.43 -167.06 1.22 Allowed 'General case' 0 C--N 1.389 2.285 0 CA-C-N 109.258 -3.61 . . . . 0.0 111.716 177.112 . . . . . . . . 3 3 . 1 . 064 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.704 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.2 t60 34.73 18.99 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.875 177.862 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.84 -40.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 CA-C-O 122.141 0.972 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.15 83.61 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 105.596 -3.002 . . . . 0.0 105.596 174.487 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.476 ' O ' ' CA ' ' A' ' 22' ' ' ASN . 5.5 m170 -103.64 -7.65 20.56 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.978 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 84.52 20.3 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.389 -179.296 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.18 14.41 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 84.5 t -152.43 -10.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.455 -178.966 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.2 t-20 101.05 -34.84 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.14 0.9 . . . . 0.0 109.956 -179.308 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -171.57 101.5 0.19 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.602 -179.83 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -163.25 -1.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.287 179.845 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.251 179.819 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' NH2' ' NE2' ' A' ' 11' ' ' HIS . 45.1 ttp85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.133 0.492 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.647 ' C ' ' H ' ' A' ' 13' ' ' ALA . 82.9 m-70 -146.95 147.17 30.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.423 179.577 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.996 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.21 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.727 1.892 . . . . 0.0 109.986 -178.121 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.647 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.94 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.434 -5.765 . . . . 0.0 95.434 165.194 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.996 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.3 tttp -116.04 -169.49 1.61 Allowed 'General case' 0 C--N 1.392 2.442 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.629 177.146 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.8 t60 34.89 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.946 177.861 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 175.62 -42.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.178 0.99 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.99 -13.39 83.73 Favored Glycine 0 C--N 1.276 -2.801 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 174.238 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.526 ' CE1' ' HZ3' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -91.19 -45.77 8.46 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 114.454 -0.873 . . . . 0.0 109.001 177.884 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.21 13.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.841 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.29 9.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.24 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ALA . 63.8 t -145.31 -8.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.335 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.6 t30 102.96 -36.28 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.526 1.142 . . . . 0.0 109.746 -179.49 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -172.52 97.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.483 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 60.1 t80 -163.67 -0.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.387 -179.925 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' H ' ' H ' ' A' ' 24' ' ' TYR . 13.1 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.615 179.965 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.856 0.36 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.9 m80 -151.54 146.24 25.74 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.712 179.657 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.089 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -31.92 0.24 Allowed 'General case' 0 CA--C 1.498 -1.058 0 O-C-N 125.757 1.911 . . . . 0.0 109.839 -178.004 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.64 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.51 2.37 0.28 Allowed 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 95.441 -5.763 . . . . 0.0 95.441 165.142 . . . . . . . . 3 3 . 1 . 066 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.089 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -116.58 -169.07 1.56 Allowed 'General case' 0 C--N 1.391 2.407 0 CA-C-N 109.445 -3.525 . . . . 0.0 111.697 177.055 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.7 m80 33.92 21.23 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.788 177.598 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 170.21 -37.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.292 1.044 . . . . 0.0 109.33 -179.458 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.84 -11.64 81.17 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.052 -3.219 . . . . 0.0 105.052 174.07 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.471 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -93.54 -36.17 12.55 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 114.277 -0.961 . . . . 0.0 109.981 178.267 . . . . . . . . 3 3 . 1 . 066 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.578 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.2 26.18 0.7 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.643 -179.58 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.41 -7.69 0.1 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.054 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' A' ' 19' ' ' ALA . 52.3 t -151.08 -24.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.353 -179.413 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 4.7 p30 -177.02 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.368 -179.291 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.631 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.0 t-160 -158.2 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.362 -179.461 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.631 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 86.2 m-85 48.79 17.44 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.319 . . . . 0.0 110.721 179.793 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.407 ' N ' ' C ' ' A' ' 23' ' ' HIS . 12.0 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.465 179.998 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 52.3 ttt180 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.402 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.63 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.6 m-70 -137.25 147.64 45.9 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 179.666 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.141 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.82 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.809 1.943 . . . . 0.0 109.996 -178.073 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.63 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.27 0.29 Allowed 'General case' 0 N--CA 1.412 -2.357 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.033 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.141 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.6 tttm -116.2 -169.29 1.58 Allowed 'General case' 0 C--N 1.392 2.414 0 CA-C-N 109.476 -3.511 . . . . 0.0 111.718 177.032 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.6 t-80 34.55 18.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.896 177.984 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.09 -42.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.123 0.963 . . . . 0.0 109.707 180.0 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.96 -13.68 83.41 Favored Glycine 0 C--N 1.276 -2.8 0 N-CA-C 105.433 -3.067 . . . . 0.0 105.433 174.229 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -95.09 -47.04 6.55 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.422 -0.889 . . . . 0.0 110.002 178.207 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 170.62 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.741 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.03 8.42 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.24 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 64.6 t -145.89 -9.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.171 179.967 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.06 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.657 1.223 . . . . 0.0 110.281 -179.98 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -167.93 94.88 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.493 -179.908 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 58.9 t80 -162.95 0.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.242 179.996 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.405 ' H ' ' H ' ' A' ' 24' ' ' TYR . 1.9 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.803 0.335 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.643 ' C ' ' H ' ' A' ' 13' ' ' ALA . 57.8 t-80 -159.78 146.35 16.2 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.722 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.05 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.7 -31.7 0.23 Allowed 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 125.712 1.883 . . . . 0.0 110.02 -178.219 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.411 -2.394 1 N-CA-C 95.397 -5.779 . . . . 0.0 95.397 165.071 . . . . . . . . 3 3 . 1 . 068 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.05 ' H ' ' C ' ' A' ' 12' ' ' ALA . 31.0 tttt -115.98 -169.21 1.55 Allowed 'General case' 0 C--N 1.394 2.524 0 CA-C-N 109.345 -3.571 . . . . 0.0 111.818 177.091 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.692 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m80 34.43 18.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.846 178.144 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.64 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 CA-C-O 122.068 0.937 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.0 -13.66 82.47 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.72 -2.952 . . . . 0.0 105.72 174.781 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.417 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.83 -44.53 8.44 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.162 177.964 . . . . . . . . 3 3 . 1 . 068 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.46 11.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.994 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.51 10.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 93.1 t -145.68 -8.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.876 -179.549 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.7 m-20 99.04 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.72 1.263 . . . . 0.0 110.239 -179.622 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -168.64 97.23 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.473 179.968 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 24' ' ' TYR . 51.4 t80 -165.89 0.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.308 -179.886 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -179.98 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.494 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 13.0 ptm180 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.732 0.301 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.684 ' C ' ' H ' ' A' ' 13' ' ' ALA . 65.4 m-70 -148.25 144.89 27.96 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.493 179.481 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.077 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.46 -28.96 0.18 Allowed 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 125.632 1.832 . . . . 0.0 109.777 -177.989 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.684 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.33 2.08 0.43 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 94.793 -6.003 . . . . 0.0 94.793 164.209 . . . . . . . . 3 3 . 1 . 069 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.077 ' H ' ' C ' ' A' ' 12' ' ' ALA . 6.0 ttmt -116.68 -160.65 0.77 Allowed 'General case' 0 C--N 1.398 2.686 0 CA-C-N 109.314 -3.585 . . . . 0.0 110.647 177.062 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.1 t-80 30.16 21.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 112.222 178.659 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 173.17 -47.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-O 122.231 1.015 . . . . 0.0 109.509 -179.453 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.53 -13.73 74.49 Favored Glycine 0 C--N 1.271 -3.077 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 175.107 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.53 -46.39 6.36 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 114.432 -0.884 . . . . 0.0 109.775 178.366 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.96 11.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.632 -179.744 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.19 8.27 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.042 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 44.6 t -148.23 -9.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.883 179.948 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.5 t-20 100.47 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.515 1.134 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.502 ' C ' ' H ' ' A' ' 25' ' ' LEU . 78.6 m80 -159.74 120.56 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.668 -179.622 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -55.57 -10.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.13 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.1 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.8 t-80 -156.12 145.08 20.42 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 179.515 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.091 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.85 -30.91 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.736 1.898 . . . . 0.0 109.801 -177.948 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.13 0.3 Allowed 'General case' 0 N--CA 1.41 -2.438 1 N-CA-C 95.288 -5.819 . . . . 0.0 95.288 164.749 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.091 ' H ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.13 -168.56 1.45 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.473 -3.512 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.674 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.0 m80 34.3 18.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.844 178.144 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.3 -46.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.21 1.005 . . . . 0.0 109.381 -179.624 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.02 -13.64 80.85 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.523 -3.031 . . . . 0.0 105.523 174.697 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.405 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.59 -43.59 9.56 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.606 178.2 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.629 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.252 -179.122 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.14 -16.15 0.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.676 -179.445 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.629 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.2 t -148.91 -35.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.931 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 156.03 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.782 0.676 . . . . 0.0 109.223 -179.953 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 37.9 t-80 -162.34 29.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.696 -179.695 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD2' ' O ' ' A' ' 24' ' ' TYR . 64.1 t80 -77.0 -7.02 54.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.476 -179.881 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.2 t-80 -158.21 145.81 18.23 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.033 0.444 . . . . 0.0 110.915 179.564 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.086 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.91 -31.92 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.721 1.888 . . . . 0.0 109.975 -178.175 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.64 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.91 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.405 -5.776 . . . . 0.0 95.405 165.09 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.086 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttp -115.48 -169.6 1.61 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.436 -3.529 . . . . 0.0 111.806 176.953 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.0 t-80 34.47 18.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.015 178.021 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 176.13 -45.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.31 1.052 . . . . 0.0 109.089 -179.932 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.0 81.54 Favored Glycine 0 C--N 1.273 -2.968 0 N-CA-C 105.499 -3.04 . . . . 0.0 105.499 174.28 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.606 ' CE1' ' HZ1' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -91.51 -47.01 7.66 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.154 178.005 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.88 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.876 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.71 8.1 1.23 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.215 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ALA . 56.3 t -144.88 -8.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.217 -179.953 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.17 -36.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.639 1.212 . . . . 0.0 110.222 -179.772 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 31.9 m80 -155.26 -168.56 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 65.28 25.83 12.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.471 179.709 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.646 ' C ' ' H ' ' A' ' 13' ' ' ALA . 79.7 t60 -164.71 142.03 6.32 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 179.615 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.073 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.53 -32.14 0.23 Allowed 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 125.668 1.855 . . . . 0.0 109.805 -178.188 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.26 1.4 0.33 Allowed 'General case' 0 N--CA 1.41 -2.47 1 N-CA-C 95.444 -5.762 . . . . 0.0 95.444 165.003 . . . . . . . . 3 3 . 1 . 072 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.073 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.7 tttp -114.33 -169.59 1.56 Allowed 'General case' 0 C--N 1.396 2.617 0 CA-C-N 109.48 -3.509 . . . . 0.0 111.842 176.98 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.1 t60 33.21 20.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.853 177.953 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 173.85 -47.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.695 0 CA-C-O 122.187 0.994 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.86 -14.49 78.39 Favored Glycine 0 C--N 1.271 -3.064 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 174.331 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' CD2' ' HZ2' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -87.59 -46.43 9.55 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.283 177.983 . . . . . . . . 3 3 . 1 . 072 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.38 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.266 -179.386 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.64 -14.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.863 -179.666 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.2 t -149.34 -29.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 121.422 -0.111 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.8 t-20 148.56 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.944 0.777 . . . . 0.0 109.148 -179.728 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -170.28 64.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.403 -179.762 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -71.29 -19.55 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.62 -179.94 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.099 179.946 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.638 ' C ' ' H ' ' A' ' 13' ' ' ALA . 4.9 p-80 -163.92 143.34 7.96 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.768 179.385 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.064 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.27 -31.92 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.76 1.912 . . . . 0.0 109.982 -178.207 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.638 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.36 1.67 0.32 Allowed 'General case' 0 N--CA 1.411 -2.41 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 165.066 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.064 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.31 -168.95 1.48 Allowed 'General case' 0 C--N 1.394 2.54 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.877 176.973 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.692 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 74.6 t60 34.31 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.795 177.861 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tt 174.29 -46.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 CA-C-O 122.24 1.019 . . . . 0.0 109.363 -179.855 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.36 -13.92 79.6 Favored Glycine 0 C--N 1.271 -3.051 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.737 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.436 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.89 -44.27 9.49 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.66 -0.77 . . . . 0.0 109.533 178.071 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.612 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.57 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.859 -0.737 . . . . 0.0 112.145 -179.311 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.51 -20.42 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.358 -179.206 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.612 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.2 t -149.6 -31.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.655 ' ND2' ' HD1' ' A' ' 15' ' ' HIS . 11.6 m-20 157.64 -48.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.62 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 25' ' ' LEU . 74.4 t60 -169.61 3.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.699 -179.735 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -76.65 40.84 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.58 -179.98 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.422 179.92 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.126 0.488 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.666 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.0 t60 -150.39 143.72 25.01 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.633 179.461 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.79 -29.52 0.19 Allowed 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 125.641 1.838 . . . . 0.0 109.766 -177.987 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.666 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.02 0.43 Allowed 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 94.879 -5.971 . . . . 0.0 94.879 164.463 . . . . . . . . 3 3 . 1 . 074 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.8 tttp -116.76 -161.11 0.79 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.266 -3.606 . . . . 0.0 110.549 177.005 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.614 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 30.92 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.852 0.72 . . . . 0.0 112.238 178.34 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.722 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.7 tt 172.75 -47.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 CA-C-O 122.226 1.012 . . . . 0.0 109.513 -179.446 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.66 74.62 Favored Glycine 0 C--N 1.271 -3.062 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 175.268 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 2.0 m170 -95.96 -45.18 7.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.443 178.181 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' CB ' ' H ' ' A' ' 24' ' ' TYR . . . 164.99 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.862 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.18 7.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.289 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -146.44 -9.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.863 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.6 t30 104.53 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.491 1.119 . . . . 0.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -173.36 80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.451 179.974 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.546 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 63.2 t80 -84.64 -13.96 50.02 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.942 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 179.938 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.666 0.269 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.645 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.4 t60 -159.11 146.98 17.68 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.052 0.453 . . . . 0.0 110.857 179.305 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.107 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.04 -31.94 0.24 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.755 1.91 . . . . 0.0 110.007 -178.239 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.645 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.3 1.92 0.29 Allowed 'General case' 0 N--CA 1.413 -2.323 1 N-CA-C 95.445 -5.761 . . . . 0.0 95.445 165.132 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.107 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttm -115.8 -169.33 1.57 Allowed 'General case' 0 C--N 1.393 2.478 0 CA-C-N 109.363 -3.562 . . . . 0.0 111.725 177.076 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.682 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.8 t-80 34.31 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.914 177.963 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.06 -45.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.428 -179.958 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.72 79.99 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.284 -3.126 . . . . 0.0 105.284 174.422 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.413 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.27 -49.76 6.19 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.301 -0.949 . . . . 0.0 109.364 177.987 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.85 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.192 0.308 . . . . 0.0 110.196 -179.728 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.02 10.33 1.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.739 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 87.5 t -144.34 -9.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.425 -179.865 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 102.58 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.53 1.144 . . . . 0.0 110.45 179.896 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 16.9 t60 84.28 4.6 0.71 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.873 -179.143 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -62.95 -23.14 67.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.471 179.897 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.415 179.939 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.93 0.395 . . . . 0.0 110.263 . . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' HD1' ' A' ' 11' ' ' HIS . 2.1 t-80 -150.02 70.94 1.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.311 1.053 . . . . 0.0 109.714 179.353 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.986 ' C ' ' H ' ' A' ' 14' ' ' LYS 0.272 . . 169.78 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 111.921 -2.399 . . . . 0.0 105.721 -179.363 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.09 -1.3 0.66 Allowed 'General case' 0 N--CA 1.412 -2.331 1 N-CA-C 95.254 -5.832 . . . . 0.0 95.254 164.125 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.986 ' H ' ' C ' ' A' ' 12' ' ' ALA . 3.2 ttpt -114.89 -166.49 1.12 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.309 -3.587 . . . . 0.0 111.501 176.325 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.707 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.8 t-80 33.2 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.042 178.378 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 173.56 -47.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 122.282 1.039 . . . . 0.0 109.305 179.96 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.03 -14.17 76.13 Favored Glycine 0 C--N 1.27 -3.115 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 174.907 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -94.97 -46.28 6.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.765 -0.718 . . . . 0.0 109.636 177.966 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.53 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.504 -179.754 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.63 6.95 1.23 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.076 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.0 t -147.16 -9.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.236 -179.926 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t30 102.82 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.444 1.09 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -178.83 64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.953 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -51.83 -33.94 38.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.667 -179.819 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.115 -179.969 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.659 ' C ' ' H ' ' A' ' 13' ' ' ALA . 89.1 m-70 -147.21 144.85 29.21 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.08 179.435 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.015 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.47 -31.56 0.23 Allowed 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 125.587 1.804 . . . . 0.0 109.642 -177.761 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.13 0.29 Allowed 'General case' 0 N--CA 1.412 -2.337 1 N-CA-C 95.44 -5.763 . . . . 0.0 95.44 165.034 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.015 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.6 tttp -115.94 -169.25 1.56 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-N 109.365 -3.561 . . . . 0.0 111.74 177.082 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.689 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 86.8 m-70 34.52 18.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.965 178.045 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.54 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-O 122.363 1.078 . . . . 0.0 109.113 -179.821 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.25 79.3 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 174.493 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.529 ' CD2' ' HZ3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -91.53 -47.34 7.47 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.543 -0.829 . . . . 0.0 109.219 178.024 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.0 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.773 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.66 7.52 1.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.146 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 43.5 t -144.99 -9.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.4 t-20 105.32 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.54 1.15 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -173.13 -99.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.315 -179.923 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.661 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 64.5 t80 55.44 10.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.445 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 76.5 mtt85 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.817 0.342 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.66 ' C ' ' H ' ' A' ' 13' ' ' ALA . 97.7 m-70 -155.81 144.96 20.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.602 179.528 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.707 1.879 . . . . 0.0 109.849 -177.888 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.44 1.89 0.31 Allowed 'General case' 0 N--CA 1.411 -2.42 1 N-CA-C 95.363 -5.792 . . . . 0.0 95.363 164.988 . . . . . . . . 3 3 . 1 . 078 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.061 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -115.89 -169.15 1.54 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.412 -3.54 . . . . 0.0 111.646 177.074 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.7 m-70 34.86 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.892 178.031 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.62 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.091 0.948 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.25 -13.71 82.55 Favored Glycine 0 C--N 1.273 -2.961 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.59 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.15 -45.64 8.17 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 114.511 -0.845 . . . . 0.0 109.286 177.981 . . . . . . . . 3 3 . 1 . 078 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.05 13.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.838 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.18 9.23 0.94 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.17 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' ALA . 57.7 t -145.95 -9.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.189 -179.873 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t-20 103.14 -36.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.503 1.127 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -172.05 89.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.398 -179.966 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 83.4 t80 -159.89 16.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.062 -179.84 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.564 179.982 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt-85 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.785 0.326 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.581 ' NE2' ' NE2' ' A' ' 15' ' ' HIS . 48.8 t-80 -157.6 92.43 1.21 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.209 0.528 . . . . 0.0 110.074 179.339 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.032 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 134.84 -31.79 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.424 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.54 -0.41 0.61 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.895 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.032 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.8 tttt -114.86 -168.12 1.33 Allowed 'General case' 0 C--N 1.393 2.488 0 CA-C-N 109.376 -3.556 . . . . 0.0 111.768 176.696 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.683 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 79.5 m-70 33.77 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.958 178.24 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.39 -47.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.324 1.059 . . . . 0.0 109.025 -179.873 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.66 -13.73 78.03 Favored Glycine 0 C--N 1.27 -3.099 0 N-CA-C 105.885 -2.886 . . . . 0.0 105.885 174.853 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.75 -44.39 9.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.899 . . . . . . . . 3 3 . 1 . 079 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 160.87 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.868 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 61.37 5.57 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.289 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 40.7 t -145.28 -10.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.202 -179.817 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.0 t-20 116.4 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.504 1.128 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -171.89 -3.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.515 -179.923 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.416 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 34.1 t80 -49.06 -18.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.712 -179.633 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.136 -179.978 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 121.004 0.431 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.633 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.1 t-80 -153.21 145.56 23.99 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.673 179.508 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.142 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -31.74 0.23 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.715 1.885 . . . . 0.0 109.738 -177.985 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.633 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.18 0.29 Allowed 'General case' 0 N--CA 1.412 -2.373 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 165.091 . . . . . . . . 3 3 . 1 . 080 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.142 ' H ' ' C ' ' A' ' 12' ' ' ALA . 15.8 tttp -116.14 -169.49 1.62 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.76 177.037 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.693 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 33.39 21.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.708 177.927 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.651 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.16 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 CA-C-O 122.302 1.049 . . . . 0.0 109.377 -179.658 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.94 -11.55 81.21 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 104.983 -3.247 . . . . 0.0 104.983 173.981 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.444 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -93.43 -36.33 12.53 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 114.445 -0.878 . . . . 0.0 109.932 178.238 . . . . . . . . 3 3 . 1 . 080 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.15 28.22 0.51 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.365 -179.441 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.5 -9.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.114 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.586 ' H ' ' C ' ' A' ' 19' ' ' ALA . 83.0 t -152.44 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.284 -179.387 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -171.66 -96.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.496 -179.198 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.492 ' C ' ' H ' ' A' ' 25' ' ' LEU . 75.8 t60 -152.07 8.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.711 -179.372 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.14 22.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.938 0.399 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.8 m-70 -144.72 146.73 32.34 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.023 0.44 . . . . 0.0 111.012 179.49 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.135 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.91 -31.45 0.22 Allowed 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 125.813 1.945 . . . . 0.0 109.944 -178.156 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.4 2.08 0.29 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.344 -5.798 . . . . 0.0 95.344 165.028 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.135 ' H ' ' C ' ' A' ' 12' ' ' ALA . 13.8 ttpp -116.01 -169.29 1.57 Allowed 'General case' 0 C--N 1.394 2.503 0 CA-C-N 109.407 -3.542 . . . . 0.0 111.817 177.16 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.686 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.1 t60 33.98 19.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.89 178.122 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 174.69 -46.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-O 122.24 1.019 . . . . 0.0 109.275 179.977 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.05 79.4 Favored Glycine 0 C--N 1.271 -3.083 0 N-CA-C 105.773 -2.931 . . . . 0.0 105.773 174.722 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.14 -45.62 7.8 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.659 -0.771 . . . . 0.0 109.431 178.036 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.23 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.877 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.78 5.89 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 109.667 -179.291 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 45.9 t -144.05 -9.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.335 179.975 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 27.8 t-20 105.84 -36.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.646 1.216 . . . . 0.0 110.046 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.2 t-160 -170.1 -130.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.138 179.972 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.61 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 29.6 m-85 48.62 28.67 1.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.775 0.322 . . . . 0.0 110.752 179.673 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.081 -179.923 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -97.29 71.06 2.36 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.138 0.971 . . . . 0.0 110.11 179.437 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' H ' ' A' ' 14' ' ' LYS 0.265 . . 169.34 -30.88 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 112.165 -2.289 . . . . 0.0 105.712 -179.738 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -1.0 0.57 Allowed 'General case' 0 N--CA 1.414 -2.274 1 N-CA-C 95.378 -5.786 . . . . 0.0 95.378 164.068 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.033 ' H ' ' C ' ' A' ' 12' ' ' ALA 0.257 23.7 tttp -115.99 -166.73 1.17 Allowed 'General case' 0 C--N 1.393 2.457 0 CA-C-N 109.42 -3.536 . . . . 0.0 111.953 176.859 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.717 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 55.6 t60 34.01 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.609 177.756 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.7 tt 170.72 -42.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.078 0.942 . . . . 0.0 109.381 -179.894 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.96 -14.28 81.87 Favored Glycine 0 C--N 1.274 -2.894 0 N-CA-C 105.81 -2.916 . . . . 0.0 105.81 175.071 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -88.94 -34.36 16.93 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.044 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.07 -73.18 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.61 179.397 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.23 -23.14 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.815 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 34.0 t -150.85 -12.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.542 179.614 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 5.1 t30 155.55 -36.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.779 0.674 . . . . 0.0 109.551 -179.658 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -166.14 120.38 1.15 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.952 -178.443 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -71.87 -0.17 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.421 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 -179.931 . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 . . . . . 0 N--CA 1.464 0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.66 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.2 t60 -153.58 146.58 24.52 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.443 179.382 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.11 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.31 -30.82 0.21 Allowed 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 125.715 1.885 . . . . 0.0 109.683 -177.695 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.71 2.88 0.25 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 164.915 . . . . . . . . 3 3 . 1 . 083 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.11 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.1 tttm -118.13 -167.3 1.33 Allowed 'General case' 0 C--N 1.393 2.471 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.593 177.275 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.67 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 66.2 t60 33.05 23.3 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 170.04 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.585 0 CA-C-O 122.107 0.956 . . . . 0.0 109.103 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -15.12 79.13 Favored Glycine 0 C--N 1.274 -2.909 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.752 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 6.3 t60 -83.43 -39.64 20.33 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.859 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.94 -69.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 -19.81 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.877 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 10.1 t -149.58 -16.31 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.966 179.679 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 4.7 t30 158.58 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.692 0.62 . . . . 0.0 109.758 -179.669 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 43.9 t-80 -166.51 14.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.723 -178.692 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 72.3 t80 -78.82 43.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.432 -179.883 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 66.4 mtp180 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.667 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.4 m80 -154.75 145.56 22.47 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.557 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.073 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.48 -30.72 0.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 125.654 1.846 . . . . 0.0 109.555 -177.713 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.667 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.75 0.26 Allowed 'General case' 0 N--CA 1.412 -2.351 1 N-CA-C 95.282 -5.822 . . . . 0.0 95.282 164.787 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.073 ' H ' ' C ' ' A' ' 12' ' ' ALA . 11.5 ttpp -117.73 -167.59 1.36 Allowed 'General case' 0 C--N 1.392 2.44 0 CA-C-N 109.524 -3.489 . . . . 0.0 111.671 177.152 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.676 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.5 m80 33.11 23.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.716 177.67 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.648 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 170.02 -45.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 CA-C-O 122.229 1.014 . . . . 0.0 109.061 -179.752 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.19 78.66 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 174.773 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 5.9 t60 -82.54 -40.85 20.39 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.659 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -160.37 -68.05 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.402 179.51 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.34 -19.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.956 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.411 ' H ' ' H ' ' A' ' 22' ' ' ASN . 40.4 t -151.26 -18.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.092 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.489 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 7.8 t-20 163.76 -38.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.576 0.548 . . . . 0.0 109.993 -179.709 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 48.2 t-80 -171.7 33.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 -178.644 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -49.82 -14.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 110.544 -179.969 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.783 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.182 0.515 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.638 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.8 t-80 -162.8 143.4 9.64 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 179.294 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.077 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.3 -31.68 0.22 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.836 1.96 . . . . 0.0 110.022 -178.133 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.638 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 1.81 0.33 Allowed 'General case' 0 N--CA 1.411 -2.381 1 N-CA-C 95.304 -5.813 . . . . 0.0 95.304 164.963 . . . . . . . . 3 3 . 1 . 085 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.077 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.9 tttt -115.67 -168.8 1.47 Allowed 'General case' 0 C--N 1.393 2.499 0 CA-C-N 109.417 -3.538 . . . . 0.0 111.758 176.998 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.6 t-80 34.21 19.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.849 177.98 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.08 -47.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.271 1.034 . . . . 0.0 109.199 -179.894 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.26 -14.06 76.79 Favored Glycine 0 C--N 1.27 -3.13 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 174.918 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.408 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -94.5 -45.6 7.35 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.512 178.093 . . . . . . . . 3 3 . 1 . 085 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.3 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.762 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.17 9.65 1.04 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.973 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ALA . 58.5 t -147.97 -8.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.196 -179.542 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.7 m120 100.04 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.662 1.226 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 25' ' ' LEU . 86.3 t60 -167.22 -105.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.5 -179.834 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.514 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 25.7 t80 65.96 -7.34 0.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 -179.977 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 23' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.822 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 85.6 mtt-85 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.788 0.327 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.658 ' C ' ' H ' ' A' ' 13' ' ' ALA . 94.7 m-70 -155.79 146.08 21.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.626 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.02 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.71 -31.67 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.823 1.952 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.8 0.31 Allowed 'General case' 0 N--CA 1.412 -2.343 1 N-CA-C 95.414 -5.773 . . . . 0.0 95.414 165.167 . . . . . . . . 3 3 . 1 . 086 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.02 ' N ' ' C ' ' A' ' 12' ' ' ALA . 16.5 tttp -116.31 -168.22 1.4 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.327 -3.579 . . . . 0.0 111.644 177.158 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 40.4 m-70 34.05 20.98 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.803 177.706 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 171.3 -46.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.515 0 CA-C-O 122.286 1.041 . . . . 0.0 109.245 -179.682 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.16 -12.42 83.48 Favored Glycine 0 C--N 1.274 -2.908 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 175.125 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.514 ' CE1' ' HZ2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -89.29 -30.88 18.14 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.316 . . . . . . . . 3 3 . 1 . 086 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.57 -66.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.677 179.285 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.64 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.759 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -152.7 -18.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 179.925 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 t30 165.66 -38.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.549 0.531 . . . . 0.0 110.145 -179.799 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.456 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 34.5 t-80 -170.04 26.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -178.709 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -49.08 -15.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 -179.741 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.7 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.278 -179.944 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' H ' ' H ' ' A' ' 11' ' ' HIS . 66.3 ttt180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.268 0.556 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.671 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 t60 -156.8 142.2 17.45 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.61 -31.73 0.23 Allowed 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 125.594 1.809 . . . . 0.0 109.492 -177.863 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.54 0.33 Allowed 'General case' 0 N--CA 1.41 -2.439 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 164.978 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.0 tttp -115.1 -169.82 1.63 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.438 -3.528 . . . . 0.0 111.731 176.922 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.693 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.9 t-80 34.78 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.934 177.926 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.28 -44.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.171 0.986 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.82 -14.38 81.57 Favored Glycine 0 C--N 1.274 -2.895 0 N-CA-C 105.335 -3.106 . . . . 0.0 105.335 174.249 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.437 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -89.85 -49.03 6.85 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.295 -0.953 . . . . 0.0 109.02 177.892 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.28 9.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.458 0.474 . . . . 0.0 110.177 -179.94 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.72 10.07 1.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 -178.158 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 19' ' ' ALA . 91.1 t -143.1 -8.56 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.948 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.2 m-20 97.67 -35.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.637 1.211 . . . . 0.0 111.08 179.81 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.502 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.4 t-80 80.19 7.84 1.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.774 -179.154 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.1 t80 -77.08 27.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.0 tt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' C ' ' ND1' ' A' ' 11' ' ' HIS . 81.5 mtp180 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.922 0.392 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 41.2 m80 -152.76 144.44 23.51 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.5 -31.29 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.633 1.833 . . . . 0.0 109.718 -177.731 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.57 2.25 0.3 Allowed 'General case' 0 N--CA 1.411 -2.407 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.069 ' H ' ' C ' ' A' ' 12' ' ' ALA . 12.0 ttpt -115.98 -168.98 1.51 Allowed 'General case' 0 C--N 1.395 2.544 0 CA-C-N 109.401 -3.545 . . . . 0.0 111.492 176.995 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.682 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 61.5 t60 33.65 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.917 178.036 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.76 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 CA-C-O 122.229 1.014 . . . . 0.0 109.308 179.982 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -14.24 80.18 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 174.497 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -90.69 -44.21 9.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 114.431 -0.884 . . . . 0.0 109.857 178.179 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.598 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 42.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.336 -179.177 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.6 -21.65 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.515 -179.47 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.0 t -148.32 -30.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.636 179.802 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t-20 153.39 -43.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 41.9 t60 -168.78 174.96 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.27 179.7 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.608 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.5 t80 56.28 10.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.656 179.917 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.653 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.5 t60 -160.8 147.1 15.01 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.059 0.457 . . . . 0.0 111.04 179.688 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.097 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.5 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 125.872 1.982 . . . . 0.0 110.085 -178.23 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.08 0.28 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.411 -5.774 . . . . 0.0 95.411 165.218 . . . . . . . . 3 3 . 1 . 089 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.097 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -116.03 -169.31 1.58 Allowed 'General case' 0 C--N 1.393 2.491 0 CA-C-N 109.435 -3.529 . . . . 0.0 111.767 177.03 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 10.9 t60 34.72 18.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.914 178.056 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tt 175.35 -41.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 CA-C-O 122.019 0.914 . . . . 0.0 109.582 179.923 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.63 -13.07 83.88 Favored Glycine 0 C--N 1.275 -2.858 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 174.316 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.2 m170 -92.89 -44.78 8.29 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.541 -0.829 . . . . 0.0 109.136 178.05 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.89 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.46 9.61 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.025 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -147.57 -9.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.152 -179.777 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.8 t-20 100.31 -35.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.395 1.06 . . . . 0.0 110.023 -179.627 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.479 ' C ' ' H ' ' A' ' 25' ' ' LEU . 79.9 m-70 -145.76 119.37 9.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -62.43 -4.26 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 23' ' ' HIS . 19.0 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.655 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.0 t-80 -169.55 145.29 3.14 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 179.571 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.71 -31.78 0.23 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.767 1.917 . . . . 0.0 109.94 -178.156 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.77 0.31 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.274 -5.824 . . . . 0.0 95.274 165.074 . . . . . . . . 3 3 . 1 . 090 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.048 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -115.6 -169.35 1.56 Allowed 'General case' 0 C--N 1.394 2.509 0 CA-C-N 109.483 -3.508 . . . . 0.0 111.766 176.909 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.3 t-80 34.89 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.944 177.952 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.71 -43.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.144 0.974 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.94 82.39 Favored Glycine 0 C--N 1.274 -2.907 0 N-CA-C 105.434 -3.066 . . . . 0.0 105.434 174.41 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.418 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.41 -47.44 7.45 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.437 -0.881 . . . . 0.0 109.21 177.983 . . . . . . . . 3 3 . 1 . 090 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.23 9.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.259 0.349 . . . . 0.0 110.179 -179.885 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.5 9.88 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.25 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' ALA . 85.1 t -144.57 -9.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.2 -179.82 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.626 HD22 ' HZ1' ' A' ' 14' ' ' LYS . 11.0 t-20 99.43 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 O-C-N 124.33 1.019 . . . . 0.0 110.798 179.826 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 5.2 t60 81.98 44.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.349 -179.385 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 41.7 p90 -66.55 -31.09 71.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.565 -179.942 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.756 -179.948 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.315 0.579 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.626 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.5 m-70 68.81 140.59 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.849 179.22 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.053 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 67.24 -33.33 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 126.267 2.23 . . . . 0.0 111.023 -179.106 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.626 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 0.98 0.37 Allowed 'General case' 0 N--CA 1.411 -2.406 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 165.152 . . . . . . . . 3 3 . 1 . 091 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.053 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.5 tttp -114.02 -168.89 1.42 Allowed 'General case' 0 C--N 1.395 2.57 0 CA-C-N 109.554 -3.475 . . . . 0.0 111.743 176.769 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 34.15 18.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.959 177.968 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.17 -46.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 122.286 1.041 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.71 -14.56 77.98 Favored Glycine 0 C--N 1.27 -3.097 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 174.52 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.603 ' CE1' ' HZ2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -90.82 -47.79 7.41 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.144 177.804 . . . . . . . . 3 3 . 1 . 091 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.56 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.799 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.53 6.84 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.292 0.568 . . . . 0.0 109.54 -179.149 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 50.6 t -143.02 -9.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.5 t-20 106.13 -36.81 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.62 1.2 . . . . 0.0 110.019 -179.809 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 79.7 t60 -171.08 -117.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.273 179.871 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.57 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 92.4 m-85 50.9 13.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 23' ' ' HIS . 15.7 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.215 -179.965 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 59.2 mtp85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.657 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.1 m-70 -156.69 145.78 20.3 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.541 179.457 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.086 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.23 -31.72 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.75 1.906 . . . . 0.0 109.839 -177.996 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.657 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.99 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.078 . . . . . . . . 3 3 . 1 . 092 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.086 ' H ' ' C ' ' A' ' 12' ' ' ALA . 33.2 tttt -116.0 -169.56 1.62 Allowed 'General case' 0 C--N 1.392 2.418 0 CA-C-N 109.389 -3.551 . . . . 0.0 111.735 177.031 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.679 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 3.1 t60 34.48 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.935 178.089 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.06 -41.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.549 0 CA-C-O 122.02 0.914 . . . . 0.0 109.659 179.918 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.59 -13.16 83.79 Favored Glycine 0 C--N 1.275 -2.826 0 N-CA-C 105.506 -3.038 . . . . 0.0 105.506 174.327 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.65 -44.36 8.22 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 114.579 -0.81 . . . . 0.0 109.491 178.083 . . . . . . . . 3 3 . 1 . 092 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.96 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.57 10.14 0.95 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.972 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 19' ' ' ALA . 65.9 t -148.22 -9.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.189 -179.837 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.1 t-20 100.34 -35.58 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.388 1.055 . . . . 0.0 110.003 -179.643 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' LEU . 43.9 m80 -151.72 120.06 6.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.42 -179.766 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -69.48 5.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 23' ' ' HIS . 3.0 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.37 -179.792 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.664 0.269 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.677 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.9 t60 -149.38 144.27 26.29 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.919 0.39 . . . . 0.0 110.825 179.601 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.079 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.45 -29.62 0.19 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.558 1.786 . . . . 0.0 109.851 -178.081 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.18 1.78 0.44 Allowed 'General case' 0 N--CA 1.411 -2.414 1 N-CA-C 94.855 -5.98 . . . . 0.0 94.855 164.342 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.079 ' H ' ' C ' ' A' ' 12' ' ' ALA . 4.6 tttp -116.07 -161.98 0.82 Allowed 'General case' 0 C--N 1.398 2.696 0 CA-C-N 109.264 -3.607 . . . . 0.0 110.726 176.929 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.614 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.4 t60 31.49 20.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.459 0.704 . . . . 0.0 112.144 178.291 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 172.95 -49.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 CA-C-O 122.429 1.109 . . . . 0.0 109.321 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.21 -13.71 70.57 Favored Glycine 0 C--N 1.27 -3.1 0 N-CA-C 106.257 -2.737 . . . . 0.0 106.257 175.351 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.6 m170 -94.69 -45.05 7.52 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.039 178.071 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 161.72 13.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.858 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.4 7.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.114 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.5 t -143.59 -9.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.575 -179.933 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 106.49 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.548 1.155 . . . . 0.0 110.246 179.969 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -173.09 100.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.533 -179.933 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 60.8 t80 -166.0 4.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.427 179.975 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.51 -179.97 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.644 ' C ' ' H ' ' A' ' 13' ' ' ALA . 49.2 t60 -164.0 143.97 8.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.597 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.132 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.11 -31.61 0.23 Allowed 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 125.619 1.825 . . . . 0.0 109.656 -178.045 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.644 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.23 1.54 0.31 Allowed 'General case' 0 N--CA 1.411 -2.416 1 N-CA-C 95.364 -5.791 . . . . 0.0 95.364 165.014 . . . . . . . . 3 3 . 1 . 094 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.132 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.2 tttm -114.89 -169.32 1.53 Allowed 'General case' 0 C--N 1.396 2.608 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.909 177.067 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.678 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 7.8 m-70 32.73 21.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.788 177.974 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 172.63 -47.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 CA-C-O 122.256 1.027 . . . . 0.0 109.374 -179.951 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.25 -14.39 79.18 Favored Glycine 0 C--N 1.271 -3.046 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 174.404 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.459 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.75 -44.07 11.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.466 178.034 . . . . . . . . 3 3 . 1 . 094 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.57 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.39 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.205 -179.315 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 -1.44 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.192 179.496 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.57 ' H ' ' C ' ' A' ' 19' ' ' ALA . 39.5 t -150.97 -25.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.732 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.9 t30 130.18 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.737 1.273 . . . . 0.0 109.299 -179.726 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.486 ' HD1' ' C ' ' A' ' 23' ' ' HIS . 2.9 t-80 -163.17 97.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.906 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 77.4 t80 -164.31 -6.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.945 179.816 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.431 ' H ' ' H ' ' A' ' 24' ' ' TYR . 15.7 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.245 179.881 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.1 t60 -152.55 145.21 24.23 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.141 0.496 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.077 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.8 -30.66 0.21 Allowed 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 125.78 1.925 . . . . 0.0 109.261 -177.426 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.9 3.71 0.21 Allowed 'General case' 0 N--CA 1.41 -2.458 1 N-CA-C 95.372 -5.788 . . . . 0.0 95.372 164.698 . . . . . . . . 3 3 . 1 . 095 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.077 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -119.36 -168.11 1.52 Allowed 'General case' 0 C--N 1.395 2.549 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.828 177.464 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.8 m170 31.67 25.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.411 178.12 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.6 tt 167.52 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 CA-C-O 122.171 0.986 . . . . 0.0 109.217 -179.841 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.34 -13.71 78.1 Favored Glycine 0 C--N 1.275 -2.837 0 N-CA-C 104.675 -3.37 . . . . 0.0 104.675 173.523 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.462 ' H ' ' H ' ' A' ' 16' ' ' ILE . 9.9 t60 -89.16 -40.3 12.99 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.399 177.897 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -144.33 23.38 1.65 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.885 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.59 -2.36 0.18 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.251 179.139 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 19' ' ' ALA . 42.9 t -150.89 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 121.335 -0.146 . . . . 0.0 111.066 -179.57 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER 175.83 -83.87 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.947 0.404 . . . . 0.0 110.84 -179.443 . . . . . . . . 3 3 . 1 . 095 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.659 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.6 OUTLIER -155.47 -172.27 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.76 -179.589 . . . . . . . . 3 3 . 1 . 095 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 50.6 t80 57.01 20.16 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.51 179.999 . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.638 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.1 t-80 -157.47 145.78 19.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.589 179.518 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.93 -31.63 0.23 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.773 1.92 . . . . 0.0 109.804 -178.028 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.638 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.01 0.31 Allowed 'General case' 0 N--CA 1.412 -2.375 1 N-CA-C 95.323 -5.806 . . . . 0.0 95.323 165.037 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.025 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.5 tttt -115.86 -168.76 1.47 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.509 -3.496 . . . . 0.0 111.557 177.045 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.691 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 8.8 m-70 33.98 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 177.968 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.63 -44.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.105 0.955 . . . . 0.0 109.518 179.885 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.11 81.87 Favored Glycine 0 C--N 1.273 -2.937 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.362 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.416 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.3 m170 -93.08 -49.28 6.08 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.563 177.99 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 170.46 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.488 -179.616 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.41 9.65 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.947 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' A' ' 19' ' ' ALA . 59.7 t -146.7 -8.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.911 -179.856 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 18.8 m-20 99.42 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.819 1.324 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 93.2 m-70 -160.19 108.87 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -62.25 -11.78 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.318 179.986 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 7.9 ptm180 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.905 0.383 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.653 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 m-70 -155.45 146.52 22.54 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 179.507 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.082 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.05 -31.91 0.23 Allowed 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 125.719 1.887 . . . . 0.0 109.922 -178.071 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.14 1.76 0.29 Allowed 'General case' 0 N--CA 1.413 -2.295 1 N-CA-C 95.421 -5.77 . . . . 0.0 95.421 165.158 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.082 ' H ' ' C ' ' A' ' 12' ' ' ALA . 3.0 ttmm -115.56 -169.76 1.64 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.403 -3.544 . . . . 0.0 111.716 177.252 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.665 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.8 m-70 34.09 19.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.698 178.036 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.04 -46.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.686 0 CA-C-O 122.178 0.99 . . . . 0.0 109.641 -179.936 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.91 -14.66 78.46 Favored Glycine 0 C--N 1.272 -3.013 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 174.726 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.642 ' CD2' ' HZ2' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -92.43 -42.74 9.59 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 114.721 -0.739 . . . . 0.0 110.038 178.363 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.82 42.1 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.353 -179.212 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.67 -17.1 0.13 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.663 -179.52 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -148.77 -33.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 179.974 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER 155.38 -47.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.867 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 80.5 t60 -166.86 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.222 179.835 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.549 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 98.3 m-85 46.89 18.32 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.6 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.14 -179.91 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 11' ' ' HIS . 95.0 mtt180 . . . . . 0 N--CA 1.46 0.044 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.671 ' C ' ' H ' ' A' ' 13' ' ' ALA . 2.2 t60 58.41 136.47 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.09 -179.814 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.047 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.68 -32.01 0.22 Allowed 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.761 -178.042 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.12 0.34 Allowed 'General case' 0 N--CA 1.41 -2.453 1 N-CA-C 95.268 -5.827 . . . . 0.0 95.268 164.709 . . . . . . . . 3 3 . 1 . 098 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.047 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.6 tttm -114.71 -169.45 1.55 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.557 -3.474 . . . . 0.0 111.813 176.871 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.8 m80 34.54 18.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.894 178.085 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.41 -44.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 CA-C-O 122.051 0.929 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.59 -14.04 81.48 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 174.554 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 -46.27 7.7 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.402 177.995 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.47 12.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.43 -179.882 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.33 8.24 1.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.041 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 52.3 t -146.02 -9.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.054 -179.939 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 62.9 t30 102.27 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.543 1.152 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -175.07 75.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.403 179.997 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.462 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 52.8 t80 -79.15 -20.92 47.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.541 -179.979 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.978 . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -155.05 72.2 0.82 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.289 1.042 . . . . 0.0 109.95 178.761 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.973 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.275 . . 174.67 -31.07 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.504 179.978 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.81 -1.53 0.65 Allowed 'General case' 0 N--CA 1.416 -2.154 1 N-CA-C 95.486 -5.746 . . . . 0.0 95.486 164.734 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.973 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.258 19.1 tttm -115.1 -166.86 1.16 Allowed 'General case' 0 C--N 1.388 2.262 0 CA-C-N 109.085 -3.689 . . . . 0.0 111.569 176.794 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.682 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.3 t60 34.4 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.146 177.812 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 174.37 -43.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.145 0.974 . . . . 0.0 109.489 179.797 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.95 -13.77 82.29 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 174.71 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.5 -44.67 8.52 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.605 -0.798 . . . . 0.0 109.049 177.907 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.32 11.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.222 0.326 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.54 10.89 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.907 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' H ' ' C ' ' A' ' 19' ' ' ALA . 96.0 t -145.1 -7.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.821 -179.674 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.4 m-20 99.48 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.796 1.31 . . . . 0.0 110.228 -179.566 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.447 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 25.2 p-80 -162.9 112.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.633 179.984 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.2 t80 -69.82 -3.1 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.989 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.746 0.308 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.655 ' C ' ' H ' ' A' ' 13' ' ' ALA . 42.7 t60 -148.8 145.59 27.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.238 179.315 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.042 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.87 -31.42 0.23 Allowed 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 125.65 1.844 . . . . 0.0 109.521 -177.728 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.53 2.32 0.29 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.982 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.042 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.3 tttm -116.3 -169.53 1.63 Allowed 'General case' 0 C--N 1.394 2.512 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.778 177.01 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 7.4 m-70 34.1 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.812 178.2 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 174.8 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.077 0.941 . . . . 0.0 109.641 179.836 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.35 83.58 Favored Glycine 0 C--N 1.275 -2.855 0 N-CA-C 105.508 -3.037 . . . . 0.0 105.508 174.358 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.408 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.85 -45.91 7.43 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.483 178.046 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.48 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.615 -179.787 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.32 8.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.882 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 50.5 t -147.08 -7.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.657 -179.866 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 m120 97.24 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.692 1.245 . . . . 0.0 109.835 -179.374 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.583 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -170.66 -113.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 31.5 t80 64.64 -6.01 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.931 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' H ' ' C ' ' A' ' 23' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.45 107.53 5.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.24 11.37 44.08 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.8 p -48.89 109.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.499 ' C ' ' H ' ' A' ' 7' ' ' LYS . 8.1 pt -74.95 71.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 56.49 7.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.658 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 5' ' ' ILE . 18.3 tptp -64.34 -64.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -89.62 51.14 2.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.01 15.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.996 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 11' ' ' HIS . 56.6 ttt180 -170.55 -2.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.132 0.491 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.7 t60 -153.68 144.62 22.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.054 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.15 -31.78 0.23 Allowed 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 125.786 1.929 . . . . 0.0 109.901 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.64 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.67 0.3 Allowed 'General case' 0 N--CA 1.411 -2.378 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.054 ' H ' ' C ' ' A' ' 12' ' ' ALA . 29.5 tttt -115.26 -169.19 1.52 Allowed 'General case' 0 C--N 1.395 2.559 0 CA-C-N 109.446 -3.524 . . . . 0.0 111.826 177.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.695 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 9.5 m-70 32.96 21.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.84 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 173.52 -47.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.63 0 CA-C-O 122.191 0.996 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.74 -14.8 77.99 Favored Glycine 0 C--N 1.271 -3.073 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.446 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.96 -45.92 9.81 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 114.264 -0.968 . . . . 0.0 109.531 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.27 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.941 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.7 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.223 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.2 t -151.01 -29.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.528 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 18.8 t30 136.12 -39.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.63 1.206 . . . . 0.0 109.096 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.528 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 85.5 m-70 -151.93 -131.37 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.31 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.453 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.7 t80 55.53 13.94 1.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.921 0.391 . . . . 0.0 110.311 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.5 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.298 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CD1' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.496 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 6.5 m-90 -157.05 -59.76 0.09 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.2 14.59 56.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.055 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.5 p -53.44 109.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.455 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 10.3 mt -72.85 -41.21 61.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.425 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 60.4 m-85 -158.69 -11.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 9' ' ' GLY . 62.6 tttm -51.28 -21.47 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.427 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -72.81 10.57 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -179.58 27.61 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.042 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HE ' ' CA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -103.2 -1.35 29.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.049 0.452 . . . . 0.0 109.923 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.645 ' C ' ' H ' ' A' ' 13' ' ' ALA . 18.1 p80 -152.19 145.58 24.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.418 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.099 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.99 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 125.742 1.901 . . . . 0.0 109.917 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.645 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.311 1 N-CA-C 95.42 -5.771 . . . . 0.0 95.42 165.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.099 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -116.18 -168.26 1.41 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.47 -3.514 . . . . 0.0 111.55 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.2 m-70 34.27 19.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.915 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.33 -45.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 122.253 1.025 . . . . 0.0 109.364 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.39 -13.68 81.44 Favored Glycine 0 C--N 1.273 -2.95 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.432 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -92.09 -43.15 9.55 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.82 178.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.621 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.96 41.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.241 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.75 -17.97 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.5 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.621 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.2 t -148.63 -34.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 154.89 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.833 0.708 . . . . 0.0 109.115 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -160.9 45.32 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.28 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -66.59 -19.16 65.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.6 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.941 -0.463 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -165.57 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.491 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.41 -3.39 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.98 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.558 ' HG ' ' N ' ' A' ' 5' ' ' ILE . 34.9 t -54.7 171.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.558 ' N ' ' HG ' ' A' ' 4' ' ' SER . 12.3 mm -76.07 72.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 51.55 16.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tptp -68.3 -67.94 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.505 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -78.76 73.68 5.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.56 -51.58 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 88.7 mtt180 -99.78 -1.89 36.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.972 0.415 . . . . 0.0 110.276 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.654 ' C ' ' H ' ' A' ' 13' ' ' ALA . 46.5 m80 -151.85 143.83 23.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.291 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.86 -31.58 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.675 1.859 . . . . 0.0 109.497 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.34 0.28 Allowed 'General case' 0 N--CA 1.413 -2.324 1 N-CA-C 95.467 -5.753 . . . . 0.0 95.467 164.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.97 -169.04 1.52 Allowed 'General case' 0 C--N 1.394 2.5 0 CA-C-N 109.454 -3.521 . . . . 0.0 111.642 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.8 m-70 33.84 19.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.848 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.677 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.69 -45.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.226 1.012 . . . . 0.0 109.382 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.28 -13.95 81.06 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 105.489 -3.044 . . . . 0.0 105.489 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.431 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -91.38 -43.72 9.58 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.806 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.22 41.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.255 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.94 -19.29 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.497 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.8 t -148.78 -32.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 155.44 -47.88 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -172.49 96.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.263 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 55.4 t80 -164.0 1.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.314 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.408 ' H ' ' H ' ' A' ' 24' ' ' TYR . 2.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.18 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 3' ' ' GLY . 11.8 p90 -160.63 -54.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.694 0.283 . . . . 0.0 110.306 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 2' ' ' TRP . . . 59.19 27.52 62.86 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.146 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 t -47.9 158.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.614 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -73.3 74.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 53.08 67.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -143.27 -61.69 0.41 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.17 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -78.01 44.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.38 -23.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.974 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -98.61 -3.69 35.64 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 0.0 109.722 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 64.5 t-80 -146.57 144.38 29.53 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.181 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.59 -31.41 0.22 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.641 1.838 . . . . 0.0 109.544 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.28 0.28 Allowed 'General case' 0 N--CA 1.412 -2.355 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.048 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttm -116.34 -169.49 1.63 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 109.493 -3.503 . . . . 0.0 111.71 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.672 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 23.5 m-70 34.82 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.851 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.4 tt 175.22 -41.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 CA-C-O 122.027 0.917 . . . . 0.0 109.679 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.37 -12.94 84.09 Favored Glycine 0 C--N 1.275 -2.82 0 N-CA-C 105.622 -2.991 . . . . 0.0 105.622 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.438 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.55 -42.75 8.27 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.639 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.37 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.768 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.63 8.62 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -149.41 -9.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.804 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -37.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.468 1.105 . . . . 0.0 110.563 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.648 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 18.9 t60 -171.86 178.1 3.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.792 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.648 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 23.9 p90 41.9 26.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.485 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -55.83 133.11 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 0.0 110.538 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.91 3.93 55.12 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.007 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 p -69.79 157.77 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.684 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 15.2 tt -168.04 -45.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 35.5 p90 -98.0 -22.97 15.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.309 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -69.92 -67.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.618 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.485 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -76.52 67.8 2.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.693 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.17 -46.25 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.41 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -99.68 -0.0 41.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.833 0.349 . . . . 0.0 110.678 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.654 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.2 t-80 -159.29 143.64 15.27 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.669 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.037 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.5 -31.71 0.23 Allowed 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 125.854 1.971 . . . . 0.0 109.723 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.29 0.27 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.532 -5.729 . . . . 0.0 95.532 165.118 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.037 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.8 tttm -116.61 -169.28 1.6 Allowed 'General case' 0 C--N 1.392 2.421 0 CA-C-N 109.452 -3.522 . . . . 0.0 111.822 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.693 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.3 m-70 33.11 22.26 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.789 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.4 tt 169.52 -37.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-O 122.258 1.028 . . . . 0.0 109.186 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.32 -11.81 79.88 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 104.753 -3.339 . . . . 0.0 104.753 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.463 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.2 -36.2 13.4 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 114.397 -0.901 . . . . 0.0 109.879 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.35 26.18 0.6 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.66 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.41 -4.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.279 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.573 ' H ' ' C ' ' A' ' 19' ' ' ALA . 47.4 t -151.3 -27.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.047 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -174.24 -92.26 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.131 0.491 . . . . 0.0 110.978 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.3 t60 -159.62 27.37 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 53.3 t80 -74.92 17.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.685 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 23' ' ' HIS . 9.2 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.421 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -168.44 -59.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 0.0 110.429 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.16 -25.03 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 77.54 9.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.777 0.323 . . . . 0.0 110.502 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.466 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 11.9 mt -70.82 -28.64 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.292 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 66.8 m-85 -158.63 -3.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.25 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' H ' ' H ' ' A' ' 6' ' ' PHE . 19.8 ttpp -44.59 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.958 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.624 ' HD1' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -70.81 0.65 6.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.42 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.624 ' N ' ' HD1' ' A' ' 8' ' ' HIS . . . -82.34 -18.06 67.53 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.287 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -165.48 28.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.93 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.652 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t60 -164.18 146.51 9.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.127 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.61 -32.0 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.88 1.988 . . . . 0.0 110.087 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.652 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.85 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.383 -5.784 . . . . 0.0 95.383 165.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.127 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.7 tttm -115.61 -169.83 1.66 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.9 t-80 34.34 18.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.961 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tt 175.65 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.137 0.97 . . . . 0.0 109.583 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.62 -13.34 83.29 Favored Glycine 0 C--N 1.277 -2.697 0 N-CA-C 105.14 -3.184 . . . . 0.0 105.14 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -91.95 -45.54 8.29 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 114.394 -0.903 . . . . 0.0 109.242 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.18 13.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.47 8.48 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.8 t -144.26 -9.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER 105.44 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.581 1.175 . . . . 0.0 110.322 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.629 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 17.0 t-80 -169.83 -134.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.629 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 85.9 m-85 54.06 20.0 2.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' H2 ' ' H ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.462 ' H ' ' H2 ' ' A' ' 1' ' ' GLY . 68.7 t-105 -63.37 -76.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.582 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 175.61 6.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.181 -0.533 . . . . 0.0 111.824 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.411 ' H ' ' H ' ' A' ' 3' ' ' GLY . 15.2 m -161.5 106.55 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.878 0.371 . . . . 0.0 110.446 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 16.8 tt -51.26 -43.86 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 4.8 m-85 -175.04 4.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -54.64 -29.4 52.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.732 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -85.31 52.69 2.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.65 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.06 -21.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.194 -0.526 . . . . 0.0 111.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -79.81 -114.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.644 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.6 t-80 -90.4 145.55 24.85 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.251 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.54 -32.43 0.23 Allowed 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 125.751 1.907 . . . . 0.0 110.302 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.644 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.96 0.48 0.38 Allowed 'General case' 0 N--CA 1.412 -2.338 1 N-CA-C 95.324 -5.806 . . . . 0.0 95.324 165.071 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttm -113.53 -169.36 1.49 Allowed 'General case' 0 C--N 1.393 2.477 0 CA-C-N 109.24 -3.618 . . . . 0.0 112.046 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.695 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 30.2 t-80 34.7 18.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.95 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.68 -46.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.257 1.027 . . . . 0.0 109.121 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.28 78.93 Favored Glycine 0 C--N 1.27 -3.108 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -91.1 -47.04 7.77 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.091 177.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.89 13.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.11 8.27 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' H ' ' C ' ' A' ' 19' ' ' ALA . 59.0 t -144.35 -9.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.432 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.1 t30 103.89 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.521 1.138 . . . . 0.0 109.921 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -178.14 92.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.92 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 88.0 t80 -143.3 9.18 1.63 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.195 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.464 ' CG ' ' O ' ' A' ' 2' ' ' TRP . 76.1 t-105 -166.51 10.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.783 0.325 . . . . 0.0 110.532 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.49 -5.96 26.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.877 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 76.4 p 48.9 97.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.775 0.322 . . . . 0.0 110.769 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 8.0 tt -69.12 -42.42 81.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.198 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 37.6 m-85 -155.78 -5.22 0.12 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -57.41 -73.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.069 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.88 67.59 7.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.461 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -168.83 -16.53 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.005 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 15.1 ptm180 -173.14 17.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.654 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.65 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.9 m-70 -157.37 146.31 19.8 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.089 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.52 -31.52 0.22 Allowed 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 125.797 1.935 . . . . 0.0 110.01 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 1.94 0.31 Allowed 'General case' 0 N--CA 1.412 -2.329 1 N-CA-C 95.299 -5.815 . . . . 0.0 95.299 165.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.089 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.04 -169.46 1.61 Allowed 'General case' 0 C--N 1.392 2.447 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.8 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.689 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.5 m80 34.78 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.865 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 174.96 -42.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.116 0.96 . . . . 0.0 109.669 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.48 83.45 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.09 -44.77 7.86 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 114.591 -0.805 . . . . 0.0 109.565 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.5 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.444 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.89 8.4 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 49.4 t -148.28 -9.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.241 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.43 1.081 . . . . 0.0 109.874 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.553 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -174.95 176.4 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.423 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 53.58 31.59 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -60.61 -10.21 4.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.506 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.21 -0.26 32.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.085 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 m 50.8 178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 16.7 pt -89.03 -35.02 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.692 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 68.1 m-85 -160.83 -5.1 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' H ' ' H ' ' A' ' 6' ' ' PHE . 83.3 tttt -51.82 -66.47 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 110.429 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -75.46 72.81 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.507 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.86 -13.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.866 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 67.6 mtp180 -143.8 10.92 1.6 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.664 ' C ' ' H ' ' A' ' 13' ' ' ALA . 70.3 m80 -153.12 145.66 24.16 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.104 0.478 . . . . 0.0 110.818 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.082 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.55 -31.52 0.23 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.83 1.956 . . . . 0.0 109.586 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.72 3.12 0.23 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.477 -5.749 . . . . 0.0 95.477 164.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.082 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.0 tttp -117.68 -169.37 1.66 Allowed 'General case' 0 C--N 1.392 2.443 0 CA-C-N 109.487 -3.506 . . . . 0.0 111.925 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.683 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.2 m-70 31.81 25.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.625 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.1 tt 168.08 -35.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.026 0.917 . . . . 0.0 109.029 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.34 -13.3 74.02 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.516 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.5 t60 -86.79 -39.79 15.59 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 114.181 -1.009 . . . . 0.0 110.154 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -149.16 23.51 0.94 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.152 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.91 5.48 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.551 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.1 t -150.59 -31.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.551 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' VAL . 3.9 m-20 167.82 -74.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.424 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -163.59 24.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.386 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -50.11 -26.96 5.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -61.84 -159.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.24 9.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.062 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.2 p 50.78 100.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.847 0.356 . . . . 0.0 110.714 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mt -71.77 74.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.375 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 52.71 22.09 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.73 -56.6 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.43 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -73.0 79.17 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -48.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -102.12 0.19 34.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 110.227 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.0 m80 -153.16 144.08 22.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.254 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.098 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.36 -31.11 0.22 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.678 1.862 . . . . 0.0 109.564 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.32 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.098 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -116.56 -168.9 1.53 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.393 -3.548 . . . . 0.0 111.667 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.1 m80 34.23 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.814 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.08 -43.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 CA-C-O 122.109 0.957 . . . . 0.0 109.734 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.44 -13.13 83.7 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.403 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -95.42 -44.09 7.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 114.589 -0.806 . . . . 0.0 109.624 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.64 8.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.569 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.02 8.74 1.54 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.2 t -148.44 -8.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.647 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 20.5 m-20 97.13 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.555 1.159 . . . . 0.0 110.275 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.9 t60 -170.76 -162.63 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.074 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.661 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.1 t80 56.0 12.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.201 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -62.33 -18.45 61.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.68 -10.41 31.46 Favored Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -91.91 102.01 14.59 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mt -65.73 -42.91 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -166.85 -8.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -53.85 -66.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -81.67 67.33 7.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.523 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.59 -21.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.809 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 99.4 mtt180 -137.1 6.6 2.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.207 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.665 ' C ' ' H ' ' A' ' 13' ' ' ALA . 21.7 m80 -152.69 146.41 25.11 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.21 -31.03 0.21 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.814 1.946 . . . . 0.0 110.095 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.665 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 1.98 0.31 Allowed 'General case' 0 N--CA 1.411 -2.388 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 10.6 ttpt -116.22 -168.86 1.5 Allowed 'General case' 0 C--N 1.395 2.565 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.691 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.681 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 83.2 t60 35.02 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.992 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.3 tt 175.65 -44.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.193 0.997 . . . . 0.0 109.507 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.81 -13.77 82.06 Favored Glycine 0 C--N 1.274 -2.877 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.428 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.25 -45.39 8.65 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.46 -0.87 . . . . 0.0 108.838 177.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 162.36 12.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.89 11.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 19' ' ' ALA . 95.4 t -145.12 -7.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.11 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.1 m120 100.6 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.89 1.369 . . . . 0.0 110.103 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.65 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.8 t-80 -167.42 -136.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.219 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.65 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.5 m-85 46.47 31.6 1.36 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -53.47 131.66 38.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.862 0.363 . . . . 0.0 110.51 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.98 -23.62 72.85 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.0 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.5 m -53.03 95.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 mt -69.6 -26.76 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.233 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.402 ' H ' ' H ' ' A' ' 7' ' ' LYS . 13.2 p90 -161.12 -9.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.66 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' H ' ' H ' ' A' ' 6' ' ' PHE . 11.7 ttmm -56.07 -30.97 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.34 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -123.23 50.32 1.57 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.118 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.01 -8.05 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 14.9 ptm180 -167.43 23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.483 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.632 ' C ' ' H ' ' A' ' 13' ' ' ALA . 27.4 m-70 -144.0 146.99 33.27 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.612 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.098 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.13 -31.51 0.23 Allowed 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 125.61 1.818 . . . . 0.0 109.812 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.632 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.61 2.4 0.29 Allowed 'General case' 0 N--CA 1.411 -2.397 1 N-CA-C 95.339 -5.8 . . . . 0.0 95.339 165.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.098 ' H ' ' C ' ' A' ' 12' ' ' ALA . 17.8 tttp -116.19 -168.81 1.49 Allowed 'General case' 0 C--N 1.394 2.504 0 CA-C-N 109.479 -3.509 . . . . 0.0 111.561 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m-70 34.1 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.946 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.38 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.55 -14.05 81.41 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 105.486 -3.046 . . . . 0.0 105.486 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.449 ' CE1' ' HZ2' ' A' ' 14' ' ' LYS . 1.2 m170 -93.78 -48.48 6.29 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 114.398 -0.901 . . . . 0.0 109.77 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 171.69 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.66 9.32 1.1 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 19' ' ' ALA . 98.2 t -146.95 -8.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.784 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 25.6 m-20 97.94 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.702 1.251 . . . . 0.0 110.334 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 55.7 m80 -157.48 -160.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.448 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 55.21 22.75 4.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.572 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.289 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.25 -70.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 110.624 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.25 -24.64 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.965 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.0 p -58.9 122.25 13.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.443 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.493 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.9 mt -69.77 -50.89 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 54.9 m-85 -161.09 -3.82 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' C ' ' H ' ' A' ' 9' ' ' GLY . 3.4 mptp? -58.1 -59.41 5.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.163 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.484 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 54.9 t-80 -76.97 40.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -177.74 20.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -166.41 34.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.115 0.483 . . . . 0.0 110.047 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.643 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.6 t-80 -156.58 145.39 20.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.139 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.41 -31.38 0.22 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.825 1.953 . . . . 0.0 109.629 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.1 0.3 Allowed 'General case' 0 N--CA 1.411 -2.399 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.139 ' H ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.2 -169.3 1.58 Allowed 'General case' 0 C--N 1.393 2.475 0 CA-C-N 109.423 -3.535 . . . . 0.0 111.737 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.696 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.23 19.64 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.791 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 173.87 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 CA-C-O 122.054 0.93 . . . . 0.0 109.567 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.17 -12.87 84.21 Favored Glycine 0 C--N 1.274 -2.89 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.441 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.78 -44.49 8.11 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.075 177.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 162.3 13.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.12 9.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 19' ' ' ALA . 59.8 t -144.76 -9.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.324 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t30 104.38 -36.79 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.628 1.205 . . . . 0.0 110.214 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.633 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 20.8 t-80 -170.38 -126.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.379 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.633 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 97.1 m-85 53.44 11.99 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.559 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.2 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' C ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.439 ' CG ' ' C ' ' A' ' 1' ' ' GLY . 9.7 m-90 -155.65 -5.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.449 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.76 2.56 61.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.16 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 m -68.37 125.04 25.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.523 ' C ' ' H ' ' A' ' 7' ' ' LYS . 19.1 tt -72.73 71.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.591 0.71 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.522 ' CG ' ' NH2' ' A' ' 10' ' ' ARG . 47.1 m-85 55.81 4.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.93 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 5' ' ' ILE . 81.4 tttt -65.14 -21.57 66.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 17.6 t-80 -76.52 9.29 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.77 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' NH2' ' CG ' ' A' ' 6' ' ' PHE . 28.1 ttm180 -171.31 34.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.407 . . . . 0.0 110.208 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.65 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.1 t60 -157.3 147.3 20.69 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.54 -31.6 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.758 1.912 . . . . 0.0 110.048 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 2.1 0.3 Allowed 'General case' 0 N--CA 1.412 -2.349 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 165.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.3 tttt -116.08 -168.79 1.49 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.696 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.677 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.4 t-80 34.23 19.31 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.847 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 174.57 -46.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 CA-C-O 122.308 1.052 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.54 -14.23 77.57 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.411 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.33 -46.88 7.16 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.523 -0.839 . . . . 0.0 109.559 178.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.88 14.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.93 5.65 1.03 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.9 t -144.6 -8.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.343 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 15.5 t30 105.35 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.578 1.174 . . . . 0.0 109.958 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.549 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 2.2 p-80 -170.58 107.74 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -59.92 -9.54 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.453 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 3.6 m0 -64.29 -138.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.688 0.28 . . . . 0.0 110.383 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.38 27.86 0.16 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.851 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -61.52 92.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -66.28 77.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.473 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 54.43 24.21 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.771 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -75.6 -44.47 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.626 ' N ' ' HD1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.38 50.55 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.0 -18.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -120.56 8.81 10.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.202 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.659 ' C ' ' H ' ' A' ' 13' ' ' ALA . 48.2 t-80 -156.75 145.65 20.12 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.047 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.74 -31.65 0.23 Allowed 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 125.835 1.959 . . . . 0.0 109.889 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.46 2.14 0.29 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.047 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttp -116.24 -169.09 1.54 Allowed 'General case' 0 C--N 1.393 2.497 0 CA-C-N 109.435 -3.53 . . . . 0.0 111.68 177.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.686 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.36 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.961 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.12 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.61 0 CA-C-O 122.015 0.912 . . . . 0.0 109.524 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.35 -13.29 83.42 Favored Glycine 0 C--N 1.276 -2.781 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.426 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.5 m170 -94.66 -47.52 6.47 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.709 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 171.0 12.85 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.26 7.45 1.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.373 0.606 . . . . 0.0 109.388 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.3 t -148.31 -9.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.106 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 39.8 t-20 101.66 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.463 1.102 . . . . 0.0 110.084 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' LEU . 76.4 m80 -150.48 112.85 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.383 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 61.8 t80 -53.8 -10.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' HIS . 14.9 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.446 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -54.98 132.85 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.626 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 4' ' ' SER . . . -76.87 -13.68 83.37 Favored Glycine 0 C--N 1.33 0.228 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 3' ' ' GLY . 12.7 p 59.92 118.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.707 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 7' ' ' LYS . 16.5 pt -78.01 45.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.624 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 10' ' ' ARG . 4.6 m-85 74.3 -12.5 0.88 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 9' ' ' GLY . 55.6 tttp -55.67 -37.58 68.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.489 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -73.43 11.05 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.344 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -154.81 6.59 0.3 Allowed Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 6' ' ' PHE . 51.2 mtt-85 -156.18 163.55 39.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.659 ' C ' ' H ' ' A' ' 13' ' ' ALA . 39.7 m80 60.08 136.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.544 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.69 -32.43 0.24 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.631 1.832 . . . . 0.0 109.637 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.18 1.32 0.32 Allowed 'General case' 0 N--CA 1.41 -2.431 1 N-CA-C 95.34 -5.8 . . . . 0.0 95.34 164.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.1 tttt -114.62 -169.05 1.47 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.592 -3.458 . . . . 0.0 111.843 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 56.8 m-70 34.44 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.763 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 174.61 -46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-O 122.2 1.0 . . . . 0.0 109.422 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -13.69 80.06 Favored Glycine 0 C--N 1.271 -3.071 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.431 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.27 -43.14 9.45 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.643 -0.778 . . . . 0.0 109.853 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.226 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.93 -17.89 0.16 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.55 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.613 ' H ' ' C ' ' A' ' 19' ' ' ALA . 24.0 t -149.24 -32.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.759 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 156.87 -47.7 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -166.98 68.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.556 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -58.22 -21.66 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.566 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.481 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -70.14 -163.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.744 0.307 . . . . 0.0 110.501 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.7 21.58 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.038 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.9 p -168.73 148.13 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.509 ' C ' ' H ' ' A' ' 7' ' ' LYS . 6.3 mm -79.5 59.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.996 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 54.2 8.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 5' ' ' ILE . 65.6 tttm -66.38 -57.0 8.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -80.15 35.83 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -167.1 16.03 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.099 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -165.51 29.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.1 t-80 -158.85 146.8 17.96 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.72 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.991 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.97 0.24 Allowed 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 125.791 1.932 . . . . 0.0 109.991 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.92 0.29 Allowed 'General case' 0 N--CA 1.412 -2.35 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 165.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.991 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttp -115.59 -169.68 1.63 Allowed 'General case' 0 C--N 1.393 2.465 0 CA-C-N 109.323 -3.58 . . . . 0.0 111.623 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.681 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.5 t60 34.47 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.033 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 176.07 -43.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 CA-C-O 122.093 0.949 . . . . 0.0 109.477 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.55 -14.48 81.99 Favored Glycine 0 C--N 1.274 -2.863 0 N-CA-C 105.197 -3.161 . . . . 0.0 105.197 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.438 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -90.29 -49.38 6.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.179 177.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.57 13.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.16 0.288 . . . . 0.0 110.309 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.48 7.85 1.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.9 t -141.71 -9.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t-20 105.17 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.607 1.192 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.0 t-80 84.71 26.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.008 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.38 -13.66 62.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.277 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -73.88 173.09 10.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.13 -14.69 76.48 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.861 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 m 59.56 148.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -98.67 -26.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.494 ' C ' ' H ' ' A' ' 8' ' ' HIS . 74.6 m-85 -144.3 57.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 53.79 9.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.494 ' H ' ' C ' ' A' ' 6' ' ' PHE . 10.8 t-80 48.93 19.37 0.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.528 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.48 -17.71 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.184 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 69.83 43.12 0.97 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.837 0.351 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 98.5 m-70 -136.48 92.02 2.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.318 0.58 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 138.74 -32.86 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -0.39 0.58 Allowed 'General case' 0 N--CA 1.414 -2.25 1 N-CA-C 95.398 -5.779 . . . . 0.0 95.398 164.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.029 ' H ' ' C ' ' A' ' 12' ' ' ALA . 31.9 tttt -114.59 -168.78 1.42 Allowed 'General case' 0 C--N 1.391 2.378 0 CA-C-N 109.441 -3.527 . . . . 0.0 112.001 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.717 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 81.4 m-70 33.45 21.7 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.833 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.75 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.237 1.018 . . . . 0.0 109.452 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.37 -11.5 80.32 Favored Glycine 0 C--N 1.276 -2.751 0 N-CA-C 104.848 -3.301 . . . . 0.0 104.848 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.499 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -91.76 -36.75 13.39 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.843 178.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.45 26.22 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.707 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.13 0.15 0.05 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.269 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.582 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.5 t -151.47 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.266 0.079 . . . . 0.0 110.823 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.64 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -178.87 -89.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.64 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 1.7 t60 -166.51 50.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.428 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 48.4 t80 -74.58 -15.81 60.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.585 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.501 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -70.13 -68.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.489 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.22 -15.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.0 m 52.08 -178.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.851 0.358 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' C ' ' H ' ' A' ' 7' ' ' LYS . 5.4 pt -152.69 76.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.778 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.47 ' H ' ' CE1' ' A' ' 8' ' ' HIS . 5.5 m-85 75.54 -40.36 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.632 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 9' ' ' GLY . 62.7 mttp -50.9 -23.73 3.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.606 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' CE1' ' H ' ' A' ' 6' ' ' PHE . 4.6 p-80 -61.98 0.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.269 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . 166.68 34.21 0.02 OUTLIER Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.729 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -154.15 27.75 0.46 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.658 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.6 t60 -157.52 146.25 19.54 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.632 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.99 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 125.71 1.881 . . . . 0.0 109.898 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.27 1.95 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.044 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.061 ' H ' ' C ' ' A' ' 12' ' ' ALA . 31.4 tttt -115.69 -169.26 1.55 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.744 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 33.89 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.792 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.4 tt 174.37 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-O 122.202 1.001 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.0 -13.86 80.66 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.495 -3.042 . . . . 0.0 105.495 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -91.05 -43.53 9.87 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.674 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.37 41.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.221 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.7 -16.99 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.587 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.7 t -148.95 -34.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t30 155.28 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.827 0.704 . . . . 0.0 109.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.581 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 29.4 t60 -162.89 -117.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.581 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 59.6 t80 54.62 18.0 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.336 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -67.69 173.34 4.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.568 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.25 0.24 64.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.94 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -52.65 98.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mt -76.34 -40.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -146.82 -14.64 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.417 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -50.23 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.723 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -77.39 66.21 3.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.65 -13.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.889 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -148.16 14.67 1.02 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.85 0.357 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.639 ' C ' ' H ' ' A' ' 13' ' ' ALA . 91.8 m-70 -152.8 145.39 24.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.55 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.073 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.36 -31.25 0.22 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.701 1.876 . . . . 0.0 109.726 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.639 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 2.02 0.31 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.353 -5.795 . . . . 0.0 95.353 164.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.073 ' H ' ' C ' ' A' ' 12' ' ' ALA . 13.2 ttpt -115.9 -169.28 1.56 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.424 -3.535 . . . . 0.0 111.577 176.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.2 t-80 34.45 17.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.001 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.7 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.123 0.964 . . . . 0.0 109.565 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -13.68 83.17 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 105.386 -3.086 . . . . 0.0 105.386 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.18 -47.42 7.53 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.211 -0.995 . . . . 0.0 109.251 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.45 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.273 0.358 . . . . 0.0 110.135 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.07 10.2 1.54 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 92.5 t -142.63 -9.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 22.7 t-20 101.89 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.464 1.102 . . . . 0.0 110.813 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.622 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.5 t60 81.63 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.237 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.622 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.1 m-85 50.36 31.95 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.244 -179.923 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -66.27 -164.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.611 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.51 23.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.867 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m 55.12 82.64 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 110.429 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 pt -71.53 87.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.342 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 57.09 11.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 9' ' ' GLY . 64.5 tttp -72.4 -57.26 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.378 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 1.3 t60 -79.96 42.6 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.434 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -159.5 -4.53 0.06 OUTLIER Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.734 -0.547 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 61.9 mtp180 -144.32 6.87 1.32 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.232 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.647 ' C ' ' H ' ' A' ' 13' ' ' ALA . 90.6 m-70 -156.38 144.85 19.94 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.098 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.96 -31.93 0.23 Allowed 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 125.737 1.898 . . . . 0.0 109.892 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.647 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.91 0.31 Allowed 'General case' 0 N--CA 1.412 -2.37 1 N-CA-C 95.406 -5.776 . . . . 0.0 95.406 165.057 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.098 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.3 tttm -115.15 -169.78 1.63 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.5 -3.5 . . . . 0.0 111.803 176.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.0 t60 34.39 17.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.108 178.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 176.38 -44.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.224 1.011 . . . . 0.0 109.078 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.35 -13.93 82.4 Favored Glycine 0 C--N 1.274 -2.905 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 174.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.434 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.1 m170 -92.28 -47.91 6.96 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.465 -0.867 . . . . 0.0 109.457 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.38 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.641 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.54 7.83 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.411 0.624 . . . . 0.0 109.46 -179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.9 t -146.22 -8.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.958 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.0 t-20 102.52 -37.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.631 1.207 . . . . 0.0 110.031 -179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -173.93 104.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.618 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 48.2 t80 -171.68 -4.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.13 180.0 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.6 m95 53.57 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 172.87 6.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.253 -0.499 . . . . 0.0 111.918 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.444 ' H ' ' H ' ' A' ' 3' ' ' GLY . 52.3 p -169.58 119.97 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 0.0 110.445 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 7' ' ' LYS . 9.4 pt -73.46 69.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 54.98 9.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.769 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 5' ' ' ILE . 60.6 tttp -55.01 -68.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.363 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -82.44 68.59 8.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.78 -16.07 0.03 OUTLIER Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 11' ' ' HIS . 13.9 ptm180 -151.54 -0.97 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.215 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.659 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.9 m170 -135.82 146.75 47.84 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.278 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.101 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.23 -31.62 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.734 1.896 . . . . 0.0 109.851 -177.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 1.99 0.31 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.443 -5.762 . . . . 0.0 95.443 165.051 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.101 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.7 tttp -115.57 -169.12 1.52 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.406 -3.543 . . . . 0.0 111.737 176.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.692 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.8 t60 33.72 19.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.89 178.044 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.31 -45.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.125 0.964 . . . . 0.0 109.551 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.05 -14.33 80.44 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 105.402 -3.079 . . . . 0.0 105.402 174.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.446 ' HD1' ' HZ3' ' A' ' 14' ' ' LYS . 1.1 m170 -91.67 -48.96 6.54 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.325 -0.937 . . . . 0.0 109.182 177.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.08 14.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.29 9.63 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.5 t -144.63 -10.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.845 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.2 t-20 105.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.542 1.151 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 4.9 t-160 83.98 28.02 0.08 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.372 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.61 -19.37 25.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -55.07 160.25 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.707 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.07 -18.06 79.64 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.1 t -164.48 173.67 11.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 110.467 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 7' ' ' LYS . 18.4 mt -74.55 70.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.432 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 52.45 13.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 5' ' ' ILE . 18.4 tptm -62.53 -50.1 72.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 46.84 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.475 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.85 -2.64 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.167 -0.54 . . . . 0.0 111.9 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -144.3 1.75 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 110.015 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.685 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.4 t-80 -157.22 143.6 18.02 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.324 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.85 -30.73 0.21 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.37 -177.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.685 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.87 3.29 0.24 Allowed 'General case' 0 N--CA 1.41 -2.46 1 N-CA-C 95.332 -5.803 . . . . 0.0 95.332 164.741 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.051 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.8 tttp -119.05 -168.13 1.51 Allowed 'General case' 0 C--N 1.392 2.428 0 CA-C-N 109.457 -3.52 . . . . 0.0 111.684 177.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.4 m80 33.5 23.27 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.556 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.63 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.3 tt 167.41 -34.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.166 0.984 . . . . 0.0 109.256 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.63 -12.37 77.99 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 104.902 -3.279 . . . . 0.0 104.902 174.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 18' ' ' HIS . 18.4 t-160 -92.56 -36.04 13.25 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 114.425 -0.887 . . . . 0.0 110.013 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -146.91 22.88 1.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.96 -2.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.3 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.9 -30.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.738 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -176.63 -90.16 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.011 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.497 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.1 p80 -149.75 25.99 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.48 ' N ' ' CB ' ' A' ' 19' ' ' ALA . 45.5 t80 -72.46 12.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.4 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.253 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -58.19 -99.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.7 0.286 . . . . 0.0 110.559 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.36 -14.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.6 m -81.49 69.71 8.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.765 0.317 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.48 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -44.0 -46.57 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -179.718 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 73.7 m-85 -160.12 -1.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.328 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' H ' ' H ' ' A' ' 6' ' ' PHE . 57.7 tttm -51.58 -55.81 17.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -78.19 47.66 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.83 7.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -150.43 11.72 0.7 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.662 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.1 t60 -157.49 145.24 18.82 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.114 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.81 -31.72 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.706 1.879 . . . . 0.0 109.805 -178.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.86 0.3 Allowed 'General case' 0 N--CA 1.412 -2.361 1 N-CA-C 95.303 -5.814 . . . . 0.0 95.303 164.95 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.114 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.556 -3.474 . . . . 0.0 111.876 177.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.678 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 49.3 t-80 33.91 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.787 178.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.14 -46.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 122.234 1.016 . . . . 0.0 109.319 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -13.63 80.57 Favored Glycine 0 C--N 1.271 -3.076 0 N-CA-C 105.571 -3.011 . . . . 0.0 105.571 174.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.436 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.21 -43.09 10.05 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.533 178.181 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.42 41.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.181 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.41 -15.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.612 -179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.615 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.17 -35.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.2 t30 155.53 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.806 0.691 . . . . 0.0 109.19 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -166.11 65.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.6 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 65.1 t80 -70.12 -13.59 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.451 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.005 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.537 ' CG ' ' N ' ' A' ' 3' ' ' GLY . 72.0 t-105 -64.62 174.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' CG ' ' A' ' 2' ' ' TRP . . . -74.51 4.23 36.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.231 -0.509 . . . . 0.0 111.889 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t 59.03 160.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.615 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.2 mt -80.83 67.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.749 -179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 53.91 10.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.193 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 5' ' ' ILE . 44.3 mtmt -70.76 -68.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.181 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -76.3 65.42 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.23 -26.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.108 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -157.3 17.62 0.28 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.661 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.0 t60 -157.25 145.2 19.12 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.075 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.03 -31.57 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.702 1.876 . . . . 0.0 109.75 -177.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.661 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.85 0.31 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.416 -5.772 . . . . 0.0 95.416 164.914 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.075 ' H ' ' C ' ' A' ' 12' ' ' ALA . 31.8 tttt -115.35 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.45 -3.523 . . . . 0.0 111.759 176.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.691 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 11.7 t-80 34.51 18.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.985 177.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.668 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.88 -46.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.307 1.051 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.16 -14.49 79.0 Favored Glycine 0 C--N 1.271 -3.035 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.433 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.3 -48.63 6.58 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.471 -0.865 . . . . 0.0 109.539 178.113 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 170.26 12.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.433 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.1 8.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 19' ' ' ALA . 89.5 t -145.78 -7.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.783 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.6 m-20 98.57 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.764 1.29 . . . . 0.0 110.19 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.61 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -176.76 87.15 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.352 -179.927 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -66.82 -21.38 66.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.984 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -65.21 -85.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 110.565 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.47 2.65 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.946 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 5' ' ' ILE . 13.8 t 56.4 164.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 7' ' ' LYS . 14.7 tt -73.95 83.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.491 0.662 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 44.96 16.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.389 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ILE . 34.0 ttpt -67.13 -42.38 84.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -78.34 55.13 1.51 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.608 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.99 1.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.125 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -145.09 25.9 1.38 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 110.529 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.652 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 t-80 -160.82 144.05 13.16 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.463 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.133 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.58 -31.11 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.568 1.792 . . . . 0.0 109.458 -177.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.652 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.34 0.3 Allowed 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 95.317 -5.808 . . . . 0.0 95.317 164.758 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.133 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.1 tttm -116.33 -169.29 1.59 Allowed 'General case' 0 C--N 1.393 2.468 0 CA-C-N 109.525 -3.489 . . . . 0.0 111.556 177.063 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 34.77 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.99 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 175.83 -41.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.58 0 CA-C-O 122.042 0.925 . . . . 0.0 109.471 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.1 -13.01 83.8 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 105.331 -3.108 . . . . 0.0 105.331 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.431 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.4 m170 -94.38 -46.29 7.09 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.541 178.17 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.63 13.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.772 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.55 5.92 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 20.7 t -148.13 -10.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.391 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 58.2 t-20 110.53 -42.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.632 1.208 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' C ' ' H ' ' A' ' 25' ' ' LEU . 63.2 t-80 -173.9 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.649 0.262 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.05 39.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.477 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.2 tp . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -73.82 -171.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.639 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.78 26.19 24.92 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -41.75 159.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 -179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 pt -78.02 56.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.589 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 55.55 56.71 5.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.524 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -122.24 -48.01 2.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.486 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 5.9 t60 -80.28 42.19 0.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 -13.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.195 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.16 -3.75 43.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.264 0.554 . . . . 0.0 109.802 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.5 t60 -150.16 144.73 25.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.42 -31.4 0.22 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 125.75 1.906 . . . . 0.0 109.648 -177.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.4 0.27 Allowed 'General case' 0 N--CA 1.413 -2.308 1 N-CA-C 95.363 -5.791 . . . . 0.0 95.363 164.952 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.057 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.2 tttt -116.63 -168.63 1.48 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.485 -3.507 . . . . 0.0 111.669 177.096 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.678 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.1 m-70 33.82 20.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.825 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 173.76 -43.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 122.108 0.956 . . . . 0.0 109.61 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.22 -13.24 83.48 Favored Glycine 0 C--N 1.274 -2.911 0 N-CA-C 105.57 -3.012 . . . . 0.0 105.57 174.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -94.77 -45.51 7.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.483 178.117 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.62 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.34 7.16 1.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' H ' ' C ' ' A' ' 19' ' ' ALA . 42.4 t -146.59 -9.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.369 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 37.7 t-20 103.46 -35.93 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.514 1.134 . . . . 0.0 110.058 -179.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.595 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -171.58 112.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.346 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -64.17 -1.03 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.634 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -65.14 135.26 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 4' ' ' SER . . . -70.87 -6.69 60.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.947 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 3' ' ' GLY . 31.9 p 48.55 84.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.644 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 6.8 tt -55.81 -42.96 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.416 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 40.0 m-85 -158.28 -8.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.976 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -52.09 -17.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.46 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 13.4 t-80 -72.79 3.8 4.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.826 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 22.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.197 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -96.93 -1.58 45.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.977 0.418 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.66 ' C ' ' H ' ' A' ' 13' ' ' ALA . 5.7 p80 -155.04 143.77 20.68 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.63 -31.07 0.22 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.694 1.871 . . . . 0.0 109.523 -177.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.02 0.29 Allowed 'General case' 0 N--CA 1.411 -2.391 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 165.078 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.039 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.9 ttpt -116.96 -168.18 1.42 Allowed 'General case' 0 C--N 1.393 2.498 0 CA-C-N 109.398 -3.546 . . . . 0.0 111.498 177.331 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.4 t-80 34.11 20.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.631 177.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 171.36 -46.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 CA-C-O 122.303 1.049 . . . . 0.0 109.254 -179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.69 -13.12 80.6 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.975 -2.85 . . . . 0.0 105.975 175.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -32.21 18.27 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.84 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.795 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.56 -20.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CD2' ' A' ' 15' ' ' HIS . 59.9 t -152.0 -17.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.562 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 164.58 -38.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.958 0.409 . . . . 0.0 110.017 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 31.4 t60 -171.34 26.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.352 -178.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -47.62 -18.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.303 179.935 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -165.12 -67.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.2 -6.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.904 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 m 55.75 71.03 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.663 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.492 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 12.1 mt -67.23 -37.58 79.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.165 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 59.0 m-85 -160.51 -1.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.864 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -58.64 -77.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.546 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -73.81 75.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.08 -28.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -163.74 26.26 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.344 . . . . 0.0 110.5 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.651 ' C ' ' H ' ' A' ' 13' ' ' ALA . 74.9 t60 -158.48 146.4 18.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.073 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.05 -31.31 0.22 Allowed 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 125.821 1.951 . . . . 0.0 109.738 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.651 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.79 0.26 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.313 -5.81 . . . . 0.0 95.313 164.957 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.073 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -117.37 -168.62 1.52 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.462 -3.517 . . . . 0.0 111.859 177.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.1 t60 33.86 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.331 178.124 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 172.13 -45.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 CA-C-O 122.058 0.933 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.13 76.34 Favored Glycine 0 C--N 1.272 -3.026 0 N-CA-C 105.812 -2.915 . . . . 0.0 105.812 175.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' C ' ' HD1' ' A' ' 18' ' ' HIS . 7.9 t-80 -93.29 -41.95 9.59 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.31 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.635 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.39 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.621 -179.379 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.62 -12.51 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.016 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.635 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.0 t -148.94 -36.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 121.284 -0.166 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.3 t-20 157.52 -46.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.79 95.8 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.713 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.432 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.4 t80 -170.32 1.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.71 179.965 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -63.49 -74.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.508 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.99 -5.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.04 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m 56.54 163.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 110.509 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.7 pt -66.1 -151.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.946 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -62.48 0.71 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.701 0.286 . . . . 0.0 110.814 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 5' ' ' ILE . 59.4 tttp -62.91 -46.55 87.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 110.407 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -84.54 66.99 9.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' N ' ' CB ' ' A' ' 13' ' ' ALA . . . 171.39 -30.53 0.12 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.453 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.417 ' C ' ' HD1' ' A' ' 11' ' ' HIS . 68.0 mtt-85 -78.57 -113.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.653 ' C ' ' H ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -90.14 146.28 24.41 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.201 -179.543 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.65 -32.47 0.23 Allowed 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 125.582 1.801 . . . . 0.0 110.18 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.86 0.39 0.38 Allowed 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 95.382 -5.784 . . . . 0.0 95.382 165.031 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.2 tttt -113.39 -169.93 1.59 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.138 -3.665 . . . . 0.0 112.169 176.546 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.682 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.0 m80 34.47 18.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.896 177.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.83 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 CA-C-O 122.284 1.04 . . . . 0.0 109.169 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.19 -14.62 78.98 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 105.516 -3.033 . . . . 0.0 105.516 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.439 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.72 -47.99 6.8 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.686 -0.757 . . . . 0.0 109.654 177.996 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 171.38 11.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.37 8.73 1.23 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 19' ' ' ALA . 57.7 t -148.04 -7.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.872 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 6.3 m-20 97.61 -36.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.605 1.191 . . . . 0.0 110.087 -179.452 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 75.4 m80 -158.43 -166.15 1.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.221 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 55.94 27.01 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 8.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.118 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.72 -59.44 2.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.76 6.48 67.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.09 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.4 p -72.31 154.66 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 9' ' ' GLY . 6.7 mm -67.89 81.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.095 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 55.79 46.43 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.425 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 mttp 56.88 74.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.304 179.625 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 t60 61.93 50.92 3.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.389 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.467 ' O ' ' ND1' ' A' ' 11' ' ' HIS . . . 59.34 45.77 94.93 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.037 179.066 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 67.71 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 9' ' ' GLY . 74.9 m80 -145.06 93.37 2.38 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.414 0.626 . . . . 0.0 109.638 178.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.072 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 137.45 -31.46 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -178.161 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.69 0.54 0.49 Allowed 'General case' 0 N--CA 1.413 -2.3 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 163.9 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.072 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.5 tttm -116.76 -167.89 1.37 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.383 -3.553 . . . . 0.0 111.703 177.024 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.719 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 58.1 m80 33.9 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.955 178.076 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.655 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.8 tt 171.5 -37.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.265 1.031 . . . . 0.0 109.166 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.13 -11.35 81.18 Favored Glycine 0 C--N 1.275 -2.808 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 174.119 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.444 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.3 m170 -95.86 -34.16 11.95 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.078 178.385 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.05 26.6 0.62 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.437 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.22 -11.71 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.581 ' H ' ' C ' ' A' ' 19' ' ' ALA . 90.3 t -152.96 -23.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.322 -179.31 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 38.0 t30 -170.45 -96.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.374 -179.003 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 33.4 m80 -145.51 127.2 15.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.724 -178.616 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 67.4 t80 -75.64 -4.38 39.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.124 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.486 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 92.1 m95 -158.99 -83.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 110.403 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 173.85 4.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.442 ' H ' ' H ' ' A' ' 3' ' ' GLY . 7.1 t 53.85 175.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.3 -40.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.989 179.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.01 53.54 2.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.686 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 9' ' ' GLY . 54.7 mttm 57.7 69.13 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 48.62 15.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . 85.65 55.63 2.52 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.298 179.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 57.86 37.71 27.0 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.57 179.802 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 10' ' ' ARG . 32.8 m80 -146.6 75.01 1.38 Allowed 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 178.642 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' H ' ' A' ' 14' ' ' LYS 0.278 . . 172.2 -32.19 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.513 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.73 -1.73 0.67 Allowed 'General case' 0 N--CA 1.416 -2.126 1 N-CA-C 95.548 -5.723 . . . . 0.0 95.548 164.827 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.029 ' H ' ' C ' ' A' ' 12' ' ' ALA 0.259 20.8 tttm -114.01 -167.74 1.25 Allowed 'General case' 0 C--N 1.387 2.217 0 CA-C-N 109.179 -3.646 . . . . 0.0 111.705 176.648 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.88 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.978 177.697 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.2 tt 174.22 -44.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.142 0.973 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.45 -13.43 81.72 Favored Glycine 0 C--N 1.273 -2.955 0 N-CA-C 105.843 -2.903 . . . . 0.0 105.843 174.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.46 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.7 -42.79 10.52 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.682 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 18' ' ' HIS . . . 156.33 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 61.68 7.56 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.053 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.6 t -144.88 -11.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -179.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 49.4 t30 119.13 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.607 1.192 . . . . 0.0 110.091 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.503 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.8 t60 -172.47 -8.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.643 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -76.06 32.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.9 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.206 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -168.9 -173.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.87 34.32 0.24 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.862 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -162.93 113.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.3 mt -71.8 -47.66 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 62.8 m-85 -159.93 -9.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.352 179.616 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' H ' ' H ' ' A' ' 6' ' ' PHE . 84.0 tttt -50.47 -73.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -73.88 70.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 -14.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.83 18.61 1.28 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.224 179.894 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.641 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.6 t-80 -149.52 145.94 27.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.579 179.513 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.34 -31.3 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.668 1.855 . . . . 0.0 109.719 -177.859 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.641 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.64 2.24 0.3 Allowed 'General case' 0 N--CA 1.412 -2.335 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 164.896 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.04 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.2 ttpt -115.95 -168.92 1.5 Allowed 'General case' 0 C--N 1.395 2.554 0 CA-C-N 109.448 -3.524 . . . . 0.0 111.546 176.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.4 m80 34.72 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.013 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 176.06 -44.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.204 1.002 . . . . 0.0 109.46 -179.822 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.76 -14.0 81.8 Favored Glycine 0 C--N 1.273 -2.954 0 N-CA-C 105.449 -3.061 . . . . 0.0 105.449 174.43 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.408 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.43 -47.27 7.54 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.407 177.948 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.75 11.61 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.26 8.85 1.19 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.749 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 77.4 t -144.03 -9.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.113 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.7 t-20 100.15 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.525 1.141 . . . . 0.0 110.252 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.6 t60 89.4 -38.97 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.893 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -76.58 13.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.462 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.3 tt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -75.65 126.42 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 0.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' O ' ' OG ' ' A' ' 4' ' ' SER . . . -72.44 -12.85 77.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.03 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 6' ' ' PHE . 51.4 p 48.71 95.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 7' ' ' LYS . 21.3 mt -64.59 77.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' SER . 97.2 m-85 49.82 15.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 5' ' ' ILE . 52.4 tttp -66.95 -37.82 84.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.558 179.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.89 56.62 2.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.83 -5.84 0.03 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -111.19 -113.2 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.128 0.489 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.666 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 m170 -84.63 144.44 28.6 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.279 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.21 -32.05 0.24 Allowed 'General case' 0 CA--C 1.501 -0.922 0 O-C-N 125.403 1.689 . . . . 0.0 109.613 -177.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.07 0.5 0.4 Allowed 'General case' 0 N--CA 1.413 -2.285 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 164.855 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.031 ' H ' ' C ' ' A' ' 12' ' ' ALA . 29.4 tttt -113.87 -169.66 1.56 Allowed 'General case' 0 C--N 1.39 2.369 0 CA-C-N 109.083 -3.69 . . . . 0.0 111.974 176.432 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.9 t-80 35.16 17.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.977 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 176.19 -43.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.031 0.919 . . . . 0.0 109.465 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 -14.27 82.18 Favored Glycine 0 C--N 1.272 -3.02 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 174.336 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.418 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.94 -47.83 7.09 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.464 -0.868 . . . . 0.0 109.55 177.938 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.77 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.92 10.44 1.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.682 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 19' ' ' ALA . 98.2 t -146.57 -7.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.764 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.3 m120 97.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.567 1.167 . . . . 0.0 110.228 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 96.1 m-70 -159.34 101.78 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -55.14 -14.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.04 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 26.1 m-90 -158.4 -81.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.744 0.306 . . . . 0.0 110.413 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.21 -17.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.927 179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.9 p -76.7 120.52 22.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.3 mt -71.53 -46.71 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.426 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.438 ' H ' ' H ' ' A' ' 7' ' ' LYS . 42.5 p90 -162.61 -2.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' H ' ' H ' ' A' ' 6' ' ' PHE . 38.5 tptt -65.68 -74.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.222 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -85.25 5.95 28.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 110.263 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.52 -25.83 37.84 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 16.2 ptm180 -162.25 25.28 0.11 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.024 -179.705 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.65 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 m-70 -155.52 145.54 21.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.932 0.396 . . . . 0.0 110.554 179.291 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.09 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.92 -31.85 0.23 Allowed 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 125.689 1.868 . . . . 0.0 109.657 -177.831 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.35 2.06 0.29 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 165.063 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.09 ' H ' ' C ' ' A' ' 12' ' ' ALA . 33.1 tttt -115.63 -169.69 1.63 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.821 177.098 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.692 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 34.3 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.792 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.62 -45.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.142 0.972 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.37 -13.94 81.21 Favored Glycine 0 C--N 1.273 -2.956 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.488 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.426 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.28 -43.91 9.52 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.85 178.159 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.617 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.24 -179.131 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.23 -17.05 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.535 -179.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.617 ' H ' ' C ' ' A' ' 19' ' ' ALA . 15.8 t -148.21 -34.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.4 t-20 154.22 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.501 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.1 t60 -168.67 113.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -56.42 -7.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.428 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.353 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.1 m95 51.09 -129.51 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.445 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.42 13.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.762 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m -166.06 171.35 12.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.55 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -69.37 -37.91 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.377 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -166.89 -11.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.495 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' NZ ' ' CB ' ' A' ' 7' ' ' LYS . 8.6 mtmp? -68.22 -12.53 61.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.437 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.461 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 40.8 t60 -152.55 38.63 0.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 179.964 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.76 1.7 0.28 Allowed Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -149.8 -2.07 0.42 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.689 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.7 t-80 -111.4 146.27 37.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.662 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -30.37 0.21 Allowed 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 125.663 1.852 . . . . 0.0 109.391 -177.376 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.689 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.05 3.47 0.24 Allowed 'General case' 0 N--CA 1.41 -2.444 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.602 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 26.8 tttt -119.46 -167.49 1.42 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.605 177.424 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.3 m-70 34.31 22.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 177.705 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.8 tt 169.0 -35.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.239 1.018 . . . . 0.0 109.22 -179.293 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.91 -12.12 80.27 Favored Glycine 0 C--N 1.275 -2.814 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 174.114 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 18' ' ' HIS . 1.2 t60 -93.66 -37.18 11.97 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.938 177.898 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -147.8 25.98 1.03 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.895 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 63.63 -9.25 0.14 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' H ' ' C ' ' A' ' 19' ' ' ALA . 61.4 t -151.23 -26.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.263 -179.346 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 34.3 t30 -171.18 -94.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.277 -179.173 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.557 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 0.6 OUTLIER -152.65 28.55 0.54 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.857 -179.662 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 95.8 m-85 -77.53 19.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.477 179.787 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.6 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.26 179.913 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 62.8 m95 -156.58 0.48 0.13 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.45 -7.52 38.75 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.994 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p 48.48 64.51 1.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.5 pt -61.98 -18.2 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.66 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -165.51 -13.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.771 -179.801 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 6' ' ' PHE . 64.7 mttp -53.16 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.328 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -80.48 64.21 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.57 -14.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.003 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 93.4 mtt180 -145.63 5.12 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.337 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.656 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 m80 -156.52 144.52 19.52 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.504 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.86 -31.7 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.77 1.919 . . . . 0.0 109.803 -178.073 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.656 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.63 0.31 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 95.39 -5.781 . . . . 0.0 95.39 164.961 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.025 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttm -115.04 -169.22 1.51 Allowed 'General case' 0 C--N 1.395 2.553 0 CA-C-N 109.484 -3.507 . . . . 0.0 111.802 176.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.691 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 33.98 19.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.847 178.062 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.7 -46.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 CA-C-O 122.23 1.014 . . . . 0.0 109.247 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 -13.97 79.7 Favored Glycine 0 C--N 1.271 -3.042 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 174.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -90.83 -43.86 9.79 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.582 178.177 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.249 -179.178 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 67.33 -17.82 0.14 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.705 -179.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.6 t -149.29 -31.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 122.493 -0.13 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t-20 155.69 -47.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.804 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.645 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 9.0 t60 -163.91 -130.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.645 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.7 m-85 54.23 22.43 3.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.486 -179.854 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.543 179.96 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -56.45 -15.62 4.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.807 0.337 . . . . 0.0 110.662 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.99 71.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.891 179.975 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.1 m -162.63 160.98 26.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 pt -153.49 -30.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.281 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.88 45.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 179.719 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 52.61 50.92 17.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 0.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 1.1 t60 44.13 34.6 1.01 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.753 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.03 27.22 29.13 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.94 -179.848 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 59.68 39.68 20.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.257 0.551 . . . . 0.0 109.677 -179.621 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.646 ' C ' ' H ' ' A' ' 13' ' ' ALA . 6.1 p-80 -169.62 143.43 2.73 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.07 179.441 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.102 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 72.0 -31.31 0.22 Allowed 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 125.632 1.833 . . . . 0.0 109.287 -177.566 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 2.65 0.25 Allowed 'General case' 0 N--CA 1.411 -2.415 1 N-CA-C 95.39 -5.782 . . . . 0.0 95.39 164.975 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.102 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.5 ttpp -116.19 -169.6 1.64 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.679 177.008 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.1 m-70 34.11 18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.904 178.154 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 175.07 -43.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.118 0.961 . . . . 0.0 109.477 179.838 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.4 83.49 Favored Glycine 0 C--N 1.274 -2.888 0 N-CA-C 105.411 -3.075 . . . . 0.0 105.411 174.425 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.427 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.37 -45.92 7.59 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 114.537 -0.832 . . . . 0.0 109.44 178.049 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.34 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.061 0.226 . . . . 0.0 110.444 -179.803 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.68 10.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.914 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ALA . 61.1 t -147.75 -8.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.981 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.4 m-20 99.47 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.609 1.193 . . . . 0.0 110.265 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 42.8 p-80 -171.94 97.91 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.803 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -76.25 9.61 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' HIS . 14.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.539 179.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -60.85 -114.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.595 0.236 . . . . 0.0 110.466 -179.954 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.24 -24.95 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.053 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.5 m -71.66 178.85 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 0.0 110.509 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -166.36 -43.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.655 -179.894 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -78.2 49.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.842 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' ARG . 93.0 mttt 52.76 50.79 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 0.0 110.353 179.756 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 46.9 t60 42.79 35.35 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.497 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.37 27.23 25.77 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.701 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER 57.29 35.75 26.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.458 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.658 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.9 m80 -162.12 145.25 11.75 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.064 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.2 -31.35 0.22 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.621 1.826 . . . . 0.0 109.538 -177.752 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.45 0.26 Allowed 'General case' 0 N--CA 1.412 -2.356 1 N-CA-C 95.29 -5.818 . . . . 0.0 95.29 165.033 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.064 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.1 tttt -116.35 -169.24 1.58 Allowed 'General case' 0 C--N 1.394 2.51 0 CA-C-N 109.547 -3.478 . . . . 0.0 111.795 177.074 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.683 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.7 t60 34.65 17.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.975 178.094 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 175.43 -41.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.043 0.925 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.62 -13.02 83.94 Favored Glycine 0 C--N 1.276 -2.783 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 174.412 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.433 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.01 -43.78 8.74 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 114.439 -0.88 . . . . 0.0 109.209 178.046 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.27 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.55 10.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.06 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.1 t -145.81 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.02 -179.828 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.8 t-20 102.46 -36.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.585 1.178 . . . . 0.0 110.189 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.455 ' HD1' ' C ' ' A' ' 23' ' ' HIS . 5.4 t-80 -170.48 102.95 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.649 -179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 51.9 t80 -167.68 -4.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.216 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.428 ' H ' ' H ' ' A' ' 24' ' ' TYR . 2.3 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -61.51 -29.32 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.861 0.362 . . . . 0.0 110.611 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.22 2.67 20.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.737 -179.882 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.0 m -76.84 114.04 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.643 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.433 ' C ' ' H ' ' A' ' 7' ' ' LYS . 15.2 mt -75.97 66.45 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.272 179.87 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 57.26 8.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.504 -179.911 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 5' ' ' ILE . 63.3 mttp -61.2 -35.06 76.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.473 179.889 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.406 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 43.0 p-80 -70.62 4.0 2.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -167.39 39.62 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.065 -179.962 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -164.59 41.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 179.88 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.668 ' C ' ' H ' ' A' ' 13' ' ' ALA . 51.2 t-80 -170.06 143.75 2.55 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.453 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.037 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.44 -31.45 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.596 1.81 . . . . 0.0 109.547 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.668 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.34 1.74 0.31 Allowed 'General case' 0 N--CA 1.41 -2.433 1 N-CA-C 95.386 -5.783 . . . . 0.0 95.386 164.899 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.037 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.6 tttm -115.47 -169.53 1.59 Allowed 'General case' 0 C--N 1.393 2.492 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.711 177.014 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.8 m-70 34.48 17.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.97 178.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.05 -44.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.135 0.969 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.06 -14.26 81.97 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 174.335 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -89.89 -48.12 7.43 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.246 -0.977 . . . . 0.0 109.102 177.87 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.89 13.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.49 10.85 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 94.1 t -140.23 -9.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 44.9 t-20 107.56 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.65 1.219 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 19.1 t60 80.64 34.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.035 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.47 -31.71 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.249 -179.887 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 56.5 11.22 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.793 0.33 . . . . 0.0 110.466 -179.957 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 77.41 -3.01 60.45 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.244 -0.503 . . . . 0.0 111.883 -179.931 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.6 p -55.48 127.36 29.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 0.0 110.486 179.955 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 7.8 mt -73.55 -52.64 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 45.5 m-85 -159.84 -8.64 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.18 179.736 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' H ' ' A' ' 6' ' ' PHE . 34.2 tptt -54.96 -69.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.175 179.997 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -82.91 67.2 8.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.302 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.98 -23.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.235 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.932 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -153.22 15.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 53.8 t-80 -164.51 145.0 7.83 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.868 179.407 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -31.71 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.706 1.879 . . . . 0.0 109.99 -178.087 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 1.88 0.32 Allowed 'General case' 0 N--CA 1.413 -2.32 1 N-CA-C 95.389 -5.782 . . . . 0.0 95.389 164.922 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.515 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.71 176.895 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 41.5 m80 33.94 18.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.995 178.094 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.6 tt 175.29 -43.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-O 122.011 0.91 . . . . 0.0 109.483 179.842 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -13.89 82.68 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.325 -3.11 . . . . 0.0 105.325 174.34 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.434 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -91.25 -47.58 7.42 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 114.368 -0.916 . . . . 0.0 109.23 177.95 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.6 14.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 56.82 11.29 0.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.873 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 97.1 t -140.85 -9.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 17.8 t-20 106.85 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.603 1.19 . . . . 0.0 110.427 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 1.2 t-80 83.05 -1.09 1.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.216 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -76.38 -7.85 55.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.501 -179.99 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -66.97 -61.24 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.523 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.04 16.81 80.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.258 -0.496 . . . . 0.0 111.974 -179.957 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 p -166.16 101.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 0.0 110.554 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.5 mt -66.9 76.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.374 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 52.73 10.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.568 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 5' ' ' ILE . 56.5 mttm -54.35 -50.7 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.434 179.897 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.05 45.42 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.19 9.71 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.443 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 77.6 mtp180 -147.05 18.86 1.25 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.356 . . . . 0.0 110.189 179.975 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.628 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.0 m80 -151.68 147.01 26.21 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 179.636 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.017 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.89 0.23 Allowed 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 125.678 1.861 . . . . 0.0 110.018 -178.227 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.628 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 95.426 -5.768 . . . . 0.0 95.426 165.158 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.017 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.9 tttm -115.51 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 109.409 -3.541 . . . . 0.0 111.818 177.058 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.2 t60 33.99 19.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.86 177.842 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.48 -45.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.363 -179.982 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.43 -13.99 81.28 Favored Glycine 0 C--N 1.273 -2.971 0 N-CA-C 105.406 -3.078 . . . . 0.0 105.406 174.317 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.431 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.52 9.65 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 114.495 -0.853 . . . . 0.0 109.677 178.111 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.67 41.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.176 -179.076 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.92 -19.73 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.471 -179.361 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.609 ' H ' ' C ' ' A' ' 19' ' ' ALA . 39.4 t -149.05 -31.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 156.09 -48.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 25.4 t60 -171.54 5.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 50.5 t80 -73.62 10.53 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.475 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.464 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.6 tt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.122 -179.969 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.491 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 78.4 m95 -157.3 137.1 12.36 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.03 0.98 61.06 Favored Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.745 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.3 m -162.32 157.33 22.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 16.6 mm -78.54 56.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.243 179.926 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 36.6 p90 42.24 19.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.295 -179.58 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' ILE . 3.0 ttmp? -87.58 -57.89 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.121 179.77 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -101.51 60.41 0.89 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.17 -19.74 0.02 OUTLIER Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.904 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.9 mtp-105 -136.48 6.46 3.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.914 0.387 . . . . 0.0 110.081 179.808 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.653 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.8 t-80 -158.88 143.64 15.88 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.427 179.537 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.06 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.37 -31.58 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.641 1.838 . . . . 0.0 109.673 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.84 0.31 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.387 -5.782 . . . . 0.0 95.387 164.838 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.06 ' H ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.6 -169.22 1.54 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.432 -3.531 . . . . 0.0 111.658 176.936 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.695 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.7 t-80 34.98 17.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.903 177.902 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.87 -46.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.413 1.101 . . . . 0.0 109.231 -179.875 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.76 79.82 Favored Glycine 0 C--N 1.272 -3.003 0 N-CA-C 105.825 -2.91 . . . . 0.0 105.825 174.627 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.82 -44.48 8.92 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.655 -0.772 . . . . 0.0 109.128 177.917 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 162.02 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.63 8.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.165 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' ALA . 74.4 t -144.06 -9.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.386 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.0 t30 105.31 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.662 1.226 . . . . 0.0 110.14 -179.837 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.636 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 16.8 t-80 -169.38 -127.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.636 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 69.7 m-85 50.18 23.54 1.2 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.799 0.333 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.989 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -61.25 -165.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.287 . . . . 0.0 110.359 179.997 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.88 10.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.253 -179.918 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t 50.42 -177.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 7' ' ' LYS . 11.8 mt -78.66 57.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.188 179.789 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 57.64 3.13 0.18 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.999 -179.832 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 5' ' ' ILE . 3.1 mmmp? -68.08 -19.76 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.16 179.795 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 58.8 t-80 -74.5 0.92 13.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.786 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.35 57.0 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.7 179.936 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -171.38 35.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.296 179.513 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.645 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.6 t-80 -169.11 145.7 3.48 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.954 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.084 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.84 -31.79 0.23 Allowed 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 125.811 1.944 . . . . 0.0 109.974 -178.306 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.645 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.74 0.3 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.327 -5.805 . . . . 0.0 95.327 165.206 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.084 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -115.94 -169.55 1.62 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.942 177.152 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.7 18.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.787 178.103 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.93 -44.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.169 0.985 . . . . 0.0 109.605 -179.871 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.91 -13.62 82.35 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 174.854 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.41 -43.19 9.35 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.831 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 160.36 11.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 11.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.697 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' H ' ' C ' ' A' ' 19' ' ' ALA . 91.4 t -145.41 -8.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.018 -179.596 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.5 m120 100.16 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.737 1.273 . . . . 0.0 110.398 -179.597 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.644 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.7 t60 -165.14 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.2 m-85 49.13 21.45 0.5 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.756 0.313 . . . . 0.0 110.671 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.466 -179.987 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -51.6 147.81 6.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.86 0.362 . . . . 0.0 110.488 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.14 -24.56 68.5 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.107 -179.899 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -71.51 86.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.684 -179.866 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.483 ' C ' ' H ' ' A' ' 7' ' ' LYS . 9.8 mm -66.9 84.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.432 179.857 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 53.09 10.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.539 -179.97 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 5' ' ' ILE . 47.0 tttp -61.4 -65.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -70.99 76.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.976 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 -27.15 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.056 -0.593 . . . . 0.0 111.99 179.972 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -127.23 12.54 7.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.396 -179.97 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.672 ' C ' ' H ' ' A' ' 13' ' ' ALA . 40.0 t60 -162.85 144.91 10.36 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 179.378 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -30.8 0.21 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.866 1.978 . . . . 0.0 109.75 -177.819 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.83 3.05 0.25 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 164.808 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.4 tttp -118.2 -168.31 1.5 Allowed 'General case' 0 C--N 1.394 2.517 0 CA-C-N 109.606 -3.452 . . . . 0.0 111.687 177.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.69 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.3 m-70 33.71 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.418 178.186 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 172.87 -43.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 179.84 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.41 78.64 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 174.703 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 22' ' ' ASN . 6.9 t-80 -92.85 -43.45 8.98 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.344 178.099 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.641 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 46.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.468 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 64.17 -18.69 0.07 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.961 -179.589 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.641 ' H ' ' C ' ' A' ' 19' ' ' ALA . 25.7 t -148.76 -32.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.03 -179.834 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.6 t-20 158.34 -49.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.607 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -171.81 62.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.394 -179.784 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -56.63 -24.33 47.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.491 -179.889 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -61.37 -156.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.46 -37.14 94.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.726 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -68.16 115.32 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.301 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 10.1 mt -70.88 -41.87 77.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.531 -179.801 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 60.8 m-85 -158.84 5.64 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.302 179.752 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -66.7 -74.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -179.948 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -83.58 73.87 10.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.473 179.937 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.23 -30.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.159 -179.953 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -162.32 33.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.605 -179.949 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.662 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.3 t60 -160.08 144.53 14.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.412 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.078 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.78 -29.18 0.19 Allowed 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 125.521 1.763 . . . . 0.0 109.798 -177.934 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.13 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 1 N-CA-C 94.819 -5.993 . . . . 0.0 94.819 164.293 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.078 ' H ' ' C ' ' A' ' 12' ' ' ALA . 11.6 tttt -116.96 -160.28 0.76 Allowed 'General case' 0 C--N 1.397 2.657 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.637 176.967 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.609 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.7 t60 30.62 20.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.448 0.699 . . . . 0.0 112.199 178.59 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 173.14 -48.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-O 122.435 1.112 . . . . 0.0 109.228 -179.27 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.6 -13.67 71.61 Favored Glycine 0 C--N 1.27 -3.09 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 175.297 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.403 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.95 -44.5 7.33 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 114.546 -0.827 . . . . 0.0 109.455 178.216 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.46 10.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -179.943 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.61 7.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.981 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.5 t -144.75 -8.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.919 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 61.5 t30 102.18 -37.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.525 1.141 . . . . 0.0 110.4 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -173.8 78.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 54.3 t80 -72.88 -19.08 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.502 179.828 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.433 179.947 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -171.11 -174.31 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.57 41.29 0.36 Allowed Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.968 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -153.16 98.18 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 110.336 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' C ' ' H ' ' A' ' 7' ' ' LYS . 17.1 mt -66.25 77.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.278 179.967 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 54.08 10.4 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' GLY . 29.3 mmtp -57.39 -39.83 76.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.203 179.639 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -74.07 12.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 179.931 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -164.09 37.59 0.31 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.937 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -162.08 33.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.08 0.467 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.672 ' C ' ' H ' ' A' ' 13' ' ' ALA . 38.8 t-80 -165.71 143.02 5.59 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.702 179.454 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.043 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 72.01 -30.92 0.22 Allowed 'General case' 0 CA--C 1.497 -1.069 0 O-C-N 125.632 1.833 . . . . 0.0 109.212 -177.513 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.3 0.29 Allowed 'General case' 0 N--CA 1.41 -2.467 1 N-CA-C 95.273 -5.825 . . . . 0.0 95.273 164.848 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.043 ' H ' ' C ' ' A' ' 12' ' ' ALA . 2.3 ttpm? -116.86 -169.43 1.64 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.497 -3.502 . . . . 0.0 111.621 177.056 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.698 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 48.6 t-80 33.97 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.82 177.702 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.85 -37.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.256 1.027 . . . . 0.0 109.423 -179.363 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.33 -11.29 80.8 Favored Glycine 0 C--N 1.275 -2.853 0 N-CA-C 105.029 -3.228 . . . . 0.0 105.029 174.074 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.439 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.47 -35.87 12.74 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.776 178.212 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.42 26.76 0.59 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.641 -179.619 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 62.27 -8.18 0.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.567 179.025 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 19' ' ' ALA . 60.5 t -151.48 -25.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.254 -179.355 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -171.45 -94.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.312 -179.272 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' C ' ' H ' ' A' ' 25' ' ' LEU . 13.8 t-160 -158.86 17.98 0.19 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.448 -179.589 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -70.96 8.33 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 23' ' ' HIS . 16.3 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.217 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 58.31 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.649 0.261 . . . . 0.0 110.727 179.933 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 164.86 -27.68 0.2 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.855 180.0 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -77.23 92.82 3.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 -179.933 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.499 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 11.8 pt -61.69 -34.81 63.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.369 179.891 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 66.6 m-85 -160.96 -5.65 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 179.814 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -49.07 -55.25 12.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -74.62 70.42 1.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.516 179.898 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.16 -42.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.048 -179.979 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -114.66 2.98 14.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.842 0.353 . . . . 0.0 110.424 179.949 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.655 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 t60 -151.64 145.44 25.08 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.659 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.082 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.93 -31.71 0.23 Allowed 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.734 1.896 . . . . 0.0 109.848 -178.008 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.91 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.422 -5.77 . . . . 0.0 95.422 165.085 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.082 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.51 -169.18 1.53 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.424 -3.534 . . . . 0.0 111.744 177.081 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.7 t60 33.92 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.816 177.966 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.24 -46.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.288 1.042 . . . . 0.0 109.306 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.61 -14.01 79.94 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 174.517 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.452 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.02 9.99 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.624 178.21 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.28 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.251 -179.054 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.48 -18.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.523 -179.435 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.606 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.9 t -148.29 -32.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.908 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 155.19 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.982 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.437 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -164.2 65.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.621 -179.866 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.42 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 62.0 t80 -50.84 -14.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -66.75 -61.24 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.25 15.15 56.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.073 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -165.79 56.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 0.0 110.492 179.992 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.7 tt -82.22 -43.88 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.758 -179.905 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -90.97 -35.74 14.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.954 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -51.4 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.914 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.422 ' HD1' ' C ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -77.9 65.34 3.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.303 179.791 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.97 -30.69 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -153.7 28.05 0.49 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.849 0.356 . . . . 0.0 110.366 179.907 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.654 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.2 t60 -163.61 146.15 9.77 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.376 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.092 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.83 -31.62 0.23 Allowed 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 125.775 1.922 . . . . 0.0 109.956 -178.072 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.13 0.29 Allowed 'General case' 0 N--CA 1.411 -2.385 1 N-CA-C 95.341 -5.8 . . . . 0.0 95.341 164.995 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.092 ' H ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.96 -169.33 1.58 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.825 177.012 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.0 t60 33.95 18.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.991 178.169 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.18 -42.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 CA-C-O 122.093 0.949 . . . . 0.0 109.459 179.817 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.39 -13.29 83.72 Favored Glycine 0 C--N 1.276 -2.77 0 N-CA-C 105.355 -3.098 . . . . 0.0 105.355 174.168 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.425 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -94.01 -46.46 7.14 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.615 178.15 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 170.4 10.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.63 -179.764 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.15 10.36 1.21 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.722 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 66.0 t -148.87 -8.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.628 -179.723 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.0 m120 96.48 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.545 1.153 . . . . 0.0 110.169 -179.555 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -172.54 93.15 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.524 179.969 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.47 11.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.836 -179.812 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -52.12 174.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 110.595 179.996 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' O ' ' OG ' ' A' ' 4' ' ' SER . . . -72.35 -14.17 77.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.898 179.915 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' PHE . 78.1 p 49.21 78.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 110.781 -179.973 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.8 mm -60.82 79.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 4' ' ' SER . 37.2 m-85 53.06 10.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.621 -179.863 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 5' ' ' ILE . 62.1 tttm -61.19 -38.51 86.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.329 179.99 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -65.3 -0.4 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.041 179.663 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -143.48 -164.53 10.35 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.825 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.06 -118.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.472 -179.973 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -79.13 72.93 5.7 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.986 0.898 . . . . 0.0 110.056 -179.915 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.975 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.276 . . 174.81 -32.06 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 112.635 -2.075 . . . . 0.0 106.782 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -2.62 0.79 Allowed 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 164.663 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.975 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.252 20.5 tttm -112.75 -168.13 1.28 Allowed 'General case' 0 C--N 1.389 2.314 0 CA-C-N 109.206 -3.634 . . . . 0.0 112.13 176.515 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.707 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 44.9 m80 34.23 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.812 177.879 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 175.47 -47.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.855 0 CA-C-O 122.269 1.033 . . . . 0.0 109.158 -179.749 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.88 -14.15 78.56 Favored Glycine 0 C--N 1.274 -2.903 0 N-CA-C 105.636 -2.985 . . . . 0.0 105.636 174.736 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.451 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.92 -44.02 9.63 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.673 178.059 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.14 42.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.321 -179.084 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.81 -15.9 0.11 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.602 -179.435 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.631 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.4 t -148.79 -35.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.9 t30 154.78 -44.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.911 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.6 t60 -168.83 50.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.519 -179.88 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -64.52 -28.34 69.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.228 -179.924 . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -62.41 -176.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 -179.933 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.83 16.06 52.49 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.915 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.425 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 26.2 m -149.04 86.6 1.5 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 110.52 -179.87 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 1.6 mp -81.27 -16.92 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.975 179.955 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -160.56 -19.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -49.15 -46.96 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 179.983 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.425 ' CD2' ' N ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -78.35 47.72 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.94 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -170.81 -9.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.144 -179.942 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 79.4 mtt-85 -136.19 15.86 3.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.662 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.8 m80 -157.53 144.04 17.92 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.369 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.096 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.5 -31.23 0.22 Allowed 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 125.603 1.814 . . . . 0.0 109.485 -177.823 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.41 1.87 0.31 Allowed 'General case' 0 N--CA 1.41 -2.428 1 N-CA-C 95.35 -5.796 . . . . 0.0 95.35 164.981 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.096 ' H ' ' C ' ' A' ' 12' ' ' ALA . 13.9 ttpt -115.54 -169.58 1.61 Allowed 'General case' 0 C--N 1.394 2.519 0 CA-C-N 109.399 -3.546 . . . . 0.0 111.655 177.012 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.677 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.7 t-80 34.44 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.079 178.092 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tp 176.33 -46.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.643 0 CA-C-O 122.371 1.082 . . . . 0.0 109.074 -179.924 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.55 -14.69 77.53 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 174.409 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -89.62 -48.71 7.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.325 -0.938 . . . . 0.0 108.885 177.823 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.4 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.995 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.18 9.99 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.938 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.3 t -139.07 -10.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.774 -179.698 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.0 t-20 108.44 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.63 1.206 . . . . 0.0 110.586 179.855 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 8.8 t60 80.08 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.171 -179.61 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -79.54 -15.76 57.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.746 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.401 -179.683 . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -52.44 -38.66 59.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 110.668 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.65 25.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.683 -179.7 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -68.81 114.77 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 110.494 179.965 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.7 mt -85.42 -29.14 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.05 3.77 18.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.938 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 9' ' ' GLY . 18.7 ttpp 54.19 103.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.487 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.437 ' CD2' ' N ' ' A' ' 8' ' ' HIS . 3.5 m170 65.48 -2.85 0.75 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.95 179.558 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -86.36 1.08 87.4 Favored Glycine 0 C--N 1.329 0.143 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' H ' ' H ' ' A' ' 11' ' ' HIS . 9.3 ptm180 -170.28 -3.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.096 -179.865 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.652 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 t-80 -102.91 147.49 26.85 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.289 179.454 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.119 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.52 -31.57 0.22 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.716 1.885 . . . . 0.0 110.099 -178.085 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.652 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.89 0.31 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.318 -5.808 . . . . 0.0 95.318 165.052 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.119 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.6 tttm -116.23 -169.0 1.53 Allowed 'General case' 0 C--N 1.393 2.473 0 CA-C-N 109.315 -3.584 . . . . 0.0 111.773 176.971 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 75.0 t60 35.02 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.784 177.96 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 174.64 -42.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.044 0.926 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.52 -13.36 83.52 Favored Glycine 0 C--N 1.275 -2.859 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.645 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.79 -44.2 7.88 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 114.634 -0.783 . . . . 0.0 109.738 178.189 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.26 12.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.501 -179.878 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.17 9.15 0.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.098 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ALA . 54.4 t -147.91 -9.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.142 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.5 t-20 101.79 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.544 1.152 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 35.6 m80 -160.58 109.67 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.466 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 77.8 t80 -74.13 11.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.295 179.64 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.1 tp . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.433 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 71.3 t-105 -168.6 5.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 62.56 11.88 37.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.951 -179.92 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 t 56.57 -179.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.57 179.995 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.9 pt -77.96 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 -179.975 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 67.36 -7.15 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 5' ' ' ILE . 63.5 tttm -44.55 -47.67 10.23 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.934 179.985 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -84.38 63.01 7.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' N ' ' CB ' ' A' ' 13' ' ' ALA . . . 171.93 -23.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.36 179.859 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -75.19 -118.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.652 ' C ' ' H ' ' A' ' 13' ' ' ALA . 31.1 m-70 -90.96 145.02 25.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.933 179.996 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.12 -31.9 0.23 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.635 1.834 . . . . 0.0 109.99 -178.138 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.652 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.19 0.93 0.36 Allowed 'General case' 0 N--CA 1.412 -2.33 1 N-CA-C 95.297 -5.816 . . . . 0.0 95.297 164.978 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.8 tttt -114.47 -169.4 1.53 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.24 -3.618 . . . . 0.0 111.87 176.621 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.6 m80 34.92 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.922 177.999 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 175.58 -43.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.114 0.959 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.72 -13.41 83.06 Favored Glycine 0 C--N 1.272 -2.977 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 174.668 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.33 -43.64 9.15 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.062 177.944 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.23 12.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.958 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.13 8.29 1.02 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.7 t -145.83 -8.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.128 -179.844 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.7 t30 103.99 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.502 1.126 . . . . 0.0 109.996 -179.739 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -173.26 103.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.479 179.743 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.438 ' H ' ' H ' ' A' ' 25' ' ' LEU . 84.1 t80 -171.58 -7.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.938 179.897 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' H ' ' A' ' 24' ' ' TYR . 34.4 mt . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 179.812 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -70.74 131.52 43.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 -179.999 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.96 2.03 71.38 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.011 179.909 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.2 m -163.34 161.89 24.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.954 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 tt -161.16 -41.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.409 179.903 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -99.11 -18.73 17.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.567 179.939 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.72 -60.53 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.444 179.813 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -78.51 50.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.92 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.59 -32.51 0.02 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.972 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -112.81 -0.84 14.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.988 0.423 . . . . 0.0 109.973 179.634 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.664 ' C ' ' H ' ' A' ' 13' ' ' ALA . 92.6 m-70 -140.62 145.41 36.61 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.449 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.67 -31.54 0.23 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.584 1.803 . . . . 0.0 109.571 -177.786 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.1 0.28 Allowed 'General case' 0 N--CA 1.412 -2.334 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 164.951 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.061 ' H ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.14 -169.24 1.57 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.395 -3.548 . . . . 0.0 111.585 177.062 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.9 t-80 34.67 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.028 178.066 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 175.78 -42.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.159 0.98 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.41 -13.57 83.25 Favored Glycine 0 C--N 1.275 -2.824 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 174.278 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.1 -46.01 8.36 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.299 -0.95 . . . . 0.0 109.066 177.957 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.49 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.845 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.11 9.32 0.94 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.103 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 89.5 t -142.83 -9.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.367 -179.843 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 25.7 t30 105.44 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.581 1.176 . . . . 0.0 110.104 -179.954 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.581 ' ND1' ' N ' ' A' ' 24' ' ' TYR . 49.8 t-80 -162.19 -100.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.581 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 62.3 t80 51.97 14.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' HIS . 13.0 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -179.989 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 94.7 m95 -157.96 -77.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.408 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.89 27.75 73.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 111.892 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.0 p -167.31 77.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.988 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt -66.59 -31.29 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.412 179.902 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' H ' ' H ' ' A' ' 7' ' ' LYS . 70.9 m-85 -153.33 -10.16 0.16 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 179.982 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' H ' ' H ' ' A' ' 6' ' ' PHE . 91.5 mttt -51.71 -75.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.787 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.67 68.06 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.464 179.798 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 -21.41 0.02 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.042 -179.896 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -162.01 17.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.642 ' C ' ' H ' ' A' ' 13' ' ' ALA . 37.5 m80 -135.42 146.29 48.13 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.518 179.663 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.104 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.65 -31.1 0.21 Allowed 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.691 1.869 . . . . 0.0 109.761 -177.985 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.642 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.59 2.07 0.31 Allowed 'General case' 0 N--CA 1.411 -2.384 1 N-CA-C 95.381 -5.785 . . . . 0.0 95.381 164.85 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.104 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.8 tttp -116.11 -168.95 1.51 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.486 -3.506 . . . . 0.0 111.627 176.941 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.679 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.2 m80 34.56 18.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.945 178.079 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.89 -42.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.096 0.95 . . . . 0.0 109.628 179.923 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.51 -12.74 84.24 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.545 -3.022 . . . . 0.0 105.545 174.457 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.482 ' CE1' ' HZ3' ' A' ' 14' ' ' LYS . 1.2 m170 -93.63 -44.19 8.31 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.258 177.969 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.99 10.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.31 10.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.829 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ALA . 97.5 t -147.78 -8.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.046 -179.58 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.6 m120 98.13 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.581 1.175 . . . . 0.0 110.192 -179.512 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 84.3 m-70 -157.84 107.67 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.436 -179.925 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -61.25 -13.63 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.994 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.001 -179.969 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -60.98 -75.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.667 179.985 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.7 59.52 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.009 179.973 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.7 p -55.87 110.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.06 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.231 0.539 . . . . 0.0 110.491 -179.963 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 47.3 55.96 7.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.85 -179.787 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 55.05 63.8 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.99 179.882 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 5.7 m80 45.92 26.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.983 179.637 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.13 53.95 4.0 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.974 -179.978 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER 55.94 31.1 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.341 0.115 . . . . 0.0 110.811 179.728 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -115.96 71.69 0.79 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.922 0.868 . . . . 0.0 110.333 179.388 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.02 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 168.73 -31.9 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.503 -2.135 . . . . 0.0 105.85 -179.655 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.75 -2.29 0.8 Allowed 'General case' 0 N--CA 1.414 -2.256 1 N-CA-C 95.458 -5.756 . . . . 0.0 95.458 164.313 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.02 ' N ' ' C ' ' A' ' 12' ' ' ALA . 35.0 tttt -112.84 -168.56 1.34 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 109.277 -3.601 . . . . 0.0 111.83 176.408 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.718 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.6 t-80 34.52 17.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.004 178.04 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.52 -44.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-O 122.124 0.964 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.19 -13.63 82.6 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 174.56 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.55 -44.79 9.34 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.683 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 162.44 11.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.786 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.31 11.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.684 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ALA . 97.9 t -144.73 -8.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.9 m120 100.68 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.768 1.293 . . . . 0.0 110.698 -179.837 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 90.8 m-70 -158.09 -94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 62.2 t80 57.25 8.52 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.652 -179.822 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 23' ' ' HIS . 16.2 tp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.336 179.876 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.021 -0.431 . . . . 0.0 112.021 . . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 56.05 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 0.0 110.713 -179.95 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 179.11 -4.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.755 -179.999 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 3' ' ' GLY . 49.3 p -173.13 113.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 pt -67.75 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.995 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.53 -7.5 58.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.878 0.371 . . . . 0.0 110.353 179.963 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 9' ' ' GLY . 61.5 tttm -57.03 -39.57 75.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.836 -179.854 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.94 77.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -179.865 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 7' ' ' LYS . . . 42.38 81.71 0.03 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.493 179.848 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -167.22 11.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 110.28 179.953 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.676 ' H ' ' HD1' ' A' ' 11' ' ' HIS . 1.2 p-80 -140.12 145.19 37.28 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 179.812 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.56 -29.6 0.19 Allowed 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 125.513 1.758 . . . . 0.0 110.117 -178.336 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.43 1.15 0.57 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 94.73 -6.026 . . . . 0.0 94.73 164.382 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 7.5 ttmt -114.71 -158.51 0.67 Allowed 'General case' 0 C--N 1.397 2.644 0 CA-C-N 109.286 -3.597 . . . . 0.0 110.106 176.268 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.0 t60 28.41 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 112.262 177.955 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 168.33 -52.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-O 122.463 1.125 . . . . 0.0 109.224 -179.143 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.05 -12.8 63.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 176.034 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -32.85 16.87 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.375 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' CB ' ' N ' ' A' ' 24' ' ' TYR . . . -167.56 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.51 -21.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.878 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.445 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 60.2 t -151.98 -18.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.025 179.905 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 166.35 -39.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.547 0.529 . . . . 0.0 110.045 -179.785 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.652 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -160.95 126.58 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 111.291 -178.616 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 75.2 t80 -66.92 -5.1 11.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.06 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 23' ' ' HIS . 20.2 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.469 179.91 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 3' ' ' GLY . 8.5 t90 54.77 -173.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.977 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 2' ' ' TRP . . . -56.96 -18.87 27.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.7 179.967 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 m -68.59 139.21 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.504 179.834 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt -75.14 67.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 -179.858 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 50.94 20.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -71.63 -66.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.398 179.97 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -93.66 70.23 4.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.382 179.838 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.96 -23.86 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.941 -179.932 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 12.7 ptm180 -167.6 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.671 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.5 m80 -158.48 145.22 17.45 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 179.412 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.09 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -30.94 0.22 Allowed 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 125.698 1.874 . . . . 0.0 109.535 -177.729 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.8 2.82 0.26 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.78 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.09 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -117.52 -168.5 1.5 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.562 -3.472 . . . . 0.0 111.689 177.159 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.691 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 37.8 m80 34.09 20.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.917 178.09 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.663 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 174.35 -42.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 122.339 1.066 . . . . 0.0 108.831 179.713 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.31 -13.05 83.99 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 105.687 -2.965 . . . . 0.0 105.687 174.398 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 22' ' ' ASN . 4.5 m170 -103.02 -7.66 21.24 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.023 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 82.53 22.04 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.239 -179.123 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.65 14.19 0.16 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.874 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.2 t -151.58 -11.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.623 -179.119 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.605 HD21 ' HD1' ' A' ' 23' ' ' HIS . 0.9 OUTLIER 104.79 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.282 0.989 . . . . 0.0 110.473 -179.657 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.605 ' HD1' HD21 ' A' ' 22' ' ' ASN . 34.2 p-80 -169.79 117.51 0.59 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -67.6 -0.99 4.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.225 179.65 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' HIS . 33.9 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.378 179.892 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -51.06 -71.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.6 179.957 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.64 -29.6 0.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.952 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.1 p 49.74 -175.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.98 -29.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.931 179.936 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 7' ' ' LYS . 27.8 p90 -168.43 -12.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.257 179.714 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' H ' ' H ' ' A' ' 6' ' ' PHE . 62.7 tttp -70.99 -20.29 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.387 179.884 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 55.5 t-80 -79.46 52.49 1.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.646 -179.987 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.56 83.55 0.23 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.205 179.858 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' H ' ' H ' ' A' ' 11' ' ' HIS . 59.3 ttt180 -164.9 -3.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.445 . . . . 0.0 109.954 179.81 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.666 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.2 t-80 -151.2 143.67 24.24 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.232 179.264 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.9 -31.34 0.22 Allowed 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.624 1.828 . . . . 0.0 109.436 -177.583 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.69 2.49 0.29 Allowed 'General case' 0 N--CA 1.412 -2.374 1 N-CA-C 95.431 -5.766 . . . . 0.0 95.431 164.844 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.025 ' H ' ' C ' ' A' ' 12' ' ' ALA . 15.3 ttpt -116.65 -169.01 1.55 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.455 -3.52 . . . . 0.0 111.456 176.97 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.699 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.2 m80 34.25 20.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.79 177.9 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.659 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.21 -37.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-O 122.364 1.078 . . . . 0.0 109.316 -179.311 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.51 -11.1 80.74 Favored Glycine 0 C--N 1.277 -2.745 0 N-CA-C 105.088 -3.205 . . . . 0.0 105.088 174.082 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.461 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -94.99 -33.94 12.55 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.407 -0.896 . . . . 0.0 109.973 178.275 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.47 23.74 0.71 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.834 -178.968 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.01 -0.34 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.244 179.322 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.589 ' H ' ' C ' ' A' ' 19' ' ' ALA . 45.0 t -152.48 -27.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 121.5 -0.08 . . . . 0.0 110.952 -179.41 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER 176.17 -85.94 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 111.554 -179.354 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.659 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 35.2 m80 -146.95 126.05 12.9 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 -178.837 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 75.4 t80 -73.72 -3.92 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.187 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.332 -0.196 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.495 179.903 . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -55.5 -91.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.53 -9.85 0.13 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -179.962 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -165.43 101.66 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt -69.68 75.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.605 -179.738 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 53.44 26.46 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.736 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -73.84 -63.41 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.235 179.665 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.38 66.55 2.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.91 -24.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.197 -179.948 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -154.7 26.18 0.44 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.88 0.372 . . . . 0.0 110.386 179.953 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.632 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t-80 -161.9 146.81 12.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.565 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.092 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.72 -31.82 0.23 Allowed 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 125.775 1.922 . . . . 0.0 110.043 -178.271 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.632 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.1 0.29 Allowed 'General case' 0 N--CA 1.413 -2.302 1 N-CA-C 95.342 -5.799 . . . . 0.0 95.342 165.157 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.092 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.5 tttt -116.17 -168.95 1.52 Allowed 'General case' 0 C--N 1.393 2.46 0 CA-C-N 109.502 -3.499 . . . . 0.0 111.648 177.018 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 34.33 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.885 177.983 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 174.6 -43.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.137 0.97 . . . . 0.0 109.547 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.36 -13.22 83.58 Favored Glycine 0 C--N 1.274 -2.862 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 174.47 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.423 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.2 m170 -93.25 -45.06 8.02 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.176 177.964 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.18 13.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.86 9.54 0.91 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.131 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 19' ' ' ALA . 83.3 t -146.37 -9.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.332 -179.762 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 40.9 t-20 103.2 -36.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.511 1.132 . . . . 0.0 110.066 -179.784 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 91.1 m-70 -160.43 106.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 67.6 t80 -59.72 -15.09 17.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.72 -67.68 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 179.989 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.39 -3.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.956 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 m 52.91 75.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.669 179.937 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.507 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.4 mt -62.64 -28.61 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.049 179.792 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' NH2' ' A' ' 10' ' ' ARG . 94.6 m-85 -76.99 26.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.581 179.92 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 5' ' ' ILE . 43.7 mttp 53.84 77.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 47.96 14.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.982 179.729 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . 79.6 73.77 1.12 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.594 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 10.2 mpt_? 55.76 46.1 23.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 110.815 179.552 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.476 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 79.2 m-70 -153.28 94.82 1.87 Allowed 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.239 0.543 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.032 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 132.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.03 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 0.23 0.55 Allowed 'General case' 0 N--CA 1.413 -2.297 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.649 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.032 ' H ' ' C ' ' A' ' 12' ' ' ALA . 28.6 tttt -115.89 -168.34 1.41 Allowed 'General case' 0 C--N 1.393 2.479 0 CA-C-N 109.504 -3.498 . . . . 0.0 111.641 176.885 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.705 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 94.3 m-70 33.73 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.836 178.257 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.78 -43.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.089 0.947 . . . . 0.0 109.596 179.88 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.35 -13.29 83.5 Favored Glycine 0 C--N 1.274 -2.893 0 N-CA-C 105.582 -3.007 . . . . 0.0 105.582 174.67 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.41 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.97 -44.76 7.91 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-N 114.538 -0.831 . . . . 0.0 109.335 177.947 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.22 10.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.899 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.75 10.7 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.839 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' ALA . 77.3 t -146.94 -8.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.848 -179.682 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.8 m-20 98.61 -36.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.729 1.268 . . . . 0.0 110.104 -179.539 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.6 p-80 -173.18 101.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 74.9 t80 -62.41 -10.13 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.485 179.996 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.061 -179.941 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -54.61 -19.77 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.88 15.39 73.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.776 -179.969 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.5 m -164.59 59.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 110.412 -179.952 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 7' ' ' LYS . 14.0 tt -60.01 105.45 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.16 0.505 . . . . 0.0 110.342 -179.89 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 44.69 17.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 -179.791 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 5' ' ' ILE . 84.1 tttt -68.82 -57.31 5.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.277 179.885 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.602 ' HD1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -83.83 40.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.552 179.788 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 27.3 0.09 OUTLIER Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.026 -179.955 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -169.15 18.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 109.994 179.941 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 67.6 m-70 -143.53 146.1 33.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.767 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.062 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.5 -29.88 0.19 Allowed 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 125.59 1.806 . . . . 0.0 110.237 -178.506 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.26 1.08 0.54 Allowed 'General case' 0 N--CA 1.411 -2.412 1 N-CA-C 94.814 -5.995 . . . . 0.0 94.814 164.541 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.062 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.9 tttm -115.11 -158.86 0.69 Allowed 'General case' 0 C--N 1.394 2.527 0 CA-C-N 109.149 -3.659 . . . . 0.0 110.175 176.397 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.7 t60 29.04 23.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 112.187 177.692 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 167.43 -52.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 CA-C-O 122.369 1.081 . . . . 0.0 109.194 -179.067 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.73 63.3 Favored Glycine 0 C--N 1.269 -3.14 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.185 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.92 -33.05 16.57 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.36 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.85 -65.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.788 179.529 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.29 -22.33 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.878 -179.693 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 t -150.6 -18.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 170.03 -38.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.237 0.336 . . . . 0.0 110.274 -179.687 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.62 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 27.3 t60 -171.72 -136.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.109 -178.99 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.62 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 76.5 m-85 53.14 27.11 5.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.0 110.765 179.773 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.036 179.993 . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -59.24 -22.64 61.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.72 4.17 69.93 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 -179.925 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.4 p -70.31 109.92 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' C ' ' H ' ' A' ' 7' ' ' LYS . 11.2 mm -75.6 66.8 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.27 4.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 5' ' ' ILE . 28.3 mmtp -63.14 -55.47 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.33 179.909 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.444 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 21.9 t60 -79.17 32.71 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.566 179.924 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -168.73 22.5 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.093 179.956 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -165.62 14.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.448 . . . . 0.0 110.158 179.891 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.627 ' C ' ' H ' ' A' ' 13' ' ' ALA . 54.0 t-80 -153.52 147.84 25.9 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.135 0.493 . . . . 0.0 110.909 179.583 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.054 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.34 -31.71 0.22 Allowed 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.905 2.003 . . . . 0.0 110.211 -178.25 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.316 1 N-CA-C 95.344 -5.799 . . . . 0.0 95.344 165.152 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.054 ' N ' ' C ' ' A' ' 12' ' ' ALA . 19.6 tttm -116.49 -168.73 1.49 Allowed 'General case' 0 C--N 1.392 2.423 0 CA-C-N 109.44 -3.527 . . . . 0.0 111.592 177.124 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.6 t60 34.75 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.834 177.881 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 174.25 -44.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 122.116 0.96 . . . . 0.0 109.633 -179.84 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.89 -13.68 82.27 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.681 -2.968 . . . . 0.0 105.681 174.718 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.67 -45.58 7.64 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 114.515 -0.843 . . . . 0.0 109.309 178.089 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.71 13.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.79 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.69 7.16 0.99 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.272 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 61.2 t -145.41 -9.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.493 -179.868 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 10.4 t-20 105.37 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.479 1.112 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.612 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 1.8 t60 -171.49 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.313 179.903 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.612 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.4 m-85 49.24 18.76 0.27 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 110.597 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.192 -179.973 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -54.63 -70.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.457 -179.831 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 176.56 -8.04 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.001 179.969 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.403 ' H ' ' H ' ' A' ' 3' ' ' GLY . 59.8 p -169.81 73.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.769 0.319 . . . . 0.0 110.539 -179.978 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 7' ' ' LYS . 11.3 mt -78.9 -40.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.564 -179.868 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.49 35.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.735 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 5' ' ' ILE . 47.5 mttp 53.1 69.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.733 179.851 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m80 48.43 21.91 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.69 179.842 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.491 ' C ' ' HE ' ' A' ' 10' ' ' ARG . . . 76.06 59.27 3.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.313 -0.47 . . . . 0.0 111.977 -179.973 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' HE ' ' C ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER 55.3 40.35 31.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.966 0.412 . . . . 0.0 110.131 -179.974 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -148.14 72.76 1.23 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.289 1.042 . . . . 0.0 110.173 178.987 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.043 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.274 . . 172.98 -30.82 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 112.133 -2.303 . . . . 0.0 106.179 179.966 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -0.73 0.55 Allowed 'General case' 0 N--CA 1.415 -2.192 1 N-CA-C 95.502 -5.74 . . . . 0.0 95.502 164.354 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.043 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.255 19.6 tttp -116.43 -167.06 1.22 Allowed 'General case' 0 C--N 1.389 2.285 0 CA-C-N 109.258 -3.61 . . . . 0.0 111.716 177.112 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.704 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.2 t60 34.73 18.99 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.875 177.862 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.84 -40.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 CA-C-O 122.141 0.972 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.15 83.61 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 105.596 -3.002 . . . . 0.0 105.596 174.487 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.476 ' O ' ' CA ' ' A' ' 22' ' ' ASN . 5.5 m170 -103.64 -7.65 20.56 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.978 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 84.52 20.3 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.389 -179.296 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.18 14.41 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 84.5 t -152.43 -10.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.455 -178.966 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.2 t-20 101.05 -34.84 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.14 0.9 . . . . 0.0 109.956 -179.308 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -171.57 101.5 0.19 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.602 -179.83 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -163.25 -1.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.287 179.845 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.251 179.819 . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 51.09 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.86 -13.93 57.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.812 179.899 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 m -58.17 112.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.581 -179.993 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 mt -67.29 -36.58 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.193 179.76 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -169.31 -11.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 9' ' ' GLY . 84.5 tttt -52.41 -61.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 179.906 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 0.8 OUTLIER -81.08 37.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.392 179.82 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -166.09 21.04 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -179.89 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' NH2' ' NE2' ' A' ' 11' ' ' HIS . 45.1 ttp85 -166.6 17.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 109.971 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.647 ' C ' ' H ' ' A' ' 13' ' ' ALA . 82.9 m-70 -146.95 147.17 30.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.423 179.577 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.996 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.21 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.727 1.892 . . . . 0.0 109.986 -178.121 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.647 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.94 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.434 -5.765 . . . . 0.0 95.434 165.194 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.996 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.3 tttp -116.04 -169.49 1.61 Allowed 'General case' 0 C--N 1.392 2.442 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.629 177.146 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.8 t60 34.89 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.946 177.861 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 175.62 -42.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.178 0.99 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.99 -13.39 83.73 Favored Glycine 0 C--N 1.276 -2.801 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 174.238 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.526 ' CE1' ' HZ3' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -91.19 -45.77 8.46 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 114.454 -0.873 . . . . 0.0 109.001 177.884 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 164.21 13.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.841 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.29 9.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.24 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ALA . 63.8 t -145.31 -8.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.335 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.6 t30 102.96 -36.28 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.526 1.142 . . . . 0.0 109.746 -179.49 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -172.52 97.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.483 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 60.1 t80 -163.67 -0.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.387 -179.925 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' H ' ' H ' ' A' ' 24' ' ' TYR . 13.1 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.615 179.965 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -56.56 147.0 23.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.04 -33.31 85.09 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -77.65 111.23 13.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.531 179.956 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.88 75.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.337 179.87 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 53.54 14.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -72.2 -61.81 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.197 179.821 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.463 ' N ' ' HD1' ' A' ' 8' ' ' HIS . 1.7 m-70 -79.96 62.8 4.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.911 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.61 -21.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.998 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -125.41 6.33 7.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.856 0.36 . . . . 0.0 110.12 179.949 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.9 m80 -151.54 146.24 25.74 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.712 179.657 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.089 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -31.92 0.24 Allowed 'General case' 0 CA--C 1.498 -1.058 0 O-C-N 125.757 1.911 . . . . 0.0 109.839 -178.004 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.64 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.51 2.37 0.28 Allowed 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 95.441 -5.763 . . . . 0.0 95.441 165.142 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.089 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -116.58 -169.07 1.56 Allowed 'General case' 0 C--N 1.391 2.407 0 CA-C-N 109.445 -3.525 . . . . 0.0 111.697 177.055 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.7 m80 33.92 21.23 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.788 177.598 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 170.21 -37.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.292 1.044 . . . . 0.0 109.33 -179.458 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.84 -11.64 81.17 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.052 -3.219 . . . . 0.0 105.052 174.07 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.471 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -93.54 -36.17 12.55 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 114.277 -0.961 . . . . 0.0 109.981 178.267 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.2 26.18 0.7 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.643 -179.58 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.41 -7.69 0.1 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.054 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' A' ' 19' ' ' ALA . 52.3 t -151.08 -24.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.353 -179.413 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 4.7 p30 -177.02 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.368 -179.291 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.631 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.0 t-160 -158.2 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.362 -179.461 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.631 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 86.2 m-85 48.79 17.44 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.319 . . . . 0.0 110.721 179.793 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.407 ' N ' ' C ' ' A' ' 23' ' ' HIS . 12.0 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.465 179.998 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -72.38 158.11 36.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 110.557 179.937 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.14 70.04 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.114 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 6' ' ' PHE . 76.5 p 50.15 71.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.476 -179.957 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.7 mm -59.84 79.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.431 -179.827 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 4' ' ' SER . 98.9 m-85 53.94 15.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.746 179.736 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.42 -68.14 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -81.84 57.88 3.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.433 179.909 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.06 15.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.046 179.985 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 52.3 ttt180 -164.55 3.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.63 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.6 m-70 -137.25 147.64 45.9 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 179.666 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.141 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.82 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.809 1.943 . . . . 0.0 109.996 -178.073 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.63 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.27 0.29 Allowed 'General case' 0 N--CA 1.412 -2.357 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.033 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.141 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.6 tttm -116.2 -169.29 1.58 Allowed 'General case' 0 C--N 1.392 2.414 0 CA-C-N 109.476 -3.511 . . . . 0.0 111.718 177.032 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.6 t-80 34.55 18.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.896 177.984 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.09 -42.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.123 0.963 . . . . 0.0 109.707 180.0 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.96 -13.68 83.41 Favored Glycine 0 C--N 1.276 -2.8 0 N-CA-C 105.433 -3.067 . . . . 0.0 105.433 174.229 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -95.09 -47.04 6.55 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.422 -0.889 . . . . 0.0 110.002 178.207 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 170.62 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.741 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.03 8.42 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.24 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 64.6 t -145.89 -9.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.171 179.967 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.06 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.657 1.223 . . . . 0.0 110.281 -179.98 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -167.93 94.88 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.493 -179.908 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 58.9 t80 -162.95 0.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.242 179.996 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.405 ' H ' ' H ' ' A' ' 24' ' ' TYR . 1.9 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 95.8 m95 -158.74 -174.57 4.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 110.479 179.945 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.34 27.68 0.23 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 -179.986 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -170.48 92.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.994 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.7 tt -70.2 -40.58 78.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.451 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 44.8 m-85 -161.58 -8.74 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.897 179.231 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -47.49 -71.5 0.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.669 -179.937 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -75.27 68.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.15 -17.88 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.923 179.993 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -159.52 23.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 110.419 179.98 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.643 ' C ' ' H ' ' A' ' 13' ' ' ALA . 57.8 t-80 -159.78 146.35 16.2 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.722 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.05 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.7 -31.7 0.23 Allowed 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 125.712 1.883 . . . . 0.0 110.02 -178.219 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.643 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.411 -2.394 1 N-CA-C 95.397 -5.779 . . . . 0.0 95.397 165.071 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.05 ' H ' ' C ' ' A' ' 12' ' ' ALA . 31.0 tttt -115.98 -169.21 1.55 Allowed 'General case' 0 C--N 1.394 2.524 0 CA-C-N 109.345 -3.571 . . . . 0.0 111.818 177.091 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.692 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m80 34.43 18.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.846 178.144 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.64 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 CA-C-O 122.068 0.937 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.0 -13.66 82.47 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.72 -2.952 . . . . 0.0 105.72 174.781 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.417 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.83 -44.53 8.44 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.162 177.964 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.46 11.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.994 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.51 10.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 93.1 t -145.68 -8.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.876 -179.549 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.7 m-20 99.04 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.72 1.263 . . . . 0.0 110.239 -179.622 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -168.64 97.23 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.473 179.968 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 24' ' ' TYR . 51.4 t80 -165.89 0.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.308 -179.886 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -179.98 . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -70.72 6.11 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.473 -179.96 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 71.09 1.66 42.5 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.975 179.934 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m 54.91 -179.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.768 0.318 . . . . 0.0 110.484 179.967 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.1 mt -75.31 -49.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.479 -179.882 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -156.66 -4.2 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.247 179.822 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -50.39 -74.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.39 179.945 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -80.42 65.92 5.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.335 179.689 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.36 -16.9 0.03 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.151 -179.826 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.494 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 13.0 ptm180 -160.06 22.33 0.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.699 179.843 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.684 ' C ' ' H ' ' A' ' 13' ' ' ALA . 65.4 m-70 -148.25 144.89 27.96 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.493 179.481 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.077 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.46 -28.96 0.18 Allowed 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 125.632 1.832 . . . . 0.0 109.777 -177.989 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.684 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.33 2.08 0.43 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 94.793 -6.003 . . . . 0.0 94.793 164.209 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.077 ' H ' ' C ' ' A' ' 12' ' ' ALA . 6.0 ttmt -116.68 -160.65 0.77 Allowed 'General case' 0 C--N 1.398 2.686 0 CA-C-N 109.314 -3.585 . . . . 0.0 110.647 177.062 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.1 t-80 30.16 21.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 112.222 178.659 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 173.17 -47.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-O 122.231 1.015 . . . . 0.0 109.509 -179.453 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.53 -13.73 74.49 Favored Glycine 0 C--N 1.271 -3.077 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 175.107 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.53 -46.39 6.36 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 114.432 -0.884 . . . . 0.0 109.775 178.366 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.96 11.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.632 -179.744 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.19 8.27 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.042 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 44.6 t -148.23 -9.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.883 179.948 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.5 t-20 100.47 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.515 1.134 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.502 ' C ' ' H ' ' A' ' 25' ' ' LEU . 78.6 m80 -159.74 120.56 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.668 -179.622 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -55.57 -10.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.13 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.1 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 38.5 t90 -68.08 -62.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 -179.921 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.88 -9.48 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.998 -179.967 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m -161.63 93.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -179.942 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 3.9 tp -59.84 -43.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.205 -179.905 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.487 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 54.6 m-85 -161.33 25.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.219 179.422 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -73.25 -43.03 61.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.743 -179.914 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -78.57 52.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.17 -6.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.863 -179.955 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -145.54 11.08 1.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.982 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.8 t-80 -156.12 145.08 20.42 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 179.515 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.091 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.85 -30.91 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.736 1.898 . . . . 0.0 109.801 -177.948 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.13 0.3 Allowed 'General case' 0 N--CA 1.41 -2.438 1 N-CA-C 95.288 -5.819 . . . . 0.0 95.288 164.749 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.091 ' H ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.13 -168.56 1.45 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.473 -3.512 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.674 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.0 m80 34.3 18.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.844 178.144 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.3 -46.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.21 1.005 . . . . 0.0 109.381 -179.624 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.02 -13.64 80.85 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.523 -3.031 . . . . 0.0 105.523 174.697 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.405 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.59 -43.59 9.56 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.606 178.2 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.629 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.252 -179.122 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.14 -16.15 0.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.676 -179.445 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.629 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.2 t -148.91 -35.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.931 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 156.03 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.782 0.676 . . . . 0.0 109.223 -179.953 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 37.9 t-80 -162.34 29.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.696 -179.695 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD2' ' O ' ' A' ' 24' ' ' TYR . 64.1 t80 -77.0 -7.02 54.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.476 -179.881 . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 57.56 171.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.48 -3.85 55.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.162 -0.542 . . . . 0.0 111.966 -179.966 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.2 p -69.17 87.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.526 179.971 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.02 -31.39 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.387 179.943 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -168.26 -0.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.998 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -51.16 -86.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -76.34 64.84 2.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.539 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.9 -18.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.007 -179.88 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -148.42 12.86 0.94 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.2 t-80 -158.21 145.81 18.23 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.033 0.444 . . . . 0.0 110.915 179.564 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.086 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.91 -31.92 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.721 1.888 . . . . 0.0 109.975 -178.175 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.64 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.91 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.405 -5.776 . . . . 0.0 95.405 165.09 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.086 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttp -115.48 -169.6 1.61 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.436 -3.529 . . . . 0.0 111.806 176.953 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.688 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.0 t-80 34.47 18.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.015 178.021 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 176.13 -45.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.31 1.052 . . . . 0.0 109.089 -179.932 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.0 81.54 Favored Glycine 0 C--N 1.273 -2.968 0 N-CA-C 105.499 -3.04 . . . . 0.0 105.499 174.28 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.606 ' CE1' ' HZ1' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -91.51 -47.01 7.66 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.154 178.005 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.88 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.876 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.71 8.1 1.23 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.215 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ALA . 56.3 t -144.88 -8.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.217 -179.953 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.17 -36.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.639 1.212 . . . . 0.0 110.222 -179.772 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 31.9 m80 -155.26 -168.56 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 65.28 25.83 12.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.471 179.709 . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -52.26 159.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 110.572 -179.918 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.51 72.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.915 179.986 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m 53.6 101.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.827 0.346 . . . . 0.0 110.677 -179.952 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' H ' ' HZ2' ' A' ' 7' ' ' LYS . 14.1 mm -74.1 69.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.367 179.832 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 52.66 12.29 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.977 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' HZ2' ' H ' ' A' ' 5' ' ' ILE . 1.3 ptpp? -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -89.46 68.85 7.92 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.444 179.881 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.36 -46.42 0.28 Allowed Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -179.885 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -89.9 -1.24 57.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 179.977 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.646 ' C ' ' H ' ' A' ' 13' ' ' ALA . 79.7 t60 -164.71 142.03 6.32 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 179.615 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.073 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.53 -32.14 0.23 Allowed 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 125.668 1.855 . . . . 0.0 109.805 -178.188 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.26 1.4 0.33 Allowed 'General case' 0 N--CA 1.41 -2.47 1 N-CA-C 95.444 -5.762 . . . . 0.0 95.444 165.003 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.073 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.7 tttp -114.33 -169.59 1.56 Allowed 'General case' 0 C--N 1.396 2.617 0 CA-C-N 109.48 -3.509 . . . . 0.0 111.842 176.98 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.697 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.1 t60 33.21 20.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.853 177.953 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 173.85 -47.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.695 0 CA-C-O 122.187 0.994 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.86 -14.49 78.39 Favored Glycine 0 C--N 1.271 -3.064 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 174.331 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' CD2' ' HZ2' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -87.59 -46.43 9.55 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.283 177.983 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.38 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.266 -179.386 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.64 -14.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.863 -179.666 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.2 t -149.34 -29.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 121.422 -0.111 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.8 t-20 148.56 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.944 0.777 . . . . 0.0 109.148 -179.728 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -170.28 64.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.403 -179.762 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -71.29 -19.55 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.62 -179.94 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.099 179.946 . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -50.99 144.83 8.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.595 -179.967 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.02 0.97 50.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.807 179.855 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.6 m -50.4 131.4 24.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 110.66 -179.949 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.7 mt -75.55 69.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.425 179.877 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 54.46 18.48 1.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.706 179.985 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -72.76 -53.34 11.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.352 179.829 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -76.21 65.36 2.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.553 179.87 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.12 -43.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -89.98 -1.9 58.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 110.329 179.902 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.638 ' C ' ' H ' ' A' ' 13' ' ' ALA . 4.9 p-80 -163.92 143.34 7.96 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.768 179.385 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.064 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.27 -31.92 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.76 1.912 . . . . 0.0 109.982 -178.207 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.638 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.36 1.67 0.32 Allowed 'General case' 0 N--CA 1.411 -2.41 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 165.066 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.064 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.31 -168.95 1.48 Allowed 'General case' 0 C--N 1.394 2.54 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.877 176.973 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.692 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 74.6 t60 34.31 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.795 177.861 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tt 174.29 -46.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 CA-C-O 122.24 1.019 . . . . 0.0 109.363 -179.855 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.36 -13.92 79.6 Favored Glycine 0 C--N 1.271 -3.051 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.737 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.436 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.89 -44.27 9.49 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.66 -0.77 . . . . 0.0 109.533 178.071 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.612 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.57 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.859 -0.737 . . . . 0.0 112.145 -179.311 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.51 -20.42 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.358 -179.206 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.612 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.2 t -149.6 -31.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.655 ' ND2' ' HD1' ' A' ' 15' ' ' HIS . 11.6 m-20 157.64 -48.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.62 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 25' ' ' LEU . 74.4 t60 -169.61 3.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.699 -179.735 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -76.65 40.84 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.58 -179.98 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.422 179.92 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -72.66 -78.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 -179.966 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.91 11.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.927 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 m -157.35 83.7 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.26 179.947 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 1.7 mp -80.05 -80.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.119 -179.844 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -71.22 -34.68 71.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.763 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -49.61 -64.35 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 20.7 t-160 -76.79 64.5 2.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.374 179.857 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.07 -25.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.08 -180.0 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -102.09 -1.91 30.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.126 0.488 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.666 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.0 t60 -150.39 143.72 25.01 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.633 179.461 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.79 -29.52 0.19 Allowed 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 125.641 1.838 . . . . 0.0 109.766 -177.987 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.02 0.43 Allowed 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 94.879 -5.971 . . . . 0.0 94.879 164.463 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.8 tttp -116.76 -161.11 0.79 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.266 -3.606 . . . . 0.0 110.549 177.005 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.614 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 30.92 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.852 0.72 . . . . 0.0 112.238 178.34 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.722 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.7 tt 172.75 -47.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 CA-C-O 122.226 1.012 . . . . 0.0 109.513 -179.446 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.66 74.62 Favored Glycine 0 C--N 1.271 -3.062 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 175.268 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.414 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 2.0 m170 -95.96 -45.18 7.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.443 178.181 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' CB ' ' H ' ' A' ' 24' ' ' TYR . . . 164.99 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.862 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.18 7.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.289 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -146.44 -9.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.863 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.6 t30 104.53 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.491 1.119 . . . . 0.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -173.36 80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.451 179.974 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.546 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 63.2 t80 -84.64 -13.96 50.02 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.942 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 179.938 . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.004 -0.439 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 50.07 -98.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.712 0.291 . . . . 0.0 110.606 -179.958 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.22 14.27 59.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.707 -179.811 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 p -169.61 154.57 5.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.374 -179.954 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.1 mt -77.25 62.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.265 179.941 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 55.0 13.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.749 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -68.9 -72.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.26 179.714 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -74.85 2.56 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.374 179.733 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 -16.22 64.73 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.17 -179.944 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -168.11 29.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.076 -179.749 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.645 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.4 t60 -159.11 146.98 17.68 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.052 0.453 . . . . 0.0 110.857 179.305 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.107 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.04 -31.94 0.24 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.755 1.91 . . . . 0.0 110.007 -178.239 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.645 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.3 1.92 0.29 Allowed 'General case' 0 N--CA 1.413 -2.323 1 N-CA-C 95.445 -5.761 . . . . 0.0 95.445 165.132 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.107 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttm -115.8 -169.33 1.57 Allowed 'General case' 0 C--N 1.393 2.478 0 CA-C-N 109.363 -3.562 . . . . 0.0 111.725 177.076 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.682 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.8 t-80 34.31 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.914 177.963 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.06 -45.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.428 -179.958 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.72 79.99 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.284 -3.126 . . . . 0.0 105.284 174.422 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.413 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.27 -49.76 6.19 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.301 -0.949 . . . . 0.0 109.364 177.987 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.85 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.192 0.308 . . . . 0.0 110.196 -179.728 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.02 10.33 1.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.739 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 87.5 t -144.34 -9.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.425 -179.865 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 102.58 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.53 1.144 . . . . 0.0 110.45 179.896 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 16.9 t60 84.28 4.6 0.71 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.873 -179.143 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -62.95 -23.14 67.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.471 179.897 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.415 179.939 . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -72.57 -167.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.764 0.316 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.91 17.22 0.22 Allowed Glycine 0 C--N 1.332 0.331 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -179.934 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -176.19 138.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.885 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mm -62.11 -38.16 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.427 -179.767 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.71 7.15 4.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt 59.72 71.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.7 m80 48.85 32.73 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.773 179.819 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.15 58.86 8.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.097 179.809 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER 54.62 48.27 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 110.263 179.94 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' HD1' ' A' ' 11' ' ' HIS . 2.1 t-80 -150.02 70.94 1.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.311 1.053 . . . . 0.0 109.714 179.353 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.986 ' C ' ' H ' ' A' ' 14' ' ' LYS 0.272 . . 169.78 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 111.921 -2.399 . . . . 0.0 105.721 -179.363 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.09 -1.3 0.66 Allowed 'General case' 0 N--CA 1.412 -2.331 1 N-CA-C 95.254 -5.832 . . . . 0.0 95.254 164.125 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.986 ' H ' ' C ' ' A' ' 12' ' ' ALA . 3.2 ttpt -114.89 -166.49 1.12 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.309 -3.587 . . . . 0.0 111.501 176.325 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.707 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.8 t-80 33.2 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.042 178.378 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 173.56 -47.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 122.282 1.039 . . . . 0.0 109.305 179.96 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.03 -14.17 76.13 Favored Glycine 0 C--N 1.27 -3.115 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 174.907 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -94.97 -46.28 6.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.765 -0.718 . . . . 0.0 109.636 177.966 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.53 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.504 -179.754 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.63 6.95 1.23 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.076 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.0 t -147.16 -9.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.236 -179.926 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t30 102.82 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.444 1.09 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -178.83 64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.953 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -51.83 -33.94 38.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.667 -179.819 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.115 -179.969 . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 53.83 10.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.742 0.306 . . . . 0.0 110.461 -179.978 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 68.14 6.48 46.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.855 -179.973 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -57.6 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.491 -179.955 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.52 ' C ' ' H ' ' A' ' 7' ' ' LYS . 10.2 pt -154.53 62.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.145 -179.883 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 74.11 -32.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 5' ' ' ILE . 95.2 mttt -57.29 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.34 . . . . 0.0 110.346 179.725 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.593 ' N ' ' HD1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -77.49 64.49 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 179.876 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.02 -40.72 0.02 OUTLIER Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.938 -179.996 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -103.02 -1.93 28.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.659 ' C ' ' H ' ' A' ' 13' ' ' ALA . 89.1 m-70 -147.21 144.85 29.21 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.08 179.435 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.015 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.47 -31.56 0.23 Allowed 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 125.587 1.804 . . . . 0.0 109.642 -177.761 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.13 0.29 Allowed 'General case' 0 N--CA 1.412 -2.337 1 N-CA-C 95.44 -5.763 . . . . 0.0 95.44 165.034 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.015 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.6 tttp -115.94 -169.25 1.56 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-N 109.365 -3.561 . . . . 0.0 111.74 177.082 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.689 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 86.8 m-70 34.52 18.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.965 178.045 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.54 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-O 122.363 1.078 . . . . 0.0 109.113 -179.821 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.25 79.3 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 174.493 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.529 ' CD2' ' HZ3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -91.53 -47.34 7.47 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.543 -0.829 . . . . 0.0 109.219 178.024 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.0 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.773 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.66 7.52 1.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.146 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 43.5 t -144.99 -9.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.4 t-20 105.32 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.54 1.15 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -173.13 -99.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.315 -179.923 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.661 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 64.5 t80 55.44 10.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.445 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 63.8 m95 50.66 -93.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.556 -179.975 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 63.15 25.41 68.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.053 179.949 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -168.8 96.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.35 179.944 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -74.13 79.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.576 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 60.69 6.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.353 179.335 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -73.55 -61.57 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.409 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 53.7 t60 -76.43 64.93 2.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.508 179.804 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.03 -30.05 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.059 -179.919 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 76.5 mtt85 -129.4 5.84 5.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.817 0.342 . . . . 0.0 110.314 179.977 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.66 ' C ' ' H ' ' A' ' 13' ' ' ALA . 97.7 m-70 -155.81 144.96 20.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.602 179.528 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.707 1.879 . . . . 0.0 109.849 -177.888 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.44 1.89 0.31 Allowed 'General case' 0 N--CA 1.411 -2.42 1 N-CA-C 95.363 -5.792 . . . . 0.0 95.363 164.988 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.061 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -115.89 -169.15 1.54 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.412 -3.54 . . . . 0.0 111.646 177.074 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.684 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.7 m-70 34.86 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.892 178.031 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.62 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.091 0.948 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.25 -13.71 82.55 Favored Glycine 0 C--N 1.273 -2.961 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.59 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.15 -45.64 8.17 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 114.511 -0.845 . . . . 0.0 109.286 177.981 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.05 13.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.838 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.18 9.23 0.94 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.17 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' ALA . 57.7 t -145.95 -9.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.189 -179.873 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t-20 103.14 -36.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.503 1.127 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -172.05 89.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.398 -179.966 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 83.4 t80 -159.89 16.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.062 -179.84 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.564 179.982 . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 95.2 m95 -158.08 139.51 13.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.412 -179.977 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -11.15 56.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.971 -179.947 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 p -167.55 165.89 14.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.343 . . . . 0.0 110.438 -179.999 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.4 mt -142.57 -55.95 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -77.91 44.57 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.495 179.791 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER 55.1 72.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.343 -179.993 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.637 ' N ' ' HD1' ' A' ' 8' ' ' HIS . 0.7 OUTLIER 46.9 26.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.256 179.502 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.19 64.28 2.34 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.779 179.308 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt-85 58.45 49.79 10.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.785 0.326 . . . . 0.0 111.125 179.309 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.581 ' NE2' ' NE2' ' A' ' 15' ' ' HIS . 48.8 t-80 -157.6 92.43 1.21 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.209 0.528 . . . . 0.0 110.074 179.339 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.032 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 134.84 -31.79 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.424 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.54 -0.41 0.61 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.895 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.032 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.8 tttt -114.86 -168.12 1.33 Allowed 'General case' 0 C--N 1.393 2.488 0 CA-C-N 109.376 -3.556 . . . . 0.0 111.768 176.696 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.683 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 79.5 m-70 33.77 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.958 178.24 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.39 -47.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.324 1.059 . . . . 0.0 109.025 -179.873 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.66 -13.73 78.03 Favored Glycine 0 C--N 1.27 -3.099 0 N-CA-C 105.885 -2.886 . . . . 0.0 105.885 174.853 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.75 -44.39 9.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.899 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 160.87 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.868 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 61.37 5.57 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.289 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 40.7 t -145.28 -10.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.202 -179.817 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.0 t-20 116.4 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.504 1.128 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -171.89 -3.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.515 -179.923 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.416 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 34.1 t80 -49.06 -18.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.712 -179.633 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.136 -179.978 . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 39.4 t-105 -68.29 -18.92 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.515 -179.939 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 4' ' ' SER . . . 73.58 27.0 68.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.635 -179.566 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 3' ' ' GLY . 7.3 m -58.12 -153.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.789 -179.928 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.52 -21.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 -179.86 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -151.42 -18.61 0.2 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -53.76 -64.18 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.404 179.96 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.502 ' HD1' ' C ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -86.27 45.35 1.22 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.703 179.997 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.31 23.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.193 179.983 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 -168.14 9.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.219 179.81 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.633 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.1 t-80 -153.21 145.56 23.99 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.673 179.508 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.142 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -31.74 0.23 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.715 1.885 . . . . 0.0 109.738 -177.985 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.633 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.18 0.29 Allowed 'General case' 0 N--CA 1.412 -2.373 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 165.091 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.142 ' H ' ' C ' ' A' ' 12' ' ' ALA . 15.8 tttp -116.14 -169.49 1.62 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.76 177.037 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.693 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 33.39 21.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.708 177.927 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.651 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.16 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 CA-C-O 122.302 1.049 . . . . 0.0 109.377 -179.658 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.94 -11.55 81.21 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 104.983 -3.247 . . . . 0.0 104.983 173.981 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.444 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -93.43 -36.33 12.53 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 114.445 -0.878 . . . . 0.0 109.932 178.238 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.15 28.22 0.51 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.365 -179.441 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.5 -9.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.114 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.586 ' H ' ' C ' ' A' ' 19' ' ' ALA . 83.0 t -152.44 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.284 -179.387 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -171.66 -96.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.496 -179.198 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.492 ' C ' ' H ' ' A' ' 25' ' ' LEU . 75.8 t60 -152.07 8.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.711 -179.372 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.14 22.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.491 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 13.1 m-90 -157.56 -57.09 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.885 0.374 . . . . 0.0 110.517 -179.977 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.15 -0.43 88.74 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.852 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.4 m -78.55 77.2 5.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.765 0.317 . . . . 0.0 110.377 179.852 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 10.5 mt -73.89 -28.97 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.714 -179.778 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 67.7 m-85 -155.68 4.56 0.19 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 -179.949 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -59.8 -70.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.243 179.827 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 70.6 t60 -80.66 43.62 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.2 26.46 0.12 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.235 -179.979 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -166.03 3.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.353 179.747 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.8 m-70 -144.72 146.73 32.34 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.023 0.44 . . . . 0.0 111.012 179.49 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.135 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.91 -31.45 0.22 Allowed 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 125.813 1.945 . . . . 0.0 109.944 -178.156 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.4 2.08 0.29 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.344 -5.798 . . . . 0.0 95.344 165.028 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.135 ' H ' ' C ' ' A' ' 12' ' ' ALA . 13.8 ttpp -116.01 -169.29 1.57 Allowed 'General case' 0 C--N 1.394 2.503 0 CA-C-N 109.407 -3.542 . . . . 0.0 111.817 177.16 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.686 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.1 t60 33.98 19.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.89 178.122 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 174.69 -46.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-O 122.24 1.019 . . . . 0.0 109.275 179.977 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.05 79.4 Favored Glycine 0 C--N 1.271 -3.083 0 N-CA-C 105.773 -2.931 . . . . 0.0 105.773 174.722 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.14 -45.62 7.8 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.659 -0.771 . . . . 0.0 109.431 178.036 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.23 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.877 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.78 5.89 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 109.667 -179.291 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 45.9 t -144.05 -9.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.335 179.975 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 27.8 t-20 105.84 -36.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.646 1.216 . . . . 0.0 110.046 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.2 t-160 -170.1 -130.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.138 179.972 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.61 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 29.6 m-85 48.62 28.67 1.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.775 0.322 . . . . 0.0 110.752 179.673 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.081 -179.923 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' H3 ' ' H ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.404 ' H ' ' H3 ' ' A' ' 1' ' ' GLY . 82.8 m95 -57.87 -45.16 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.823 0.344 . . . . 0.0 110.528 -179.956 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.76 68.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.114 179.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -66.26 116.13 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.583 179.858 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 7' ' ' LYS . 18.8 mt -67.18 -51.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.089 179.92 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.475 ' C ' ' H ' ' A' ' 8' ' ' HIS . 45.0 m-85 -82.99 21.76 1.02 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.333 179.816 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 12.2 mptt 54.76 8.92 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.34 -179.919 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 6' ' ' PHE . 81.6 t60 45.77 19.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.72 179.833 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . -160.46 -3.12 0.06 OUTLIER Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.286 -179.746 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 60.89 27.92 17.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -97.29 71.06 2.36 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.138 0.971 . . . . 0.0 110.11 179.437 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' H ' ' A' ' 14' ' ' LYS 0.265 . . 169.34 -30.88 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 112.165 -2.289 . . . . 0.0 105.712 -179.738 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -1.0 0.57 Allowed 'General case' 0 N--CA 1.414 -2.274 1 N-CA-C 95.378 -5.786 . . . . 0.0 95.378 164.068 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.033 ' H ' ' C ' ' A' ' 12' ' ' ALA 0.257 23.7 tttp -115.99 -166.73 1.17 Allowed 'General case' 0 C--N 1.393 2.457 0 CA-C-N 109.42 -3.536 . . . . 0.0 111.953 176.859 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.717 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 55.6 t60 34.01 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.609 177.756 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.7 tt 170.72 -42.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.078 0.942 . . . . 0.0 109.381 -179.894 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.96 -14.28 81.87 Favored Glycine 0 C--N 1.274 -2.894 0 N-CA-C 105.81 -2.916 . . . . 0.0 105.81 175.071 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -88.94 -34.36 16.93 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.044 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.07 -73.18 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.61 179.397 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.23 -23.14 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.815 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 34.0 t -150.85 -12.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.542 179.614 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 5.1 t30 155.55 -36.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.779 0.674 . . . . 0.0 109.551 -179.658 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -166.14 120.38 1.15 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.952 -178.443 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -71.87 -0.17 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.421 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 -179.931 . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 1' ' ' GLY . 95.9 m95 54.72 166.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.97 -4.32 88.61 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.162 -179.823 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 p 52.88 97.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 110.388 -179.807 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.8 mt -78.82 -33.78 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 -179.64 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -156.15 -7.3 0.11 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.999 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -50.74 -73.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 -179.813 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.36 70.11 10.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.483 179.988 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . 176.67 -12.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.851 -179.972 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 9' ' ' GLY . 75.0 mtp180 -149.11 23.91 0.94 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.871 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.66 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.2 t60 -153.58 146.58 24.52 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.443 179.382 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.11 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.31 -30.82 0.21 Allowed 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 125.715 1.885 . . . . 0.0 109.683 -177.695 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.71 2.88 0.25 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 164.915 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.11 ' H ' ' C ' ' A' ' 12' ' ' ALA . 20.1 tttm -118.13 -167.3 1.33 Allowed 'General case' 0 C--N 1.393 2.471 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.593 177.275 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.67 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 66.2 t60 33.05 23.3 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 170.04 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.585 0 CA-C-O 122.107 0.956 . . . . 0.0 109.103 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -15.12 79.13 Favored Glycine 0 C--N 1.274 -2.909 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.752 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 6.3 t60 -83.43 -39.64 20.33 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.859 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.94 -69.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 -19.81 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.877 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 10.1 t -149.58 -16.31 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.966 179.679 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 4.7 t30 158.58 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.692 0.62 . . . . 0.0 109.758 -179.669 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 43.9 t-80 -166.51 14.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.723 -178.692 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 72.3 t80 -78.82 43.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.432 -179.883 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.236 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 86.9 m95 -158.44 168.85 25.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.769 0.318 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.3 -8.33 83.44 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.257 -0.497 . . . . 0.0 111.95 179.974 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 51.62 -164.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 110.535 179.903 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' H ' ' H ' ' A' ' 6' ' ' PHE . 18.8 tt -164.21 -19.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.205 -179.948 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -161.27 -25.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.37 179.7 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.512 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 35.5 ttpt -60.47 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.967 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -78.6 48.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.594 179.882 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.74 -19.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.085 -179.911 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 66.4 mtp180 -139.54 16.84 2.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.23 179.857 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.667 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.4 m80 -154.75 145.56 22.47 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.557 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.073 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.48 -30.72 0.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 125.654 1.846 . . . . 0.0 109.555 -177.713 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.667 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.75 0.26 Allowed 'General case' 0 N--CA 1.412 -2.351 1 N-CA-C 95.282 -5.822 . . . . 0.0 95.282 164.787 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.073 ' H ' ' C ' ' A' ' 12' ' ' ALA . 11.5 ttpp -117.73 -167.59 1.36 Allowed 'General case' 0 C--N 1.392 2.44 0 CA-C-N 109.524 -3.489 . . . . 0.0 111.671 177.152 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.676 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.5 m80 33.11 23.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.716 177.67 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.648 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 170.02 -45.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 CA-C-O 122.229 1.014 . . . . 0.0 109.061 -179.752 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.19 78.66 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 174.773 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 5.9 t60 -82.54 -40.85 20.39 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.659 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -160.37 -68.05 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.402 179.51 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.34 -19.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.956 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' H ' ' H ' ' A' ' 22' ' ' ASN . 40.4 t -151.26 -18.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.092 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.489 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 7.8 t-20 163.76 -38.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.576 0.548 . . . . 0.0 109.993 -179.709 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 48.2 t-80 -171.7 33.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 -178.644 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -49.82 -14.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 110.544 -179.969 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.783 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.454 -0.165 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.448 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 29.3 m-90 -157.15 -87.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.737 0.303 . . . . 0.0 110.46 -179.893 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.13 8.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.126 179.866 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -165.3 120.56 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.921 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.6 tt -75.88 -40.6 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.382 179.97 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.473 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 41.4 m-85 -162.51 7.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.052 179.437 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -57.44 -73.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.361 179.86 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -79.6 43.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.415 179.859 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.6 14.69 0.1 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.077 -179.886 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -166.85 -3.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.182 0.515 . . . . 0.0 110.182 179.792 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.638 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.8 t-80 -162.8 143.4 9.64 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 179.294 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.077 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.3 -31.68 0.22 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.836 1.96 . . . . 0.0 110.022 -178.133 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.638 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 1.81 0.33 Allowed 'General case' 0 N--CA 1.411 -2.381 1 N-CA-C 95.304 -5.813 . . . . 0.0 95.304 164.963 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.077 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.9 tttt -115.67 -168.8 1.47 Allowed 'General case' 0 C--N 1.393 2.499 0 CA-C-N 109.417 -3.538 . . . . 0.0 111.758 176.998 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.694 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.6 t-80 34.21 19.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.849 177.98 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.08 -47.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.271 1.034 . . . . 0.0 109.199 -179.894 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.26 -14.06 76.79 Favored Glycine 0 C--N 1.27 -3.13 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 174.918 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.408 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -94.5 -45.6 7.35 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.512 178.093 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 166.3 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.762 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.17 9.65 1.04 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.973 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ALA . 58.5 t -147.97 -8.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.196 -179.542 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.7 m120 100.04 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.662 1.226 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 25' ' ' LEU . 86.3 t60 -167.22 -105.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.5 -179.834 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.514 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 25.7 t80 65.96 -7.34 0.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 -179.977 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 23' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.822 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -69.51 126.0 28.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.614 179.93 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.21 -21.81 78.49 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.764 179.752 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.8 m -97.64 92.63 5.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.674 0.273 . . . . 0.0 110.511 179.967 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 mt -67.37 -37.88 79.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.777 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.418 ' H ' ' H ' ' A' ' 7' ' ' LYS . 36.4 p90 -165.74 1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.884 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.418 ' H ' ' H ' ' A' ' 6' ' ' PHE . 79.4 tttt -54.88 -62.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.347 179.926 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.14 65.65 2.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.459 179.931 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.0 -13.6 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.902 -179.945 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 85.6 mtt-85 -140.9 6.99 2.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.788 0.327 . . . . 0.0 110.265 179.894 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.658 ' C ' ' H ' ' A' ' 13' ' ' ALA . 94.7 m-70 -155.79 146.08 21.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.626 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.02 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.71 -31.67 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.823 1.952 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.8 0.31 Allowed 'General case' 0 N--CA 1.412 -2.343 1 N-CA-C 95.414 -5.773 . . . . 0.0 95.414 165.167 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.02 ' N ' ' C ' ' A' ' 12' ' ' ALA . 16.5 tttp -116.31 -168.22 1.4 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.327 -3.579 . . . . 0.0 111.644 177.158 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 40.4 m-70 34.05 20.98 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.803 177.706 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 171.3 -46.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.515 0 CA-C-O 122.286 1.041 . . . . 0.0 109.245 -179.682 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.16 -12.42 83.48 Favored Glycine 0 C--N 1.274 -2.908 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 175.125 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' CE1' ' HZ2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -89.29 -30.88 18.14 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.316 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.57 -66.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.677 179.285 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.64 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.759 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -152.7 -18.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 179.925 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 t30 165.66 -38.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.549 0.531 . . . . 0.0 110.145 -179.799 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.456 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 34.5 t-80 -170.04 26.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -178.709 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -49.08 -15.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 -179.741 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.7 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.278 -179.944 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -75.02 -54.28 7.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.723 0.296 . . . . 0.0 110.528 -179.946 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.56 69.82 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.912 -179.876 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.504 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 58.8 m -165.43 96.88 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -76.94 -30.21 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.44 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -157.84 13.06 0.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.326 179.995 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -78.97 -27.12 43.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.268 179.759 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 4' ' ' SER . 38.4 m170 -78.56 77.12 5.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 51.45 83.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.287 179.805 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' H ' ' H ' ' A' ' 11' ' ' HIS . 66.3 ttt180 -169.53 -4.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.268 0.556 . . . . 0.0 110.003 179.644 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.671 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 t60 -156.8 142.2 17.45 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.61 -31.73 0.23 Allowed 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 125.594 1.809 . . . . 0.0 109.492 -177.863 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.54 0.33 Allowed 'General case' 0 N--CA 1.41 -2.439 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 164.978 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.0 tttp -115.1 -169.82 1.63 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.438 -3.528 . . . . 0.0 111.731 176.922 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.693 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.9 t-80 34.78 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.934 177.926 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.28 -44.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.171 0.986 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.82 -14.38 81.57 Favored Glycine 0 C--N 1.274 -2.895 0 N-CA-C 105.335 -3.106 . . . . 0.0 105.335 174.249 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.437 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -89.85 -49.03 6.85 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.295 -0.953 . . . . 0.0 109.02 177.892 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.28 9.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.458 0.474 . . . . 0.0 110.177 -179.94 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.72 10.07 1.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 -178.158 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 19' ' ' ALA . 91.1 t -143.1 -8.56 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.948 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.2 m-20 97.67 -35.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.637 1.211 . . . . 0.0 111.08 179.81 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.502 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.4 t-80 80.19 7.84 1.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.774 -179.154 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.1 t80 -77.08 27.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.0 tt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 111.931 -0.467 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -69.25 -171.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 110.67 179.962 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.35 -21.95 72.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.994 179.97 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.7 m 54.36 -169.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.593 179.919 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 pt -78.34 56.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.521 -179.943 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 60.09 16.71 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.872 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -70.0 -63.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.363 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -78.96 53.12 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.824 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.28 -17.52 0.02 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.062 -179.903 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' C ' ' ND1' ' A' ' 11' ' ' HIS . 81.5 mtp180 -124.55 1.95 8.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.922 0.392 . . . . 0.0 110.219 179.868 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.648 ' C ' ' H ' ' A' ' 13' ' ' ALA . 41.2 m80 -152.76 144.44 23.51 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.5 -31.29 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.633 1.833 . . . . 0.0 109.718 -177.731 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.57 2.25 0.3 Allowed 'General case' 0 N--CA 1.411 -2.407 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.069 ' H ' ' C ' ' A' ' 12' ' ' ALA . 12.0 ttpt -115.98 -168.98 1.51 Allowed 'General case' 0 C--N 1.395 2.544 0 CA-C-N 109.401 -3.545 . . . . 0.0 111.492 176.995 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.682 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 61.5 t60 33.65 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.917 178.036 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.76 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 CA-C-O 122.229 1.014 . . . . 0.0 109.308 179.982 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -14.24 80.18 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 174.497 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -90.69 -44.21 9.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 114.431 -0.884 . . . . 0.0 109.857 178.179 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.598 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 42.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.336 -179.177 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.6 -21.65 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.515 -179.47 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.0 t -148.32 -30.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.636 179.802 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t-20 153.39 -43.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 41.9 t60 -168.78 174.96 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.27 179.7 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.608 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.5 t80 56.28 10.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.656 179.917 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.45 ' H1 ' ' H ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.45 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 76.4 t-105 -69.58 -73.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.557 -179.998 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.31 -0.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.851 179.999 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m 54.31 106.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.846 0.355 . . . . 0.0 110.706 -179.983 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.48 -35.78 58.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.472 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' H ' ' H ' ' A' ' 7' ' ' LYS . 33.8 p90 -164.34 -4.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.47 179.795 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' H ' ' H ' ' A' ' 6' ' ' PHE . 94.9 mttt -57.64 -84.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 -179.92 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -74.54 85.94 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 179.93 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.78 -45.52 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.091 -179.933 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 26.14 0.64 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.97 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.653 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.5 t60 -160.8 147.1 15.01 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.059 0.457 . . . . 0.0 111.04 179.688 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.097 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.5 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 125.872 1.982 . . . . 0.0 110.085 -178.23 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.08 0.28 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.411 -5.774 . . . . 0.0 95.411 165.218 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.097 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -116.03 -169.31 1.58 Allowed 'General case' 0 C--N 1.393 2.491 0 CA-C-N 109.435 -3.529 . . . . 0.0 111.767 177.03 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 10.9 t60 34.72 18.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.914 178.056 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tt 175.35 -41.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 CA-C-O 122.019 0.914 . . . . 0.0 109.582 179.923 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.63 -13.07 83.88 Favored Glycine 0 C--N 1.275 -2.858 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 174.316 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.423 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.2 m170 -92.89 -44.78 8.29 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.541 -0.829 . . . . 0.0 109.136 178.05 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.89 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.46 9.61 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.025 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -147.57 -9.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.152 -179.777 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.8 t-20 100.31 -35.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.395 1.06 . . . . 0.0 110.023 -179.627 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.479 ' C ' ' H ' ' A' ' 25' ' ' LEU . 79.9 m-70 -145.76 119.37 9.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -62.43 -4.26 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 23' ' ' HIS . 19.0 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.6 m95 51.56 -153.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 0.0 110.464 179.988 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.42 ' H ' ' H ' ' A' ' 4' ' ' SER . . . -177.69 -0.58 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 179.996 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 3' ' ' GLY . 10.2 t 55.8 165.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 110.572 -179.999 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 mt -76.21 -42.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' H ' ' H ' ' A' ' 7' ' ' LYS . 34.9 p90 -166.11 -11.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 179.906 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 9' ' ' GLY . 81.2 tttt -62.22 -8.39 5.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.423 -179.958 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.435 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 69.9 t60 -61.83 -2.55 0.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.962 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . 145.23 59.97 0.02 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.116 179.813 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -161.65 33.27 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 179.729 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.655 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.0 t-80 -169.55 145.29 3.14 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 179.571 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.71 -31.78 0.23 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.767 1.917 . . . . 0.0 109.94 -178.156 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.77 0.31 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.274 -5.824 . . . . 0.0 95.274 165.074 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.048 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -115.6 -169.35 1.56 Allowed 'General case' 0 C--N 1.394 2.509 0 CA-C-N 109.483 -3.508 . . . . 0.0 111.766 176.909 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.3 t-80 34.89 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.944 177.952 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.71 -43.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.144 0.974 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.94 82.39 Favored Glycine 0 C--N 1.274 -2.907 0 N-CA-C 105.434 -3.066 . . . . 0.0 105.434 174.41 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.418 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.41 -47.44 7.45 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.437 -0.881 . . . . 0.0 109.21 177.983 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 168.23 9.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.259 0.349 . . . . 0.0 110.179 -179.885 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.5 9.88 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.25 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' ALA . 85.1 t -144.57 -9.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.2 -179.82 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.626 HD22 ' HZ1' ' A' ' 14' ' ' LYS . 11.0 t-20 99.43 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 O-C-N 124.33 1.019 . . . . 0.0 110.798 179.826 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 5.2 t60 81.98 44.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.349 -179.385 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 41.7 p90 -66.55 -31.09 71.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.565 -179.942 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.756 -179.948 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 71.6 m95 52.01 -164.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.52 7.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.832 179.977 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t 58.22 -142.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.434 -179.97 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.6 tt -158.77 -38.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.932 179.786 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 10' ' ' ARG . 35.0 m-85 -81.72 64.73 6.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.238 179.482 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 9' ' ' GLY . 50.9 mmtt 45.69 28.11 0.51 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.317 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 85.1 t60 49.95 12.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -174.53 -16.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' N ' ' O ' ' A' ' 6' ' ' PHE . 43.0 ttp180 66.3 96.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.315 0.579 . . . . 0.0 111.43 179.484 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.626 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.5 m-70 68.81 140.59 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.849 179.22 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.053 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 67.24 -33.33 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 126.267 2.23 . . . . 0.0 111.023 -179.106 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.626 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 0.98 0.37 Allowed 'General case' 0 N--CA 1.411 -2.406 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 165.152 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.053 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.5 tttp -114.02 -168.89 1.42 Allowed 'General case' 0 C--N 1.395 2.57 0 CA-C-N 109.554 -3.475 . . . . 0.0 111.743 176.769 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 34.15 18.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.959 177.968 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.17 -46.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 122.286 1.041 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.71 -14.56 77.98 Favored Glycine 0 C--N 1.27 -3.097 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 174.52 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.603 ' CE1' ' HZ2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -90.82 -47.79 7.41 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.144 177.804 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.56 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.799 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.53 6.84 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.292 0.568 . . . . 0.0 109.54 -179.149 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 50.6 t -143.02 -9.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.5 t-20 106.13 -36.81 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.62 1.2 . . . . 0.0 110.019 -179.809 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 79.7 t60 -171.08 -117.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.273 179.871 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.57 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 92.4 m-85 50.9 13.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 23' ' ' HIS . 15.7 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.215 -179.965 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -70.93 -24.94 62.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.508 -179.996 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.97 50.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.033 179.946 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 5' ' ' ILE . 30.3 t 52.8 -177.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.741 0.305 . . . . 0.0 110.565 -179.929 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 9.2 mt -73.86 -44.87 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 -179.908 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 55.6 m-85 -159.84 -13.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' H ' ' H ' ' A' ' 6' ' ' PHE . 61.2 mttp -50.67 -61.6 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.953 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -77.87 61.56 2.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.99 -13.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.161 -0.543 . . . . 0.0 111.922 -179.997 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 59.2 mtp85 -137.52 14.56 2.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 110.097 179.912 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.657 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.1 m-70 -156.69 145.78 20.3 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.541 179.457 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.086 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.23 -31.72 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.75 1.906 . . . . 0.0 109.839 -177.996 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.657 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.99 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.078 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.086 ' H ' ' C ' ' A' ' 12' ' ' ALA . 33.2 tttt -116.0 -169.56 1.62 Allowed 'General case' 0 C--N 1.392 2.418 0 CA-C-N 109.389 -3.551 . . . . 0.0 111.735 177.031 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.679 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 3.1 t60 34.48 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.935 178.089 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.06 -41.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.549 0 CA-C-O 122.02 0.914 . . . . 0.0 109.659 179.918 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.59 -13.16 83.79 Favored Glycine 0 C--N 1.275 -2.826 0 N-CA-C 105.506 -3.038 . . . . 0.0 105.506 174.327 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.65 -44.36 8.22 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 114.579 -0.81 . . . . 0.0 109.491 178.083 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 165.96 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.57 10.14 0.95 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.972 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 19' ' ' ALA . 65.9 t -148.22 -9.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.189 -179.837 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.1 t-20 100.34 -35.58 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.388 1.055 . . . . 0.0 110.003 -179.643 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' LEU . 43.9 m80 -151.72 120.06 6.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.42 -179.766 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -69.48 5.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 23' ' ' HIS . 3.0 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.37 -179.792 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 50.8 -147.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.983 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.05 -4.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.219 -0.515 . . . . 0.0 111.838 -179.946 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.4 p 50.77 -165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.738 179.893 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.95 -29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.683 179.963 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -168.57 -21.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.942 179.525 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.512 ' CB ' ' HZ3' ' A' ' 7' ' ' LYS . 9.7 mtmp? -48.96 -68.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.551 179.787 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -77.6 63.93 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.295 179.704 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.04 -24.37 0.02 OUTLIER Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.123 -179.868 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -151.18 10.21 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.664 0.269 . . . . 0.0 110.757 -179.921 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.677 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.9 t60 -149.38 144.27 26.29 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.919 0.39 . . . . 0.0 110.825 179.601 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.079 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.45 -29.62 0.19 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.558 1.786 . . . . 0.0 109.851 -178.081 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.18 1.78 0.44 Allowed 'General case' 0 N--CA 1.411 -2.414 1 N-CA-C 94.855 -5.98 . . . . 0.0 94.855 164.342 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.079 ' H ' ' C ' ' A' ' 12' ' ' ALA . 4.6 tttp -116.07 -161.98 0.82 Allowed 'General case' 0 C--N 1.398 2.696 0 CA-C-N 109.264 -3.607 . . . . 0.0 110.726 176.929 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.614 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.4 t60 31.49 20.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.459 0.704 . . . . 0.0 112.144 178.291 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 172.95 -49.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 CA-C-O 122.429 1.109 . . . . 0.0 109.321 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.21 -13.71 70.57 Favored Glycine 0 C--N 1.27 -3.1 0 N-CA-C 106.257 -2.737 . . . . 0.0 106.257 175.351 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.6 m170 -94.69 -45.05 7.52 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.039 178.071 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 161.72 13.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.858 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.4 7.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.114 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.5 t -143.59 -9.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.575 -179.933 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 106.49 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.548 1.155 . . . . 0.0 110.246 179.969 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -173.09 100.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.533 -179.933 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 60.8 t80 -166.0 4.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.427 179.975 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.51 -179.97 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -75.87 143.1 41.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.55 179.986 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.99 0.53 21.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.871 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.9 m -58.71 -178.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.528 -179.958 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.82 -72.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.936 179.826 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.82 -35.4 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.186 179.5 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 9' ' ' GLY . 53.8 mttm -53.16 -33.71 53.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.492 179.91 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.481 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 22.5 t-80 -75.24 17.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.74 -179.974 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -177.83 25.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.994 -179.964 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -161.06 20.42 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.153 179.992 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.644 ' C ' ' H ' ' A' ' 13' ' ' ALA . 49.2 t60 -164.0 143.97 8.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.597 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.132 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.11 -31.61 0.23 Allowed 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 125.619 1.825 . . . . 0.0 109.656 -178.045 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.644 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.23 1.54 0.31 Allowed 'General case' 0 N--CA 1.411 -2.416 1 N-CA-C 95.364 -5.791 . . . . 0.0 95.364 165.014 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.132 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.2 tttm -114.89 -169.32 1.53 Allowed 'General case' 0 C--N 1.396 2.608 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.909 177.067 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.678 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 7.8 m-70 32.73 21.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.788 177.974 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 172.63 -47.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 CA-C-O 122.256 1.027 . . . . 0.0 109.374 -179.951 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.25 -14.39 79.18 Favored Glycine 0 C--N 1.271 -3.046 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 174.404 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.459 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.75 -44.07 11.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.466 178.034 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.39 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.205 -179.315 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 -1.44 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.192 179.496 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.57 ' H ' ' C ' ' A' ' 19' ' ' ALA . 39.5 t -150.97 -25.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.732 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.9 t30 130.18 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.737 1.273 . . . . 0.0 109.299 -179.726 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.486 ' HD1' ' C ' ' A' ' 23' ' ' HIS . 2.9 t-80 -163.17 97.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.906 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 77.4 t80 -164.31 -6.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.945 179.816 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' H ' ' H ' ' A' ' 24' ' ' TYR . 15.7 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.245 179.881 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.2 m95 50.54 -174.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.2 -14.75 54.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.825 179.88 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.2 m -164.99 166.4 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.319 . . . . 0.0 110.33 179.981 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.36 -54.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.506 -179.834 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -160.95 3.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 12.6 mptt -61.09 -60.1 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.156 -179.903 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -71.2 73.26 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.548 -179.993 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.29 -23.74 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.97 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -140.65 17.98 2.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.157 179.917 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.663 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.1 t60 -152.55 145.21 24.23 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.141 0.496 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.077 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.8 -30.66 0.21 Allowed 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 125.78 1.925 . . . . 0.0 109.261 -177.426 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.9 3.71 0.21 Allowed 'General case' 0 N--CA 1.41 -2.458 1 N-CA-C 95.372 -5.788 . . . . 0.0 95.372 164.698 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.077 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -119.36 -168.11 1.52 Allowed 'General case' 0 C--N 1.395 2.549 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.828 177.464 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.8 m170 31.67 25.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.411 178.12 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.6 tt 167.52 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 CA-C-O 122.171 0.986 . . . . 0.0 109.217 -179.841 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.34 -13.71 78.1 Favored Glycine 0 C--N 1.275 -2.837 0 N-CA-C 104.675 -3.37 . . . . 0.0 104.675 173.523 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.462 ' H ' ' H ' ' A' ' 16' ' ' ILE . 9.9 t60 -89.16 -40.3 12.99 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.399 177.897 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -144.33 23.38 1.65 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.885 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.59 -2.36 0.18 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.251 179.139 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 19' ' ' ALA . 42.9 t -150.89 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 121.335 -0.146 . . . . 0.0 111.066 -179.57 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER 175.83 -83.87 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.947 0.404 . . . . 0.0 110.84 -179.443 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.659 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.6 OUTLIER -155.47 -172.27 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.76 -179.589 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 50.6 t80 57.01 20.16 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.51 179.999 . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -66.55 -20.28 65.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 110.518 -179.971 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.88 18.08 78.77 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 -179.708 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 m 58.34 -150.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.6 -179.956 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.43 -25.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -152.71 -20.58 0.16 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.256 179.563 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -57.58 -54.72 43.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.27 179.754 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -79.13 47.6 0.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.407 179.844 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.33 -16.88 0.02 OUTLIER Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.877 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -128.73 13.75 6.41 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.043 179.837 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.638 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.1 t-80 -157.47 145.78 19.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.589 179.518 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.93 -31.63 0.23 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.773 1.92 . . . . 0.0 109.804 -178.028 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.638 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.01 0.31 Allowed 'General case' 0 N--CA 1.412 -2.375 1 N-CA-C 95.323 -5.806 . . . . 0.0 95.323 165.037 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.025 ' H ' ' C ' ' A' ' 12' ' ' ALA . 27.5 tttt -115.86 -168.76 1.47 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.509 -3.496 . . . . 0.0 111.557 177.045 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.691 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 8.8 m-70 33.98 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 177.968 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.63 -44.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.105 0.955 . . . . 0.0 109.518 179.885 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.11 81.87 Favored Glycine 0 C--N 1.273 -2.937 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.362 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.416 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.3 m170 -93.08 -49.28 6.08 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.563 177.99 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 170.46 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.488 -179.616 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.41 9.65 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.947 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' A' ' 19' ' ' ALA . 59.7 t -146.7 -8.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.911 -179.856 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 18.8 m-20 99.42 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.819 1.324 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 93.2 m-70 -160.19 108.87 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -62.25 -11.78 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.318 179.986 . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.87 175.92 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.25 -21.7 75.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.776 179.847 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m 47.49 45.7 17.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.812 0.339 . . . . 0.0 110.679 179.951 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.4 tt -55.62 90.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.304 0.573 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 49.43 12.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 5' ' ' ILE . 2.7 ttmp? -72.18 -68.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -77.71 65.21 3.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.518 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.37 -26.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 7.9 ptm180 -161.95 24.91 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.383 . . . . 0.0 110.459 179.894 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.653 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 m-70 -155.45 146.52 22.54 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 179.507 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.082 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.05 -31.91 0.23 Allowed 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 125.719 1.887 . . . . 0.0 109.922 -178.071 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.14 1.76 0.29 Allowed 'General case' 0 N--CA 1.413 -2.295 1 N-CA-C 95.421 -5.77 . . . . 0.0 95.421 165.158 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.082 ' H ' ' C ' ' A' ' 12' ' ' ALA . 3.0 ttmm -115.56 -169.76 1.64 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.403 -3.544 . . . . 0.0 111.716 177.252 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.665 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.8 m-70 34.09 19.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.698 178.036 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.04 -46.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.686 0 CA-C-O 122.178 0.99 . . . . 0.0 109.641 -179.936 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.91 -14.66 78.46 Favored Glycine 0 C--N 1.272 -3.013 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 174.726 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.642 ' CD2' ' HZ2' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -92.43 -42.74 9.59 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 114.721 -0.739 . . . . 0.0 110.038 178.363 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.82 42.1 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.353 -179.212 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.67 -17.1 0.13 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.663 -179.52 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -148.77 -33.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 179.974 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER 155.38 -47.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.867 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 80.5 t60 -166.86 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.222 179.835 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.549 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 98.3 m-85 46.89 18.32 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.6 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.14 -179.91 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.442 ' H ' ' H ' ' A' ' 3' ' ' GLY . 67.4 t-105 -167.87 -2.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.332 . . . . 0.0 110.474 179.929 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 2' ' ' TRP . . . 76.81 1.47 72.63 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.111 179.943 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 m -169.17 59.77 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.481 179.952 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.3 pt -83.96 21.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 10' ' ' ARG . 34.2 p90 -163.15 -36.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.77 179.743 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 9' ' ' GLY . 90.9 mttt -55.82 -37.19 68.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.462 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 1.1 t60 -67.62 4.95 0.92 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 -179.747 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -154.26 8.54 0.4 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 11' ' ' HIS . 95.0 mtt180 -154.74 164.04 39.37 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.837 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.671 ' C ' ' H ' ' A' ' 13' ' ' ALA . 2.2 t60 58.41 136.47 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.09 -179.814 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.047 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.68 -32.01 0.22 Allowed 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.761 -178.042 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.12 0.34 Allowed 'General case' 0 N--CA 1.41 -2.453 1 N-CA-C 95.268 -5.827 . . . . 0.0 95.268 164.709 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.047 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.6 tttm -114.71 -169.45 1.55 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.557 -3.474 . . . . 0.0 111.813 176.871 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.68 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.8 m80 34.54 18.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.894 178.085 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.41 -44.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 CA-C-O 122.051 0.929 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.59 -14.04 81.48 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 174.554 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 -46.27 7.7 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.402 177.995 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 167.47 12.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.43 -179.882 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.33 8.24 1.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.041 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ALA . 52.3 t -146.02 -9.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.054 -179.939 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 62.9 t30 102.27 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.543 1.152 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -175.07 75.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.403 179.997 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 52.8 t80 -79.15 -20.92 47.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.541 -179.979 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.978 . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 55.3 t-105 -66.32 0.94 1.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 80.06 -3.61 70.34 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.023 179.983 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.7 p -75.28 141.58 43.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.531 179.935 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 1.8 mp -78.47 93.26 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.909 180.0 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 49.35 60.92 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp 53.69 57.2 6.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.212 -179.779 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 19.5 t-160 55.37 21.56 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.171 -179.75 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 56.03 3.79 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.163 -179.982 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.7 OUTLIER 54.9 43.09 30.51 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.931 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -155.05 72.2 0.82 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.289 1.042 . . . . 0.0 109.95 178.761 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.973 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.275 . . 174.67 -31.07 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.504 179.978 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.81 -1.53 0.65 Allowed 'General case' 0 N--CA 1.416 -2.154 1 N-CA-C 95.486 -5.746 . . . . 0.0 95.486 164.734 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.973 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.258 19.1 tttm -115.1 -166.86 1.16 Allowed 'General case' 0 C--N 1.388 2.262 0 CA-C-N 109.085 -3.689 . . . . 0.0 111.569 176.794 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.682 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.3 t60 34.4 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.146 177.812 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 174.37 -43.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.145 0.974 . . . . 0.0 109.489 179.797 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.95 -13.77 82.29 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 174.71 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.42 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.5 -44.67 8.52 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.605 -0.798 . . . . 0.0 109.049 177.907 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 163.32 11.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.222 0.326 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.54 10.89 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.907 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' H ' ' C ' ' A' ' 19' ' ' ALA . 96.0 t -145.1 -7.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.821 -179.674 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.4 m-20 99.48 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.796 1.31 . . . . 0.0 110.228 -179.566 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.447 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.2 p-80 -162.9 112.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.633 179.984 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.2 t80 -69.82 -3.1 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.989 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 5.0 m-90 -159.28 -91.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.879 0.371 . . . . 0.0 110.389 179.989 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 4' ' ' SER . . . -177.19 10.38 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.912 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.4 ' H ' ' H ' ' A' ' 3' ' ' GLY . 58.9 m -150.66 83.55 1.35 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 110.32 -179.988 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.497 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 9.7 pt -61.11 -37.78 78.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.758 -179.882 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 65.7 m-85 -161.47 2.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.39 179.898 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -48.46 -56.99 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.556 179.97 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -82.07 60.31 4.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.671 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.57 -11.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.169 -179.937 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -163.33 28.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.746 0.308 . . . . 0.0 110.503 -179.97 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.655 ' C ' ' H ' ' A' ' 13' ' ' ALA . 42.7 t60 -148.8 145.59 27.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.238 179.315 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.042 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.87 -31.42 0.23 Allowed 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 125.65 1.844 . . . . 0.0 109.521 -177.728 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.53 2.32 0.29 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.982 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.042 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.3 tttm -116.3 -169.53 1.63 Allowed 'General case' 0 C--N 1.394 2.512 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.778 177.01 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.687 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 7.4 m-70 34.1 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.812 178.2 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 174.8 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.077 0.941 . . . . 0.0 109.641 179.836 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.35 83.58 Favored Glycine 0 C--N 1.275 -2.855 0 N-CA-C 105.508 -3.037 . . . . 0.0 105.508 174.358 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.408 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.85 -45.91 7.43 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.483 178.046 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . 169.48 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.615 -179.787 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.32 8.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.882 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 50.5 t -147.08 -7.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.657 -179.866 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 m120 97.24 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.692 1.245 . . . . 0.0 109.835 -179.374 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.583 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -170.66 -113.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 31.5 t80 64.64 -6.01 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.931 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' H ' ' C ' ' A' ' 23' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 . . . . . 0 N--CA 1.459 -0.015 0 CA-C-O 121.132 0.491 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.511 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.7 t60 -153.68 144.62 22.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.034 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.15 -31.78 0.23 Allowed 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 125.786 1.929 . . . . 0.0 109.901 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.67 0.3 Allowed 'General case' 0 N--CA 1.411 -2.378 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.034 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.5 tttt -115.26 -169.19 1.52 Allowed 'General case' 0 C--N 1.395 2.559 0 CA-C-N 109.446 -3.524 . . . . 0.0 111.826 177.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 9.5 m-70 32.96 21.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.84 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 173.52 -47.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.63 0 CA-C-O 122.191 0.996 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.74 -14.8 77.99 Favored Glycine 0 C--N 1.271 -3.073 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.466 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.96 -45.92 9.81 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 114.264 -0.968 . . . . 0.0 109.531 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.27 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.941 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.7 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.223 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.2 t -151.01 -29.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.528 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 18.8 t30 136.12 -39.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.63 1.206 . . . . 0.0 109.096 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.528 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 85.5 m-70 -151.93 -131.37 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.31 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.453 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.7 t80 55.53 13.94 1.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.921 0.391 . . . . 0.0 110.311 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.5 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.298 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HE ' ' CA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.049 0.452 . . . . 0.0 109.923 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 18.1 p80 -152.19 145.58 24.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.418 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.046 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 125.742 1.901 . . . . 0.0 109.917 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.311 1 N-CA-C 95.42 -5.771 . . . . 0.0 95.42 165.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.046 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -116.18 -168.26 1.41 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.47 -3.514 . . . . 0.0 111.55 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 30.4 m80 34.27 19.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.915 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.33 -45.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 122.253 1.025 . . . . 0.0 109.364 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.39 -13.68 81.44 Favored Glycine 0 C--N 1.273 -2.95 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.46 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -92.09 -43.15 9.55 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.82 178.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.96 41.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.241 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.75 -17.97 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.5 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.2 t -148.63 -34.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.1 t-20 154.89 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.833 0.708 . . . . 0.0 109.115 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -160.9 45.32 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.28 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -66.59 -19.16 65.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.6 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 88.7 mtt180 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.972 0.415 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 46.5 m80 -151.85 143.83 23.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.291 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.86 -31.58 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.675 1.859 . . . . 0.0 109.497 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.34 0.28 Allowed 'General case' 0 N--CA 1.413 -2.324 1 N-CA-C 95.467 -5.753 . . . . 0.0 95.467 164.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.97 -169.04 1.52 Allowed 'General case' 0 C--N 1.394 2.5 0 CA-C-N 109.454 -3.521 . . . . 0.0 111.642 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.8 m-70 33.84 19.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.848 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.677 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.69 -45.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.226 1.012 . . . . 0.0 109.382 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.28 -13.95 81.06 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 105.489 -3.044 . . . . 0.0 105.489 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.463 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -91.38 -43.72 9.58 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.806 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.22 41.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.255 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.94 -19.29 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.497 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.8 t -148.78 -32.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 155.44 -47.88 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -172.49 96.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.263 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 55.4 t80 -164.0 1.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.314 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.18 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 64.5 t-80 -146.57 144.38 29.53 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.181 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.59 -31.41 0.22 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.641 1.838 . . . . 0.0 109.544 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.28 0.28 Allowed 'General case' 0 N--CA 1.412 -2.355 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttm -116.34 -169.49 1.63 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 109.493 -3.503 . . . . 0.0 111.71 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.618 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.9 m170 34.82 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.851 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.4 tt 175.22 -41.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 CA-C-O 122.027 0.917 . . . . 0.0 109.679 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.37 -12.94 84.09 Favored Glycine 0 C--N 1.275 -2.82 0 N-CA-C 105.622 -2.991 . . . . 0.0 105.622 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.62 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.55 -42.75 8.27 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.639 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.37 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.768 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.63 8.62 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -149.41 -9.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.804 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -37.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.468 1.105 . . . . 0.0 110.563 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 18.9 t60 -171.86 178.1 3.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.792 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.593 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 23.9 p90 41.9 26.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.485 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.833 0.349 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.2 t-80 -159.29 143.64 15.27 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.669 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.71 0.23 Allowed 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 125.854 1.971 . . . . 0.0 109.723 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.29 0.27 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.532 -5.729 . . . . 0.0 95.532 165.118 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.8 tttm -116.61 -169.28 1.6 Allowed 'General case' 0 C--N 1.392 2.421 0 CA-C-N 109.452 -3.522 . . . . 0.0 111.822 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.2 m170 33.11 22.26 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.789 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.4 tt 169.52 -37.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-O 122.258 1.028 . . . . 0.0 109.186 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.32 -11.81 79.88 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 104.753 -3.339 . . . . 0.0 104.753 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.5 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.2 -36.2 13.4 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 114.397 -0.901 . . . . 0.0 109.879 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.35 26.18 0.6 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.66 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.41 -4.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.279 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 47.4 t -151.3 -27.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.047 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -174.24 -92.26 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.131 0.491 . . . . 0.0 110.978 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.3 t60 -159.62 27.37 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 53.3 t80 -74.92 17.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.685 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' HIS . 9.2 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.421 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.508 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t60 -164.18 146.51 9.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.018 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -32.0 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.88 1.988 . . . . 0.0 110.087 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.85 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.383 -5.784 . . . . 0.0 95.383 165.118 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.018 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.7 tttm -115.61 -169.83 1.66 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.612 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.9 t-80 34.34 18.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.961 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tt 175.65 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.137 0.97 . . . . 0.0 109.583 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.62 -13.34 83.29 Favored Glycine 0 C--N 1.277 -2.697 0 N-CA-C 105.14 -3.184 . . . . 0.0 105.14 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.95 -45.54 8.29 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 114.394 -0.903 . . . . 0.0 109.242 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.18 13.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.47 8.48 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.8 t -144.26 -9.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 22.3 t-20 105.44 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.581 1.175 . . . . 0.0 110.322 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 17.0 t-80 -169.83 -134.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.569 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 85.9 m-85 54.06 20.0 2.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.7 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.992 0.425 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.513 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.6 t-80 -90.4 145.55 24.85 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.251 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.54 -32.43 0.23 Allowed 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 125.751 1.907 . . . . 0.0 110.302 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.96 0.48 0.38 Allowed 'General case' 0 N--CA 1.412 -2.338 1 N-CA-C 95.324 -5.806 . . . . 0.0 95.324 165.071 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttm -113.53 -169.36 1.49 Allowed 'General case' 0 C--N 1.393 2.477 0 CA-C-N 109.24 -3.618 . . . . 0.0 112.046 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.635 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 30.2 t-80 34.7 18.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.95 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.68 -46.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.257 1.027 . . . . 0.0 109.121 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.28 78.93 Favored Glycine 0 C--N 1.27 -3.108 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.579 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.1 -47.04 7.77 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.091 177.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.89 13.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.11 8.27 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.0 t -144.35 -9.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.432 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.6 t-20 103.89 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.521 1.138 . . . . 0.0 109.921 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -178.14 92.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.92 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 88.0 t80 -143.3 9.18 1.63 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.195 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 15.1 ptm180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.701 0.286 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.9 m-70 -157.37 146.31 19.8 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.963 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.52 -31.52 0.22 Allowed 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 125.797 1.935 . . . . 0.0 110.01 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 1.94 0.31 Allowed 'General case' 0 N--CA 1.412 -2.329 1 N-CA-C 95.299 -5.815 . . . . 0.0 95.299 165.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.963 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.04 -169.46 1.61 Allowed 'General case' 0 C--N 1.392 2.447 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.8 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.5 m80 34.78 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.865 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 174.96 -42.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.116 0.96 . . . . 0.0 109.669 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.48 83.45 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.09 -44.77 7.86 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 114.591 -0.805 . . . . 0.0 109.565 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.5 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.444 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.89 8.4 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 49.4 t -148.28 -9.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.241 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.43 1.081 . . . . 0.0 109.874 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.551 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -174.95 176.4 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.423 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 53.58 31.59 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 67.6 mtp180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 70.3 m80 -153.12 145.66 24.16 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.104 0.478 . . . . 0.0 110.818 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.071 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.55 -31.52 0.23 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.83 1.956 . . . . 0.0 109.586 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.72 3.12 0.23 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.477 -5.749 . . . . 0.0 95.477 164.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.071 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.0 tttp -117.68 -169.37 1.66 Allowed 'General case' 0 C--N 1.392 2.443 0 CA-C-N 109.487 -3.506 . . . . 0.0 111.925 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.2 m-70 31.81 25.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.625 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.1 tt 168.08 -35.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.026 0.917 . . . . 0.0 109.029 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.34 -13.3 74.02 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.541 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.5 t60 -86.79 -39.79 15.59 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 114.181 -1.009 . . . . 0.0 110.154 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -149.16 23.51 0.94 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.152 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.91 5.48 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.1 t -150.59 -31.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.551 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' VAL . 3.9 m-20 167.82 -74.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.4 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -163.59 24.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.386 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -50.11 -26.96 5.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.0 m80 -153.16 144.08 22.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.254 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.024 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.36 -31.11 0.22 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.678 1.862 . . . . 0.0 109.564 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.32 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.024 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -116.56 -168.9 1.53 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.393 -3.548 . . . . 0.0 111.667 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.1 m80 34.23 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.814 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.08 -43.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 CA-C-O 122.109 0.957 . . . . 0.0 109.734 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.44 -13.13 83.7 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.42 -44.09 7.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 114.589 -0.806 . . . . 0.0 109.624 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.64 8.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.569 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.02 8.74 1.54 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 21' ' ' VAL . 48.2 t -148.44 -8.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.647 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 20.5 m-20 97.13 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.555 1.159 . . . . 0.0 110.275 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.9 t60 -170.76 -162.63 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.074 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.605 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.1 t80 56.0 12.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.435 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 99.4 mtt180 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 21.7 m80 -152.69 146.41 25.11 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.21 -31.03 0.21 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.814 1.946 . . . . 0.0 110.095 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 1.98 0.31 Allowed 'General case' 0 N--CA 1.411 -2.388 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 10.6 ttpt -116.22 -168.86 1.5 Allowed 'General case' 0 C--N 1.395 2.565 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.691 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 83.2 t60 35.02 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.992 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.3 tt 175.65 -44.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.193 0.997 . . . . 0.0 109.507 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.81 -13.77 82.06 Favored Glycine 0 C--N 1.274 -2.877 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.25 -45.39 8.65 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.46 -0.87 . . . . 0.0 108.838 177.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.36 12.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 56.89 11.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 21' ' ' VAL . 95.4 t -145.12 -7.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.11 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.1 m120 100.6 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.89 1.369 . . . . 0.0 110.103 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.8 t-80 -167.42 -136.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.219 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.593 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.5 m-85 46.47 31.6 1.36 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 14.9 ptm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 27.4 m-70 -144.0 146.99 33.27 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.612 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.13 -31.51 0.23 Allowed 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 125.61 1.818 . . . . 0.0 109.812 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.61 2.4 0.29 Allowed 'General case' 0 N--CA 1.411 -2.397 1 N-CA-C 95.339 -5.8 . . . . 0.0 95.339 165.062 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.8 tttp -116.19 -168.81 1.49 Allowed 'General case' 0 C--N 1.394 2.504 0 CA-C-N 109.479 -3.509 . . . . 0.0 111.561 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m-70 34.1 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.946 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.38 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.55 -14.05 81.41 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 105.486 -3.046 . . . . 0.0 105.486 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.78 -48.48 6.29 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 114.398 -0.901 . . . . 0.0 109.77 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.69 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.66 9.32 1.1 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 21' ' ' VAL . 98.2 t -146.95 -8.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.784 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 25.6 m-20 97.94 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.702 1.251 . . . . 0.0 110.334 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 55.7 m80 -157.48 -160.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.448 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 55.21 22.75 4.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.572 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.289 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 121.115 0.483 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.6 t-80 -156.58 145.39 20.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.41 -31.38 0.22 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.825 1.953 . . . . 0.0 109.629 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.1 0.3 Allowed 'General case' 0 N--CA 1.411 -2.399 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.2 -169.3 1.58 Allowed 'General case' 0 C--N 1.393 2.475 0 CA-C-N 109.423 -3.535 . . . . 0.0 111.737 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.23 19.64 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.791 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 173.87 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 CA-C-O 122.054 0.93 . . . . 0.0 109.567 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.17 -12.87 84.21 Favored Glycine 0 C--N 1.274 -2.89 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.614 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.78 -44.49 8.11 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.075 177.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.3 13.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.12 9.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -144.76 -9.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.324 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t30 104.38 -36.79 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.628 1.205 . . . . 0.0 110.214 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 20.8 t-80 -170.38 -126.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.379 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.57 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 97.1 m-85 53.44 11.99 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.559 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.956 0.407 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.1 t60 -157.3 147.3 20.69 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.54 -31.6 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.758 1.912 . . . . 0.0 110.048 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 2.1 0.3 Allowed 'General case' 0 N--CA 1.412 -2.349 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 165.016 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.3 tttt -116.08 -168.79 1.49 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.696 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.4 t-80 34.23 19.31 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.847 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 174.57 -46.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 CA-C-O 122.308 1.052 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.54 -14.23 77.57 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.33 -46.88 7.16 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.523 -0.839 . . . . 0.0 109.559 178.004 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.88 14.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.93 5.65 1.03 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.9 t -144.6 -8.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.343 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 15.5 t30 105.35 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.578 1.174 . . . . 0.0 109.958 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 2.2 p-80 -170.58 107.74 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -59.92 -9.54 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.453 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 48.2 t-80 -156.75 145.65 20.12 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.006 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.74 -31.65 0.23 Allowed 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 125.835 1.959 . . . . 0.0 109.889 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.46 2.14 0.29 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.006 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttp -116.24 -169.09 1.54 Allowed 'General case' 0 C--N 1.393 2.497 0 CA-C-N 109.435 -3.53 . . . . 0.0 111.68 177.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.36 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.961 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.12 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.61 0 CA-C-O 122.015 0.912 . . . . 0.0 109.524 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.35 -13.29 83.42 Favored Glycine 0 C--N 1.276 -2.781 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.537 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.5 m170 -94.66 -47.52 6.47 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.709 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.0 12.85 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.26 7.45 1.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.373 0.606 . . . . 0.0 109.388 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.3 t -148.31 -9.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.106 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 39.8 t-20 101.66 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.463 1.102 . . . . 0.0 110.084 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' A' ' 25' ' ' LEU . 76.4 m80 -150.48 112.85 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.383 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 61.8 t80 -53.8 -10.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 23' ' ' HIS . 14.9 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.446 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 11' ' ' HIS . 51.2 mtt-85 . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 39.7 m80 60.08 136.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.544 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.69 -32.43 0.24 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.631 1.832 . . . . 0.0 109.637 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.18 1.32 0.32 Allowed 'General case' 0 N--CA 1.41 -2.431 1 N-CA-C 95.34 -5.8 . . . . 0.0 95.34 164.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.1 tttt -114.62 -169.05 1.47 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.592 -3.458 . . . . 0.0 111.843 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 56.8 m-70 34.44 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.763 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 174.61 -46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-O 122.2 1.0 . . . . 0.0 109.422 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -13.69 80.06 Favored Glycine 0 C--N 1.271 -3.071 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.27 -43.14 9.45 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.643 -0.778 . . . . 0.0 109.853 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.226 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.93 -17.89 0.16 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.55 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 19' ' ' ALA . 24.0 t -149.24 -32.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.759 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 156.87 -47.7 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -166.98 68.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.556 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.459 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 68.7 t80 -58.22 -21.66 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.566 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.481 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.505 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.1 t-80 -158.85 146.8 17.96 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.72 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.022 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.99 -31.97 0.24 Allowed 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 125.791 1.932 . . . . 0.0 109.991 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.92 0.29 Allowed 'General case' 0 N--CA 1.412 -2.35 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 165.153 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.022 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttp -115.59 -169.68 1.63 Allowed 'General case' 0 C--N 1.393 2.465 0 CA-C-N 109.323 -3.58 . . . . 0.0 111.623 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.614 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.5 t60 34.47 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.033 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 176.07 -43.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 CA-C-O 122.093 0.949 . . . . 0.0 109.477 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.55 -14.48 81.99 Favored Glycine 0 C--N 1.274 -2.863 0 N-CA-C 105.197 -3.161 . . . . 0.0 105.197 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -90.29 -49.38 6.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.179 177.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.57 13.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.16 0.288 . . . . 0.0 110.309 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.48 7.85 1.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.9 t -141.71 -9.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t-20 105.17 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.607 1.192 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.0 t-80 84.71 26.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.008 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.38 -13.66 62.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.277 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.837 0.351 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 98.5 m-70 -136.48 92.02 2.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.318 0.58 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.0 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 138.74 -32.86 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -0.39 0.58 Allowed 'General case' 0 N--CA 1.414 -2.25 1 N-CA-C 95.398 -5.779 . . . . 0.0 95.398 164.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.0 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.9 tttt -114.59 -168.78 1.42 Allowed 'General case' 0 C--N 1.391 2.378 0 CA-C-N 109.441 -3.527 . . . . 0.0 112.001 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 81.4 m-70 33.45 21.7 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.833 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.75 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.237 1.018 . . . . 0.0 109.452 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.37 -11.5 80.32 Favored Glycine 0 C--N 1.276 -2.751 0 N-CA-C 104.848 -3.301 . . . . 0.0 104.848 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.498 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -91.76 -36.75 13.39 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.843 178.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.45 26.22 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.707 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.13 0.15 0.05 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.269 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.5 t -151.47 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.266 0.079 . . . . 0.0 110.823 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.433 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 4.6 p30 -178.87 -89.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.91 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.433 ' H ' ' CG ' ' A' ' 22' ' ' ASN . 1.7 t60 -166.51 50.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.407 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 48.4 t80 -74.58 -15.81 60.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.585 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.501 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.6 t60 -157.52 146.25 19.54 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.632 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 125.71 1.881 . . . . 0.0 109.898 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.27 1.95 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.044 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.4 tttt -115.69 -169.26 1.55 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.744 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.62 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 33.89 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.792 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.4 tt 174.37 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-O 122.202 1.001 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.0 -13.86 80.66 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.495 -3.042 . . . . 0.0 105.495 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.447 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -91.05 -43.53 9.87 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.674 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.37 41.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.221 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.7 -16.99 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.587 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.7 t -148.95 -34.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t30 155.28 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.827 0.704 . . . . 0.0 109.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.54 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 29.4 t60 -162.89 -117.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.54 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 59.6 t80 54.62 18.0 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.336 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.85 0.357 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.4 m80 -152.8 145.39 24.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.55 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.36 -31.25 0.22 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.701 1.876 . . . . 0.0 109.726 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 2.02 0.31 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.353 -5.795 . . . . 0.0 95.353 164.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.029 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.2 ttpt -115.9 -169.28 1.56 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.424 -3.535 . . . . 0.0 111.577 176.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.2 t-80 34.45 17.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.001 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.7 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.123 0.964 . . . . 0.0 109.565 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -13.68 83.17 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 105.386 -3.086 . . . . 0.0 105.386 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.18 -47.42 7.53 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.211 -0.995 . . . . 0.0 109.251 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.45 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.273 0.358 . . . . 0.0 110.135 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.07 10.2 1.54 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 92.5 t -142.63 -9.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 22.7 t-20 101.89 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.464 1.102 . . . . 0.0 110.813 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.553 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.5 t60 81.63 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.237 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.553 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.1 m-85 50.36 31.95 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.244 -179.923 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 61.9 mtp180 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 90.6 m-70 -156.38 144.85 19.94 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.96 -31.93 0.23 Allowed 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 125.737 1.898 . . . . 0.0 109.892 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.91 0.31 Allowed 'General case' 0 N--CA 1.412 -2.37 1 N-CA-C 95.406 -5.776 . . . . 0.0 95.406 165.057 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.3 tttm -115.15 -169.78 1.63 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.5 -3.5 . . . . 0.0 111.803 176.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.0 t60 34.39 17.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.108 178.059 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 176.38 -44.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.224 1.011 . . . . 0.0 109.078 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.35 -13.93 82.4 Favored Glycine 0 C--N 1.274 -2.905 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 174.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 m170 -92.28 -47.91 6.96 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.465 -0.867 . . . . 0.0 109.457 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.38 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.641 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.54 7.83 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.411 0.624 . . . . 0.0 109.46 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 48.9 t -146.22 -8.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.958 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.0 t-20 102.52 -37.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.631 1.207 . . . . 0.0 110.031 -179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -173.93 104.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.618 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 48.2 t80 -171.68 -4.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' H ' ' H ' ' A' ' 24' ' ' TYR . 15.9 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.13 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.816 0.341 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.0 m-70 -135.82 146.75 47.84 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.278 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.993 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -31.62 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.734 1.896 . . . . 0.0 109.851 -177.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 1.99 0.31 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.443 -5.762 . . . . 0.0 95.443 165.051 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.993 ' N ' ' C ' ' A' ' 12' ' ' ALA . 18.7 tttp -115.57 -169.12 1.52 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.406 -3.543 . . . . 0.0 111.737 176.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.8 t60 33.72 19.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.89 178.044 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.31 -45.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.125 0.964 . . . . 0.0 109.551 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.05 -14.33 80.44 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 105.402 -3.079 . . . . 0.0 105.402 174.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 m170 -91.67 -48.96 6.54 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.325 -0.937 . . . . 0.0 109.182 177.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.08 14.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.29 9.63 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.5 t -144.63 -10.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.845 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.2 t-20 105.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.542 1.151 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 4.9 t-160 83.98 28.02 0.08 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.372 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.61 -19.37 25.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.4 t-80 -157.22 143.6 18.02 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.324 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.85 -30.73 0.21 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.37 -177.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.87 3.29 0.24 Allowed 'General case' 0 N--CA 1.41 -2.46 1 N-CA-C 95.332 -5.803 . . . . 0.0 95.332 164.741 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.023 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.8 tttp -119.05 -168.13 1.51 Allowed 'General case' 0 C--N 1.392 2.428 0 CA-C-N 109.457 -3.52 . . . . 0.0 111.684 177.28 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.4 m80 33.5 23.27 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.556 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.63 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.3 tt 167.41 -34.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.166 0.984 . . . . 0.0 109.256 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.63 -12.37 77.99 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 104.902 -3.279 . . . . 0.0 104.902 174.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 18' ' ' HIS . 18.4 t-160 -92.56 -36.04 13.25 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 114.425 -0.887 . . . . 0.0 110.013 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -146.91 22.88 1.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.96 -2.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.3 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.9 -30.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.738 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -176.63 -90.16 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.011 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.1 p80 -149.75 25.99 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.48 ' N ' ' CB ' ' A' ' 19' ' ' ALA . 45.5 t80 -72.46 12.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.4 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.253 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.1 t60 -157.49 145.24 18.82 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.024 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.81 -31.72 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.706 1.879 . . . . 0.0 109.805 -178.103 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.86 0.3 Allowed 'General case' 0 N--CA 1.412 -2.361 1 N-CA-C 95.303 -5.814 . . . . 0.0 95.303 164.95 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.024 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.556 -3.474 . . . . 0.0 111.876 177.109 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 49.3 t-80 33.91 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.787 178.012 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.14 -46.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 122.234 1.016 . . . . 0.0 109.319 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -13.63 80.57 Favored Glycine 0 C--N 1.271 -3.076 0 N-CA-C 105.571 -3.011 . . . . 0.0 105.571 174.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.434 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.21 -43.09 10.05 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.533 178.181 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.42 41.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.181 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.41 -15.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.612 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.17 -35.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.2 t30 155.53 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.806 0.691 . . . . 0.0 109.19 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -166.11 65.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.6 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.469 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 65.1 t80 -70.12 -13.59 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.451 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.005 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.0 t60 -157.25 145.2 19.12 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.041 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.03 -31.57 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.702 1.876 . . . . 0.0 109.75 -177.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.85 0.31 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.416 -5.772 . . . . 0.0 95.416 164.914 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.041 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.8 tttt -115.35 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.45 -3.523 . . . . 0.0 111.759 176.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 11.7 t-80 34.51 18.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.985 177.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.668 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.88 -46.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.307 1.051 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.16 -14.49 79.0 Favored Glycine 0 C--N 1.271 -3.035 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.369 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.3 -48.63 6.58 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.471 -0.865 . . . . 0.0 109.539 178.113 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.26 12.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.433 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.1 8.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 21' ' ' VAL . 89.5 t -145.78 -7.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.783 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.6 m-20 98.57 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.764 1.29 . . . . 0.0 110.19 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -176.76 87.15 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.352 -179.927 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -66.82 -21.38 66.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.984 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 t-80 -160.82 144.05 13.16 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.463 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.05 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.58 -31.11 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.568 1.792 . . . . 0.0 109.458 -177.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.34 0.3 Allowed 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 95.317 -5.808 . . . . 0.0 95.317 164.758 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.05 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.1 tttm -116.33 -169.29 1.59 Allowed 'General case' 0 C--N 1.393 2.468 0 CA-C-N 109.525 -3.489 . . . . 0.0 111.556 177.063 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 34.77 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.99 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 175.83 -41.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.58 0 CA-C-O 122.042 0.925 . . . . 0.0 109.471 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.1 -13.01 83.8 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 105.331 -3.108 . . . . 0.0 105.331 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.4 m170 -94.38 -46.29 7.09 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.541 178.17 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.63 13.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.772 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.55 5.92 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 20.7 t -148.13 -10.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.391 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 58.2 t-20 110.53 -42.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.632 1.208 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 63.2 t-80 -173.9 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.649 0.262 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.05 39.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.477 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.2 tp . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.264 0.554 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.5 t60 -150.16 144.73 25.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.006 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.42 -31.4 0.22 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 125.75 1.906 . . . . 0.0 109.648 -177.629 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.4 0.27 Allowed 'General case' 0 N--CA 1.413 -2.308 1 N-CA-C 95.363 -5.791 . . . . 0.0 95.363 164.952 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.006 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.2 tttt -116.63 -168.63 1.48 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.485 -3.507 . . . . 0.0 111.669 177.096 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.1 m-70 33.82 20.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.825 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 173.76 -43.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 122.108 0.956 . . . . 0.0 109.61 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.22 -13.24 83.48 Favored Glycine 0 C--N 1.274 -2.911 0 N-CA-C 105.57 -3.012 . . . . 0.0 105.57 174.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.77 -45.51 7.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.483 178.117 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.62 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.34 7.16 1.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -146.59 -9.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.369 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 37.7 t-20 103.46 -35.93 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.514 1.134 . . . . 0.0 110.058 -179.643 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.535 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -171.58 112.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.346 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -64.17 -1.03 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.634 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.977 0.418 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' ALA . 5.7 p80 -155.04 143.77 20.68 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.63 -31.07 0.22 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.694 1.871 . . . . 0.0 109.523 -177.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.02 0.29 Allowed 'General case' 0 N--CA 1.411 -2.391 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 165.078 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.045 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.9 ttpt -116.96 -168.18 1.42 Allowed 'General case' 0 C--N 1.393 2.498 0 CA-C-N 109.398 -3.546 . . . . 0.0 111.498 177.331 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.4 t-80 34.11 20.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.631 177.519 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 171.36 -46.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 CA-C-O 122.303 1.049 . . . . 0.0 109.254 -179.744 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.69 -13.12 80.6 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.975 -2.85 . . . . 0.0 105.975 175.283 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.43 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.55 -32.21 18.27 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.84 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.795 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -172.56 -20.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CD2' ' A' ' 15' ' ' HIS . 59.9 t -152.0 -17.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.562 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 164.58 -38.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.958 0.409 . . . . 0.0 110.017 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 31.4 t60 -171.34 26.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.352 -178.746 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -47.62 -18.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.303 179.935 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.821 0.344 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.53 ' C ' ' H ' ' A' ' 13' ' ' ALA . 74.9 t60 -158.48 146.4 18.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.05 -31.31 0.22 Allowed 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 125.821 1.951 . . . . 0.0 109.738 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.79 0.26 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.313 -5.81 . . . . 0.0 95.313 164.957 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.039 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -117.37 -168.62 1.52 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.462 -3.517 . . . . 0.0 111.859 177.181 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.1 t60 33.86 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.331 178.124 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 172.13 -45.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 CA-C-O 122.058 0.933 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.13 76.34 Favored Glycine 0 C--N 1.272 -3.026 0 N-CA-C 105.812 -2.915 . . . . 0.0 105.812 175.017 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 7.9 t-80 -93.29 -41.95 9.59 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.31 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.39 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.621 -179.379 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.62 -12.51 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.016 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.0 t -148.94 -36.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 121.284 -0.166 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.3 t-20 157.52 -46.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.79 95.8 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.713 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.432 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.4 t80 -170.32 1.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.71 179.965 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.561 ' ND1' ' N ' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -90.14 146.28 24.41 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.201 -179.543 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.65 -32.47 0.23 Allowed 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 125.582 1.801 . . . . 0.0 110.18 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.86 0.39 0.38 Allowed 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 95.382 -5.784 . . . . 0.0 95.382 165.031 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.2 tttt -113.39 -169.93 1.59 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.138 -3.665 . . . . 0.0 112.169 176.546 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.0 m80 34.47 18.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.896 177.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.83 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 CA-C-O 122.284 1.04 . . . . 0.0 109.169 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.19 -14.62 78.98 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 105.516 -3.033 . . . . 0.0 105.516 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.72 -47.99 6.8 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.686 -0.757 . . . . 0.0 109.654 177.996 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.38 11.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.37 8.73 1.23 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 21' ' ' VAL . 57.7 t -148.04 -7.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.872 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 6.3 m-20 97.61 -36.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.605 1.191 . . . . 0.0 110.087 -179.452 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 75.4 m80 -158.43 -166.15 1.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.221 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 55.94 27.01 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.118 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 74.9 m80 -145.06 93.37 2.38 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.414 0.626 . . . . 0.0 109.638 178.932 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 137.45 -31.46 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -178.161 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.69 0.54 0.49 Allowed 'General case' 0 N--CA 1.413 -2.3 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 163.9 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.5 tttm -116.76 -167.89 1.37 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.383 -3.553 . . . . 0.0 111.703 177.024 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.659 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 99.0 m-70 33.9 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.955 178.076 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.655 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.8 tt 171.5 -37.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.265 1.031 . . . . 0.0 109.166 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.13 -11.35 81.18 Favored Glycine 0 C--N 1.275 -2.808 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 174.119 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.468 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.3 m170 -95.86 -34.16 11.95 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.078 178.385 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.05 26.6 0.62 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.437 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.22 -11.71 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 19' ' ' ALA . 90.3 t -152.96 -23.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.322 -179.31 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 38.0 t30 -170.45 -96.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.374 -179.003 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 33.4 m80 -145.51 127.2 15.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.724 -178.616 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 67.4 t80 -75.64 -4.38 39.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.124 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.414 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 10' ' ' ARG . 32.8 m80 -146.6 75.01 1.38 Allowed 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 178.642 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.012 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 172.2 -32.19 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.513 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.73 -1.73 0.67 Allowed 'General case' 0 N--CA 1.416 -2.126 1 N-CA-C 95.548 -5.723 . . . . 0.0 95.548 164.827 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.012 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.259 20.8 tttm -114.01 -167.74 1.25 Allowed 'General case' 0 C--N 1.387 2.217 0 CA-C-N 109.179 -3.646 . . . . 0.0 111.705 176.648 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.64 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.88 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.978 177.697 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.2 tt 174.22 -44.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.142 0.973 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.45 -13.43 81.72 Favored Glycine 0 C--N 1.273 -2.955 0 N-CA-C 105.843 -2.903 . . . . 0.0 105.843 174.966 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.616 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.7 -42.79 10.52 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.682 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 156.33 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.68 7.56 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.053 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.6 t -144.88 -11.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -179.85 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 49.4 t30 119.13 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.607 1.192 . . . . 0.0 110.091 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.437 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.8 t60 -172.47 -8.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.643 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -76.06 32.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.9 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.206 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.6 t-80 -149.52 145.94 27.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.579 179.513 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.042 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.34 -31.3 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.668 1.855 . . . . 0.0 109.719 -177.859 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.64 2.24 0.3 Allowed 'General case' 0 N--CA 1.412 -2.335 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 164.896 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.042 ' H ' ' C ' ' A' ' 12' ' ' ALA . 11.2 ttpt -115.95 -168.92 1.5 Allowed 'General case' 0 C--N 1.395 2.554 0 CA-C-N 109.448 -3.524 . . . . 0.0 111.546 176.901 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.4 m80 34.72 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.013 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 176.06 -44.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.204 1.002 . . . . 0.0 109.46 -179.822 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.76 -14.0 81.8 Favored Glycine 0 C--N 1.273 -2.954 0 N-CA-C 105.449 -3.061 . . . . 0.0 105.449 174.43 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.554 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.43 -47.27 7.54 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.407 177.948 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.75 11.61 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.26 8.85 1.19 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.749 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 77.4 t -144.03 -9.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.113 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.7 t-20 100.15 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.525 1.141 . . . . 0.0 110.252 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.6 t60 89.4 -38.97 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.893 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -76.58 13.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.3 tt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.128 0.489 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 m170 -84.63 144.44 28.6 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.279 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.015 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.21 -32.05 0.24 Allowed 'General case' 0 CA--C 1.501 -0.922 0 O-C-N 125.403 1.689 . . . . 0.0 109.613 -177.856 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.07 0.5 0.4 Allowed 'General case' 0 N--CA 1.413 -2.285 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 164.855 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.015 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.4 tttt -113.87 -169.66 1.56 Allowed 'General case' 0 C--N 1.39 2.369 0 CA-C-N 109.083 -3.69 . . . . 0.0 111.974 176.432 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.9 t-80 35.16 17.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.977 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 176.19 -43.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.031 0.919 . . . . 0.0 109.465 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 -14.27 82.18 Favored Glycine 0 C--N 1.272 -3.02 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 174.336 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.94 -47.83 7.09 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.464 -0.868 . . . . 0.0 109.55 177.938 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.77 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.92 10.44 1.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 21' ' ' VAL . 98.2 t -146.57 -7.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.764 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 9.6 m-20 97.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.567 1.167 . . . . 0.0 110.228 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 96.1 m-70 -159.34 101.78 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -55.14 -14.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.04 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 16.2 ptm180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.668 0.27 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 m-70 -155.52 145.54 21.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.932 0.396 . . . . 0.0 110.554 179.291 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.92 -31.85 0.23 Allowed 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 125.689 1.868 . . . . 0.0 109.657 -177.831 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.35 2.06 0.29 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 165.063 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.029 ' N ' ' C ' ' A' ' 12' ' ' ALA . 33.1 tttt -115.63 -169.69 1.63 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.821 177.098 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 34.3 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.792 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.62 -45.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.142 0.972 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.37 -13.94 81.21 Favored Glycine 0 C--N 1.273 -2.956 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.488 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.28 -43.91 9.52 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.85 178.159 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.24 -179.131 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.23 -17.05 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.535 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 19' ' ' ALA . 15.8 t -148.21 -34.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.4 t-20 154.22 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.1 t60 -168.67 113.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -56.42 -7.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.428 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.353 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.564 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.7 t-80 -111.4 146.27 37.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.662 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -30.37 0.21 Allowed 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 125.663 1.852 . . . . 0.0 109.391 -177.376 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.05 3.47 0.24 Allowed 'General case' 0 N--CA 1.41 -2.444 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.602 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 26.8 tttt -119.46 -167.49 1.42 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.605 177.424 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.3 m-70 34.31 22.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 177.705 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.8 tt 169.0 -35.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.239 1.018 . . . . 0.0 109.22 -179.293 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.91 -12.12 80.27 Favored Glycine 0 C--N 1.275 -2.814 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 174.114 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 18' ' ' HIS . 1.2 t60 -93.66 -37.18 11.97 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.938 177.898 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -147.8 25.98 1.03 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.895 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.63 -9.25 0.14 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.917 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 19' ' ' ALA . 61.4 t -151.23 -26.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.263 -179.346 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -171.18 -94.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.277 -179.173 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.65 28.55 0.54 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.857 -179.662 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -77.53 19.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.477 179.787 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.26 179.913 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 93.4 mtt180 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 m80 -156.52 144.52 19.52 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.504 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.86 -31.7 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.77 1.919 . . . . 0.0 109.803 -178.073 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.63 0.31 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 95.39 -5.781 . . . . 0.0 95.39 164.961 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.025 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttm -115.04 -169.22 1.51 Allowed 'General case' 0 C--N 1.395 2.553 0 CA-C-N 109.484 -3.507 . . . . 0.0 111.802 176.971 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 33.98 19.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.847 178.062 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.7 -46.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 CA-C-O 122.23 1.014 . . . . 0.0 109.247 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 -13.97 79.7 Favored Glycine 0 C--N 1.271 -3.042 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 174.533 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.469 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -90.83 -43.86 9.79 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.582 178.177 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.249 -179.178 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.33 -17.82 0.14 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.705 -179.501 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.6 t -149.29 -31.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 122.493 -0.13 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t-20 155.69 -47.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.804 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 9.0 t60 -163.91 -130.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.582 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.7 m-85 54.23 22.43 3.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.486 -179.854 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.543 179.96 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 CA--C 1.518 -0.271 0 CA-C-O 121.257 0.551 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.54 ' C ' ' H ' ' A' ' 13' ' ' ALA . 16.2 p80 -169.62 143.43 2.73 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.07 179.441 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 72.0 -31.31 0.22 Allowed 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 125.632 1.833 . . . . 0.0 109.287 -177.566 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 2.65 0.25 Allowed 'General case' 0 N--CA 1.411 -2.415 1 N-CA-C 95.39 -5.782 . . . . 0.0 95.39 164.975 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.031 ' N ' ' C ' ' A' ' 12' ' ' ALA . 16.5 ttpp -116.19 -169.6 1.64 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.679 177.008 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.1 m-70 34.11 18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.904 178.154 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 175.07 -43.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.118 0.961 . . . . 0.0 109.477 179.838 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.4 83.49 Favored Glycine 0 C--N 1.274 -2.888 0 N-CA-C 105.411 -3.075 . . . . 0.0 105.411 174.425 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.37 -45.92 7.59 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 114.537 -0.832 . . . . 0.0 109.44 178.049 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.34 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.061 0.226 . . . . 0.0 110.444 -179.803 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.68 10.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.914 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 21' ' ' VAL . 61.1 t -147.75 -8.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.981 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.4 m-20 99.47 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.609 1.193 . . . . 0.0 110.265 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 42.8 p-80 -171.94 97.91 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.803 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -76.25 9.61 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.539 179.882 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.9 m80 -162.12 145.25 11.75 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.064 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.2 -31.35 0.22 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.621 1.826 . . . . 0.0 109.538 -177.752 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.45 0.26 Allowed 'General case' 0 N--CA 1.412 -2.356 1 N-CA-C 95.29 -5.818 . . . . 0.0 95.29 165.033 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.064 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.1 tttt -116.35 -169.24 1.58 Allowed 'General case' 0 C--N 1.394 2.51 0 CA-C-N 109.547 -3.478 . . . . 0.0 111.795 177.074 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.7 t60 34.65 17.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.975 178.094 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 175.43 -41.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.043 0.925 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.62 -13.02 83.94 Favored Glycine 0 C--N 1.276 -2.783 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 174.412 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.01 -43.78 8.74 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 114.439 -0.88 . . . . 0.0 109.209 178.046 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.27 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.55 10.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.06 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.1 t -145.81 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.02 -179.828 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.8 t-20 102.46 -36.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.585 1.178 . . . . 0.0 110.189 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -170.48 102.95 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.649 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 51.9 t80 -167.68 -4.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.216 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 51.2 t-80 -170.06 143.75 2.55 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.453 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.44 -31.45 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.596 1.81 . . . . 0.0 109.547 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.34 1.74 0.31 Allowed 'General case' 0 N--CA 1.41 -2.433 1 N-CA-C 95.386 -5.783 . . . . 0.0 95.386 164.899 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.6 tttm -115.47 -169.53 1.59 Allowed 'General case' 0 C--N 1.393 2.492 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.711 177.014 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 34.4 m170 34.48 17.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.97 178.149 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.05 -44.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.135 0.969 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.06 -14.26 81.97 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 174.335 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.89 -48.12 7.43 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.246 -0.977 . . . . 0.0 109.102 177.87 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.89 13.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.49 10.85 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.904 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 94.1 t -140.23 -9.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 44.9 t-20 107.56 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.65 1.219 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 19.1 t60 80.64 34.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.035 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.47 -31.71 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.249 -179.887 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 53.8 t-80 -164.51 145.0 7.83 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.868 179.407 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -31.71 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.706 1.879 . . . . 0.0 109.99 -178.087 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 1.88 0.32 Allowed 'General case' 0 N--CA 1.413 -2.32 1 N-CA-C 95.389 -5.782 . . . . 0.0 95.389 164.922 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.515 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.71 176.895 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 41.5 m80 33.94 18.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.995 178.094 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.6 tt 175.29 -43.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-O 122.011 0.91 . . . . 0.0 109.483 179.842 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -13.89 82.68 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.325 -3.11 . . . . 0.0 105.325 174.34 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.25 -47.58 7.42 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 114.368 -0.916 . . . . 0.0 109.23 177.95 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.6 14.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 11.29 0.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.873 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 97.1 t -140.85 -9.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 17.8 t-20 106.85 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.603 1.19 . . . . 0.0 110.427 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 1.2 t-80 83.05 -1.09 1.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.216 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -76.38 -7.85 55.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.501 -179.99 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.443 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 77.6 mtp180 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.356 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.0 m80 -151.68 147.01 26.21 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 179.636 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.034 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.93 -31.89 0.23 Allowed 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 125.678 1.861 . . . . 0.0 110.018 -178.227 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 95.426 -5.768 . . . . 0.0 95.426 165.158 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.034 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.9 tttm -115.51 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 109.409 -3.541 . . . . 0.0 111.818 177.058 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.2 t60 33.99 19.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.86 177.842 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.48 -45.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.363 -179.982 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.43 -13.99 81.28 Favored Glycine 0 C--N 1.273 -2.971 0 N-CA-C 105.406 -3.078 . . . . 0.0 105.406 174.317 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.474 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.52 9.65 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 114.495 -0.853 . . . . 0.0 109.677 178.111 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.67 41.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.176 -179.076 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.92 -19.73 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.471 -179.361 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 19' ' ' ALA . 39.4 t -149.05 -31.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 156.09 -48.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 25.4 t60 -171.54 5.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 50.5 t80 -73.62 10.53 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.475 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.6 tt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.122 -179.969 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.9 mtp-105 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.914 0.387 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.8 t-80 -158.88 143.64 15.88 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.427 179.537 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.37 -31.58 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.641 1.838 . . . . 0.0 109.673 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.84 0.31 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.387 -5.782 . . . . 0.0 95.387 164.838 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.6 -169.22 1.54 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.432 -3.531 . . . . 0.0 111.658 176.936 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.7 t-80 34.98 17.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.903 177.902 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.87 -46.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.413 1.101 . . . . 0.0 109.231 -179.875 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.76 79.82 Favored Glycine 0 C--N 1.272 -3.003 0 N-CA-C 105.825 -2.91 . . . . 0.0 105.825 174.627 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.82 -44.48 8.92 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.655 -0.772 . . . . 0.0 109.128 177.917 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.02 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.63 8.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.165 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 74.4 t -144.06 -9.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.386 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.0 t30 105.31 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.662 1.226 . . . . 0.0 110.14 -179.837 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 16.8 t-80 -169.38 -127.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 69.7 m-85 50.18 23.54 1.2 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.799 0.333 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.455 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.989 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.97 0.414 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.6 t-80 -169.11 145.7 3.48 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.954 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.046 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.84 -31.79 0.23 Allowed 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 125.811 1.944 . . . . 0.0 109.974 -178.306 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.74 0.3 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.327 -5.805 . . . . 0.0 95.327 165.206 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.046 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -115.94 -169.55 1.62 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.942 177.152 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.7 18.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.787 178.103 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.93 -44.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.169 0.985 . . . . 0.0 109.605 -179.871 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.91 -13.62 82.35 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 174.854 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.613 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.41 -43.19 9.35 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.831 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 160.36 11.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 11.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.697 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 21' ' ' VAL . 91.4 t -145.41 -8.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.018 -179.596 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.5 m120 100.16 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.737 1.273 . . . . 0.0 110.398 -179.597 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.7 t60 -165.14 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.2 m-85 49.13 21.45 0.5 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.756 0.313 . . . . 0.0 110.671 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.466 -179.987 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 40.0 t60 -162.85 144.91 10.36 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 179.378 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -30.8 0.21 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.866 1.978 . . . . 0.0 109.75 -177.819 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.83 3.05 0.25 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 164.808 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.4 tttp -118.2 -168.31 1.5 Allowed 'General case' 0 C--N 1.394 2.517 0 CA-C-N 109.606 -3.452 . . . . 0.0 111.687 177.437 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.3 m-70 33.71 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.418 178.186 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 172.87 -43.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 179.84 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.41 78.64 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 174.703 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 22' ' ' ASN . 6.9 t-80 -92.85 -43.45 8.98 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.344 178.099 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 46.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.468 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 64.17 -18.69 0.07 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.961 -179.589 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 19' ' ' ALA . 25.7 t -148.76 -32.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.03 -179.834 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.6 t-20 158.34 -49.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.607 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -171.81 62.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.394 -179.784 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -56.63 -24.33 47.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.491 -179.889 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.828 0.347 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.3 t60 -160.08 144.53 14.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.412 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.032 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.78 -29.18 0.19 Allowed 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 125.521 1.763 . . . . 0.0 109.798 -177.934 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.13 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 1 N-CA-C 94.819 -5.993 . . . . 0.0 94.819 164.293 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.032 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.6 tttt -116.96 -160.28 0.76 Allowed 'General case' 0 C--N 1.397 2.657 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.637 176.967 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.553 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.7 t60 30.62 20.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.448 0.699 . . . . 0.0 112.199 178.59 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 173.14 -48.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-O 122.435 1.112 . . . . 0.0 109.228 -179.27 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.6 -13.67 71.61 Favored Glycine 0 C--N 1.27 -3.09 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 175.297 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.586 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.95 -44.5 7.33 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 114.546 -0.827 . . . . 0.0 109.455 178.216 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.46 10.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -179.943 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.61 7.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.981 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 48.5 t -144.75 -8.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.919 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 61.5 t30 102.18 -37.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.525 1.141 . . . . 0.0 110.4 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -173.8 78.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.473 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 54.3 t80 -72.88 -19.08 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.502 179.828 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.433 179.947 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.08 0.467 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.68 ' CD2' ' N ' ' A' ' 12' ' ' ALA . 6.3 t60 -165.71 143.02 5.59 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.702 179.454 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.993 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 72.01 -30.92 0.22 Allowed 'General case' 0 CA--C 1.497 -1.069 0 O-C-N 125.632 1.833 . . . . 0.0 109.212 -177.513 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.3 0.29 Allowed 'General case' 0 N--CA 1.41 -2.467 1 N-CA-C 95.273 -5.825 . . . . 0.0 95.273 164.848 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.993 ' N ' ' C ' ' A' ' 12' ' ' ALA . 2.3 ttpm? -116.86 -169.43 1.64 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.497 -3.502 . . . . 0.0 111.621 177.056 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.638 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 48.6 t-80 33.97 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.82 177.702 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.85 -37.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.256 1.027 . . . . 0.0 109.423 -179.363 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.33 -11.29 80.8 Favored Glycine 0 C--N 1.275 -2.853 0 N-CA-C 105.029 -3.228 . . . . 0.0 105.029 174.074 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.478 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.47 -35.87 12.74 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.776 178.212 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.42 26.76 0.59 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.641 -179.619 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.27 -8.18 0.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.567 179.025 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' ALA . 60.5 t -151.48 -25.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.254 -179.355 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -171.45 -94.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.312 -179.272 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 13.8 t-160 -158.86 17.98 0.19 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.448 -179.589 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -70.96 8.33 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 16.3 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.217 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.842 0.353 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 t60 -151.64 145.44 25.08 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.659 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.07 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.71 0.23 Allowed 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.734 1.896 . . . . 0.0 109.848 -178.008 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.91 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.422 -5.77 . . . . 0.0 95.422 165.085 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.07 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.51 -169.18 1.53 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.424 -3.534 . . . . 0.0 111.744 177.081 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.7 t60 33.92 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.816 177.966 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.24 -46.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.288 1.042 . . . . 0.0 109.306 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.61 -14.01 79.94 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 174.517 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.02 9.99 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.624 178.21 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.28 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.251 -179.054 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.48 -18.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.523 -179.435 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.9 t -148.29 -32.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.908 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.0 t-20 155.19 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.982 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -164.2 65.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.621 -179.866 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.51 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 62.0 t80 -50.84 -14.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.849 0.356 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.2 t60 -163.61 146.15 9.77 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.376 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.075 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -31.62 0.23 Allowed 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 125.775 1.922 . . . . 0.0 109.956 -178.072 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.13 0.29 Allowed 'General case' 0 N--CA 1.411 -2.385 1 N-CA-C 95.341 -5.8 . . . . 0.0 95.341 164.995 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.075 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.96 -169.33 1.58 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.825 177.012 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.0 t60 33.95 18.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.991 178.169 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.18 -42.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 CA-C-O 122.093 0.949 . . . . 0.0 109.459 179.817 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.39 -13.29 83.72 Favored Glycine 0 C--N 1.276 -2.77 0 N-CA-C 105.355 -3.098 . . . . 0.0 105.355 174.168 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.539 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.01 -46.46 7.14 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.615 178.15 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.4 10.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.63 -179.764 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.15 10.36 1.21 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.722 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 21' ' ' VAL . 66.0 t -148.87 -8.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.628 -179.723 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.4 m-20 96.48 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.545 1.153 . . . . 0.0 110.169 -179.555 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -172.54 93.15 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.524 179.969 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.47 11.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.836 -179.812 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.697 0.284 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -79.13 72.93 5.7 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.986 0.898 . . . . 0.0 110.056 -179.915 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.975 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.276 . . 174.81 -32.06 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 112.635 -2.075 . . . . 0.0 106.782 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -2.62 0.79 Allowed 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 164.663 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.975 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.252 20.5 tttm -112.75 -168.13 1.28 Allowed 'General case' 0 C--N 1.389 2.314 0 CA-C-N 109.206 -3.634 . . . . 0.0 112.13 176.515 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 44.9 m80 34.23 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.812 177.879 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 175.47 -47.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.855 0 CA-C-O 122.269 1.033 . . . . 0.0 109.158 -179.749 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.88 -14.15 78.56 Favored Glycine 0 C--N 1.274 -2.903 0 N-CA-C 105.636 -2.985 . . . . 0.0 105.636 174.736 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.448 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.92 -44.02 9.63 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.673 178.059 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.14 42.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.321 -179.084 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 65.81 -15.9 0.11 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.602 -179.435 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.4 t -148.79 -35.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.9 t30 154.78 -44.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.911 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.6 t60 -168.83 50.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.519 -179.88 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -64.52 -28.34 69.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.228 -179.924 . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 79.4 mtt-85 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.8 m80 -157.53 144.04 17.92 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.369 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.999 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.23 0.22 Allowed 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 125.603 1.814 . . . . 0.0 109.485 -177.823 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.41 1.87 0.31 Allowed 'General case' 0 N--CA 1.41 -2.428 1 N-CA-C 95.35 -5.796 . . . . 0.0 95.35 164.981 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.999 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.9 ttpt -115.54 -169.58 1.61 Allowed 'General case' 0 C--N 1.394 2.519 0 CA-C-N 109.399 -3.546 . . . . 0.0 111.655 177.012 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.7 t-80 34.44 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.079 178.092 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tp 176.33 -46.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.643 0 CA-C-O 122.371 1.082 . . . . 0.0 109.074 -179.924 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.55 -14.69 77.53 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 174.409 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.62 -48.71 7.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.325 -0.938 . . . . 0.0 108.885 177.823 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.4 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.995 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.18 9.99 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.938 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.3 t -139.07 -10.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.774 -179.698 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.0 t-20 108.44 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.63 1.206 . . . . 0.0 110.586 179.855 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 8.8 t60 80.08 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.171 -179.61 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -79.54 -15.76 57.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.746 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.401 -179.683 . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.955 0.407 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 67.0 t60 -102.91 147.49 26.85 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.289 179.454 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.52 -31.57 0.22 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.716 1.885 . . . . 0.0 110.099 -178.085 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.89 0.31 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.318 -5.808 . . . . 0.0 95.318 165.052 . . . . . . . . 3 3 . 1 . 052 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.6 tttm -116.23 -169.0 1.53 Allowed 'General case' 0 C--N 1.393 2.473 0 CA-C-N 109.315 -3.584 . . . . 0.0 111.773 176.971 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 48.2 t-80 35.02 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.784 177.96 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 174.64 -42.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.044 0.926 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.52 -13.36 83.52 Favored Glycine 0 C--N 1.275 -2.859 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.645 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.596 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.79 -44.2 7.88 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 114.634 -0.783 . . . . 0.0 109.738 178.189 . . . . . . . . 3 3 . 1 . 052 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.26 12.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.501 -179.878 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.17 9.15 0.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.098 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.4 t -147.91 -9.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.142 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.5 t-20 101.79 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.544 1.152 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 86.0 m-70 -160.58 109.67 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.466 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 77.8 t80 -74.13 11.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.295 179.64 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.1 tp . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 31.1 m-70 -90.96 145.02 25.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.933 179.996 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.12 -31.9 0.23 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.635 1.834 . . . . 0.0 109.99 -178.138 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.19 0.93 0.36 Allowed 'General case' 0 N--CA 1.412 -2.33 1 N-CA-C 95.297 -5.816 . . . . 0.0 95.297 164.978 . . . . . . . . 3 3 . 1 . 053 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.8 tttt -114.47 -169.4 1.53 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.24 -3.618 . . . . 0.0 111.87 176.621 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.6 m80 34.92 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.922 177.999 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 175.58 -43.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.114 0.959 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.72 -13.41 83.06 Favored Glycine 0 C--N 1.272 -2.977 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 174.668 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.33 -43.64 9.15 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.062 177.944 . . . . . . . . 3 3 . 1 . 053 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.23 12.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.958 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.13 8.29 1.02 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.7 t -145.83 -8.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.128 -179.844 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.7 t30 103.99 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.502 1.126 . . . . 0.0 109.996 -179.739 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -173.26 103.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.479 179.743 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' H ' ' H ' ' A' ' 25' ' ' LEU . 84.1 t80 -171.58 -7.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.938 179.897 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 24' ' ' TYR . 34.4 mt . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 179.812 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.988 0.423 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 92.6 m-70 -140.62 145.41 36.61 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.449 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.01 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.67 -31.54 0.23 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.584 1.803 . . . . 0.0 109.571 -177.786 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.1 0.28 Allowed 'General case' 0 N--CA 1.412 -2.334 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 164.951 . . . . . . . . 3 3 . 1 . 054 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.01 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.14 -169.24 1.57 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.395 -3.548 . . . . 0.0 111.585 177.062 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.9 t-80 34.67 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.028 178.066 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 175.78 -42.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.159 0.98 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.41 -13.57 83.25 Favored Glycine 0 C--N 1.275 -2.824 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 174.278 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.1 -46.01 8.36 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.299 -0.95 . . . . 0.0 109.066 177.957 . . . . . . . . 3 3 . 1 . 054 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.49 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.845 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.11 9.32 0.94 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.103 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 89.5 t -142.83 -9.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.367 -179.843 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 25.7 t30 105.44 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.581 1.176 . . . . 0.0 110.104 -179.954 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.581 ' ND1' ' N ' ' A' ' 24' ' ' TYR . 49.8 t-80 -162.19 -100.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.581 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 62.3 t80 51.97 14.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' N ' ' C ' ' A' ' 23' ' ' HIS . 13.0 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -179.989 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.736 0.303 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.6 m-70 -135.42 146.29 48.13 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.518 179.663 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.65 -31.1 0.21 Allowed 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.691 1.869 . . . . 0.0 109.761 -177.985 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.59 2.07 0.31 Allowed 'General case' 0 N--CA 1.411 -2.384 1 N-CA-C 95.381 -5.785 . . . . 0.0 95.381 164.85 . . . . . . . . 3 3 . 1 . 055 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.8 tttp -116.11 -168.95 1.51 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.486 -3.506 . . . . 0.0 111.627 176.941 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 69.2 m-70 34.56 18.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.945 178.079 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.89 -42.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.096 0.95 . . . . 0.0 109.628 179.923 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.51 -12.74 84.24 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.545 -3.022 . . . . 0.0 105.545 174.457 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.63 -44.19 8.31 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.258 177.969 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.99 10.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.31 10.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.829 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 21' ' ' VAL . 97.5 t -147.78 -8.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.046 -179.58 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.6 m120 98.13 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.581 1.175 . . . . 0.0 110.192 -179.512 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 84.3 m-70 -157.84 107.67 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.436 -179.925 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -61.25 -13.63 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.994 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.001 -179.969 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.341 0.115 . . . . 0.0 110.811 . . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 9.4 m-70 -115.96 71.69 0.79 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.922 0.868 . . . . 0.0 110.333 179.388 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.02 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 168.73 -31.9 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.503 -2.135 . . . . 0.0 105.85 -179.655 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.75 -2.29 0.8 Allowed 'General case' 0 N--CA 1.414 -2.256 1 N-CA-C 95.458 -5.756 . . . . 0.0 95.458 164.313 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.02 ' N ' ' C ' ' A' ' 12' ' ' ALA . 35.0 tttt -112.84 -168.56 1.34 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 109.277 -3.601 . . . . 0.0 111.83 176.408 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.656 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.6 t-80 34.52 17.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.004 178.04 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.52 -44.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-O 122.124 0.964 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.19 -13.63 82.6 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 174.56 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.6 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.55 -44.79 9.34 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.683 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.44 11.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.786 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.31 11.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.684 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 21' ' ' VAL . 97.9 t -144.73 -8.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 14.4 m-20 100.68 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.768 1.293 . . . . 0.0 110.698 -179.837 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 90.8 m-70 -158.09 -94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 62.2 t80 57.25 8.52 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.652 -179.822 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.336 179.876 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.94 0.4 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.54 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.2 p-80 -140.12 145.19 37.28 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 179.812 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.011 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.56 -29.6 0.19 Allowed 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 125.513 1.758 . . . . 0.0 110.117 -178.336 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.43 1.15 0.57 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 94.73 -6.026 . . . . 0.0 94.73 164.382 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.011 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.5 ttmt -114.71 -158.51 0.67 Allowed 'General case' 0 C--N 1.397 2.644 0 CA-C-N 109.286 -3.597 . . . . 0.0 110.106 176.268 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.569 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.0 t60 28.41 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 112.262 177.955 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 168.33 -52.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-O 122.463 1.125 . . . . 0.0 109.224 -179.143 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' H ' HG23 ' A' ' 16' ' ' ILE . . . -68.05 -12.8 63.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 176.034 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -32.85 16.87 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.375 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.457 ' CB ' ' N ' ' A' ' 24' ' ' TYR . . . -167.56 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.51 -21.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.878 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.445 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 60.2 t -151.98 -18.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.025 179.905 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 166.35 -39.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.547 0.529 . . . . 0.0 110.045 -179.785 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -160.95 126.58 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 111.291 -178.616 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 75.2 t80 -66.92 -5.1 11.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.06 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.469 179.91 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 12.7 ptm180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.844 0.354 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.5 m80 -158.48 145.22 17.45 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 179.412 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.027 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.39 -30.94 0.22 Allowed 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 125.698 1.874 . . . . 0.0 109.535 -177.729 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.8 2.82 0.26 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.78 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.027 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -117.52 -168.5 1.5 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.562 -3.472 . . . . 0.0 111.689 177.159 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 37.8 m80 34.09 20.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.917 178.09 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.663 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 174.35 -42.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 122.339 1.066 . . . . 0.0 108.831 179.713 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.31 -13.05 83.99 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 105.687 -2.965 . . . . 0.0 105.687 174.398 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.605 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 4.5 m170 -103.02 -7.66 21.24 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.023 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 18' ' ' HIS . . . 82.53 22.04 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.239 -179.123 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.65 14.19 0.16 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.874 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.2 t -151.58 -11.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.623 -179.119 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.1 t-20 104.79 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.282 0.989 . . . . 0.0 110.473 -179.657 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 34.2 p-80 -169.79 117.51 0.59 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -67.6 -0.99 4.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.225 179.65 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.378 179.892 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.033 0.445 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.2 t-80 -151.2 143.67 24.24 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.232 179.264 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.018 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.9 -31.34 0.22 Allowed 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.624 1.828 . . . . 0.0 109.436 -177.583 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.69 2.49 0.29 Allowed 'General case' 0 N--CA 1.412 -2.374 1 N-CA-C 95.431 -5.766 . . . . 0.0 95.431 164.844 . . . . . . . . 3 3 . 1 . 059 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.018 ' N ' ' C ' ' A' ' 12' ' ' ALA . 15.3 ttpt -116.65 -169.01 1.55 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.455 -3.52 . . . . 0.0 111.456 176.97 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.64 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.2 m80 34.25 20.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.79 177.9 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.659 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.21 -37.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-O 122.364 1.078 . . . . 0.0 109.316 -179.311 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.51 -11.1 80.74 Favored Glycine 0 C--N 1.277 -2.745 0 N-CA-C 105.088 -3.205 . . . . 0.0 105.088 174.082 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.484 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -94.99 -33.94 12.55 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.407 -0.896 . . . . 0.0 109.973 178.275 . . . . . . . . 3 3 . 1 . 059 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.47 23.74 0.71 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.834 -178.968 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.01 -0.34 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.244 179.322 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 19' ' ' ALA . 45.0 t -152.48 -27.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 121.5 -0.08 . . . . 0.0 110.952 -179.41 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' A' ' 22' ' ' ASN . 1.6 p30 176.17 -85.94 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 111.554 -179.354 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -146.95 126.05 12.9 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 -178.837 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 75.4 t80 -73.72 -3.92 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.187 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.332 -0.196 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.495 179.903 . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.372 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t-80 -161.9 146.81 12.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.565 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.72 -31.82 0.23 Allowed 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 125.775 1.922 . . . . 0.0 110.043 -178.271 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.1 0.29 Allowed 'General case' 0 N--CA 1.413 -2.302 1 N-CA-C 95.342 -5.799 . . . . 0.0 95.342 165.157 . . . . . . . . 3 3 . 1 . 060 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.5 tttt -116.17 -168.95 1.52 Allowed 'General case' 0 C--N 1.393 2.46 0 CA-C-N 109.502 -3.499 . . . . 0.0 111.648 177.018 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 34.33 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.885 177.983 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 174.6 -43.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.137 0.97 . . . . 0.0 109.547 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.36 -13.22 83.58 Favored Glycine 0 C--N 1.274 -2.862 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 174.47 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.25 -45.06 8.02 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.176 177.964 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.18 13.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.86 9.54 0.91 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.131 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 83.3 t -146.37 -9.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.332 -179.762 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 40.9 t-20 103.2 -36.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.511 1.132 . . . . 0.0 110.066 -179.784 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 91.1 m-70 -160.43 106.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 67.6 t80 -59.72 -15.09 17.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 10.2 mpt_? . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.726 0.298 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 79.2 m-70 -153.28 94.82 1.87 Allowed 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.239 0.543 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.008 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 132.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.03 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 0.23 0.55 Allowed 'General case' 0 N--CA 1.413 -2.297 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.649 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.008 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.6 tttt -115.89 -168.34 1.41 Allowed 'General case' 0 C--N 1.393 2.479 0 CA-C-N 109.504 -3.498 . . . . 0.0 111.641 176.885 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.647 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 94.3 m-70 33.73 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.836 178.257 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.78 -43.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.089 0.947 . . . . 0.0 109.596 179.88 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.35 -13.29 83.5 Favored Glycine 0 C--N 1.274 -2.893 0 N-CA-C 105.582 -3.007 . . . . 0.0 105.582 174.67 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.583 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.97 -44.76 7.91 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-N 114.538 -0.831 . . . . 0.0 109.335 177.947 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.22 10.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.899 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.75 10.7 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.839 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 21' ' ' VAL . 77.3 t -146.94 -8.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.848 -179.682 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.8 m-20 98.61 -36.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.729 1.268 . . . . 0.0 110.104 -179.539 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.6 p-80 -173.18 101.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 74.9 t80 -62.41 -10.13 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.485 179.996 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.061 -179.941 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.033 0.444 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 75.9 m80 -143.53 146.1 33.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.767 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.987 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.5 -29.88 0.19 Allowed 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 125.59 1.806 . . . . 0.0 110.237 -178.506 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.26 1.08 0.54 Allowed 'General case' 0 N--CA 1.411 -2.412 1 N-CA-C 94.814 -5.995 . . . . 0.0 94.814 164.541 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.987 ' N ' ' C ' ' A' ' 12' ' ' ALA . 7.9 tttm -115.11 -158.86 0.69 Allowed 'General case' 0 C--N 1.394 2.527 0 CA-C-N 109.149 -3.659 . . . . 0.0 110.175 176.397 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.568 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.7 t60 29.04 23.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 112.187 177.692 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 167.43 -52.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 CA-C-O 122.369 1.081 . . . . 0.0 109.194 -179.067 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.73 63.3 Favored Glycine 0 C--N 1.269 -3.14 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.185 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.92 -33.05 16.57 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.36 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.85 -65.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.788 179.529 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.29 -22.33 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.878 -179.693 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 t -150.6 -18.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 170.03 -38.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.237 0.336 . . . . 0.0 110.274 -179.687 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 27.3 t60 -171.72 -136.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.109 -178.99 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 76.5 m-85 53.14 27.11 5.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.0 110.765 179.773 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.036 179.993 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.04 0.448 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 54.0 t-80 -153.52 147.84 25.9 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.135 0.493 . . . . 0.0 110.909 179.583 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.054 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.34 -31.71 0.22 Allowed 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.905 2.003 . . . . 0.0 110.211 -178.25 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.316 1 N-CA-C 95.344 -5.799 . . . . 0.0 95.344 165.152 . . . . . . . . 3 3 . 1 . 063 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.054 ' N ' ' C ' ' A' ' 12' ' ' ALA . 19.6 tttm -116.49 -168.73 1.49 Allowed 'General case' 0 C--N 1.392 2.423 0 CA-C-N 109.44 -3.527 . . . . 0.0 111.592 177.124 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.6 t60 34.75 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.834 177.881 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 174.25 -44.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 122.116 0.96 . . . . 0.0 109.633 -179.84 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.89 -13.68 82.27 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.681 -2.968 . . . . 0.0 105.681 174.718 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.603 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.67 -45.58 7.64 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 114.515 -0.843 . . . . 0.0 109.309 178.089 . . . . . . . . 3 3 . 1 . 063 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.71 13.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.79 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.69 7.16 0.99 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.272 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 61.2 t -145.41 -9.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.493 -179.868 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 10.4 t-20 105.37 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.479 1.112 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.561 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 1.8 t60 -171.49 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.313 179.903 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.561 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.4 m-85 49.24 18.76 0.27 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 110.597 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.966 0.412 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -148.14 72.76 1.23 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.289 1.042 . . . . 0.0 110.173 178.987 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.043 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.274 . . 172.98 -30.82 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 112.133 -2.303 . . . . 0.0 106.179 179.966 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -0.73 0.55 Allowed 'General case' 0 N--CA 1.415 -2.192 1 N-CA-C 95.502 -5.74 . . . . 0.0 95.502 164.354 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.043 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.255 19.6 tttp -116.43 -167.06 1.22 Allowed 'General case' 0 C--N 1.389 2.285 0 CA-C-N 109.258 -3.61 . . . . 0.0 111.716 177.112 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.2 t60 34.73 18.99 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.875 177.862 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.84 -40.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 CA-C-O 122.141 0.972 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.15 83.61 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 105.596 -3.002 . . . . 0.0 105.596 174.487 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.614 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 5.5 m170 -103.64 -7.65 20.56 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.978 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 18' ' ' HIS . . . 84.52 20.3 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.389 -179.296 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.18 14.41 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 84.5 t -152.43 -10.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.455 -178.966 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.2 t-20 101.05 -34.84 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.14 0.9 . . . . 0.0 109.956 -179.308 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -171.57 101.5 0.19 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.602 -179.83 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' H ' ' H ' ' A' ' 25' ' ' LEU . 74.8 t80 -163.25 -1.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.287 179.845 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 24' ' ' TYR . 1.3 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.251 179.819 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' NH2' ' NE2' ' A' ' 11' ' ' HIS . 45.1 ttp85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.133 0.492 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' NE2' ' NH2' ' A' ' 10' ' ' ARG . 82.9 m-70 -146.95 147.17 30.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.423 179.577 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.21 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.727 1.892 . . . . 0.0 109.986 -178.121 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.94 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.434 -5.765 . . . . 0.0 95.434 165.194 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.023 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.3 tttp -116.04 -169.49 1.61 Allowed 'General case' 0 C--N 1.392 2.442 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.629 177.146 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.8 t60 34.89 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.946 177.861 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 175.62 -42.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.178 0.99 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.99 -13.39 83.73 Favored Glycine 0 C--N 1.276 -2.801 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 174.238 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.19 -45.77 8.46 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 114.454 -0.873 . . . . 0.0 109.001 177.884 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.21 13.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.841 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.29 9.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.24 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 63.8 t -145.31 -8.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.335 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.6 t30 102.96 -36.28 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.526 1.142 . . . . 0.0 109.746 -179.49 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -172.52 97.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.483 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 60.1 t80 -163.67 -0.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.387 -179.925 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.405 ' H ' ' H ' ' A' ' 24' ' ' TYR . 13.1 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.615 179.965 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.856 0.36 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.9 m80 -151.54 146.24 25.74 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.712 179.657 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -31.92 0.24 Allowed 'General case' 0 CA--C 1.498 -1.058 0 O-C-N 125.757 1.911 . . . . 0.0 109.839 -178.004 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.51 2.37 0.28 Allowed 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 95.441 -5.763 . . . . 0.0 95.441 165.142 . . . . . . . . 3 3 . 1 . 066 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.04 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -116.58 -169.07 1.56 Allowed 'General case' 0 C--N 1.391 2.407 0 CA-C-N 109.445 -3.525 . . . . 0.0 111.697 177.055 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.7 m80 33.92 21.23 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.788 177.598 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 170.21 -37.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.292 1.044 . . . . 0.0 109.33 -179.458 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.84 -11.64 81.17 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.052 -3.219 . . . . 0.0 105.052 174.07 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.471 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -93.54 -36.17 12.55 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 114.277 -0.961 . . . . 0.0 109.981 178.267 . . . . . . . . 3 3 . 1 . 066 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.2 26.18 0.7 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.643 -179.58 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.41 -7.69 0.1 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.054 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 19' ' ' ALA . 52.3 t -151.08 -24.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.353 -179.413 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 4.7 p30 -177.02 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.368 -179.291 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.566 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.0 t-160 -158.2 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.362 -179.461 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.566 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 86.2 m-85 48.79 17.44 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.319 . . . . 0.0 110.721 179.793 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.407 ' N ' ' C ' ' A' ' 23' ' ' HIS . 12.0 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.465 179.998 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 52.3 ttt180 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.402 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.52 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.6 m-70 -137.25 147.64 45.9 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 179.666 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.82 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.809 1.943 . . . . 0.0 109.996 -178.073 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.27 0.29 Allowed 'General case' 0 N--CA 1.412 -2.357 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.033 . . . . . . . . 3 3 . 1 . 067 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.6 tttm -116.2 -169.29 1.58 Allowed 'General case' 0 C--N 1.392 2.414 0 CA-C-N 109.476 -3.511 . . . . 0.0 111.718 177.032 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.641 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.6 t-80 34.55 18.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.896 177.984 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.09 -42.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.123 0.963 . . . . 0.0 109.707 180.0 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.96 -13.68 83.41 Favored Glycine 0 C--N 1.276 -2.8 0 N-CA-C 105.433 -3.067 . . . . 0.0 105.433 174.229 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.09 -47.04 6.55 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.422 -0.889 . . . . 0.0 110.002 178.207 . . . . . . . . 3 3 . 1 . 067 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.62 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.741 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.03 8.42 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.24 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 64.6 t -145.89 -9.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.171 179.967 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.06 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.657 1.223 . . . . 0.0 110.281 -179.98 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -167.93 94.88 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.493 -179.908 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 58.9 t80 -162.95 0.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.242 179.996 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.803 0.335 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 13' ' ' ALA . 57.8 t-80 -159.78 146.35 16.2 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.722 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.035 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.7 -31.7 0.23 Allowed 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 125.712 1.883 . . . . 0.0 110.02 -178.219 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.411 -2.394 1 N-CA-C 95.397 -5.779 . . . . 0.0 95.397 165.071 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.035 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.0 tttt -115.98 -169.21 1.55 Allowed 'General case' 0 C--N 1.394 2.524 0 CA-C-N 109.345 -3.571 . . . . 0.0 111.818 177.091 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m80 34.43 18.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.846 178.144 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.64 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 CA-C-O 122.068 0.937 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.0 -13.66 82.47 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.72 -2.952 . . . . 0.0 105.72 174.781 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.601 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.83 -44.53 8.44 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.162 177.964 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.46 11.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.994 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.51 10.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 21' ' ' VAL . 93.1 t -145.68 -8.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.876 -179.549 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.7 m-20 99.04 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.72 1.263 . . . . 0.0 110.239 -179.622 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -168.64 97.23 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.473 179.968 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.4 t80 -165.89 0.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.308 -179.886 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -179.98 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.494 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 13.0 ptm180 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.732 0.301 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.557 ' C ' ' H ' ' A' ' 13' ' ' ALA . 65.4 m-70 -148.25 144.89 27.96 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.493 179.481 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.46 -28.96 0.18 Allowed 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 125.632 1.832 . . . . 0.0 109.777 -177.989 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.33 2.08 0.43 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 94.793 -6.003 . . . . 0.0 94.793 164.209 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 6.0 ttmt -116.68 -160.65 0.77 Allowed 'General case' 0 C--N 1.398 2.686 0 CA-C-N 109.314 -3.585 . . . . 0.0 110.647 177.062 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.56 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.1 t-80 30.16 21.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 112.222 178.659 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 173.17 -47.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-O 122.231 1.015 . . . . 0.0 109.509 -179.453 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.53 -13.73 74.49 Favored Glycine 0 C--N 1.271 -3.077 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 175.107 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -96.53 -46.39 6.36 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 114.432 -0.884 . . . . 0.0 109.775 178.366 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.96 11.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.632 -179.744 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.19 8.27 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.042 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 44.6 t -148.23 -9.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.883 179.948 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.5 t-20 100.47 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.515 1.134 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 78.6 m80 -159.74 120.56 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.668 -179.622 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -55.57 -10.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.13 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.1 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.8 t-80 -156.12 145.08 20.42 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 179.515 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.997 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.85 -30.91 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.736 1.898 . . . . 0.0 109.801 -177.948 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.13 0.3 Allowed 'General case' 0 N--CA 1.41 -2.438 1 N-CA-C 95.288 -5.819 . . . . 0.0 95.288 164.749 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.997 ' N ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.13 -168.56 1.45 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.473 -3.512 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.0 m80 34.3 18.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.844 178.144 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.3 -46.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.21 1.005 . . . . 0.0 109.381 -179.624 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.02 -13.64 80.85 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.523 -3.031 . . . . 0.0 105.523 174.697 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.59 -43.59 9.56 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.606 178.2 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.252 -179.122 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.14 -16.15 0.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.676 -179.445 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.2 t -148.91 -35.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.931 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 156.03 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.782 0.676 . . . . 0.0 109.223 -179.953 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 37.9 t-80 -162.34 29.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.696 -179.695 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.461 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 64.1 t80 -77.0 -7.02 54.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.476 -179.881 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.2 t-80 -158.21 145.81 18.23 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.033 0.444 . . . . 0.0 110.915 179.564 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.98 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.91 -31.92 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.721 1.888 . . . . 0.0 109.975 -178.175 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.91 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.405 -5.776 . . . . 0.0 95.405 165.09 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.98 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttp -115.48 -169.6 1.61 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.436 -3.529 . . . . 0.0 111.806 176.953 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.0 t-80 34.47 18.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.015 178.021 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 176.13 -45.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.31 1.052 . . . . 0.0 109.089 -179.932 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.0 81.54 Favored Glycine 0 C--N 1.273 -2.968 0 N-CA-C 105.499 -3.04 . . . . 0.0 105.499 174.28 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.51 -47.01 7.66 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.154 178.005 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.88 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.876 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.71 8.1 1.23 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.215 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 56.3 t -144.88 -8.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.217 -179.953 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.647 ' ND2' ' CE1' ' A' ' 23' ' ' HIS . 1.6 t30 103.17 -36.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.639 1.212 . . . . 0.0 110.222 -179.772 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.647 ' CE1' ' ND2' ' A' ' 22' ' ' ASN . 31.9 m80 -155.26 -168.56 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 65.28 25.83 12.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.471 179.709 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 79.7 t60 -164.71 142.03 6.32 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 179.615 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.53 -32.14 0.23 Allowed 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 125.668 1.855 . . . . 0.0 109.805 -178.188 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.26 1.4 0.33 Allowed 'General case' 0 N--CA 1.41 -2.47 1 N-CA-C 95.444 -5.762 . . . . 0.0 95.444 165.003 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.039 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.7 tttp -114.33 -169.59 1.56 Allowed 'General case' 0 C--N 1.396 2.617 0 CA-C-N 109.48 -3.509 . . . . 0.0 111.842 176.98 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.1 t60 33.21 20.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.853 177.953 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 173.85 -47.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.695 0 CA-C-O 122.187 0.994 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.86 -14.49 78.39 Favored Glycine 0 C--N 1.271 -3.064 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 174.331 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' CD2' ' HA ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -87.59 -46.43 9.55 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.283 177.983 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.38 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.266 -179.386 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 65.64 -14.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.863 -179.666 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.2 t -149.34 -29.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 121.422 -0.111 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.8 t-20 148.56 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.944 0.777 . . . . 0.0 109.148 -179.728 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -170.28 64.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.403 -179.762 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -71.29 -19.55 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.62 -179.94 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.099 179.946 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 13' ' ' ALA . 11.1 p80 -163.92 143.34 7.96 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.768 179.385 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.016 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.27 -31.92 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.76 1.912 . . . . 0.0 109.982 -178.207 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.36 1.67 0.32 Allowed 'General case' 0 N--CA 1.411 -2.41 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 165.066 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.016 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.31 -168.95 1.48 Allowed 'General case' 0 C--N 1.394 2.54 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.877 176.973 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 74.6 t60 34.31 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.795 177.861 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tt 174.29 -46.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 CA-C-O 122.24 1.019 . . . . 0.0 109.363 -179.855 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.36 -13.92 79.6 Favored Glycine 0 C--N 1.271 -3.051 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.737 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.451 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.89 -44.27 9.49 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.66 -0.77 . . . . 0.0 109.533 178.071 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.57 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.859 -0.737 . . . . 0.0 112.145 -179.311 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.51 -20.42 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.358 -179.206 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.2 t -149.6 -31.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER 157.64 -48.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.62 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 57.3 t-80 -169.61 3.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.699 -179.735 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -76.65 40.84 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.58 -179.98 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.422 179.92 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.126 0.488 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.548 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.0 t60 -150.39 143.72 25.01 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.633 179.461 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.79 -29.52 0.19 Allowed 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 125.641 1.838 . . . . 0.0 109.766 -177.987 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.02 0.43 Allowed 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 94.879 -5.971 . . . . 0.0 94.879 164.463 . . . . . . . . 3 3 . 1 . 074 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.8 tttp -116.76 -161.11 0.79 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.266 -3.606 . . . . 0.0 110.549 177.005 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.562 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 30.92 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.852 0.72 . . . . 0.0 112.238 178.34 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.722 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.7 tt 172.75 -47.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 CA-C-O 122.226 1.012 . . . . 0.0 109.513 -179.446 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.66 74.62 Favored Glycine 0 C--N 1.271 -3.062 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 175.268 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 2.0 m170 -95.96 -45.18 7.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.443 178.181 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.99 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.862 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.18 7.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.289 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -146.44 -9.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.863 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.6 t30 104.53 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.491 1.119 . . . . 0.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -173.36 80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.451 179.974 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.542 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 63.2 t80 -84.64 -13.96 50.02 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.942 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 179.938 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.666 0.269 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.4 t60 -159.11 146.98 17.68 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.052 0.453 . . . . 0.0 110.857 179.305 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.988 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.04 -31.94 0.24 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.755 1.91 . . . . 0.0 110.007 -178.239 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.3 1.92 0.29 Allowed 'General case' 0 N--CA 1.413 -2.323 1 N-CA-C 95.445 -5.761 . . . . 0.0 95.445 165.132 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.988 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttm -115.8 -169.33 1.57 Allowed 'General case' 0 C--N 1.393 2.478 0 CA-C-N 109.363 -3.562 . . . . 0.0 111.725 177.076 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.8 t-80 34.31 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.914 177.963 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.06 -45.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.428 -179.958 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.72 79.99 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.284 -3.126 . . . . 0.0 105.284 174.422 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.27 -49.76 6.19 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.301 -0.949 . . . . 0.0 109.364 177.987 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.85 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.192 0.308 . . . . 0.0 110.196 -179.728 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.02 10.33 1.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.739 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.5 t -144.34 -9.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.425 -179.865 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 14.1 t-20 102.58 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.53 1.144 . . . . 0.0 110.45 179.896 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 16.9 t60 84.28 4.6 0.71 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.873 -179.143 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -62.95 -23.14 67.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.471 179.897 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.415 179.939 . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.93 0.395 . . . . 0.0 110.263 . . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -150.02 70.94 1.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.311 1.053 . . . . 0.0 109.714 179.353 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.968 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.272 . . 169.78 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 111.921 -2.399 . . . . 0.0 105.721 -179.363 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.09 -1.3 0.66 Allowed 'General case' 0 N--CA 1.412 -2.331 1 N-CA-C 95.254 -5.832 . . . . 0.0 95.254 164.125 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.968 ' N ' ' C ' ' A' ' 12' ' ' ALA . 3.2 ttpt -114.89 -166.49 1.12 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.309 -3.587 . . . . 0.0 111.501 176.325 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.8 t-80 33.2 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.042 178.378 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 173.56 -47.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 122.282 1.039 . . . . 0.0 109.305 179.96 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.03 -14.17 76.13 Favored Glycine 0 C--N 1.27 -3.115 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 174.907 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.97 -46.28 6.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.765 -0.718 . . . . 0.0 109.636 177.966 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.53 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.504 -179.754 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.63 6.95 1.23 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.076 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.0 t -147.16 -9.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.236 -179.926 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t30 102.82 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.444 1.09 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -178.83 64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.953 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -51.83 -33.94 38.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.667 -179.819 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.115 -179.969 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.0 m80 -147.21 144.85 29.21 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.08 179.435 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.03 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.47 -31.56 0.23 Allowed 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 125.587 1.804 . . . . 0.0 109.642 -177.761 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.13 0.29 Allowed 'General case' 0 N--CA 1.412 -2.337 1 N-CA-C 95.44 -5.763 . . . . 0.0 95.44 165.034 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.03 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.6 tttp -115.94 -169.25 1.56 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-N 109.365 -3.561 . . . . 0.0 111.74 177.082 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 86.8 m-70 34.52 18.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.965 178.045 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.54 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-O 122.363 1.078 . . . . 0.0 109.113 -179.821 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.25 79.3 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 174.493 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -91.53 -47.34 7.47 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.543 -0.829 . . . . 0.0 109.219 178.024 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.0 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.773 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 61.66 7.52 1.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.146 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 43.5 t -144.99 -9.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER 105.32 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.54 1.15 . . . . 0.0 110.05 -179.843 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.597 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -173.13 -99.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.315 -179.923 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.597 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 64.5 t80 55.44 10.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 76.5 mtt85 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.817 0.342 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 97.7 m-70 -155.81 144.96 20.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.602 179.528 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.707 1.879 . . . . 0.0 109.849 -177.888 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.44 1.89 0.31 Allowed 'General case' 0 N--CA 1.411 -2.42 1 N-CA-C 95.363 -5.792 . . . . 0.0 95.363 164.988 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.061 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -115.89 -169.15 1.54 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.412 -3.54 . . . . 0.0 111.646 177.074 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.7 m-70 34.86 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.892 178.031 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.62 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.091 0.948 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.25 -13.71 82.55 Favored Glycine 0 C--N 1.273 -2.961 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.59 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.15 -45.64 8.17 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 114.511 -0.845 . . . . 0.0 109.286 177.981 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.05 13.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.838 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.18 9.23 0.94 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.17 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -145.95 -9.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.189 -179.873 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t-20 103.14 -36.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.503 1.127 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -172.05 89.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.398 -179.966 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 83.4 t80 -159.89 16.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.062 -179.84 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.564 179.982 . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt-85 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.785 0.326 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.581 ' NE2' ' NE2' ' A' ' 15' ' ' HIS . 48.8 t-80 -157.6 92.43 1.21 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.209 0.528 . . . . 0.0 110.074 179.339 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.96 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 134.84 -31.79 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.424 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.54 -0.41 0.61 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.895 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.96 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.8 tttt -114.86 -168.12 1.33 Allowed 'General case' 0 C--N 1.393 2.488 0 CA-C-N 109.376 -3.556 . . . . 0.0 111.768 176.696 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 79.5 m-70 33.77 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.958 178.24 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.39 -47.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.324 1.059 . . . . 0.0 109.025 -179.873 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.66 -13.73 78.03 Favored Glycine 0 C--N 1.27 -3.099 0 N-CA-C 105.885 -2.886 . . . . 0.0 105.885 174.853 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.75 -44.39 9.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.899 . . . . . . . . 3 3 . 1 . 079 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 160.87 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.868 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.37 5.57 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.289 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 40.7 t -145.28 -10.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.202 -179.817 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.0 t-20 116.4 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.504 1.128 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -171.89 -3.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.515 -179.923 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.416 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 34.1 t80 -49.06 -18.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.712 -179.633 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.136 -179.978 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 121.004 0.431 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.1 t-80 -153.21 145.56 23.99 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.673 179.508 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.063 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.39 -31.74 0.23 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.715 1.885 . . . . 0.0 109.738 -177.985 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.18 0.29 Allowed 'General case' 0 N--CA 1.412 -2.373 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 165.091 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.063 ' N ' ' C ' ' A' ' 12' ' ' ALA . 15.8 tttp -116.14 -169.49 1.62 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.76 177.037 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 33.39 21.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.708 177.927 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.651 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.16 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 CA-C-O 122.302 1.049 . . . . 0.0 109.377 -179.658 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.94 -11.55 81.21 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 104.983 -3.247 . . . . 0.0 104.983 173.981 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.476 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -93.43 -36.33 12.53 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 114.445 -0.878 . . . . 0.0 109.932 178.238 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.15 28.22 0.51 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.365 -179.441 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.5 -9.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.114 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 19' ' ' ALA . 83.0 t -152.44 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.284 -179.387 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -171.66 -96.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.496 -179.198 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 25' ' ' LEU . 75.8 t60 -152.07 8.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.711 -179.372 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.14 22.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.938 0.399 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.8 m-70 -144.72 146.73 32.34 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.023 0.44 . . . . 0.0 111.012 179.49 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.066 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.91 -31.45 0.22 Allowed 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 125.813 1.945 . . . . 0.0 109.944 -178.156 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.4 2.08 0.29 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.344 -5.798 . . . . 0.0 95.344 165.028 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.066 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.8 ttpp -116.01 -169.29 1.57 Allowed 'General case' 0 C--N 1.394 2.503 0 CA-C-N 109.407 -3.542 . . . . 0.0 111.817 177.16 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.1 t60 33.98 19.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.89 178.122 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 174.69 -46.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-O 122.24 1.019 . . . . 0.0 109.275 179.977 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.05 79.4 Favored Glycine 0 C--N 1.271 -3.083 0 N-CA-C 105.773 -2.931 . . . . 0.0 105.773 174.722 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.597 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.14 -45.62 7.8 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.659 -0.771 . . . . 0.0 109.431 178.036 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.23 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.877 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.78 5.89 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 109.667 -179.291 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 45.9 t -144.05 -9.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.335 179.975 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 27.8 t-20 105.84 -36.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.646 1.216 . . . . 0.0 110.046 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.541 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -170.1 -130.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.138 179.972 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.541 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 29.6 m-85 48.62 28.67 1.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.775 0.322 . . . . 0.0 110.752 179.673 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.081 -179.923 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 28.8 t60 -97.29 71.06 2.36 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.138 0.971 . . . . 0.0 110.11 179.437 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.005 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.265 . . 169.34 -30.88 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 112.165 -2.289 . . . . 0.0 105.712 -179.738 . . . . . . . . 3 3 . 1 . 082 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -1.0 0.57 Allowed 'General case' 0 N--CA 1.414 -2.274 1 N-CA-C 95.378 -5.786 . . . . 0.0 95.378 164.068 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.005 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.257 23.7 tttp -115.99 -166.73 1.17 Allowed 'General case' 0 C--N 1.393 2.457 0 CA-C-N 109.42 -3.536 . . . . 0.0 111.953 176.859 . . . . . . . . 3 3 . 1 . 082 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.652 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 55.6 t60 34.01 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.609 177.756 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.7 tt 170.72 -42.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.078 0.942 . . . . 0.0 109.381 -179.894 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.96 -14.28 81.87 Favored Glycine 0 C--N 1.274 -2.894 0 N-CA-C 105.81 -2.916 . . . . 0.0 105.81 175.071 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -88.94 -34.36 16.93 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.044 . . . . . . . . 3 3 . 1 . 082 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.07 -73.18 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.61 179.397 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -167.23 -23.14 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.815 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 34.0 t -150.85 -12.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.542 179.614 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 5.1 t30 155.55 -36.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.779 0.674 . . . . 0.0 109.551 -179.658 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 2.3 p-80 -166.14 120.38 1.15 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.952 -178.443 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -71.87 -0.17 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.421 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 -179.931 . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 . . . . . 0 N--CA 1.464 0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.2 t60 -153.58 146.58 24.52 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.443 179.382 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.31 -30.82 0.21 Allowed 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 125.715 1.885 . . . . 0.0 109.683 -177.695 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.71 2.88 0.25 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 164.915 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.1 tttm -118.13 -167.3 1.33 Allowed 'General case' 0 C--N 1.393 2.471 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.593 177.275 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.61 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 66.2 t60 33.05 23.3 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 170.04 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.585 0 CA-C-O 122.107 0.956 . . . . 0.0 109.103 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -15.12 79.13 Favored Glycine 0 C--N 1.274 -2.909 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.752 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.443 ' H ' ' H ' ' A' ' 16' ' ' ILE . 26.5 t-80 -83.43 -39.64 20.33 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.859 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.94 -69.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 -19.81 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.877 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 10.1 t -149.58 -16.31 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.966 179.679 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.7 t30 158.58 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.692 0.62 . . . . 0.0 109.758 -179.669 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 43.9 t-80 -166.51 14.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.723 -178.692 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 72.3 t80 -78.82 43.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.432 -179.883 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 66.4 mtp180 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.4 m80 -154.75 145.56 22.47 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.557 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.48 -30.72 0.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 125.654 1.846 . . . . 0.0 109.555 -177.713 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.75 0.26 Allowed 'General case' 0 N--CA 1.412 -2.351 1 N-CA-C 95.282 -5.822 . . . . 0.0 95.282 164.787 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.5 ttpp -117.73 -167.59 1.36 Allowed 'General case' 0 C--N 1.392 2.44 0 CA-C-N 109.524 -3.489 . . . . 0.0 111.671 177.152 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.611 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 55.1 m-70 33.11 23.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.716 177.67 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.648 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 170.02 -45.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 CA-C-O 122.229 1.014 . . . . 0.0 109.061 -179.752 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.19 78.66 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 174.773 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 25.4 t-80 -82.54 -40.85 20.39 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.659 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -160.37 -68.05 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.402 179.51 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -169.34 -19.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.956 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.402 ' H ' ' H ' ' A' ' 20' ' ' ALA . 40.4 t -151.26 -18.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.092 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 7.8 t-20 163.76 -38.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.576 0.548 . . . . 0.0 109.993 -179.709 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 48.2 t-80 -171.7 33.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 -178.644 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -49.82 -14.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 110.544 -179.969 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.783 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.182 0.515 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.8 t-80 -162.8 143.4 9.64 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 179.294 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.3 -31.68 0.22 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.836 1.96 . . . . 0.0 110.022 -178.133 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 1.81 0.33 Allowed 'General case' 0 N--CA 1.411 -2.381 1 N-CA-C 95.304 -5.813 . . . . 0.0 95.304 164.963 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.04 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.9 tttt -115.67 -168.8 1.47 Allowed 'General case' 0 C--N 1.393 2.499 0 CA-C-N 109.417 -3.538 . . . . 0.0 111.758 176.998 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.633 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.6 t-80 34.21 19.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.849 177.98 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.08 -47.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.271 1.034 . . . . 0.0 109.199 -179.894 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.26 -14.06 76.79 Favored Glycine 0 C--N 1.27 -3.13 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 174.918 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.5 -45.6 7.35 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.512 178.093 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.3 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.762 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.17 9.65 1.04 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.973 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 21' ' ' VAL . 58.5 t -147.97 -8.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.196 -179.542 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.7 m120 100.04 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.662 1.226 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.514 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 47.8 t-80 -167.22 -105.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.5 -179.834 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.514 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 25.7 t80 65.96 -7.34 0.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 -179.977 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.822 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 85.6 mtt-85 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.788 0.327 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 94.7 m-70 -155.79 146.08 21.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.626 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.71 -31.67 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.823 1.952 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.8 0.31 Allowed 'General case' 0 N--CA 1.412 -2.343 1 N-CA-C 95.414 -5.773 . . . . 0.0 95.414 165.167 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.031 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.5 tttp -116.31 -168.22 1.4 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.327 -3.579 . . . . 0.0 111.644 177.158 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 40.4 m-70 34.05 20.98 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.803 177.706 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 171.3 -46.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.515 0 CA-C-O 122.286 1.041 . . . . 0.0 109.245 -179.682 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.16 -12.42 83.48 Favored Glycine 0 C--N 1.274 -2.908 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 175.125 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.449 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -89.29 -30.88 18.14 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.316 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.57 -66.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.677 179.285 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -171.64 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.759 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' H ' ' H ' ' A' ' 20' ' ' ALA . 59.9 t -152.7 -18.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 t30 165.66 -38.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.549 0.531 . . . . 0.0 110.145 -179.799 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.456 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 34.5 t-80 -170.04 26.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -178.709 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -49.08 -15.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 -179.741 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.278 -179.944 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.268 0.556 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.539 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 t60 -156.8 142.2 17.45 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.61 -31.73 0.23 Allowed 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 125.594 1.809 . . . . 0.0 109.492 -177.863 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.54 0.33 Allowed 'General case' 0 N--CA 1.41 -2.439 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 164.978 . . . . . . . . 3 3 . 1 . 087 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.0 tttp -115.1 -169.82 1.63 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.438 -3.528 . . . . 0.0 111.731 176.922 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.9 t-80 34.78 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.934 177.926 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.28 -44.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.171 0.986 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.82 -14.38 81.57 Favored Glycine 0 C--N 1.274 -2.895 0 N-CA-C 105.335 -3.106 . . . . 0.0 105.335 174.249 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.85 -49.03 6.85 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.295 -0.953 . . . . 0.0 109.02 177.892 . . . . . . . . 3 3 . 1 . 087 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.28 9.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.458 0.474 . . . . 0.0 110.177 -179.94 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.426 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.72 10.07 1.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 -178.158 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 21' ' ' VAL . 91.1 t -143.1 -8.56 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.948 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.2 m-20 97.67 -35.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.637 1.211 . . . . 0.0 111.08 179.81 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.4 t-80 80.19 7.84 1.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.774 -179.154 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.1 t80 -77.08 27.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.0 tt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' C ' ' ND1' ' A' ' 11' ' ' HIS . 81.5 mtp180 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.922 0.392 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 41.2 m80 -152.76 144.44 23.51 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.29 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.633 1.833 . . . . 0.0 109.718 -177.731 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.57 2.25 0.3 Allowed 'General case' 0 N--CA 1.411 -2.407 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 12.0 ttpt -115.98 -168.98 1.51 Allowed 'General case' 0 C--N 1.395 2.544 0 CA-C-N 109.401 -3.545 . . . . 0.0 111.492 176.995 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 61.5 t60 33.65 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.917 178.036 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.76 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 CA-C-O 122.229 1.014 . . . . 0.0 109.308 179.982 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -14.24 80.18 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 174.497 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.454 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -90.69 -44.21 9.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 114.431 -0.884 . . . . 0.0 109.857 178.179 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 42.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.336 -179.177 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 69.6 -21.65 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.515 -179.47 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.0 t -148.32 -30.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.636 179.802 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t-20 153.39 -43.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.557 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 41.9 t60 -168.78 174.96 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.27 179.7 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.557 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.5 t80 56.28 10.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.656 179.917 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.5 t60 -160.8 147.1 15.01 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.059 0.457 . . . . 0.0 111.04 179.688 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.008 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.5 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 125.872 1.982 . . . . 0.0 110.085 -178.23 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.08 0.28 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.411 -5.774 . . . . 0.0 95.411 165.218 . . . . . . . . 3 3 . 1 . 089 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.008 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -116.03 -169.31 1.58 Allowed 'General case' 0 C--N 1.393 2.491 0 CA-C-N 109.435 -3.529 . . . . 0.0 111.767 177.03 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 10.9 t60 34.72 18.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.914 178.056 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tt 175.35 -41.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 CA-C-O 122.019 0.914 . . . . 0.0 109.582 179.923 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.63 -13.07 83.88 Favored Glycine 0 C--N 1.275 -2.858 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 174.316 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -92.89 -44.78 8.29 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.541 -0.829 . . . . 0.0 109.136 178.05 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.89 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.46 9.61 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.025 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -147.57 -9.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.152 -179.777 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.8 t-20 100.31 -35.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.395 1.06 . . . . 0.0 110.023 -179.627 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 25' ' ' LEU . 79.9 m-70 -145.76 119.37 9.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -62.43 -4.26 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 23' ' ' HIS . 19.0 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.534 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.0 t-80 -169.55 145.29 3.14 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 179.571 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.963 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.71 -31.78 0.23 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.767 1.917 . . . . 0.0 109.94 -178.156 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.77 0.31 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.274 -5.824 . . . . 0.0 95.274 165.074 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.963 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -115.6 -169.35 1.56 Allowed 'General case' 0 C--N 1.394 2.509 0 CA-C-N 109.483 -3.508 . . . . 0.0 111.766 176.909 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.3 t-80 34.89 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.944 177.952 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.71 -43.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.144 0.974 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.94 82.39 Favored Glycine 0 C--N 1.274 -2.907 0 N-CA-C 105.434 -3.066 . . . . 0.0 105.434 174.41 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -91.41 -47.44 7.45 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.437 -0.881 . . . . 0.0 109.21 177.983 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.23 9.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.259 0.349 . . . . 0.0 110.179 -179.885 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.5 9.88 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.25 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 85.1 t -144.57 -9.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.2 -179.82 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.1 t30 99.43 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 O-C-N 124.33 1.019 . . . . 0.0 110.798 179.826 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 5.2 t60 81.98 44.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.349 -179.385 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 41.7 p90 -66.55 -31.09 71.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.565 -179.942 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.756 -179.948 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.315 0.579 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.5 m-70 68.81 140.59 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.849 179.22 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.053 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 67.24 -33.33 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 126.267 2.23 . . . . 0.0 111.023 -179.106 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 0.98 0.37 Allowed 'General case' 0 N--CA 1.411 -2.406 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 165.152 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.053 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.5 tttp -114.02 -168.89 1.42 Allowed 'General case' 0 C--N 1.395 2.57 0 CA-C-N 109.554 -3.475 . . . . 0.0 111.743 176.769 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 34.15 18.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.959 177.968 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.17 -46.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 122.286 1.041 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.71 -14.56 77.98 Favored Glycine 0 C--N 1.27 -3.097 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 174.52 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -90.82 -47.79 7.41 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.144 177.804 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.56 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.799 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.53 6.84 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.292 0.568 . . . . 0.0 109.54 -179.149 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 50.6 t -143.02 -9.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER 106.13 -36.81 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.62 1.2 . . . . 0.0 110.019 -179.809 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.519 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 26.7 t-80 -171.08 -117.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.273 179.871 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.519 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 92.4 m-85 50.9 13.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.7 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.215 -179.965 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 59.2 mtp85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.3 m80 -156.69 145.78 20.3 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.541 179.457 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.986 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -31.72 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.75 1.906 . . . . 0.0 109.839 -177.996 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.99 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.078 . . . . . . . . 3 3 . 1 . 092 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.986 ' N ' ' C ' ' A' ' 12' ' ' ALA . 33.2 tttt -116.0 -169.56 1.62 Allowed 'General case' 0 C--N 1.392 2.418 0 CA-C-N 109.389 -3.551 . . . . 0.0 111.735 177.031 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 3.1 t60 34.48 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.935 178.089 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.06 -41.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.549 0 CA-C-O 122.02 0.914 . . . . 0.0 109.659 179.918 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.59 -13.16 83.79 Favored Glycine 0 C--N 1.275 -2.826 0 N-CA-C 105.506 -3.038 . . . . 0.0 105.506 174.327 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.65 -44.36 8.22 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 114.579 -0.81 . . . . 0.0 109.491 178.083 . . . . . . . . 3 3 . 1 . 092 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.96 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.57 10.14 0.95 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.972 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 65.9 t -148.22 -9.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.189 -179.837 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.1 t-20 100.34 -35.58 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.388 1.055 . . . . 0.0 110.003 -179.643 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' A' ' 25' ' ' LEU . 96.0 m-70 -151.72 120.06 6.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.42 -179.766 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -69.48 5.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' HIS . 3.0 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.37 -179.792 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.664 0.269 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.9 t60 -149.38 144.27 26.29 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.919 0.39 . . . . 0.0 110.825 179.601 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.45 -29.62 0.19 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.558 1.786 . . . . 0.0 109.851 -178.081 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.18 1.78 0.44 Allowed 'General case' 0 N--CA 1.411 -2.414 1 N-CA-C 94.855 -5.98 . . . . 0.0 94.855 164.342 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.6 tttp -116.07 -161.98 0.82 Allowed 'General case' 0 C--N 1.398 2.696 0 CA-C-N 109.264 -3.607 . . . . 0.0 110.726 176.929 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.561 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.4 t60 31.49 20.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.459 0.704 . . . . 0.0 112.144 178.291 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 172.95 -49.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 CA-C-O 122.429 1.109 . . . . 0.0 109.321 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.21 -13.71 70.57 Favored Glycine 0 C--N 1.27 -3.1 0 N-CA-C 106.257 -2.737 . . . . 0.0 106.257 175.351 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.6 m170 -94.69 -45.05 7.52 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.039 178.071 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 161.72 13.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.858 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.4 7.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.114 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.5 t -143.59 -9.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.575 -179.933 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 106.49 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.548 1.155 . . . . 0.0 110.246 179.969 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -173.09 100.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.533 -179.933 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 60.8 t80 -166.0 4.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.427 179.975 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.51 -179.97 . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 49.2 t60 -164.0 143.97 8.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.597 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.61 0.23 Allowed 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 125.619 1.825 . . . . 0.0 109.656 -178.045 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.23 1.54 0.31 Allowed 'General case' 0 N--CA 1.411 -2.416 1 N-CA-C 95.364 -5.791 . . . . 0.0 95.364 165.014 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 18.2 tttm -114.89 -169.32 1.53 Allowed 'General case' 0 C--N 1.396 2.608 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.909 177.067 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 51.5 m170 32.73 21.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.788 177.974 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 172.63 -47.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 CA-C-O 122.256 1.027 . . . . 0.0 109.374 -179.951 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.25 -14.39 79.18 Favored Glycine 0 C--N 1.271 -3.046 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 174.404 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.75 -44.07 11.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.466 178.034 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.39 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.205 -179.315 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 -1.44 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.192 179.496 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.5 t -150.97 -25.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.732 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.9 t30 130.18 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.737 1.273 . . . . 0.0 109.299 -179.726 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -163.17 97.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.906 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.464 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 77.4 t80 -164.31 -6.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.945 179.816 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.245 179.881 . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.561 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.1 t60 -152.55 145.21 24.23 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.141 0.496 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.8 -30.66 0.21 Allowed 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 125.78 1.925 . . . . 0.0 109.261 -177.426 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.9 3.71 0.21 Allowed 'General case' 0 N--CA 1.41 -2.458 1 N-CA-C 95.372 -5.788 . . . . 0.0 95.372 164.698 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.023 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -119.36 -168.11 1.52 Allowed 'General case' 0 C--N 1.395 2.549 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.828 177.464 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.8 m170 31.67 25.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.411 178.12 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.6 tt 167.52 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 CA-C-O 122.171 0.986 . . . . 0.0 109.217 -179.841 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.34 -13.71 78.1 Favored Glycine 0 C--N 1.275 -2.837 0 N-CA-C 104.675 -3.37 . . . . 0.0 104.675 173.523 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.492 ' H ' ' H ' ' A' ' 16' ' ' ILE . 56.4 t-80 -89.16 -40.3 12.99 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.399 177.897 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -144.33 23.38 1.65 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.885 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.59 -2.36 0.18 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.251 179.139 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' ALA . 42.9 t -150.89 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 121.335 -0.146 . . . . 0.0 111.066 -179.57 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 1.4 p30 175.83 -83.87 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.947 0.404 . . . . 0.0 110.84 -179.443 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.47 -172.27 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.76 -179.589 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 50.6 t80 57.01 20.16 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.51 179.999 . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.1 t-80 -157.47 145.78 19.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.589 179.518 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.999 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.63 0.23 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.773 1.92 . . . . 0.0 109.804 -178.028 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.01 0.31 Allowed 'General case' 0 N--CA 1.412 -2.375 1 N-CA-C 95.323 -5.806 . . . . 0.0 95.323 165.037 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.999 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.5 tttt -115.86 -168.76 1.47 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.509 -3.496 . . . . 0.0 111.557 177.045 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 8.8 m-70 33.98 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 177.968 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.63 -44.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.105 0.955 . . . . 0.0 109.518 179.885 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.11 81.87 Favored Glycine 0 C--N 1.273 -2.937 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.362 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 m170 -93.08 -49.28 6.08 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.563 177.99 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.46 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.488 -179.616 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.41 9.65 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.947 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 21' ' ' VAL . 59.7 t -146.7 -8.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.911 -179.856 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 18.8 m-20 99.42 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.819 1.324 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 93.2 m-70 -160.19 108.87 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -62.25 -11.78 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.318 179.986 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 7.9 ptm180 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.905 0.383 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 m-70 -155.45 146.52 22.54 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 179.507 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.05 -31.91 0.23 Allowed 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 125.719 1.887 . . . . 0.0 109.922 -178.071 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.14 1.76 0.29 Allowed 'General case' 0 N--CA 1.413 -2.295 1 N-CA-C 95.421 -5.77 . . . . 0.0 95.421 165.158 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 3.0 ttmm -115.56 -169.76 1.64 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.403 -3.544 . . . . 0.0 111.716 177.252 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.8 m-70 34.09 19.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.698 178.036 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.04 -46.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.686 0 CA-C-O 122.178 0.99 . . . . 0.0 109.641 -179.936 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.91 -14.66 78.46 Favored Glycine 0 C--N 1.272 -3.013 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 174.726 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.594 ' NE2' ' NZ ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -92.43 -42.74 9.59 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 114.721 -0.739 . . . . 0.0 110.038 178.363 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.82 42.1 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.353 -179.212 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.67 -17.1 0.13 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.663 -179.52 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -148.77 -33.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 179.974 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.3 t-20 155.38 -47.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.867 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 27.8 t-80 -166.86 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.222 179.835 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.549 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 98.3 m-85 46.89 18.32 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.6 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.14 -179.91 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 11' ' ' HIS . 95.0 mtt180 . . . . . 0 N--CA 1.46 0.044 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 2.2 t60 58.41 136.47 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.09 -179.814 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.047 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.68 -32.01 0.22 Allowed 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.761 -178.042 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.12 0.34 Allowed 'General case' 0 N--CA 1.41 -2.453 1 N-CA-C 95.268 -5.827 . . . . 0.0 95.268 164.709 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.047 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.6 tttm -114.71 -169.45 1.55 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.557 -3.474 . . . . 0.0 111.813 176.871 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.8 m80 34.54 18.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.894 178.085 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.41 -44.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 CA-C-O 122.051 0.929 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.59 -14.04 81.48 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 174.554 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.567 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.56 -46.27 7.7 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.402 177.995 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.47 12.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.43 -179.882 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.33 8.24 1.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.041 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 52.3 t -146.02 -9.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.054 -179.939 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 62.9 t30 102.27 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.543 1.152 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -175.07 75.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.403 179.997 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 52.8 t80 -79.15 -20.92 47.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.541 -179.979 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.978 . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.451 ' CD2' ' HD3' ' A' ' 14' ' ' LYS . 55.7 t-80 -155.05 72.2 0.82 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.289 1.042 . . . . 0.0 109.95 178.761 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.973 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.275 . . 174.67 -31.07 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.504 179.978 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.81 -1.53 0.65 Allowed 'General case' 0 N--CA 1.416 -2.154 1 N-CA-C 95.486 -5.746 . . . . 0.0 95.486 164.734 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.973 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.258 19.1 tttm -115.1 -166.86 1.16 Allowed 'General case' 0 C--N 1.388 2.262 0 CA-C-N 109.085 -3.689 . . . . 0.0 111.569 176.794 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.3 t60 34.4 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.146 177.812 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 174.37 -43.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.145 0.974 . . . . 0.0 109.489 179.797 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.95 -13.77 82.29 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 174.71 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.5 -44.67 8.52 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.605 -0.798 . . . . 0.0 109.049 177.907 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.32 11.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.222 0.326 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.54 10.89 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.907 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' VAL . 96.0 t -145.1 -7.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.821 -179.674 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.4 m-20 99.48 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.796 1.31 . . . . 0.0 110.228 -179.566 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.447 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.2 p-80 -162.9 112.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.633 179.984 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.2 t80 -69.82 -3.1 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.989 . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.746 0.308 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 42.7 t60 -148.8 145.59 27.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.238 179.315 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.027 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.87 -31.42 0.23 Allowed 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 125.65 1.844 . . . . 0.0 109.521 -177.728 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.53 2.32 0.29 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.982 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.027 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.3 tttm -116.3 -169.53 1.63 Allowed 'General case' 0 C--N 1.394 2.512 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.778 177.01 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.6 m170 34.1 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.812 178.2 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 174.8 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.077 0.941 . . . . 0.0 109.641 179.836 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.35 83.58 Favored Glycine 0 C--N 1.275 -2.855 0 N-CA-C 105.508 -3.037 . . . . 0.0 105.508 174.358 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.85 -45.91 7.43 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.483 178.046 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.48 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.615 -179.787 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.32 8.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.882 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 21' ' ' VAL . 50.5 t -147.08 -7.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.657 -179.866 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 15.7 m-20 97.24 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.692 1.245 . . . . 0.0 109.835 -179.374 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.513 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -170.66 -113.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.513 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 31.5 t80 64.64 -6.01 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.931 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 19' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.45 107.53 5.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.24 11.37 44.08 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.8 p -48.89 109.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 7' ' ' LYS . 8.1 pt -74.95 71.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 56.49 7.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.658 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 5' ' ' ILE . 18.3 tptp -64.34 -64.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -89.62 51.14 2.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.01 15.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.996 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' H ' ' H ' ' A' ' 11' ' ' HIS . 56.6 ttt180 -170.55 -2.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.132 0.491 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.511 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.7 t60 -153.68 144.62 22.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.034 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.15 -31.78 0.23 Allowed 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 125.786 1.929 . . . . 0.0 109.901 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.67 0.3 Allowed 'General case' 0 N--CA 1.411 -2.378 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.034 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.5 tttt -115.26 -169.19 1.52 Allowed 'General case' 0 C--N 1.395 2.559 0 CA-C-N 109.446 -3.524 . . . . 0.0 111.826 177.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 9.5 m-70 32.96 21.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.84 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 173.52 -47.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.63 0 CA-C-O 122.191 0.996 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.74 -14.8 77.99 Favored Glycine 0 C--N 1.271 -3.073 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.466 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.96 -45.92 9.81 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 114.264 -0.968 . . . . 0.0 109.531 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.27 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.941 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.7 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.223 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.2 t -151.01 -29.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.528 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 18.8 t30 136.12 -39.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.63 1.206 . . . . 0.0 109.096 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.528 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 85.5 m-70 -151.93 -131.37 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.31 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.453 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.7 t80 55.53 13.94 1.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.921 0.391 . . . . 0.0 110.311 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.5 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.298 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CD1' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.496 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 6.5 m-90 -157.05 -59.76 0.09 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.2 14.59 56.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.055 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.5 p -53.44 109.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.455 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 10.3 mt -72.85 -41.21 61.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.425 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 60.4 m-85 -158.69 -11.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' H ' ' H ' ' A' ' 6' ' ' PHE . 62.6 tttm -51.28 -21.47 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.427 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -72.81 10.57 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -179.58 27.61 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.042 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HE ' ' CA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -103.2 -1.35 29.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.049 0.452 . . . . 0.0 109.923 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 18.1 p80 -152.19 145.58 24.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.418 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.046 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 125.742 1.901 . . . . 0.0 109.917 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.311 1 N-CA-C 95.42 -5.771 . . . . 0.0 95.42 165.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.046 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -116.18 -168.26 1.41 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.47 -3.514 . . . . 0.0 111.55 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 30.4 m80 34.27 19.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.915 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.33 -45.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 122.253 1.025 . . . . 0.0 109.364 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.39 -13.68 81.44 Favored Glycine 0 C--N 1.273 -2.95 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.46 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -92.09 -43.15 9.55 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.82 178.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.96 41.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.241 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.75 -17.97 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.5 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.2 t -148.63 -34.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.1 t-20 154.89 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.833 0.708 . . . . 0.0 109.115 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -160.9 45.32 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.28 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -66.59 -19.16 65.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.6 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.941 -0.463 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -165.57 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.491 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 176.41 -3.39 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.98 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 3' ' ' GLY . 34.9 t -54.7 171.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 mm -76.07 72.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 51.55 16.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tptp -68.3 -67.94 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.505 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -78.76 73.68 5.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.56 -51.58 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 88.7 mtt180 -99.78 -1.89 36.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.972 0.415 . . . . 0.0 110.276 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 46.5 m80 -151.85 143.83 23.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.291 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.86 -31.58 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.675 1.859 . . . . 0.0 109.497 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.34 0.28 Allowed 'General case' 0 N--CA 1.413 -2.324 1 N-CA-C 95.467 -5.753 . . . . 0.0 95.467 164.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.97 -169.04 1.52 Allowed 'General case' 0 C--N 1.394 2.5 0 CA-C-N 109.454 -3.521 . . . . 0.0 111.642 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.8 m-70 33.84 19.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.848 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.677 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.69 -45.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.226 1.012 . . . . 0.0 109.382 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.28 -13.95 81.06 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 105.489 -3.044 . . . . 0.0 105.489 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.463 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -91.38 -43.72 9.58 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.806 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.22 41.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.255 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.94 -19.29 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.497 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.8 t -148.78 -32.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 155.44 -47.88 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -172.49 96.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.263 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 55.4 t80 -164.0 1.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.314 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.18 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 3' ' ' GLY . 11.8 p90 -160.63 -54.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.694 0.283 . . . . 0.0 110.306 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 2' ' ' TRP . . . 59.19 27.52 62.86 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.146 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 t -47.9 158.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.614 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -73.3 74.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 53.08 67.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -143.27 -61.69 0.41 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.17 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -78.01 44.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.38 -23.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.974 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -98.61 -3.69 35.64 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 0.0 109.722 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 64.5 t-80 -146.57 144.38 29.53 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.181 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.59 -31.41 0.22 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.641 1.838 . . . . 0.0 109.544 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.28 0.28 Allowed 'General case' 0 N--CA 1.412 -2.355 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttm -116.34 -169.49 1.63 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 109.493 -3.503 . . . . 0.0 111.71 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.618 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.9 m170 34.82 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.851 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.4 tt 175.22 -41.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 CA-C-O 122.027 0.917 . . . . 0.0 109.679 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.37 -12.94 84.09 Favored Glycine 0 C--N 1.275 -2.82 0 N-CA-C 105.622 -2.991 . . . . 0.0 105.622 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.62 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.55 -42.75 8.27 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.639 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.37 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.768 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.63 8.62 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -149.41 -9.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.804 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -37.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.468 1.105 . . . . 0.0 110.563 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 18.9 t60 -171.86 178.1 3.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.792 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.593 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 23.9 p90 41.9 26.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.485 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -55.83 133.11 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 0.0 110.538 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.91 3.93 55.12 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.007 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 p -69.79 157.77 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.684 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.679 ' HA ' ' HE1' ' A' ' 8' ' ' HIS . 15.2 tt -168.04 -45.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.545 ' N ' HG23 ' A' ' 5' ' ' ILE . 35.5 p90 -98.0 -22.97 15.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.309 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -69.92 -67.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.618 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.679 ' HE1' ' HA ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -76.52 67.8 2.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.693 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.17 -46.25 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.41 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -99.68 -0.0 41.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.833 0.349 . . . . 0.0 110.678 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.2 t-80 -159.29 143.64 15.27 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.669 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.71 0.23 Allowed 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 125.854 1.971 . . . . 0.0 109.723 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.29 0.27 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.532 -5.729 . . . . 0.0 95.532 165.118 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.8 tttm -116.61 -169.28 1.6 Allowed 'General case' 0 C--N 1.392 2.421 0 CA-C-N 109.452 -3.522 . . . . 0.0 111.822 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.2 m170 33.11 22.26 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.789 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.4 tt 169.52 -37.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-O 122.258 1.028 . . . . 0.0 109.186 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.32 -11.81 79.88 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 104.753 -3.339 . . . . 0.0 104.753 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.5 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.2 -36.2 13.4 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 114.397 -0.901 . . . . 0.0 109.879 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.35 26.18 0.6 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.66 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.41 -4.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.279 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 47.4 t -151.3 -27.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.047 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -174.24 -92.26 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.131 0.491 . . . . 0.0 110.978 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.3 t60 -159.62 27.37 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 53.3 t80 -74.92 17.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.685 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' HIS . 9.2 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.421 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -168.44 -59.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 0.0 110.429 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.16 -25.03 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 77.54 9.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.777 0.323 . . . . 0.0 110.502 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.466 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 11.9 mt -70.82 -28.64 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.292 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 66.8 m-85 -158.63 -3.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.25 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -44.59 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.958 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 0.65 6.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.42 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.34 -18.06 67.53 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.287 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -165.48 28.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.93 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.508 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t60 -164.18 146.51 9.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.018 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -32.0 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.88 1.988 . . . . 0.0 110.087 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.85 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.383 -5.784 . . . . 0.0 95.383 165.118 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.018 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.7 tttm -115.61 -169.83 1.66 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.612 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.9 t-80 34.34 18.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.961 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tt 175.65 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.137 0.97 . . . . 0.0 109.583 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.62 -13.34 83.29 Favored Glycine 0 C--N 1.277 -2.697 0 N-CA-C 105.14 -3.184 . . . . 0.0 105.14 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.95 -45.54 8.29 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 114.394 -0.903 . . . . 0.0 109.242 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.18 13.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.47 8.48 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.8 t -144.26 -9.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 22.3 t-20 105.44 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.581 1.175 . . . . 0.0 110.322 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 17.0 t-80 -169.83 -134.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.569 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 85.9 m-85 54.06 20.0 2.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.7 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.37 -76.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.582 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.61 6.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.181 -0.533 . . . . 0.0 111.824 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 m -161.5 106.55 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.878 0.371 . . . . 0.0 110.446 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 6' ' ' PHE . 16.8 tt -51.26 -43.86 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.518 ' N ' HG23 ' A' ' 5' ' ' ILE . 4.8 m-85 -175.04 4.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' H ' ' H ' ' A' ' 6' ' ' PHE . 55.0 tttm -54.64 -29.4 52.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.732 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.31 52.69 2.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.65 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.06 -21.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.194 -0.526 . . . . 0.0 111.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -79.81 -114.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.513 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.6 t-80 -90.4 145.55 24.85 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.251 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.54 -32.43 0.23 Allowed 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 125.751 1.907 . . . . 0.0 110.302 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.96 0.48 0.38 Allowed 'General case' 0 N--CA 1.412 -2.338 1 N-CA-C 95.324 -5.806 . . . . 0.0 95.324 165.071 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttm -113.53 -169.36 1.49 Allowed 'General case' 0 C--N 1.393 2.477 0 CA-C-N 109.24 -3.618 . . . . 0.0 112.046 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.635 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 30.2 t-80 34.7 18.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.95 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.68 -46.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.257 1.027 . . . . 0.0 109.121 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.28 78.93 Favored Glycine 0 C--N 1.27 -3.108 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.579 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.1 -47.04 7.77 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.091 177.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.89 13.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.11 8.27 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.0 t -144.35 -9.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.432 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.6 t-20 103.89 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.521 1.138 . . . . 0.0 109.921 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -178.14 92.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.92 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 88.0 t80 -143.3 9.18 1.63 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.195 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.464 ' CG ' ' O ' ' A' ' 2' ' ' TRP . 76.1 t-105 -166.51 10.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.783 0.325 . . . . 0.0 110.532 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.49 -5.96 26.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.877 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 76.4 p 48.9 97.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.775 0.322 . . . . 0.0 110.769 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 6' ' ' PHE . 8.0 tt -69.12 -42.42 81.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.198 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.481 ' N ' HG23 ' A' ' 5' ' ' ILE . 37.6 m-85 -155.78 -5.22 0.12 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' H ' ' H ' ' A' ' 6' ' ' PHE . 30.7 mmtp -57.41 -73.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.069 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.88 67.59 7.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.461 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.83 -16.53 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.005 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 15.1 ptm180 -173.14 17.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.654 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.9 m-70 -157.37 146.31 19.8 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.963 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.52 -31.52 0.22 Allowed 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 125.797 1.935 . . . . 0.0 110.01 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 1.94 0.31 Allowed 'General case' 0 N--CA 1.412 -2.329 1 N-CA-C 95.299 -5.815 . . . . 0.0 95.299 165.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.963 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.04 -169.46 1.61 Allowed 'General case' 0 C--N 1.392 2.447 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.8 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.5 m80 34.78 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.865 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 174.96 -42.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.116 0.96 . . . . 0.0 109.669 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.48 83.45 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.09 -44.77 7.86 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 114.591 -0.805 . . . . 0.0 109.565 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.5 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.444 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.89 8.4 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 49.4 t -148.28 -9.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.241 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.43 1.081 . . . . 0.0 109.874 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.551 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -174.95 176.4 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.423 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 53.58 31.59 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -60.61 -10.21 4.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.506 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.21 -0.26 32.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.085 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 m 50.8 178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 16.7 pt -89.03 -35.02 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.692 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 68.1 m-85 -160.83 -5.1 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -51.82 -66.47 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -75.46 72.81 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.507 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.86 -13.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.866 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 67.6 mtp180 -143.8 10.92 1.6 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 70.3 m80 -153.12 145.66 24.16 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.104 0.478 . . . . 0.0 110.818 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.071 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.55 -31.52 0.23 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.83 1.956 . . . . 0.0 109.586 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.72 3.12 0.23 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.477 -5.749 . . . . 0.0 95.477 164.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.071 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.0 tttp -117.68 -169.37 1.66 Allowed 'General case' 0 C--N 1.392 2.443 0 CA-C-N 109.487 -3.506 . . . . 0.0 111.925 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.2 m-70 31.81 25.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.625 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.1 tt 168.08 -35.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.026 0.917 . . . . 0.0 109.029 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.34 -13.3 74.02 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.541 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.5 t60 -86.79 -39.79 15.59 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 114.181 -1.009 . . . . 0.0 110.154 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -149.16 23.51 0.94 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.152 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.91 5.48 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.1 t -150.59 -31.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.551 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' VAL . 3.9 m-20 167.82 -74.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.4 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -163.59 24.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.386 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -50.11 -26.96 5.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -61.84 -159.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.24 9.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.062 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.2 p 50.78 100.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.847 0.356 . . . . 0.0 110.714 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mt -71.77 74.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.375 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 52.71 22.09 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.73 -56.6 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.43 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -73.0 79.17 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -48.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -102.12 0.19 34.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 110.227 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.0 m80 -153.16 144.08 22.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.254 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.024 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.36 -31.11 0.22 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.678 1.862 . . . . 0.0 109.564 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.32 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.024 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -116.56 -168.9 1.53 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.393 -3.548 . . . . 0.0 111.667 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.1 m80 34.23 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.814 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.08 -43.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 CA-C-O 122.109 0.957 . . . . 0.0 109.734 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.44 -13.13 83.7 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.42 -44.09 7.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 114.589 -0.806 . . . . 0.0 109.624 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.64 8.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.569 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.02 8.74 1.54 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 21' ' ' VAL . 48.2 t -148.44 -8.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.647 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 20.5 m-20 97.13 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.555 1.159 . . . . 0.0 110.275 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.9 t60 -170.76 -162.63 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.074 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.1 t80 56.0 12.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -62.33 -18.45 61.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.68 -10.41 31.46 Favored Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -91.91 102.01 14.59 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mt -65.73 -42.91 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' H ' ' H ' ' A' ' 7' ' ' LYS . 42.9 p90 -166.85 -8.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' H ' ' A' ' 6' ' ' PHE . 59.7 mttm -53.85 -66.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -81.67 67.33 7.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.523 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.59 -21.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.809 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 99.4 mtt180 -137.1 6.6 2.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.207 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 21.7 m80 -152.69 146.41 25.11 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.21 -31.03 0.21 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.814 1.946 . . . . 0.0 110.095 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 1.98 0.31 Allowed 'General case' 0 N--CA 1.411 -2.388 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 10.6 ttpt -116.22 -168.86 1.5 Allowed 'General case' 0 C--N 1.395 2.565 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.691 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 83.2 t60 35.02 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.992 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.3 tt 175.65 -44.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.193 0.997 . . . . 0.0 109.507 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.81 -13.77 82.06 Favored Glycine 0 C--N 1.274 -2.877 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.25 -45.39 8.65 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.46 -0.87 . . . . 0.0 108.838 177.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.36 12.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 56.89 11.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 21' ' ' VAL . 95.4 t -145.12 -7.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.11 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.1 m120 100.6 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.89 1.369 . . . . 0.0 110.103 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.8 t-80 -167.42 -136.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.219 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.593 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.5 m-85 46.47 31.6 1.36 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -53.47 131.66 38.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.862 0.363 . . . . 0.0 110.51 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.98 -23.62 72.85 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.0 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.5 m -53.03 95.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 mt -69.6 -26.76 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.233 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -161.12 -9.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.66 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -56.07 -30.97 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.34 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -123.23 50.32 1.57 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.118 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.01 -8.05 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 14.9 ptm180 -167.43 23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.483 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 27.4 m-70 -144.0 146.99 33.27 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.612 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.13 -31.51 0.23 Allowed 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 125.61 1.818 . . . . 0.0 109.812 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.61 2.4 0.29 Allowed 'General case' 0 N--CA 1.411 -2.397 1 N-CA-C 95.339 -5.8 . . . . 0.0 95.339 165.062 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.8 tttp -116.19 -168.81 1.49 Allowed 'General case' 0 C--N 1.394 2.504 0 CA-C-N 109.479 -3.509 . . . . 0.0 111.561 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m-70 34.1 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.946 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.38 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.55 -14.05 81.41 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 105.486 -3.046 . . . . 0.0 105.486 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.78 -48.48 6.29 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 114.398 -0.901 . . . . 0.0 109.77 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.69 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.66 9.32 1.1 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 21' ' ' VAL . 98.2 t -146.95 -8.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.784 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 25.6 m-20 97.94 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.702 1.251 . . . . 0.0 110.334 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 55.7 m80 -157.48 -160.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.448 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 55.21 22.75 4.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.572 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.289 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.25 -70.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 110.624 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.25 -24.64 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.965 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.0 p -58.9 122.25 13.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.443 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.493 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.9 mt -69.77 -50.89 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 54.9 m-85 -161.09 -3.82 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 3.4 mptp? -58.1 -59.41 5.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.163 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.484 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 54.9 t-80 -76.97 40.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.74 20.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -166.41 34.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.115 0.483 . . . . 0.0 110.047 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.6 t-80 -156.58 145.39 20.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.41 -31.38 0.22 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.825 1.953 . . . . 0.0 109.629 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.1 0.3 Allowed 'General case' 0 N--CA 1.411 -2.399 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.2 -169.3 1.58 Allowed 'General case' 0 C--N 1.393 2.475 0 CA-C-N 109.423 -3.535 . . . . 0.0 111.737 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.23 19.64 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.791 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 173.87 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 CA-C-O 122.054 0.93 . . . . 0.0 109.567 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.17 -12.87 84.21 Favored Glycine 0 C--N 1.274 -2.89 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.614 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.78 -44.49 8.11 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.075 177.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.3 13.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.12 9.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -144.76 -9.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.324 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t30 104.38 -36.79 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.628 1.205 . . . . 0.0 110.214 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 20.8 t-80 -170.38 -126.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.379 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.57 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 97.1 m-85 53.44 11.99 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.559 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' C ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.439 ' CG ' ' C ' ' A' ' 1' ' ' GLY . 9.7 m-90 -155.65 -5.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.449 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 2' ' ' TRP . . . 73.76 2.56 61.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.16 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 m -68.37 125.04 25.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 5' ' ' ILE . 19.1 tt -72.73 71.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.591 0.71 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.522 ' CG ' ' NH2' ' A' ' 10' ' ' ARG . 47.1 m-85 55.81 4.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.93 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 5' ' ' ILE . 81.4 tttt -65.14 -21.57 66.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 17.6 t-80 -76.52 9.29 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.77 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' NH2' ' CG ' ' A' ' 6' ' ' PHE . 28.1 ttm180 -171.31 34.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.407 . . . . 0.0 110.208 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.1 t60 -157.3 147.3 20.69 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.54 -31.6 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.758 1.912 . . . . 0.0 110.048 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 2.1 0.3 Allowed 'General case' 0 N--CA 1.412 -2.349 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 165.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.3 tttt -116.08 -168.79 1.49 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.696 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.4 t-80 34.23 19.31 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.847 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 174.57 -46.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 CA-C-O 122.308 1.052 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.54 -14.23 77.57 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.33 -46.88 7.16 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.523 -0.839 . . . . 0.0 109.559 178.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.88 14.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.93 5.65 1.03 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.9 t -144.6 -8.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.343 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 15.5 t30 105.35 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.578 1.174 . . . . 0.0 109.958 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 2.2 p-80 -170.58 107.74 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -59.92 -9.54 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.453 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 3.6 m0 -64.29 -138.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.688 0.28 . . . . 0.0 110.383 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.38 27.86 0.16 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.851 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -61.52 92.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -66.28 77.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.473 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 54.43 24.21 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.771 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -75.6 -44.47 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.525 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.38 50.55 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.0 -18.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -120.56 8.81 10.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.202 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 48.2 t-80 -156.75 145.65 20.12 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.006 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.74 -31.65 0.23 Allowed 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 125.835 1.959 . . . . 0.0 109.889 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.46 2.14 0.29 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.006 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttp -116.24 -169.09 1.54 Allowed 'General case' 0 C--N 1.393 2.497 0 CA-C-N 109.435 -3.53 . . . . 0.0 111.68 177.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.36 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.961 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.12 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.61 0 CA-C-O 122.015 0.912 . . . . 0.0 109.524 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.35 -13.29 83.42 Favored Glycine 0 C--N 1.276 -2.781 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.537 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.5 m170 -94.66 -47.52 6.47 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.709 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.0 12.85 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.26 7.45 1.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.373 0.606 . . . . 0.0 109.388 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.3 t -148.31 -9.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.106 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 39.8 t-20 101.66 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.463 1.102 . . . . 0.0 110.084 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' A' ' 25' ' ' LEU . 76.4 m80 -150.48 112.85 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.383 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 61.8 t80 -53.8 -10.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 23' ' ' HIS . 14.9 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.446 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -54.98 132.85 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.626 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.87 -13.68 83.37 Favored Glycine 0 C--N 1.33 0.228 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.7 p 59.92 118.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.707 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' C ' ' CG ' ' A' ' 6' ' ' PHE . 16.5 pt -78.01 45.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.624 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 10' ' ' ARG . 4.6 m-85 74.3 -12.5 0.88 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 9' ' ' GLY . 55.6 tttp -55.67 -37.58 68.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.489 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -73.43 11.05 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.344 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -154.81 6.59 0.3 Allowed Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 6' ' ' PHE . 51.2 mtt-85 -156.18 163.55 39.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 39.7 m80 60.08 136.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.544 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.69 -32.43 0.24 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.631 1.832 . . . . 0.0 109.637 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.18 1.32 0.32 Allowed 'General case' 0 N--CA 1.41 -2.431 1 N-CA-C 95.34 -5.8 . . . . 0.0 95.34 164.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.1 tttt -114.62 -169.05 1.47 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.592 -3.458 . . . . 0.0 111.843 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 56.8 m-70 34.44 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.763 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 174.61 -46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-O 122.2 1.0 . . . . 0.0 109.422 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -13.69 80.06 Favored Glycine 0 C--N 1.271 -3.071 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.27 -43.14 9.45 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.643 -0.778 . . . . 0.0 109.853 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.226 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.93 -17.89 0.16 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.55 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 19' ' ' ALA . 24.0 t -149.24 -32.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.759 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 156.87 -47.7 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -166.98 68.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.556 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.459 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 68.7 t80 -58.22 -21.66 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.566 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.481 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -70.14 -163.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.744 0.307 . . . . 0.0 110.501 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.7 21.58 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.038 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.9 p -168.73 148.13 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' C ' ' H ' ' A' ' 7' ' ' LYS . 6.3 mm -79.5 59.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.996 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 54.2 8.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 5' ' ' ILE . 65.6 tttm -66.38 -57.0 8.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -80.15 35.83 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.1 16.03 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.099 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -165.51 29.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.505 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.1 t-80 -158.85 146.8 17.96 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.72 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.022 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.99 -31.97 0.24 Allowed 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 125.791 1.932 . . . . 0.0 109.991 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.92 0.29 Allowed 'General case' 0 N--CA 1.412 -2.35 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 165.153 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.022 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttp -115.59 -169.68 1.63 Allowed 'General case' 0 C--N 1.393 2.465 0 CA-C-N 109.323 -3.58 . . . . 0.0 111.623 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.614 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.5 t60 34.47 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.033 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 176.07 -43.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 CA-C-O 122.093 0.949 . . . . 0.0 109.477 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.55 -14.48 81.99 Favored Glycine 0 C--N 1.274 -2.863 0 N-CA-C 105.197 -3.161 . . . . 0.0 105.197 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -90.29 -49.38 6.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.179 177.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.57 13.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.16 0.288 . . . . 0.0 110.309 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.48 7.85 1.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.9 t -141.71 -9.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t-20 105.17 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.607 1.192 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.0 t-80 84.71 26.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.008 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.38 -13.66 62.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.277 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -73.88 173.09 10.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.13 -14.69 76.48 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.861 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 m 59.56 148.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -98.67 -26.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 8' ' ' HIS . 74.6 m-85 -144.3 57.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 53.79 9.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.447 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 10.8 t-80 48.93 19.37 0.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.528 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.48 -17.71 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.184 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 69.83 43.12 0.97 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.837 0.351 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 98.5 m-70 -136.48 92.02 2.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.318 0.58 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.0 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 138.74 -32.86 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -0.39 0.58 Allowed 'General case' 0 N--CA 1.414 -2.25 1 N-CA-C 95.398 -5.779 . . . . 0.0 95.398 164.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.0 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.9 tttt -114.59 -168.78 1.42 Allowed 'General case' 0 C--N 1.391 2.378 0 CA-C-N 109.441 -3.527 . . . . 0.0 112.001 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 81.4 m-70 33.45 21.7 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.833 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.75 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.237 1.018 . . . . 0.0 109.452 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.37 -11.5 80.32 Favored Glycine 0 C--N 1.276 -2.751 0 N-CA-C 104.848 -3.301 . . . . 0.0 104.848 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.498 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -91.76 -36.75 13.39 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.843 178.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.45 26.22 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.707 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.13 0.15 0.05 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.269 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.5 t -151.47 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.266 0.079 . . . . 0.0 110.823 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.433 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 4.6 p30 -178.87 -89.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.91 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.433 ' H ' ' CG ' ' A' ' 22' ' ' ASN . 1.7 t60 -166.51 50.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.407 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 48.4 t80 -74.58 -15.81 60.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.585 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.501 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -70.13 -68.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.489 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.22 -15.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.0 m 52.08 -178.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.851 0.358 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' CG ' ' A' ' 6' ' ' PHE . 5.4 pt -152.69 76.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.778 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.407 ' CG ' ' C ' ' A' ' 5' ' ' ILE . 5.5 m-85 75.54 -40.36 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.632 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 9' ' ' GLY . 62.7 mttp -50.9 -23.73 3.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.606 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -61.98 0.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.269 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . 166.68 34.21 0.02 OUTLIER Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.729 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -154.15 27.75 0.46 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.6 t60 -157.52 146.25 19.54 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.632 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 125.71 1.881 . . . . 0.0 109.898 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.27 1.95 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.044 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.4 tttt -115.69 -169.26 1.55 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.744 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.62 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 33.89 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.792 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.4 tt 174.37 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-O 122.202 1.001 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.0 -13.86 80.66 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.495 -3.042 . . . . 0.0 105.495 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.447 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -91.05 -43.53 9.87 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.674 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.37 41.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.221 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.7 -16.99 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.587 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.7 t -148.95 -34.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t30 155.28 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.827 0.704 . . . . 0.0 109.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.54 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 29.4 t60 -162.89 -117.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.54 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 59.6 t80 54.62 18.0 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.336 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -67.69 173.34 4.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.568 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.25 0.24 64.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.94 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -52.65 98.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 6' ' ' PHE . 10.1 mt -76.34 -40.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 5' ' ' ILE . 63.7 m-85 -146.82 -14.64 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.417 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -50.23 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.723 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -77.39 66.21 3.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.65 -13.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.889 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -148.16 14.67 1.02 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.85 0.357 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.4 m80 -152.8 145.39 24.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.55 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.36 -31.25 0.22 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.701 1.876 . . . . 0.0 109.726 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 2.02 0.31 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.353 -5.795 . . . . 0.0 95.353 164.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.029 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.2 ttpt -115.9 -169.28 1.56 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.424 -3.535 . . . . 0.0 111.577 176.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.2 t-80 34.45 17.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.001 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.7 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.123 0.964 . . . . 0.0 109.565 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -13.68 83.17 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 105.386 -3.086 . . . . 0.0 105.386 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.18 -47.42 7.53 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.211 -0.995 . . . . 0.0 109.251 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.45 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.273 0.358 . . . . 0.0 110.135 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.07 10.2 1.54 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 92.5 t -142.63 -9.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 22.7 t-20 101.89 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.464 1.102 . . . . 0.0 110.813 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.553 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.5 t60 81.63 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.237 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.553 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.1 m-85 50.36 31.95 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.244 -179.923 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -66.27 -164.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.611 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.51 23.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.867 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m 55.12 82.64 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 110.429 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 pt -71.53 87.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.342 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 57.09 11.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -72.4 -57.26 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.378 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 1.3 t60 -79.96 42.6 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.434 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -159.5 -4.53 0.06 OUTLIER Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.734 -0.547 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 61.9 mtp180 -144.32 6.87 1.32 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.232 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 90.6 m-70 -156.38 144.85 19.94 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.96 -31.93 0.23 Allowed 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 125.737 1.898 . . . . 0.0 109.892 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.91 0.31 Allowed 'General case' 0 N--CA 1.412 -2.37 1 N-CA-C 95.406 -5.776 . . . . 0.0 95.406 165.057 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.3 tttm -115.15 -169.78 1.63 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.5 -3.5 . . . . 0.0 111.803 176.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.0 t60 34.39 17.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.108 178.059 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 176.38 -44.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.224 1.011 . . . . 0.0 109.078 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.35 -13.93 82.4 Favored Glycine 0 C--N 1.274 -2.905 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 174.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 m170 -92.28 -47.91 6.96 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.465 -0.867 . . . . 0.0 109.457 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.38 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.641 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.54 7.83 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.411 0.624 . . . . 0.0 109.46 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 48.9 t -146.22 -8.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.958 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.0 t-20 102.52 -37.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.631 1.207 . . . . 0.0 110.031 -179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -173.93 104.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.618 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 48.2 t80 -171.68 -4.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' H ' ' H ' ' A' ' 24' ' ' TYR . 15.9 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.13 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.6 m95 53.57 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 172.87 6.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.253 -0.499 . . . . 0.0 111.918 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 3' ' ' GLY . 52.3 p -169.58 119.97 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 0.0 110.445 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' H ' ' A' ' 7' ' ' LYS . 9.4 pt -73.46 69.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 54.98 9.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.769 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 5' ' ' ILE . 60.6 tttp -55.01 -68.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.363 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -82.44 68.59 8.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -163.78 -16.07 0.03 OUTLIER Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 9' ' ' GLY . 13.9 ptm180 -151.54 -0.97 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.215 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.0 m-70 -135.82 146.75 47.84 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.278 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.993 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -31.62 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.734 1.896 . . . . 0.0 109.851 -177.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 1.99 0.31 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.443 -5.762 . . . . 0.0 95.443 165.051 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.993 ' N ' ' C ' ' A' ' 12' ' ' ALA . 18.7 tttp -115.57 -169.12 1.52 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.406 -3.543 . . . . 0.0 111.737 176.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.8 t60 33.72 19.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.89 178.044 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.31 -45.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.125 0.964 . . . . 0.0 109.551 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.05 -14.33 80.44 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 105.402 -3.079 . . . . 0.0 105.402 174.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 m170 -91.67 -48.96 6.54 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.325 -0.937 . . . . 0.0 109.182 177.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.08 14.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.29 9.63 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.5 t -144.63 -10.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.845 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.2 t-20 105.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.542 1.151 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 4.9 t-160 83.98 28.02 0.08 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.372 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.61 -19.37 25.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -55.07 160.25 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.707 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.07 -18.06 79.64 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.1 t -164.48 173.67 11.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 110.467 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' C ' ' N ' ' A' ' 7' ' ' LYS . 18.4 mt -74.55 70.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.432 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 52.45 13.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 5' ' ' ILE . 18.4 tptm -62.53 -50.1 72.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 46.84 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.475 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.85 -2.64 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.167 -0.54 . . . . 0.0 111.9 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -144.3 1.75 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 110.015 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.4 t-80 -157.22 143.6 18.02 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.324 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.85 -30.73 0.21 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.37 -177.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.87 3.29 0.24 Allowed 'General case' 0 N--CA 1.41 -2.46 1 N-CA-C 95.332 -5.803 . . . . 0.0 95.332 164.741 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.023 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.8 tttp -119.05 -168.13 1.51 Allowed 'General case' 0 C--N 1.392 2.428 0 CA-C-N 109.457 -3.52 . . . . 0.0 111.684 177.28 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.4 m80 33.5 23.27 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.556 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.63 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.3 tt 167.41 -34.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.166 0.984 . . . . 0.0 109.256 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.63 -12.37 77.99 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 104.902 -3.279 . . . . 0.0 104.902 174.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 18' ' ' HIS . 18.4 t-160 -92.56 -36.04 13.25 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 114.425 -0.887 . . . . 0.0 110.013 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -146.91 22.88 1.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.96 -2.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.3 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.9 -30.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.738 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -176.63 -90.16 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.011 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.1 p80 -149.75 25.99 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.48 ' N ' ' CB ' ' A' ' 19' ' ' ALA . 45.5 t80 -72.46 12.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.4 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.253 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -58.19 -99.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.7 0.286 . . . . 0.0 110.559 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.36 -14.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.6 m -81.49 69.71 8.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.765 0.317 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -44.0 -46.57 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -179.718 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 73.7 m-85 -160.12 -1.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.328 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -51.58 -55.81 17.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -78.19 47.66 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.83 7.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -150.43 11.72 0.7 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.1 t60 -157.49 145.24 18.82 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.024 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.81 -31.72 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.706 1.879 . . . . 0.0 109.805 -178.103 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.86 0.3 Allowed 'General case' 0 N--CA 1.412 -2.361 1 N-CA-C 95.303 -5.814 . . . . 0.0 95.303 164.95 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.024 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.556 -3.474 . . . . 0.0 111.876 177.109 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 49.3 t-80 33.91 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.787 178.012 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.14 -46.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 122.234 1.016 . . . . 0.0 109.319 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -13.63 80.57 Favored Glycine 0 C--N 1.271 -3.076 0 N-CA-C 105.571 -3.011 . . . . 0.0 105.571 174.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.434 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.21 -43.09 10.05 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.533 178.181 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.42 41.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.181 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.41 -15.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.612 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.17 -35.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.2 t30 155.53 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.806 0.691 . . . . 0.0 109.19 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -166.11 65.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.6 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.469 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 65.1 t80 -70.12 -13.59 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.451 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.005 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.537 ' CG ' ' N ' ' A' ' 3' ' ' GLY . 72.0 t-105 -64.62 174.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' CG ' ' A' ' 2' ' ' TRP . . . -74.51 4.23 36.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.231 -0.509 . . . . 0.0 111.889 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t 59.03 160.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.615 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -80.83 67.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.749 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 53.91 10.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.193 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -70.76 -68.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.181 179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.3 65.42 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.23 -26.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.108 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -157.3 17.62 0.28 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.0 t60 -157.25 145.2 19.12 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.041 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.03 -31.57 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.702 1.876 . . . . 0.0 109.75 -177.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.85 0.31 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.416 -5.772 . . . . 0.0 95.416 164.914 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.041 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.8 tttt -115.35 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.45 -3.523 . . . . 0.0 111.759 176.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 11.7 t-80 34.51 18.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.985 177.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.668 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.88 -46.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.307 1.051 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.16 -14.49 79.0 Favored Glycine 0 C--N 1.271 -3.035 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.369 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.3 -48.63 6.58 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.471 -0.865 . . . . 0.0 109.539 178.113 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.26 12.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.433 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.1 8.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 21' ' ' VAL . 89.5 t -145.78 -7.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.783 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.6 m-20 98.57 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.764 1.29 . . . . 0.0 110.19 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -176.76 87.15 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.352 -179.927 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -66.82 -21.38 66.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.984 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -65.21 -85.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 110.565 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.47 2.65 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.946 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 t 56.4 164.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 110.484 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 5' ' ' ILE . 14.7 tt -73.95 83.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.491 0.662 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 44.96 16.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.389 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ILE . 34.0 ttpt -67.13 -42.38 84.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -78.34 55.13 1.51 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.608 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.99 1.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.125 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -145.09 25.9 1.38 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 110.529 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 t-80 -160.82 144.05 13.16 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.463 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.05 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.58 -31.11 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.568 1.792 . . . . 0.0 109.458 -177.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.34 0.3 Allowed 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 95.317 -5.808 . . . . 0.0 95.317 164.758 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.05 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.1 tttm -116.33 -169.29 1.59 Allowed 'General case' 0 C--N 1.393 2.468 0 CA-C-N 109.525 -3.489 . . . . 0.0 111.556 177.063 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 34.77 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.99 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 175.83 -41.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.58 0 CA-C-O 122.042 0.925 . . . . 0.0 109.471 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.1 -13.01 83.8 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 105.331 -3.108 . . . . 0.0 105.331 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.4 m170 -94.38 -46.29 7.09 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.541 178.17 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.63 13.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.772 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.55 5.92 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 20.7 t -148.13 -10.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.391 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 58.2 t-20 110.53 -42.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.632 1.208 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 63.2 t-80 -173.9 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.649 0.262 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.05 39.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.477 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.2 tp . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -73.82 -171.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.639 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.78 26.19 24.92 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -41.75 159.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 -179.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 pt -78.02 56.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.589 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 55.55 56.71 5.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.524 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -122.24 -48.01 2.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.486 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 5.9 t60 -80.28 42.19 0.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 -13.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.195 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.16 -3.75 43.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.264 0.554 . . . . 0.0 109.802 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.5 t60 -150.16 144.73 25.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.006 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.42 -31.4 0.22 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 125.75 1.906 . . . . 0.0 109.648 -177.629 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.4 0.27 Allowed 'General case' 0 N--CA 1.413 -2.308 1 N-CA-C 95.363 -5.791 . . . . 0.0 95.363 164.952 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.006 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.2 tttt -116.63 -168.63 1.48 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.485 -3.507 . . . . 0.0 111.669 177.096 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.1 m-70 33.82 20.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.825 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 173.76 -43.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 122.108 0.956 . . . . 0.0 109.61 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.22 -13.24 83.48 Favored Glycine 0 C--N 1.274 -2.911 0 N-CA-C 105.57 -3.012 . . . . 0.0 105.57 174.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.77 -45.51 7.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.483 178.117 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.62 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.34 7.16 1.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -146.59 -9.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.369 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 37.7 t-20 103.46 -35.93 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.514 1.134 . . . . 0.0 110.058 -179.643 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.535 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -171.58 112.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.346 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -64.17 -1.03 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.634 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -65.14 135.26 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.87 -6.69 60.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.947 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 p 48.55 84.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.644 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 6' ' ' PHE . 6.8 tt -55.81 -42.96 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.486 ' N ' HG23 ' A' ' 5' ' ' ILE . 40.0 m-85 -158.28 -8.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.976 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' H ' ' H ' ' A' ' 6' ' ' PHE . 44.9 mtmt -52.09 -17.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.46 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 13.4 t-80 -72.79 3.8 4.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.826 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 22.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.197 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -96.93 -1.58 45.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.977 0.418 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' ALA . 5.7 p80 -155.04 143.77 20.68 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.63 -31.07 0.22 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.694 1.871 . . . . 0.0 109.523 -177.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.02 0.29 Allowed 'General case' 0 N--CA 1.411 -2.391 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 165.078 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.045 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.9 ttpt -116.96 -168.18 1.42 Allowed 'General case' 0 C--N 1.393 2.498 0 CA-C-N 109.398 -3.546 . . . . 0.0 111.498 177.331 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.4 t-80 34.11 20.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.631 177.519 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 171.36 -46.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 CA-C-O 122.303 1.049 . . . . 0.0 109.254 -179.744 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.69 -13.12 80.6 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.975 -2.85 . . . . 0.0 105.975 175.283 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.43 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.55 -32.21 18.27 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.84 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.795 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -172.56 -20.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CD2' ' A' ' 15' ' ' HIS . 59.9 t -152.0 -17.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.562 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 164.58 -38.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.958 0.409 . . . . 0.0 110.017 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 31.4 t60 -171.34 26.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.352 -178.746 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -47.62 -18.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.303 179.935 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -165.12 -67.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.2 -6.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.904 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 m 55.75 71.03 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.663 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.492 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 12.1 mt -67.23 -37.58 79.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.165 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 59.0 m-85 -160.51 -1.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.864 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -58.64 -77.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.546 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -73.81 75.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.08 -28.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -163.74 26.26 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.344 . . . . 0.0 110.5 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.53 ' C ' ' H ' ' A' ' 13' ' ' ALA . 74.9 t60 -158.48 146.4 18.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.05 -31.31 0.22 Allowed 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 125.821 1.951 . . . . 0.0 109.738 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.79 0.26 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.313 -5.81 . . . . 0.0 95.313 164.957 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.039 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -117.37 -168.62 1.52 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.462 -3.517 . . . . 0.0 111.859 177.181 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.1 t60 33.86 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.331 178.124 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 172.13 -45.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 CA-C-O 122.058 0.933 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.13 76.34 Favored Glycine 0 C--N 1.272 -3.026 0 N-CA-C 105.812 -2.915 . . . . 0.0 105.812 175.017 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 7.9 t-80 -93.29 -41.95 9.59 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.31 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.39 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.621 -179.379 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.62 -12.51 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.016 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.0 t -148.94 -36.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 121.284 -0.166 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.3 t-20 157.52 -46.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.79 95.8 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.713 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.432 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.4 t80 -170.32 1.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.71 179.965 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -63.49 -74.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.508 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.99 -5.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.04 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m 56.54 163.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 110.509 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.7 pt -66.1 -151.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.946 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -62.48 0.71 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.701 0.286 . . . . 0.0 110.814 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 5' ' ' ILE . 59.4 tttp -62.91 -46.55 87.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 110.407 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -84.54 66.99 9.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' N ' ' CB ' ' A' ' 13' ' ' ALA . . . 171.39 -30.53 0.12 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.453 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -78.57 -113.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.561 ' ND1' ' N ' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -90.14 146.28 24.41 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.201 -179.543 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.65 -32.47 0.23 Allowed 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 125.582 1.801 . . . . 0.0 110.18 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.86 0.39 0.38 Allowed 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 95.382 -5.784 . . . . 0.0 95.382 165.031 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.2 tttt -113.39 -169.93 1.59 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.138 -3.665 . . . . 0.0 112.169 176.546 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.0 m80 34.47 18.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.896 177.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.83 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 CA-C-O 122.284 1.04 . . . . 0.0 109.169 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.19 -14.62 78.98 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 105.516 -3.033 . . . . 0.0 105.516 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.72 -47.99 6.8 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.686 -0.757 . . . . 0.0 109.654 177.996 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.38 11.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.37 8.73 1.23 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 21' ' ' VAL . 57.7 t -148.04 -7.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.872 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 6.3 m-20 97.61 -36.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.605 1.191 . . . . 0.0 110.087 -179.452 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 75.4 m80 -158.43 -166.15 1.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.221 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 55.94 27.01 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.118 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.72 -59.44 2.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.76 6.48 67.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.09 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.4 p -72.31 154.66 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 9' ' ' GLY . 6.7 mm -67.89 81.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.095 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 55.79 46.43 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.425 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 mttp 56.88 74.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.304 179.625 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 t60 61.93 50.92 3.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.389 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.467 ' O ' ' ND1' ' A' ' 11' ' ' HIS . . . 59.34 45.77 94.93 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.037 179.066 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 67.71 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 74.9 m80 -145.06 93.37 2.38 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.414 0.626 . . . . 0.0 109.638 178.932 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 137.45 -31.46 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -178.161 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.69 0.54 0.49 Allowed 'General case' 0 N--CA 1.413 -2.3 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 163.9 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.5 tttm -116.76 -167.89 1.37 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.383 -3.553 . . . . 0.0 111.703 177.024 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.659 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 99.0 m-70 33.9 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.955 178.076 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.655 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.8 tt 171.5 -37.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.265 1.031 . . . . 0.0 109.166 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.13 -11.35 81.18 Favored Glycine 0 C--N 1.275 -2.808 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 174.119 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.468 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.3 m170 -95.86 -34.16 11.95 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.078 178.385 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.05 26.6 0.62 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.437 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.22 -11.71 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 19' ' ' ALA . 90.3 t -152.96 -23.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.322 -179.31 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 38.0 t30 -170.45 -96.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.374 -179.003 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 33.4 m80 -145.51 127.2 15.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.724 -178.616 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 67.4 t80 -75.64 -4.38 39.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.124 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.486 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 92.1 m95 -158.99 -83.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 110.403 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 173.85 4.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.425 ' H ' ' H ' ' A' ' 3' ' ' GLY . 7.1 t 53.85 175.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.3 -40.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.989 179.974 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.01 53.54 2.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.686 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 9' ' ' GLY . 54.7 mttm 57.7 69.13 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 48.62 15.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.424 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . 85.65 55.63 2.52 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.298 179.931 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 57.86 37.71 27.0 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.57 179.802 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 10' ' ' ARG . 32.8 m80 -146.6 75.01 1.38 Allowed 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 178.642 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.012 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 172.2 -32.19 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.513 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.73 -1.73 0.67 Allowed 'General case' 0 N--CA 1.416 -2.126 1 N-CA-C 95.548 -5.723 . . . . 0.0 95.548 164.827 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.012 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.259 20.8 tttm -114.01 -167.74 1.25 Allowed 'General case' 0 C--N 1.387 2.217 0 CA-C-N 109.179 -3.646 . . . . 0.0 111.705 176.648 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.64 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.88 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.978 177.697 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.2 tt 174.22 -44.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.142 0.973 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.45 -13.43 81.72 Favored Glycine 0 C--N 1.273 -2.955 0 N-CA-C 105.843 -2.903 . . . . 0.0 105.843 174.966 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.616 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.7 -42.79 10.52 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.682 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 156.33 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.68 7.56 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.053 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.6 t -144.88 -11.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -179.85 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 49.4 t30 119.13 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.607 1.192 . . . . 0.0 110.091 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.437 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.8 t60 -172.47 -8.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.643 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -76.06 32.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.9 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.206 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -168.9 -173.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.87 34.32 0.24 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.862 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -162.93 113.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.3 mt -71.8 -47.66 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 62.8 m-85 -159.93 -9.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.352 179.616 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -50.47 -73.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -73.88 70.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 -14.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.83 18.61 1.28 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.224 179.894 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.6 t-80 -149.52 145.94 27.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.579 179.513 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.042 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.34 -31.3 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.668 1.855 . . . . 0.0 109.719 -177.859 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.64 2.24 0.3 Allowed 'General case' 0 N--CA 1.412 -2.335 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 164.896 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.042 ' H ' ' C ' ' A' ' 12' ' ' ALA . 11.2 ttpt -115.95 -168.92 1.5 Allowed 'General case' 0 C--N 1.395 2.554 0 CA-C-N 109.448 -3.524 . . . . 0.0 111.546 176.901 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.4 m80 34.72 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.013 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 176.06 -44.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.204 1.002 . . . . 0.0 109.46 -179.822 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.76 -14.0 81.8 Favored Glycine 0 C--N 1.273 -2.954 0 N-CA-C 105.449 -3.061 . . . . 0.0 105.449 174.43 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.554 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.43 -47.27 7.54 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.407 177.948 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.75 11.61 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.26 8.85 1.19 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.749 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 77.4 t -144.03 -9.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.113 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.7 t-20 100.15 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.525 1.141 . . . . 0.0 110.252 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.6 t60 89.4 -38.97 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.893 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -76.58 13.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.3 tt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -75.65 126.42 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 0.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.44 -12.85 77.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.03 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 6' ' ' PHE . 51.4 p 48.71 95.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.4 ' C ' ' N ' ' A' ' 7' ' ' LYS . 21.3 mt -64.59 77.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' SER . 97.2 m-85 49.82 15.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 52.4 tttp -66.95 -37.82 84.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.558 179.96 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.89 56.62 2.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.83 -5.84 0.03 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -111.19 -113.2 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.128 0.489 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 m170 -84.63 144.44 28.6 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.279 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.015 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.21 -32.05 0.24 Allowed 'General case' 0 CA--C 1.501 -0.922 0 O-C-N 125.403 1.689 . . . . 0.0 109.613 -177.856 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.07 0.5 0.4 Allowed 'General case' 0 N--CA 1.413 -2.285 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 164.855 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.015 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.4 tttt -113.87 -169.66 1.56 Allowed 'General case' 0 C--N 1.39 2.369 0 CA-C-N 109.083 -3.69 . . . . 0.0 111.974 176.432 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.9 t-80 35.16 17.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.977 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 176.19 -43.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.031 0.919 . . . . 0.0 109.465 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 -14.27 82.18 Favored Glycine 0 C--N 1.272 -3.02 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 174.336 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.94 -47.83 7.09 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.464 -0.868 . . . . 0.0 109.55 177.938 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.77 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.92 10.44 1.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 21' ' ' VAL . 98.2 t -146.57 -7.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.764 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 9.6 m-20 97.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.567 1.167 . . . . 0.0 110.228 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 96.1 m-70 -159.34 101.78 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -55.14 -14.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.04 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 26.1 m-90 -158.4 -81.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.744 0.306 . . . . 0.0 110.413 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.21 -17.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.927 179.98 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.9 p -76.7 120.52 22.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.3 mt -71.53 -46.71 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.426 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 7' ' ' LYS . 42.5 p90 -162.61 -2.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.977 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 6' ' ' PHE . 38.5 tptt -65.68 -74.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.222 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -85.25 5.95 28.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 110.263 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.52 -25.83 37.84 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 16.2 ptm180 -162.25 25.28 0.11 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.024 -179.705 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 m-70 -155.52 145.54 21.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.932 0.396 . . . . 0.0 110.554 179.291 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.92 -31.85 0.23 Allowed 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 125.689 1.868 . . . . 0.0 109.657 -177.831 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.35 2.06 0.29 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 165.063 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.029 ' N ' ' C ' ' A' ' 12' ' ' ALA . 33.1 tttt -115.63 -169.69 1.63 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.821 177.098 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 34.3 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.792 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.62 -45.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.142 0.972 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.37 -13.94 81.21 Favored Glycine 0 C--N 1.273 -2.956 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.488 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.28 -43.91 9.52 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.85 178.159 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.24 -179.131 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.23 -17.05 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.535 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 19' ' ' ALA . 15.8 t -148.21 -34.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.4 t-20 154.22 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.1 t60 -168.67 113.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -56.42 -7.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.428 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.353 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.1 m95 51.09 -129.51 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.445 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.42 13.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.762 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m -166.06 171.35 12.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.55 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -69.37 -37.91 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.377 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' H ' ' H ' ' A' ' 7' ' ' LYS . 33.6 p90 -166.89 -11.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.495 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' H ' ' H ' ' A' ' 6' ' ' PHE . 8.6 mtmp? -68.22 -12.53 61.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.437 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -152.55 38.63 0.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 179.964 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.76 1.7 0.28 Allowed Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -149.8 -2.07 0.42 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.564 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.7 t-80 -111.4 146.27 37.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.662 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -30.37 0.21 Allowed 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 125.663 1.852 . . . . 0.0 109.391 -177.376 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.05 3.47 0.24 Allowed 'General case' 0 N--CA 1.41 -2.444 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.602 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 26.8 tttt -119.46 -167.49 1.42 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.605 177.424 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.3 m-70 34.31 22.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 177.705 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.8 tt 169.0 -35.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.239 1.018 . . . . 0.0 109.22 -179.293 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.91 -12.12 80.27 Favored Glycine 0 C--N 1.275 -2.814 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 174.114 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 18' ' ' HIS . 1.2 t60 -93.66 -37.18 11.97 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.938 177.898 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -147.8 25.98 1.03 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.895 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.63 -9.25 0.14 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.917 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 19' ' ' ALA . 61.4 t -151.23 -26.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.263 -179.346 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -171.18 -94.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.277 -179.173 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.65 28.55 0.54 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.857 -179.662 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -77.53 19.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.477 179.787 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.26 179.913 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 62.8 m95 -156.58 0.48 0.13 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.45 -7.52 38.75 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.994 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p 48.48 64.51 1.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.5 pt -61.98 -18.2 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.66 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -165.51 -13.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.771 -179.801 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 6' ' ' PHE . 64.7 mttp -53.16 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.328 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -80.48 64.21 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.57 -14.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.003 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 93.4 mtt180 -145.63 5.12 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.337 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 m80 -156.52 144.52 19.52 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.504 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.86 -31.7 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.77 1.919 . . . . 0.0 109.803 -178.073 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.63 0.31 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 95.39 -5.781 . . . . 0.0 95.39 164.961 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.025 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttm -115.04 -169.22 1.51 Allowed 'General case' 0 C--N 1.395 2.553 0 CA-C-N 109.484 -3.507 . . . . 0.0 111.802 176.971 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 33.98 19.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.847 178.062 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.7 -46.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 CA-C-O 122.23 1.014 . . . . 0.0 109.247 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 -13.97 79.7 Favored Glycine 0 C--N 1.271 -3.042 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 174.533 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.469 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -90.83 -43.86 9.79 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.582 178.177 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.249 -179.178 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.33 -17.82 0.14 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.705 -179.501 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.6 t -149.29 -31.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 122.493 -0.13 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t-20 155.69 -47.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.804 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 9.0 t60 -163.91 -130.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.582 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.7 m-85 54.23 22.43 3.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.486 -179.854 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.543 179.96 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -56.45 -15.62 4.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.807 0.337 . . . . 0.0 110.662 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.99 71.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.891 179.975 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.1 m -162.63 160.98 26.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 pt -153.49 -30.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.281 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.88 45.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 179.719 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 52.61 50.92 17.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 0.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 1.1 t60 44.13 34.6 1.01 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.753 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.03 27.22 29.13 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.94 -179.848 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 59.68 39.68 20.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.257 0.551 . . . . 0.0 109.677 -179.621 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.54 ' C ' ' H ' ' A' ' 13' ' ' ALA . 6.1 p-80 -169.62 143.43 2.73 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.07 179.441 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 72.0 -31.31 0.22 Allowed 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 125.632 1.833 . . . . 0.0 109.287 -177.566 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 2.65 0.25 Allowed 'General case' 0 N--CA 1.411 -2.415 1 N-CA-C 95.39 -5.782 . . . . 0.0 95.39 164.975 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.031 ' N ' ' C ' ' A' ' 12' ' ' ALA . 16.5 ttpp -116.19 -169.6 1.64 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.679 177.008 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.1 m-70 34.11 18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.904 178.154 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 175.07 -43.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.118 0.961 . . . . 0.0 109.477 179.838 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.4 83.49 Favored Glycine 0 C--N 1.274 -2.888 0 N-CA-C 105.411 -3.075 . . . . 0.0 105.411 174.425 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.37 -45.92 7.59 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 114.537 -0.832 . . . . 0.0 109.44 178.049 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.34 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.061 0.226 . . . . 0.0 110.444 -179.803 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.68 10.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.914 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 21' ' ' VAL . 61.1 t -147.75 -8.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.981 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.4 m-20 99.47 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.609 1.193 . . . . 0.0 110.265 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 42.8 p-80 -171.94 97.91 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.803 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -76.25 9.61 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.539 179.882 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -60.85 -114.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.595 0.236 . . . . 0.0 110.466 -179.954 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.24 -24.95 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.053 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.5 m -71.66 178.85 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 0.0 110.509 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 6' ' ' PHE . 17.3 tt -166.36 -43.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.655 -179.894 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.52 ' N ' HG23 ' A' ' 5' ' ' ILE . 47.6 m-85 -78.2 49.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.842 -179.808 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' ARG . 93.0 mttt 52.76 50.79 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 0.0 110.353 179.756 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 42.79 35.35 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.497 179.898 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.37 27.23 25.77 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.701 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER 57.29 35.75 26.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.458 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.9 m80 -162.12 145.25 11.75 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.064 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.2 -31.35 0.22 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.621 1.826 . . . . 0.0 109.538 -177.752 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.45 0.26 Allowed 'General case' 0 N--CA 1.412 -2.356 1 N-CA-C 95.29 -5.818 . . . . 0.0 95.29 165.033 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.064 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.1 tttt -116.35 -169.24 1.58 Allowed 'General case' 0 C--N 1.394 2.51 0 CA-C-N 109.547 -3.478 . . . . 0.0 111.795 177.074 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.7 t60 34.65 17.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.975 178.094 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 175.43 -41.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.043 0.925 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.62 -13.02 83.94 Favored Glycine 0 C--N 1.276 -2.783 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 174.412 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.01 -43.78 8.74 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 114.439 -0.88 . . . . 0.0 109.209 178.046 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.27 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.55 10.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.06 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.1 t -145.81 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.02 -179.828 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.8 t-20 102.46 -36.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.585 1.178 . . . . 0.0 110.189 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -170.48 102.95 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.649 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 51.9 t80 -167.68 -4.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.216 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -61.51 -29.32 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.861 0.362 . . . . 0.0 110.611 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.22 2.67 20.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.737 -179.882 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.0 m -76.84 114.04 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.643 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mt -75.97 66.45 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.272 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 57.26 8.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.504 -179.911 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -61.2 -35.06 76.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.473 179.889 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -70.62 4.0 2.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.515 179.964 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.39 39.62 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.065 -179.962 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -164.59 41.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 179.88 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 51.2 t-80 -170.06 143.75 2.55 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.453 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.44 -31.45 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.596 1.81 . . . . 0.0 109.547 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.34 1.74 0.31 Allowed 'General case' 0 N--CA 1.41 -2.433 1 N-CA-C 95.386 -5.783 . . . . 0.0 95.386 164.899 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.6 tttm -115.47 -169.53 1.59 Allowed 'General case' 0 C--N 1.393 2.492 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.711 177.014 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 34.4 m170 34.48 17.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.97 178.149 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.05 -44.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.135 0.969 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.06 -14.26 81.97 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 174.335 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.89 -48.12 7.43 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.246 -0.977 . . . . 0.0 109.102 177.87 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.89 13.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.49 10.85 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.904 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 94.1 t -140.23 -9.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 44.9 t-20 107.56 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.65 1.219 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 19.1 t60 80.64 34.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.035 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.47 -31.71 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.249 -179.887 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 56.5 11.22 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.793 0.33 . . . . 0.0 110.466 -179.957 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.41 -3.01 60.45 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.244 -0.503 . . . . 0.0 111.883 -179.931 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.6 p -55.48 127.36 29.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 0.0 110.486 179.955 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 7.8 mt -73.55 -52.64 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 45.5 m-85 -159.84 -8.64 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.18 179.736 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -54.96 -69.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.175 179.997 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -82.91 67.2 8.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.302 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.98 -23.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.235 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.932 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -153.22 15.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 53.8 t-80 -164.51 145.0 7.83 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.868 179.407 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -31.71 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.706 1.879 . . . . 0.0 109.99 -178.087 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 1.88 0.32 Allowed 'General case' 0 N--CA 1.413 -2.32 1 N-CA-C 95.389 -5.782 . . . . 0.0 95.389 164.922 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.515 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.71 176.895 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 41.5 m80 33.94 18.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.995 178.094 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.6 tt 175.29 -43.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-O 122.011 0.91 . . . . 0.0 109.483 179.842 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -13.89 82.68 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.325 -3.11 . . . . 0.0 105.325 174.34 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.25 -47.58 7.42 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 114.368 -0.916 . . . . 0.0 109.23 177.95 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.6 14.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 11.29 0.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.873 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 97.1 t -140.85 -9.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 17.8 t-20 106.85 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.603 1.19 . . . . 0.0 110.427 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 1.2 t-80 83.05 -1.09 1.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.216 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -76.38 -7.85 55.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.501 -179.99 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -66.97 -61.24 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.523 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.04 16.81 80.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.258 -0.496 . . . . 0.0 111.974 -179.957 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 p -166.16 101.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 0.0 110.554 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.5 mt -66.9 76.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.374 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 52.73 10.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.568 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 5' ' ' ILE . 56.5 mttm -54.35 -50.7 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.434 179.897 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.05 45.42 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.19 9.71 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.443 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 77.6 mtp180 -147.05 18.86 1.25 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.356 . . . . 0.0 110.189 179.975 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.0 m80 -151.68 147.01 26.21 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 179.636 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.034 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.93 -31.89 0.23 Allowed 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 125.678 1.861 . . . . 0.0 110.018 -178.227 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 95.426 -5.768 . . . . 0.0 95.426 165.158 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.034 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.9 tttm -115.51 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 109.409 -3.541 . . . . 0.0 111.818 177.058 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.2 t60 33.99 19.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.86 177.842 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.48 -45.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.363 -179.982 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.43 -13.99 81.28 Favored Glycine 0 C--N 1.273 -2.971 0 N-CA-C 105.406 -3.078 . . . . 0.0 105.406 174.317 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.474 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.52 9.65 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 114.495 -0.853 . . . . 0.0 109.677 178.111 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.67 41.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.176 -179.076 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.92 -19.73 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.471 -179.361 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 19' ' ' ALA . 39.4 t -149.05 -31.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 156.09 -48.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 25.4 t60 -171.54 5.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 50.5 t80 -73.62 10.53 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.475 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.6 tt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.122 -179.969 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.491 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 78.4 m95 -157.3 137.1 12.36 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.03 0.98 61.06 Favored Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.745 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.3 m -162.32 157.33 22.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.552 HG22 ' CE1' ' A' ' 6' ' ' PHE . 16.6 mm -78.54 56.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.243 179.926 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 5' ' ' ILE . 36.6 p90 42.24 19.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.295 -179.58 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' ILE . 3.0 ttmp? -87.58 -57.89 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.121 179.77 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -101.51 60.41 0.89 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.17 -19.74 0.02 OUTLIER Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.904 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.9 mtp-105 -136.48 6.46 3.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.914 0.387 . . . . 0.0 110.081 179.808 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.8 t-80 -158.88 143.64 15.88 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.427 179.537 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.37 -31.58 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.641 1.838 . . . . 0.0 109.673 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.84 0.31 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.387 -5.782 . . . . 0.0 95.387 164.838 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.6 -169.22 1.54 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.432 -3.531 . . . . 0.0 111.658 176.936 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.7 t-80 34.98 17.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.903 177.902 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.87 -46.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.413 1.101 . . . . 0.0 109.231 -179.875 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.76 79.82 Favored Glycine 0 C--N 1.272 -3.003 0 N-CA-C 105.825 -2.91 . . . . 0.0 105.825 174.627 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.82 -44.48 8.92 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.655 -0.772 . . . . 0.0 109.128 177.917 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.02 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.63 8.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.165 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 74.4 t -144.06 -9.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.386 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.0 t30 105.31 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.662 1.226 . . . . 0.0 110.14 -179.837 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 16.8 t-80 -169.38 -127.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 69.7 m-85 50.18 23.54 1.2 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.799 0.333 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.455 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.989 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -61.25 -165.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.287 . . . . 0.0 110.359 179.997 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.88 10.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.253 -179.918 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t 50.42 -177.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.47 ' C ' ' H ' ' A' ' 7' ' ' LYS . 11.8 mt -78.66 57.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.188 179.789 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 57.64 3.13 0.18 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.999 -179.832 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 5' ' ' ILE . 3.1 mmmp? -68.08 -19.76 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.16 179.795 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 58.8 t-80 -74.5 0.92 13.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.786 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.35 57.0 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.7 179.936 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -171.38 35.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.296 179.513 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.6 t-80 -169.11 145.7 3.48 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.954 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.046 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.84 -31.79 0.23 Allowed 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 125.811 1.944 . . . . 0.0 109.974 -178.306 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.74 0.3 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.327 -5.805 . . . . 0.0 95.327 165.206 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.046 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -115.94 -169.55 1.62 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.942 177.152 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.7 18.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.787 178.103 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.93 -44.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.169 0.985 . . . . 0.0 109.605 -179.871 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.91 -13.62 82.35 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 174.854 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.613 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.41 -43.19 9.35 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.831 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 160.36 11.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 11.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.697 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 21' ' ' VAL . 91.4 t -145.41 -8.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.018 -179.596 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.5 m120 100.16 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.737 1.273 . . . . 0.0 110.398 -179.597 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.7 t60 -165.14 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.2 m-85 49.13 21.45 0.5 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.756 0.313 . . . . 0.0 110.671 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.466 -179.987 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -51.6 147.81 6.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.86 0.362 . . . . 0.0 110.488 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.14 -24.56 68.5 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.107 -179.899 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -71.51 86.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.684 -179.866 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' C ' ' N ' ' A' ' 7' ' ' LYS . 9.8 mm -66.9 84.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.432 179.857 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 53.09 10.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.539 -179.97 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' N ' ' C ' ' A' ' 5' ' ' ILE . 47.0 tttp -61.4 -65.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -70.99 76.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.976 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 -27.15 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.056 -0.593 . . . . 0.0 111.99 179.972 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -127.23 12.54 7.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.396 -179.97 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 40.0 t60 -162.85 144.91 10.36 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 179.378 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -30.8 0.21 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.866 1.978 . . . . 0.0 109.75 -177.819 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.83 3.05 0.25 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 164.808 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.4 tttp -118.2 -168.31 1.5 Allowed 'General case' 0 C--N 1.394 2.517 0 CA-C-N 109.606 -3.452 . . . . 0.0 111.687 177.437 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.3 m-70 33.71 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.418 178.186 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 172.87 -43.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 179.84 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.41 78.64 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 174.703 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 22' ' ' ASN . 6.9 t-80 -92.85 -43.45 8.98 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.344 178.099 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 46.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.468 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 64.17 -18.69 0.07 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.961 -179.589 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 19' ' ' ALA . 25.7 t -148.76 -32.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.03 -179.834 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.6 t-20 158.34 -49.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.607 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -171.81 62.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.394 -179.784 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -56.63 -24.33 47.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.491 -179.889 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -61.37 -156.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.46 -37.14 94.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.726 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -68.16 115.32 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.301 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 10.1 mt -70.88 -41.87 77.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.531 -179.801 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 60.8 m-85 -158.84 5.64 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.302 179.752 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -66.7 -74.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -179.948 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -83.58 73.87 10.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.473 179.937 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.23 -30.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.159 -179.953 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -162.32 33.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.605 -179.949 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.3 t60 -160.08 144.53 14.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.412 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.032 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.78 -29.18 0.19 Allowed 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 125.521 1.763 . . . . 0.0 109.798 -177.934 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.13 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 1 N-CA-C 94.819 -5.993 . . . . 0.0 94.819 164.293 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.032 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.6 tttt -116.96 -160.28 0.76 Allowed 'General case' 0 C--N 1.397 2.657 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.637 176.967 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.553 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.7 t60 30.62 20.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.448 0.699 . . . . 0.0 112.199 178.59 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 173.14 -48.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-O 122.435 1.112 . . . . 0.0 109.228 -179.27 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.6 -13.67 71.61 Favored Glycine 0 C--N 1.27 -3.09 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 175.297 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.586 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.95 -44.5 7.33 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 114.546 -0.827 . . . . 0.0 109.455 178.216 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.46 10.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -179.943 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.61 7.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.981 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 48.5 t -144.75 -8.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.919 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 61.5 t30 102.18 -37.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.525 1.141 . . . . 0.0 110.4 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -173.8 78.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.473 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 54.3 t80 -72.88 -19.08 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.502 179.828 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.433 179.947 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -171.11 -174.31 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.57 41.29 0.36 Allowed Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.968 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -153.16 98.18 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 110.336 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 7' ' ' LYS . 17.1 mt -66.25 77.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.278 179.967 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 54.08 10.4 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 9' ' ' GLY . 29.3 mmtp -57.39 -39.83 76.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.203 179.639 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -74.07 12.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 179.931 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -164.09 37.59 0.31 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.937 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -162.08 33.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.08 0.467 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.68 ' CD2' ' N ' ' A' ' 12' ' ' ALA . 6.3 t60 -165.71 143.02 5.59 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.702 179.454 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.993 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 72.01 -30.92 0.22 Allowed 'General case' 0 CA--C 1.497 -1.069 0 O-C-N 125.632 1.833 . . . . 0.0 109.212 -177.513 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.3 0.29 Allowed 'General case' 0 N--CA 1.41 -2.467 1 N-CA-C 95.273 -5.825 . . . . 0.0 95.273 164.848 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.993 ' N ' ' C ' ' A' ' 12' ' ' ALA . 2.3 ttpm? -116.86 -169.43 1.64 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.497 -3.502 . . . . 0.0 111.621 177.056 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.638 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 48.6 t-80 33.97 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.82 177.702 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.85 -37.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.256 1.027 . . . . 0.0 109.423 -179.363 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.33 -11.29 80.8 Favored Glycine 0 C--N 1.275 -2.853 0 N-CA-C 105.029 -3.228 . . . . 0.0 105.029 174.074 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.478 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.47 -35.87 12.74 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.776 178.212 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.42 26.76 0.59 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.641 -179.619 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.27 -8.18 0.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.567 179.025 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' ALA . 60.5 t -151.48 -25.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.254 -179.355 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -171.45 -94.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.312 -179.272 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 13.8 t-160 -158.86 17.98 0.19 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.448 -179.589 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -70.96 8.33 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 16.3 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.217 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 58.31 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.649 0.261 . . . . 0.0 110.727 179.933 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 164.86 -27.68 0.2 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.855 180.0 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -77.23 92.82 3.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 -179.933 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.499 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 11.8 pt -61.69 -34.81 63.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.369 179.891 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 66.6 m-85 -160.96 -5.65 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 179.814 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 6' ' ' PHE . 52.7 tttm -49.07 -55.25 12.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.665 -179.953 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -74.62 70.42 1.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.516 179.898 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.16 -42.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.048 -179.979 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -114.66 2.98 14.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.842 0.353 . . . . 0.0 110.424 179.949 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 t60 -151.64 145.44 25.08 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.659 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.07 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.71 0.23 Allowed 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.734 1.896 . . . . 0.0 109.848 -178.008 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.91 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.422 -5.77 . . . . 0.0 95.422 165.085 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.07 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.51 -169.18 1.53 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.424 -3.534 . . . . 0.0 111.744 177.081 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.7 t60 33.92 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.816 177.966 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.24 -46.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.288 1.042 . . . . 0.0 109.306 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.61 -14.01 79.94 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 174.517 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.02 9.99 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.624 178.21 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.28 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.251 -179.054 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.48 -18.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.523 -179.435 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.9 t -148.29 -32.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.908 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.0 t-20 155.19 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.982 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -164.2 65.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.621 -179.866 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.51 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 62.0 t80 -50.84 -14.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -66.75 -61.24 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.25 15.15 56.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.073 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -165.79 56.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 0.0 110.492 179.992 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 6' ' ' PHE . 17.7 tt -82.22 -43.88 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.758 -179.905 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' N ' HG23 ' A' ' 5' ' ' ILE . 51.0 p90 -90.97 -35.74 14.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.954 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -51.4 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.914 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.9 65.34 3.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.303 179.791 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.97 -30.69 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -153.7 28.05 0.49 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.849 0.356 . . . . 0.0 110.366 179.907 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.2 t60 -163.61 146.15 9.77 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.376 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.075 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -31.62 0.23 Allowed 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 125.775 1.922 . . . . 0.0 109.956 -178.072 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.13 0.29 Allowed 'General case' 0 N--CA 1.411 -2.385 1 N-CA-C 95.341 -5.8 . . . . 0.0 95.341 164.995 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.075 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.96 -169.33 1.58 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.825 177.012 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.0 t60 33.95 18.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.991 178.169 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.18 -42.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 CA-C-O 122.093 0.949 . . . . 0.0 109.459 179.817 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.39 -13.29 83.72 Favored Glycine 0 C--N 1.276 -2.77 0 N-CA-C 105.355 -3.098 . . . . 0.0 105.355 174.168 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.539 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.01 -46.46 7.14 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.615 178.15 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.4 10.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.63 -179.764 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.15 10.36 1.21 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.722 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 21' ' ' VAL . 66.0 t -148.87 -8.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.628 -179.723 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.4 m-20 96.48 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.545 1.153 . . . . 0.0 110.169 -179.555 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -172.54 93.15 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.524 179.969 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.47 11.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.836 -179.812 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -52.12 174.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 110.595 179.996 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.35 -14.17 77.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.898 179.915 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' PHE . 78.1 p 49.21 78.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 110.781 -179.973 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.8 mm -60.82 79.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 4' ' ' SER . 37.2 m-85 53.06 10.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.621 -179.863 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 5' ' ' ILE . 62.1 tttm -61.19 -38.51 86.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.329 179.99 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -65.3 -0.4 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.041 179.663 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -143.48 -164.53 10.35 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.825 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.06 -118.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.472 -179.973 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -79.13 72.93 5.7 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.986 0.898 . . . . 0.0 110.056 -179.915 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.975 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.276 . . 174.81 -32.06 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 112.635 -2.075 . . . . 0.0 106.782 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -2.62 0.79 Allowed 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 164.663 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.975 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.252 20.5 tttm -112.75 -168.13 1.28 Allowed 'General case' 0 C--N 1.389 2.314 0 CA-C-N 109.206 -3.634 . . . . 0.0 112.13 176.515 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 44.9 m80 34.23 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.812 177.879 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 175.47 -47.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.855 0 CA-C-O 122.269 1.033 . . . . 0.0 109.158 -179.749 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.88 -14.15 78.56 Favored Glycine 0 C--N 1.274 -2.903 0 N-CA-C 105.636 -2.985 . . . . 0.0 105.636 174.736 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.448 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.92 -44.02 9.63 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.673 178.059 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.14 42.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.321 -179.084 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 65.81 -15.9 0.11 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.602 -179.435 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.4 t -148.79 -35.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.9 t30 154.78 -44.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.911 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.6 t60 -168.83 50.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.519 -179.88 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -64.52 -28.34 69.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.228 -179.924 . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -62.41 -176.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 -179.933 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.83 16.06 52.49 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.915 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.622 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 26.2 m -149.04 86.6 1.5 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 110.52 -179.87 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -81.27 -16.92 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.975 179.955 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' H ' ' H ' ' A' ' 7' ' ' LYS . 45.2 p90 -160.56 -19.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 6' ' ' PHE . 61.9 mttp -49.15 -46.96 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 179.983 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.622 ' CE1' ' O ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -78.35 47.72 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.94 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.81 -9.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.144 -179.942 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 79.4 mtt-85 -136.19 15.86 3.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.8 m80 -157.53 144.04 17.92 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.369 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.999 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.23 0.22 Allowed 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 125.603 1.814 . . . . 0.0 109.485 -177.823 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.41 1.87 0.31 Allowed 'General case' 0 N--CA 1.41 -2.428 1 N-CA-C 95.35 -5.796 . . . . 0.0 95.35 164.981 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.999 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.9 ttpt -115.54 -169.58 1.61 Allowed 'General case' 0 C--N 1.394 2.519 0 CA-C-N 109.399 -3.546 . . . . 0.0 111.655 177.012 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.7 t-80 34.44 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.079 178.092 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tp 176.33 -46.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.643 0 CA-C-O 122.371 1.082 . . . . 0.0 109.074 -179.924 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.55 -14.69 77.53 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 174.409 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.62 -48.71 7.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.325 -0.938 . . . . 0.0 108.885 177.823 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.4 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.995 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.18 9.99 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.938 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.3 t -139.07 -10.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.774 -179.698 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.0 t-20 108.44 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.63 1.206 . . . . 0.0 110.586 179.855 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 8.8 t60 80.08 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.171 -179.61 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -79.54 -15.76 57.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.746 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.401 -179.683 . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -52.44 -38.66 59.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 110.668 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.65 25.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.683 -179.7 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -68.81 114.77 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 110.494 179.965 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.7 mt -85.42 -29.14 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.05 3.77 18.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.938 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 9' ' ' GLY . 18.7 ttpp 54.19 103.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.487 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.437 ' CD2' ' N ' ' A' ' 8' ' ' HIS . 3.5 m170 65.48 -2.85 0.75 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.95 179.558 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -86.36 1.08 87.4 Favored Glycine 0 C--N 1.329 0.143 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 11' ' ' HIS . 9.3 ptm180 -170.28 -3.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.096 -179.865 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 67.0 t60 -102.91 147.49 26.85 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.289 179.454 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.52 -31.57 0.22 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.716 1.885 . . . . 0.0 110.099 -178.085 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.89 0.31 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.318 -5.808 . . . . 0.0 95.318 165.052 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.6 tttm -116.23 -169.0 1.53 Allowed 'General case' 0 C--N 1.393 2.473 0 CA-C-N 109.315 -3.584 . . . . 0.0 111.773 176.971 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 48.2 t-80 35.02 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.784 177.96 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 174.64 -42.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.044 0.926 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.52 -13.36 83.52 Favored Glycine 0 C--N 1.275 -2.859 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.645 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.596 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.79 -44.2 7.88 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 114.634 -0.783 . . . . 0.0 109.738 178.189 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.26 12.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.501 -179.878 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.17 9.15 0.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.098 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.4 t -147.91 -9.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.142 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.5 t-20 101.79 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.544 1.152 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 86.0 m-70 -160.58 109.67 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.466 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 77.8 t80 -74.13 11.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.295 179.64 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.1 tp . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.433 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 71.3 t-105 -168.6 5.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 2' ' ' TRP . . . 62.56 11.88 37.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.951 -179.92 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 t 56.57 -179.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.57 179.995 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.9 pt -77.96 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 -179.975 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 67.36 -7.15 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 5' ' ' ILE . 63.5 tttm -44.55 -47.67 10.23 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.934 179.985 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -84.38 63.01 7.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' N ' ' CB ' ' A' ' 13' ' ' ALA . . . 171.93 -23.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.36 179.859 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -75.19 -118.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 31.1 m-70 -90.96 145.02 25.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.933 179.996 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.12 -31.9 0.23 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.635 1.834 . . . . 0.0 109.99 -178.138 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.19 0.93 0.36 Allowed 'General case' 0 N--CA 1.412 -2.33 1 N-CA-C 95.297 -5.816 . . . . 0.0 95.297 164.978 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.8 tttt -114.47 -169.4 1.53 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.24 -3.618 . . . . 0.0 111.87 176.621 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.6 m80 34.92 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.922 177.999 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 175.58 -43.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.114 0.959 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.72 -13.41 83.06 Favored Glycine 0 C--N 1.272 -2.977 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 174.668 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.33 -43.64 9.15 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.062 177.944 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.23 12.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.958 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.13 8.29 1.02 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.7 t -145.83 -8.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.128 -179.844 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.7 t30 103.99 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.502 1.126 . . . . 0.0 109.996 -179.739 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -173.26 103.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.479 179.743 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' H ' ' H ' ' A' ' 25' ' ' LEU . 84.1 t80 -171.58 -7.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.938 179.897 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 24' ' ' TYR . 34.4 mt . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 179.812 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -70.74 131.52 43.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 -179.999 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.96 2.03 71.38 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.011 179.909 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.2 m -163.34 161.89 24.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.954 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 6' ' ' PHE . 17.6 tt -161.16 -41.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.409 179.903 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' N ' HG23 ' A' ' 5' ' ' ILE . 45.0 p90 -99.11 -18.73 17.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.567 179.939 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.72 -60.53 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.444 179.813 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -78.51 50.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.92 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.59 -32.51 0.02 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.972 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -112.81 -0.84 14.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.988 0.423 . . . . 0.0 109.973 179.634 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 92.6 m-70 -140.62 145.41 36.61 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.449 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.01 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.67 -31.54 0.23 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.584 1.803 . . . . 0.0 109.571 -177.786 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.1 0.28 Allowed 'General case' 0 N--CA 1.412 -2.334 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 164.951 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.01 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.14 -169.24 1.57 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.395 -3.548 . . . . 0.0 111.585 177.062 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.9 t-80 34.67 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.028 178.066 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 175.78 -42.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.159 0.98 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.41 -13.57 83.25 Favored Glycine 0 C--N 1.275 -2.824 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 174.278 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.1 -46.01 8.36 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.299 -0.95 . . . . 0.0 109.066 177.957 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.49 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.845 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.11 9.32 0.94 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.103 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 89.5 t -142.83 -9.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.367 -179.843 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 25.7 t30 105.44 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.581 1.176 . . . . 0.0 110.104 -179.954 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.581 ' ND1' ' N ' ' A' ' 24' ' ' TYR . 49.8 t-80 -162.19 -100.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.581 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 62.3 t80 51.97 14.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' N ' ' C ' ' A' ' 23' ' ' HIS . 13.0 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -179.989 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 94.7 m95 -157.96 -77.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.408 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.89 27.75 73.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 111.892 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.0 p -167.31 77.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.988 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' CE1' ' A' ' 6' ' ' PHE . 12.0 mt -66.59 -31.29 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.412 179.902 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.457 ' CE1' HG22 ' A' ' 5' ' ' ILE . 70.9 m-85 -153.33 -10.16 0.16 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 179.982 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -51.71 -75.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.787 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.67 68.06 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.464 179.798 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 -21.41 0.02 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.042 -179.896 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -162.01 17.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 37.5 m80 -135.42 146.29 48.13 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.518 179.663 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.65 -31.1 0.21 Allowed 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.691 1.869 . . . . 0.0 109.761 -177.985 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.59 2.07 0.31 Allowed 'General case' 0 N--CA 1.411 -2.384 1 N-CA-C 95.381 -5.785 . . . . 0.0 95.381 164.85 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.8 tttp -116.11 -168.95 1.51 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.486 -3.506 . . . . 0.0 111.627 176.941 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 69.2 m-70 34.56 18.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.945 178.079 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.89 -42.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.096 0.95 . . . . 0.0 109.628 179.923 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.51 -12.74 84.24 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.545 -3.022 . . . . 0.0 105.545 174.457 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.63 -44.19 8.31 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.258 177.969 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.99 10.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.31 10.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.829 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 21' ' ' VAL . 97.5 t -147.78 -8.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.046 -179.58 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.6 m120 98.13 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.581 1.175 . . . . 0.0 110.192 -179.512 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 84.3 m-70 -157.84 107.67 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.436 -179.925 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -61.25 -13.63 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.994 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.001 -179.969 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -60.98 -75.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.667 179.985 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.7 59.52 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.009 179.973 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.7 p -55.87 110.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 5' ' ' ILE . 12.9 tt -67.06 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.231 0.539 . . . . 0.0 110.491 -179.963 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 47.3 55.96 7.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.85 -179.787 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 55.05 63.8 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.99 179.882 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 5.7 m80 45.92 26.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.983 179.637 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.13 53.95 4.0 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.974 -179.978 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER 55.94 31.1 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.341 0.115 . . . . 0.0 110.811 179.728 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 9.4 m-70 -115.96 71.69 0.79 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.922 0.868 . . . . 0.0 110.333 179.388 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.02 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 168.73 -31.9 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.503 -2.135 . . . . 0.0 105.85 -179.655 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.75 -2.29 0.8 Allowed 'General case' 0 N--CA 1.414 -2.256 1 N-CA-C 95.458 -5.756 . . . . 0.0 95.458 164.313 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.02 ' N ' ' C ' ' A' ' 12' ' ' ALA . 35.0 tttt -112.84 -168.56 1.34 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 109.277 -3.601 . . . . 0.0 111.83 176.408 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.656 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.6 t-80 34.52 17.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.004 178.04 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.52 -44.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-O 122.124 0.964 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.19 -13.63 82.6 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 174.56 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.6 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.55 -44.79 9.34 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.683 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.44 11.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.786 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.31 11.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.684 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 21' ' ' VAL . 97.9 t -144.73 -8.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 14.4 m-20 100.68 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.768 1.293 . . . . 0.0 110.698 -179.837 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 90.8 m-70 -158.09 -94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 62.2 t80 57.25 8.52 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.652 -179.822 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.336 179.876 . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.021 -0.431 . . . . 0.0 112.021 . . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 56.05 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 0.0 110.713 -179.95 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 179.11 -4.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.755 -179.999 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.431 ' H ' ' H ' ' A' ' 3' ' ' GLY . 49.3 p -173.13 113.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 pt -67.75 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.995 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.53 -7.5 58.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.878 0.371 . . . . 0.0 110.353 179.963 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 9' ' ' GLY . 61.5 tttm -57.03 -39.57 75.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.836 -179.854 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.94 77.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -179.865 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' LYS . . . 42.38 81.71 0.03 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.493 179.848 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -167.22 11.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 110.28 179.953 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.54 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.2 p-80 -140.12 145.19 37.28 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 179.812 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.011 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.56 -29.6 0.19 Allowed 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 125.513 1.758 . . . . 0.0 110.117 -178.336 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.43 1.15 0.57 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 94.73 -6.026 . . . . 0.0 94.73 164.382 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.011 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.5 ttmt -114.71 -158.51 0.67 Allowed 'General case' 0 C--N 1.397 2.644 0 CA-C-N 109.286 -3.597 . . . . 0.0 110.106 176.268 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.569 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.0 t60 28.41 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 112.262 177.955 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 168.33 -52.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-O 122.463 1.125 . . . . 0.0 109.224 -179.143 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' H ' HG23 ' A' ' 16' ' ' ILE . . . -68.05 -12.8 63.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 176.034 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -32.85 16.87 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.375 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' CB ' ' N ' ' A' ' 24' ' ' TYR . . . -167.56 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.51 -21.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.878 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.445 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 60.2 t -151.98 -18.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.025 179.905 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 166.35 -39.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.547 0.529 . . . . 0.0 110.045 -179.785 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -160.95 126.58 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 111.291 -178.616 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 75.2 t80 -66.92 -5.1 11.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.06 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.469 179.91 . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 3' ' ' GLY . 8.5 t90 54.77 -173.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.977 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 2' ' ' TRP . . . -56.96 -18.87 27.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.7 179.967 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 m -68.59 139.21 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.504 179.834 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt -75.14 67.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 -179.858 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 50.94 20.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -71.63 -66.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.398 179.97 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -93.66 70.23 4.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.382 179.838 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.96 -23.86 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.941 -179.932 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 12.7 ptm180 -167.6 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.5 m80 -158.48 145.22 17.45 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 179.412 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.027 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.39 -30.94 0.22 Allowed 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 125.698 1.874 . . . . 0.0 109.535 -177.729 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.8 2.82 0.26 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.78 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.027 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -117.52 -168.5 1.5 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.562 -3.472 . . . . 0.0 111.689 177.159 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 37.8 m80 34.09 20.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.917 178.09 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.663 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 174.35 -42.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 122.339 1.066 . . . . 0.0 108.831 179.713 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.31 -13.05 83.99 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 105.687 -2.965 . . . . 0.0 105.687 174.398 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.605 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 4.5 m170 -103.02 -7.66 21.24 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.023 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 18' ' ' HIS . . . 82.53 22.04 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.239 -179.123 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.65 14.19 0.16 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.874 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.2 t -151.58 -11.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.623 -179.119 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.1 t-20 104.79 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.282 0.989 . . . . 0.0 110.473 -179.657 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 34.2 p-80 -169.79 117.51 0.59 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -67.6 -0.99 4.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.225 179.65 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.378 179.892 . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -51.06 -71.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.6 179.957 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.64 -29.6 0.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.952 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.1 p 49.74 -175.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.98 -29.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.931 179.936 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 7' ' ' LYS . 27.8 p90 -168.43 -12.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.257 179.714 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 6' ' ' PHE . 62.7 tttp -70.99 -20.29 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.387 179.884 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 55.5 t-80 -79.46 52.49 1.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.646 -179.987 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.56 83.55 0.23 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.205 179.858 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -164.9 -3.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.445 . . . . 0.0 109.954 179.81 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.2 t-80 -151.2 143.67 24.24 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.232 179.264 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.018 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.9 -31.34 0.22 Allowed 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.624 1.828 . . . . 0.0 109.436 -177.583 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.69 2.49 0.29 Allowed 'General case' 0 N--CA 1.412 -2.374 1 N-CA-C 95.431 -5.766 . . . . 0.0 95.431 164.844 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.018 ' N ' ' C ' ' A' ' 12' ' ' ALA . 15.3 ttpt -116.65 -169.01 1.55 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.455 -3.52 . . . . 0.0 111.456 176.97 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.64 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.2 m80 34.25 20.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.79 177.9 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.659 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.21 -37.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-O 122.364 1.078 . . . . 0.0 109.316 -179.311 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.51 -11.1 80.74 Favored Glycine 0 C--N 1.277 -2.745 0 N-CA-C 105.088 -3.205 . . . . 0.0 105.088 174.082 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.484 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -94.99 -33.94 12.55 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.407 -0.896 . . . . 0.0 109.973 178.275 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.47 23.74 0.71 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.834 -178.968 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.01 -0.34 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.244 179.322 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 19' ' ' ALA . 45.0 t -152.48 -27.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 121.5 -0.08 . . . . 0.0 110.952 -179.41 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' A' ' 22' ' ' ASN . 1.6 p30 176.17 -85.94 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 111.554 -179.354 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -146.95 126.05 12.9 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 -178.837 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 75.4 t80 -73.72 -3.92 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.187 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.332 -0.196 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.495 179.903 . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -55.5 -91.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.53 -9.85 0.13 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -179.962 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -165.43 101.66 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt -69.68 75.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.605 -179.738 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 53.44 26.46 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.736 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -73.84 -63.41 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.235 179.665 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.38 66.55 2.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.91 -24.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.197 -179.948 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -154.7 26.18 0.44 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.88 0.372 . . . . 0.0 110.386 179.953 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t-80 -161.9 146.81 12.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.565 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.72 -31.82 0.23 Allowed 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 125.775 1.922 . . . . 0.0 110.043 -178.271 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.1 0.29 Allowed 'General case' 0 N--CA 1.413 -2.302 1 N-CA-C 95.342 -5.799 . . . . 0.0 95.342 165.157 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.5 tttt -116.17 -168.95 1.52 Allowed 'General case' 0 C--N 1.393 2.46 0 CA-C-N 109.502 -3.499 . . . . 0.0 111.648 177.018 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 34.33 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.885 177.983 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 174.6 -43.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.137 0.97 . . . . 0.0 109.547 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.36 -13.22 83.58 Favored Glycine 0 C--N 1.274 -2.862 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 174.47 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.25 -45.06 8.02 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.176 177.964 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.18 13.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.86 9.54 0.91 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.131 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 83.3 t -146.37 -9.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.332 -179.762 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 40.9 t-20 103.2 -36.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.511 1.132 . . . . 0.0 110.066 -179.784 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 91.1 m-70 -160.43 106.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 67.6 t80 -59.72 -15.09 17.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.72 -67.68 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 179.989 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 169.39 -3.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.956 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.402 ' H ' ' H ' ' A' ' 3' ' ' GLY . 8.2 m 52.91 75.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.669 179.937 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.4 mt -62.64 -28.61 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.049 179.792 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' NH2' ' A' ' 10' ' ' ARG . 94.6 m-85 -76.99 26.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.581 179.92 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' C ' ' N ' ' A' ' 9' ' ' GLY . 43.7 mttp 53.84 77.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 47.96 14.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.982 179.729 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . 79.6 73.77 1.12 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.594 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 10.2 mpt_? 55.76 46.1 23.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 110.815 179.552 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 79.2 m-70 -153.28 94.82 1.87 Allowed 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.239 0.543 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.008 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 132.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.03 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 0.23 0.55 Allowed 'General case' 0 N--CA 1.413 -2.297 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.649 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.008 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.6 tttt -115.89 -168.34 1.41 Allowed 'General case' 0 C--N 1.393 2.479 0 CA-C-N 109.504 -3.498 . . . . 0.0 111.641 176.885 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.647 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 94.3 m-70 33.73 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.836 178.257 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.78 -43.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.089 0.947 . . . . 0.0 109.596 179.88 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.35 -13.29 83.5 Favored Glycine 0 C--N 1.274 -2.893 0 N-CA-C 105.582 -3.007 . . . . 0.0 105.582 174.67 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.583 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.97 -44.76 7.91 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-N 114.538 -0.831 . . . . 0.0 109.335 177.947 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.22 10.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.899 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.75 10.7 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.839 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 21' ' ' VAL . 77.3 t -146.94 -8.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.848 -179.682 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.8 m-20 98.61 -36.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.729 1.268 . . . . 0.0 110.104 -179.539 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.6 p-80 -173.18 101.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 74.9 t80 -62.41 -10.13 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.485 179.996 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.061 -179.941 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -54.61 -19.77 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.88 15.39 73.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.776 -179.969 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.5 m -164.59 59.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 110.412 -179.952 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 5' ' ' ILE . 14.0 tt -60.01 105.45 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.16 0.505 . . . . 0.0 110.342 -179.89 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 44.69 17.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 -179.791 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 5' ' ' ILE . 84.1 tttt -68.82 -57.31 5.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.277 179.885 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -83.83 40.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.552 179.788 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 27.3 0.09 OUTLIER Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.026 -179.955 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -169.15 18.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 109.994 179.941 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 75.9 m80 -143.53 146.1 33.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.767 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.987 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.5 -29.88 0.19 Allowed 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 125.59 1.806 . . . . 0.0 110.237 -178.506 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.26 1.08 0.54 Allowed 'General case' 0 N--CA 1.411 -2.412 1 N-CA-C 94.814 -5.995 . . . . 0.0 94.814 164.541 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.987 ' N ' ' C ' ' A' ' 12' ' ' ALA . 7.9 tttm -115.11 -158.86 0.69 Allowed 'General case' 0 C--N 1.394 2.527 0 CA-C-N 109.149 -3.659 . . . . 0.0 110.175 176.397 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.568 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.7 t60 29.04 23.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 112.187 177.692 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 167.43 -52.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 CA-C-O 122.369 1.081 . . . . 0.0 109.194 -179.067 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.73 63.3 Favored Glycine 0 C--N 1.269 -3.14 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.185 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.92 -33.05 16.57 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.36 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.85 -65.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.788 179.529 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.29 -22.33 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.878 -179.693 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 t -150.6 -18.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 170.03 -38.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.237 0.336 . . . . 0.0 110.274 -179.687 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 27.3 t60 -171.72 -136.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.109 -178.99 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 76.5 m-85 53.14 27.11 5.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.0 110.765 179.773 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.036 179.993 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -59.24 -22.64 61.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.72 4.17 69.93 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 -179.925 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.4 p -70.31 109.92 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 7' ' ' LYS . 11.2 mm -75.6 66.8 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.27 4.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 5' ' ' ILE . 28.3 mmtp -63.14 -55.47 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.33 179.909 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.444 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 21.9 t60 -79.17 32.71 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.566 179.924 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -168.73 22.5 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.093 179.956 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -165.62 14.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.448 . . . . 0.0 110.158 179.891 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 54.0 t-80 -153.52 147.84 25.9 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.135 0.493 . . . . 0.0 110.909 179.583 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.054 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.34 -31.71 0.22 Allowed 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.905 2.003 . . . . 0.0 110.211 -178.25 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.316 1 N-CA-C 95.344 -5.799 . . . . 0.0 95.344 165.152 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.054 ' N ' ' C ' ' A' ' 12' ' ' ALA . 19.6 tttm -116.49 -168.73 1.49 Allowed 'General case' 0 C--N 1.392 2.423 0 CA-C-N 109.44 -3.527 . . . . 0.0 111.592 177.124 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.6 t60 34.75 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.834 177.881 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 174.25 -44.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 122.116 0.96 . . . . 0.0 109.633 -179.84 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.89 -13.68 82.27 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.681 -2.968 . . . . 0.0 105.681 174.718 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.603 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.67 -45.58 7.64 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 114.515 -0.843 . . . . 0.0 109.309 178.089 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.71 13.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.79 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.69 7.16 0.99 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.272 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 61.2 t -145.41 -9.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.493 -179.868 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 10.4 t-20 105.37 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.479 1.112 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.561 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 1.8 t60 -171.49 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.313 179.903 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.561 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.4 m-85 49.24 18.76 0.27 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 110.597 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -54.63 -70.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.457 -179.831 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.56 -8.04 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.001 179.969 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -169.81 73.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.769 0.319 . . . . 0.0 110.539 -179.978 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 mt -78.9 -40.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.564 -179.868 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.49 35.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.735 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mttp 53.1 69.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.733 179.851 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m80 48.43 21.91 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.69 179.842 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.517 ' C ' ' HE ' ' A' ' 10' ' ' ARG . . . 76.06 59.27 3.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.313 -0.47 . . . . 0.0 111.977 -179.973 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HE ' ' C ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER 55.3 40.35 31.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.966 0.412 . . . . 0.0 110.131 -179.974 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -148.14 72.76 1.23 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.289 1.042 . . . . 0.0 110.173 178.987 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.043 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.274 . . 172.98 -30.82 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 112.133 -2.303 . . . . 0.0 106.179 179.966 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -0.73 0.55 Allowed 'General case' 0 N--CA 1.415 -2.192 1 N-CA-C 95.502 -5.74 . . . . 0.0 95.502 164.354 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.043 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.255 19.6 tttp -116.43 -167.06 1.22 Allowed 'General case' 0 C--N 1.389 2.285 0 CA-C-N 109.258 -3.61 . . . . 0.0 111.716 177.112 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.2 t60 34.73 18.99 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.875 177.862 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.84 -40.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 CA-C-O 122.141 0.972 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.15 83.61 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 105.596 -3.002 . . . . 0.0 105.596 174.487 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.614 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 5.5 m170 -103.64 -7.65 20.56 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.978 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 18' ' ' HIS . . . 84.52 20.3 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.389 -179.296 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.18 14.41 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 84.5 t -152.43 -10.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.455 -178.966 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.2 t-20 101.05 -34.84 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.14 0.9 . . . . 0.0 109.956 -179.308 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -171.57 101.5 0.19 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.602 -179.83 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' H ' ' H ' ' A' ' 25' ' ' LEU . 74.8 t80 -163.25 -1.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.287 179.845 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 24' ' ' TYR . 1.3 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.251 179.819 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 51.09 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.86 -13.93 57.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.812 179.899 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 m -58.17 112.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.581 -179.993 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 mt -67.29 -36.58 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.193 179.76 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -169.31 -11.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -52.41 -61.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 179.906 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 0.8 OUTLIER -81.08 37.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.392 179.82 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.09 21.04 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -179.89 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' NH2' ' NE2' ' A' ' 11' ' ' HIS . 45.1 ttp85 -166.6 17.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 109.971 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' NE2' ' NH2' ' A' ' 10' ' ' ARG . 82.9 m-70 -146.95 147.17 30.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.423 179.577 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.21 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.727 1.892 . . . . 0.0 109.986 -178.121 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.94 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.434 -5.765 . . . . 0.0 95.434 165.194 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.023 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.3 tttp -116.04 -169.49 1.61 Allowed 'General case' 0 C--N 1.392 2.442 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.629 177.146 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.8 t60 34.89 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.946 177.861 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 175.62 -42.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.178 0.99 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.99 -13.39 83.73 Favored Glycine 0 C--N 1.276 -2.801 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 174.238 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.19 -45.77 8.46 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 114.454 -0.873 . . . . 0.0 109.001 177.884 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.21 13.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.841 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.29 9.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.24 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 63.8 t -145.31 -8.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.335 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.6 t30 102.96 -36.28 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.526 1.142 . . . . 0.0 109.746 -179.49 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -172.52 97.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.483 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 60.1 t80 -163.67 -0.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.387 -179.925 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.405 ' H ' ' H ' ' A' ' 24' ' ' TYR . 13.1 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.615 179.965 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -56.56 147.0 23.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.04 -33.31 85.09 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -77.65 111.23 13.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.531 179.956 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.88 75.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.337 179.87 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 53.54 14.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -72.2 -61.81 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.197 179.821 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 1.7 m-70 -79.96 62.8 4.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.911 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.61 -21.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.998 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -125.41 6.33 7.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.856 0.36 . . . . 0.0 110.12 179.949 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.9 m80 -151.54 146.24 25.74 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.712 179.657 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -31.92 0.24 Allowed 'General case' 0 CA--C 1.498 -1.058 0 O-C-N 125.757 1.911 . . . . 0.0 109.839 -178.004 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.51 2.37 0.28 Allowed 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 95.441 -5.763 . . . . 0.0 95.441 165.142 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.04 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -116.58 -169.07 1.56 Allowed 'General case' 0 C--N 1.391 2.407 0 CA-C-N 109.445 -3.525 . . . . 0.0 111.697 177.055 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.7 m80 33.92 21.23 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.788 177.598 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 170.21 -37.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.292 1.044 . . . . 0.0 109.33 -179.458 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.84 -11.64 81.17 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.052 -3.219 . . . . 0.0 105.052 174.07 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.471 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -93.54 -36.17 12.55 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 114.277 -0.961 . . . . 0.0 109.981 178.267 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.2 26.18 0.7 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.643 -179.58 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.41 -7.69 0.1 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.054 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 19' ' ' ALA . 52.3 t -151.08 -24.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.353 -179.413 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 4.7 p30 -177.02 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.368 -179.291 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.566 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.0 t-160 -158.2 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.362 -179.461 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.566 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 86.2 m-85 48.79 17.44 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.319 . . . . 0.0 110.721 179.793 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.407 ' N ' ' C ' ' A' ' 23' ' ' HIS . 12.0 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.465 179.998 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -72.38 158.11 36.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 110.557 179.937 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.14 70.04 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.114 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 6' ' ' PHE . 76.5 p 50.15 71.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.476 -179.957 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.7 mm -59.84 79.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.431 -179.827 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 4' ' ' SER . 98.9 m-85 53.94 15.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.746 179.736 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.42 -68.14 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -81.84 57.88 3.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.433 179.909 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.06 15.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.046 179.985 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 52.3 ttt180 -164.55 3.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.52 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.6 m-70 -137.25 147.64 45.9 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 179.666 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.82 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.809 1.943 . . . . 0.0 109.996 -178.073 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.27 0.29 Allowed 'General case' 0 N--CA 1.412 -2.357 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.033 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.6 tttm -116.2 -169.29 1.58 Allowed 'General case' 0 C--N 1.392 2.414 0 CA-C-N 109.476 -3.511 . . . . 0.0 111.718 177.032 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.641 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.6 t-80 34.55 18.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.896 177.984 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.09 -42.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.123 0.963 . . . . 0.0 109.707 180.0 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.96 -13.68 83.41 Favored Glycine 0 C--N 1.276 -2.8 0 N-CA-C 105.433 -3.067 . . . . 0.0 105.433 174.229 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.09 -47.04 6.55 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.422 -0.889 . . . . 0.0 110.002 178.207 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.62 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.741 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.03 8.42 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.24 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 64.6 t -145.89 -9.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.171 179.967 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.06 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.657 1.223 . . . . 0.0 110.281 -179.98 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -167.93 94.88 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.493 -179.908 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 58.9 t80 -162.95 0.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.242 179.996 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.446 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 95.8 m95 -158.74 -174.57 4.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 110.479 179.945 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.34 27.68 0.23 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 -179.986 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -170.48 92.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.994 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.7 tt -70.2 -40.58 78.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.451 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 44.8 m-85 -161.58 -8.74 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.897 179.231 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -47.49 -71.5 0.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.669 -179.937 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -75.27 68.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.15 -17.88 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.923 179.993 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -159.52 23.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 110.419 179.98 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 13' ' ' ALA . 57.8 t-80 -159.78 146.35 16.2 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.722 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.035 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.7 -31.7 0.23 Allowed 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 125.712 1.883 . . . . 0.0 110.02 -178.219 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.411 -2.394 1 N-CA-C 95.397 -5.779 . . . . 0.0 95.397 165.071 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.035 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.0 tttt -115.98 -169.21 1.55 Allowed 'General case' 0 C--N 1.394 2.524 0 CA-C-N 109.345 -3.571 . . . . 0.0 111.818 177.091 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m80 34.43 18.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.846 178.144 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.64 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 CA-C-O 122.068 0.937 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.0 -13.66 82.47 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.72 -2.952 . . . . 0.0 105.72 174.781 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.601 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.83 -44.53 8.44 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.162 177.964 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.46 11.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.994 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.51 10.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 21' ' ' VAL . 93.1 t -145.68 -8.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.876 -179.549 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.7 m-20 99.04 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.72 1.263 . . . . 0.0 110.239 -179.622 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -168.64 97.23 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.473 179.968 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.4 t80 -165.89 0.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.308 -179.886 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -179.98 . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -70.72 6.11 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.473 -179.96 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 71.09 1.66 42.5 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.975 179.934 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m 54.91 -179.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.768 0.318 . . . . 0.0 110.484 179.967 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 6' ' ' PHE . 7.1 mt -75.31 -49.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.479 -179.882 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD2' HG22 ' A' ' 5' ' ' ILE . 56.4 m-85 -156.66 -4.2 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.247 179.822 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -50.39 -74.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.39 179.945 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -80.42 65.92 5.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.335 179.689 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.36 -16.9 0.03 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.151 -179.826 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.494 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 13.0 ptm180 -160.06 22.33 0.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.699 179.843 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.557 ' C ' ' H ' ' A' ' 13' ' ' ALA . 65.4 m-70 -148.25 144.89 27.96 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.493 179.481 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.46 -28.96 0.18 Allowed 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 125.632 1.832 . . . . 0.0 109.777 -177.989 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.33 2.08 0.43 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 94.793 -6.003 . . . . 0.0 94.793 164.209 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 6.0 ttmt -116.68 -160.65 0.77 Allowed 'General case' 0 C--N 1.398 2.686 0 CA-C-N 109.314 -3.585 . . . . 0.0 110.647 177.062 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.56 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.1 t-80 30.16 21.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 112.222 178.659 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 173.17 -47.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-O 122.231 1.015 . . . . 0.0 109.509 -179.453 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.53 -13.73 74.49 Favored Glycine 0 C--N 1.271 -3.077 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 175.107 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -96.53 -46.39 6.36 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 114.432 -0.884 . . . . 0.0 109.775 178.366 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.96 11.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.632 -179.744 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.19 8.27 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.042 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 44.6 t -148.23 -9.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.883 179.948 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.5 t-20 100.47 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.515 1.134 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 78.6 m80 -159.74 120.56 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.668 -179.622 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -55.57 -10.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.13 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.1 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 38.5 t90 -68.08 -62.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 -179.921 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.88 -9.48 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.998 -179.967 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m -161.63 93.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -179.942 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 6' ' ' PHE . 3.9 tp -59.84 -43.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.205 -179.905 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' N ' HG23 ' A' ' 5' ' ' ILE . 54.6 m-85 -161.33 25.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.219 179.422 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -73.25 -43.03 61.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.743 -179.914 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.57 52.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.17 -6.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.863 -179.955 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -145.54 11.08 1.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.982 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.8 t-80 -156.12 145.08 20.42 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 179.515 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.997 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.85 -30.91 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.736 1.898 . . . . 0.0 109.801 -177.948 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.13 0.3 Allowed 'General case' 0 N--CA 1.41 -2.438 1 N-CA-C 95.288 -5.819 . . . . 0.0 95.288 164.749 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.997 ' N ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.13 -168.56 1.45 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.473 -3.512 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.0 m80 34.3 18.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.844 178.144 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.3 -46.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.21 1.005 . . . . 0.0 109.381 -179.624 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.02 -13.64 80.85 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.523 -3.031 . . . . 0.0 105.523 174.697 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.59 -43.59 9.56 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.606 178.2 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.252 -179.122 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.14 -16.15 0.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.676 -179.445 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.2 t -148.91 -35.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.931 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 156.03 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.782 0.676 . . . . 0.0 109.223 -179.953 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 37.9 t-80 -162.34 29.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.696 -179.695 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.461 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 64.1 t80 -77.0 -7.02 54.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.476 -179.881 . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 57.56 171.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.48 -3.85 55.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.162 -0.542 . . . . 0.0 111.966 -179.966 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.2 p -69.17 87.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.526 179.971 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.02 -31.39 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.387 179.943 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -168.26 -0.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.998 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -51.16 -86.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -76.34 64.84 2.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.539 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.9 -18.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.007 -179.88 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -148.42 12.86 0.94 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.2 t-80 -158.21 145.81 18.23 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.033 0.444 . . . . 0.0 110.915 179.564 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.98 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.91 -31.92 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.721 1.888 . . . . 0.0 109.975 -178.175 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.91 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.405 -5.776 . . . . 0.0 95.405 165.09 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.98 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttp -115.48 -169.6 1.61 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.436 -3.529 . . . . 0.0 111.806 176.953 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.0 t-80 34.47 18.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.015 178.021 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 176.13 -45.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.31 1.052 . . . . 0.0 109.089 -179.932 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.0 81.54 Favored Glycine 0 C--N 1.273 -2.968 0 N-CA-C 105.499 -3.04 . . . . 0.0 105.499 174.28 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.51 -47.01 7.66 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.154 178.005 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.88 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.876 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.71 8.1 1.23 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.215 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 56.3 t -144.88 -8.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.217 -179.953 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.647 ' ND2' ' CE1' ' A' ' 23' ' ' HIS . 1.6 t30 103.17 -36.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.639 1.212 . . . . 0.0 110.222 -179.772 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.647 ' CE1' ' ND2' ' A' ' 22' ' ' ASN . 31.9 m80 -155.26 -168.56 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 65.28 25.83 12.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.471 179.709 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -52.26 159.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 110.572 -179.918 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.51 72.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.915 179.986 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m 53.6 101.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.827 0.346 . . . . 0.0 110.677 -179.952 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' C ' ' N ' ' A' ' 7' ' ' LYS . 14.1 mm -74.1 69.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.367 179.832 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 52.66 12.29 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.977 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' N ' ' C ' ' A' ' 5' ' ' ILE . 1.3 ptpp? -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -89.46 68.85 7.92 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.444 179.881 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.36 -46.42 0.28 Allowed Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -179.885 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -89.9 -1.24 57.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 179.977 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 79.7 t60 -164.71 142.03 6.32 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 179.615 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.53 -32.14 0.23 Allowed 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 125.668 1.855 . . . . 0.0 109.805 -178.188 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.26 1.4 0.33 Allowed 'General case' 0 N--CA 1.41 -2.47 1 N-CA-C 95.444 -5.762 . . . . 0.0 95.444 165.003 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.039 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.7 tttp -114.33 -169.59 1.56 Allowed 'General case' 0 C--N 1.396 2.617 0 CA-C-N 109.48 -3.509 . . . . 0.0 111.842 176.98 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.1 t60 33.21 20.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.853 177.953 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 173.85 -47.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.695 0 CA-C-O 122.187 0.994 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.86 -14.49 78.39 Favored Glycine 0 C--N 1.271 -3.064 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 174.331 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' CD2' ' HA ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -87.59 -46.43 9.55 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.283 177.983 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.38 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.266 -179.386 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 65.64 -14.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.863 -179.666 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.2 t -149.34 -29.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 121.422 -0.111 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.8 t-20 148.56 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.944 0.777 . . . . 0.0 109.148 -179.728 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -170.28 64.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.403 -179.762 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -71.29 -19.55 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.62 -179.94 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.099 179.946 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -50.99 144.83 8.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.595 -179.967 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.02 0.97 50.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.807 179.855 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.6 m -50.4 131.4 24.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 110.66 -179.949 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.7 mt -75.55 69.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.425 179.877 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 54.46 18.48 1.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.706 179.985 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -72.76 -53.34 11.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.352 179.829 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -76.21 65.36 2.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.553 179.87 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.12 -43.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -89.98 -1.9 58.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 110.329 179.902 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 13' ' ' ALA . 11.1 p80 -163.92 143.34 7.96 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.768 179.385 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.016 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.27 -31.92 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.76 1.912 . . . . 0.0 109.982 -178.207 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.36 1.67 0.32 Allowed 'General case' 0 N--CA 1.411 -2.41 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 165.066 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.016 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.31 -168.95 1.48 Allowed 'General case' 0 C--N 1.394 2.54 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.877 176.973 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 74.6 t60 34.31 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.795 177.861 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tt 174.29 -46.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 CA-C-O 122.24 1.019 . . . . 0.0 109.363 -179.855 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.36 -13.92 79.6 Favored Glycine 0 C--N 1.271 -3.051 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.737 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.451 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.89 -44.27 9.49 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.66 -0.77 . . . . 0.0 109.533 178.071 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.57 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.859 -0.737 . . . . 0.0 112.145 -179.311 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.51 -20.42 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.358 -179.206 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.2 t -149.6 -31.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER 157.64 -48.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.62 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 57.3 t-80 -169.61 3.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.699 -179.735 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -76.65 40.84 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.58 -179.98 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.422 179.92 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -72.66 -78.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 -179.966 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 167.91 11.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.927 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.429 ' H ' ' H ' ' A' ' 3' ' ' GLY . 59.1 m -157.35 83.7 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.26 179.947 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.718 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.7 mp -80.05 -80.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.119 -179.844 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -71.22 -34.68 71.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.763 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -49.61 -64.35 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 20.7 t-160 -76.79 64.5 2.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.374 179.857 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.07 -25.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.08 -180.0 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -102.09 -1.91 30.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.126 0.488 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.548 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.0 t60 -150.39 143.72 25.01 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.633 179.461 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.79 -29.52 0.19 Allowed 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 125.641 1.838 . . . . 0.0 109.766 -177.987 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.02 0.43 Allowed 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 94.879 -5.971 . . . . 0.0 94.879 164.463 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.8 tttp -116.76 -161.11 0.79 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.266 -3.606 . . . . 0.0 110.549 177.005 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.562 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 30.92 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.852 0.72 . . . . 0.0 112.238 178.34 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.722 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.7 tt 172.75 -47.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 CA-C-O 122.226 1.012 . . . . 0.0 109.513 -179.446 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.66 74.62 Favored Glycine 0 C--N 1.271 -3.062 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 175.268 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 2.0 m170 -95.96 -45.18 7.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.443 178.181 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.99 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.862 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.18 7.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.289 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -146.44 -9.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.863 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.6 t30 104.53 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.491 1.119 . . . . 0.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -173.36 80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.451 179.974 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.542 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 63.2 t80 -84.64 -13.96 50.02 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.942 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 179.938 . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.004 -0.439 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 50.07 -98.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.712 0.291 . . . . 0.0 110.606 -179.958 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.22 14.27 59.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.707 -179.811 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 p -169.61 154.57 5.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.374 -179.954 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.1 mt -77.25 62.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.265 179.941 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 55.0 13.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.749 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -68.9 -72.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.26 179.714 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -74.85 2.56 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.374 179.733 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 -16.22 64.73 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.17 -179.944 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -168.11 29.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.076 -179.749 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.4 t60 -159.11 146.98 17.68 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.052 0.453 . . . . 0.0 110.857 179.305 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.988 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.04 -31.94 0.24 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.755 1.91 . . . . 0.0 110.007 -178.239 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.3 1.92 0.29 Allowed 'General case' 0 N--CA 1.413 -2.323 1 N-CA-C 95.445 -5.761 . . . . 0.0 95.445 165.132 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.988 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttm -115.8 -169.33 1.57 Allowed 'General case' 0 C--N 1.393 2.478 0 CA-C-N 109.363 -3.562 . . . . 0.0 111.725 177.076 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.8 t-80 34.31 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.914 177.963 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.06 -45.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.428 -179.958 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.72 79.99 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.284 -3.126 . . . . 0.0 105.284 174.422 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.27 -49.76 6.19 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.301 -0.949 . . . . 0.0 109.364 177.987 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.85 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.192 0.308 . . . . 0.0 110.196 -179.728 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.02 10.33 1.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.739 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.5 t -144.34 -9.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.425 -179.865 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 14.1 t-20 102.58 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.53 1.144 . . . . 0.0 110.45 179.896 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 16.9 t60 84.28 4.6 0.71 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.873 -179.143 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -62.95 -23.14 67.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.471 179.897 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.415 179.939 . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -72.57 -167.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.764 0.316 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.91 17.22 0.22 Allowed Glycine 0 C--N 1.332 0.331 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -179.934 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -176.19 138.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.885 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mm -62.11 -38.16 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.427 -179.767 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.71 7.15 4.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt 59.72 71.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.7 m80 48.85 32.73 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.773 179.819 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.15 58.86 8.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.097 179.809 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER 54.62 48.27 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 110.263 179.94 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -150.02 70.94 1.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.311 1.053 . . . . 0.0 109.714 179.353 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.968 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.272 . . 169.78 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 111.921 -2.399 . . . . 0.0 105.721 -179.363 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.09 -1.3 0.66 Allowed 'General case' 0 N--CA 1.412 -2.331 1 N-CA-C 95.254 -5.832 . . . . 0.0 95.254 164.125 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.968 ' N ' ' C ' ' A' ' 12' ' ' ALA . 3.2 ttpt -114.89 -166.49 1.12 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.309 -3.587 . . . . 0.0 111.501 176.325 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.8 t-80 33.2 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.042 178.378 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 173.56 -47.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 122.282 1.039 . . . . 0.0 109.305 179.96 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.03 -14.17 76.13 Favored Glycine 0 C--N 1.27 -3.115 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 174.907 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.97 -46.28 6.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.765 -0.718 . . . . 0.0 109.636 177.966 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.53 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.504 -179.754 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.63 6.95 1.23 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.076 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.0 t -147.16 -9.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.236 -179.926 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t30 102.82 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.444 1.09 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -178.83 64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.953 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -51.83 -33.94 38.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.667 -179.819 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.115 -179.969 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 53.83 10.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.742 0.306 . . . . 0.0 110.461 -179.978 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 68.14 6.48 46.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.855 -179.973 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -57.6 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.491 -179.955 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 7' ' ' LYS . 10.2 pt -154.53 62.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.145 -179.883 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 74.11 -32.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 5' ' ' ILE . 95.2 mttt -57.29 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.34 . . . . 0.0 110.346 179.725 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.472 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -77.49 64.49 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 179.876 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.02 -40.72 0.02 OUTLIER Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.938 -179.996 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -103.02 -1.93 28.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.0 m80 -147.21 144.85 29.21 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.08 179.435 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.03 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.47 -31.56 0.23 Allowed 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 125.587 1.804 . . . . 0.0 109.642 -177.761 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.13 0.29 Allowed 'General case' 0 N--CA 1.412 -2.337 1 N-CA-C 95.44 -5.763 . . . . 0.0 95.44 165.034 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.03 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.6 tttp -115.94 -169.25 1.56 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-N 109.365 -3.561 . . . . 0.0 111.74 177.082 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 86.8 m-70 34.52 18.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.965 178.045 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.54 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-O 122.363 1.078 . . . . 0.0 109.113 -179.821 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.25 79.3 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 174.493 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -91.53 -47.34 7.47 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.543 -0.829 . . . . 0.0 109.219 178.024 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.0 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.773 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 61.66 7.52 1.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.146 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 43.5 t -144.99 -9.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER 105.32 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.54 1.15 . . . . 0.0 110.05 -179.843 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.597 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -173.13 -99.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.315 -179.923 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.597 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 64.5 t80 55.44 10.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 63.8 m95 50.66 -93.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.556 -179.975 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 63.15 25.41 68.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.053 179.949 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -168.8 96.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.35 179.944 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -74.13 79.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.576 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 60.69 6.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.353 179.335 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -73.55 -61.57 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -76.43 64.93 2.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.508 179.804 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.03 -30.05 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.059 -179.919 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 76.5 mtt85 -129.4 5.84 5.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.817 0.342 . . . . 0.0 110.314 179.977 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 97.7 m-70 -155.81 144.96 20.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.602 179.528 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.707 1.879 . . . . 0.0 109.849 -177.888 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.44 1.89 0.31 Allowed 'General case' 0 N--CA 1.411 -2.42 1 N-CA-C 95.363 -5.792 . . . . 0.0 95.363 164.988 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.061 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -115.89 -169.15 1.54 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.412 -3.54 . . . . 0.0 111.646 177.074 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.7 m-70 34.86 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.892 178.031 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.62 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.091 0.948 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.25 -13.71 82.55 Favored Glycine 0 C--N 1.273 -2.961 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.59 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.15 -45.64 8.17 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 114.511 -0.845 . . . . 0.0 109.286 177.981 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.05 13.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.838 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.18 9.23 0.94 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.17 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -145.95 -9.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.189 -179.873 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t-20 103.14 -36.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.503 1.127 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -172.05 89.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.398 -179.966 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 83.4 t80 -159.89 16.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.062 -179.84 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.564 179.982 . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 95.2 m95 -158.08 139.51 13.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.412 -179.977 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -11.15 56.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.971 -179.947 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 p -167.55 165.89 14.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.343 . . . . 0.0 110.438 -179.999 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -142.57 -55.95 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.228 -179.926 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -77.91 44.57 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.495 179.791 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER 55.1 72.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.343 -179.993 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.555 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.7 OUTLIER 46.9 26.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.256 179.502 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.19 64.28 2.34 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.779 179.308 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt-85 58.45 49.79 10.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.785 0.326 . . . . 0.0 111.125 179.309 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.581 ' NE2' ' NE2' ' A' ' 15' ' ' HIS . 48.8 t-80 -157.6 92.43 1.21 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.209 0.528 . . . . 0.0 110.074 179.339 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.96 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 134.84 -31.79 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.424 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.54 -0.41 0.61 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.895 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.96 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.8 tttt -114.86 -168.12 1.33 Allowed 'General case' 0 C--N 1.393 2.488 0 CA-C-N 109.376 -3.556 . . . . 0.0 111.768 176.696 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 79.5 m-70 33.77 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.958 178.24 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.39 -47.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.324 1.059 . . . . 0.0 109.025 -179.873 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.66 -13.73 78.03 Favored Glycine 0 C--N 1.27 -3.099 0 N-CA-C 105.885 -2.886 . . . . 0.0 105.885 174.853 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.75 -44.39 9.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.899 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 160.87 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.868 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.37 5.57 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.289 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 40.7 t -145.28 -10.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.202 -179.817 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.0 t-20 116.4 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.504 1.128 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -171.89 -3.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.515 -179.923 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.416 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 34.1 t80 -49.06 -18.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.712 -179.633 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.136 -179.978 . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 39.4 t-105 -68.29 -18.92 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.515 -179.939 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 4' ' ' SER . . . 73.58 27.0 68.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.635 -179.566 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 3' ' ' GLY . 7.3 m -58.12 -153.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.789 -179.928 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.52 -21.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 -179.86 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -151.42 -18.61 0.2 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -53.76 -64.18 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.404 179.96 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.27 45.35 1.22 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.703 179.997 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.31 23.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.193 179.983 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 -168.14 9.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.219 179.81 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.1 t-80 -153.21 145.56 23.99 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.673 179.508 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.063 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.39 -31.74 0.23 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.715 1.885 . . . . 0.0 109.738 -177.985 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.18 0.29 Allowed 'General case' 0 N--CA 1.412 -2.373 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 165.091 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.063 ' N ' ' C ' ' A' ' 12' ' ' ALA . 15.8 tttp -116.14 -169.49 1.62 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.76 177.037 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 33.39 21.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.708 177.927 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.651 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.16 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 CA-C-O 122.302 1.049 . . . . 0.0 109.377 -179.658 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.94 -11.55 81.21 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 104.983 -3.247 . . . . 0.0 104.983 173.981 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.476 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -93.43 -36.33 12.53 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 114.445 -0.878 . . . . 0.0 109.932 178.238 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.15 28.22 0.51 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.365 -179.441 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.5 -9.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.114 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 19' ' ' ALA . 83.0 t -152.44 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.284 -179.387 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -171.66 -96.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.496 -179.198 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 25' ' ' LEU . 75.8 t60 -152.07 8.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.711 -179.372 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.14 22.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.491 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 13.1 m-90 -157.56 -57.09 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.885 0.374 . . . . 0.0 110.517 -179.977 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.15 -0.43 88.74 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.852 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.4 m -78.55 77.2 5.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.765 0.317 . . . . 0.0 110.377 179.852 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.433 HG22 ' CE1' ' A' ' 6' ' ' PHE . 10.5 mt -73.89 -28.97 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.714 -179.778 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 5' ' ' ILE . 67.7 m-85 -155.68 4.56 0.19 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 -179.949 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -59.8 -70.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.243 179.827 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.43 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 54.5 t-80 -80.66 43.62 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.2 26.46 0.12 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.235 -179.979 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -166.03 3.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.353 179.747 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.8 m-70 -144.72 146.73 32.34 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.023 0.44 . . . . 0.0 111.012 179.49 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.066 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.91 -31.45 0.22 Allowed 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 125.813 1.945 . . . . 0.0 109.944 -178.156 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.4 2.08 0.29 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.344 -5.798 . . . . 0.0 95.344 165.028 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.066 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.8 ttpp -116.01 -169.29 1.57 Allowed 'General case' 0 C--N 1.394 2.503 0 CA-C-N 109.407 -3.542 . . . . 0.0 111.817 177.16 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.1 t60 33.98 19.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.89 178.122 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 174.69 -46.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-O 122.24 1.019 . . . . 0.0 109.275 179.977 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.05 79.4 Favored Glycine 0 C--N 1.271 -3.083 0 N-CA-C 105.773 -2.931 . . . . 0.0 105.773 174.722 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.597 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.14 -45.62 7.8 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.659 -0.771 . . . . 0.0 109.431 178.036 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.23 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.877 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.78 5.89 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 109.667 -179.291 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 45.9 t -144.05 -9.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.335 179.975 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 27.8 t-20 105.84 -36.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.646 1.216 . . . . 0.0 110.046 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.541 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -170.1 -130.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.138 179.972 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.541 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 29.6 m-85 48.62 28.67 1.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.775 0.322 . . . . 0.0 110.752 179.673 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.081 -179.923 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -57.87 -45.16 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.823 0.344 . . . . 0.0 110.528 -179.956 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.76 68.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.114 179.872 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -66.26 116.13 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.583 179.858 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.8 mt -67.18 -51.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.089 179.92 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 8' ' ' HIS . 45.0 m-85 -82.99 21.76 1.02 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.333 179.816 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 12.2 mptt 54.76 8.92 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.34 -179.919 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 81.6 t60 45.77 19.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.72 179.833 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . -160.46 -3.12 0.06 OUTLIER Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.286 -179.746 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 60.89 27.92 17.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 28.8 t60 -97.29 71.06 2.36 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.138 0.971 . . . . 0.0 110.11 179.437 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.005 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.265 . . 169.34 -30.88 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 112.165 -2.289 . . . . 0.0 105.712 -179.738 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -1.0 0.57 Allowed 'General case' 0 N--CA 1.414 -2.274 1 N-CA-C 95.378 -5.786 . . . . 0.0 95.378 164.068 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.005 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.257 23.7 tttp -115.99 -166.73 1.17 Allowed 'General case' 0 C--N 1.393 2.457 0 CA-C-N 109.42 -3.536 . . . . 0.0 111.953 176.859 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.652 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 55.6 t60 34.01 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.609 177.756 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.7 tt 170.72 -42.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.078 0.942 . . . . 0.0 109.381 -179.894 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.96 -14.28 81.87 Favored Glycine 0 C--N 1.274 -2.894 0 N-CA-C 105.81 -2.916 . . . . 0.0 105.81 175.071 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -88.94 -34.36 16.93 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.044 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.07 -73.18 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.61 179.397 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -167.23 -23.14 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.815 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 34.0 t -150.85 -12.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.542 179.614 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 5.1 t30 155.55 -36.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.779 0.674 . . . . 0.0 109.551 -179.658 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 2.3 p-80 -166.14 120.38 1.15 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.952 -178.443 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -71.87 -0.17 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.421 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 -179.931 . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 1' ' ' GLY . 95.9 m95 54.72 166.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.97 -4.32 88.61 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.162 -179.823 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 p 52.88 97.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 110.388 -179.807 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.44 HG22 ' CE2' ' A' ' 6' ' ' PHE . 10.8 mt -78.82 -33.78 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 -179.64 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.44 ' CE2' HG22 ' A' ' 5' ' ' ILE . 63.8 m-85 -156.15 -7.3 0.11 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.999 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' H ' ' A' ' 6' ' ' PHE . 16.4 tptp -50.74 -73.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 -179.813 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.36 70.11 10.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.483 179.988 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.67 -12.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.851 -179.972 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -149.11 23.91 0.94 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.871 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.2 t60 -153.58 146.58 24.52 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.443 179.382 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.31 -30.82 0.21 Allowed 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 125.715 1.885 . . . . 0.0 109.683 -177.695 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.71 2.88 0.25 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 164.915 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.1 tttm -118.13 -167.3 1.33 Allowed 'General case' 0 C--N 1.393 2.471 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.593 177.275 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.61 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 66.2 t60 33.05 23.3 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 170.04 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.585 0 CA-C-O 122.107 0.956 . . . . 0.0 109.103 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -15.12 79.13 Favored Glycine 0 C--N 1.274 -2.909 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.752 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.443 ' H ' ' H ' ' A' ' 16' ' ' ILE . 26.5 t-80 -83.43 -39.64 20.33 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.859 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.94 -69.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 -19.81 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.877 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 10.1 t -149.58 -16.31 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.966 179.679 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.7 t30 158.58 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.692 0.62 . . . . 0.0 109.758 -179.669 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 43.9 t-80 -166.51 14.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.723 -178.692 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 72.3 t80 -78.82 43.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.432 -179.883 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.236 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 86.9 m95 -158.44 168.85 25.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.769 0.318 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.3 -8.33 83.44 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.257 -0.497 . . . . 0.0 111.95 179.974 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 51.62 -164.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 110.535 179.903 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.8 tt -164.21 -19.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.205 -179.948 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -161.27 -25.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.37 179.7 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.512 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 35.5 ttpt -60.47 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.967 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -78.6 48.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.594 179.882 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.74 -19.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.085 -179.911 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 66.4 mtp180 -139.54 16.84 2.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.23 179.857 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.4 m80 -154.75 145.56 22.47 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.557 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.48 -30.72 0.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 125.654 1.846 . . . . 0.0 109.555 -177.713 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.75 0.26 Allowed 'General case' 0 N--CA 1.412 -2.351 1 N-CA-C 95.282 -5.822 . . . . 0.0 95.282 164.787 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.5 ttpp -117.73 -167.59 1.36 Allowed 'General case' 0 C--N 1.392 2.44 0 CA-C-N 109.524 -3.489 . . . . 0.0 111.671 177.152 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.611 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 55.1 m-70 33.11 23.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.716 177.67 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.648 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 170.02 -45.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 CA-C-O 122.229 1.014 . . . . 0.0 109.061 -179.752 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.19 78.66 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 174.773 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 25.4 t-80 -82.54 -40.85 20.39 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.659 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -160.37 -68.05 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.402 179.51 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -169.34 -19.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.956 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.402 ' H ' ' H ' ' A' ' 20' ' ' ALA . 40.4 t -151.26 -18.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.092 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 7.8 t-20 163.76 -38.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.576 0.548 . . . . 0.0 109.993 -179.709 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 48.2 t-80 -171.7 33.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 -178.644 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -49.82 -14.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 110.544 -179.969 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.783 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.454 -0.165 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.448 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 29.3 m-90 -157.15 -87.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.737 0.303 . . . . 0.0 110.46 -179.893 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.13 8.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.126 179.866 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -165.3 120.56 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.921 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.6 tt -75.88 -40.6 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.382 179.97 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.473 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 41.4 m-85 -162.51 7.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.052 179.437 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -57.44 -73.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.361 179.86 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -79.6 43.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.415 179.859 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.6 14.69 0.1 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.077 -179.886 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -166.85 -3.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.182 0.515 . . . . 0.0 110.182 179.792 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.8 t-80 -162.8 143.4 9.64 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 179.294 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.3 -31.68 0.22 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.836 1.96 . . . . 0.0 110.022 -178.133 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 1.81 0.33 Allowed 'General case' 0 N--CA 1.411 -2.381 1 N-CA-C 95.304 -5.813 . . . . 0.0 95.304 164.963 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.04 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.9 tttt -115.67 -168.8 1.47 Allowed 'General case' 0 C--N 1.393 2.499 0 CA-C-N 109.417 -3.538 . . . . 0.0 111.758 176.998 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.633 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.6 t-80 34.21 19.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.849 177.98 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.08 -47.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.271 1.034 . . . . 0.0 109.199 -179.894 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.26 -14.06 76.79 Favored Glycine 0 C--N 1.27 -3.13 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 174.918 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.5 -45.6 7.35 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.512 178.093 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.3 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.762 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.17 9.65 1.04 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.973 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 21' ' ' VAL . 58.5 t -147.97 -8.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.196 -179.542 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.7 m120 100.04 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.662 1.226 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.514 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 47.8 t-80 -167.22 -105.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.5 -179.834 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.514 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 25.7 t80 65.96 -7.34 0.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 -179.977 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.822 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -69.51 126.0 28.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.614 179.93 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.21 -21.81 78.49 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.764 179.752 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.8 m -97.64 92.63 5.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.674 0.273 . . . . 0.0 110.511 179.967 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 mt -67.37 -37.88 79.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.777 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.41 ' H ' ' H ' ' A' ' 7' ' ' LYS . 36.4 p90 -165.74 1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.884 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 6' ' ' PHE . 79.4 tttt -54.88 -62.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.347 179.926 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.14 65.65 2.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.459 179.931 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -177.0 -13.6 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.902 -179.945 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 85.6 mtt-85 -140.9 6.99 2.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.788 0.327 . . . . 0.0 110.265 179.894 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 94.7 m-70 -155.79 146.08 21.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.626 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.71 -31.67 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.823 1.952 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.8 0.31 Allowed 'General case' 0 N--CA 1.412 -2.343 1 N-CA-C 95.414 -5.773 . . . . 0.0 95.414 165.167 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.031 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.5 tttp -116.31 -168.22 1.4 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.327 -3.579 . . . . 0.0 111.644 177.158 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 40.4 m-70 34.05 20.98 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.803 177.706 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 171.3 -46.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.515 0 CA-C-O 122.286 1.041 . . . . 0.0 109.245 -179.682 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.16 -12.42 83.48 Favored Glycine 0 C--N 1.274 -2.908 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 175.125 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.449 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -89.29 -30.88 18.14 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.316 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.57 -66.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.677 179.285 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -171.64 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.759 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' H ' ' H ' ' A' ' 20' ' ' ALA . 59.9 t -152.7 -18.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 t30 165.66 -38.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.549 0.531 . . . . 0.0 110.145 -179.799 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 34.5 t-80 -170.04 26.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -178.709 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -49.08 -15.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 -179.741 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.278 -179.944 . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -75.02 -54.28 7.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.723 0.296 . . . . 0.0 110.528 -179.946 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.56 69.82 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.912 -179.876 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.504 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 58.8 m -165.43 96.88 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -76.94 -30.21 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.44 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -157.84 13.06 0.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.326 179.995 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -78.97 -27.12 43.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.268 179.759 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 4' ' ' SER . 38.4 m170 -78.56 77.12 5.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 51.45 83.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.287 179.805 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' H ' ' H ' ' A' ' 11' ' ' HIS . 66.3 ttt180 -169.53 -4.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.268 0.556 . . . . 0.0 110.003 179.644 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.539 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 t60 -156.8 142.2 17.45 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.61 -31.73 0.23 Allowed 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 125.594 1.809 . . . . 0.0 109.492 -177.863 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.54 0.33 Allowed 'General case' 0 N--CA 1.41 -2.439 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 164.978 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.0 tttp -115.1 -169.82 1.63 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.438 -3.528 . . . . 0.0 111.731 176.922 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.9 t-80 34.78 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.934 177.926 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.28 -44.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.171 0.986 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.82 -14.38 81.57 Favored Glycine 0 C--N 1.274 -2.895 0 N-CA-C 105.335 -3.106 . . . . 0.0 105.335 174.249 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.85 -49.03 6.85 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.295 -0.953 . . . . 0.0 109.02 177.892 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.28 9.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.458 0.474 . . . . 0.0 110.177 -179.94 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.72 10.07 1.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 -178.158 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 21' ' ' VAL . 91.1 t -143.1 -8.56 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.948 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.2 m-20 97.67 -35.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.637 1.211 . . . . 0.0 111.08 179.81 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.4 t-80 80.19 7.84 1.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.774 -179.154 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.1 t80 -77.08 27.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.0 tt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 111.931 -0.467 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -69.25 -171.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 110.67 179.962 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.35 -21.95 72.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.994 179.97 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.7 m 54.36 -169.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.593 179.919 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 pt -78.34 56.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.521 -179.943 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 60.09 16.71 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.872 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -70.0 -63.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.363 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -78.96 53.12 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.824 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.28 -17.52 0.02 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.062 -179.903 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' C ' ' ND1' ' A' ' 11' ' ' HIS . 81.5 mtp180 -124.55 1.95 8.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.922 0.392 . . . . 0.0 110.219 179.868 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 41.2 m80 -152.76 144.44 23.51 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.29 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.633 1.833 . . . . 0.0 109.718 -177.731 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.57 2.25 0.3 Allowed 'General case' 0 N--CA 1.411 -2.407 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 12.0 ttpt -115.98 -168.98 1.51 Allowed 'General case' 0 C--N 1.395 2.544 0 CA-C-N 109.401 -3.545 . . . . 0.0 111.492 176.995 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 61.5 t60 33.65 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.917 178.036 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.76 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 CA-C-O 122.229 1.014 . . . . 0.0 109.308 179.982 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -14.24 80.18 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 174.497 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.454 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -90.69 -44.21 9.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 114.431 -0.884 . . . . 0.0 109.857 178.179 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 42.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.336 -179.177 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 69.6 -21.65 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.515 -179.47 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.0 t -148.32 -30.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.636 179.802 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t-20 153.39 -43.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.557 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 41.9 t60 -168.78 174.96 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.27 179.7 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.557 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.5 t80 56.28 10.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.656 179.917 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -69.58 -73.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.557 -179.998 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.31 -0.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.851 179.999 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m 54.31 106.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.846 0.355 . . . . 0.0 110.706 -179.983 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.48 -35.78 58.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.472 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -164.34 -4.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.47 179.795 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -57.64 -84.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 -179.92 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -74.54 85.94 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 179.93 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.78 -45.52 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.091 -179.933 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 26.14 0.64 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.97 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.5 t60 -160.8 147.1 15.01 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.059 0.457 . . . . 0.0 111.04 179.688 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.008 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.5 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 125.872 1.982 . . . . 0.0 110.085 -178.23 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.08 0.28 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.411 -5.774 . . . . 0.0 95.411 165.218 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.008 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -116.03 -169.31 1.58 Allowed 'General case' 0 C--N 1.393 2.491 0 CA-C-N 109.435 -3.529 . . . . 0.0 111.767 177.03 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 10.9 t60 34.72 18.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.914 178.056 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tt 175.35 -41.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 CA-C-O 122.019 0.914 . . . . 0.0 109.582 179.923 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.63 -13.07 83.88 Favored Glycine 0 C--N 1.275 -2.858 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 174.316 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -92.89 -44.78 8.29 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.541 -0.829 . . . . 0.0 109.136 178.05 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.89 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.46 9.61 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.025 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -147.57 -9.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.152 -179.777 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.8 t-20 100.31 -35.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.395 1.06 . . . . 0.0 110.023 -179.627 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 25' ' ' LEU . 79.9 m-70 -145.76 119.37 9.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -62.43 -4.26 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 23' ' ' HIS . 19.0 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.6 m95 51.56 -153.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 0.0 110.464 179.988 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' A' ' 4' ' ' SER . . . -177.69 -0.58 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 179.996 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.425 ' H ' ' H ' ' A' ' 3' ' ' GLY . 10.2 t 55.8 165.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 110.572 -179.999 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 mt -76.21 -42.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -166.11 -11.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 179.906 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 9' ' ' GLY . 81.2 tttt -62.22 -8.39 5.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.423 -179.958 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 57.2 t-80 -61.83 -2.55 0.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.962 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . 145.23 59.97 0.02 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.116 179.813 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -161.65 33.27 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 179.729 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.534 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.0 t-80 -169.55 145.29 3.14 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 179.571 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.963 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.71 -31.78 0.23 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.767 1.917 . . . . 0.0 109.94 -178.156 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.77 0.31 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.274 -5.824 . . . . 0.0 95.274 165.074 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.963 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -115.6 -169.35 1.56 Allowed 'General case' 0 C--N 1.394 2.509 0 CA-C-N 109.483 -3.508 . . . . 0.0 111.766 176.909 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.3 t-80 34.89 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.944 177.952 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.71 -43.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.144 0.974 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.94 82.39 Favored Glycine 0 C--N 1.274 -2.907 0 N-CA-C 105.434 -3.066 . . . . 0.0 105.434 174.41 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -91.41 -47.44 7.45 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.437 -0.881 . . . . 0.0 109.21 177.983 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.23 9.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.259 0.349 . . . . 0.0 110.179 -179.885 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.5 9.88 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.25 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 85.1 t -144.57 -9.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.2 -179.82 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.1 t30 99.43 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 O-C-N 124.33 1.019 . . . . 0.0 110.798 179.826 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 5.2 t60 81.98 44.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.349 -179.385 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 41.7 p90 -66.55 -31.09 71.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.565 -179.942 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.756 -179.948 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 71.6 m95 52.01 -164.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.52 7.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.832 179.977 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t 58.22 -142.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.434 -179.97 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 6' ' ' PHE . 16.6 tt -158.77 -38.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.932 179.786 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 10' ' ' ARG . 35.0 m-85 -81.72 64.73 6.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.238 179.482 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' C ' ' N ' ' A' ' 9' ' ' GLY . 50.9 mmtt 45.69 28.11 0.51 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.317 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 85.1 t60 49.95 12.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . -174.53 -16.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' N ' ' O ' ' A' ' 6' ' ' PHE . 43.0 ttp180 66.3 96.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.315 0.579 . . . . 0.0 111.43 179.484 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.5 m-70 68.81 140.59 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.849 179.22 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.053 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 67.24 -33.33 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 126.267 2.23 . . . . 0.0 111.023 -179.106 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 0.98 0.37 Allowed 'General case' 0 N--CA 1.411 -2.406 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 165.152 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.053 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.5 tttp -114.02 -168.89 1.42 Allowed 'General case' 0 C--N 1.395 2.57 0 CA-C-N 109.554 -3.475 . . . . 0.0 111.743 176.769 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 34.15 18.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.959 177.968 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.17 -46.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 122.286 1.041 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.71 -14.56 77.98 Favored Glycine 0 C--N 1.27 -3.097 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 174.52 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -90.82 -47.79 7.41 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.144 177.804 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.56 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.799 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.53 6.84 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.292 0.568 . . . . 0.0 109.54 -179.149 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 50.6 t -143.02 -9.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER 106.13 -36.81 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.62 1.2 . . . . 0.0 110.019 -179.809 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.519 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 26.7 t-80 -171.08 -117.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.273 179.871 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.519 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 92.4 m-85 50.9 13.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.7 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.215 -179.965 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -70.93 -24.94 62.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.508 -179.996 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.97 50.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.033 179.946 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 5' ' ' ILE . 30.3 t 52.8 -177.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.741 0.305 . . . . 0.0 110.565 -179.929 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 9.2 mt -73.86 -44.87 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 -179.908 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 55.6 m-85 -159.84 -13.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -50.67 -61.6 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.953 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -77.87 61.56 2.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.99 -13.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.161 -0.543 . . . . 0.0 111.922 -179.997 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 59.2 mtp85 -137.52 14.56 2.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 110.097 179.912 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.3 m80 -156.69 145.78 20.3 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.541 179.457 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.986 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -31.72 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.75 1.906 . . . . 0.0 109.839 -177.996 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.99 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.078 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.986 ' N ' ' C ' ' A' ' 12' ' ' ALA . 33.2 tttt -116.0 -169.56 1.62 Allowed 'General case' 0 C--N 1.392 2.418 0 CA-C-N 109.389 -3.551 . . . . 0.0 111.735 177.031 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 3.1 t60 34.48 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.935 178.089 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.06 -41.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.549 0 CA-C-O 122.02 0.914 . . . . 0.0 109.659 179.918 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.59 -13.16 83.79 Favored Glycine 0 C--N 1.275 -2.826 0 N-CA-C 105.506 -3.038 . . . . 0.0 105.506 174.327 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.65 -44.36 8.22 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 114.579 -0.81 . . . . 0.0 109.491 178.083 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.96 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.57 10.14 0.95 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.972 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 65.9 t -148.22 -9.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.189 -179.837 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.1 t-20 100.34 -35.58 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.388 1.055 . . . . 0.0 110.003 -179.643 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' A' ' 25' ' ' LEU . 96.0 m-70 -151.72 120.06 6.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.42 -179.766 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -69.48 5.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' HIS . 3.0 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.37 -179.792 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 50.8 -147.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.983 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.05 -4.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.219 -0.515 . . . . 0.0 111.838 -179.946 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.4 p 50.77 -165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.738 179.893 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.95 -29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.683 179.963 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' H ' ' H ' ' A' ' 7' ' ' LYS . 34.4 p90 -168.57 -21.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.942 179.525 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 6' ' ' PHE . 9.7 mtmp? -48.96 -68.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.551 179.787 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -77.6 63.93 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.295 179.704 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.04 -24.37 0.02 OUTLIER Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.123 -179.868 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -151.18 10.21 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.664 0.269 . . . . 0.0 110.757 -179.921 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.9 t60 -149.38 144.27 26.29 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.919 0.39 . . . . 0.0 110.825 179.601 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.45 -29.62 0.19 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.558 1.786 . . . . 0.0 109.851 -178.081 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.18 1.78 0.44 Allowed 'General case' 0 N--CA 1.411 -2.414 1 N-CA-C 94.855 -5.98 . . . . 0.0 94.855 164.342 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.6 tttp -116.07 -161.98 0.82 Allowed 'General case' 0 C--N 1.398 2.696 0 CA-C-N 109.264 -3.607 . . . . 0.0 110.726 176.929 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.561 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.4 t60 31.49 20.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.459 0.704 . . . . 0.0 112.144 178.291 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 172.95 -49.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 CA-C-O 122.429 1.109 . . . . 0.0 109.321 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.21 -13.71 70.57 Favored Glycine 0 C--N 1.27 -3.1 0 N-CA-C 106.257 -2.737 . . . . 0.0 106.257 175.351 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.6 m170 -94.69 -45.05 7.52 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.039 178.071 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 161.72 13.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.858 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.4 7.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.114 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.5 t -143.59 -9.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.575 -179.933 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 106.49 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.548 1.155 . . . . 0.0 110.246 179.969 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -173.09 100.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.533 -179.933 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 60.8 t80 -166.0 4.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.427 179.975 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.51 -179.97 . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -75.87 143.1 41.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.55 179.986 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.99 0.53 21.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.871 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.9 m -58.71 -178.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.528 -179.958 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.82 -72.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.936 179.826 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.82 -35.4 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.186 179.5 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 9' ' ' GLY . 53.8 mttm -53.16 -33.71 53.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.492 179.91 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.481 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 22.5 t-80 -75.24 17.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.74 -179.974 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -177.83 25.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.994 -179.964 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -161.06 20.42 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.153 179.992 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 49.2 t60 -164.0 143.97 8.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.597 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.61 0.23 Allowed 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 125.619 1.825 . . . . 0.0 109.656 -178.045 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.23 1.54 0.31 Allowed 'General case' 0 N--CA 1.411 -2.416 1 N-CA-C 95.364 -5.791 . . . . 0.0 95.364 165.014 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 18.2 tttm -114.89 -169.32 1.53 Allowed 'General case' 0 C--N 1.396 2.608 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.909 177.067 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 51.5 m170 32.73 21.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.788 177.974 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 172.63 -47.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 CA-C-O 122.256 1.027 . . . . 0.0 109.374 -179.951 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.25 -14.39 79.18 Favored Glycine 0 C--N 1.271 -3.046 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 174.404 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.75 -44.07 11.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.466 178.034 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.39 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.205 -179.315 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 -1.44 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.192 179.496 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.5 t -150.97 -25.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.732 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.9 t30 130.18 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.737 1.273 . . . . 0.0 109.299 -179.726 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -163.17 97.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.906 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 77.4 t80 -164.31 -6.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.945 179.816 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.245 179.881 . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.2 m95 50.54 -174.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.2 -14.75 54.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.825 179.88 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.2 m -164.99 166.4 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.319 . . . . 0.0 110.33 179.981 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.36 -54.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.506 -179.834 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -160.95 3.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 12.6 mptt -61.09 -60.1 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.156 -179.903 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -71.2 73.26 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.548 -179.993 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.29 -23.74 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.97 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -140.65 17.98 2.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.157 179.917 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.561 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.1 t60 -152.55 145.21 24.23 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.141 0.496 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.8 -30.66 0.21 Allowed 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 125.78 1.925 . . . . 0.0 109.261 -177.426 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.9 3.71 0.21 Allowed 'General case' 0 N--CA 1.41 -2.458 1 N-CA-C 95.372 -5.788 . . . . 0.0 95.372 164.698 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.023 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -119.36 -168.11 1.52 Allowed 'General case' 0 C--N 1.395 2.549 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.828 177.464 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.8 m170 31.67 25.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.411 178.12 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.6 tt 167.52 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 CA-C-O 122.171 0.986 . . . . 0.0 109.217 -179.841 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.34 -13.71 78.1 Favored Glycine 0 C--N 1.275 -2.837 0 N-CA-C 104.675 -3.37 . . . . 0.0 104.675 173.523 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.492 ' H ' ' H ' ' A' ' 16' ' ' ILE . 56.4 t-80 -89.16 -40.3 12.99 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.399 177.897 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -144.33 23.38 1.65 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.885 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.59 -2.36 0.18 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.251 179.139 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' ALA . 42.9 t -150.89 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 121.335 -0.146 . . . . 0.0 111.066 -179.57 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 1.4 p30 175.83 -83.87 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.947 0.404 . . . . 0.0 110.84 -179.443 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.47 -172.27 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.76 -179.589 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 50.6 t80 57.01 20.16 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.51 179.999 . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -66.55 -20.28 65.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 110.518 -179.971 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.88 18.08 78.77 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 -179.708 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.596 ' HG ' ' CE1' ' A' ' 8' ' ' HIS . 7.6 m 58.34 -150.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.6 -179.956 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.43 -25.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -152.71 -20.58 0.16 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.256 179.563 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -57.58 -54.72 43.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.27 179.754 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.596 ' CE1' ' HG ' ' A' ' 4' ' ' SER . 35.1 m170 -79.13 47.6 0.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.407 179.844 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.33 -16.88 0.02 OUTLIER Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.877 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -128.73 13.75 6.41 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.043 179.837 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.1 t-80 -157.47 145.78 19.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.589 179.518 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.999 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.63 0.23 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.773 1.92 . . . . 0.0 109.804 -178.028 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.01 0.31 Allowed 'General case' 0 N--CA 1.412 -2.375 1 N-CA-C 95.323 -5.806 . . . . 0.0 95.323 165.037 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.999 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.5 tttt -115.86 -168.76 1.47 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.509 -3.496 . . . . 0.0 111.557 177.045 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 8.8 m-70 33.98 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 177.968 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.63 -44.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.105 0.955 . . . . 0.0 109.518 179.885 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.11 81.87 Favored Glycine 0 C--N 1.273 -2.937 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.362 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 m170 -93.08 -49.28 6.08 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.563 177.99 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.46 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.488 -179.616 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.41 9.65 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.947 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 21' ' ' VAL . 59.7 t -146.7 -8.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.911 -179.856 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 18.8 m-20 99.42 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.819 1.324 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 93.2 m-70 -160.19 108.87 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -62.25 -11.78 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.318 179.986 . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.87 175.92 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.25 -21.7 75.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.776 179.847 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m 47.49 45.7 17.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.812 0.339 . . . . 0.0 110.679 179.951 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 5' ' ' ILE . 13.4 tt -55.62 90.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.304 0.573 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 49.43 12.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' N ' ' C ' ' A' ' 5' ' ' ILE . 2.7 ttmp? -72.18 -68.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -77.71 65.21 3.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.518 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.37 -26.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 7.9 ptm180 -161.95 24.91 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.383 . . . . 0.0 110.459 179.894 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 m-70 -155.45 146.52 22.54 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 179.507 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.05 -31.91 0.23 Allowed 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 125.719 1.887 . . . . 0.0 109.922 -178.071 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.14 1.76 0.29 Allowed 'General case' 0 N--CA 1.413 -2.295 1 N-CA-C 95.421 -5.77 . . . . 0.0 95.421 165.158 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 3.0 ttmm -115.56 -169.76 1.64 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.403 -3.544 . . . . 0.0 111.716 177.252 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.8 m-70 34.09 19.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.698 178.036 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.04 -46.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.686 0 CA-C-O 122.178 0.99 . . . . 0.0 109.641 -179.936 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.91 -14.66 78.46 Favored Glycine 0 C--N 1.272 -3.013 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 174.726 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.594 ' NE2' ' NZ ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -92.43 -42.74 9.59 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 114.721 -0.739 . . . . 0.0 110.038 178.363 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.82 42.1 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.353 -179.212 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.67 -17.1 0.13 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.663 -179.52 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -148.77 -33.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 179.974 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.3 t-20 155.38 -47.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.867 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 27.8 t-80 -166.86 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.222 179.835 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.549 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 98.3 m-85 46.89 18.32 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.6 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.14 -179.91 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -167.87 -2.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.332 . . . . 0.0 110.474 179.929 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.81 1.47 72.63 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.111 179.943 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 m -169.17 59.77 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.481 179.952 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.3 pt -83.96 21.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 10' ' ' ARG . 34.2 p90 -163.15 -36.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.77 179.743 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 9' ' ' GLY . 90.9 mttt -55.82 -37.19 68.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.462 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 1.1 t60 -67.62 4.95 0.92 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 -179.747 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -154.26 8.54 0.4 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 11' ' ' HIS . 95.0 mtt180 -154.74 164.04 39.37 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.837 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 2.2 t60 58.41 136.47 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.09 -179.814 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.047 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.68 -32.01 0.22 Allowed 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.761 -178.042 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.12 0.34 Allowed 'General case' 0 N--CA 1.41 -2.453 1 N-CA-C 95.268 -5.827 . . . . 0.0 95.268 164.709 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.047 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.6 tttm -114.71 -169.45 1.55 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.557 -3.474 . . . . 0.0 111.813 176.871 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.8 m80 34.54 18.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.894 178.085 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.41 -44.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 CA-C-O 122.051 0.929 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.59 -14.04 81.48 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 174.554 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.567 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.56 -46.27 7.7 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.402 177.995 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.47 12.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.43 -179.882 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.33 8.24 1.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.041 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 52.3 t -146.02 -9.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.054 -179.939 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 62.9 t30 102.27 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.543 1.152 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -175.07 75.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.403 179.997 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 52.8 t80 -79.15 -20.92 47.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.541 -179.979 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.978 . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 55.3 t-105 -66.32 0.94 1.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 80.06 -3.61 70.34 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.023 179.983 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.7 p -75.28 141.58 43.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.531 179.935 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.718 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.8 mp -78.47 93.26 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.909 180.0 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 49.35 60.92 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp 53.69 57.2 6.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.212 -179.779 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 1.1 t60 55.37 21.56 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.171 -179.75 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 56.03 3.79 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.163 -179.982 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 10' ' ' ARG . 0.7 OUTLIER 54.9 43.09 30.51 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.931 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.451 ' CD2' ' HD3' ' A' ' 14' ' ' LYS . 55.7 t-80 -155.05 72.2 0.82 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.289 1.042 . . . . 0.0 109.95 178.761 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.973 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.275 . . 174.67 -31.07 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.504 179.978 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.81 -1.53 0.65 Allowed 'General case' 0 N--CA 1.416 -2.154 1 N-CA-C 95.486 -5.746 . . . . 0.0 95.486 164.734 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.973 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.258 19.1 tttm -115.1 -166.86 1.16 Allowed 'General case' 0 C--N 1.388 2.262 0 CA-C-N 109.085 -3.689 . . . . 0.0 111.569 176.794 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.3 t60 34.4 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.146 177.812 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 174.37 -43.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.145 0.974 . . . . 0.0 109.489 179.797 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.95 -13.77 82.29 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 174.71 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.5 -44.67 8.52 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.605 -0.798 . . . . 0.0 109.049 177.907 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.32 11.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.222 0.326 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.54 10.89 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.907 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' VAL . 96.0 t -145.1 -7.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.821 -179.674 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.4 m-20 99.48 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.796 1.31 . . . . 0.0 110.228 -179.566 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.447 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.2 p-80 -162.9 112.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.633 179.984 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.2 t80 -69.82 -3.1 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.989 . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 5.0 m-90 -159.28 -91.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.879 0.371 . . . . 0.0 110.389 179.989 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.19 10.38 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.9 m -150.66 83.55 1.35 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 110.32 -179.988 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.497 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 9.7 pt -61.11 -37.78 78.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.758 -179.882 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 65.7 m-85 -161.47 2.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.39 179.898 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -48.46 -56.99 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.556 179.97 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -82.07 60.31 4.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.671 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -168.57 -11.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.169 -179.937 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' H ' ' H ' ' A' ' 9' ' ' GLY . 9.8 ptp180 -163.33 28.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.746 0.308 . . . . 0.0 110.503 -179.97 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 42.7 t60 -148.8 145.59 27.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.238 179.315 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.027 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.87 -31.42 0.23 Allowed 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 125.65 1.844 . . . . 0.0 109.521 -177.728 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.53 2.32 0.29 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.982 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.027 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.3 tttm -116.3 -169.53 1.63 Allowed 'General case' 0 C--N 1.394 2.512 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.778 177.01 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.6 m170 34.1 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.812 178.2 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 174.8 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.077 0.941 . . . . 0.0 109.641 179.836 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.35 83.58 Favored Glycine 0 C--N 1.275 -2.855 0 N-CA-C 105.508 -3.037 . . . . 0.0 105.508 174.358 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.85 -45.91 7.43 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.483 178.046 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.48 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.615 -179.787 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.32 8.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.882 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 21' ' ' VAL . 50.5 t -147.08 -7.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.657 -179.866 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 15.7 m-20 97.24 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.692 1.245 . . . . 0.0 109.835 -179.374 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.513 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -170.66 -113.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.513 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 31.5 t80 64.64 -6.01 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.931 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 19' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 . . . . . 0 N--CA 1.459 -0.015 0 CA-C-O 121.132 0.491 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.511 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.7 t60 -153.68 144.62 22.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.034 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.15 -31.78 0.23 Allowed 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 125.786 1.929 . . . . 0.0 109.901 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.67 0.3 Allowed 'General case' 0 N--CA 1.411 -2.378 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.034 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.5 tttt -115.26 -169.19 1.52 Allowed 'General case' 0 C--N 1.395 2.559 0 CA-C-N 109.446 -3.524 . . . . 0.0 111.826 177.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 9.5 m-70 32.96 21.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.84 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 173.52 -47.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.63 0 CA-C-O 122.191 0.996 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.74 -14.8 77.99 Favored Glycine 0 C--N 1.271 -3.073 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.466 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.96 -45.92 9.81 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 114.264 -0.968 . . . . 0.0 109.531 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.27 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.941 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.7 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.223 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.2 t -151.01 -29.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.528 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 18.8 t30 136.12 -39.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.63 1.206 . . . . 0.0 109.096 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.528 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 85.5 m-70 -151.93 -131.37 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.31 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.453 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.7 t80 55.53 13.94 1.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.921 0.391 . . . . 0.0 110.311 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.5 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.298 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HE ' ' CA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.049 0.452 . . . . 0.0 109.923 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 18.1 p80 -152.19 145.58 24.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.418 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.046 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 125.742 1.901 . . . . 0.0 109.917 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.311 1 N-CA-C 95.42 -5.771 . . . . 0.0 95.42 165.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.046 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -116.18 -168.26 1.41 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.47 -3.514 . . . . 0.0 111.55 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.2 m-70 34.27 19.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.915 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.33 -45.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 122.253 1.025 . . . . 0.0 109.364 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.39 -13.68 81.44 Favored Glycine 0 C--N 1.273 -2.95 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.46 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -92.09 -43.15 9.55 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.82 178.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.96 41.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.241 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.75 -17.97 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.5 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.2 t -148.63 -34.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 154.89 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.833 0.708 . . . . 0.0 109.115 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -160.9 45.32 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.28 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -66.59 -19.16 65.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.6 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 88.7 mtt180 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.972 0.415 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 46.5 m80 -151.85 143.83 23.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.291 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.86 -31.58 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.675 1.859 . . . . 0.0 109.497 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.34 0.28 Allowed 'General case' 0 N--CA 1.413 -2.324 1 N-CA-C 95.467 -5.753 . . . . 0.0 95.467 164.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.97 -169.04 1.52 Allowed 'General case' 0 C--N 1.394 2.5 0 CA-C-N 109.454 -3.521 . . . . 0.0 111.642 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.8 m-70 33.84 19.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.848 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.677 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.69 -45.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.226 1.012 . . . . 0.0 109.382 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.28 -13.95 81.06 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 105.489 -3.044 . . . . 0.0 105.489 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.463 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -91.38 -43.72 9.58 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.806 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.22 41.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.255 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.94 -19.29 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.497 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.8 t -148.78 -32.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 155.44 -47.88 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -172.49 96.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.263 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 55.4 t80 -164.0 1.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.314 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.18 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 64.5 t-80 -146.57 144.38 29.53 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.181 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.59 -31.41 0.22 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.641 1.838 . . . . 0.0 109.544 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.28 0.28 Allowed 'General case' 0 N--CA 1.412 -2.355 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttm -116.34 -169.49 1.63 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 109.493 -3.503 . . . . 0.0 111.71 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.618 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 23.5 m-70 34.82 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.851 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.4 tt 175.22 -41.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 CA-C-O 122.027 0.917 . . . . 0.0 109.679 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.37 -12.94 84.09 Favored Glycine 0 C--N 1.275 -2.82 0 N-CA-C 105.622 -2.991 . . . . 0.0 105.622 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.62 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.55 -42.75 8.27 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.639 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.37 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.768 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.63 8.62 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -149.41 -9.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.804 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -37.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.468 1.105 . . . . 0.0 110.563 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 18.9 t60 -171.86 178.1 3.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.792 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.593 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 23.9 p90 41.9 26.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.485 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.833 0.349 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.2 t-80 -159.29 143.64 15.27 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.669 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.71 0.23 Allowed 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 125.854 1.971 . . . . 0.0 109.723 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.29 0.27 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.532 -5.729 . . . . 0.0 95.532 165.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.8 tttm -116.61 -169.28 1.6 Allowed 'General case' 0 C--N 1.392 2.421 0 CA-C-N 109.452 -3.522 . . . . 0.0 111.822 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.3 m-70 33.11 22.26 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.789 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.4 tt 169.52 -37.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-O 122.258 1.028 . . . . 0.0 109.186 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.32 -11.81 79.88 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 104.753 -3.339 . . . . 0.0 104.753 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.5 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.2 -36.2 13.4 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 114.397 -0.901 . . . . 0.0 109.879 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.35 26.18 0.6 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.66 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.41 -4.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.279 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 47.4 t -151.3 -27.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.047 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -174.24 -92.26 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.131 0.491 . . . . 0.0 110.978 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.3 t60 -159.62 27.37 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 53.3 t80 -74.92 17.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.685 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' HIS . 9.2 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.421 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.508 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t60 -164.18 146.51 9.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.018 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -32.0 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.88 1.988 . . . . 0.0 110.087 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.85 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.383 -5.784 . . . . 0.0 95.383 165.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.018 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.7 tttm -115.61 -169.83 1.66 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.612 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.9 t-80 34.34 18.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.961 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tt 175.65 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.137 0.97 . . . . 0.0 109.583 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.62 -13.34 83.29 Favored Glycine 0 C--N 1.277 -2.697 0 N-CA-C 105.14 -3.184 . . . . 0.0 105.14 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.95 -45.54 8.29 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 114.394 -0.903 . . . . 0.0 109.242 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.18 13.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.47 8.48 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.8 t -144.26 -9.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER 105.44 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.581 1.175 . . . . 0.0 110.322 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 17.0 t-80 -169.83 -134.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.569 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 85.9 m-85 54.06 20.0 2.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.7 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.992 0.425 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.513 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.6 t-80 -90.4 145.55 24.85 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.251 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.54 -32.43 0.23 Allowed 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 125.751 1.907 . . . . 0.0 110.302 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.96 0.48 0.38 Allowed 'General case' 0 N--CA 1.412 -2.338 1 N-CA-C 95.324 -5.806 . . . . 0.0 95.324 165.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttm -113.53 -169.36 1.49 Allowed 'General case' 0 C--N 1.393 2.477 0 CA-C-N 109.24 -3.618 . . . . 0.0 112.046 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.635 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 30.2 t-80 34.7 18.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.95 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.68 -46.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.257 1.027 . . . . 0.0 109.121 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.28 78.93 Favored Glycine 0 C--N 1.27 -3.108 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.579 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.1 -47.04 7.77 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.091 177.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.89 13.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.11 8.27 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.0 t -144.35 -9.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.432 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.1 t30 103.89 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.521 1.138 . . . . 0.0 109.921 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -178.14 92.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.92 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 88.0 t80 -143.3 9.18 1.63 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.195 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 15.1 ptm180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.701 0.286 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.9 m-70 -157.37 146.31 19.8 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.963 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.52 -31.52 0.22 Allowed 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 125.797 1.935 . . . . 0.0 110.01 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 1.94 0.31 Allowed 'General case' 0 N--CA 1.412 -2.329 1 N-CA-C 95.299 -5.815 . . . . 0.0 95.299 165.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.963 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.04 -169.46 1.61 Allowed 'General case' 0 C--N 1.392 2.447 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.8 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.5 m80 34.78 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.865 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 174.96 -42.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.116 0.96 . . . . 0.0 109.669 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.48 83.45 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.09 -44.77 7.86 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 114.591 -0.805 . . . . 0.0 109.565 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.5 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.444 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.89 8.4 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 49.4 t -148.28 -9.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.241 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.43 1.081 . . . . 0.0 109.874 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.551 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -174.95 176.4 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.423 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 53.58 31.59 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 67.6 mtp180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 70.3 m80 -153.12 145.66 24.16 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.104 0.478 . . . . 0.0 110.818 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.071 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.55 -31.52 0.23 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.83 1.956 . . . . 0.0 109.586 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.72 3.12 0.23 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.477 -5.749 . . . . 0.0 95.477 164.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.071 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.0 tttp -117.68 -169.37 1.66 Allowed 'General case' 0 C--N 1.392 2.443 0 CA-C-N 109.487 -3.506 . . . . 0.0 111.925 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.2 m-70 31.81 25.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.625 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.1 tt 168.08 -35.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.026 0.917 . . . . 0.0 109.029 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.34 -13.3 74.02 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.541 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.5 t60 -86.79 -39.79 15.59 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 114.181 -1.009 . . . . 0.0 110.154 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -149.16 23.51 0.94 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.152 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.91 5.48 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.1 t -150.59 -31.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.551 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' VAL . 3.9 m-20 167.82 -74.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.4 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -163.59 24.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.386 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -50.11 -26.96 5.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.0 m80 -153.16 144.08 22.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.254 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.024 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.36 -31.11 0.22 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.678 1.862 . . . . 0.0 109.564 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.32 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.024 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -116.56 -168.9 1.53 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.393 -3.548 . . . . 0.0 111.667 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.1 m80 34.23 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.814 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.08 -43.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 CA-C-O 122.109 0.957 . . . . 0.0 109.734 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.44 -13.13 83.7 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.42 -44.09 7.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 114.589 -0.806 . . . . 0.0 109.624 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.64 8.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.569 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.02 8.74 1.54 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 21' ' ' VAL . 48.2 t -148.44 -8.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.647 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 20.5 m-20 97.13 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.555 1.159 . . . . 0.0 110.275 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.9 t60 -170.76 -162.63 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.074 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.605 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.1 t80 56.0 12.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 99.4 mtt180 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 21.7 m80 -152.69 146.41 25.11 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.21 -31.03 0.21 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.814 1.946 . . . . 0.0 110.095 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 1.98 0.31 Allowed 'General case' 0 N--CA 1.411 -2.388 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 10.6 ttpt -116.22 -168.86 1.5 Allowed 'General case' 0 C--N 1.395 2.565 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.691 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 83.2 t60 35.02 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.992 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.3 tt 175.65 -44.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.193 0.997 . . . . 0.0 109.507 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.81 -13.77 82.06 Favored Glycine 0 C--N 1.274 -2.877 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.25 -45.39 8.65 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.46 -0.87 . . . . 0.0 108.838 177.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.36 12.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 56.89 11.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 21' ' ' VAL . 95.4 t -145.12 -7.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.11 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.1 m120 100.6 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.89 1.369 . . . . 0.0 110.103 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.8 t-80 -167.42 -136.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.219 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.593 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.5 m-85 46.47 31.6 1.36 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 14.9 ptm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 27.4 m-70 -144.0 146.99 33.27 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.612 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.13 -31.51 0.23 Allowed 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 125.61 1.818 . . . . 0.0 109.812 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.61 2.4 0.29 Allowed 'General case' 0 N--CA 1.411 -2.397 1 N-CA-C 95.339 -5.8 . . . . 0.0 95.339 165.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.8 tttp -116.19 -168.81 1.49 Allowed 'General case' 0 C--N 1.394 2.504 0 CA-C-N 109.479 -3.509 . . . . 0.0 111.561 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m-70 34.1 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.946 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.38 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.55 -14.05 81.41 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 105.486 -3.046 . . . . 0.0 105.486 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.78 -48.48 6.29 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 114.398 -0.901 . . . . 0.0 109.77 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.69 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.66 9.32 1.1 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 21' ' ' VAL . 98.2 t -146.95 -8.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.784 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 25.6 m-20 97.94 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.702 1.251 . . . . 0.0 110.334 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 55.7 m80 -157.48 -160.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.448 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 55.21 22.75 4.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.572 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.289 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 121.115 0.483 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.6 t-80 -156.58 145.39 20.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.41 -31.38 0.22 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.825 1.953 . . . . 0.0 109.629 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.1 0.3 Allowed 'General case' 0 N--CA 1.411 -2.399 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.2 -169.3 1.58 Allowed 'General case' 0 C--N 1.393 2.475 0 CA-C-N 109.423 -3.535 . . . . 0.0 111.737 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.23 19.64 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.791 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 173.87 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 CA-C-O 122.054 0.93 . . . . 0.0 109.567 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.17 -12.87 84.21 Favored Glycine 0 C--N 1.274 -2.89 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.614 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.78 -44.49 8.11 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.075 177.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.3 13.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.12 9.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -144.76 -9.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.324 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t30 104.38 -36.79 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.628 1.205 . . . . 0.0 110.214 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 20.8 t-80 -170.38 -126.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.379 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.57 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 97.1 m-85 53.44 11.99 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.559 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.956 0.407 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.1 t60 -157.3 147.3 20.69 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.54 -31.6 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.758 1.912 . . . . 0.0 110.048 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 2.1 0.3 Allowed 'General case' 0 N--CA 1.412 -2.349 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 165.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.3 tttt -116.08 -168.79 1.49 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.696 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.4 t-80 34.23 19.31 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.847 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 174.57 -46.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 CA-C-O 122.308 1.052 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.54 -14.23 77.57 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.33 -46.88 7.16 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.523 -0.839 . . . . 0.0 109.559 178.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.88 14.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.93 5.65 1.03 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.9 t -144.6 -8.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.343 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 15.5 t30 105.35 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.578 1.174 . . . . 0.0 109.958 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 2.2 p-80 -170.58 107.74 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 72.9 t80 -59.92 -9.54 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.453 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 48.2 t-80 -156.75 145.65 20.12 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.006 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.74 -31.65 0.23 Allowed 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 125.835 1.959 . . . . 0.0 109.889 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.46 2.14 0.29 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.006 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttp -116.24 -169.09 1.54 Allowed 'General case' 0 C--N 1.393 2.497 0 CA-C-N 109.435 -3.53 . . . . 0.0 111.68 177.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.36 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.961 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.12 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.61 0 CA-C-O 122.015 0.912 . . . . 0.0 109.524 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.35 -13.29 83.42 Favored Glycine 0 C--N 1.276 -2.781 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.537 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.5 m170 -94.66 -47.52 6.47 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.709 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.0 12.85 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.26 7.45 1.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.373 0.606 . . . . 0.0 109.388 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.3 t -148.31 -9.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.106 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 39.8 t-20 101.66 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.463 1.102 . . . . 0.0 110.084 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' A' ' 25' ' ' LEU . 76.4 m80 -150.48 112.85 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.383 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.45 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 61.8 t80 -53.8 -10.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 23' ' ' HIS . 14.9 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.446 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 11' ' ' HIS . 51.2 mtt-85 . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 39.7 m80 60.08 136.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.544 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.69 -32.43 0.24 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.631 1.832 . . . . 0.0 109.637 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.18 1.32 0.32 Allowed 'General case' 0 N--CA 1.41 -2.431 1 N-CA-C 95.34 -5.8 . . . . 0.0 95.34 164.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.1 tttt -114.62 -169.05 1.47 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.592 -3.458 . . . . 0.0 111.843 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 56.8 m-70 34.44 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.763 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 174.61 -46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-O 122.2 1.0 . . . . 0.0 109.422 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -13.69 80.06 Favored Glycine 0 C--N 1.271 -3.071 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.27 -43.14 9.45 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.643 -0.778 . . . . 0.0 109.853 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.226 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.93 -17.89 0.16 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.55 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 19' ' ' ALA . 24.0 t -149.24 -32.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.759 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 156.87 -47.7 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -166.98 68.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.556 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.459 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 68.7 t80 -58.22 -21.66 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.566 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.481 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.505 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.1 t-80 -158.85 146.8 17.96 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.72 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.022 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.99 -31.97 0.24 Allowed 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 125.791 1.932 . . . . 0.0 109.991 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.92 0.29 Allowed 'General case' 0 N--CA 1.412 -2.35 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 165.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.022 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttp -115.59 -169.68 1.63 Allowed 'General case' 0 C--N 1.393 2.465 0 CA-C-N 109.323 -3.58 . . . . 0.0 111.623 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.614 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.5 t60 34.47 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.033 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 176.07 -43.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 CA-C-O 122.093 0.949 . . . . 0.0 109.477 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.55 -14.48 81.99 Favored Glycine 0 C--N 1.274 -2.863 0 N-CA-C 105.197 -3.161 . . . . 0.0 105.197 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -90.29 -49.38 6.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.179 177.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.57 13.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.16 0.288 . . . . 0.0 110.309 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.48 7.85 1.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.9 t -141.71 -9.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t-20 105.17 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.607 1.192 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.0 t-80 84.71 26.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.008 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.38 -13.66 62.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.277 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.837 0.351 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 98.5 m-70 -136.48 92.02 2.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.318 0.58 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.0 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 138.74 -32.86 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -0.39 0.58 Allowed 'General case' 0 N--CA 1.414 -2.25 1 N-CA-C 95.398 -5.779 . . . . 0.0 95.398 164.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.0 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.9 tttt -114.59 -168.78 1.42 Allowed 'General case' 0 C--N 1.391 2.378 0 CA-C-N 109.441 -3.527 . . . . 0.0 112.001 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 81.4 m-70 33.45 21.7 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.833 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.75 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.237 1.018 . . . . 0.0 109.452 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.37 -11.5 80.32 Favored Glycine 0 C--N 1.276 -2.751 0 N-CA-C 104.848 -3.301 . . . . 0.0 104.848 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.498 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -91.76 -36.75 13.39 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.843 178.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.45 26.22 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.707 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.13 0.15 0.05 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.269 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.5 t -151.47 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.266 0.079 . . . . 0.0 110.823 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.598 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -178.87 -89.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.598 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 1.7 t60 -166.51 50.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.407 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 48.4 t80 -74.58 -15.81 60.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.585 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.501 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.6 t60 -157.52 146.25 19.54 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.632 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 125.71 1.881 . . . . 0.0 109.898 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.27 1.95 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.044 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.4 tttt -115.69 -169.26 1.55 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.744 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.62 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 33.89 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.792 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.4 tt 174.37 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-O 122.202 1.001 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.0 -13.86 80.66 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.495 -3.042 . . . . 0.0 105.495 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.447 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -91.05 -43.53 9.87 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.674 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.37 41.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.221 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.7 -16.99 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.587 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.7 t -148.95 -34.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t30 155.28 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.827 0.704 . . . . 0.0 109.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.54 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 29.4 t60 -162.89 -117.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.54 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 59.6 t80 54.62 18.0 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.336 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.85 0.357 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 91.8 m-70 -152.8 145.39 24.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.55 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.36 -31.25 0.22 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.701 1.876 . . . . 0.0 109.726 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 2.02 0.31 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.353 -5.795 . . . . 0.0 95.353 164.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.029 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.2 ttpt -115.9 -169.28 1.56 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.424 -3.535 . . . . 0.0 111.577 176.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.2 t-80 34.45 17.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.001 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.7 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.123 0.964 . . . . 0.0 109.565 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -13.68 83.17 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 105.386 -3.086 . . . . 0.0 105.386 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.18 -47.42 7.53 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.211 -0.995 . . . . 0.0 109.251 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.45 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.273 0.358 . . . . 0.0 110.135 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.07 10.2 1.54 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 92.5 t -142.63 -9.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 22.7 t-20 101.89 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.464 1.102 . . . . 0.0 110.813 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.553 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.5 t60 81.63 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.237 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.553 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.1 m-85 50.36 31.95 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.244 -179.923 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 61.9 mtp180 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 90.6 m-70 -156.38 144.85 19.94 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.96 -31.93 0.23 Allowed 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 125.737 1.898 . . . . 0.0 109.892 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.91 0.31 Allowed 'General case' 0 N--CA 1.412 -2.37 1 N-CA-C 95.406 -5.776 . . . . 0.0 95.406 165.057 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.3 tttm -115.15 -169.78 1.63 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.5 -3.5 . . . . 0.0 111.803 176.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.0 t60 34.39 17.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.108 178.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 176.38 -44.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.224 1.011 . . . . 0.0 109.078 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.35 -13.93 82.4 Favored Glycine 0 C--N 1.274 -2.905 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 174.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 m170 -92.28 -47.91 6.96 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.465 -0.867 . . . . 0.0 109.457 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.38 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.641 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.54 7.83 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.411 0.624 . . . . 0.0 109.46 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 48.9 t -146.22 -8.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.958 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.0 t-20 102.52 -37.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.631 1.207 . . . . 0.0 110.031 -179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -173.93 104.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.618 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 48.2 t80 -171.68 -4.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' H ' ' H ' ' A' ' 24' ' ' TYR . 15.9 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.13 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 11' ' ' HIS . 13.9 ptm180 . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.816 0.341 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.9 m170 -135.82 146.75 47.84 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.278 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.993 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -31.62 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.734 1.896 . . . . 0.0 109.851 -177.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 1.99 0.31 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.443 -5.762 . . . . 0.0 95.443 165.051 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.993 ' N ' ' C ' ' A' ' 12' ' ' ALA . 18.7 tttp -115.57 -169.12 1.52 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.406 -3.543 . . . . 0.0 111.737 176.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.8 t60 33.72 19.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.89 178.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.31 -45.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.125 0.964 . . . . 0.0 109.551 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.05 -14.33 80.44 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 105.402 -3.079 . . . . 0.0 105.402 174.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 m170 -91.67 -48.96 6.54 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.325 -0.937 . . . . 0.0 109.182 177.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.08 14.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.29 9.63 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.5 t -144.63 -10.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.845 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.2 t-20 105.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.542 1.151 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 4.9 t-160 83.98 28.02 0.08 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.372 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.61 -19.37 25.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.4 t-80 -157.22 143.6 18.02 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.324 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.85 -30.73 0.21 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.37 -177.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.87 3.29 0.24 Allowed 'General case' 0 N--CA 1.41 -2.46 1 N-CA-C 95.332 -5.803 . . . . 0.0 95.332 164.741 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.023 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.8 tttp -119.05 -168.13 1.51 Allowed 'General case' 0 C--N 1.392 2.428 0 CA-C-N 109.457 -3.52 . . . . 0.0 111.684 177.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.4 m80 33.5 23.27 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.556 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.63 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.3 tt 167.41 -34.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.166 0.984 . . . . 0.0 109.256 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.63 -12.37 77.99 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 104.902 -3.279 . . . . 0.0 104.902 174.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 18' ' ' HIS . 18.4 t-160 -92.56 -36.04 13.25 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 114.425 -0.887 . . . . 0.0 110.013 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -146.91 22.88 1.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.96 -2.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.3 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.9 -30.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.738 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -176.63 -90.16 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.011 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.1 p80 -149.75 25.99 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.48 ' N ' ' CB ' ' A' ' 19' ' ' ALA . 45.5 t80 -72.46 12.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.4 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.253 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.1 t60 -157.49 145.24 18.82 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.024 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.81 -31.72 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.706 1.879 . . . . 0.0 109.805 -178.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.86 0.3 Allowed 'General case' 0 N--CA 1.412 -2.361 1 N-CA-C 95.303 -5.814 . . . . 0.0 95.303 164.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.024 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.556 -3.474 . . . . 0.0 111.876 177.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 49.3 t-80 33.91 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.787 178.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.14 -46.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 122.234 1.016 . . . . 0.0 109.319 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -13.63 80.57 Favored Glycine 0 C--N 1.271 -3.076 0 N-CA-C 105.571 -3.011 . . . . 0.0 105.571 174.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.434 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.21 -43.09 10.05 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.533 178.181 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.42 41.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.181 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.41 -15.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.612 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.17 -35.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.2 t30 155.53 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.806 0.691 . . . . 0.0 109.19 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -166.11 65.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.6 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.469 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 65.1 t80 -70.12 -13.59 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.451 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.005 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.0 t60 -157.25 145.2 19.12 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.041 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.03 -31.57 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.702 1.876 . . . . 0.0 109.75 -177.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.85 0.31 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.416 -5.772 . . . . 0.0 95.416 164.914 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.041 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.8 tttt -115.35 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.45 -3.523 . . . . 0.0 111.759 176.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 11.7 t-80 34.51 18.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.985 177.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.668 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.88 -46.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.307 1.051 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.16 -14.49 79.0 Favored Glycine 0 C--N 1.271 -3.035 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.3 -48.63 6.58 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.471 -0.865 . . . . 0.0 109.539 178.113 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.26 12.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.433 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.1 8.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 21' ' ' VAL . 89.5 t -145.78 -7.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.783 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.6 m-20 98.57 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.764 1.29 . . . . 0.0 110.19 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -176.76 87.15 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.352 -179.927 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -66.82 -21.38 66.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.984 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 t-80 -160.82 144.05 13.16 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.463 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.05 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.58 -31.11 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.568 1.792 . . . . 0.0 109.458 -177.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.34 0.3 Allowed 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 95.317 -5.808 . . . . 0.0 95.317 164.758 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.05 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.1 tttm -116.33 -169.29 1.59 Allowed 'General case' 0 C--N 1.393 2.468 0 CA-C-N 109.525 -3.489 . . . . 0.0 111.556 177.063 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 34.77 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.99 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 175.83 -41.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.58 0 CA-C-O 122.042 0.925 . . . . 0.0 109.471 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.1 -13.01 83.8 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 105.331 -3.108 . . . . 0.0 105.331 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.4 m170 -94.38 -46.29 7.09 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.541 178.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.63 13.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.772 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.55 5.92 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 20.7 t -148.13 -10.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.391 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 58.2 t-20 110.53 -42.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.632 1.208 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 63.2 t-80 -173.9 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.649 0.262 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.05 39.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.477 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.2 tp . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.264 0.554 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.5 t60 -150.16 144.73 25.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.006 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.42 -31.4 0.22 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 125.75 1.906 . . . . 0.0 109.648 -177.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.4 0.27 Allowed 'General case' 0 N--CA 1.413 -2.308 1 N-CA-C 95.363 -5.791 . . . . 0.0 95.363 164.952 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.006 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.2 tttt -116.63 -168.63 1.48 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.485 -3.507 . . . . 0.0 111.669 177.096 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.1 m-70 33.82 20.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.825 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 173.76 -43.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 122.108 0.956 . . . . 0.0 109.61 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.22 -13.24 83.48 Favored Glycine 0 C--N 1.274 -2.911 0 N-CA-C 105.57 -3.012 . . . . 0.0 105.57 174.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.77 -45.51 7.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.483 178.117 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.62 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.34 7.16 1.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -146.59 -9.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.369 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 37.7 t-20 103.46 -35.93 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.514 1.134 . . . . 0.0 110.058 -179.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.535 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -171.58 112.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.346 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -64.17 -1.03 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.634 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.977 0.418 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' ALA . 5.7 p80 -155.04 143.77 20.68 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.63 -31.07 0.22 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.694 1.871 . . . . 0.0 109.523 -177.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.02 0.29 Allowed 'General case' 0 N--CA 1.411 -2.391 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 165.078 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.045 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.9 ttpt -116.96 -168.18 1.42 Allowed 'General case' 0 C--N 1.393 2.498 0 CA-C-N 109.398 -3.546 . . . . 0.0 111.498 177.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.4 t-80 34.11 20.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.631 177.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 171.36 -46.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 CA-C-O 122.303 1.049 . . . . 0.0 109.254 -179.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.69 -13.12 80.6 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.975 -2.85 . . . . 0.0 105.975 175.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.43 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.55 -32.21 18.27 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.84 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.795 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -172.56 -20.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CD2' ' A' ' 15' ' ' HIS . 59.9 t -152.0 -17.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.562 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 164.58 -38.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.958 0.409 . . . . 0.0 110.017 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 31.4 t60 -171.34 26.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.352 -178.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -47.62 -18.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.303 179.935 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.821 0.344 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.53 ' C ' ' H ' ' A' ' 13' ' ' ALA . 74.9 t60 -158.48 146.4 18.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.05 -31.31 0.22 Allowed 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 125.821 1.951 . . . . 0.0 109.738 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.79 0.26 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.313 -5.81 . . . . 0.0 95.313 164.957 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.039 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -117.37 -168.62 1.52 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.462 -3.517 . . . . 0.0 111.859 177.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.1 t60 33.86 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.331 178.124 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 172.13 -45.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 CA-C-O 122.058 0.933 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.13 76.34 Favored Glycine 0 C--N 1.272 -3.026 0 N-CA-C 105.812 -2.915 . . . . 0.0 105.812 175.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 7.9 t-80 -93.29 -41.95 9.59 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.31 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.39 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.621 -179.379 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.62 -12.51 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.016 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.0 t -148.94 -36.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 121.284 -0.166 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.3 t-20 157.52 -46.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.79 95.8 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.713 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.432 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.4 t80 -170.32 1.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.71 179.965 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.561 ' N ' ' ND1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -90.14 146.28 24.41 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.201 -179.543 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.65 -32.47 0.23 Allowed 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 125.582 1.801 . . . . 0.0 110.18 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.86 0.39 0.38 Allowed 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 95.382 -5.784 . . . . 0.0 95.382 165.031 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.2 tttt -113.39 -169.93 1.59 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.138 -3.665 . . . . 0.0 112.169 176.546 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.0 m80 34.47 18.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.896 177.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.83 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 CA-C-O 122.284 1.04 . . . . 0.0 109.169 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.19 -14.62 78.98 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 105.516 -3.033 . . . . 0.0 105.516 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.72 -47.99 6.8 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.686 -0.757 . . . . 0.0 109.654 177.996 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.38 11.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.37 8.73 1.23 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 21' ' ' VAL . 57.7 t -148.04 -7.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.872 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 6.3 m-20 97.61 -36.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.605 1.191 . . . . 0.0 110.087 -179.452 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 75.4 m80 -158.43 -166.15 1.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.221 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 55.94 27.01 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.118 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 74.9 m80 -145.06 93.37 2.38 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.414 0.626 . . . . 0.0 109.638 178.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 137.45 -31.46 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -178.161 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.69 0.54 0.49 Allowed 'General case' 0 N--CA 1.413 -2.3 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 163.9 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.5 tttm -116.76 -167.89 1.37 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.383 -3.553 . . . . 0.0 111.703 177.024 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.659 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 58.1 m80 33.9 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.955 178.076 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.655 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.8 tt 171.5 -37.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.265 1.031 . . . . 0.0 109.166 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.13 -11.35 81.18 Favored Glycine 0 C--N 1.275 -2.808 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 174.119 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.468 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.3 m170 -95.86 -34.16 11.95 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.078 178.385 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.05 26.6 0.62 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.437 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.22 -11.71 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 19' ' ' ALA . 90.3 t -152.96 -23.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.322 -179.31 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 38.0 t30 -170.45 -96.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.374 -179.003 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 33.4 m80 -145.51 127.2 15.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.724 -178.616 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.486 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 67.4 t80 -75.64 -4.38 39.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.124 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.414 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 10' ' ' ARG . 32.8 m80 -146.6 75.01 1.38 Allowed 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 178.642 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.012 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 172.2 -32.19 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.513 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.73 -1.73 0.67 Allowed 'General case' 0 N--CA 1.416 -2.126 1 N-CA-C 95.548 -5.723 . . . . 0.0 95.548 164.827 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.012 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.259 20.8 tttm -114.01 -167.74 1.25 Allowed 'General case' 0 C--N 1.387 2.217 0 CA-C-N 109.179 -3.646 . . . . 0.0 111.705 176.648 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.64 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.88 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.978 177.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.2 tt 174.22 -44.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.142 0.973 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.45 -13.43 81.72 Favored Glycine 0 C--N 1.273 -2.955 0 N-CA-C 105.843 -2.903 . . . . 0.0 105.843 174.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.616 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.7 -42.79 10.52 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.682 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 156.33 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.68 7.56 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.6 t -144.88 -11.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -179.85 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 49.4 t30 119.13 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.607 1.192 . . . . 0.0 110.091 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.437 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.8 t60 -172.47 -8.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.643 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -76.06 32.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.9 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.206 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.6 t-80 -149.52 145.94 27.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.579 179.513 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.042 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.34 -31.3 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.668 1.855 . . . . 0.0 109.719 -177.859 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.64 2.24 0.3 Allowed 'General case' 0 N--CA 1.412 -2.335 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 164.896 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.042 ' H ' ' C ' ' A' ' 12' ' ' ALA . 11.2 ttpt -115.95 -168.92 1.5 Allowed 'General case' 0 C--N 1.395 2.554 0 CA-C-N 109.448 -3.524 . . . . 0.0 111.546 176.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.4 m80 34.72 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.013 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 176.06 -44.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.204 1.002 . . . . 0.0 109.46 -179.822 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.76 -14.0 81.8 Favored Glycine 0 C--N 1.273 -2.954 0 N-CA-C 105.449 -3.061 . . . . 0.0 105.449 174.43 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.554 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.43 -47.27 7.54 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.407 177.948 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.75 11.61 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.26 8.85 1.19 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.749 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 77.4 t -144.03 -9.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.113 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.7 t-20 100.15 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.525 1.141 . . . . 0.0 110.252 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.6 t60 89.4 -38.97 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.893 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -76.58 13.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.3 tt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.128 0.489 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 m170 -84.63 144.44 28.6 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.279 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.015 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.21 -32.05 0.24 Allowed 'General case' 0 CA--C 1.501 -0.922 0 O-C-N 125.403 1.689 . . . . 0.0 109.613 -177.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.07 0.5 0.4 Allowed 'General case' 0 N--CA 1.413 -2.285 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 164.855 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.015 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.4 tttt -113.87 -169.66 1.56 Allowed 'General case' 0 C--N 1.39 2.369 0 CA-C-N 109.083 -3.69 . . . . 0.0 111.974 176.432 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.9 t-80 35.16 17.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.977 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 176.19 -43.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.031 0.919 . . . . 0.0 109.465 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 -14.27 82.18 Favored Glycine 0 C--N 1.272 -3.02 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 174.336 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.94 -47.83 7.09 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.464 -0.868 . . . . 0.0 109.55 177.938 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.77 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.92 10.44 1.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 21' ' ' VAL . 98.2 t -146.57 -7.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.764 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.3 m120 97.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.567 1.167 . . . . 0.0 110.228 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 96.1 m-70 -159.34 101.78 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -55.14 -14.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.04 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 16.2 ptm180 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.668 0.27 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 m-70 -155.52 145.54 21.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.932 0.396 . . . . 0.0 110.554 179.291 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.92 -31.85 0.23 Allowed 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 125.689 1.868 . . . . 0.0 109.657 -177.831 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.35 2.06 0.29 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 165.063 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.029 ' N ' ' C ' ' A' ' 12' ' ' ALA . 33.1 tttt -115.63 -169.69 1.63 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.821 177.098 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 34.3 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.792 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.62 -45.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.142 0.972 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.37 -13.94 81.21 Favored Glycine 0 C--N 1.273 -2.956 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.488 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.28 -43.91 9.52 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.85 178.159 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.24 -179.131 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.23 -17.05 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.535 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 19' ' ' ALA . 15.8 t -148.21 -34.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.4 t-20 154.22 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.1 t60 -168.67 113.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -56.42 -7.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.428 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.353 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.564 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.7 t-80 -111.4 146.27 37.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.662 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -30.37 0.21 Allowed 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 125.663 1.852 . . . . 0.0 109.391 -177.376 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.05 3.47 0.24 Allowed 'General case' 0 N--CA 1.41 -2.444 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.602 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 26.8 tttt -119.46 -167.49 1.42 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.605 177.424 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.3 m-70 34.31 22.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 177.705 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.8 tt 169.0 -35.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.239 1.018 . . . . 0.0 109.22 -179.293 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.91 -12.12 80.27 Favored Glycine 0 C--N 1.275 -2.814 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 174.114 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.509 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.2 t60 -93.66 -37.18 11.97 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.938 177.898 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -147.8 25.98 1.03 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.895 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.63 -9.25 0.14 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 19' ' ' ALA . 61.4 t -151.23 -26.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.263 -179.346 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 34.3 t30 -171.18 -94.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.277 -179.173 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.557 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 0.6 OUTLIER -152.65 28.55 0.54 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.857 -179.662 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -77.53 19.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.477 179.787 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.6 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.26 179.913 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 93.4 mtt180 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 m80 -156.52 144.52 19.52 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.504 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.86 -31.7 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.77 1.919 . . . . 0.0 109.803 -178.073 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.63 0.31 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 95.39 -5.781 . . . . 0.0 95.39 164.961 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.025 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttm -115.04 -169.22 1.51 Allowed 'General case' 0 C--N 1.395 2.553 0 CA-C-N 109.484 -3.507 . . . . 0.0 111.802 176.971 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 33.98 19.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.847 178.062 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.7 -46.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 CA-C-O 122.23 1.014 . . . . 0.0 109.247 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 -13.97 79.7 Favored Glycine 0 C--N 1.271 -3.042 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 174.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.469 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -90.83 -43.86 9.79 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.582 178.177 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.249 -179.178 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.33 -17.82 0.14 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.705 -179.501 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.6 t -149.29 -31.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 122.493 -0.13 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t-20 155.69 -47.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.804 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 9.0 t60 -163.91 -130.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.582 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.7 m-85 54.23 22.43 3.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.486 -179.854 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.543 179.96 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 CA--C 1.518 -0.271 0 CA-C-O 121.257 0.551 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.54 ' C ' ' H ' ' A' ' 13' ' ' ALA . 6.1 p-80 -169.62 143.43 2.73 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.07 179.441 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 72.0 -31.31 0.22 Allowed 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 125.632 1.833 . . . . 0.0 109.287 -177.566 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 2.65 0.25 Allowed 'General case' 0 N--CA 1.411 -2.415 1 N-CA-C 95.39 -5.782 . . . . 0.0 95.39 164.975 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.031 ' N ' ' C ' ' A' ' 12' ' ' ALA . 16.5 ttpp -116.19 -169.6 1.64 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.679 177.008 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.1 m-70 34.11 18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.904 178.154 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 175.07 -43.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.118 0.961 . . . . 0.0 109.477 179.838 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.4 83.49 Favored Glycine 0 C--N 1.274 -2.888 0 N-CA-C 105.411 -3.075 . . . . 0.0 105.411 174.425 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.37 -45.92 7.59 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 114.537 -0.832 . . . . 0.0 109.44 178.049 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.34 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.061 0.226 . . . . 0.0 110.444 -179.803 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.68 10.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.914 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 21' ' ' VAL . 61.1 t -147.75 -8.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.981 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.4 m-20 99.47 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.609 1.193 . . . . 0.0 110.265 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 42.8 p-80 -171.94 97.91 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.803 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -76.25 9.61 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.539 179.882 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.9 m80 -162.12 145.25 11.75 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.064 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.2 -31.35 0.22 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.621 1.826 . . . . 0.0 109.538 -177.752 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.45 0.26 Allowed 'General case' 0 N--CA 1.412 -2.356 1 N-CA-C 95.29 -5.818 . . . . 0.0 95.29 165.033 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.064 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.1 tttt -116.35 -169.24 1.58 Allowed 'General case' 0 C--N 1.394 2.51 0 CA-C-N 109.547 -3.478 . . . . 0.0 111.795 177.074 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.7 t60 34.65 17.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.975 178.094 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 175.43 -41.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.043 0.925 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.62 -13.02 83.94 Favored Glycine 0 C--N 1.276 -2.783 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 174.412 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.01 -43.78 8.74 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 114.439 -0.88 . . . . 0.0 109.209 178.046 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.27 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.55 10.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.06 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.1 t -145.81 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.02 -179.828 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.8 t-20 102.46 -36.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.585 1.178 . . . . 0.0 110.189 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -170.48 102.95 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.649 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 51.9 t80 -167.68 -4.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.216 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 51.2 t-80 -170.06 143.75 2.55 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.453 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.44 -31.45 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.596 1.81 . . . . 0.0 109.547 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.34 1.74 0.31 Allowed 'General case' 0 N--CA 1.41 -2.433 1 N-CA-C 95.386 -5.783 . . . . 0.0 95.386 164.899 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.6 tttm -115.47 -169.53 1.59 Allowed 'General case' 0 C--N 1.393 2.492 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.711 177.014 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.8 m-70 34.48 17.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.97 178.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.05 -44.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.135 0.969 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.06 -14.26 81.97 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 174.335 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.89 -48.12 7.43 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.246 -0.977 . . . . 0.0 109.102 177.87 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.89 13.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.49 10.85 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 94.1 t -140.23 -9.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 44.9 t-20 107.56 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.65 1.219 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 19.1 t60 80.64 34.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.035 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.47 -31.71 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.249 -179.887 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 53.8 t-80 -164.51 145.0 7.83 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.868 179.407 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -31.71 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.706 1.879 . . . . 0.0 109.99 -178.087 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 1.88 0.32 Allowed 'General case' 0 N--CA 1.413 -2.32 1 N-CA-C 95.389 -5.782 . . . . 0.0 95.389 164.922 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.515 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.71 176.895 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 41.5 m80 33.94 18.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.995 178.094 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.6 tt 175.29 -43.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-O 122.011 0.91 . . . . 0.0 109.483 179.842 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -13.89 82.68 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.325 -3.11 . . . . 0.0 105.325 174.34 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.25 -47.58 7.42 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 114.368 -0.916 . . . . 0.0 109.23 177.95 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.6 14.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 11.29 0.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.873 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 97.1 t -140.85 -9.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 17.8 t-20 106.85 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.603 1.19 . . . . 0.0 110.427 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 1.2 t-80 83.05 -1.09 1.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.216 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -76.38 -7.85 55.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.501 -179.99 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.443 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 77.6 mtp180 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.356 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.0 m80 -151.68 147.01 26.21 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 179.636 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.034 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.93 -31.89 0.23 Allowed 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 125.678 1.861 . . . . 0.0 110.018 -178.227 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 95.426 -5.768 . . . . 0.0 95.426 165.158 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.034 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.9 tttm -115.51 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 109.409 -3.541 . . . . 0.0 111.818 177.058 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.2 t60 33.99 19.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.86 177.842 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.48 -45.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.363 -179.982 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.43 -13.99 81.28 Favored Glycine 0 C--N 1.273 -2.971 0 N-CA-C 105.406 -3.078 . . . . 0.0 105.406 174.317 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.474 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.52 9.65 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 114.495 -0.853 . . . . 0.0 109.677 178.111 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.67 41.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.176 -179.076 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.92 -19.73 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.471 -179.361 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 19' ' ' ALA . 39.4 t -149.05 -31.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 156.09 -48.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 25.4 t60 -171.54 5.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 50.5 t80 -73.62 10.53 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.475 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.6 tt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.122 -179.969 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.9 mtp-105 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.914 0.387 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.8 t-80 -158.88 143.64 15.88 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.427 179.537 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.37 -31.58 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.641 1.838 . . . . 0.0 109.673 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.84 0.31 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.387 -5.782 . . . . 0.0 95.387 164.838 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.6 -169.22 1.54 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.432 -3.531 . . . . 0.0 111.658 176.936 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.7 t-80 34.98 17.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.903 177.902 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.87 -46.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.413 1.101 . . . . 0.0 109.231 -179.875 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.76 79.82 Favored Glycine 0 C--N 1.272 -3.003 0 N-CA-C 105.825 -2.91 . . . . 0.0 105.825 174.627 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.82 -44.48 8.92 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.655 -0.772 . . . . 0.0 109.128 177.917 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.02 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.63 8.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.165 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 74.4 t -144.06 -9.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.386 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.0 t30 105.31 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.662 1.226 . . . . 0.0 110.14 -179.837 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 16.8 t-80 -169.38 -127.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 69.7 m-85 50.18 23.54 1.2 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.799 0.333 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.989 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.97 0.414 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.6 t-80 -169.11 145.7 3.48 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.954 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.046 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.84 -31.79 0.23 Allowed 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 125.811 1.944 . . . . 0.0 109.974 -178.306 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.74 0.3 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.327 -5.805 . . . . 0.0 95.327 165.206 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.046 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -115.94 -169.55 1.62 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.942 177.152 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.7 18.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.787 178.103 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.93 -44.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.169 0.985 . . . . 0.0 109.605 -179.871 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.91 -13.62 82.35 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 174.854 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.613 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.41 -43.19 9.35 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.831 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 160.36 11.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 11.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.697 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 21' ' ' VAL . 91.4 t -145.41 -8.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.018 -179.596 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.5 m120 100.16 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.737 1.273 . . . . 0.0 110.398 -179.597 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.7 t60 -165.14 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.2 m-85 49.13 21.45 0.5 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.756 0.313 . . . . 0.0 110.671 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.466 -179.987 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 40.0 t60 -162.85 144.91 10.36 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 179.378 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -30.8 0.21 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.866 1.978 . . . . 0.0 109.75 -177.819 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.83 3.05 0.25 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 164.808 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.4 tttp -118.2 -168.31 1.5 Allowed 'General case' 0 C--N 1.394 2.517 0 CA-C-N 109.606 -3.452 . . . . 0.0 111.687 177.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.3 m-70 33.71 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.418 178.186 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 172.87 -43.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 179.84 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.41 78.64 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 174.703 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 22' ' ' ASN . 6.9 t-80 -92.85 -43.45 8.98 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.344 178.099 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 46.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.468 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 64.17 -18.69 0.07 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.961 -179.589 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 19' ' ' ALA . 25.7 t -148.76 -32.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.03 -179.834 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.6 t-20 158.34 -49.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.607 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -171.81 62.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.394 -179.784 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -56.63 -24.33 47.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.491 -179.889 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.828 0.347 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.3 t60 -160.08 144.53 14.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.412 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.032 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.78 -29.18 0.19 Allowed 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 125.521 1.763 . . . . 0.0 109.798 -177.934 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.13 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 1 N-CA-C 94.819 -5.993 . . . . 0.0 94.819 164.293 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.032 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.6 tttt -116.96 -160.28 0.76 Allowed 'General case' 0 C--N 1.397 2.657 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.637 176.967 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.553 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.7 t60 30.62 20.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.448 0.699 . . . . 0.0 112.199 178.59 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 173.14 -48.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-O 122.435 1.112 . . . . 0.0 109.228 -179.27 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.6 -13.67 71.61 Favored Glycine 0 C--N 1.27 -3.09 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 175.297 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.586 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.95 -44.5 7.33 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 114.546 -0.827 . . . . 0.0 109.455 178.216 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.46 10.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -179.943 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.61 7.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.981 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 48.5 t -144.75 -8.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.919 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 61.5 t30 102.18 -37.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.525 1.141 . . . . 0.0 110.4 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -173.8 78.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.473 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 54.3 t80 -72.88 -19.08 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.502 179.828 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.433 179.947 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.08 0.467 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.554 ' C ' ' H ' ' A' ' 13' ' ' ALA . 38.8 t-80 -165.71 143.02 5.59 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.702 179.454 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.993 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 72.01 -30.92 0.22 Allowed 'General case' 0 CA--C 1.497 -1.069 0 O-C-N 125.632 1.833 . . . . 0.0 109.212 -177.513 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.3 0.29 Allowed 'General case' 0 N--CA 1.41 -2.467 1 N-CA-C 95.273 -5.825 . . . . 0.0 95.273 164.848 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.993 ' N ' ' C ' ' A' ' 12' ' ' ALA . 2.3 ttpm? -116.86 -169.43 1.64 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.497 -3.502 . . . . 0.0 111.621 177.056 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.638 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 48.6 t-80 33.97 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.82 177.702 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.85 -37.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.256 1.027 . . . . 0.0 109.423 -179.363 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.33 -11.29 80.8 Favored Glycine 0 C--N 1.275 -2.853 0 N-CA-C 105.029 -3.228 . . . . 0.0 105.029 174.074 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.478 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.47 -35.87 12.74 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.776 178.212 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.42 26.76 0.59 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.641 -179.619 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.27 -8.18 0.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.567 179.025 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' ALA . 60.5 t -151.48 -25.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.254 -179.355 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -171.45 -94.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.312 -179.272 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 13.8 t-160 -158.86 17.98 0.19 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.448 -179.589 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -70.96 8.33 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 16.3 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.217 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.842 0.353 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 t60 -151.64 145.44 25.08 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.659 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.07 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.71 0.23 Allowed 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.734 1.896 . . . . 0.0 109.848 -178.008 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.91 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.422 -5.77 . . . . 0.0 95.422 165.085 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.07 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.51 -169.18 1.53 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.424 -3.534 . . . . 0.0 111.744 177.081 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.7 t60 33.92 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.816 177.966 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.24 -46.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.288 1.042 . . . . 0.0 109.306 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.61 -14.01 79.94 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 174.517 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.02 9.99 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.624 178.21 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.28 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.251 -179.054 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.48 -18.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.523 -179.435 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.9 t -148.29 -32.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.908 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 155.19 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.982 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -164.2 65.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.621 -179.866 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.51 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 62.0 t80 -50.84 -14.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.849 0.356 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.2 t60 -163.61 146.15 9.77 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.376 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.075 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -31.62 0.23 Allowed 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 125.775 1.922 . . . . 0.0 109.956 -178.072 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.13 0.29 Allowed 'General case' 0 N--CA 1.411 -2.385 1 N-CA-C 95.341 -5.8 . . . . 0.0 95.341 164.995 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.075 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.96 -169.33 1.58 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.825 177.012 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.0 t60 33.95 18.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.991 178.169 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.18 -42.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 CA-C-O 122.093 0.949 . . . . 0.0 109.459 179.817 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.39 -13.29 83.72 Favored Glycine 0 C--N 1.276 -2.77 0 N-CA-C 105.355 -3.098 . . . . 0.0 105.355 174.168 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.539 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.01 -46.46 7.14 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.615 178.15 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.4 10.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.63 -179.764 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.15 10.36 1.21 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.722 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 21' ' ' VAL . 66.0 t -148.87 -8.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.628 -179.723 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.0 m120 96.48 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.545 1.153 . . . . 0.0 110.169 -179.555 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -172.54 93.15 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.524 179.969 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.47 11.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.836 -179.812 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.697 0.284 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -79.13 72.93 5.7 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.986 0.898 . . . . 0.0 110.056 -179.915 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.975 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.276 . . 174.81 -32.06 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 112.635 -2.075 . . . . 0.0 106.782 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -2.62 0.79 Allowed 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 164.663 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.975 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.252 20.5 tttm -112.75 -168.13 1.28 Allowed 'General case' 0 C--N 1.389 2.314 0 CA-C-N 109.206 -3.634 . . . . 0.0 112.13 176.515 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 44.9 m80 34.23 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.812 177.879 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 175.47 -47.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.855 0 CA-C-O 122.269 1.033 . . . . 0.0 109.158 -179.749 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.88 -14.15 78.56 Favored Glycine 0 C--N 1.274 -2.903 0 N-CA-C 105.636 -2.985 . . . . 0.0 105.636 174.736 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.448 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.92 -44.02 9.63 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.673 178.059 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.14 42.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.321 -179.084 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 65.81 -15.9 0.11 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.602 -179.435 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.4 t -148.79 -35.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.9 t30 154.78 -44.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.911 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.6 t60 -168.83 50.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.519 -179.88 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -64.52 -28.34 69.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.228 -179.924 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 79.4 mtt-85 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.8 m80 -157.53 144.04 17.92 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.369 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.999 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.23 0.22 Allowed 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 125.603 1.814 . . . . 0.0 109.485 -177.823 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.41 1.87 0.31 Allowed 'General case' 0 N--CA 1.41 -2.428 1 N-CA-C 95.35 -5.796 . . . . 0.0 95.35 164.981 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.999 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.9 ttpt -115.54 -169.58 1.61 Allowed 'General case' 0 C--N 1.394 2.519 0 CA-C-N 109.399 -3.546 . . . . 0.0 111.655 177.012 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.7 t-80 34.44 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.079 178.092 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tp 176.33 -46.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.643 0 CA-C-O 122.371 1.082 . . . . 0.0 109.074 -179.924 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.55 -14.69 77.53 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 174.409 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.62 -48.71 7.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.325 -0.938 . . . . 0.0 108.885 177.823 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.4 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.995 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.18 9.99 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.938 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.3 t -139.07 -10.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.774 -179.698 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.0 t-20 108.44 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.63 1.206 . . . . 0.0 110.586 179.855 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 8.8 t60 80.08 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.171 -179.61 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -79.54 -15.76 57.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.746 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.401 -179.683 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.955 0.407 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 t-80 -102.91 147.49 26.85 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.289 179.454 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.52 -31.57 0.22 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.716 1.885 . . . . 0.0 110.099 -178.085 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.89 0.31 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.318 -5.808 . . . . 0.0 95.318 165.052 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.6 tttm -116.23 -169.0 1.53 Allowed 'General case' 0 C--N 1.393 2.473 0 CA-C-N 109.315 -3.584 . . . . 0.0 111.773 176.971 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 75.0 t60 35.02 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.784 177.96 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 174.64 -42.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.044 0.926 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.52 -13.36 83.52 Favored Glycine 0 C--N 1.275 -2.859 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.645 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.596 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.79 -44.2 7.88 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 114.634 -0.783 . . . . 0.0 109.738 178.189 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.26 12.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.501 -179.878 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.17 9.15 0.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.098 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.4 t -147.91 -9.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.142 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.5 t-20 101.79 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.544 1.152 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 35.6 m80 -160.58 109.67 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.466 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 77.8 t80 -74.13 11.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.295 179.64 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.1 tp . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 31.1 m-70 -90.96 145.02 25.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.933 179.996 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.12 -31.9 0.23 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.635 1.834 . . . . 0.0 109.99 -178.138 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.19 0.93 0.36 Allowed 'General case' 0 N--CA 1.412 -2.33 1 N-CA-C 95.297 -5.816 . . . . 0.0 95.297 164.978 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.8 tttt -114.47 -169.4 1.53 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.24 -3.618 . . . . 0.0 111.87 176.621 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.6 m80 34.92 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.922 177.999 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 175.58 -43.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.114 0.959 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.72 -13.41 83.06 Favored Glycine 0 C--N 1.272 -2.977 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 174.668 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.33 -43.64 9.15 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.062 177.944 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.23 12.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.958 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.13 8.29 1.02 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.7 t -145.83 -8.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.128 -179.844 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.7 t30 103.99 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.502 1.126 . . . . 0.0 109.996 -179.739 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -173.26 103.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.479 179.743 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' H ' ' H ' ' A' ' 25' ' ' LEU . 84.1 t80 -171.58 -7.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.938 179.897 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 24' ' ' TYR . 34.4 mt . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 179.812 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.988 0.423 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 92.6 m-70 -140.62 145.41 36.61 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.449 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.01 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.67 -31.54 0.23 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.584 1.803 . . . . 0.0 109.571 -177.786 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.1 0.28 Allowed 'General case' 0 N--CA 1.412 -2.334 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 164.951 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.01 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.14 -169.24 1.57 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.395 -3.548 . . . . 0.0 111.585 177.062 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.9 t-80 34.67 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.028 178.066 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 175.78 -42.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.159 0.98 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.41 -13.57 83.25 Favored Glycine 0 C--N 1.275 -2.824 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 174.278 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.1 -46.01 8.36 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.299 -0.95 . . . . 0.0 109.066 177.957 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.49 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.845 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.11 9.32 0.94 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.103 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 89.5 t -142.83 -9.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.367 -179.843 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 25.7 t30 105.44 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.581 1.176 . . . . 0.0 110.104 -179.954 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.581 ' ND1' ' N ' ' A' ' 24' ' ' TYR . 49.8 t-80 -162.19 -100.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.581 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 62.3 t80 51.97 14.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' N ' ' C ' ' A' ' 23' ' ' HIS . 13.0 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -179.989 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.736 0.303 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 37.5 m80 -135.42 146.29 48.13 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.518 179.663 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.65 -31.1 0.21 Allowed 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.691 1.869 . . . . 0.0 109.761 -177.985 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.59 2.07 0.31 Allowed 'General case' 0 N--CA 1.411 -2.384 1 N-CA-C 95.381 -5.785 . . . . 0.0 95.381 164.85 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.8 tttp -116.11 -168.95 1.51 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.486 -3.506 . . . . 0.0 111.627 176.941 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.2 m80 34.56 18.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.945 178.079 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.89 -42.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.096 0.95 . . . . 0.0 109.628 179.923 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.51 -12.74 84.24 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.545 -3.022 . . . . 0.0 105.545 174.457 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.63 -44.19 8.31 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.258 177.969 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.99 10.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.31 10.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.829 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 21' ' ' VAL . 97.5 t -147.78 -8.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.046 -179.58 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.6 m120 98.13 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.581 1.175 . . . . 0.0 110.192 -179.512 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 84.3 m-70 -157.84 107.67 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.436 -179.925 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -61.25 -13.63 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.994 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.001 -179.969 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.341 0.115 . . . . 0.0 110.811 . . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 9.4 m-70 -115.96 71.69 0.79 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.922 0.868 . . . . 0.0 110.333 179.388 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.02 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 168.73 -31.9 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.503 -2.135 . . . . 0.0 105.85 -179.655 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.75 -2.29 0.8 Allowed 'General case' 0 N--CA 1.414 -2.256 1 N-CA-C 95.458 -5.756 . . . . 0.0 95.458 164.313 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.02 ' N ' ' C ' ' A' ' 12' ' ' ALA . 35.0 tttt -112.84 -168.56 1.34 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 109.277 -3.601 . . . . 0.0 111.83 176.408 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.656 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.6 t-80 34.52 17.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.004 178.04 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.52 -44.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-O 122.124 0.964 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.19 -13.63 82.6 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 174.56 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.6 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.55 -44.79 9.34 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.683 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.44 11.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.786 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.31 11.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.684 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 21' ' ' VAL . 97.9 t -144.73 -8.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.9 m120 100.68 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.768 1.293 . . . . 0.0 110.698 -179.837 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 90.8 m-70 -158.09 -94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 62.2 t80 57.25 8.52 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.652 -179.822 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.336 179.876 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.94 0.4 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.54 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.2 p-80 -140.12 145.19 37.28 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 179.812 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.011 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.56 -29.6 0.19 Allowed 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 125.513 1.758 . . . . 0.0 110.117 -178.336 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.43 1.15 0.57 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 94.73 -6.026 . . . . 0.0 94.73 164.382 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.011 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.5 ttmt -114.71 -158.51 0.67 Allowed 'General case' 0 C--N 1.397 2.644 0 CA-C-N 109.286 -3.597 . . . . 0.0 110.106 176.268 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.569 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.0 t60 28.41 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 112.262 177.955 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 168.33 -52.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-O 122.463 1.125 . . . . 0.0 109.224 -179.143 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' H ' HG23 ' A' ' 16' ' ' ILE . . . -68.05 -12.8 63.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 176.034 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -32.85 16.87 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.375 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.457 ' CB ' ' N ' ' A' ' 24' ' ' TYR . . . -167.56 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.51 -21.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.878 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.445 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 60.2 t -151.98 -18.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.025 179.905 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 166.35 -39.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.547 0.529 . . . . 0.0 110.045 -179.785 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -160.95 126.58 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 111.291 -178.616 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 75.2 t80 -66.92 -5.1 11.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.06 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.469 179.91 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 12.7 ptm180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.844 0.354 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.5 m80 -158.48 145.22 17.45 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 179.412 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.027 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.39 -30.94 0.22 Allowed 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 125.698 1.874 . . . . 0.0 109.535 -177.729 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.8 2.82 0.26 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.78 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.027 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -117.52 -168.5 1.5 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.562 -3.472 . . . . 0.0 111.689 177.159 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 37.8 m80 34.09 20.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.917 178.09 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.663 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 174.35 -42.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 122.339 1.066 . . . . 0.0 108.831 179.713 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.31 -13.05 83.99 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 105.687 -2.965 . . . . 0.0 105.687 174.398 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.605 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 4.5 m170 -103.02 -7.66 21.24 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.023 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 18' ' ' HIS . . . 82.53 22.04 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.239 -179.123 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.65 14.19 0.16 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.874 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.2 t -151.58 -11.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.623 -179.119 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER 104.79 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.282 0.989 . . . . 0.0 110.473 -179.657 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 34.2 p-80 -169.79 117.51 0.59 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -67.6 -0.99 4.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.225 179.65 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.378 179.892 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.033 0.445 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.2 t-80 -151.2 143.67 24.24 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.232 179.264 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.018 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.9 -31.34 0.22 Allowed 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.624 1.828 . . . . 0.0 109.436 -177.583 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.69 2.49 0.29 Allowed 'General case' 0 N--CA 1.412 -2.374 1 N-CA-C 95.431 -5.766 . . . . 0.0 95.431 164.844 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.018 ' N ' ' C ' ' A' ' 12' ' ' ALA . 15.3 ttpt -116.65 -169.01 1.55 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.455 -3.52 . . . . 0.0 111.456 176.97 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.64 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.2 m80 34.25 20.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.79 177.9 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.659 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.21 -37.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-O 122.364 1.078 . . . . 0.0 109.316 -179.311 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.51 -11.1 80.74 Favored Glycine 0 C--N 1.277 -2.745 0 N-CA-C 105.088 -3.205 . . . . 0.0 105.088 174.082 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.484 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -94.99 -33.94 12.55 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.407 -0.896 . . . . 0.0 109.973 178.275 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.47 23.74 0.71 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.834 -178.968 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.01 -0.34 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.244 179.322 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 19' ' ' ALA . 45.0 t -152.48 -27.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 121.5 -0.08 . . . . 0.0 110.952 -179.41 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.624 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER 176.17 -85.94 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 111.554 -179.354 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.624 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 35.2 m80 -146.95 126.05 12.9 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 -178.837 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 75.4 t80 -73.72 -3.92 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.187 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.332 -0.196 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.495 179.903 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.372 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t-80 -161.9 146.81 12.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.565 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.72 -31.82 0.23 Allowed 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 125.775 1.922 . . . . 0.0 110.043 -178.271 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.1 0.29 Allowed 'General case' 0 N--CA 1.413 -2.302 1 N-CA-C 95.342 -5.799 . . . . 0.0 95.342 165.157 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.5 tttt -116.17 -168.95 1.52 Allowed 'General case' 0 C--N 1.393 2.46 0 CA-C-N 109.502 -3.499 . . . . 0.0 111.648 177.018 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 34.33 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.885 177.983 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 174.6 -43.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.137 0.97 . . . . 0.0 109.547 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.36 -13.22 83.58 Favored Glycine 0 C--N 1.274 -2.862 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 174.47 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.25 -45.06 8.02 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.176 177.964 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.18 13.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.86 9.54 0.91 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.131 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 83.3 t -146.37 -9.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.332 -179.762 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 40.9 t-20 103.2 -36.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.511 1.132 . . . . 0.0 110.066 -179.784 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 91.1 m-70 -160.43 106.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.405 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 67.6 t80 -59.72 -15.09 17.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 10.2 mpt_? . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.726 0.298 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 79.2 m-70 -153.28 94.82 1.87 Allowed 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.239 0.543 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.008 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 132.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.03 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 0.23 0.55 Allowed 'General case' 0 N--CA 1.413 -2.297 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.649 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.008 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.6 tttt -115.89 -168.34 1.41 Allowed 'General case' 0 C--N 1.393 2.479 0 CA-C-N 109.504 -3.498 . . . . 0.0 111.641 176.885 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.647 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 94.3 m-70 33.73 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.836 178.257 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.78 -43.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.089 0.947 . . . . 0.0 109.596 179.88 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.35 -13.29 83.5 Favored Glycine 0 C--N 1.274 -2.893 0 N-CA-C 105.582 -3.007 . . . . 0.0 105.582 174.67 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.583 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.97 -44.76 7.91 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-N 114.538 -0.831 . . . . 0.0 109.335 177.947 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.22 10.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.899 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.75 10.7 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.839 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 21' ' ' VAL . 77.3 t -146.94 -8.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.848 -179.682 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.8 m-20 98.61 -36.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.729 1.268 . . . . 0.0 110.104 -179.539 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 25.6 p-80 -173.18 101.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 74.9 t80 -62.41 -10.13 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.485 179.996 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.061 -179.941 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.033 0.444 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 67.6 m-70 -143.53 146.1 33.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.767 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.987 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.5 -29.88 0.19 Allowed 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 125.59 1.806 . . . . 0.0 110.237 -178.506 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.26 1.08 0.54 Allowed 'General case' 0 N--CA 1.411 -2.412 1 N-CA-C 94.814 -5.995 . . . . 0.0 94.814 164.541 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.987 ' N ' ' C ' ' A' ' 12' ' ' ALA . 7.9 tttm -115.11 -158.86 0.69 Allowed 'General case' 0 C--N 1.394 2.527 0 CA-C-N 109.149 -3.659 . . . . 0.0 110.175 176.397 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.568 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.7 t60 29.04 23.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 112.187 177.692 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 167.43 -52.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 CA-C-O 122.369 1.081 . . . . 0.0 109.194 -179.067 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.73 63.3 Favored Glycine 0 C--N 1.269 -3.14 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.185 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.92 -33.05 16.57 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.36 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.85 -65.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.788 179.529 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.29 -22.33 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.878 -179.693 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 t -150.6 -18.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 170.03 -38.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.237 0.336 . . . . 0.0 110.274 -179.687 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 27.3 t60 -171.72 -136.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.109 -178.99 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 76.5 m-85 53.14 27.11 5.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.0 110.765 179.773 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.036 179.993 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.04 0.448 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 54.0 t-80 -153.52 147.84 25.9 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.135 0.493 . . . . 0.0 110.909 179.583 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.054 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.34 -31.71 0.22 Allowed 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.905 2.003 . . . . 0.0 110.211 -178.25 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.316 1 N-CA-C 95.344 -5.799 . . . . 0.0 95.344 165.152 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.054 ' N ' ' C ' ' A' ' 12' ' ' ALA . 19.6 tttm -116.49 -168.73 1.49 Allowed 'General case' 0 C--N 1.392 2.423 0 CA-C-N 109.44 -3.527 . . . . 0.0 111.592 177.124 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.6 t60 34.75 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.834 177.881 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 174.25 -44.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 122.116 0.96 . . . . 0.0 109.633 -179.84 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.89 -13.68 82.27 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.681 -2.968 . . . . 0.0 105.681 174.718 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.603 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.67 -45.58 7.64 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 114.515 -0.843 . . . . 0.0 109.309 178.089 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.71 13.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.79 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.69 7.16 0.99 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.272 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 61.2 t -145.41 -9.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.493 -179.868 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 10.4 t-20 105.37 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.479 1.112 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.561 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 1.8 t60 -171.49 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.313 179.903 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.561 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.4 m-85 49.24 18.76 0.27 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 110.597 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.966 0.412 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -148.14 72.76 1.23 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.289 1.042 . . . . 0.0 110.173 178.987 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.043 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.274 . . 172.98 -30.82 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 112.133 -2.303 . . . . 0.0 106.179 179.966 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -0.73 0.55 Allowed 'General case' 0 N--CA 1.415 -2.192 1 N-CA-C 95.502 -5.74 . . . . 0.0 95.502 164.354 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.043 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.255 19.6 tttp -116.43 -167.06 1.22 Allowed 'General case' 0 C--N 1.389 2.285 0 CA-C-N 109.258 -3.61 . . . . 0.0 111.716 177.112 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.2 t60 34.73 18.99 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.875 177.862 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.84 -40.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 CA-C-O 122.141 0.972 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.15 83.61 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 105.596 -3.002 . . . . 0.0 105.596 174.487 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.614 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 5.5 m170 -103.64 -7.65 20.56 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.978 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 18' ' ' HIS . . . 84.52 20.3 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.389 -179.296 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.18 14.41 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 84.5 t -152.43 -10.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.455 -178.966 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.2 t-20 101.05 -34.84 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.14 0.9 . . . . 0.0 109.956 -179.308 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -171.57 101.5 0.19 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.602 -179.83 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' H ' ' H ' ' A' ' 25' ' ' LEU . 74.8 t80 -163.25 -1.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.287 179.845 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 24' ' ' TYR . 1.3 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.251 179.819 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' NH2' ' NE2' ' A' ' 11' ' ' HIS . 45.1 ttp85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.133 0.492 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' NE2' ' NH2' ' A' ' 10' ' ' ARG . 82.9 m-70 -146.95 147.17 30.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.423 179.577 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.21 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.727 1.892 . . . . 0.0 109.986 -178.121 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.94 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.434 -5.765 . . . . 0.0 95.434 165.194 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.023 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.3 tttp -116.04 -169.49 1.61 Allowed 'General case' 0 C--N 1.392 2.442 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.629 177.146 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.8 t60 34.89 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.946 177.861 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 175.62 -42.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.178 0.99 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.99 -13.39 83.73 Favored Glycine 0 C--N 1.276 -2.801 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 174.238 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.19 -45.77 8.46 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 114.454 -0.873 . . . . 0.0 109.001 177.884 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.21 13.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.841 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.29 9.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.24 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 63.8 t -145.31 -8.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.335 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.6 t30 102.96 -36.28 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.526 1.142 . . . . 0.0 109.746 -179.49 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -172.52 97.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.483 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 60.1 t80 -163.67 -0.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.387 -179.925 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.405 ' H ' ' H ' ' A' ' 24' ' ' TYR . 13.1 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.615 179.965 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.856 0.36 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.9 m80 -151.54 146.24 25.74 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.712 179.657 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -31.92 0.24 Allowed 'General case' 0 CA--C 1.498 -1.058 0 O-C-N 125.757 1.911 . . . . 0.0 109.839 -178.004 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.51 2.37 0.28 Allowed 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 95.441 -5.763 . . . . 0.0 95.441 165.142 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.04 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -116.58 -169.07 1.56 Allowed 'General case' 0 C--N 1.391 2.407 0 CA-C-N 109.445 -3.525 . . . . 0.0 111.697 177.055 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.7 m80 33.92 21.23 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.788 177.598 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 170.21 -37.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.292 1.044 . . . . 0.0 109.33 -179.458 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.84 -11.64 81.17 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.052 -3.219 . . . . 0.0 105.052 174.07 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.471 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -93.54 -36.17 12.55 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 114.277 -0.961 . . . . 0.0 109.981 178.267 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.2 26.18 0.7 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.643 -179.58 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.41 -7.69 0.1 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.054 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 19' ' ' ALA . 52.3 t -151.08 -24.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.353 -179.413 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 4.7 p30 -177.02 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.368 -179.291 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.566 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.0 t-160 -158.2 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.362 -179.461 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.566 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 86.2 m-85 48.79 17.44 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.319 . . . . 0.0 110.721 179.793 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.407 ' N ' ' C ' ' A' ' 23' ' ' HIS . 12.0 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.465 179.998 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 52.3 ttt180 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.402 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.52 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.6 m-70 -137.25 147.64 45.9 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 179.666 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.82 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.809 1.943 . . . . 0.0 109.996 -178.073 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.27 0.29 Allowed 'General case' 0 N--CA 1.412 -2.357 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.033 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.6 tttm -116.2 -169.29 1.58 Allowed 'General case' 0 C--N 1.392 2.414 0 CA-C-N 109.476 -3.511 . . . . 0.0 111.718 177.032 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.641 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.6 t-80 34.55 18.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.896 177.984 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.09 -42.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.123 0.963 . . . . 0.0 109.707 180.0 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.96 -13.68 83.41 Favored Glycine 0 C--N 1.276 -2.8 0 N-CA-C 105.433 -3.067 . . . . 0.0 105.433 174.229 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.09 -47.04 6.55 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.422 -0.889 . . . . 0.0 110.002 178.207 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.62 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.741 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.03 8.42 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.24 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 64.6 t -145.89 -9.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.171 179.967 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.06 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.657 1.223 . . . . 0.0 110.281 -179.98 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -167.93 94.88 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.493 -179.908 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.424 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 58.9 t80 -162.95 0.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.242 179.996 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.803 0.335 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 13' ' ' ALA . 57.8 t-80 -159.78 146.35 16.2 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.722 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.035 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.7 -31.7 0.23 Allowed 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 125.712 1.883 . . . . 0.0 110.02 -178.219 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.411 -2.394 1 N-CA-C 95.397 -5.779 . . . . 0.0 95.397 165.071 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.035 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.0 tttt -115.98 -169.21 1.55 Allowed 'General case' 0 C--N 1.394 2.524 0 CA-C-N 109.345 -3.571 . . . . 0.0 111.818 177.091 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m80 34.43 18.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.846 178.144 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.64 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 CA-C-O 122.068 0.937 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.0 -13.66 82.47 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.72 -2.952 . . . . 0.0 105.72 174.781 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.601 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.83 -44.53 8.44 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.162 177.964 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.46 11.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.994 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.51 10.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 21' ' ' VAL . 93.1 t -145.68 -8.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.876 -179.549 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.7 m-20 99.04 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.72 1.263 . . . . 0.0 110.239 -179.622 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -168.64 97.23 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.473 179.968 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.4 t80 -165.89 0.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.308 -179.886 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -179.98 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.494 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 13.0 ptm180 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.732 0.301 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.557 ' C ' ' H ' ' A' ' 13' ' ' ALA . 65.4 m-70 -148.25 144.89 27.96 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.493 179.481 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.46 -28.96 0.18 Allowed 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 125.632 1.832 . . . . 0.0 109.777 -177.989 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.33 2.08 0.43 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 94.793 -6.003 . . . . 0.0 94.793 164.209 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 6.0 ttmt -116.68 -160.65 0.77 Allowed 'General case' 0 C--N 1.398 2.686 0 CA-C-N 109.314 -3.585 . . . . 0.0 110.647 177.062 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.56 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.1 t-80 30.16 21.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 112.222 178.659 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 173.17 -47.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-O 122.231 1.015 . . . . 0.0 109.509 -179.453 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.53 -13.73 74.49 Favored Glycine 0 C--N 1.271 -3.077 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 175.107 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -96.53 -46.39 6.36 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 114.432 -0.884 . . . . 0.0 109.775 178.366 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.96 11.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.632 -179.744 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.19 8.27 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.042 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 44.6 t -148.23 -9.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.883 179.948 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.5 t-20 100.47 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.515 1.134 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 78.6 m80 -159.74 120.56 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.668 -179.622 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -55.57 -10.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.13 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.1 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.8 t-80 -156.12 145.08 20.42 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 179.515 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.997 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.85 -30.91 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.736 1.898 . . . . 0.0 109.801 -177.948 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.13 0.3 Allowed 'General case' 0 N--CA 1.41 -2.438 1 N-CA-C 95.288 -5.819 . . . . 0.0 95.288 164.749 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.997 ' N ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.13 -168.56 1.45 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.473 -3.512 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.0 m80 34.3 18.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.844 178.144 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.3 -46.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.21 1.005 . . . . 0.0 109.381 -179.624 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.02 -13.64 80.85 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.523 -3.031 . . . . 0.0 105.523 174.697 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.59 -43.59 9.56 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.606 178.2 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.252 -179.122 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.14 -16.15 0.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.676 -179.445 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.2 t -148.91 -35.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.931 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 156.03 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.782 0.676 . . . . 0.0 109.223 -179.953 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 37.9 t-80 -162.34 29.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.696 -179.695 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.461 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 64.1 t80 -77.0 -7.02 54.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.476 -179.881 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.2 t-80 -158.21 145.81 18.23 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.033 0.444 . . . . 0.0 110.915 179.564 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.98 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.91 -31.92 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.721 1.888 . . . . 0.0 109.975 -178.175 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.91 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.405 -5.776 . . . . 0.0 95.405 165.09 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.98 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttp -115.48 -169.6 1.61 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.436 -3.529 . . . . 0.0 111.806 176.953 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.0 t-80 34.47 18.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.015 178.021 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 176.13 -45.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.31 1.052 . . . . 0.0 109.089 -179.932 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.0 81.54 Favored Glycine 0 C--N 1.273 -2.968 0 N-CA-C 105.499 -3.04 . . . . 0.0 105.499 174.28 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.51 -47.01 7.66 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.154 178.005 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.88 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.876 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.71 8.1 1.23 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.215 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 56.3 t -144.88 -8.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.217 -179.953 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.17 -36.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.639 1.212 . . . . 0.0 110.222 -179.772 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 31.9 m80 -155.26 -168.56 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 65.28 25.83 12.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.471 179.709 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 79.7 t60 -164.71 142.03 6.32 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 179.615 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.53 -32.14 0.23 Allowed 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 125.668 1.855 . . . . 0.0 109.805 -178.188 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.26 1.4 0.33 Allowed 'General case' 0 N--CA 1.41 -2.47 1 N-CA-C 95.444 -5.762 . . . . 0.0 95.444 165.003 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.039 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.7 tttp -114.33 -169.59 1.56 Allowed 'General case' 0 C--N 1.396 2.617 0 CA-C-N 109.48 -3.509 . . . . 0.0 111.842 176.98 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.1 t60 33.21 20.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.853 177.953 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 173.85 -47.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.695 0 CA-C-O 122.187 0.994 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.86 -14.49 78.39 Favored Glycine 0 C--N 1.271 -3.064 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 174.331 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -87.59 -46.43 9.55 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.283 177.983 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.38 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.266 -179.386 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 65.64 -14.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.863 -179.666 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.2 t -149.34 -29.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 121.422 -0.111 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.8 t-20 148.56 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.944 0.777 . . . . 0.0 109.148 -179.728 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -170.28 64.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.403 -179.762 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -71.29 -19.55 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.62 -179.94 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.099 179.946 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 13' ' ' ALA . 4.9 p-80 -163.92 143.34 7.96 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.768 179.385 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.016 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.27 -31.92 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.76 1.912 . . . . 0.0 109.982 -178.207 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.36 1.67 0.32 Allowed 'General case' 0 N--CA 1.411 -2.41 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 165.066 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.016 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.31 -168.95 1.48 Allowed 'General case' 0 C--N 1.394 2.54 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.877 176.973 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 74.6 t60 34.31 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.795 177.861 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tt 174.29 -46.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 CA-C-O 122.24 1.019 . . . . 0.0 109.363 -179.855 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.36 -13.92 79.6 Favored Glycine 0 C--N 1.271 -3.051 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.737 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.451 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.89 -44.27 9.49 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.66 -0.77 . . . . 0.0 109.533 178.071 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.57 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.859 -0.737 . . . . 0.0 112.145 -179.311 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.51 -20.42 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.358 -179.206 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.2 t -149.6 -31.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.6 m-20 157.64 -48.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.62 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 74.4 t60 -169.61 3.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.699 -179.735 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -76.65 40.84 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.58 -179.98 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.422 179.92 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.126 0.488 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.548 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.0 t60 -150.39 143.72 25.01 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.633 179.461 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.79 -29.52 0.19 Allowed 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 125.641 1.838 . . . . 0.0 109.766 -177.987 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.02 0.43 Allowed 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 94.879 -5.971 . . . . 0.0 94.879 164.463 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.8 tttp -116.76 -161.11 0.79 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.266 -3.606 . . . . 0.0 110.549 177.005 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.562 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 30.92 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.852 0.72 . . . . 0.0 112.238 178.34 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.722 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.7 tt 172.75 -47.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 CA-C-O 122.226 1.012 . . . . 0.0 109.513 -179.446 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.66 74.62 Favored Glycine 0 C--N 1.271 -3.062 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 175.268 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 2.0 m170 -95.96 -45.18 7.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.443 178.181 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.99 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.862 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.18 7.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.289 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -146.44 -9.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.863 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.6 t30 104.53 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.491 1.119 . . . . 0.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -173.36 80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.451 179.974 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.542 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 63.2 t80 -84.64 -13.96 50.02 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.942 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 179.938 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.666 0.269 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.4 t60 -159.11 146.98 17.68 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.052 0.453 . . . . 0.0 110.857 179.305 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.988 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.04 -31.94 0.24 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.755 1.91 . . . . 0.0 110.007 -178.239 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.3 1.92 0.29 Allowed 'General case' 0 N--CA 1.413 -2.323 1 N-CA-C 95.445 -5.761 . . . . 0.0 95.445 165.132 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.988 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttm -115.8 -169.33 1.57 Allowed 'General case' 0 C--N 1.393 2.478 0 CA-C-N 109.363 -3.562 . . . . 0.0 111.725 177.076 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.8 t-80 34.31 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.914 177.963 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.06 -45.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.428 -179.958 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.72 79.99 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.284 -3.126 . . . . 0.0 105.284 174.422 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.27 -49.76 6.19 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.301 -0.949 . . . . 0.0 109.364 177.987 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.85 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.192 0.308 . . . . 0.0 110.196 -179.728 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.02 10.33 1.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.739 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.5 t -144.34 -9.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.425 -179.865 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 102.58 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.53 1.144 . . . . 0.0 110.45 179.896 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 16.9 t60 84.28 4.6 0.71 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.873 -179.143 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -62.95 -23.14 67.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.471 179.897 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.415 179.939 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.93 0.395 . . . . 0.0 110.263 . . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -150.02 70.94 1.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.311 1.053 . . . . 0.0 109.714 179.353 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.968 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.272 . . 169.78 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 111.921 -2.399 . . . . 0.0 105.721 -179.363 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.09 -1.3 0.66 Allowed 'General case' 0 N--CA 1.412 -2.331 1 N-CA-C 95.254 -5.832 . . . . 0.0 95.254 164.125 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.968 ' N ' ' C ' ' A' ' 12' ' ' ALA . 3.2 ttpt -114.89 -166.49 1.12 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.309 -3.587 . . . . 0.0 111.501 176.325 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.8 t-80 33.2 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.042 178.378 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 173.56 -47.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 122.282 1.039 . . . . 0.0 109.305 179.96 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.03 -14.17 76.13 Favored Glycine 0 C--N 1.27 -3.115 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 174.907 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.97 -46.28 6.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.765 -0.718 . . . . 0.0 109.636 177.966 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.53 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.504 -179.754 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.63 6.95 1.23 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.076 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.0 t -147.16 -9.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.236 -179.926 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t30 102.82 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.444 1.09 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -178.83 64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.953 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -51.83 -33.94 38.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.667 -179.819 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.115 -179.969 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 89.1 m-70 -147.21 144.85 29.21 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.08 179.435 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.03 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.47 -31.56 0.23 Allowed 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 125.587 1.804 . . . . 0.0 109.642 -177.761 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.13 0.29 Allowed 'General case' 0 N--CA 1.412 -2.337 1 N-CA-C 95.44 -5.763 . . . . 0.0 95.44 165.034 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.03 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.6 tttp -115.94 -169.25 1.56 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-N 109.365 -3.561 . . . . 0.0 111.74 177.082 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 86.8 m-70 34.52 18.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.965 178.045 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.54 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-O 122.363 1.078 . . . . 0.0 109.113 -179.821 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.25 79.3 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 174.493 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.53 -47.34 7.47 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.543 -0.829 . . . . 0.0 109.219 178.024 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.0 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.773 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 61.66 7.52 1.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.146 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 43.5 t -144.99 -9.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.4 t-20 105.32 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.54 1.15 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.597 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -173.13 -99.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.315 -179.923 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.597 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 64.5 t80 55.44 10.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 76.5 mtt85 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.817 0.342 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 97.7 m-70 -155.81 144.96 20.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.602 179.528 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.707 1.879 . . . . 0.0 109.849 -177.888 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.44 1.89 0.31 Allowed 'General case' 0 N--CA 1.411 -2.42 1 N-CA-C 95.363 -5.792 . . . . 0.0 95.363 164.988 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.061 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -115.89 -169.15 1.54 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.412 -3.54 . . . . 0.0 111.646 177.074 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.7 m-70 34.86 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.892 178.031 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.62 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.091 0.948 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.25 -13.71 82.55 Favored Glycine 0 C--N 1.273 -2.961 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.59 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.15 -45.64 8.17 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 114.511 -0.845 . . . . 0.0 109.286 177.981 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.05 13.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.838 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.18 9.23 0.94 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.17 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -145.95 -9.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.189 -179.873 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t-20 103.14 -36.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.503 1.127 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -172.05 89.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.398 -179.966 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 83.4 t80 -159.89 16.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.062 -179.84 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.564 179.982 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt-85 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.785 0.326 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.581 ' NE2' ' NE2' ' A' ' 15' ' ' HIS . 48.8 t-80 -157.6 92.43 1.21 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.209 0.528 . . . . 0.0 110.074 179.339 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.96 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 134.84 -31.79 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.424 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.54 -0.41 0.61 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.895 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.96 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.8 tttt -114.86 -168.12 1.33 Allowed 'General case' 0 C--N 1.393 2.488 0 CA-C-N 109.376 -3.556 . . . . 0.0 111.768 176.696 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 79.5 m-70 33.77 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.958 178.24 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.39 -47.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.324 1.059 . . . . 0.0 109.025 -179.873 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.66 -13.73 78.03 Favored Glycine 0 C--N 1.27 -3.099 0 N-CA-C 105.885 -2.886 . . . . 0.0 105.885 174.853 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.75 -44.39 9.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.899 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 160.87 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.868 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.37 5.57 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.289 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 40.7 t -145.28 -10.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.202 -179.817 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.0 t-20 116.4 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.504 1.128 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -171.89 -3.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.515 -179.923 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.416 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 34.1 t80 -49.06 -18.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.712 -179.633 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.136 -179.978 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 121.004 0.431 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.1 t-80 -153.21 145.56 23.99 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.673 179.508 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.063 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.39 -31.74 0.23 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.715 1.885 . . . . 0.0 109.738 -177.985 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.18 0.29 Allowed 'General case' 0 N--CA 1.412 -2.373 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 165.091 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.063 ' N ' ' C ' ' A' ' 12' ' ' ALA . 15.8 tttp -116.14 -169.49 1.62 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.76 177.037 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 33.39 21.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.708 177.927 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.651 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.16 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 CA-C-O 122.302 1.049 . . . . 0.0 109.377 -179.658 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.94 -11.55 81.21 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 104.983 -3.247 . . . . 0.0 104.983 173.981 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.476 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -93.43 -36.33 12.53 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 114.445 -0.878 . . . . 0.0 109.932 178.238 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.15 28.22 0.51 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.365 -179.441 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.5 -9.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.114 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 19' ' ' ALA . 83.0 t -152.44 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.284 -179.387 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -171.66 -96.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.496 -179.198 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 25' ' ' LEU . 75.8 t60 -152.07 8.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.711 -179.372 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.14 22.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.938 0.399 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.8 m-70 -144.72 146.73 32.34 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.023 0.44 . . . . 0.0 111.012 179.49 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.066 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.91 -31.45 0.22 Allowed 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 125.813 1.945 . . . . 0.0 109.944 -178.156 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.4 2.08 0.29 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.344 -5.798 . . . . 0.0 95.344 165.028 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.066 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.8 ttpp -116.01 -169.29 1.57 Allowed 'General case' 0 C--N 1.394 2.503 0 CA-C-N 109.407 -3.542 . . . . 0.0 111.817 177.16 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.1 t60 33.98 19.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.89 178.122 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 174.69 -46.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-O 122.24 1.019 . . . . 0.0 109.275 179.977 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.05 79.4 Favored Glycine 0 C--N 1.271 -3.083 0 N-CA-C 105.773 -2.931 . . . . 0.0 105.773 174.722 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.597 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.14 -45.62 7.8 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.659 -0.771 . . . . 0.0 109.431 178.036 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.23 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.877 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.78 5.89 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 109.667 -179.291 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 45.9 t -144.05 -9.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.335 179.975 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 27.8 t-20 105.84 -36.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.646 1.216 . . . . 0.0 110.046 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.541 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.2 t-160 -170.1 -130.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.138 179.972 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.541 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 29.6 m-85 48.62 28.67 1.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.775 0.322 . . . . 0.0 110.752 179.673 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.081 -179.923 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 28.8 t60 -97.29 71.06 2.36 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.138 0.971 . . . . 0.0 110.11 179.437 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.005 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.265 . . 169.34 -30.88 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 112.165 -2.289 . . . . 0.0 105.712 -179.738 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -1.0 0.57 Allowed 'General case' 0 N--CA 1.414 -2.274 1 N-CA-C 95.378 -5.786 . . . . 0.0 95.378 164.068 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.005 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.257 23.7 tttp -115.99 -166.73 1.17 Allowed 'General case' 0 C--N 1.393 2.457 0 CA-C-N 109.42 -3.536 . . . . 0.0 111.953 176.859 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.652 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 55.6 t60 34.01 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.609 177.756 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.7 tt 170.72 -42.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.078 0.942 . . . . 0.0 109.381 -179.894 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.96 -14.28 81.87 Favored Glycine 0 C--N 1.274 -2.894 0 N-CA-C 105.81 -2.916 . . . . 0.0 105.81 175.071 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -88.94 -34.36 16.93 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.044 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.07 -73.18 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.61 179.397 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -167.23 -23.14 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.815 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 34.0 t -150.85 -12.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.542 179.614 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 5.1 t30 155.55 -36.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.779 0.674 . . . . 0.0 109.551 -179.658 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -166.14 120.38 1.15 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.952 -178.443 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -71.87 -0.17 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.421 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 -179.931 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 . . . . . 0 N--CA 1.464 0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.2 t60 -153.58 146.58 24.52 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.443 179.382 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.31 -30.82 0.21 Allowed 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 125.715 1.885 . . . . 0.0 109.683 -177.695 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.71 2.88 0.25 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 164.915 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.1 tttm -118.13 -167.3 1.33 Allowed 'General case' 0 C--N 1.393 2.471 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.593 177.275 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.61 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 66.2 t60 33.05 23.3 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 170.04 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.585 0 CA-C-O 122.107 0.956 . . . . 0.0 109.103 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -15.12 79.13 Favored Glycine 0 C--N 1.274 -2.909 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.752 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 6.3 t60 -83.43 -39.64 20.33 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.859 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.94 -69.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 -19.81 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.877 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 10.1 t -149.58 -16.31 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.966 179.679 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 4.7 t30 158.58 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.692 0.62 . . . . 0.0 109.758 -179.669 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 43.9 t-80 -166.51 14.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.723 -178.692 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 72.3 t80 -78.82 43.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.432 -179.883 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 66.4 mtp180 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.4 m80 -154.75 145.56 22.47 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.557 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.48 -30.72 0.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 125.654 1.846 . . . . 0.0 109.555 -177.713 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.75 0.26 Allowed 'General case' 0 N--CA 1.412 -2.351 1 N-CA-C 95.282 -5.822 . . . . 0.0 95.282 164.787 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.5 ttpp -117.73 -167.59 1.36 Allowed 'General case' 0 C--N 1.392 2.44 0 CA-C-N 109.524 -3.489 . . . . 0.0 111.671 177.152 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.611 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.5 m80 33.11 23.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.716 177.67 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.648 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 170.02 -45.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 CA-C-O 122.229 1.014 . . . . 0.0 109.061 -179.752 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.19 78.66 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 174.773 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 5.9 t60 -82.54 -40.85 20.39 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.659 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -160.37 -68.05 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.402 179.51 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -169.34 -19.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.956 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.402 ' H ' ' H ' ' A' ' 20' ' ' ALA . 40.4 t -151.26 -18.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.092 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.489 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 7.8 t-20 163.76 -38.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.576 0.548 . . . . 0.0 109.993 -179.709 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 48.2 t-80 -171.7 33.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 -178.644 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -49.82 -14.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 110.544 -179.969 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.783 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.182 0.515 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.8 t-80 -162.8 143.4 9.64 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 179.294 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.3 -31.68 0.22 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.836 1.96 . . . . 0.0 110.022 -178.133 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 1.81 0.33 Allowed 'General case' 0 N--CA 1.411 -2.381 1 N-CA-C 95.304 -5.813 . . . . 0.0 95.304 164.963 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.04 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.9 tttt -115.67 -168.8 1.47 Allowed 'General case' 0 C--N 1.393 2.499 0 CA-C-N 109.417 -3.538 . . . . 0.0 111.758 176.998 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.633 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.6 t-80 34.21 19.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.849 177.98 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.08 -47.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.271 1.034 . . . . 0.0 109.199 -179.894 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.26 -14.06 76.79 Favored Glycine 0 C--N 1.27 -3.13 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 174.918 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.5 -45.6 7.35 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.512 178.093 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.3 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.762 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.17 9.65 1.04 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.973 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 21' ' ' VAL . 58.5 t -147.97 -8.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.196 -179.542 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.7 m120 100.04 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.662 1.226 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.514 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 86.3 t60 -167.22 -105.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.5 -179.834 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.514 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 25.7 t80 65.96 -7.34 0.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 -179.977 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.822 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 85.6 mtt-85 . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.788 0.327 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 94.7 m-70 -155.79 146.08 21.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.626 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.71 -31.67 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.823 1.952 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.8 0.31 Allowed 'General case' 0 N--CA 1.412 -2.343 1 N-CA-C 95.414 -5.773 . . . . 0.0 95.414 165.167 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.031 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.5 tttp -116.31 -168.22 1.4 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.327 -3.579 . . . . 0.0 111.644 177.158 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 40.4 m-70 34.05 20.98 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.803 177.706 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 171.3 -46.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.515 0 CA-C-O 122.286 1.041 . . . . 0.0 109.245 -179.682 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.16 -12.42 83.48 Favored Glycine 0 C--N 1.274 -2.908 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 175.125 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.449 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -89.29 -30.88 18.14 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.316 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.57 -66.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.677 179.285 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -171.64 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.759 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' H ' ' H ' ' A' ' 20' ' ' ALA . 59.9 t -152.7 -18.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 t30 165.66 -38.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.549 0.531 . . . . 0.0 110.145 -179.799 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 34.5 t-80 -170.04 26.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -178.709 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -49.08 -15.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 -179.741 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.278 -179.944 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.268 0.556 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.539 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 t60 -156.8 142.2 17.45 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.61 -31.73 0.23 Allowed 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 125.594 1.809 . . . . 0.0 109.492 -177.863 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.54 0.33 Allowed 'General case' 0 N--CA 1.41 -2.439 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 164.978 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.0 tttp -115.1 -169.82 1.63 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.438 -3.528 . . . . 0.0 111.731 176.922 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.9 t-80 34.78 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.934 177.926 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.28 -44.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.171 0.986 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.82 -14.38 81.57 Favored Glycine 0 C--N 1.274 -2.895 0 N-CA-C 105.335 -3.106 . . . . 0.0 105.335 174.249 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.85 -49.03 6.85 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.295 -0.953 . . . . 0.0 109.02 177.892 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.28 9.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.458 0.474 . . . . 0.0 110.177 -179.94 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.426 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.72 10.07 1.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 -178.158 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 21' ' ' VAL . 91.1 t -143.1 -8.56 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.948 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.2 m-20 97.67 -35.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.637 1.211 . . . . 0.0 111.08 179.81 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.4 t-80 80.19 7.84 1.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.774 -179.154 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.1 t80 -77.08 27.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.0 tt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' C ' ' ND1' ' A' ' 11' ' ' HIS . 81.5 mtp180 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.922 0.392 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 41.2 m80 -152.76 144.44 23.51 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.29 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.633 1.833 . . . . 0.0 109.718 -177.731 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.57 2.25 0.3 Allowed 'General case' 0 N--CA 1.411 -2.407 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 12.0 ttpt -115.98 -168.98 1.51 Allowed 'General case' 0 C--N 1.395 2.544 0 CA-C-N 109.401 -3.545 . . . . 0.0 111.492 176.995 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 61.5 t60 33.65 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.917 178.036 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.76 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 CA-C-O 122.229 1.014 . . . . 0.0 109.308 179.982 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -14.24 80.18 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 174.497 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.454 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -90.69 -44.21 9.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 114.431 -0.884 . . . . 0.0 109.857 178.179 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 42.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.336 -179.177 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 69.6 -21.65 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.515 -179.47 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.0 t -148.32 -30.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.636 179.802 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t-20 153.39 -43.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.557 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 41.9 t60 -168.78 174.96 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.27 179.7 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.557 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.5 t80 56.28 10.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.656 179.917 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.5 t60 -160.8 147.1 15.01 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.059 0.457 . . . . 0.0 111.04 179.688 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.008 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.5 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 125.872 1.982 . . . . 0.0 110.085 -178.23 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.08 0.28 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.411 -5.774 . . . . 0.0 95.411 165.218 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.008 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -116.03 -169.31 1.58 Allowed 'General case' 0 C--N 1.393 2.491 0 CA-C-N 109.435 -3.529 . . . . 0.0 111.767 177.03 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 10.9 t60 34.72 18.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.914 178.056 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tt 175.35 -41.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 CA-C-O 122.019 0.914 . . . . 0.0 109.582 179.923 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.63 -13.07 83.88 Favored Glycine 0 C--N 1.275 -2.858 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 174.316 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -92.89 -44.78 8.29 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.541 -0.829 . . . . 0.0 109.136 178.05 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.89 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.46 9.61 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.025 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -147.57 -9.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.152 -179.777 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.8 t-20 100.31 -35.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.395 1.06 . . . . 0.0 110.023 -179.627 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 25' ' ' LEU . 79.9 m-70 -145.76 119.37 9.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -62.43 -4.26 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 23' ' ' HIS . 19.0 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.534 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.0 t-80 -169.55 145.29 3.14 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 179.571 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.963 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.71 -31.78 0.23 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.767 1.917 . . . . 0.0 109.94 -178.156 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.77 0.31 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.274 -5.824 . . . . 0.0 95.274 165.074 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.963 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -115.6 -169.35 1.56 Allowed 'General case' 0 C--N 1.394 2.509 0 CA-C-N 109.483 -3.508 . . . . 0.0 111.766 176.909 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.3 t-80 34.89 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.944 177.952 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.71 -43.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.144 0.974 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.94 82.39 Favored Glycine 0 C--N 1.274 -2.907 0 N-CA-C 105.434 -3.066 . . . . 0.0 105.434 174.41 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.41 -47.44 7.45 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.437 -0.881 . . . . 0.0 109.21 177.983 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.23 9.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.259 0.349 . . . . 0.0 110.179 -179.885 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.5 9.88 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.25 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 85.1 t -144.57 -9.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.2 -179.82 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.0 t-20 99.43 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 O-C-N 124.33 1.019 . . . . 0.0 110.798 179.826 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 5.2 t60 81.98 44.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.349 -179.385 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 41.7 p90 -66.55 -31.09 71.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.565 -179.942 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.756 -179.948 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.315 0.579 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.5 m-70 68.81 140.59 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.849 179.22 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.053 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 67.24 -33.33 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 126.267 2.23 . . . . 0.0 111.023 -179.106 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 0.98 0.37 Allowed 'General case' 0 N--CA 1.411 -2.406 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 165.152 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.053 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.5 tttp -114.02 -168.89 1.42 Allowed 'General case' 0 C--N 1.395 2.57 0 CA-C-N 109.554 -3.475 . . . . 0.0 111.743 176.769 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 34.15 18.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.959 177.968 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.17 -46.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 122.286 1.041 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.71 -14.56 77.98 Favored Glycine 0 C--N 1.27 -3.097 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 174.52 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -90.82 -47.79 7.41 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.144 177.804 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.56 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.799 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.53 6.84 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.292 0.568 . . . . 0.0 109.54 -179.149 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 50.6 t -143.02 -9.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.5 t-20 106.13 -36.81 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.62 1.2 . . . . 0.0 110.019 -179.809 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.538 ' CD2' ' H ' ' A' ' 24' ' ' TYR . 79.7 t60 -171.08 -117.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.273 179.871 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.538 ' H ' ' CD2' ' A' ' 23' ' ' HIS . 92.4 m-85 50.9 13.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.7 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.215 -179.965 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 59.2 mtp85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.1 m-70 -156.69 145.78 20.3 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.541 179.457 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.986 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -31.72 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.75 1.906 . . . . 0.0 109.839 -177.996 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.99 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.078 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.986 ' N ' ' C ' ' A' ' 12' ' ' ALA . 33.2 tttt -116.0 -169.56 1.62 Allowed 'General case' 0 C--N 1.392 2.418 0 CA-C-N 109.389 -3.551 . . . . 0.0 111.735 177.031 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 3.1 t60 34.48 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.935 178.089 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.06 -41.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.549 0 CA-C-O 122.02 0.914 . . . . 0.0 109.659 179.918 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.59 -13.16 83.79 Favored Glycine 0 C--N 1.275 -2.826 0 N-CA-C 105.506 -3.038 . . . . 0.0 105.506 174.327 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.65 -44.36 8.22 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 114.579 -0.81 . . . . 0.0 109.491 178.083 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.96 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.57 10.14 0.95 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.972 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 65.9 t -148.22 -9.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.189 -179.837 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.1 t-20 100.34 -35.58 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.388 1.055 . . . . 0.0 110.003 -179.643 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' A' ' 25' ' ' LEU . 43.9 m80 -151.72 120.06 6.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.42 -179.766 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -69.48 5.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' HIS . 3.0 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.37 -179.792 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.664 0.269 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.9 t60 -149.38 144.27 26.29 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.919 0.39 . . . . 0.0 110.825 179.601 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.45 -29.62 0.19 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.558 1.786 . . . . 0.0 109.851 -178.081 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.18 1.78 0.44 Allowed 'General case' 0 N--CA 1.411 -2.414 1 N-CA-C 94.855 -5.98 . . . . 0.0 94.855 164.342 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.6 tttp -116.07 -161.98 0.82 Allowed 'General case' 0 C--N 1.398 2.696 0 CA-C-N 109.264 -3.607 . . . . 0.0 110.726 176.929 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.561 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.4 t60 31.49 20.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.459 0.704 . . . . 0.0 112.144 178.291 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 172.95 -49.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 CA-C-O 122.429 1.109 . . . . 0.0 109.321 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.21 -13.71 70.57 Favored Glycine 0 C--N 1.27 -3.1 0 N-CA-C 106.257 -2.737 . . . . 0.0 106.257 175.351 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.6 m170 -94.69 -45.05 7.52 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.039 178.071 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 161.72 13.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.858 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.4 7.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.114 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.5 t -143.59 -9.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.575 -179.933 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 106.49 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.548 1.155 . . . . 0.0 110.246 179.969 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -173.09 100.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.533 -179.933 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 60.8 t80 -166.0 4.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.427 179.975 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.51 -179.97 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 49.2 t60 -164.0 143.97 8.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.597 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.61 0.23 Allowed 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 125.619 1.825 . . . . 0.0 109.656 -178.045 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.23 1.54 0.31 Allowed 'General case' 0 N--CA 1.411 -2.416 1 N-CA-C 95.364 -5.791 . . . . 0.0 95.364 165.014 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 18.2 tttm -114.89 -169.32 1.53 Allowed 'General case' 0 C--N 1.396 2.608 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.909 177.067 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 7.8 m-70 32.73 21.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.788 177.974 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 172.63 -47.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 CA-C-O 122.256 1.027 . . . . 0.0 109.374 -179.951 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.25 -14.39 79.18 Favored Glycine 0 C--N 1.271 -3.046 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 174.404 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.75 -44.07 11.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.466 178.034 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.39 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.205 -179.315 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 -1.44 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.192 179.496 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.5 t -150.97 -25.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.732 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.9 t30 130.18 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.737 1.273 . . . . 0.0 109.299 -179.726 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -163.17 97.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.906 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.464 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 77.4 t80 -164.31 -6.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.945 179.816 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.245 179.881 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.561 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.1 t60 -152.55 145.21 24.23 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.141 0.496 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.8 -30.66 0.21 Allowed 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 125.78 1.925 . . . . 0.0 109.261 -177.426 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.9 3.71 0.21 Allowed 'General case' 0 N--CA 1.41 -2.458 1 N-CA-C 95.372 -5.788 . . . . 0.0 95.372 164.698 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.023 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -119.36 -168.11 1.52 Allowed 'General case' 0 C--N 1.395 2.549 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.828 177.464 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.8 m170 31.67 25.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.411 178.12 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.6 tt 167.52 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 CA-C-O 122.171 0.986 . . . . 0.0 109.217 -179.841 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.34 -13.71 78.1 Favored Glycine 0 C--N 1.275 -2.837 0 N-CA-C 104.675 -3.37 . . . . 0.0 104.675 173.523 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.492 ' H ' ' H ' ' A' ' 16' ' ' ILE . 9.9 t60 -89.16 -40.3 12.99 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.399 177.897 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -144.33 23.38 1.65 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.885 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.59 -2.36 0.18 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.251 179.139 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' ALA . 42.9 t -150.89 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 121.335 -0.146 . . . . 0.0 111.066 -179.57 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER 175.83 -83.87 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.947 0.404 . . . . 0.0 110.84 -179.443 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.605 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.6 OUTLIER -155.47 -172.27 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.76 -179.589 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 50.6 t80 57.01 20.16 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.51 179.999 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.1 t-80 -157.47 145.78 19.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.589 179.518 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.999 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.63 0.23 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.773 1.92 . . . . 0.0 109.804 -178.028 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.01 0.31 Allowed 'General case' 0 N--CA 1.412 -2.375 1 N-CA-C 95.323 -5.806 . . . . 0.0 95.323 165.037 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.999 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.5 tttt -115.86 -168.76 1.47 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.509 -3.496 . . . . 0.0 111.557 177.045 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 8.8 m-70 33.98 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 177.968 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.63 -44.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.105 0.955 . . . . 0.0 109.518 179.885 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.11 81.87 Favored Glycine 0 C--N 1.273 -2.937 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.362 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 m170 -93.08 -49.28 6.08 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.563 177.99 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.46 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.488 -179.616 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.41 9.65 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.947 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 21' ' ' VAL . 59.7 t -146.7 -8.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.911 -179.856 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 18.8 m-20 99.42 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.819 1.324 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 93.2 m-70 -160.19 108.87 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -62.25 -11.78 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.318 179.986 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 7.9 ptm180 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.905 0.383 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 m-70 -155.45 146.52 22.54 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 179.507 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.05 -31.91 0.23 Allowed 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 125.719 1.887 . . . . 0.0 109.922 -178.071 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.14 1.76 0.29 Allowed 'General case' 0 N--CA 1.413 -2.295 1 N-CA-C 95.421 -5.77 . . . . 0.0 95.421 165.158 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 3.0 ttmm -115.56 -169.76 1.64 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.403 -3.544 . . . . 0.0 111.716 177.252 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.8 m-70 34.09 19.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.698 178.036 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.04 -46.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.686 0 CA-C-O 122.178 0.99 . . . . 0.0 109.641 -179.936 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.91 -14.66 78.46 Favored Glycine 0 C--N 1.272 -3.013 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 174.726 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.594 ' NE2' ' NZ ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -92.43 -42.74 9.59 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 114.721 -0.739 . . . . 0.0 110.038 178.363 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.82 42.1 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.353 -179.212 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.67 -17.1 0.13 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.663 -179.52 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -148.77 -33.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 179.974 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER 155.38 -47.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.867 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 80.5 t60 -166.86 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.222 179.835 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.549 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 98.3 m-85 46.89 18.32 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.6 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.14 -179.91 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 11' ' ' HIS . 95.0 mtt180 . . . . . 0 N--CA 1.46 0.044 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 2.2 t60 58.41 136.47 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.09 -179.814 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.047 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.68 -32.01 0.22 Allowed 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.761 -178.042 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.12 0.34 Allowed 'General case' 0 N--CA 1.41 -2.453 1 N-CA-C 95.268 -5.827 . . . . 0.0 95.268 164.709 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.047 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.6 tttm -114.71 -169.45 1.55 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.557 -3.474 . . . . 0.0 111.813 176.871 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.8 m80 34.54 18.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.894 178.085 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.41 -44.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 CA-C-O 122.051 0.929 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.59 -14.04 81.48 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 174.554 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.567 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.56 -46.27 7.7 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.402 177.995 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.47 12.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.43 -179.882 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.33 8.24 1.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.041 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 52.3 t -146.02 -9.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.054 -179.939 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 62.9 t30 102.27 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.543 1.152 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -175.07 75.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.403 179.997 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 52.8 t80 -79.15 -20.92 47.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.541 -179.979 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.978 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -155.05 72.2 0.82 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.289 1.042 . . . . 0.0 109.95 178.761 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.973 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.275 . . 174.67 -31.07 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.504 179.978 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.81 -1.53 0.65 Allowed 'General case' 0 N--CA 1.416 -2.154 1 N-CA-C 95.486 -5.746 . . . . 0.0 95.486 164.734 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.973 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.258 19.1 tttm -115.1 -166.86 1.16 Allowed 'General case' 0 C--N 1.388 2.262 0 CA-C-N 109.085 -3.689 . . . . 0.0 111.569 176.794 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.3 t60 34.4 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.146 177.812 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 174.37 -43.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.145 0.974 . . . . 0.0 109.489 179.797 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.95 -13.77 82.29 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 174.71 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.5 -44.67 8.52 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.605 -0.798 . . . . 0.0 109.049 177.907 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.32 11.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.222 0.326 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.54 10.89 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.907 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 21' ' ' VAL . 96.0 t -145.1 -7.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.821 -179.674 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.4 m-20 99.48 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.796 1.31 . . . . 0.0 110.228 -179.566 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.447 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 25.2 p-80 -162.9 112.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.633 179.984 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.2 t80 -69.82 -3.1 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.989 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.746 0.308 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 42.7 t60 -148.8 145.59 27.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.238 179.315 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.027 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.87 -31.42 0.23 Allowed 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 125.65 1.844 . . . . 0.0 109.521 -177.728 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.53 2.32 0.29 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.982 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.027 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.3 tttm -116.3 -169.53 1.63 Allowed 'General case' 0 C--N 1.394 2.512 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.778 177.01 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 7.4 m-70 34.1 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.812 178.2 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 174.8 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.077 0.941 . . . . 0.0 109.641 179.836 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.35 83.58 Favored Glycine 0 C--N 1.275 -2.855 0 N-CA-C 105.508 -3.037 . . . . 0.0 105.508 174.358 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.85 -45.91 7.43 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.483 178.046 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.48 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.615 -179.787 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.32 8.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.882 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 21' ' ' VAL . 50.5 t -147.08 -7.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.657 -179.866 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 m120 97.24 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.692 1.245 . . . . 0.0 109.835 -179.374 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.513 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -170.66 -113.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.513 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 31.5 t80 64.64 -6.01 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.931 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 19' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.45 107.53 5.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.24 11.37 44.08 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.8 p -48.89 109.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 7' ' ' LYS . 8.1 pt -74.95 71.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.149 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 56.49 7.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.658 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 5' ' ' ILE . 18.3 tptp -64.34 -64.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -89.62 51.14 2.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.43 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.01 15.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.996 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' H ' ' H ' ' A' ' 11' ' ' HIS . 56.6 ttt180 -170.55 -2.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.132 0.491 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.511 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.7 t60 -153.68 144.62 22.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.034 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.15 -31.78 0.23 Allowed 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 125.786 1.929 . . . . 0.0 109.901 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.67 0.3 Allowed 'General case' 0 N--CA 1.411 -2.378 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.034 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.5 tttt -115.26 -169.19 1.52 Allowed 'General case' 0 C--N 1.395 2.559 0 CA-C-N 109.446 -3.524 . . . . 0.0 111.826 177.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 9.5 m-70 32.96 21.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.84 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 173.52 -47.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.63 0 CA-C-O 122.191 0.996 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.74 -14.8 77.99 Favored Glycine 0 C--N 1.271 -3.073 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.466 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.96 -45.92 9.81 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 114.264 -0.968 . . . . 0.0 109.531 178.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.27 36.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.941 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.7 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.223 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 19' ' ' ALA . 48.2 t -151.01 -29.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.528 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 18.8 t30 136.12 -39.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.63 1.206 . . . . 0.0 109.096 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.528 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 85.5 m-70 -151.93 -131.37 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.31 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.453 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.7 t80 55.53 13.94 1.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.921 0.391 . . . . 0.0 110.311 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.5 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.298 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CD1' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.496 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 6.5 m-90 -157.05 -59.76 0.09 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.2 14.59 56.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.055 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.5 p -53.44 109.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.57 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.455 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 10.3 mt -72.85 -41.21 61.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.425 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 60.4 m-85 -158.69 -11.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' H ' ' H ' ' A' ' 6' ' ' PHE . 62.6 tttm -51.28 -21.47 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.427 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -72.81 10.57 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -179.58 27.61 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.042 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HE ' ' CA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -103.2 -1.35 29.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.049 0.452 . . . . 0.0 109.923 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 18.1 p80 -152.19 145.58 24.8 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.418 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.046 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 125.742 1.901 . . . . 0.0 109.917 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.311 1 N-CA-C 95.42 -5.771 . . . . 0.0 95.42 165.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.046 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -116.18 -168.26 1.41 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.47 -3.514 . . . . 0.0 111.55 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.2 m-70 34.27 19.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.915 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.33 -45.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 122.253 1.025 . . . . 0.0 109.364 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.39 -13.68 81.44 Favored Glycine 0 C--N 1.273 -2.95 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.46 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -92.09 -43.15 9.55 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.82 178.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.96 41.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.241 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.75 -17.97 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.5 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.2 t -148.63 -34.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 154.89 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.833 0.708 . . . . 0.0 109.115 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -160.9 45.32 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.28 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -66.59 -19.16 65.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.6 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.941 -0.463 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -165.57 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.491 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 176.41 -3.39 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.98 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 3' ' ' GLY . 34.9 t -54.7 171.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 mm -76.07 72.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 51.55 16.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tptp -68.3 -67.94 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.505 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -78.76 73.68 5.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.56 -51.58 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 88.7 mtt180 -99.78 -1.89 36.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.972 0.415 . . . . 0.0 110.276 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 46.5 m80 -151.85 143.83 23.81 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.291 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.86 -31.58 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.675 1.859 . . . . 0.0 109.497 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.34 0.28 Allowed 'General case' 0 N--CA 1.413 -2.324 1 N-CA-C 95.467 -5.753 . . . . 0.0 95.467 164.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.97 -169.04 1.52 Allowed 'General case' 0 C--N 1.394 2.5 0 CA-C-N 109.454 -3.521 . . . . 0.0 111.642 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.8 m-70 33.84 19.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.848 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.677 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.69 -45.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.226 1.012 . . . . 0.0 109.382 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.28 -13.95 81.06 Favored Glycine 0 C--N 1.272 -2.975 0 N-CA-C 105.489 -3.044 . . . . 0.0 105.489 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.463 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -91.38 -43.72 9.58 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.492 -0.854 . . . . 0.0 109.806 178.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.22 41.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.255 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.94 -19.29 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.497 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.8 t -148.78 -32.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 155.44 -47.88 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -172.49 96.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.263 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 55.4 t80 -164.0 1.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.314 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.18 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 3' ' ' GLY . 11.8 p90 -160.63 -54.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.694 0.283 . . . . 0.0 110.306 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 2' ' ' TRP . . . 59.19 27.52 62.86 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.146 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 t -47.9 158.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.614 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -73.3 74.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 53.08 67.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -143.27 -61.69 0.41 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.17 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -78.01 44.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.38 -23.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.974 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -98.61 -3.69 35.64 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.345 0.593 . . . . 0.0 109.722 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 64.5 t-80 -146.57 144.38 29.53 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.181 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.59 -31.41 0.22 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.641 1.838 . . . . 0.0 109.544 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.28 0.28 Allowed 'General case' 0 N--CA 1.412 -2.355 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttm -116.34 -169.49 1.63 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 109.493 -3.503 . . . . 0.0 111.71 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.618 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 23.5 m-70 34.82 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.851 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.4 tt 175.22 -41.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 CA-C-O 122.027 0.917 . . . . 0.0 109.679 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.37 -12.94 84.09 Favored Glycine 0 C--N 1.275 -2.82 0 N-CA-C 105.622 -2.991 . . . . 0.0 105.622 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.62 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.55 -42.75 8.27 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 114.729 -0.735 . . . . 0.0 109.639 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.37 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.768 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.63 8.62 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -149.41 -9.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.804 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -37.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.468 1.105 . . . . 0.0 110.563 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 18.9 t60 -171.86 178.1 3.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.792 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.593 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 23.9 p90 41.9 26.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.485 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -55.83 133.11 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 0.0 110.538 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.91 3.93 55.12 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.007 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 p -69.79 157.77 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.684 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 6' ' ' PHE . 15.2 tt -168.04 -45.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.545 ' N ' HG23 ' A' ' 5' ' ' ILE . 35.5 p90 -98.0 -22.97 15.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.309 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -69.92 -67.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.618 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 0.7 OUTLIER -76.52 67.8 2.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.693 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.17 -46.25 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.41 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -99.68 -0.0 41.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.833 0.349 . . . . 0.0 110.678 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.2 t-80 -159.29 143.64 15.27 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.669 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.71 0.23 Allowed 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 125.854 1.971 . . . . 0.0 109.723 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.29 0.27 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.532 -5.729 . . . . 0.0 95.532 165.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.8 tttm -116.61 -169.28 1.6 Allowed 'General case' 0 C--N 1.392 2.421 0 CA-C-N 109.452 -3.522 . . . . 0.0 111.822 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.3 m-70 33.11 22.26 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.789 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.4 tt 169.52 -37.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-O 122.258 1.028 . . . . 0.0 109.186 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.32 -11.81 79.88 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 104.753 -3.339 . . . . 0.0 104.753 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.5 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.2 -36.2 13.4 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 114.397 -0.901 . . . . 0.0 109.879 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.35 26.18 0.6 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.66 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.41 -4.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.279 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 19' ' ' ALA . 47.4 t -151.3 -27.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.047 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -174.24 -92.26 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.131 0.491 . . . . 0.0 110.978 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.3 t60 -159.62 27.37 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 53.3 t80 -74.92 17.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.685 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' HIS . 9.2 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.421 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -168.44 -59.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 0.0 110.429 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.16 -25.03 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 77.54 9.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.777 0.323 . . . . 0.0 110.502 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.466 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 11.9 mt -70.82 -28.64 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.292 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 66.8 m-85 -158.63 -3.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.25 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -44.59 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.958 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 0.65 6.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.42 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.34 -18.06 67.53 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.287 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -165.48 28.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.93 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.508 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t60 -164.18 146.51 9.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.018 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -32.0 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.88 1.988 . . . . 0.0 110.087 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.85 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.383 -5.784 . . . . 0.0 95.383 165.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.018 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.7 tttm -115.61 -169.83 1.66 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.612 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.9 t-80 34.34 18.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.961 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tt 175.65 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.137 0.97 . . . . 0.0 109.583 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.62 -13.34 83.29 Favored Glycine 0 C--N 1.277 -2.697 0 N-CA-C 105.14 -3.184 . . . . 0.0 105.14 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.95 -45.54 8.29 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 114.394 -0.903 . . . . 0.0 109.242 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.18 13.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.47 8.48 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.8 t -144.26 -9.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER 105.44 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.581 1.175 . . . . 0.0 110.322 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 17.0 t-80 -169.83 -134.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.569 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 85.9 m-85 54.06 20.0 2.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.815 0.341 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.7 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.37 -76.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.582 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.61 6.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.181 -0.533 . . . . 0.0 111.824 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 m -161.5 106.55 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.878 0.371 . . . . 0.0 110.446 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 6' ' ' PHE . 16.8 tt -51.26 -43.86 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.518 ' N ' HG23 ' A' ' 5' ' ' ILE . 4.8 m-85 -175.04 4.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' H ' ' H ' ' A' ' 6' ' ' PHE . 55.0 tttm -54.64 -29.4 52.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.732 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.533 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -85.31 52.69 2.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.65 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.06 -21.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.194 -0.526 . . . . 0.0 111.879 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -79.81 -114.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.513 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.6 t-80 -90.4 145.55 24.85 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.251 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.54 -32.43 0.23 Allowed 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 125.751 1.907 . . . . 0.0 110.302 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.96 0.48 0.38 Allowed 'General case' 0 N--CA 1.412 -2.338 1 N-CA-C 95.324 -5.806 . . . . 0.0 95.324 165.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttm -113.53 -169.36 1.49 Allowed 'General case' 0 C--N 1.393 2.477 0 CA-C-N 109.24 -3.618 . . . . 0.0 112.046 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.635 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 30.2 t-80 34.7 18.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.95 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.68 -46.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.257 1.027 . . . . 0.0 109.121 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.28 78.93 Favored Glycine 0 C--N 1.27 -3.108 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.579 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.1 -47.04 7.77 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.091 177.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.89 13.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.11 8.27 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.0 t -144.35 -9.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.432 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.1 t30 103.89 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.521 1.138 . . . . 0.0 109.921 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -178.14 92.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.92 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 88.0 t80 -143.3 9.18 1.63 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.094 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.195 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.464 ' CG ' ' O ' ' A' ' 2' ' ' TRP . 76.1 t-105 -166.51 10.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.783 0.325 . . . . 0.0 110.532 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.49 -5.96 26.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.877 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 76.4 p 48.9 97.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.775 0.322 . . . . 0.0 110.769 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 6' ' ' PHE . 8.0 tt -69.12 -42.42 81.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.198 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.481 ' N ' HG23 ' A' ' 5' ' ' ILE . 37.6 m-85 -155.78 -5.22 0.12 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' H ' ' H ' ' A' ' 6' ' ' PHE . 30.7 mmtp -57.41 -73.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.069 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.88 67.59 7.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.461 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.83 -16.53 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.005 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 15.1 ptm180 -173.14 17.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.654 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.9 m-70 -157.37 146.31 19.8 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.963 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.52 -31.52 0.22 Allowed 'General case' 0 CA--C 1.498 -1.048 0 O-C-N 125.797 1.935 . . . . 0.0 110.01 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 1.94 0.31 Allowed 'General case' 0 N--CA 1.412 -2.329 1 N-CA-C 95.299 -5.815 . . . . 0.0 95.299 165.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.963 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.04 -169.46 1.61 Allowed 'General case' 0 C--N 1.392 2.447 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.8 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.5 m80 34.78 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.865 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 174.96 -42.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.116 0.96 . . . . 0.0 109.669 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.48 83.45 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.09 -44.77 7.86 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 114.591 -0.805 . . . . 0.0 109.565 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.5 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.444 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.89 8.4 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 49.4 t -148.28 -9.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.241 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 8.8 t-20 102.28 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.43 1.081 . . . . 0.0 109.874 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.551 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -174.95 176.4 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.423 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 53.58 31.59 12.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -60.61 -10.21 4.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.506 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.21 -0.26 32.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.085 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.8 m 50.8 178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.59 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 16.7 pt -89.03 -35.02 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.692 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 68.1 m-85 -160.83 -5.1 0.05 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -51.82 -66.47 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -75.46 72.81 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.507 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.86 -13.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.866 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 67.6 mtp180 -143.8 10.92 1.6 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 70.3 m80 -153.12 145.66 24.16 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.104 0.478 . . . . 0.0 110.818 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.071 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.55 -31.52 0.23 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.83 1.956 . . . . 0.0 109.586 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.72 3.12 0.23 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.477 -5.749 . . . . 0.0 95.477 164.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.071 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.0 tttp -117.68 -169.37 1.66 Allowed 'General case' 0 C--N 1.392 2.443 0 CA-C-N 109.487 -3.506 . . . . 0.0 111.925 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 71.2 m-70 31.81 25.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.625 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.624 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.1 tt 168.08 -35.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.026 0.917 . . . . 0.0 109.029 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.34 -13.3 74.02 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.541 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.5 t60 -86.79 -39.79 15.59 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-N 114.181 -1.009 . . . . 0.0 110.154 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -149.16 23.51 0.94 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.152 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.91 5.48 0.1 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.1 t -150.59 -31.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.551 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 21' ' ' VAL . 3.9 m-20 167.82 -74.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.4 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -163.59 24.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.386 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -50.11 -26.96 5.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -61.84 -159.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.24 9.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.062 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.2 p 50.78 100.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.847 0.356 . . . . 0.0 110.714 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mt -71.77 74.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.375 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 52.71 22.09 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.73 -56.6 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.43 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -73.0 79.17 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.45 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -48.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -102.12 0.19 34.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 110.227 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 63.0 m80 -153.16 144.08 22.89 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.254 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.024 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.36 -31.11 0.22 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.678 1.862 . . . . 0.0 109.564 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.32 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.024 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -116.56 -168.9 1.53 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.393 -3.548 . . . . 0.0 111.667 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.1 m80 34.23 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.814 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.08 -43.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 CA-C-O 122.109 0.957 . . . . 0.0 109.734 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.44 -13.13 83.7 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.645 -2.982 . . . . 0.0 105.645 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.42 -44.09 7.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 114.589 -0.806 . . . . 0.0 109.624 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.64 8.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.569 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.02 8.74 1.54 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 21' ' ' VAL . 48.2 t -148.44 -8.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.647 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 20.5 m-20 97.13 -36.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.555 1.159 . . . . 0.0 110.275 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.9 t60 -170.76 -162.63 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.074 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.1 t80 56.0 12.08 0.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -62.33 -18.45 61.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.68 -10.41 31.46 Favored Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.8 m -91.91 102.01 14.59 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mt -65.73 -42.91 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' H ' ' H ' ' A' ' 7' ' ' LYS . 42.9 p90 -166.85 -8.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' H ' ' A' ' 6' ' ' PHE . 59.7 mttm -53.85 -66.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.39 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -81.67 67.33 7.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.523 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.59 -21.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.809 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' C ' ' CG ' ' A' ' 11' ' ' HIS . 99.4 mtt180 -137.1 6.6 2.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.207 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 21.7 m80 -152.69 146.41 25.11 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.21 -31.03 0.21 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.814 1.946 . . . . 0.0 110.095 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 1.98 0.31 Allowed 'General case' 0 N--CA 1.411 -2.388 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 10.6 ttpt -116.22 -168.86 1.5 Allowed 'General case' 0 C--N 1.395 2.565 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.691 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 83.2 t60 35.02 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.992 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.3 tt 175.65 -44.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.193 0.997 . . . . 0.0 109.507 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.81 -13.77 82.06 Favored Glycine 0 C--N 1.274 -2.877 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.25 -45.39 8.65 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.46 -0.87 . . . . 0.0 108.838 177.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.36 12.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 56.89 11.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 21' ' ' VAL . 95.4 t -145.12 -7.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.11 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.1 m120 100.6 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.89 1.369 . . . . 0.0 110.103 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 7.8 t-80 -167.42 -136.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.219 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.593 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.5 m-85 46.47 31.6 1.36 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -53.47 131.66 38.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.862 0.363 . . . . 0.0 110.51 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.98 -23.62 72.85 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.0 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.5 m -53.03 95.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 mt -69.6 -26.76 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.233 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -161.12 -9.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.66 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -56.07 -30.97 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.34 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -123.23 50.32 1.57 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.118 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.01 -8.05 0.13 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 14.9 ptm180 -167.43 23.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.483 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 27.4 m-70 -144.0 146.99 33.27 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.612 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.13 -31.51 0.23 Allowed 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 125.61 1.818 . . . . 0.0 109.812 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.61 2.4 0.29 Allowed 'General case' 0 N--CA 1.411 -2.397 1 N-CA-C 95.339 -5.8 . . . . 0.0 95.339 165.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.8 tttp -116.19 -168.81 1.49 Allowed 'General case' 0 C--N 1.394 2.504 0 CA-C-N 109.479 -3.509 . . . . 0.0 111.561 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m-70 34.1 19.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.946 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.38 -45.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.55 -14.05 81.41 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 105.486 -3.046 . . . . 0.0 105.486 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.78 -48.48 6.29 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 114.398 -0.901 . . . . 0.0 109.77 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.69 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.66 9.32 1.1 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 21' ' ' VAL . 98.2 t -146.95 -8.1 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.784 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 25.6 m-20 97.94 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.702 1.251 . . . . 0.0 110.334 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 55.7 m80 -157.48 -160.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.448 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 55.21 22.75 4.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.572 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.289 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.211 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.25 -70.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 110.624 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.25 -24.64 0.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.139 -0.553 . . . . 0.0 111.965 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.0 p -58.9 122.25 13.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.443 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.493 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.9 mt -69.77 -50.89 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 54.9 m-85 -161.09 -3.82 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 3.4 mptp? -58.1 -59.41 5.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.163 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 8' ' ' HIS . 54.9 t-80 -76.97 40.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.74 20.39 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -166.41 34.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.115 0.483 . . . . 0.0 110.047 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.6 t-80 -156.58 145.39 20.13 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.41 -31.38 0.22 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.825 1.953 . . . . 0.0 109.629 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.1 0.3 Allowed 'General case' 0 N--CA 1.411 -2.399 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.045 ' N ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.2 -169.3 1.58 Allowed 'General case' 0 C--N 1.393 2.475 0 CA-C-N 109.423 -3.535 . . . . 0.0 111.737 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.23 19.64 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.791 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 173.87 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 CA-C-O 122.054 0.93 . . . . 0.0 109.567 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.17 -12.87 84.21 Favored Glycine 0 C--N 1.274 -2.89 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.614 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.78 -44.49 8.11 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.075 177.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.3 13.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.12 9.11 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -144.76 -9.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.324 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t30 104.38 -36.79 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.628 1.205 . . . . 0.0 110.214 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 20.8 t-80 -170.38 -126.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.379 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.57 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 97.1 m-85 53.44 11.99 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.559 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' C ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.439 ' CG ' ' C ' ' A' ' 1' ' ' GLY . 9.7 m-90 -155.65 -5.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.812 0.339 . . . . 0.0 110.449 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 2' ' ' TRP . . . 73.76 2.56 61.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.16 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 m -68.37 125.04 25.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 5' ' ' ILE . 19.1 tt -72.73 71.82 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.591 0.71 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.522 ' CG ' ' NH2' ' A' ' 10' ' ' ARG . 47.1 m-85 55.81 4.88 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.93 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 5' ' ' ILE . 81.4 tttt -65.14 -21.57 66.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 17.6 t-80 -76.52 9.29 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.77 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' NH2' ' CG ' ' A' ' 6' ' ' PHE . 28.1 ttm180 -171.31 34.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.956 0.407 . . . . 0.0 110.208 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.1 t60 -157.3 147.3 20.69 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.54 -31.6 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.758 1.912 . . . . 0.0 110.048 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.45 2.1 0.3 Allowed 'General case' 0 N--CA 1.412 -2.349 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 165.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.3 tttt -116.08 -168.79 1.49 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.696 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.4 t-80 34.23 19.31 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.847 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 174.57 -46.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 CA-C-O 122.308 1.052 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.54 -14.23 77.57 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.33 -46.88 7.16 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.523 -0.839 . . . . 0.0 109.559 178.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.88 14.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.93 5.65 1.03 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.9 t -144.6 -8.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.343 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 15.5 t30 105.35 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.578 1.174 . . . . 0.0 109.958 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 2.2 p-80 -170.58 107.74 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 72.9 t80 -59.92 -9.54 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.472 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.453 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 3.6 m0 -64.29 -138.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.688 0.28 . . . . 0.0 110.383 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.38 27.86 0.16 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.851 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -61.52 92.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -66.28 77.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.473 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 54.43 24.21 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.771 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -75.6 -44.47 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.525 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -80.38 50.55 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.511 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.0 -18.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -120.56 8.81 10.74 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 110.202 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 48.2 t-80 -156.75 145.65 20.12 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.711 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.006 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.74 -31.65 0.23 Allowed 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 125.835 1.959 . . . . 0.0 109.889 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.46 2.14 0.29 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.006 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttp -116.24 -169.09 1.54 Allowed 'General case' 0 C--N 1.393 2.497 0 CA-C-N 109.435 -3.53 . . . . 0.0 111.68 177.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.3 t60 34.36 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.961 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.12 -41.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.61 0 CA-C-O 122.015 0.912 . . . . 0.0 109.524 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.35 -13.29 83.42 Favored Glycine 0 C--N 1.276 -2.781 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.537 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.5 m170 -94.66 -47.52 6.47 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.709 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.0 12.85 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.26 7.45 1.26 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.373 0.606 . . . . 0.0 109.388 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.3 t -148.31 -9.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.106 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 39.8 t-20 101.66 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.463 1.102 . . . . 0.0 110.084 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' A' ' 25' ' ' LEU . 76.4 m80 -150.48 112.85 4.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.383 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.45 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 61.8 t80 -53.8 -10.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 23' ' ' HIS . 14.9 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.446 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -54.98 132.85 47.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.626 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.87 -13.68 83.37 Favored Glycine 0 C--N 1.33 0.228 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.7 p 59.92 118.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.707 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' C ' ' CG ' ' A' ' 6' ' ' PHE . 16.5 pt -78.01 45.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.624 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 10' ' ' ARG . 4.6 m-85 74.3 -12.5 0.88 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 9' ' ' GLY . 55.6 tttp -55.67 -37.58 68.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.489 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -73.43 11.05 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.344 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -154.81 6.59 0.3 Allowed Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 6' ' ' PHE . 51.2 mtt-85 -156.18 163.55 39.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 39.7 m80 60.08 136.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.544 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.69 -32.43 0.24 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.631 1.832 . . . . 0.0 109.637 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.18 1.32 0.32 Allowed 'General case' 0 N--CA 1.41 -2.431 1 N-CA-C 95.34 -5.8 . . . . 0.0 95.34 164.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.1 tttt -114.62 -169.05 1.47 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.592 -3.458 . . . . 0.0 111.843 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 56.8 m-70 34.44 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.763 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 174.61 -46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-O 122.2 1.0 . . . . 0.0 109.422 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.57 -13.69 80.06 Favored Glycine 0 C--N 1.271 -3.071 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -92.27 -43.14 9.45 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.643 -0.778 . . . . 0.0 109.853 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 119.503 -0.879 . . . . 0.0 112.226 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.93 -17.89 0.16 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.55 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 19' ' ' ALA . 24.0 t -149.24 -32.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.759 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 156.87 -47.7 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -166.98 68.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.556 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.459 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 68.7 t80 -58.22 -21.66 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.566 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.481 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -70.14 -163.94 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.744 0.307 . . . . 0.0 110.501 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.7 21.58 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.038 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.9 p -168.73 148.13 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' C ' ' H ' ' A' ' 7' ' ' LYS . 6.3 mm -79.5 59.05 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.996 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 54.2 8.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 5' ' ' ILE . 65.6 tttm -66.38 -57.0 8.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -80.15 35.83 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.1 16.03 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.099 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -165.51 29.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.0 110.231 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.505 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.1 t-80 -158.85 146.8 17.96 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.72 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.022 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.99 -31.97 0.24 Allowed 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 125.791 1.932 . . . . 0.0 109.991 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.92 0.29 Allowed 'General case' 0 N--CA 1.412 -2.35 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 165.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.022 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttp -115.59 -169.68 1.63 Allowed 'General case' 0 C--N 1.393 2.465 0 CA-C-N 109.323 -3.58 . . . . 0.0 111.623 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.614 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.5 t60 34.47 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.033 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 176.07 -43.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 CA-C-O 122.093 0.949 . . . . 0.0 109.477 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.55 -14.48 81.99 Favored Glycine 0 C--N 1.274 -2.863 0 N-CA-C 105.197 -3.161 . . . . 0.0 105.197 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -90.29 -49.38 6.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.179 177.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.57 13.43 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.16 0.288 . . . . 0.0 110.309 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.48 7.85 1.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.9 t -141.71 -9.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t-20 105.17 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.607 1.192 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.452 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.0 t-80 84.71 26.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.008 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.38 -13.66 62.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.277 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -73.88 173.09 10.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.13 -14.69 76.48 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.861 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 m 59.56 148.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -98.67 -26.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.966 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 8' ' ' HIS . 74.6 m-85 -144.3 57.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 53.79 9.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 10.8 t-80 48.93 19.37 0.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.528 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.48 -17.71 0.02 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.184 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 69.83 43.12 0.97 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.837 0.351 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 98.5 m-70 -136.48 92.02 2.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.318 0.58 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.0 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 138.74 -32.86 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -0.39 0.58 Allowed 'General case' 0 N--CA 1.414 -2.25 1 N-CA-C 95.398 -5.779 . . . . 0.0 95.398 164.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.0 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.9 tttt -114.59 -168.78 1.42 Allowed 'General case' 0 C--N 1.391 2.378 0 CA-C-N 109.441 -3.527 . . . . 0.0 112.001 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 81.4 m-70 33.45 21.7 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.833 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.75 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.237 1.018 . . . . 0.0 109.452 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.37 -11.5 80.32 Favored Glycine 0 C--N 1.276 -2.751 0 N-CA-C 104.848 -3.301 . . . . 0.0 104.848 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.498 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -91.76 -36.75 13.39 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-N 114.284 -0.958 . . . . 0.0 109.843 178.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.45 26.22 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.707 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.13 0.15 0.05 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.269 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 19' ' ' ALA . 41.5 t -151.47 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.266 0.079 . . . . 0.0 110.823 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.598 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -178.87 -89.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.991 0.424 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.598 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 1.7 t60 -166.51 50.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.407 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 48.4 t80 -74.58 -15.81 60.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.585 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.501 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -70.13 -68.21 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.489 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.22 -15.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.551 . . . . 0.0 111.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.0 m 52.08 -178.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.851 0.358 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' CG ' ' A' ' 6' ' ' PHE . 5.4 pt -152.69 76.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.778 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.529 ' H ' ' CE1' ' A' ' 8' ' ' HIS . 5.5 m-85 75.54 -40.36 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.632 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 9' ' ' GLY . 62.7 mttp -50.9 -23.73 3.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.606 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.529 ' CE1' ' H ' ' A' ' 6' ' ' PHE . 4.6 p-80 -61.98 0.4 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.269 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . 166.68 34.21 0.02 OUTLIER Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.729 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -154.15 27.75 0.46 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.6 t60 -157.52 146.25 19.54 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.632 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.99 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 125.71 1.881 . . . . 0.0 109.898 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.27 1.95 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.044 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.4 tttt -115.69 -169.26 1.55 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.744 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.62 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 33.89 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.792 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.4 tt 174.37 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-O 122.202 1.001 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.0 -13.86 80.66 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.495 -3.042 . . . . 0.0 105.495 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.447 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -91.05 -43.53 9.87 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.674 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.37 41.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.221 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.7 -16.99 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.587 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.7 t -148.95 -34.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t30 155.28 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.827 0.704 . . . . 0.0 109.143 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.54 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 29.4 t60 -162.89 -117.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.54 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 59.6 t80 54.62 18.0 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.336 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -67.69 173.34 4.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.568 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.25 0.24 64.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.94 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -52.65 98.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 110.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.519 HG22 ' CE2' ' A' ' 6' ' ' PHE . 10.1 mt -76.34 -40.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 5' ' ' ILE . 63.7 m-85 -146.82 -14.64 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.417 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -50.23 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.723 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -77.39 66.21 3.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.65 -13.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.889 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -148.16 14.67 1.02 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.85 0.357 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 91.8 m-70 -152.8 145.39 24.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.55 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.36 -31.25 0.22 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.701 1.876 . . . . 0.0 109.726 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 2.02 0.31 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.353 -5.795 . . . . 0.0 95.353 164.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.029 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.2 ttpt -115.9 -169.28 1.56 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.424 -3.535 . . . . 0.0 111.577 176.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.2 t-80 34.45 17.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.001 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.7 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.123 0.964 . . . . 0.0 109.565 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -13.68 83.17 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 105.386 -3.086 . . . . 0.0 105.386 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.18 -47.42 7.53 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.211 -0.995 . . . . 0.0 109.251 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.45 11.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.273 0.358 . . . . 0.0 110.135 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.07 10.2 1.54 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 92.5 t -142.63 -9.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 22.7 t-20 101.89 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.464 1.102 . . . . 0.0 110.813 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.553 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.5 t60 81.63 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.237 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.553 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.1 m-85 50.36 31.95 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.244 -179.923 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -66.27 -164.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.611 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.51 23.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.867 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m 55.12 82.64 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 0.0 110.429 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 pt -71.53 87.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.342 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 57.09 11.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.735 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -72.4 -57.26 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.378 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 1.3 t60 -79.96 42.6 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.434 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -159.5 -4.53 0.06 OUTLIER Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.734 -0.547 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 61.9 mtp180 -144.32 6.87 1.32 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.232 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 90.6 m-70 -156.38 144.85 19.94 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.96 -31.93 0.23 Allowed 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 125.737 1.898 . . . . 0.0 109.892 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.91 0.31 Allowed 'General case' 0 N--CA 1.412 -2.37 1 N-CA-C 95.406 -5.776 . . . . 0.0 95.406 165.057 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.3 tttm -115.15 -169.78 1.63 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.5 -3.5 . . . . 0.0 111.803 176.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 2.0 t60 34.39 17.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.108 178.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 176.38 -44.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.224 1.011 . . . . 0.0 109.078 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.35 -13.93 82.4 Favored Glycine 0 C--N 1.274 -2.905 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 174.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 m170 -92.28 -47.91 6.96 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.465 -0.867 . . . . 0.0 109.457 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.38 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.641 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.54 7.83 1.1 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.411 0.624 . . . . 0.0 109.46 -179.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 48.9 t -146.22 -8.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.958 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.0 t-20 102.52 -37.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.631 1.207 . . . . 0.0 110.031 -179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -173.93 104.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.618 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 48.2 t80 -171.68 -4.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' H ' ' H ' ' A' ' 24' ' ' TYR . 15.9 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.13 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.6 m95 53.57 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.839 0.352 . . . . 0.0 110.639 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 172.87 6.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.253 -0.499 . . . . 0.0 111.918 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 3' ' ' GLY . 52.3 p -169.58 119.97 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 0.0 110.445 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' H ' ' A' ' 7' ' ' LYS . 9.4 pt -73.46 69.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 54.98 9.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.769 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 5' ' ' ILE . 60.6 tttp -55.01 -68.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.363 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -82.44 68.59 8.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -163.78 -16.07 0.03 OUTLIER Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 11' ' ' HIS . 13.9 ptm180 -151.54 -0.97 0.34 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.816 0.341 . . . . 0.0 110.215 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.9 m170 -135.82 146.75 47.84 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.278 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.993 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -31.62 0.23 Allowed 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 125.734 1.896 . . . . 0.0 109.851 -177.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 1.99 0.31 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.443 -5.762 . . . . 0.0 95.443 165.051 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.993 ' N ' ' C ' ' A' ' 12' ' ' ALA . 18.7 tttp -115.57 -169.12 1.52 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.406 -3.543 . . . . 0.0 111.737 176.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.8 t60 33.72 19.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.89 178.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.31 -45.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.125 0.964 . . . . 0.0 109.551 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.05 -14.33 80.44 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 105.402 -3.079 . . . . 0.0 105.402 174.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 m170 -91.67 -48.96 6.54 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 114.325 -0.937 . . . . 0.0 109.182 177.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.08 14.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.29 9.63 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.5 t -144.63 -10.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.845 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.2 t-20 105.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.542 1.151 . . . . 0.0 110.914 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 4.9 t-160 83.98 28.02 0.08 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.372 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -57.61 -19.37 25.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -55.07 160.25 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.707 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.07 -18.06 79.64 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.1 t -164.48 173.67 11.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.343 . . . . 0.0 110.467 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' C ' ' N ' ' A' ' 7' ' ' LYS . 18.4 mt -74.55 70.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.432 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 52.45 13.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 5' ' ' ILE . 18.4 tptm -62.53 -50.1 72.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 46.84 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.475 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.85 -2.64 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.167 -0.54 . . . . 0.0 111.9 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -144.3 1.75 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 110.015 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.4 t-80 -157.22 143.6 18.02 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.324 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.85 -30.73 0.21 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.37 -177.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.87 3.29 0.24 Allowed 'General case' 0 N--CA 1.41 -2.46 1 N-CA-C 95.332 -5.803 . . . . 0.0 95.332 164.741 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.023 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.8 tttp -119.05 -168.13 1.51 Allowed 'General case' 0 C--N 1.392 2.428 0 CA-C-N 109.457 -3.52 . . . . 0.0 111.684 177.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.4 m80 33.5 23.27 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.556 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.63 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.3 tt 167.41 -34.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.415 0 CA-C-O 122.166 0.984 . . . . 0.0 109.256 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.63 -12.37 77.99 Favored Glycine 0 C--N 1.275 -2.833 0 N-CA-C 104.902 -3.279 . . . . 0.0 104.902 174.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 18' ' ' HIS . 18.4 t-160 -92.56 -36.04 13.25 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 114.425 -0.887 . . . . 0.0 110.013 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -146.91 22.88 1.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.96 -2.66 0.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.3 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.9 -30.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.738 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -176.63 -90.16 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.011 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.1 p80 -149.75 25.99 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.48 ' N ' ' CB ' ' A' ' 19' ' ' ALA . 45.5 t80 -72.46 12.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.4 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.253 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -58.19 -99.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.7 0.286 . . . . 0.0 110.559 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.36 -14.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.6 m -81.49 69.71 8.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.765 0.317 . . . . 0.0 110.577 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -44.0 -46.57 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -179.718 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 73.7 m-85 -160.12 -1.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.328 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -51.58 -55.81 17.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -78.19 47.66 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.496 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.83 7.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -150.43 11.72 0.7 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.1 t60 -157.49 145.24 18.82 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.024 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.81 -31.72 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.706 1.879 . . . . 0.0 109.805 -178.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.86 0.3 Allowed 'General case' 0 N--CA 1.412 -2.361 1 N-CA-C 95.303 -5.814 . . . . 0.0 95.303 164.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.024 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.0 tttt -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.556 -3.474 . . . . 0.0 111.876 177.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 49.3 t-80 33.91 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.787 178.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.14 -46.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 122.234 1.016 . . . . 0.0 109.319 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -13.63 80.57 Favored Glycine 0 C--N 1.271 -3.076 0 N-CA-C 105.571 -3.011 . . . . 0.0 105.571 174.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.434 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.21 -43.09 10.05 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.533 178.181 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.42 41.45 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.181 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.41 -15.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.612 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -149.17 -35.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.2 t30 155.53 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.806 0.691 . . . . 0.0 109.19 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -166.11 65.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.6 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.469 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 65.1 t80 -70.12 -13.59 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.451 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.005 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.537 ' CG ' ' N ' ' A' ' 3' ' ' GLY . 72.0 t-105 -64.62 174.82 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' CG ' ' A' ' 2' ' ' TRP . . . -74.51 4.23 36.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.231 -0.509 . . . . 0.0 111.889 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t 59.03 160.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.615 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -80.83 67.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.749 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 53.91 10.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.193 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -70.76 -68.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.181 179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -76.3 65.42 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.23 -26.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.108 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -157.3 17.62 0.28 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.512 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.0 t60 -157.25 145.2 19.12 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.041 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.03 -31.57 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.702 1.876 . . . . 0.0 109.75 -177.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.85 0.31 Allowed 'General case' 0 N--CA 1.411 -2.411 1 N-CA-C 95.416 -5.772 . . . . 0.0 95.416 164.914 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.041 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.8 tttt -115.35 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.45 -3.523 . . . . 0.0 111.759 176.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 11.7 t-80 34.51 18.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.985 177.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.668 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.88 -46.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.307 1.051 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.16 -14.49 79.0 Favored Glycine 0 C--N 1.271 -3.035 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.3 -48.63 6.58 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.471 -0.865 . . . . 0.0 109.539 178.113 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.26 12.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.433 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.1 8.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 21' ' ' VAL . 89.5 t -145.78 -7.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.783 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.6 m-20 98.57 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.764 1.29 . . . . 0.0 110.19 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -176.76 87.15 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.352 -179.927 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -66.82 -21.38 66.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.984 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -65.21 -85.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 110.565 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.47 2.65 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.946 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 t 56.4 164.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 110.484 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 5' ' ' ILE . 14.7 tt -73.95 83.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.491 0.662 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 44.96 16.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.389 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ILE . 34.0 ttpt -67.13 -42.38 84.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -78.34 55.13 1.51 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.608 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.99 1.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.125 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -145.09 25.9 1.38 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 110.529 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 t-80 -160.82 144.05 13.16 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.463 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.05 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.58 -31.11 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.568 1.792 . . . . 0.0 109.458 -177.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.67 2.34 0.3 Allowed 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 95.317 -5.808 . . . . 0.0 95.317 164.758 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.05 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.1 tttm -116.33 -169.29 1.59 Allowed 'General case' 0 C--N 1.393 2.468 0 CA-C-N 109.525 -3.489 . . . . 0.0 111.556 177.063 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 34.77 17.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.99 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 175.83 -41.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.58 0 CA-C-O 122.042 0.925 . . . . 0.0 109.471 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.1 -13.01 83.8 Favored Glycine 0 C--N 1.276 -2.785 0 N-CA-C 105.331 -3.108 . . . . 0.0 105.331 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.4 m170 -94.38 -46.29 7.09 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 114.519 -0.84 . . . . 0.0 109.541 178.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.63 13.29 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.772 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.55 5.92 1.36 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 20.7 t -148.13 -10.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.391 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 58.2 t-20 110.53 -42.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.632 1.208 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 63.2 t-80 -173.9 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.649 0.262 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -76.05 39.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.477 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.2 tp . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -73.82 -171.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.639 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.78 26.19 24.92 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -41.75 159.65 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 -179.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 pt -78.02 56.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.589 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 55.55 56.71 5.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.524 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -122.24 -48.01 2.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.132 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 5.9 t60 -80.28 42.19 0.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.5 -13.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.195 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -96.16 -3.75 43.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.264 0.554 . . . . 0.0 109.802 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' ALA . 52.5 t60 -150.16 144.73 25.86 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.093 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.006 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.42 -31.4 0.22 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 125.75 1.906 . . . . 0.0 109.648 -177.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.4 0.27 Allowed 'General case' 0 N--CA 1.413 -2.308 1 N-CA-C 95.363 -5.791 . . . . 0.0 95.363 164.952 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.006 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.2 tttt -116.63 -168.63 1.48 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.485 -3.507 . . . . 0.0 111.669 177.096 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.1 m-70 33.82 20.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.825 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 173.76 -43.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 122.108 0.956 . . . . 0.0 109.61 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.22 -13.24 83.48 Favored Glycine 0 C--N 1.274 -2.911 0 N-CA-C 105.57 -3.012 . . . . 0.0 105.57 174.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.77 -45.51 7.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.483 178.117 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.62 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.34 7.16 1.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 42.4 t -146.59 -9.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.369 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 37.7 t-20 103.46 -35.93 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.514 1.134 . . . . 0.0 110.058 -179.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.535 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -171.58 112.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.346 -179.8 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -64.17 -1.03 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.634 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' HIS . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -65.14 135.26 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.87 -6.69 60.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.947 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 p 48.55 84.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.644 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 6' ' ' PHE . 6.8 tt -55.81 -42.96 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.486 ' N ' HG23 ' A' ' 5' ' ' ILE . 40.0 m-85 -158.28 -8.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.976 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' H ' ' H ' ' A' ' 6' ' ' PHE . 44.9 mtmt -52.09 -17.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.785 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.46 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 13.4 t-80 -72.79 3.8 4.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.826 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.17 22.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.197 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -96.93 -1.58 45.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.977 0.418 . . . . 0.0 109.968 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' ALA . 5.7 p80 -155.04 143.77 20.68 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.351 179.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.045 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.63 -31.07 0.22 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.694 1.871 . . . . 0.0 109.523 -177.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.02 0.29 Allowed 'General case' 0 N--CA 1.411 -2.391 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 165.078 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.045 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.9 ttpt -116.96 -168.18 1.42 Allowed 'General case' 0 C--N 1.393 2.498 0 CA-C-N 109.398 -3.546 . . . . 0.0 111.498 177.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.4 t-80 34.11 20.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.631 177.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.1 tt 171.36 -46.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 CA-C-O 122.303 1.049 . . . . 0.0 109.254 -179.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.69 -13.12 80.6 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.975 -2.85 . . . . 0.0 105.975 175.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.43 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.55 -32.21 18.27 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.84 -66.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.795 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -172.56 -20.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CD2' ' A' ' 15' ' ' HIS . 59.9 t -152.0 -17.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.562 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 164.58 -38.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.958 0.409 . . . . 0.0 110.017 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 31.4 t60 -171.34 26.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.352 -178.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -47.62 -18.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.303 179.935 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -165.12 -67.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.2 -6.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.904 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 m 55.75 71.03 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.663 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.492 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 12.1 mt -67.23 -37.58 79.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.165 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 59.0 m-85 -160.51 -1.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.864 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -58.64 -77.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.546 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -73.81 75.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.08 -28.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -163.74 26.26 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.344 . . . . 0.0 110.5 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.53 ' C ' ' H ' ' A' ' 13' ' ' ALA . 74.9 t60 -158.48 146.4 18.25 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 179.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.05 -31.31 0.22 Allowed 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 125.821 1.951 . . . . 0.0 109.738 -177.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.79 0.26 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.313 -5.81 . . . . 0.0 95.313 164.957 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.039 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -117.37 -168.62 1.52 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.462 -3.517 . . . . 0.0 111.859 177.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.1 t60 33.86 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.331 178.124 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 172.13 -45.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 CA-C-O 122.058 0.933 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.04 -15.13 76.34 Favored Glycine 0 C--N 1.272 -3.026 0 N-CA-C 105.812 -2.915 . . . . 0.0 105.812 175.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 7.9 t-80 -93.29 -41.95 9.59 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.31 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.39 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.464 -0.894 . . . . 0.0 112.621 -179.379 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.62 -12.51 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.016 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.0 t -148.94 -36.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 121.284 -0.166 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.3 t-20 157.52 -46.66 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.79 95.8 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.713 -179.687 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.432 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.4 t80 -170.32 1.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.16 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.71 179.965 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -63.49 -74.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.508 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.99 -5.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.04 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m 56.54 163.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 110.509 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.7 pt -66.1 -151.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.946 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -62.48 0.71 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.701 0.286 . . . . 0.0 110.814 -179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 5' ' ' ILE . 59.4 tttp -62.91 -46.55 87.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 0.0 110.407 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -84.54 66.99 9.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' N ' ' CB ' ' A' ' 13' ' ' ALA . . . 171.39 -30.53 0.12 Allowed Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.453 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -78.57 -113.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.561 ' N ' ' ND1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -90.14 146.28 24.41 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.201 -179.543 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.65 -32.47 0.23 Allowed 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 125.582 1.801 . . . . 0.0 110.18 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -61.86 0.39 0.38 Allowed 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 95.382 -5.784 . . . . 0.0 95.382 165.031 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.2 tttt -113.39 -169.93 1.59 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.138 -3.665 . . . . 0.0 112.169 176.546 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.0 m80 34.47 18.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.896 177.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.83 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 CA-C-O 122.284 1.04 . . . . 0.0 109.169 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.19 -14.62 78.98 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 105.516 -3.033 . . . . 0.0 105.516 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.72 -47.99 6.8 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.686 -0.757 . . . . 0.0 109.654 177.996 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 171.38 11.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.37 8.73 1.23 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 21' ' ' VAL . 57.7 t -148.04 -7.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.872 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 6.3 m-20 97.61 -36.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.605 1.191 . . . . 0.0 110.087 -179.452 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 75.4 m80 -158.43 -166.15 1.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.221 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 55.94 27.01 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.677 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.118 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.72 -59.44 2.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.76 6.48 67.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.09 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.4 p -72.31 154.66 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.596 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 9' ' ' GLY . 6.7 mm -67.89 81.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.095 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 55.79 46.43 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.425 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 mttp 56.88 74.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.304 179.625 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 t60 61.93 50.92 3.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.389 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.467 ' O ' ' ND1' ' A' ' 11' ' ' HIS . . . 59.34 45.77 94.93 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.037 179.066 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 67.71 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 74.9 m80 -145.06 93.37 2.38 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.414 0.626 . . . . 0.0 109.638 178.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 137.45 -31.46 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 -178.161 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.69 0.54 0.49 Allowed 'General case' 0 N--CA 1.413 -2.3 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 163.9 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.5 tttm -116.76 -167.89 1.37 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.383 -3.553 . . . . 0.0 111.703 177.024 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.659 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 58.1 m80 33.9 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.955 178.076 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.655 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.8 tt 171.5 -37.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.265 1.031 . . . . 0.0 109.166 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.13 -11.35 81.18 Favored Glycine 0 C--N 1.275 -2.808 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 174.119 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.468 ' H ' ' H ' ' A' ' 16' ' ' ILE . 1.3 m170 -95.86 -34.16 11.95 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.078 178.385 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.05 26.6 0.62 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.437 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.22 -11.71 0.09 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 19' ' ' ALA . 90.3 t -152.96 -23.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.322 -179.31 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 38.0 t30 -170.45 -96.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.374 -179.003 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 33.4 m80 -145.51 127.2 15.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.724 -178.616 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.486 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 67.4 t80 -75.64 -4.38 39.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.124 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.414 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.419 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.486 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 92.1 m95 -158.99 -83.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 110.403 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 173.85 4.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.425 ' H ' ' H ' ' A' ' 3' ' ' GLY . 7.1 t 53.85 175.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.3 -40.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.989 179.974 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.01 53.54 2.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.686 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 9' ' ' GLY . 54.7 mttm 57.7 69.13 0.76 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 48.62 15.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.424 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . 85.65 55.63 2.52 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.298 179.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER 57.86 37.71 27.0 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.57 179.802 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 10' ' ' ARG . 32.8 m80 -146.6 75.01 1.38 Allowed 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 178.642 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.012 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 172.2 -32.19 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.513 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.73 -1.73 0.67 Allowed 'General case' 0 N--CA 1.416 -2.126 1 N-CA-C 95.548 -5.723 . . . . 0.0 95.548 164.827 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.012 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.259 20.8 tttm -114.01 -167.74 1.25 Allowed 'General case' 0 C--N 1.387 2.217 0 CA-C-N 109.179 -3.646 . . . . 0.0 111.705 176.648 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.64 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.88 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.978 177.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.2 tt 174.22 -44.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.142 0.973 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.45 -13.43 81.72 Favored Glycine 0 C--N 1.273 -2.955 0 N-CA-C 105.843 -2.903 . . . . 0.0 105.843 174.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.616 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.7 -42.79 10.52 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.682 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 156.33 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.68 7.56 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.6 t -144.88 -11.16 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -179.85 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 49.4 t30 119.13 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.607 1.192 . . . . 0.0 110.091 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.437 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.8 t60 -172.47 -8.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.643 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -76.06 32.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.9 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.206 179.782 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -168.9 -173.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.544 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.87 34.32 0.24 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.862 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -162.93 113.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.3 mt -71.8 -47.66 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.872 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 62.8 m-85 -159.93 -9.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.352 179.616 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -50.47 -73.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -73.88 70.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.71 -14.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.83 18.61 1.28 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.224 179.894 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.6 t-80 -149.52 145.94 27.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.579 179.513 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.042 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.34 -31.3 0.22 Allowed 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 125.668 1.855 . . . . 0.0 109.719 -177.859 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.64 2.24 0.3 Allowed 'General case' 0 N--CA 1.412 -2.335 1 N-CA-C 95.374 -5.787 . . . . 0.0 95.374 164.896 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.042 ' H ' ' C ' ' A' ' 12' ' ' ALA . 11.2 ttpt -115.95 -168.92 1.5 Allowed 'General case' 0 C--N 1.395 2.554 0 CA-C-N 109.448 -3.524 . . . . 0.0 111.546 176.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.4 m80 34.72 17.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.013 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 176.06 -44.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.204 1.002 . . . . 0.0 109.46 -179.822 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.76 -14.0 81.8 Favored Glycine 0 C--N 1.273 -2.954 0 N-CA-C 105.449 -3.061 . . . . 0.0 105.449 174.43 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.554 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.43 -47.27 7.54 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.407 177.948 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.75 11.61 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.26 8.85 1.19 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.749 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 77.4 t -144.03 -9.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.113 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.7 t-20 100.15 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.525 1.141 . . . . 0.0 110.252 -179.823 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 2.6 t60 89.4 -38.97 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.893 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -76.58 13.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.02 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.3 tt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -75.65 126.42 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 0.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.44 -12.85 77.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.03 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 6' ' ' PHE . 51.4 p 48.71 95.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 110.611 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.4 ' C ' ' N ' ' A' ' 7' ' ' LYS . 21.3 mt -64.59 77.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' SER . 97.2 m-85 49.82 15.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 52.4 tttp -66.95 -37.82 84.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.558 179.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.89 56.62 2.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.873 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.83 -5.84 0.03 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -111.19 -113.2 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.128 0.489 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 m170 -84.63 144.44 28.6 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.279 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.015 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.21 -32.05 0.24 Allowed 'General case' 0 CA--C 1.501 -0.922 0 O-C-N 125.403 1.689 . . . . 0.0 109.613 -177.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.07 0.5 0.4 Allowed 'General case' 0 N--CA 1.413 -2.285 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 164.855 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.015 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.4 tttt -113.87 -169.66 1.56 Allowed 'General case' 0 C--N 1.39 2.369 0 CA-C-N 109.083 -3.69 . . . . 0.0 111.974 176.432 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 32.9 t-80 35.16 17.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.977 177.819 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 176.19 -43.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 CA-C-O 122.031 0.919 . . . . 0.0 109.465 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 -14.27 82.18 Favored Glycine 0 C--N 1.272 -3.02 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 174.336 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.94 -47.83 7.09 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.464 -0.868 . . . . 0.0 109.55 177.938 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.77 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.545 -179.673 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.92 10.44 1.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 21' ' ' VAL . 98.2 t -146.57 -7.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.764 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.3 m120 97.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.567 1.167 . . . . 0.0 110.228 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 96.1 m-70 -159.34 101.78 1.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -55.14 -14.98 1.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.04 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 26.1 m-90 -158.4 -81.47 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.744 0.306 . . . . 0.0 110.413 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.21 -17.74 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.927 179.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.9 p -76.7 120.52 22.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.838 0.352 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.3 mt -71.53 -46.71 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.426 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 7' ' ' LYS . 42.5 p90 -162.61 -2.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 6' ' ' PHE . 38.5 tptt -65.68 -74.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.222 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -85.25 5.95 28.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.931 0.396 . . . . 0.0 110.263 179.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.52 -25.83 37.84 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 16.2 ptm180 -162.25 25.28 0.11 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.024 -179.705 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 m-70 -155.52 145.54 21.56 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.932 0.396 . . . . 0.0 110.554 179.291 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.029 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.92 -31.85 0.23 Allowed 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 125.689 1.868 . . . . 0.0 109.657 -177.831 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.35 2.06 0.29 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 165.063 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.029 ' N ' ' C ' ' A' ' 12' ' ' ALA . 33.1 tttt -115.63 -169.69 1.63 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.821 177.098 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.3 t60 34.3 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.792 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.62 -45.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.142 0.972 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.37 -13.94 81.21 Favored Glycine 0 C--N 1.273 -2.956 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.488 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.28 -43.91 9.52 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.484 -0.858 . . . . 0.0 109.85 178.159 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.24 -179.131 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.23 -17.05 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.535 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 19' ' ' ALA . 15.8 t -148.21 -34.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.4 t-20 154.22 -44.38 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.1 t60 -168.67 113.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.435 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -56.42 -7.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.428 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.353 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 40.1 m95 51.09 -129.51 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.445 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.42 13.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.762 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m -166.06 171.35 12.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 0.0 110.55 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -69.37 -37.91 76.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.377 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' H ' ' H ' ' A' ' 7' ' ' LYS . 33.6 p90 -166.89 -11.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.495 179.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' H ' ' H ' ' A' ' 6' ' ' PHE . 8.6 mtmp? -68.22 -12.53 61.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.437 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.461 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 40.8 t60 -152.55 38.63 0.54 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 179.964 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.76 1.7 0.28 Allowed Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -149.8 -2.07 0.42 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.564 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.7 t-80 -111.4 146.27 37.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 179.662 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -30.37 0.21 Allowed 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 125.663 1.852 . . . . 0.0 109.391 -177.376 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.05 3.47 0.24 Allowed 'General case' 0 N--CA 1.41 -2.444 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.602 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 26.8 tttt -119.46 -167.49 1.42 Allowed 'General case' 0 C--N 1.394 2.529 0 CA-C-N 109.472 -3.513 . . . . 0.0 111.605 177.424 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 4.3 m-70 34.31 22.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 177.705 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.8 tt 169.0 -35.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 CA-C-O 122.239 1.018 . . . . 0.0 109.22 -179.293 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.91 -12.12 80.27 Favored Glycine 0 C--N 1.275 -2.814 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 174.114 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.509 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.2 t60 -93.66 -37.18 11.97 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.938 177.898 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -147.8 25.98 1.03 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.895 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.63 -9.25 0.14 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 19' ' ' ALA . 61.4 t -151.23 -26.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.263 -179.346 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 23' ' ' HIS . 34.3 t30 -171.18 -94.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.277 -179.173 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.557 ' CD2' ' ND2' ' A' ' 22' ' ' ASN . 0.6 OUTLIER -152.65 28.55 0.54 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.857 -179.662 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -77.53 19.57 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.477 179.787 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 23' ' ' HIS . 1.6 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.26 179.913 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 62.8 m95 -156.58 0.48 0.13 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.45 -7.52 38.75 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.994 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p 48.48 64.51 1.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.5 pt -61.98 -18.2 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.66 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -165.51 -13.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.771 -179.801 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 6' ' ' PHE . 64.7 mttp -53.16 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.328 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -80.48 64.21 5.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.474 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.57 -14.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.003 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 93.4 mtt180 -145.63 5.12 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.337 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 m80 -156.52 144.52 19.52 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.504 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.025 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.86 -31.7 0.23 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.77 1.919 . . . . 0.0 109.803 -178.073 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.29 1.63 0.31 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 95.39 -5.781 . . . . 0.0 95.39 164.961 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.025 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.6 tttm -115.04 -169.22 1.51 Allowed 'General case' 0 C--N 1.395 2.553 0 CA-C-N 109.484 -3.507 . . . . 0.0 111.802 176.971 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 33.98 19.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.847 178.062 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.7 -46.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 CA-C-O 122.23 1.014 . . . . 0.0 109.247 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 -13.97 79.7 Favored Glycine 0 C--N 1.271 -3.042 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 174.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.469 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -90.83 -43.86 9.79 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.582 178.177 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 41.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.249 -179.178 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 67.33 -17.82 0.14 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.705 -179.501 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.6 t -149.29 -31.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 122.493 -0.13 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t-20 155.69 -47.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.804 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 9.0 t60 -163.91 -130.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.47 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.582 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.7 m-85 54.23 22.43 3.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.486 -179.854 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.543 179.96 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.3 m-90 -56.45 -15.62 4.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.807 0.337 . . . . 0.0 110.662 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.99 71.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.891 179.975 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.1 m -162.63 160.98 26.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.316 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 pt -153.49 -30.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.281 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -77.88 45.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 179.719 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 52.61 50.92 17.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.89 0.376 . . . . 0.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 1.1 t60 44.13 34.6 1.01 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.753 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.03 27.22 29.13 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.94 -179.848 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 59.68 39.68 20.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.257 0.551 . . . . 0.0 109.677 -179.621 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.54 ' C ' ' H ' ' A' ' 13' ' ' ALA . 6.1 p-80 -169.62 143.43 2.73 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.07 179.441 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 72.0 -31.31 0.22 Allowed 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 125.632 1.833 . . . . 0.0 109.287 -177.566 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 2.65 0.25 Allowed 'General case' 0 N--CA 1.411 -2.415 1 N-CA-C 95.39 -5.782 . . . . 0.0 95.39 164.975 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.031 ' N ' ' C ' ' A' ' 12' ' ' ALA . 16.5 ttpp -116.19 -169.6 1.64 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.679 177.008 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 12.1 m-70 34.11 18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.904 178.154 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 175.07 -43.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.118 0.961 . . . . 0.0 109.477 179.838 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.4 83.49 Favored Glycine 0 C--N 1.274 -2.888 0 N-CA-C 105.411 -3.075 . . . . 0.0 105.411 174.425 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.37 -45.92 7.59 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 114.537 -0.832 . . . . 0.0 109.44 178.049 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.34 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.061 0.226 . . . . 0.0 110.444 -179.803 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.68 10.12 0.98 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.914 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 21' ' ' VAL . 61.1 t -147.75 -8.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.981 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.4 m-20 99.47 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.609 1.193 . . . . 0.0 110.265 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 42.8 p-80 -171.94 97.91 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.803 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.9 t80 -76.25 9.61 2.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.539 179.882 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -60.85 -114.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.595 0.236 . . . . 0.0 110.466 -179.954 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.24 -24.95 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.053 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.5 m -71.66 178.85 3.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 0.0 110.509 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 6' ' ' PHE . 17.3 tt -166.36 -43.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.655 -179.894 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.52 ' N ' HG23 ' A' ' 5' ' ' ILE . 47.6 m-85 -78.2 49.5 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.842 -179.808 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' ARG . 93.0 mttt 52.76 50.79 17.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 0.0 110.353 179.756 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 46.9 t60 42.79 35.35 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.497 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.37 27.23 25.77 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.701 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER 57.29 35.75 26.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.458 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 58.9 m80 -162.12 145.25 11.75 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.064 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.2 -31.35 0.22 Allowed 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 125.621 1.826 . . . . 0.0 109.538 -177.752 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.45 0.26 Allowed 'General case' 0 N--CA 1.412 -2.356 1 N-CA-C 95.29 -5.818 . . . . 0.0 95.29 165.033 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.064 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.1 tttt -116.35 -169.24 1.58 Allowed 'General case' 0 C--N 1.394 2.51 0 CA-C-N 109.547 -3.478 . . . . 0.0 111.795 177.074 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.7 t60 34.65 17.87 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.975 178.094 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 175.43 -41.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-O 122.043 0.925 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.62 -13.02 83.94 Favored Glycine 0 C--N 1.276 -2.783 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 174.412 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.01 -43.78 8.74 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 114.439 -0.88 . . . . 0.0 109.209 178.046 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.27 12.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.55 10.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.06 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.1 t -145.81 -8.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.02 -179.828 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.8 t-20 102.46 -36.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.585 1.178 . . . . 0.0 110.189 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -170.48 102.95 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.649 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.488 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 51.9 t80 -167.68 -4.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.216 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.213 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -61.51 -29.32 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.861 0.362 . . . . 0.0 110.611 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.22 2.67 20.38 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.737 -179.882 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.0 m -76.84 114.04 15.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.643 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mt -75.97 66.45 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.272 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 57.26 8.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.504 -179.911 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -61.2 -35.06 76.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.473 179.889 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -70.62 4.0 2.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.515 179.964 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.39 39.62 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.065 -179.962 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -164.59 41.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 179.88 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 51.2 t-80 -170.06 143.75 2.55 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.453 179.645 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.44 -31.45 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.596 1.81 . . . . 0.0 109.547 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.34 1.74 0.31 Allowed 'General case' 0 N--CA 1.41 -2.433 1 N-CA-C 95.386 -5.783 . . . . 0.0 95.386 164.899 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.6 tttm -115.47 -169.53 1.59 Allowed 'General case' 0 C--N 1.393 2.492 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.711 177.014 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.8 m-70 34.48 17.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.97 178.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.05 -44.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.135 0.969 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.06 -14.26 81.97 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 174.335 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.89 -48.12 7.43 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 114.246 -0.977 . . . . 0.0 109.102 177.87 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.89 13.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.49 10.85 1.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 94.1 t -140.23 -9.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 44.9 t-20 107.56 -35.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.65 1.219 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 19.1 t60 80.64 34.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.035 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.47 -31.71 46.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.787 -179.803 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.249 -179.887 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 56.5 11.22 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.793 0.33 . . . . 0.0 110.466 -179.957 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.41 -3.01 60.45 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.244 -0.503 . . . . 0.0 111.883 -179.931 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.6 p -55.48 127.36 29.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.341 . . . . 0.0 110.486 179.955 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 7.8 mt -73.55 -52.64 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.485 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 45.5 m-85 -159.84 -8.64 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.18 179.736 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -54.96 -69.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.175 179.997 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -82.91 67.2 8.89 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.302 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.98 -23.06 0.02 OUTLIER Glycine 0 C--N 1.33 0.235 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.932 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -153.22 15.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 53.8 t-80 -164.51 145.0 7.83 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.868 179.407 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.055 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.61 -31.71 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.706 1.879 . . . . 0.0 109.99 -178.087 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.5 1.88 0.32 Allowed 'General case' 0 N--CA 1.413 -2.32 1 N-CA-C 95.389 -5.782 . . . . 0.0 95.389 164.922 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.055 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.4 -169.29 1.54 Allowed 'General case' 0 C--N 1.394 2.515 0 CA-C-N 109.443 -3.526 . . . . 0.0 111.71 176.895 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 41.5 m80 33.94 18.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.995 178.094 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.6 tt 175.29 -43.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-O 122.011 0.91 . . . . 0.0 109.483 179.842 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -13.89 82.68 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 105.325 -3.11 . . . . 0.0 105.325 174.34 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -91.25 -47.58 7.42 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 114.368 -0.916 . . . . 0.0 109.23 177.95 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.6 14.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.82 11.29 0.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.873 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 97.1 t -140.85 -9.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 17.8 t-20 106.85 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.603 1.19 . . . . 0.0 110.427 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 1.2 t-80 83.05 -1.09 1.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.216 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -76.38 -7.85 55.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.501 -179.99 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -66.97 -61.24 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.778 0.323 . . . . 0.0 110.523 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.04 16.81 80.39 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.258 -0.496 . . . . 0.0 111.974 -179.957 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 p -166.16 101.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 0.0 110.554 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.5 mt -66.9 76.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.374 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 52.73 10.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.568 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 5' ' ' ILE . 56.5 mttm -54.35 -50.7 66.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.434 179.897 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.05 45.42 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.19 9.71 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.919 -179.994 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.443 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 77.6 mtp180 -147.05 18.86 1.25 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.356 . . . . 0.0 110.189 179.975 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 13' ' ' ALA . 72.0 m80 -151.68 147.01 26.21 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 179.636 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.034 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.93 -31.89 0.23 Allowed 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 125.678 1.861 . . . . 0.0 110.018 -178.227 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 95.426 -5.768 . . . . 0.0 95.426 165.158 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.034 ' H ' ' C ' ' A' ' 12' ' ' ALA . 22.9 tttm -115.51 -169.47 1.58 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 109.409 -3.541 . . . . 0.0 111.818 177.058 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.2 t60 33.99 19.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.86 177.842 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.48 -45.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.363 -179.982 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.43 -13.99 81.28 Favored Glycine 0 C--N 1.273 -2.971 0 N-CA-C 105.406 -3.078 . . . . 0.0 105.406 174.317 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.474 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.52 9.65 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 114.495 -0.853 . . . . 0.0 109.677 178.111 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.67 41.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.176 -179.076 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.92 -19.73 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.471 -179.361 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 19' ' ' ALA . 39.4 t -149.05 -31.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 156.09 -48.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 25.4 t60 -171.54 5.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 -179.788 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 50.5 t80 -73.62 10.53 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.475 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.6 tt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.122 -179.969 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.491 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 78.4 m95 -157.3 137.1 12.36 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.474 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.03 0.98 61.06 Favored Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.745 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.3 m -162.32 157.33 22.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.837 0.351 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.552 HG22 ' CE1' ' A' ' 6' ' ' PHE . 16.6 mm -78.54 56.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.243 179.926 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 5' ' ' ILE . 36.6 p90 42.24 19.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.295 -179.58 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' ILE . 3.0 ttmp? -87.58 -57.89 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.121 179.77 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -101.51 60.41 0.89 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.17 -19.74 0.02 OUTLIER Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.904 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.9 mtp-105 -136.48 6.46 3.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.914 0.387 . . . . 0.0 110.081 179.808 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 30.8 t-80 -158.88 143.64 15.88 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.427 179.537 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.056 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.37 -31.58 0.23 Allowed 'General case' 0 CA--C 1.498 -1.035 0 O-C-N 125.641 1.838 . . . . 0.0 109.673 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 1.84 0.31 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.387 -5.782 . . . . 0.0 95.387 164.838 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.056 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.6 -169.22 1.54 Allowed 'General case' 0 C--N 1.393 2.469 0 CA-C-N 109.432 -3.531 . . . . 0.0 111.658 176.936 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.7 t-80 34.98 17.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.903 177.902 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.87 -46.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 CA-C-O 122.413 1.101 . . . . 0.0 109.231 -179.875 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.76 79.82 Favored Glycine 0 C--N 1.272 -3.003 0 N-CA-C 105.825 -2.91 . . . . 0.0 105.825 174.627 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.82 -44.48 8.92 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.655 -0.772 . . . . 0.0 109.128 177.917 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.02 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.63 8.24 0.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.165 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 74.4 t -144.06 -9.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.386 -179.796 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 33.0 t30 105.31 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.662 1.226 . . . . 0.0 110.14 -179.837 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 16.8 t-80 -169.38 -127.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 69.7 m-85 50.18 23.54 1.2 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.799 0.333 . . . . 0.0 110.69 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.989 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -61.25 -165.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.287 . . . . 0.0 110.359 179.997 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.88 10.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.253 -179.918 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t 50.42 -177.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.47 ' C ' ' H ' ' A' ' 7' ' ' LYS . 11.8 mt -78.66 57.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.188 179.789 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 57.64 3.13 0.18 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.999 -179.832 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 5' ' ' ILE . 3.1 mmmp? -68.08 -19.76 64.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.16 179.795 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 58.8 t-80 -74.5 0.92 13.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 -179.786 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.35 57.0 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.7 179.936 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -171.38 35.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.296 179.513 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.6 t-80 -169.11 145.7 3.48 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.954 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.046 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.84 -31.79 0.23 Allowed 'General case' 0 CA--C 1.498 -1.036 0 O-C-N 125.811 1.944 . . . . 0.0 109.974 -178.306 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.74 0.3 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.327 -5.805 . . . . 0.0 95.327 165.206 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.046 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.9 tttt -115.94 -169.55 1.62 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.942 177.152 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.3 t60 34.7 18.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.787 178.103 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.93 -44.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.169 0.985 . . . . 0.0 109.605 -179.871 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.91 -13.62 82.35 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.828 -2.909 . . . . 0.0 105.828 174.854 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.613 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.41 -43.19 9.35 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.831 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 160.36 11.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.1 11.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.697 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 21' ' ' VAL . 91.4 t -145.41 -8.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.018 -179.596 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.5 m120 100.16 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.737 1.273 . . . . 0.0 110.398 -179.597 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 6.7 t60 -165.14 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 89.2 m-85 49.13 21.45 0.5 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.756 0.313 . . . . 0.0 110.671 -179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.466 -179.987 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -51.6 147.81 6.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.86 0.362 . . . . 0.0 110.488 -179.947 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.14 -24.56 68.5 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.107 -179.899 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -71.51 86.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.684 -179.866 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' C ' ' N ' ' A' ' 7' ' ' LYS . 9.8 mm -66.9 84.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.432 179.857 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 53.09 10.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.539 -179.97 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' N ' ' C ' ' A' ' 5' ' ' ILE . 47.0 tttp -61.4 -65.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -70.99 76.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.976 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.58 -27.15 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.056 -0.593 . . . . 0.0 111.99 179.972 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -127.23 12.54 7.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 110.396 -179.97 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 40.0 t60 -162.85 144.91 10.36 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.164 0.507 . . . . 0.0 110.786 179.378 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.051 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -30.8 0.21 Allowed 'General case' 0 CA--C 1.498 -1.029 0 O-C-N 125.866 1.978 . . . . 0.0 109.75 -177.819 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.83 3.05 0.25 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 164.808 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.051 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.4 tttp -118.2 -168.31 1.5 Allowed 'General case' 0 C--N 1.394 2.517 0 CA-C-N 109.606 -3.452 . . . . 0.0 111.687 177.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.3 m-70 33.71 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.418 178.186 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.6 tt 172.87 -43.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 179.84 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.41 78.64 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 174.703 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 22' ' ' ASN . 6.9 t-80 -92.85 -43.45 8.98 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.344 178.099 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 46.44 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.468 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 64.17 -18.69 0.07 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.961 -179.589 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 19' ' ' ALA . 25.7 t -148.76 -32.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.03 -179.834 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 1.6 t-20 158.34 -49.92 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.607 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -171.81 62.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.394 -179.784 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -56.63 -24.33 47.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.491 -179.889 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -61.37 -156.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.46 -37.14 94.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.726 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -68.16 115.32 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.301 179.908 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 10.1 mt -70.88 -41.87 77.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.531 -179.801 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 60.8 m-85 -158.84 5.64 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.302 179.752 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -66.7 -74.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -179.948 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -83.58 73.87 10.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.473 179.937 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.23 -30.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.159 -179.953 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -162.32 33.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.605 -179.949 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.3 t60 -160.08 144.53 14.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.412 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.032 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.78 -29.18 0.19 Allowed 'General case' 0 CA--C 1.499 -1.004 0 O-C-N 125.521 1.763 . . . . 0.0 109.798 -177.934 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.13 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 1 N-CA-C 94.819 -5.993 . . . . 0.0 94.819 164.293 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.032 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.6 tttt -116.96 -160.28 0.76 Allowed 'General case' 0 C--N 1.397 2.657 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.637 176.967 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.553 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.7 t60 30.62 20.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.448 0.699 . . . . 0.0 112.199 178.59 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 173.14 -48.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-O 122.435 1.112 . . . . 0.0 109.228 -179.27 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.6 -13.67 71.61 Favored Glycine 0 C--N 1.27 -3.09 0 N-CA-C 106.238 -2.745 . . . . 0.0 106.238 175.297 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.586 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.95 -44.5 7.33 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 114.546 -0.827 . . . . 0.0 109.455 178.216 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.46 10.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -179.943 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.61 7.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.981 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 48.5 t -144.75 -8.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.919 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 61.5 t30 102.18 -37.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.525 1.141 . . . . 0.0 110.4 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -173.8 78.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.473 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 54.3 t80 -72.88 -19.08 61.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.502 179.828 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.433 179.947 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -171.11 -174.31 1.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.304 179.964 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.57 41.29 0.36 Allowed Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.968 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -153.16 98.18 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.749 0.309 . . . . 0.0 110.336 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 7' ' ' LYS . 17.1 mt -66.25 77.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.278 179.967 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 54.08 10.4 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.712 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 9' ' ' GLY . 29.3 mmtp -57.39 -39.83 76.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.203 179.639 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -74.07 12.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 179.931 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -164.09 37.59 0.31 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.937 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -162.08 33.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.08 0.467 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.554 ' C ' ' H ' ' A' ' 13' ' ' ALA . 38.8 t-80 -165.71 143.02 5.59 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.702 179.454 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.993 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 72.01 -30.92 0.22 Allowed 'General case' 0 CA--C 1.497 -1.069 0 O-C-N 125.632 1.833 . . . . 0.0 109.212 -177.513 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.3 0.29 Allowed 'General case' 0 N--CA 1.41 -2.467 1 N-CA-C 95.273 -5.825 . . . . 0.0 95.273 164.848 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.993 ' N ' ' C ' ' A' ' 12' ' ' ALA . 2.3 ttpm? -116.86 -169.43 1.64 Allowed 'General case' 0 C--N 1.393 2.482 0 CA-C-N 109.497 -3.502 . . . . 0.0 111.621 177.056 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.638 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 48.6 t-80 33.97 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.82 177.702 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 169.85 -37.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 CA-C-O 122.256 1.027 . . . . 0.0 109.423 -179.363 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.33 -11.29 80.8 Favored Glycine 0 C--N 1.275 -2.853 0 N-CA-C 105.029 -3.228 . . . . 0.0 105.029 174.074 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.478 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -93.47 -35.87 12.74 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.776 178.212 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -152.42 26.76 0.59 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.641 -179.619 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.27 -8.18 0.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.567 179.025 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' ALA . 60.5 t -151.48 -25.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.254 -179.355 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -171.45 -94.81 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.312 -179.272 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 13.8 t-160 -158.86 17.98 0.19 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.448 -179.589 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -70.96 8.33 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 16.3 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.217 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 58.31 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.649 0.261 . . . . 0.0 110.727 179.933 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 164.86 -27.68 0.2 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.855 180.0 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -77.23 92.82 3.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 110.62 -179.933 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.499 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 11.8 pt -61.69 -34.81 63.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.369 179.891 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 66.6 m-85 -160.96 -5.65 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.124 179.814 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 6' ' ' PHE . 52.7 tttm -49.07 -55.25 12.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.665 -179.953 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -74.62 70.42 1.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.516 179.898 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.16 -42.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.048 -179.979 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -114.66 2.98 14.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.842 0.353 . . . . 0.0 110.424 179.949 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' ALA . 76.4 t60 -151.64 145.44 25.08 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.714 179.659 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.07 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.71 0.23 Allowed 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.734 1.896 . . . . 0.0 109.848 -178.008 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.91 0.3 Allowed 'General case' 0 N--CA 1.41 -2.437 1 N-CA-C 95.422 -5.77 . . . . 0.0 95.422 165.085 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.07 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.51 -169.18 1.53 Allowed 'General case' 0 C--N 1.394 2.534 0 CA-C-N 109.424 -3.534 . . . . 0.0 111.744 177.081 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 68.7 t60 33.92 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.816 177.966 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.7 tt 174.24 -46.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.288 1.042 . . . . 0.0 109.306 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.61 -14.01 79.94 Favored Glycine 0 C--N 1.271 -3.05 0 N-CA-C 105.501 -3.04 . . . . 0.0 105.501 174.517 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.4 OUTLIER -90.28 -44.02 9.99 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.624 178.21 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.28 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.251 -179.054 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.48 -18.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.523 -179.435 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.9 t -148.29 -32.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.908 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 155.19 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.982 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.431 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -164.2 65.03 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.621 -179.866 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.51 ' H ' ' HB1' ' A' ' 19' ' ' ALA . 62.0 t80 -50.84 -14.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -66.75 -61.24 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.25 15.15 56.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.073 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -165.79 56.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 0.0 110.492 179.992 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 6' ' ' PHE . 17.7 tt -82.22 -43.88 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.758 -179.905 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' N ' HG23 ' A' ' 5' ' ' ILE . 51.0 p90 -90.97 -35.74 14.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.954 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -51.4 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.279 179.914 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.9 65.34 3.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.303 179.791 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.97 -30.69 0.02 OUTLIER Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -179.948 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -153.7 28.05 0.49 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.849 0.356 . . . . 0.0 110.366 179.907 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.2 t60 -163.61 146.15 9.77 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.376 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.075 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.83 -31.62 0.23 Allowed 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 125.775 1.922 . . . . 0.0 109.956 -178.072 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.13 0.29 Allowed 'General case' 0 N--CA 1.411 -2.385 1 N-CA-C 95.341 -5.8 . . . . 0.0 95.341 164.995 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.075 ' N ' ' C ' ' A' ' 12' ' ' ALA . 29.7 tttt -115.96 -169.33 1.58 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.441 -3.527 . . . . 0.0 111.825 177.012 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 18.0 t60 33.95 18.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.991 178.169 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 175.18 -42.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 CA-C-O 122.093 0.949 . . . . 0.0 109.459 179.817 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.39 -13.29 83.72 Favored Glycine 0 C--N 1.276 -2.77 0 N-CA-C 105.355 -3.098 . . . . 0.0 105.355 174.168 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.539 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.01 -46.46 7.14 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.615 178.15 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.4 10.55 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.63 -179.764 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.15 10.36 1.21 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.722 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 21' ' ' VAL . 66.0 t -148.87 -8.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.628 -179.723 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.0 m120 96.48 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.545 1.153 . . . . 0.0 110.169 -179.555 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -172.54 93.15 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.524 179.969 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -165.47 11.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.836 -179.812 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -52.12 174.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 110.595 179.996 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.35 -14.17 77.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.898 179.915 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' PHE . 78.1 p 49.21 78.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 110.781 -179.973 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.8 mm -60.82 79.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 4' ' ' SER . 37.2 m-85 53.06 10.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.621 -179.863 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 5' ' ' ILE . 62.1 tttm -61.19 -38.51 86.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.329 179.99 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -65.3 -0.4 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 110.041 179.663 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -143.48 -164.53 10.35 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.825 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.06 -118.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.472 -179.973 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -79.13 72.93 5.7 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.986 0.898 . . . . 0.0 110.056 -179.915 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.975 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.276 . . 174.81 -32.06 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 112.635 -2.075 . . . . 0.0 106.782 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.51 -2.62 0.79 Allowed 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 164.663 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.975 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.252 20.5 tttm -112.75 -168.13 1.28 Allowed 'General case' 0 C--N 1.389 2.314 0 CA-C-N 109.206 -3.634 . . . . 0.0 112.13 176.515 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 44.9 m80 34.23 18.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.812 177.879 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 175.47 -47.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.477 -1.855 0 CA-C-O 122.269 1.033 . . . . 0.0 109.158 -179.749 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.88 -14.15 78.56 Favored Glycine 0 C--N 1.274 -2.903 0 N-CA-C 105.636 -2.985 . . . . 0.0 105.636 174.736 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.448 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.92 -44.02 9.63 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 114.709 -0.746 . . . . 0.0 109.673 178.059 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.14 42.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.321 -179.084 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 65.81 -15.9 0.11 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.602 -179.435 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' H ' ' C ' ' A' ' 19' ' ' ALA . 17.4 t -148.79 -35.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.9 t30 154.78 -44.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.911 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 1.6 t60 -168.83 50.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.519 -179.88 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -64.52 -28.34 69.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.228 -179.924 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -62.41 -176.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 -179.933 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.83 16.06 52.49 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 179.915 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.425 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 26.2 m -149.04 86.6 1.5 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 110.52 -179.87 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -81.27 -16.92 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.975 179.955 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' H ' ' H ' ' A' ' 7' ' ' LYS . 45.2 p90 -160.56 -19.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 6' ' ' PHE . 61.9 mttp -49.15 -46.96 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 179.983 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -78.35 47.72 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.94 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.81 -9.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.144 -179.942 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 79.4 mtt-85 -136.19 15.86 3.24 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.8 m80 -157.53 144.04 17.92 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.544 179.369 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.999 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.23 0.22 Allowed 'General case' 0 CA--C 1.498 -1.03 0 O-C-N 125.603 1.814 . . . . 0.0 109.485 -177.823 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.41 1.87 0.31 Allowed 'General case' 0 N--CA 1.41 -2.428 1 N-CA-C 95.35 -5.796 . . . . 0.0 95.35 164.981 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.999 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.9 ttpt -115.54 -169.58 1.61 Allowed 'General case' 0 C--N 1.394 2.519 0 CA-C-N 109.399 -3.546 . . . . 0.0 111.655 177.012 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.7 t-80 34.44 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.079 178.092 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tp 176.33 -46.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.643 0 CA-C-O 122.371 1.082 . . . . 0.0 109.074 -179.924 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.55 -14.69 77.53 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 174.409 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.62 -48.71 7.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.325 -0.938 . . . . 0.0 108.885 177.823 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.4 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.995 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.18 9.99 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.938 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.3 t -139.07 -10.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.774 -179.698 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.0 t-20 108.44 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.63 1.206 . . . . 0.0 110.586 179.855 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 8.8 t60 80.08 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.171 -179.61 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -79.54 -15.76 57.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.746 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.401 -179.683 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -52.44 -38.66 59.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 110.668 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.9 -6.65 25.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.683 -179.7 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 p -68.81 114.77 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 110.494 179.965 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.7 mt -85.42 -29.14 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.05 3.77 18.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.938 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 9' ' ' GLY . 18.7 ttpp 54.19 103.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 179.487 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.437 ' CD2' ' N ' ' A' ' 8' ' ' HIS . 3.5 m170 65.48 -2.85 0.75 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.95 179.558 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -86.36 1.08 87.4 Favored Glycine 0 C--N 1.329 0.143 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 11' ' ' HIS . 9.3 ptm180 -170.28 -3.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.096 -179.865 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.0 t-80 -102.91 147.49 26.85 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.289 179.454 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.998 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.52 -31.57 0.22 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.716 1.885 . . . . 0.0 110.099 -178.085 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 1.89 0.31 Allowed 'General case' 0 N--CA 1.412 -2.327 1 N-CA-C 95.318 -5.808 . . . . 0.0 95.318 165.052 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.998 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.6 tttm -116.23 -169.0 1.53 Allowed 'General case' 0 C--N 1.393 2.473 0 CA-C-N 109.315 -3.584 . . . . 0.0 111.773 176.971 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.634 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 75.0 t60 35.02 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.784 177.96 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.4 tt 174.64 -42.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.044 0.926 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.52 -13.36 83.52 Favored Glycine 0 C--N 1.275 -2.859 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.645 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.596 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.79 -44.2 7.88 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 114.634 -0.783 . . . . 0.0 109.738 178.189 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.26 12.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.501 -179.878 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.17 9.15 0.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.098 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.4 t -147.91 -9.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.142 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.5 t-20 101.79 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.544 1.152 . . . . 0.0 110.205 -179.898 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 35.6 m80 -160.58 109.67 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.466 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 77.8 t80 -74.13 11.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.295 179.64 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.1 tp . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.433 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 71.3 t-105 -168.6 5.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 2' ' ' TRP . . . 62.56 11.88 37.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.951 -179.92 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 t 56.57 -179.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.57 179.995 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.9 pt -77.96 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 -179.975 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 67.36 -7.15 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 5' ' ' ILE . 63.5 tttm -44.55 -47.67 10.23 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.934 179.985 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -84.38 63.01 7.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' N ' ' CB ' ' A' ' 13' ' ' ALA . . . 171.93 -23.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.36 179.859 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -75.19 -118.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 31.1 m-70 -90.96 145.02 25.06 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.933 179.996 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.12 -31.9 0.23 Allowed 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 125.635 1.834 . . . . 0.0 109.99 -178.138 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.19 0.93 0.36 Allowed 'General case' 0 N--CA 1.412 -2.33 1 N-CA-C 95.297 -5.816 . . . . 0.0 95.297 164.978 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.8 tttt -114.47 -169.4 1.53 Allowed 'General case' 0 C--N 1.392 2.456 0 CA-C-N 109.24 -3.618 . . . . 0.0 111.87 176.621 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.6 m80 34.92 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.922 177.999 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.5 tt 175.58 -43.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.65 0 CA-C-O 122.114 0.959 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.72 -13.41 83.06 Favored Glycine 0 C--N 1.272 -2.977 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 174.668 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.33 -43.64 9.15 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.062 177.944 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.23 12.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.958 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.13 8.29 1.02 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 54.7 t -145.83 -8.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.128 -179.844 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.7 t30 103.99 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.502 1.126 . . . . 0.0 109.996 -179.739 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -173.26 103.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.479 179.743 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' H ' ' H ' ' A' ' 25' ' ' LEU . 84.1 t80 -171.58 -7.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.938 179.897 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 24' ' ' TYR . 34.4 mt . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.074 179.812 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 20.9 p90 -70.74 131.52 43.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 -179.999 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.96 2.03 71.38 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.011 179.909 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.2 m -163.34 161.89 24.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.954 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 6' ' ' PHE . 17.6 tt -161.16 -41.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.409 179.903 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.491 ' N ' HG23 ' A' ' 5' ' ' ILE . 45.0 p90 -99.11 -18.73 17.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.567 179.939 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.72 -60.53 2.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.444 179.813 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -78.51 50.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.92 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.59 -32.51 0.02 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.972 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp85 -112.81 -0.84 14.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.988 0.423 . . . . 0.0 109.973 179.634 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 92.6 m-70 -140.62 145.41 36.61 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.449 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.01 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.67 -31.54 0.23 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.584 1.803 . . . . 0.0 109.571 -177.786 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 2.1 0.28 Allowed 'General case' 0 N--CA 1.412 -2.334 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 164.951 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.01 ' N ' ' C ' ' A' ' 12' ' ' ALA . 21.2 tttm -116.14 -169.24 1.57 Allowed 'General case' 0 C--N 1.393 2.49 0 CA-C-N 109.395 -3.548 . . . . 0.0 111.585 177.062 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.9 t-80 34.67 17.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.028 178.066 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 175.78 -42.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.562 0 CA-C-O 122.159 0.98 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.41 -13.57 83.25 Favored Glycine 0 C--N 1.275 -2.824 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 174.278 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.1 -46.01 8.36 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.299 -0.95 . . . . 0.0 109.066 177.957 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.49 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.845 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.11 9.32 0.94 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.103 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 89.5 t -142.83 -9.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.367 -179.843 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 25.7 t30 105.44 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.581 1.176 . . . . 0.0 110.104 -179.954 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.581 ' ND1' ' N ' ' A' ' 24' ' ' TYR . 49.8 t-80 -162.19 -100.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.581 ' N ' ' ND1' ' A' ' 23' ' ' HIS . 62.3 t80 51.97 14.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 -179.791 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' N ' ' C ' ' A' ' 23' ' ' HIS . 13.0 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -179.989 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 94.7 m95 -157.96 -77.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.408 179.994 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.89 27.75 73.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.212 -0.518 . . . . 0.0 111.892 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.0 p -167.31 77.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.988 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' CE1' ' A' ' 6' ' ' PHE . 12.0 mt -66.59 -31.29 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.412 179.902 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.457 ' CE1' HG22 ' A' ' 5' ' ' ILE . 70.9 m-85 -153.33 -10.16 0.16 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 179.982 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -51.71 -75.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.397 179.787 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.67 68.06 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.464 179.798 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.64 -21.41 0.02 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.042 -179.896 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -162.01 17.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 37.5 m80 -135.42 146.29 48.13 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.518 179.663 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.069 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.65 -31.1 0.21 Allowed 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.691 1.869 . . . . 0.0 109.761 -177.985 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.59 2.07 0.31 Allowed 'General case' 0 N--CA 1.411 -2.384 1 N-CA-C 95.381 -5.785 . . . . 0.0 95.381 164.85 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.069 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.8 tttp -116.11 -168.95 1.51 Allowed 'General case' 0 C--N 1.394 2.514 0 CA-C-N 109.486 -3.506 . . . . 0.0 111.627 176.941 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.2 m80 34.56 18.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.945 178.079 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.6 tt 174.89 -42.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.096 0.95 . . . . 0.0 109.628 179.923 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.51 -12.74 84.24 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.545 -3.022 . . . . 0.0 105.545 174.457 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.63 -44.19 8.31 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.258 177.969 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.99 10.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.31 10.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.829 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 21' ' ' VAL . 97.5 t -147.78 -8.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.046 -179.58 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.6 m120 98.13 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.581 1.175 . . . . 0.0 110.192 -179.512 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 84.3 m-70 -157.84 107.67 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.436 -179.925 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -61.25 -13.63 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.994 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.001 -179.969 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -60.98 -75.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.667 179.985 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.17 27.7 59.52 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.009 179.973 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.7 p -55.87 110.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.706 0.288 . . . . 0.0 110.564 179.89 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 5' ' ' ILE . 12.9 tt -67.06 93.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.231 0.539 . . . . 0.0 110.491 -179.963 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 47.3 55.96 7.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.85 -179.787 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 55.05 63.8 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.99 179.882 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 5.7 m80 45.92 26.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.983 179.637 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.13 53.95 4.0 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.974 -179.978 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER 55.94 31.1 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.341 0.115 . . . . 0.0 110.811 179.728 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 9.4 m-70 -115.96 71.69 0.79 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.922 0.868 . . . . 0.0 110.333 179.388 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.02 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.278 . . 168.73 -31.9 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.503 -2.135 . . . . 0.0 105.85 -179.655 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.75 -2.29 0.8 Allowed 'General case' 0 N--CA 1.414 -2.256 1 N-CA-C 95.458 -5.756 . . . . 0.0 95.458 164.313 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.02 ' N ' ' C ' ' A' ' 12' ' ' ALA . 35.0 tttt -112.84 -168.56 1.34 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 109.277 -3.601 . . . . 0.0 111.83 176.408 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.656 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.6 t-80 34.52 17.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.004 178.04 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.52 -44.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-O 122.124 0.964 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.19 -13.63 82.6 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 174.56 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.6 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -90.55 -44.79 9.34 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.683 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 162.44 11.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.786 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.31 11.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.684 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 21' ' ' VAL . 97.9 t -144.73 -8.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 3.9 m120 100.68 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.768 1.293 . . . . 0.0 110.698 -179.837 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 90.8 m-70 -158.09 -94.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 62.2 t80 57.25 8.52 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.652 -179.822 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.336 179.876 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.021 -0.431 . . . . 0.0 112.021 . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 56.05 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.693 0.282 . . . . 0.0 110.713 -179.95 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 179.11 -4.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.755 -179.999 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.431 ' H ' ' H ' ' A' ' 3' ' ' GLY . 49.3 p -173.13 113.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 pt -67.75 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.995 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.53 -7.5 58.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.878 0.371 . . . . 0.0 110.353 179.963 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 9' ' ' GLY . 61.5 tttm -57.03 -39.57 75.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.836 -179.854 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -63.94 77.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -179.865 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' LYS . . . 42.38 81.71 0.03 OUTLIER Glycine 0 C--N 1.331 0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.493 179.848 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -167.22 11.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 110.28 179.953 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.54 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.2 p-80 -140.12 145.19 37.28 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.729 179.812 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.011 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.56 -29.6 0.19 Allowed 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 125.513 1.758 . . . . 0.0 110.117 -178.336 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.43 1.15 0.57 Allowed 'General case' 0 N--CA 1.411 -2.402 1 N-CA-C 94.73 -6.026 . . . . 0.0 94.73 164.382 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.011 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.5 ttmt -114.71 -158.51 0.67 Allowed 'General case' 0 C--N 1.397 2.644 0 CA-C-N 109.286 -3.597 . . . . 0.0 110.106 176.268 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.569 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 53.0 t60 28.41 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 112.262 177.955 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 168.33 -52.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-O 122.463 1.125 . . . . 0.0 109.224 -179.143 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' H ' HG23 ' A' ' 16' ' ' ILE . . . -68.05 -12.8 63.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 176.034 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -32.85 16.87 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.375 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' CB ' ' N ' ' A' ' 24' ' ' TYR . . . -167.56 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.51 -21.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.878 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.445 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 60.2 t -151.98 -18.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.025 179.905 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 166.35 -39.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.547 0.529 . . . . 0.0 110.045 -179.785 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -160.95 126.58 3.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 111.291 -178.616 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 75.2 t80 -66.92 -5.1 11.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.06 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.469 179.91 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 3' ' ' GLY . 8.5 t90 54.77 -173.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.977 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' N ' ' CG ' ' A' ' 2' ' ' TRP . . . -56.96 -18.87 27.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.7 179.967 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 m -68.59 139.21 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.504 179.834 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt -75.14 67.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 -179.858 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 50.94 20.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -71.63 -66.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.398 179.97 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -93.66 70.23 4.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.382 179.838 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.96 -23.86 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.941 -179.932 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 12.7 ptm180 -167.6 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 35.5 m80 -158.48 145.22 17.45 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 179.412 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.027 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.39 -30.94 0.22 Allowed 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 125.698 1.874 . . . . 0.0 109.535 -177.729 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.8 2.82 0.26 Allowed 'General case' 0 N--CA 1.411 -2.405 1 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 164.78 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.027 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.9 tttm -117.52 -168.5 1.5 Allowed 'General case' 0 C--N 1.394 2.501 0 CA-C-N 109.562 -3.472 . . . . 0.0 111.689 177.159 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.63 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 37.8 m80 34.09 20.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.917 178.09 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.663 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 174.35 -42.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 122.339 1.066 . . . . 0.0 108.831 179.713 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.31 -13.05 83.99 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 105.687 -2.965 . . . . 0.0 105.687 174.398 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.605 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 4.5 m170 -103.02 -7.66 21.24 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.023 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 18' ' ' HIS . . . 82.53 22.04 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.239 -179.123 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.65 14.19 0.16 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.874 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 99.2 t -151.58 -11.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.623 -179.119 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER 104.79 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.282 0.989 . . . . 0.0 110.473 -179.657 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 34.2 p-80 -169.79 117.51 0.59 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -67.6 -0.99 4.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.225 179.65 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.9 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.378 179.892 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -51.06 -71.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.6 179.957 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.64 -29.6 0.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.952 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.1 p 49.74 -175.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.98 -29.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.931 179.936 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 7' ' ' LYS . 27.8 p90 -168.43 -12.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.257 179.714 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 6' ' ' PHE . 62.7 tttp -70.99 -20.29 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.387 179.884 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 8' ' ' HIS . 55.5 t-80 -79.46 52.49 1.39 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.646 -179.987 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.56 83.55 0.23 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.205 179.858 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -164.9 -3.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.445 . . . . 0.0 109.954 179.81 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.2 t-80 -151.2 143.67 24.24 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.232 179.264 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.018 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.9 -31.34 0.22 Allowed 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 125.624 1.828 . . . . 0.0 109.436 -177.583 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.69 2.49 0.29 Allowed 'General case' 0 N--CA 1.412 -2.374 1 N-CA-C 95.431 -5.766 . . . . 0.0 95.431 164.844 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.018 ' N ' ' C ' ' A' ' 12' ' ' ALA . 15.3 ttpt -116.65 -169.01 1.55 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.455 -3.52 . . . . 0.0 111.456 176.97 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.64 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.2 m80 34.25 20.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.79 177.9 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.659 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.21 -37.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-O 122.364 1.078 . . . . 0.0 109.316 -179.311 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.51 -11.1 80.74 Favored Glycine 0 C--N 1.277 -2.745 0 N-CA-C 105.088 -3.205 . . . . 0.0 105.088 174.082 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.484 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -94.99 -33.94 12.55 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 114.407 -0.896 . . . . 0.0 109.973 178.275 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.47 23.74 0.71 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.834 -178.968 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.01 -0.34 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.244 179.322 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 19' ' ' ALA . 45.0 t -152.48 -27.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 121.5 -0.08 . . . . 0.0 110.952 -179.41 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.624 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER 176.17 -85.94 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.972 0.415 . . . . 0.0 111.554 -179.354 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.624 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 35.2 m80 -146.95 126.05 12.9 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.473 -178.837 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 75.4 t80 -73.72 -3.92 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.187 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.332 -0.196 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.495 179.903 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -55.5 -91.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.53 -9.85 0.13 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -179.962 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -165.43 101.66 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 0.0 110.349 179.999 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt -69.68 75.47 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.605 -179.738 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 53.44 26.46 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.736 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -73.84 -63.41 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.235 179.665 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.489 ' O ' ' ND1' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -76.38 66.55 2.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.54 179.963 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.91 -24.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.197 -179.948 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -154.7 26.18 0.44 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.88 0.372 . . . . 0.0 110.386 179.953 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 66.0 t-80 -161.9 146.81 12.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.565 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.72 -31.82 0.23 Allowed 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 125.775 1.922 . . . . 0.0 110.043 -178.271 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.1 0.29 Allowed 'General case' 0 N--CA 1.413 -2.302 1 N-CA-C 95.342 -5.799 . . . . 0.0 95.342 165.157 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.5 tttt -116.17 -168.95 1.52 Allowed 'General case' 0 C--N 1.393 2.46 0 CA-C-N 109.502 -3.499 . . . . 0.0 111.648 177.018 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 34.33 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.885 177.983 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.1 tt 174.6 -43.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.137 0.97 . . . . 0.0 109.547 179.965 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.36 -13.22 83.58 Favored Glycine 0 C--N 1.274 -2.862 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 174.47 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -93.25 -45.06 8.02 Favored 'General case' 0 C--N 1.355 0.815 0 CA-C-N 114.524 -0.838 . . . . 0.0 109.176 177.964 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.18 13.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.86 9.54 0.91 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.131 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 83.3 t -146.37 -9.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.332 -179.762 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 40.9 t-20 103.2 -36.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.511 1.132 . . . . 0.0 110.066 -179.784 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 91.1 m-70 -160.43 106.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.405 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 67.6 t80 -59.72 -15.09 17.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -71.72 -67.68 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 179.989 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 169.39 -3.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.956 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.402 ' H ' ' H ' ' A' ' 3' ' ' GLY . 8.2 m 52.91 75.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.669 179.937 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.4 mt -62.64 -28.61 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.049 179.792 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' NH2' ' A' ' 10' ' ' ARG . 94.6 m-85 -76.99 26.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.581 179.92 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' C ' ' N ' ' A' ' 9' ' ' GLY . 43.7 mttp 53.84 77.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 47.96 14.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.982 179.729 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . 79.6 73.77 1.12 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.594 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 10.2 mpt_? 55.76 46.1 23.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 110.815 179.552 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 79.2 m-70 -153.28 94.82 1.87 Allowed 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.239 0.543 . . . . 0.0 109.963 178.967 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.008 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 132.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.03 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 0.23 0.55 Allowed 'General case' 0 N--CA 1.413 -2.297 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.649 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.008 ' N ' ' C ' ' A' ' 12' ' ' ALA . 28.6 tttt -115.89 -168.34 1.41 Allowed 'General case' 0 C--N 1.393 2.479 0 CA-C-N 109.504 -3.498 . . . . 0.0 111.641 176.885 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.647 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 94.3 m-70 33.73 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.836 178.257 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.78 -43.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 CA-C-O 122.089 0.947 . . . . 0.0 109.596 179.88 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.35 -13.29 83.5 Favored Glycine 0 C--N 1.274 -2.893 0 N-CA-C 105.582 -3.007 . . . . 0.0 105.582 174.67 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.583 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.97 -44.76 7.91 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-N 114.538 -0.831 . . . . 0.0 109.335 177.947 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.22 10.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.899 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.75 10.7 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.839 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 21' ' ' VAL . 77.3 t -146.94 -8.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.848 -179.682 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.8 m-20 98.61 -36.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.729 1.268 . . . . 0.0 110.104 -179.539 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 25.6 p-80 -173.18 101.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 74.9 t80 -62.41 -10.13 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.485 179.996 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.061 -179.941 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -54.61 -19.77 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.88 15.39 73.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.776 -179.969 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.5 m -164.59 59.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 110.412 -179.952 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 5' ' ' ILE . 14.0 tt -60.01 105.45 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.16 0.505 . . . . 0.0 110.342 -179.89 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 44.69 17.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.98 -179.791 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 5' ' ' ILE . 84.1 tttt -68.82 -57.31 5.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.277 179.885 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -83.83 40.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.552 179.788 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.32 27.3 0.09 OUTLIER Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.026 -179.955 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -169.15 18.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 109.994 179.941 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 67.6 m-70 -143.53 146.1 33.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.767 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.987 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.5 -29.88 0.19 Allowed 'General case' 0 CA--C 1.501 -0.941 0 O-C-N 125.59 1.806 . . . . 0.0 110.237 -178.506 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.26 1.08 0.54 Allowed 'General case' 0 N--CA 1.411 -2.412 1 N-CA-C 94.814 -5.995 . . . . 0.0 94.814 164.541 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.987 ' N ' ' C ' ' A' ' 12' ' ' ALA . 7.9 tttm -115.11 -158.86 0.69 Allowed 'General case' 0 C--N 1.394 2.527 0 CA-C-N 109.149 -3.659 . . . . 0.0 110.175 176.397 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.568 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 36.7 t60 29.04 23.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 112.187 177.692 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.2 tt 167.43 -52.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 CA-C-O 122.369 1.081 . . . . 0.0 109.194 -179.067 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.73 63.3 Favored Glycine 0 C--N 1.269 -3.14 0 N-CA-C 106.763 -2.535 . . . . 0.0 106.763 176.185 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.92 -33.05 16.57 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.36 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.85 -65.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.788 179.529 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.29 -22.33 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.878 -179.693 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 t -150.6 -18.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.945 -179.881 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 170.03 -38.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.237 0.336 . . . . 0.0 110.274 -179.687 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 27.3 t60 -171.72 -136.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.109 -178.99 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 76.5 m-85 53.14 27.11 5.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.0 110.765 179.773 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.036 179.993 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -59.24 -22.64 61.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.72 4.17 69.93 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 -179.925 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.4 p -70.31 109.92 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 110.506 179.953 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 7' ' ' LYS . 11.2 mm -75.6 66.8 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.27 4.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 5' ' ' ILE . 28.3 mmtp -63.14 -55.47 24.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.33 179.909 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 21.9 t60 -79.17 32.71 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.566 179.924 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -168.73 22.5 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.093 179.956 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -165.62 14.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.448 . . . . 0.0 110.158 179.891 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 13' ' ' ALA . 54.0 t-80 -153.52 147.84 25.9 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.135 0.493 . . . . 0.0 110.909 179.583 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.054 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.34 -31.71 0.22 Allowed 'General case' 0 CA--C 1.498 -1.034 0 O-C-N 125.905 2.003 . . . . 0.0 110.211 -178.25 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.49 2.18 0.29 Allowed 'General case' 0 N--CA 1.413 -2.316 1 N-CA-C 95.344 -5.799 . . . . 0.0 95.344 165.152 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.054 ' N ' ' C ' ' A' ' 12' ' ' ALA . 19.6 tttm -116.49 -168.73 1.49 Allowed 'General case' 0 C--N 1.392 2.423 0 CA-C-N 109.44 -3.527 . . . . 0.0 111.592 177.124 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 78.6 t60 34.75 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.834 177.881 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 174.25 -44.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 122.116 0.96 . . . . 0.0 109.633 -179.84 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.89 -13.68 82.27 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.681 -2.968 . . . . 0.0 105.681 174.718 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.603 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.67 -45.58 7.64 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 114.515 -0.843 . . . . 0.0 109.309 178.089 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.71 13.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.79 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.69 7.16 0.99 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.272 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 61.2 t -145.41 -9.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.493 -179.868 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 10.4 t-20 105.37 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.479 1.112 . . . . 0.0 109.989 -179.707 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.561 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 1.8 t60 -171.49 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.313 179.903 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.561 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 96.4 m-85 49.24 18.76 0.27 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 110.597 -179.921 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -54.63 -70.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.73 0.3 . . . . 0.0 110.457 -179.831 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.56 -8.04 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.001 179.969 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -169.81 73.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.769 0.319 . . . . 0.0 110.539 -179.978 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 mt -78.9 -40.51 22.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.564 -179.868 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.49 35.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.735 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mttp 53.1 69.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.733 179.851 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m80 48.43 21.91 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.69 179.842 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.517 ' C ' ' HE ' ' A' ' 10' ' ' ARG . . . 76.06 59.27 3.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.313 -0.47 . . . . 0.0 111.977 -179.973 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HE ' ' C ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER 55.3 40.35 31.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.966 0.412 . . . . 0.0 110.131 -179.974 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -148.14 72.76 1.23 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.289 1.042 . . . . 0.0 110.173 178.987 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.043 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.274 . . 172.98 -30.82 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 112.133 -2.303 . . . . 0.0 106.179 179.966 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -0.73 0.55 Allowed 'General case' 0 N--CA 1.415 -2.192 1 N-CA-C 95.502 -5.74 . . . . 0.0 95.502 164.354 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.043 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.255 19.6 tttp -116.43 -167.06 1.22 Allowed 'General case' 0 C--N 1.389 2.285 0 CA-C-N 109.258 -3.61 . . . . 0.0 111.716 177.112 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.2 t60 34.73 18.99 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.875 177.862 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.8 tt 173.84 -40.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 CA-C-O 122.141 0.972 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.15 83.61 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 105.596 -3.002 . . . . 0.0 105.596 174.487 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.614 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 5.5 m170 -103.64 -7.65 20.56 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.978 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 18' ' ' HIS . . . 84.52 20.3 0.14 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.389 -179.296 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.18 14.41 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.101 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 84.5 t -152.43 -10.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.455 -178.966 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 9.2 t-20 101.05 -34.84 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.14 0.9 . . . . 0.0 109.956 -179.308 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -171.57 101.5 0.19 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.602 -179.83 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' H ' ' H ' ' A' ' 25' ' ' LEU . 74.8 t80 -163.25 -1.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.287 179.845 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 24' ' ' TYR . 1.3 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.251 179.819 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 51.09 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.86 -13.93 57.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.812 179.899 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 m -58.17 112.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.581 -179.993 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 mt -67.29 -36.58 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.193 179.76 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -169.31 -11.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -52.41 -61.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.309 179.906 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 0.8 OUTLIER -81.08 37.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.392 179.82 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.09 21.04 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -179.89 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' NH2' ' NE2' ' A' ' 11' ' ' HIS . 45.1 ttp85 -166.6 17.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 109.971 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' NE2' ' NH2' ' A' ' 10' ' ' ARG . 82.9 m-70 -146.95 147.17 30.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.423 179.577 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.21 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.727 1.892 . . . . 0.0 109.986 -178.121 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.25 1.94 0.29 Allowed 'General case' 0 N--CA 1.412 -2.353 1 N-CA-C 95.434 -5.765 . . . . 0.0 95.434 165.194 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.023 ' H ' ' C ' ' A' ' 12' ' ' ALA . 24.3 tttp -116.04 -169.49 1.61 Allowed 'General case' 0 C--N 1.392 2.442 0 CA-C-N 109.379 -3.555 . . . . 0.0 111.629 177.146 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.8 t60 34.89 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.946 177.861 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.5 tt 175.62 -42.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.178 0.99 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.99 -13.39 83.73 Favored Glycine 0 C--N 1.276 -2.801 0 N-CA-C 105.405 -3.078 . . . . 0.0 105.405 174.238 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -91.19 -45.77 8.46 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 114.454 -0.873 . . . . 0.0 109.001 177.884 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.21 13.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.841 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.29 9.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.24 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 63.8 t -145.31 -8.94 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.335 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.6 t30 102.96 -36.28 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.526 1.142 . . . . 0.0 109.746 -179.49 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -172.52 97.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.483 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 60.1 t80 -163.67 -0.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.387 -179.925 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.405 ' H ' ' H ' ' A' ' 24' ' ' TYR . 13.1 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.615 179.965 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -56.56 147.0 23.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.04 -33.31 85.09 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -77.65 111.23 13.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.531 179.956 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.88 75.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.337 179.87 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 53.54 14.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -72.2 -61.81 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.197 179.821 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 1.7 m-70 -79.96 62.8 4.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.911 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.61 -21.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.998 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 mtt-85 -125.41 6.33 7.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.856 0.36 . . . . 0.0 110.12 179.949 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 50.9 m80 -151.54 146.24 25.74 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.712 179.657 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.39 -31.92 0.24 Allowed 'General case' 0 CA--C 1.498 -1.058 0 O-C-N 125.757 1.911 . . . . 0.0 109.839 -178.004 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.51 2.37 0.28 Allowed 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 95.441 -5.763 . . . . 0.0 95.441 165.142 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.04 ' H ' ' C ' ' A' ' 12' ' ' ALA . 30.7 tttt -116.58 -169.07 1.56 Allowed 'General case' 0 C--N 1.391 2.407 0 CA-C-N 109.445 -3.525 . . . . 0.0 111.697 177.055 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 54.7 m80 33.92 21.23 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.788 177.598 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.3 tt 170.21 -37.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.292 1.044 . . . . 0.0 109.33 -179.458 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.84 -11.64 81.17 Favored Glycine 0 C--N 1.275 -2.842 0 N-CA-C 105.052 -3.219 . . . . 0.0 105.052 174.07 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.471 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -93.54 -36.17 12.55 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 114.277 -0.961 . . . . 0.0 109.981 178.267 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -151.2 26.18 0.7 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.643 -179.58 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.41 -7.69 0.1 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.054 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 19' ' ' ALA . 52.3 t -151.08 -24.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.353 -179.413 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 23' ' ' HIS . 4.7 p30 -177.02 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.368 -179.291 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.566 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.0 t-160 -158.2 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.362 -179.461 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.566 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 86.2 m-85 48.79 17.44 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.319 . . . . 0.0 110.721 179.793 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.407 ' N ' ' C ' ' A' ' 23' ' ' HIS . 12.0 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.465 179.998 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -72.38 158.11 36.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 110.557 179.937 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.23 -19.14 70.04 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.114 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 6' ' ' PHE . 76.5 p 50.15 71.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.476 -179.957 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.7 mm -59.84 79.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.431 -179.827 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 4' ' ' SER . 98.9 m-85 53.94 15.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.746 179.736 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.42 -68.14 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -81.84 57.88 3.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.433 179.909 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.06 15.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.046 179.985 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 52.3 ttt180 -164.55 3.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.52 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.6 m-70 -137.25 147.64 45.9 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.741 179.666 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.82 -31.65 0.23 Allowed 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.809 1.943 . . . . 0.0 109.996 -178.073 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.27 0.29 Allowed 'General case' 0 N--CA 1.412 -2.357 1 N-CA-C 95.407 -5.775 . . . . 0.0 95.407 165.033 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' H ' ' C ' ' A' ' 12' ' ' ALA . 18.6 tttm -116.2 -169.29 1.58 Allowed 'General case' 0 C--N 1.392 2.414 0 CA-C-N 109.476 -3.511 . . . . 0.0 111.718 177.032 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.641 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 33.6 t-80 34.55 18.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.896 177.984 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 175.09 -42.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.123 0.963 . . . . 0.0 109.707 180.0 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.96 -13.68 83.41 Favored Glycine 0 C--N 1.276 -2.8 0 N-CA-C 105.433 -3.067 . . . . 0.0 105.433 174.229 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.09 -47.04 6.55 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 114.422 -0.889 . . . . 0.0 110.002 178.207 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.62 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.741 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.03 8.42 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.24 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 64.6 t -145.89 -9.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.171 179.967 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.06 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.657 1.223 . . . . 0.0 110.281 -179.98 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -167.93 94.88 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.493 -179.908 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.424 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 58.9 t80 -162.95 0.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.242 179.996 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.9 tt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.121 179.927 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 95.8 m95 -158.74 -174.57 4.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 110.479 179.945 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.34 27.68 0.23 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 -179.986 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -170.48 92.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.994 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.7 tt -70.2 -40.58 78.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.451 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 44.8 m-85 -161.58 -8.74 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.897 179.231 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -47.49 -71.5 0.07 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.669 -179.937 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -75.27 68.29 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.15 -17.88 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.923 179.993 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -159.52 23.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 110.419 179.98 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 13' ' ' ALA . 57.8 t-80 -159.78 146.35 16.2 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.722 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.035 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.7 -31.7 0.23 Allowed 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 125.712 1.883 . . . . 0.0 110.02 -178.219 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 1.9 0.3 Allowed 'General case' 0 N--CA 1.411 -2.394 1 N-CA-C 95.397 -5.779 . . . . 0.0 95.397 165.071 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.035 ' N ' ' C ' ' A' ' 12' ' ' ALA . 31.0 tttt -115.98 -169.21 1.55 Allowed 'General case' 0 C--N 1.394 2.524 0 CA-C-N 109.345 -3.571 . . . . 0.0 111.818 177.091 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.7 m80 34.43 18.59 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.846 178.144 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.9 tt 174.64 -44.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 CA-C-O 122.068 0.937 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.0 -13.66 82.47 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.72 -2.952 . . . . 0.0 105.72 174.781 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.601 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.83 -44.53 8.44 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.162 177.964 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.46 11.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.994 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 57.51 10.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 21' ' ' VAL . 93.1 t -145.68 -8.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.876 -179.549 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.7 m-20 99.04 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.72 1.263 . . . . 0.0 110.239 -179.622 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -168.64 97.23 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.473 179.968 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 51.4 t80 -165.89 0.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.308 -179.886 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -179.98 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -70.72 6.11 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.473 -179.96 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 71.09 1.66 42.5 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.975 179.934 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m 54.91 -179.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.768 0.318 . . . . 0.0 110.484 179.967 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 6' ' ' PHE . 7.1 mt -75.31 -49.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.479 -179.882 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD2' HG22 ' A' ' 5' ' ' ILE . 56.4 m-85 -156.66 -4.2 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.247 179.822 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -50.39 -74.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.39 179.945 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -80.42 65.92 5.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.335 179.689 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.36 -16.9 0.03 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.151 -179.826 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.494 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 13.0 ptm180 -160.06 22.33 0.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.732 0.301 . . . . 0.0 110.699 179.843 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.557 ' C ' ' H ' ' A' ' 13' ' ' ALA . 65.4 m-70 -148.25 144.89 27.96 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.493 179.481 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.46 -28.96 0.18 Allowed 'General case' 0 CA--C 1.5 -0.948 0 O-C-N 125.632 1.832 . . . . 0.0 109.777 -177.989 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.33 2.08 0.43 Allowed 'General case' 0 N--CA 1.411 -2.423 1 N-CA-C 94.793 -6.003 . . . . 0.0 94.793 164.209 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 6.0 ttmt -116.68 -160.65 0.77 Allowed 'General case' 0 C--N 1.398 2.686 0 CA-C-N 109.314 -3.585 . . . . 0.0 110.647 177.062 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.56 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 26.1 t-80 30.16 21.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.533 0.733 . . . . 0.0 112.222 178.659 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.725 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 173.17 -47.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-O 122.231 1.015 . . . . 0.0 109.509 -179.453 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.53 -13.73 74.49 Favored Glycine 0 C--N 1.271 -3.077 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 175.107 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -96.53 -46.39 6.36 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 114.432 -0.884 . . . . 0.0 109.775 178.366 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.96 11.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.632 -179.744 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.19 8.27 1.04 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.042 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 44.6 t -148.23 -9.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.883 179.948 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 35.5 t-20 100.47 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.515 1.134 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 78.6 m80 -159.74 120.56 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.668 -179.622 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -55.57 -10.26 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.13 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.1 tt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 38.5 t90 -68.08 -62.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 -179.921 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.88 -9.48 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.998 -179.967 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m -161.63 93.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -179.942 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 6' ' ' PHE . 3.9 tp -59.84 -43.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.205 -179.905 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' N ' HG23 ' A' ' 5' ' ' ILE . 54.6 m-85 -161.33 25.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.219 179.422 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -73.25 -43.03 61.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.743 -179.914 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -78.57 52.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.17 -6.08 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.863 -179.955 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -145.54 11.08 1.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.982 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.8 t-80 -156.12 145.08 20.42 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.62 179.515 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.997 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.85 -30.91 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 125.736 1.898 . . . . 0.0 109.801 -177.948 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.54 2.13 0.3 Allowed 'General case' 0 N--CA 1.41 -2.438 1 N-CA-C 95.288 -5.819 . . . . 0.0 95.288 164.749 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.997 ' N ' ' C ' ' A' ' 12' ' ' ALA . 14.5 ttpt -116.13 -168.56 1.45 Allowed 'General case' 0 C--N 1.395 2.55 0 CA-C-N 109.473 -3.512 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 52.0 m80 34.3 18.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.844 178.144 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.3 -46.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 CA-C-O 122.21 1.005 . . . . 0.0 109.381 -179.624 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.02 -13.64 80.85 Favored Glycine 0 C--N 1.273 -2.959 0 N-CA-C 105.523 -3.031 . . . . 0.0 105.523 174.697 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.45 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -91.59 -43.59 9.56 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.606 178.2 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.36 42.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.252 -179.122 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.14 -16.15 0.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.676 -179.445 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.2 t -148.91 -35.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.931 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.3 t30 156.03 -43.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.782 0.676 . . . . 0.0 109.223 -179.953 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 37.9 t-80 -162.34 29.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.696 -179.695 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.461 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 64.1 t80 -77.0 -7.02 54.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.48 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.476 -179.881 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 57.56 171.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.492 -179.991 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.48 -3.85 55.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.162 -0.542 . . . . 0.0 111.966 -179.966 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.2 p -69.17 87.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.526 179.971 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.02 -31.39 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.387 179.943 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -168.26 -0.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.998 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -51.16 -86.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.524 -180.0 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -76.34 64.84 2.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.539 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.9 -18.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.007 -179.88 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -148.42 12.86 0.94 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.2 t-80 -158.21 145.81 18.23 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.033 0.444 . . . . 0.0 110.915 179.564 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.98 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.91 -31.92 0.23 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.721 1.888 . . . . 0.0 109.975 -178.175 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.91 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.405 -5.776 . . . . 0.0 95.405 165.09 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.98 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.8 tttp -115.48 -169.6 1.61 Allowed 'General case' 0 C--N 1.394 2.513 0 CA-C-N 109.436 -3.529 . . . . 0.0 111.806 176.953 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 45.0 t-80 34.47 18.09 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.015 178.021 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 176.13 -45.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 CA-C-O 122.31 1.052 . . . . 0.0 109.089 -179.932 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.0 81.54 Favored Glycine 0 C--N 1.273 -2.968 0 N-CA-C 105.499 -3.04 . . . . 0.0 105.499 174.28 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.51 -47.01 7.66 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.154 178.005 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.88 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.876 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.71 8.1 1.23 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.215 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 56.3 t -144.88 -8.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.217 -179.953 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 13.5 t-20 103.17 -36.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.639 1.212 . . . . 0.0 110.222 -179.772 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 31.9 m80 -155.26 -168.56 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 65.28 25.83 12.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.7 -179.892 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.471 179.709 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -52.26 159.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 110.572 -179.918 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.51 72.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.915 179.986 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m 53.6 101.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.827 0.346 . . . . 0.0 110.677 -179.952 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' C ' ' N ' ' A' ' 7' ' ' LYS . 14.1 mm -74.1 69.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.367 179.832 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 52.66 12.29 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.56 179.977 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' N ' ' C ' ' A' ' 5' ' ' ILE . 1.3 ptpp? -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -89.46 68.85 7.92 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.444 179.881 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.36 -46.42 0.28 Allowed Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -179.885 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -89.9 -1.24 57.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 179.977 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.524 ' C ' ' H ' ' A' ' 13' ' ' ALA . 79.7 t60 -164.71 142.03 6.32 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 179.615 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.039 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.53 -32.14 0.23 Allowed 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 125.668 1.855 . . . . 0.0 109.805 -178.188 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.26 1.4 0.33 Allowed 'General case' 0 N--CA 1.41 -2.47 1 N-CA-C 95.444 -5.762 . . . . 0.0 95.444 165.003 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.039 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.7 tttp -114.33 -169.59 1.56 Allowed 'General case' 0 C--N 1.396 2.617 0 CA-C-N 109.48 -3.509 . . . . 0.0 111.842 176.98 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 1.1 t60 33.21 20.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.853 177.953 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 173.85 -47.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.695 0 CA-C-O 122.187 0.994 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.86 -14.49 78.39 Favored Glycine 0 C--N 1.271 -3.064 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 174.331 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -87.59 -46.43 9.55 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.283 177.983 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.38 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.266 -179.386 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 65.64 -14.98 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.863 -179.666 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' ALA . 19.2 t -149.34 -29.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 121.422 -0.111 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.8 t-20 148.56 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.944 0.777 . . . . 0.0 109.148 -179.728 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -170.28 64.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.403 -179.762 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -71.29 -19.55 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.62 -179.94 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.099 179.946 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -50.99 144.83 8.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.595 -179.967 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.02 0.97 50.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.807 179.855 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.6 m -50.4 131.4 24.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 110.66 -179.949 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.7 mt -75.55 69.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.425 179.877 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 54.46 18.48 1.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.706 179.985 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -72.76 -53.34 11.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.352 179.829 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -76.21 65.36 2.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.553 179.87 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.12 -43.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -89.98 -1.9 58.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 110.329 179.902 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 13' ' ' ALA . 4.9 p-80 -163.92 143.34 7.96 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.768 179.385 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.016 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.27 -31.92 0.23 Allowed 'General case' 0 CA--C 1.498 -1.037 0 O-C-N 125.76 1.912 . . . . 0.0 109.982 -178.207 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.36 1.67 0.32 Allowed 'General case' 0 N--CA 1.411 -2.41 1 N-CA-C 95.289 -5.819 . . . . 0.0 95.289 165.066 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.016 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.1 tttm -115.31 -168.95 1.48 Allowed 'General case' 0 C--N 1.394 2.54 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.877 176.973 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 74.6 t60 34.31 19.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.795 177.861 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.9 tt 174.29 -46.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.679 0 CA-C-O 122.24 1.019 . . . . 0.0 109.363 -179.855 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.36 -13.92 79.6 Favored Glycine 0 C--N 1.271 -3.051 0 N-CA-C 105.526 -3.03 . . . . 0.0 105.526 174.737 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.451 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -90.89 -44.27 9.49 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.66 -0.77 . . . . 0.0 109.533 178.071 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -172.57 43.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.859 -0.737 . . . . 0.0 112.145 -179.311 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 68.51 -20.42 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.358 -179.206 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 19' ' ' ALA . 38.2 t -149.6 -31.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.6 m-20 157.64 -48.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.62 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 74.4 t60 -169.61 3.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.699 -179.735 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -76.65 40.84 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.58 -179.98 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.422 179.92 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -72.66 -78.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 -179.966 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 4' ' ' SER . . . 167.91 11.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.927 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.429 ' H ' ' H ' ' A' ' 3' ' ' GLY . 59.1 m -157.35 83.7 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.26 179.947 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.718 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.7 mp -80.05 -80.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.119 -179.844 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -71.22 -34.68 71.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.763 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -49.61 -64.35 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 20.7 t-160 -76.79 64.5 2.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.374 179.857 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.07 -25.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.08 -180.0 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -102.09 -1.91 30.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.126 0.488 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.548 ' C ' ' H ' ' A' ' 13' ' ' ALA . 78.0 t60 -150.39 143.72 25.01 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.633 179.461 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.048 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.79 -29.52 0.19 Allowed 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 125.641 1.838 . . . . 0.0 109.766 -177.987 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.27 2.02 0.43 Allowed 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 94.879 -5.971 . . . . 0.0 94.879 164.463 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.048 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.8 tttp -116.76 -161.11 0.79 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.266 -3.606 . . . . 0.0 110.549 177.005 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.562 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 47.9 t-80 30.92 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.852 0.72 . . . . 0.0 112.238 178.34 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.722 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.7 tt 172.75 -47.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 CA-C-O 122.226 1.012 . . . . 0.0 109.513 -179.446 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.66 74.62 Favored Glycine 0 C--N 1.271 -3.062 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 175.268 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 2.0 m170 -95.96 -45.18 7.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.443 178.181 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 164.99 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.862 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.18 7.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.289 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -146.44 -9.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.32 -179.863 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 2.6 t30 104.53 -37.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.491 1.119 . . . . 0.0 110.267 -179.929 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -173.36 80.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.451 179.974 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.542 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 63.2 t80 -84.64 -13.96 50.02 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.942 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 179.938 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.004 -0.439 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 50.07 -98.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.712 0.291 . . . . 0.0 110.606 -179.958 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.22 14.27 59.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.707 -179.811 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 p -169.61 154.57 5.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.374 -179.954 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.1 mt -77.25 62.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.265 179.941 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 55.0 13.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.749 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -68.9 -72.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.26 179.714 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -74.85 2.56 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.374 179.733 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 -16.22 64.73 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.17 -179.944 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -168.11 29.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.076 -179.749 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 28.4 t60 -159.11 146.98 17.68 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.052 0.453 . . . . 0.0 110.857 179.305 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.988 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.04 -31.94 0.24 Allowed 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 125.755 1.91 . . . . 0.0 110.007 -178.239 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.3 1.92 0.29 Allowed 'General case' 0 N--CA 1.413 -2.323 1 N-CA-C 95.445 -5.761 . . . . 0.0 95.445 165.132 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.988 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.2 tttm -115.8 -169.33 1.57 Allowed 'General case' 0 C--N 1.393 2.478 0 CA-C-N 109.363 -3.562 . . . . 0.0 111.725 177.076 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.613 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.8 t-80 34.31 18.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.914 177.963 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.06 -45.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.428 -179.958 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.72 79.99 Favored Glycine 0 C--N 1.272 -2.987 0 N-CA-C 105.284 -3.126 . . . . 0.0 105.284 174.422 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.27 -49.76 6.19 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.301 -0.949 . . . . 0.0 109.364 177.987 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.85 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.192 0.308 . . . . 0.0 110.196 -179.728 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.02 10.33 1.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.739 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 87.5 t -144.34 -9.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.425 -179.865 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 1.9 t30 102.58 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.53 1.144 . . . . 0.0 110.45 179.896 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 16.9 t60 84.28 4.6 0.71 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.873 -179.143 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -62.95 -23.14 67.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.471 179.897 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.415 179.939 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -72.57 -167.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.764 0.316 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.91 17.22 0.22 Allowed Glycine 0 C--N 1.332 0.331 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -179.934 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -176.19 138.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.885 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mm -62.11 -38.16 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.427 -179.767 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.71 7.15 4.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt 59.72 71.12 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.7 m80 48.85 32.73 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.773 179.819 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.15 58.86 8.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.097 179.809 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER 54.62 48.27 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 110.263 179.94 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -150.02 70.94 1.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.311 1.053 . . . . 0.0 109.714 179.353 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.968 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.272 . . 169.78 -29.84 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 111.921 -2.399 . . . . 0.0 105.721 -179.363 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.09 -1.3 0.66 Allowed 'General case' 0 N--CA 1.412 -2.331 1 N-CA-C 95.254 -5.832 . . . . 0.0 95.254 164.125 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.968 ' N ' ' C ' ' A' ' 12' ' ' ALA . 3.2 ttpt -114.89 -166.49 1.12 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.309 -3.587 . . . . 0.0 111.501 176.325 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.655 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.8 t-80 33.2 20.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.042 178.378 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.3 tp 173.56 -47.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 122.282 1.039 . . . . 0.0 109.305 179.96 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.03 -14.17 76.13 Favored Glycine 0 C--N 1.27 -3.115 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 174.907 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.97 -46.28 6.91 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-N 114.765 -0.718 . . . . 0.0 109.636 177.966 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.53 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.504 -179.754 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.63 6.95 1.23 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.076 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 41.0 t -147.16 -9.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.236 -179.926 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 50.0 t30 102.82 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.444 1.09 . . . . 0.0 110.363 -179.947 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -178.83 64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.323 -179.953 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -51.83 -33.94 38.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.667 -179.819 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.115 -179.969 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 53.83 10.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.742 0.306 . . . . 0.0 110.461 -179.978 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 68.14 6.48 46.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.855 -179.973 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -57.6 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.491 -179.955 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 7' ' ' LYS . 10.2 pt -154.53 62.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.145 -179.883 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 74.11 -32.27 0.23 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 5' ' ' ILE . 95.2 mttt -57.29 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.34 . . . . 0.0 110.346 179.725 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.472 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -77.49 64.49 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 179.876 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.02 -40.72 0.02 OUTLIER Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.938 -179.996 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -103.02 -1.93 28.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 89.1 m-70 -147.21 144.85 29.21 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.08 179.435 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.03 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 71.47 -31.56 0.23 Allowed 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 125.587 1.804 . . . . 0.0 109.642 -177.761 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.43 2.13 0.29 Allowed 'General case' 0 N--CA 1.412 -2.337 1 N-CA-C 95.44 -5.763 . . . . 0.0 95.44 165.034 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.03 ' H ' ' C ' ' A' ' 12' ' ' ALA . 23.6 tttp -115.94 -169.25 1.56 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-N 109.365 -3.561 . . . . 0.0 111.74 177.082 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 86.8 m-70 34.52 18.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.965 178.045 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 175.54 -46.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-O 122.363 1.078 . . . . 0.0 109.113 -179.821 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.25 79.3 Favored Glycine 0 C--N 1.272 -3.019 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 174.493 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.53 -47.34 7.47 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.543 -0.829 . . . . 0.0 109.219 178.024 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.0 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.773 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 61.66 7.52 1.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.146 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 43.5 t -144.99 -9.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.497 -179.965 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 21.4 t-20 105.32 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.54 1.15 . . . . 0.0 110.05 -179.843 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.597 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -173.13 -99.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.315 -179.923 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.597 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 64.5 t80 55.44 10.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.445 -179.92 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 63.8 m95 50.66 -93.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.556 -179.975 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . 63.15 25.41 68.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.053 179.949 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -168.8 96.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.35 179.944 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -74.13 79.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.576 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 60.69 6.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.353 179.335 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -73.55 -61.57 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 53.7 t60 -76.43 64.93 2.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.508 179.804 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.03 -30.05 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.059 -179.919 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 76.5 mtt85 -129.4 5.84 5.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.817 0.342 . . . . 0.0 110.314 179.977 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ALA . 97.7 m-70 -155.81 144.96 20.7 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.602 179.528 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.061 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.48 0.23 Allowed 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.707 1.879 . . . . 0.0 109.849 -177.888 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.44 1.89 0.31 Allowed 'General case' 0 N--CA 1.411 -2.42 1 N-CA-C 95.363 -5.792 . . . . 0.0 95.363 164.988 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.061 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -115.89 -169.15 1.54 Allowed 'General case' 0 C--N 1.392 2.437 0 CA-C-N 109.412 -3.54 . . . . 0.0 111.646 177.074 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.7 m-70 34.86 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.892 178.031 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.62 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.091 0.948 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.25 -13.71 82.55 Favored Glycine 0 C--N 1.273 -2.961 0 N-CA-C 105.527 -3.029 . . . . 0.0 105.527 174.59 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.15 -45.64 8.17 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 114.511 -0.845 . . . . 0.0 109.286 177.981 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.05 13.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.838 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.18 9.23 0.94 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.17 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 57.7 t -145.95 -9.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.189 -179.873 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 30.5 t-20 103.14 -36.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.503 1.127 . . . . 0.0 110.202 -179.87 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -172.05 89.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.398 -179.966 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 83.4 t80 -159.89 16.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.062 -179.84 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.564 179.982 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 95.2 m95 -158.08 139.51 13.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 110.412 -179.977 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -11.15 56.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.971 -179.947 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 p -167.55 165.89 14.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.343 . . . . 0.0 110.438 -179.999 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -142.57 -55.95 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.228 -179.926 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -77.91 44.57 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.495 179.791 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER 55.1 72.0 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.343 -179.993 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.555 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.7 OUTLIER 46.9 26.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.256 179.502 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.19 64.28 2.34 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.779 179.308 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt-85 58.45 49.79 10.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.785 0.326 . . . . 0.0 111.125 179.309 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.581 ' NE2' ' NE2' ' A' ' 15' ' ' HIS . 48.8 t-80 -157.6 92.43 1.21 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.209 0.528 . . . . 0.0 110.074 179.339 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.96 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 134.84 -31.79 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.424 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.54 -0.41 0.61 Allowed 'General case' 0 N--CA 1.411 -2.376 1 N-CA-C 95.235 -5.839 . . . . 0.0 95.235 163.895 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.96 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.8 tttt -114.86 -168.12 1.33 Allowed 'General case' 0 C--N 1.393 2.488 0 CA-C-N 109.376 -3.556 . . . . 0.0 111.768 176.696 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 79.5 m-70 33.77 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.958 178.24 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.39 -47.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 CA-C-O 122.324 1.059 . . . . 0.0 109.025 -179.873 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.66 -13.73 78.03 Favored Glycine 0 C--N 1.27 -3.099 0 N-CA-C 105.885 -2.886 . . . . 0.0 105.885 174.853 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -91.75 -44.39 9.01 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.899 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 160.87 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.868 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.37 5.57 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.289 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 40.7 t -145.28 -10.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.202 -179.817 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.0 t-20 116.4 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.504 1.128 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -171.89 -3.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.515 -179.923 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.416 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 34.1 t80 -49.06 -18.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.712 -179.633 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.136 -179.978 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 39.4 t-105 -68.29 -18.92 64.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.515 -179.939 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 4' ' ' SER . . . 73.58 27.0 68.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.635 -179.566 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 3' ' ' GLY . 7.3 m -58.12 -153.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.789 -179.928 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.52 -21.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.339 -179.86 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -151.42 -18.61 0.2 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -179.972 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -53.76 -64.18 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.404 179.96 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.27 45.35 1.22 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.703 179.997 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.31 23.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.193 179.983 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 -168.14 9.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.219 179.81 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 55.1 t-80 -153.21 145.56 23.99 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.673 179.508 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.063 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.39 -31.74 0.23 Allowed 'General case' 0 CA--C 1.498 -1.021 0 O-C-N 125.715 1.885 . . . . 0.0 109.738 -177.985 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.42 2.18 0.29 Allowed 'General case' 0 N--CA 1.412 -2.373 1 N-CA-C 95.423 -5.769 . . . . 0.0 95.423 165.091 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.063 ' N ' ' C ' ' A' ' 12' ' ' ALA . 15.8 tttp -116.14 -169.49 1.62 Allowed 'General case' 0 C--N 1.393 2.494 0 CA-C-N 109.46 -3.518 . . . . 0.0 111.76 177.037 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.637 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 6.1 m-70 33.39 21.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.708 177.927 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.651 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.9 tt 171.16 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 CA-C-O 122.302 1.049 . . . . 0.0 109.377 -179.658 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.94 -11.55 81.21 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 104.983 -3.247 . . . . 0.0 104.983 173.981 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.476 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -93.43 -36.33 12.53 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 114.445 -0.878 . . . . 0.0 109.932 178.238 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -153.15 28.22 0.51 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.365 -179.441 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.5 -9.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.114 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 19' ' ' ALA . 83.0 t -152.44 -23.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.284 -179.387 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -171.66 -96.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.496 -179.198 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 25' ' ' LEU . 75.8 t60 -152.07 8.27 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.711 -179.372 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.14 22.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 23' ' ' HIS . 10.8 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.491 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 13.1 m-90 -157.56 -57.09 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.885 0.374 . . . . 0.0 110.517 -179.977 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.15 -0.43 88.74 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.852 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.4 m -78.55 77.2 5.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.765 0.317 . . . . 0.0 110.377 179.852 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.433 HG22 ' CE1' ' A' ' 6' ' ' PHE . 10.5 mt -73.89 -28.97 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.714 -179.778 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 5' ' ' ILE . 67.7 m-85 -155.68 4.56 0.19 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 -179.949 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -59.8 -70.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.243 179.827 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.486 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 70.6 t60 -80.66 43.62 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.2 26.46 0.12 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.235 -179.979 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -166.03 3.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.353 179.747 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.8 m-70 -144.72 146.73 32.34 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.023 0.44 . . . . 0.0 111.012 179.49 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.066 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.91 -31.45 0.22 Allowed 'General case' 0 CA--C 1.498 -1.023 0 O-C-N 125.813 1.945 . . . . 0.0 109.944 -178.156 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.4 2.08 0.29 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.344 -5.798 . . . . 0.0 95.344 165.028 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.066 ' N ' ' C ' ' A' ' 12' ' ' ALA . 13.8 ttpp -116.01 -169.29 1.57 Allowed 'General case' 0 C--N 1.394 2.503 0 CA-C-N 109.407 -3.542 . . . . 0.0 111.817 177.16 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.632 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 80.1 t60 33.98 19.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.89 178.122 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.2 tp 174.69 -46.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-O 122.24 1.019 . . . . 0.0 109.275 179.977 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.29 -14.05 79.4 Favored Glycine 0 C--N 1.271 -3.083 0 N-CA-C 105.773 -2.931 . . . . 0.0 105.773 174.722 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.597 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.14 -45.62 7.8 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.659 -0.771 . . . . 0.0 109.431 178.036 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.23 13.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.877 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.78 5.89 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 109.667 -179.291 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 45.9 t -144.05 -9.23 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.335 179.975 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 27.8 t-20 105.84 -36.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.646 1.216 . . . . 0.0 110.046 -179.757 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.541 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 11.2 t-160 -170.1 -130.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.138 179.972 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.541 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 29.6 m-85 48.62 28.67 1.87 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.775 0.322 . . . . 0.0 110.752 179.673 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 25' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.081 -179.923 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -57.87 -45.16 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.823 0.344 . . . . 0.0 110.528 -179.956 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.76 68.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.114 179.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -66.26 116.13 6.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.583 179.858 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.8 mt -67.18 -51.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.089 179.92 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 8' ' ' HIS . 45.0 m-85 -82.99 21.76 1.02 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.333 179.816 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 12.2 mptt 54.76 8.92 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.34 -179.919 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.449 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 81.6 t60 45.77 19.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.72 179.833 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . -160.46 -3.12 0.06 OUTLIER Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.286 -179.746 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 60.89 27.92 17.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 28.8 t60 -97.29 71.06 2.36 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.138 0.971 . . . . 0.0 110.11 179.437 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.005 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.265 . . 169.34 -30.88 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 112.165 -2.289 . . . . 0.0 105.712 -179.738 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -1.0 0.57 Allowed 'General case' 0 N--CA 1.414 -2.274 1 N-CA-C 95.378 -5.786 . . . . 0.0 95.378 164.068 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.005 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.257 23.7 tttp -115.99 -166.73 1.17 Allowed 'General case' 0 C--N 1.393 2.457 0 CA-C-N 109.42 -3.536 . . . . 0.0 111.953 176.859 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.652 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 55.6 t60 34.01 21.28 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.609 177.756 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.7 tt 170.72 -42.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.565 0 CA-C-O 122.078 0.942 . . . . 0.0 109.381 -179.894 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.96 -14.28 81.87 Favored Glycine 0 C--N 1.274 -2.894 0 N-CA-C 105.81 -2.916 . . . . 0.0 105.81 175.071 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -88.94 -34.36 16.93 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.044 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.07 -73.18 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.61 179.397 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -167.23 -23.14 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.815 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 34.0 t -150.85 -12.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.542 179.614 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 5.1 t30 155.55 -36.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.779 0.674 . . . . 0.0 109.551 -179.658 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -166.14 120.38 1.15 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.952 -178.443 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -71.87 -0.17 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.421 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 -179.931 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.4 ' O ' ' O ' ' A' ' 1' ' ' GLY . 95.9 m95 54.72 166.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.669 -179.993 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.97 -4.32 88.61 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.162 -179.823 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 p 52.88 97.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 110.388 -179.807 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.44 HG22 ' CE2' ' A' ' 6' ' ' PHE . 10.8 mt -78.82 -33.78 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 -179.64 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.44 ' CE2' HG22 ' A' ' 5' ' ' ILE . 63.8 m-85 -156.15 -7.3 0.11 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 179.999 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' H ' ' A' ' 6' ' ' PHE . 16.4 tptp -50.74 -73.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 -179.813 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.36 70.11 10.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.483 179.988 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.67 -12.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.227 -0.511 . . . . 0.0 111.851 -179.972 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -149.11 23.91 0.94 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.871 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 13' ' ' ALA . 56.2 t60 -153.58 146.58 24.52 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.443 179.382 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.31 -30.82 0.21 Allowed 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 125.715 1.885 . . . . 0.0 109.683 -177.695 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.71 2.88 0.25 Allowed 'General case' 0 N--CA 1.411 -2.377 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 164.915 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 20.1 tttm -118.13 -167.3 1.33 Allowed 'General case' 0 C--N 1.393 2.471 0 CA-C-N 109.449 -3.523 . . . . 0.0 111.593 177.275 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.61 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 66.2 t60 33.05 23.3 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.663 177.69 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.2 tt 170.04 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.585 0 CA-C-O 122.107 0.956 . . . . 0.0 109.103 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.45 -15.12 79.13 Favored Glycine 0 C--N 1.274 -2.909 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 174.752 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 6.3 t60 -83.43 -39.64 20.33 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.859 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.94 -69.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -170.97 -19.81 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.877 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' O ' ' ND1' ' A' ' 15' ' ' HIS . 10.1 t -149.58 -16.31 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.966 179.679 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 4.7 t30 158.58 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.692 0.62 . . . . 0.0 109.758 -179.669 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 43.9 t-80 -166.51 14.72 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.723 -178.692 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 72.3 t80 -78.82 43.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.432 -179.883 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.236 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 86.9 m95 -158.44 168.85 25.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.769 0.318 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.3 -8.33 83.44 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.257 -0.497 . . . . 0.0 111.95 179.974 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 51.62 -164.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 110.535 179.903 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.8 tt -164.21 -19.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.205 -179.948 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -161.27 -25.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.37 179.7 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.512 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 35.5 ttpt -60.47 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.422 179.967 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.449 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -78.6 48.25 0.78 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.594 179.882 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.74 -19.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.085 -179.911 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 66.4 mtp180 -139.54 16.84 2.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.23 179.857 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.537 ' C ' ' H ' ' A' ' 13' ' ' ALA . 80.4 m80 -154.75 145.56 22.47 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.557 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.007 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.48 -30.72 0.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 125.654 1.846 . . . . 0.0 109.555 -177.713 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.73 2.75 0.26 Allowed 'General case' 0 N--CA 1.412 -2.351 1 N-CA-C 95.282 -5.822 . . . . 0.0 95.282 164.787 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.007 ' N ' ' C ' ' A' ' 12' ' ' ALA . 11.5 ttpp -117.73 -167.59 1.36 Allowed 'General case' 0 C--N 1.392 2.44 0 CA-C-N 109.524 -3.489 . . . . 0.0 111.671 177.152 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.611 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 27.5 m80 33.11 23.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.716 177.67 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.648 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 170.02 -45.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 CA-C-O 122.229 1.014 . . . . 0.0 109.061 -179.752 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.11 -15.19 78.66 Favored Glycine 0 C--N 1.275 -2.854 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 174.773 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 5.9 t60 -82.54 -40.85 20.39 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.659 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -160.37 -68.05 0.07 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.402 179.51 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -169.34 -19.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.956 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.402 ' H ' ' H ' ' A' ' 20' ' ' ALA . 40.4 t -151.26 -18.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.092 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.489 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 7.8 t-20 163.76 -38.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.576 0.548 . . . . 0.0 109.993 -179.709 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 48.2 t-80 -171.7 33.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 -178.644 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -49.82 -14.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 110.544 -179.969 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 23' ' ' HIS . 10.4 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.558 179.783 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.454 -0.165 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.448 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 29.3 m-90 -157.15 -87.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.737 0.303 . . . . 0.0 110.46 -179.893 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.13 8.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.126 179.866 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -165.3 120.56 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.921 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 6.6 tt -75.88 -40.6 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.382 179.97 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.473 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 41.4 m-85 -162.51 7.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.052 179.437 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm -57.44 -73.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.361 179.86 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -79.6 43.78 0.58 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.415 179.859 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.6 14.69 0.1 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.077 -179.886 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -166.85 -3.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.182 0.515 . . . . 0.0 110.182 179.792 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 19.8 t-80 -162.8 143.4 9.64 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 179.294 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.04 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.3 -31.68 0.22 Allowed 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 125.836 1.96 . . . . 0.0 110.022 -178.133 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.52 1.81 0.33 Allowed 'General case' 0 N--CA 1.411 -2.381 1 N-CA-C 95.304 -5.813 . . . . 0.0 95.304 164.963 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.04 ' N ' ' C ' ' A' ' 12' ' ' ALA . 30.9 tttt -115.67 -168.8 1.47 Allowed 'General case' 0 C--N 1.393 2.499 0 CA-C-N 109.417 -3.538 . . . . 0.0 111.758 176.998 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.633 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 38.6 t-80 34.21 19.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.849 177.98 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 174.08 -47.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.579 0 CA-C-O 122.271 1.034 . . . . 0.0 109.199 -179.894 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.26 -14.06 76.79 Favored Glycine 0 C--N 1.27 -3.13 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 174.918 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -94.5 -45.6 7.35 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.512 178.093 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 166.3 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.762 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.17 9.65 1.04 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.973 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 21' ' ' VAL . 58.5 t -147.97 -8.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.196 -179.542 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 7.7 m120 100.04 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.662 1.226 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.514 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 86.3 t60 -167.22 -105.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.5 -179.834 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.514 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 25.7 t80 65.96 -7.34 0.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 -179.977 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.838 0.352 . . . . 0.0 110.544 179.822 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -69.51 126.0 28.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.72 0.295 . . . . 0.0 110.614 179.93 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.21 -21.81 78.49 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.764 179.752 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.8 m -97.64 92.63 5.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.674 0.273 . . . . 0.0 110.511 179.967 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 mt -67.37 -37.88 79.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.777 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.41 ' H ' ' H ' ' A' ' 7' ' ' LYS . 36.4 p90 -165.74 1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.374 179.884 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 6' ' ' PHE . 79.4 tttt -54.88 -62.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.347 179.926 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.14 65.65 2.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.459 179.931 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -177.0 -13.6 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.902 -179.945 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 85.6 mtt-85 -140.9 6.99 2.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.788 0.327 . . . . 0.0 110.265 179.894 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' ALA . 94.7 m-70 -155.79 146.08 21.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.626 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.031 ' C ' ' H ' ' A' ' 14' ' ' LYS . . . 70.71 -31.67 0.23 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.823 1.952 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.33 1.8 0.31 Allowed 'General case' 0 N--CA 1.412 -2.343 1 N-CA-C 95.414 -5.773 . . . . 0.0 95.414 165.167 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.031 ' H ' ' C ' ' A' ' 12' ' ' ALA . 16.5 tttp -116.31 -168.22 1.4 Allowed 'General case' 0 C--N 1.393 2.493 0 CA-C-N 109.327 -3.579 . . . . 0.0 111.644 177.158 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.626 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 40.4 m-70 34.05 20.98 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.803 177.706 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.656 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 171.3 -46.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.515 0 CA-C-O 122.286 1.041 . . . . 0.0 109.245 -179.682 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.16 -12.42 83.48 Favored Glycine 0 C--N 1.274 -2.908 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 175.125 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.449 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -89.29 -30.88 18.14 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.316 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.57 -66.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.677 179.285 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' H ' ' H ' ' A' ' 21' ' ' VAL . . . -171.64 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.759 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' H ' ' H ' ' A' ' 20' ' ' ALA . 59.9 t -152.7 -18.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 t30 165.66 -38.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.549 0.531 . . . . 0.0 110.145 -179.799 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.456 ' CG ' ' O ' ' A' ' 23' ' ' HIS . 34.5 t-80 -170.04 26.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -178.709 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -49.08 -15.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 -179.741 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.278 -179.944 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -75.02 -54.28 7.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.723 0.296 . . . . 0.0 110.528 -179.946 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.56 69.82 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.912 -179.876 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.504 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 58.8 m -165.43 96.88 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -76.94 -30.21 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.44 179.979 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -157.84 13.06 0.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.326 179.995 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -78.97 -27.12 43.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.268 179.759 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 4' ' ' SER . 38.4 m170 -78.56 77.12 5.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 51.45 83.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.287 179.805 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' H ' ' H ' ' A' ' 11' ' ' HIS . 66.3 ttt180 -169.53 -4.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.268 0.556 . . . . 0.0 110.003 179.644 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.539 ' C ' ' H ' ' A' ' 13' ' ' ALA . 68.7 t60 -156.8 142.2 17.45 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.057 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.61 -31.73 0.23 Allowed 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 125.594 1.809 . . . . 0.0 109.492 -177.863 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 1.54 0.33 Allowed 'General case' 0 N--CA 1.41 -2.439 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 164.978 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.057 ' N ' ' C ' ' A' ' 12' ' ' ALA . 24.0 tttp -115.1 -169.82 1.63 Allowed 'General case' 0 C--N 1.394 2.521 0 CA-C-N 109.438 -3.528 . . . . 0.0 111.731 176.922 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 29.9 t-80 34.78 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.934 177.926 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.8 tt 176.28 -44.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 122.171 0.986 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.82 -14.38 81.57 Favored Glycine 0 C--N 1.274 -2.895 0 N-CA-C 105.335 -3.106 . . . . 0.0 105.335 174.249 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.85 -49.03 6.85 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.295 -0.953 . . . . 0.0 109.02 177.892 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.28 9.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.458 0.474 . . . . 0.0 110.177 -179.94 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.72 10.07 1.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 -178.158 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 21' ' ' VAL . 91.1 t -143.1 -8.56 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.948 -179.893 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 32.2 m-20 97.67 -35.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.637 1.211 . . . . 0.0 111.08 179.81 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.4 t-80 80.19 7.84 1.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.774 -179.154 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.494 ' CG ' ' O ' ' A' ' 24' ' ' TYR . 72.1 t80 -77.08 27.23 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' HIS . 2.0 tt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 111.931 -0.467 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -69.25 -171.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 110.67 179.962 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.35 -21.95 72.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.994 179.97 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.7 m 54.36 -169.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.593 179.919 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 pt -78.34 56.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.521 -179.943 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 60.09 16.71 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.872 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -70.0 -63.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.363 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -78.96 53.12 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.824 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.28 -17.52 0.02 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.062 -179.903 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' C ' ' ND1' ' A' ' 11' ' ' HIS . 81.5 mtp180 -124.55 1.95 8.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.922 0.392 . . . . 0.0 110.219 179.868 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' C ' ' H ' ' A' ' 13' ' ' ALA . 41.2 m80 -152.76 144.44 23.51 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.014 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.5 -31.29 0.22 Allowed 'General case' 0 CA--C 1.497 -1.072 0 O-C-N 125.633 1.833 . . . . 0.0 109.718 -177.731 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.57 2.25 0.3 Allowed 'General case' 0 N--CA 1.411 -2.407 1 N-CA-C 95.415 -5.772 . . . . 0.0 95.415 164.976 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.014 ' N ' ' C ' ' A' ' 12' ' ' ALA . 12.0 ttpt -115.98 -168.98 1.51 Allowed 'General case' 0 C--N 1.395 2.544 0 CA-C-N 109.401 -3.545 . . . . 0.0 111.492 176.995 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 61.5 t60 33.65 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.917 178.036 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.8 tt 174.76 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 CA-C-O 122.229 1.014 . . . . 0.0 109.308 179.982 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.85 -14.24 80.18 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 174.497 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.454 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.7 OUTLIER -90.69 -44.21 9.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 114.431 -0.884 . . . . 0.0 109.857 178.179 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -171.43 42.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.336 -179.177 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 69.6 -21.65 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.515 -179.47 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 19' ' ' ALA . 20.0 t -148.32 -30.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.636 179.802 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 t-20 153.39 -43.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.859 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.557 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 41.9 t60 -168.78 174.96 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.27 179.7 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.557 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 63.5 t80 56.28 10.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.656 179.917 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 25' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -69.58 -73.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.557 -179.998 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.31 -0.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.851 179.999 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m 54.31 106.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.846 0.355 . . . . 0.0 110.706 -179.983 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.48 -35.78 58.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.472 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -164.34 -4.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.47 179.795 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -57.64 -84.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.44 -179.92 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -74.54 85.94 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 179.93 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.78 -45.52 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.091 -179.933 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.91 26.14 0.64 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.97 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' A' ' 13' ' ' ALA . 47.5 t60 -160.8 147.1 15.01 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.059 0.457 . . . . 0.0 111.04 179.688 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.008 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.5 -31.9 0.23 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 125.872 1.982 . . . . 0.0 110.085 -178.23 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.32 2.08 0.28 Allowed 'General case' 0 N--CA 1.412 -2.359 1 N-CA-C 95.411 -5.774 . . . . 0.0 95.411 165.218 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.008 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.0 tttt -116.03 -169.31 1.58 Allowed 'General case' 0 C--N 1.393 2.491 0 CA-C-N 109.435 -3.529 . . . . 0.0 111.767 177.03 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.622 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 10.9 t60 34.72 18.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.914 178.056 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tt 175.35 -41.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 CA-C-O 122.019 0.914 . . . . 0.0 109.582 179.923 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.63 -13.07 83.88 Favored Glycine 0 C--N 1.275 -2.858 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 174.316 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.2 m170 -92.89 -44.78 8.29 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.541 -0.829 . . . . 0.0 109.136 178.05 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.89 11.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 58.46 9.61 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.025 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 59.8 t -147.57 -9.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.152 -179.777 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.8 t-20 100.31 -35.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.395 1.06 . . . . 0.0 110.023 -179.627 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' A' ' 25' ' ' LEU . 79.9 m-70 -145.76 119.37 9.14 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.47 -179.83 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -62.43 -4.26 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 23' ' ' HIS . 19.0 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.211 179.944 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.6 m95 51.56 -153.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 0.0 110.464 179.988 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' H ' ' H ' ' A' ' 4' ' ' SER . . . -177.69 -0.58 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 179.996 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.425 ' H ' ' H ' ' A' ' 3' ' ' GLY . 10.2 t 55.8 165.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.828 0.347 . . . . 0.0 110.572 -179.999 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 mt -76.21 -42.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -166.11 -11.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 179.906 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 9' ' ' GLY . 81.2 tttt -62.22 -8.39 5.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.423 -179.958 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.435 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 69.9 t60 -61.83 -2.55 0.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.962 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . 145.23 59.97 0.02 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.116 179.813 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -161.65 33.27 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 179.729 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.534 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.0 t-80 -169.55 145.29 3.14 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.902 179.571 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.963 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.71 -31.78 0.23 Allowed 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 125.767 1.917 . . . . 0.0 109.94 -178.156 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.77 0.31 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.274 -5.824 . . . . 0.0 95.274 165.074 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.963 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -115.6 -169.35 1.56 Allowed 'General case' 0 C--N 1.394 2.509 0 CA-C-N 109.483 -3.508 . . . . 0.0 111.766 176.909 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.621 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 13.3 t-80 34.89 17.54 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.944 177.952 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.71 -43.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.573 0 CA-C-O 122.144 0.974 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.94 82.39 Favored Glycine 0 C--N 1.274 -2.907 0 N-CA-C 105.434 -3.066 . . . . 0.0 105.434 174.41 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -91.41 -47.44 7.45 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.437 -0.881 . . . . 0.0 109.21 177.983 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 168.23 9.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.259 0.349 . . . . 0.0 110.179 -179.885 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.5 9.88 1.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.25 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 85.1 t -144.57 -9.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.2 -179.82 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 11.0 t-20 99.43 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 O-C-N 124.33 1.019 . . . . 0.0 110.798 179.826 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 5.2 t60 81.98 44.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.349 -179.385 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 41.7 p90 -66.55 -31.09 71.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.565 -179.942 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.756 -179.948 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 71.6 m95 52.01 -164.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.52 7.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.832 179.977 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t 58.22 -142.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.434 -179.97 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 6' ' ' PHE . 16.6 tt -158.77 -38.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.932 179.786 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 10' ' ' ARG . 35.0 m-85 -81.72 64.73 6.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.238 179.482 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' C ' ' N ' ' A' ' 9' ' ' GLY . 50.9 mmtt 45.69 28.11 0.51 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.317 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 85.1 t60 49.95 12.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 7' ' ' LYS . . . -174.53 -16.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' N ' ' O ' ' A' ' 6' ' ' PHE . 43.0 ttp180 66.3 96.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.315 0.579 . . . . 0.0 111.43 179.484 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 13' ' ' ALA . 1.5 m-70 68.81 140.59 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.849 179.22 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.053 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 67.24 -33.33 0.21 Allowed 'General case' 0 CA--C 1.499 -1.003 0 O-C-N 126.267 2.23 . . . . 0.0 111.023 -179.106 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.31 0.98 0.37 Allowed 'General case' 0 N--CA 1.411 -2.406 1 N-CA-C 95.356 -5.794 . . . . 0.0 95.356 165.152 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.053 ' N ' ' C ' ' A' ' 12' ' ' ALA . 22.5 tttp -114.02 -168.89 1.42 Allowed 'General case' 0 C--N 1.395 2.57 0 CA-C-N 109.554 -3.475 . . . . 0.0 111.743 176.769 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 24.9 m80 34.15 18.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.959 177.968 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.676 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.1 tp 175.17 -46.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 122.286 1.041 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.71 -14.56 77.98 Favored Glycine 0 C--N 1.27 -3.097 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 174.52 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -90.82 -47.79 7.41 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 114.547 -0.826 . . . . 0.0 109.144 177.804 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.56 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.799 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.53 6.84 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.292 0.568 . . . . 0.0 109.54 -179.149 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 50.6 t -143.02 -9.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 16.5 t-20 106.13 -36.81 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.62 1.2 . . . . 0.0 110.019 -179.809 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.538 ' CD2' ' H ' ' A' ' 24' ' ' TYR . 79.7 t60 -171.08 -117.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.273 179.871 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.538 ' H ' ' CD2' ' A' ' 23' ' ' HIS . 92.4 m-85 50.9 13.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.7 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.215 -179.965 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -70.93 -24.94 62.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.508 -179.996 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.97 50.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.033 179.946 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 5' ' ' ILE . 30.3 t 52.8 -177.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.741 0.305 . . . . 0.0 110.565 -179.929 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 9.2 mt -73.86 -44.87 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 -179.908 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 55.6 m-85 -159.84 -13.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -50.67 -61.6 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.953 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -77.87 61.56 2.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.474 179.863 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.99 -13.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.161 -0.543 . . . . 0.0 111.922 -179.997 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 11' ' ' HIS . 59.2 mtp85 -137.52 14.56 2.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 110.097 179.912 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 13' ' ' ALA . 93.1 m-70 -156.69 145.78 20.3 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.541 179.457 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.986 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.23 -31.72 0.23 Allowed 'General case' 0 CA--C 1.499 -1.006 0 O-C-N 125.75 1.906 . . . . 0.0 109.839 -177.996 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.37 1.99 0.3 Allowed 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 165.078 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.986 ' N ' ' C ' ' A' ' 12' ' ' ALA . 33.2 tttt -116.0 -169.56 1.62 Allowed 'General case' 0 C--N 1.392 2.418 0 CA-C-N 109.389 -3.551 . . . . 0.0 111.735 177.031 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.623 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 3.1 t60 34.48 18.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.935 178.089 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.9 tt 175.06 -41.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.549 0 CA-C-O 122.02 0.914 . . . . 0.0 109.659 179.918 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.59 -13.16 83.79 Favored Glycine 0 C--N 1.275 -2.826 0 N-CA-C 105.506 -3.038 . . . . 0.0 105.506 174.327 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.65 -44.36 8.22 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 114.579 -0.81 . . . . 0.0 109.491 178.083 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 165.96 12.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.57 10.14 0.95 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.972 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 65.9 t -148.22 -9.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.189 -179.837 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.1 t-20 100.34 -35.58 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.388 1.055 . . . . 0.0 110.003 -179.643 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' A' ' 25' ' ' LEU . 43.9 m80 -151.72 120.06 6.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.42 -179.766 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -69.48 5.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' HIS . 3.0 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.37 -179.792 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 50.8 -147.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.983 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.05 -4.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.219 -0.515 . . . . 0.0 111.838 -179.946 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.4 p 50.77 -165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.738 179.893 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -144.95 -29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.683 179.963 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' H ' ' H ' ' A' ' 7' ' ' LYS . 34.4 p90 -168.57 -21.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.942 179.525 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 6' ' ' PHE . 9.7 mtmp? -48.96 -68.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.551 179.787 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -77.6 63.93 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.295 179.704 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.04 -24.37 0.02 OUTLIER Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.123 -179.868 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -151.18 10.21 0.59 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.664 0.269 . . . . 0.0 110.757 -179.921 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 13' ' ' ALA . 10.9 t60 -149.38 144.27 26.29 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 120.919 0.39 . . . . 0.0 110.825 179.601 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.033 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.45 -29.62 0.19 Allowed 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 125.558 1.786 . . . . 0.0 109.851 -178.081 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -63.18 1.78 0.44 Allowed 'General case' 0 N--CA 1.411 -2.414 1 N-CA-C 94.855 -5.98 . . . . 0.0 94.855 164.342 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.033 ' N ' ' C ' ' A' ' 12' ' ' ALA . 4.6 tttp -116.07 -161.98 0.82 Allowed 'General case' 0 C--N 1.398 2.696 0 CA-C-N 109.264 -3.607 . . . . 0.0 110.726 176.929 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.561 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 5.4 t60 31.49 20.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.459 0.704 . . . . 0.0 112.144 178.291 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.719 ' N ' ' O ' ' A' ' 14' ' ' LYS . 2.0 tp 172.95 -49.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 CA-C-O 122.429 1.109 . . . . 0.0 109.321 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.21 -13.71 70.57 Favored Glycine 0 C--N 1.27 -3.1 0 N-CA-C 106.257 -2.737 . . . . 0.0 106.257 175.351 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.6 m170 -94.69 -45.05 7.52 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.039 178.071 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 161.72 13.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.858 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.4 7.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.114 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 60.5 t -143.59 -9.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.575 -179.933 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 3.7 t30 106.49 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.548 1.155 . . . . 0.0 110.246 179.969 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -173.09 100.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.533 -179.933 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 24' ' ' TYR . 60.8 t80 -166.0 4.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.427 179.975 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.51 -179.97 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -75.87 143.1 41.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.55 179.986 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.99 0.53 21.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.871 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.9 m -58.71 -178.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.528 -179.958 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.82 -72.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.936 179.826 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.82 -35.4 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.186 179.5 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 9' ' ' GLY . 53.8 mttm -53.16 -33.71 53.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.492 179.91 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 8' ' ' HIS . 22.5 t-80 -75.24 17.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.74 -179.974 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -177.83 25.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.994 -179.964 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -161.06 20.42 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.976 0.417 . . . . 0.0 110.153 179.992 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' ALA . 49.2 t60 -164.0 143.97 8.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.597 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.065 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.11 -31.61 0.23 Allowed 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 125.619 1.825 . . . . 0.0 109.656 -178.045 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.23 1.54 0.31 Allowed 'General case' 0 N--CA 1.411 -2.416 1 N-CA-C 95.364 -5.791 . . . . 0.0 95.364 165.014 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.065 ' N ' ' C ' ' A' ' 12' ' ' ALA . 18.2 tttm -114.89 -169.32 1.53 Allowed 'General case' 0 C--N 1.396 2.608 0 CA-C-N 109.471 -3.513 . . . . 0.0 111.909 177.067 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 7.8 m-70 32.73 21.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.788 177.974 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 172.63 -47.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 CA-C-O 122.256 1.027 . . . . 0.0 109.374 -179.951 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.25 -14.39 79.18 Favored Glycine 0 C--N 1.271 -3.046 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 174.404 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' H ' ' H ' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -87.75 -44.07 11.41 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 114.33 -0.935 . . . . 0.0 109.466 178.034 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.39 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.205 -179.315 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.0 -1.44 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.192 179.496 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 39.5 t -150.97 -25.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.732 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 24.9 t30 130.18 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.737 1.273 . . . . 0.0 109.299 -179.726 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -163.17 97.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.906 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 77.4 t80 -164.31 -6.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.945 179.816 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.245 179.881 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.2 m95 50.54 -174.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.78 0.324 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.2 -14.75 54.89 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.825 179.88 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.2 m -164.99 166.4 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.319 . . . . 0.0 110.33 179.981 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.36 -54.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.506 -179.834 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -160.95 3.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 12.6 mptt -61.09 -60.1 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.156 -179.903 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -71.2 73.26 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.548 -179.993 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.29 -23.74 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.97 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -140.65 17.98 2.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.157 179.917 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.561 ' C ' ' H ' ' A' ' 13' ' ' ALA . 77.1 t60 -152.55 145.21 24.23 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.141 0.496 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.023 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.8 -30.66 0.21 Allowed 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 125.78 1.925 . . . . 0.0 109.261 -177.426 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.9 3.71 0.21 Allowed 'General case' 0 N--CA 1.41 -2.458 1 N-CA-C 95.372 -5.788 . . . . 0.0 95.372 164.698 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.023 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.0 tttp -119.36 -168.11 1.52 Allowed 'General case' 0 C--N 1.395 2.549 0 CA-C-N 109.573 -3.467 . . . . 0.0 111.828 177.464 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 57.8 m170 31.67 25.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.411 178.12 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' LYS . 6.6 tt 167.52 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 CA-C-O 122.171 0.986 . . . . 0.0 109.217 -179.841 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.34 -13.71 78.1 Favored Glycine 0 C--N 1.275 -2.837 0 N-CA-C 104.675 -3.37 . . . . 0.0 104.675 173.523 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.492 ' H ' ' H ' ' A' ' 16' ' ' ILE . 9.9 t60 -89.16 -40.3 12.99 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.399 177.897 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -144.33 23.38 1.65 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.885 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' ILE . . . 60.59 -2.36 0.18 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.251 179.139 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' ALA . 42.9 t -150.89 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 121.335 -0.146 . . . . 0.0 111.066 -179.57 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 23' ' ' HIS . 0.1 OUTLIER 175.83 -83.87 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.947 0.404 . . . . 0.0 110.84 -179.443 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.605 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.6 OUTLIER -155.47 -172.27 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.76 -179.589 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 50.6 t80 57.01 20.16 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.51 179.999 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -66.55 -20.28 65.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 110.518 -179.971 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.88 18.08 78.77 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 -179.708 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.596 ' HG ' ' CE1' ' A' ' 8' ' ' HIS . 7.6 m 58.34 -150.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.6 -179.956 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.43 -25.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -152.71 -20.58 0.16 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.256 179.563 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -57.58 -54.72 43.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.27 179.754 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.596 ' CE1' ' HG ' ' A' ' 4' ' ' SER . 35.1 m170 -79.13 47.6 0.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.407 179.844 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.33 -16.88 0.02 OUTLIER Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -179.877 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -128.73 13.75 6.41 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.043 179.837 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 13' ' ' ALA . 62.1 t-80 -157.47 145.78 19.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.589 179.518 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.999 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 70.93 -31.63 0.23 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 125.773 1.92 . . . . 0.0 109.804 -178.028 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.47 2.01 0.31 Allowed 'General case' 0 N--CA 1.412 -2.375 1 N-CA-C 95.323 -5.806 . . . . 0.0 95.323 165.037 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.999 ' N ' ' C ' ' A' ' 12' ' ' ALA . 27.5 tttt -115.86 -168.76 1.47 Allowed 'General case' 0 C--N 1.394 2.518 0 CA-C-N 109.509 -3.496 . . . . 0.0 111.557 177.045 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.629 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 8.8 m-70 33.98 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 177.968 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.0 tt 174.63 -44.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 CA-C-O 122.105 0.955 . . . . 0.0 109.518 179.885 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.11 81.87 Favored Glycine 0 C--N 1.273 -2.937 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.362 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 m170 -93.08 -49.28 6.08 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 114.304 -0.948 . . . . 0.0 109.563 177.99 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 170.46 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.488 -179.616 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 58.41 9.65 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.947 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 21' ' ' VAL . 59.7 t -146.7 -8.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.911 -179.856 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 23' ' ' HIS . 18.8 m-20 99.42 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.819 1.324 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 22' ' ' ASN . 93.2 m-70 -160.19 108.87 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -62.25 -11.78 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.318 179.986 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.87 175.92 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.25 -21.7 75.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.776 179.847 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m 47.49 45.7 17.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.812 0.339 . . . . 0.0 110.679 179.951 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 5' ' ' ILE . 13.4 tt -55.62 90.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.304 0.573 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 49.43 12.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' N ' ' C ' ' A' ' 5' ' ' ILE . 2.7 ttmp? -72.18 -68.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -77.71 65.21 3.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.518 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.37 -26.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' O ' ' ND1' ' A' ' 11' ' ' HIS . 7.9 ptm180 -161.95 24.91 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.383 . . . . 0.0 110.459 179.894 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 13' ' ' ALA . 61.0 m-70 -155.45 146.52 22.54 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.512 179.507 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.013 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.05 -31.91 0.23 Allowed 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 125.719 1.887 . . . . 0.0 109.922 -178.071 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.14 1.76 0.29 Allowed 'General case' 0 N--CA 1.413 -2.295 1 N-CA-C 95.421 -5.77 . . . . 0.0 95.421 165.158 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.013 ' N ' ' C ' ' A' ' 12' ' ' ALA . 3.0 ttmm -115.56 -169.76 1.64 Allowed 'General case' 0 C--N 1.393 2.472 0 CA-C-N 109.403 -3.544 . . . . 0.0 111.716 177.252 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 67.8 m-70 34.09 19.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.698 178.036 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.5 tt 174.04 -46.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.686 0 CA-C-O 122.178 0.99 . . . . 0.0 109.641 -179.936 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.91 -14.66 78.46 Favored Glycine 0 C--N 1.272 -3.013 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 174.726 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.594 ' NE2' ' NZ ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -92.43 -42.74 9.59 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 114.721 -0.739 . . . . 0.0 110.038 178.363 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' VAL . . . -170.82 42.1 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.353 -179.212 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . 66.67 -17.1 0.13 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.663 -179.52 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' ALA . 21.6 t -148.77 -33.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 179.974 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER 155.38 -47.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.867 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 24' ' ' TYR . 80.5 t60 -166.86 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.222 179.835 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.549 ' N ' ' CG ' ' A' ' 23' ' ' HIS . 98.3 m-85 46.89 18.32 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.77 179.822 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' HIS . 15.6 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.14 -179.91 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -167.87 -2.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.332 . . . . 0.0 110.474 179.929 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.81 1.47 72.63 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.111 179.943 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 m -169.17 59.77 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.481 179.952 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.3 pt -83.96 21.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 10' ' ' ARG . 34.2 p90 -163.15 -36.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.77 179.743 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 9' ' ' GLY . 90.9 mttt -55.82 -37.19 68.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 179.888 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.462 ' O ' ' ND1' ' A' ' 8' ' ' HIS . 1.1 t60 -67.62 4.95 0.92 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 -179.747 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 7' ' ' LYS . . . -154.26 8.54 0.4 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 11' ' ' HIS . 95.0 mtt180 -154.74 164.04 39.37 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.837 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.549 ' C ' ' H ' ' A' ' 13' ' ' ALA . 2.2 t60 58.41 136.47 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.09 -179.814 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.047 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 69.68 -32.01 0.22 Allowed 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.761 -178.042 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.2 1.12 0.34 Allowed 'General case' 0 N--CA 1.41 -2.453 1 N-CA-C 95.268 -5.827 . . . . 0.0 95.268 164.709 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.047 ' N ' ' C ' ' A' ' 12' ' ' ALA . 17.6 tttm -114.71 -169.45 1.55 Allowed 'General case' 0 C--N 1.397 2.638 0 CA-C-N 109.557 -3.474 . . . . 0.0 111.813 176.871 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 43.8 m80 34.54 18.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.894 178.085 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.673 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.7 tt 175.41 -44.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 CA-C-O 122.051 0.929 . . . . 0.0 109.637 179.94 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.59 -14.04 81.48 Favored Glycine 0 C--N 1.273 -2.97 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 174.554 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.567 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.56 -46.27 7.7 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.402 177.995 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 167.47 12.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.43 -179.882 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 59.33 8.24 1.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.041 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 22' ' ' ASN . 52.3 t -146.02 -9.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.054 -179.939 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 62.9 t30 102.27 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.543 1.152 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -175.07 75.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.403 179.997 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 52.8 t80 -79.15 -20.92 47.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.541 -179.979 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.444 179.978 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.492 ' O ' ' CD1' ' A' ' 2' ' ' TRP . 55.3 t-105 -66.32 0.94 1.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 179.959 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . 80.06 -3.61 70.34 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.023 179.983 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.7 p -75.28 141.58 43.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.531 179.935 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.718 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.8 mp -78.47 93.26 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.909 180.0 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 49.35 60.92 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 -179.997 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp 53.69 57.2 6.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.212 -179.779 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 19.5 t-160 55.37 21.56 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.171 -179.75 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 56.03 3.79 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.163 -179.982 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' CD ' ' N ' ' A' ' 10' ' ' ARG . 0.7 OUTLIER 54.9 43.09 30.51 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.931 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -155.05 72.2 0.82 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 122.289 1.042 . . . . 0.0 109.95 178.761 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.973 ' C ' ' N ' ' A' ' 14' ' ' LYS 0.275 . . 174.67 -31.07 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.504 179.978 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.81 -1.53 0.65 Allowed 'General case' 0 N--CA 1.416 -2.154 1 N-CA-C 95.486 -5.746 . . . . 0.0 95.486 164.734 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.973 ' N ' ' C ' ' A' ' 12' ' ' ALA 0.258 19.1 tttm -115.1 -166.86 1.16 Allowed 'General case' 0 C--N 1.388 2.262 0 CA-C-N 109.085 -3.689 . . . . 0.0 111.569 176.794 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.627 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 25.3 t60 34.4 18.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.146 177.812 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 14' ' ' LYS . 4.3 tt 174.37 -43.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 CA-C-O 122.145 0.974 . . . . 0.0 109.489 179.797 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.95 -13.77 82.29 Favored Glycine 0 C--N 1.274 -2.902 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 174.71 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -92.5 -44.67 8.52 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.605 -0.798 . . . . 0.0 109.049 177.907 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 163.32 11.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.222 0.326 . . . . 0.0 110.126 179.946 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 57.54 10.89 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.907 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 21' ' ' VAL . 96.0 t -145.1 -7.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.821 -179.674 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 12.4 m-20 99.48 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.796 1.31 . . . . 0.0 110.228 -179.566 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.447 ' CD2' ' O ' ' A' ' 23' ' ' HIS . 25.2 p-80 -162.9 112.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.633 179.984 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 89.2 t80 -69.82 -3.1 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.989 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 2' ' ' TRP . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.495 ' CG ' ' O ' ' A' ' 1' ' ' GLY . 5.0 m-90 -159.28 -91.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.879 0.371 . . . . 0.0 110.389 179.989 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.19 10.38 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.9 m -150.66 83.55 1.35 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.894 0.378 . . . . 0.0 110.32 -179.988 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.497 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 9.7 pt -61.11 -37.78 78.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.758 -179.882 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 65.7 m-85 -161.47 2.94 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.39 179.898 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -48.46 -56.99 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.556 179.97 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -82.07 60.31 4.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.671 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 10' ' ' ARG . . . -168.57 -11.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.169 -179.937 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' H ' ' H ' ' A' ' 9' ' ' GLY . 9.8 ptp180 -163.33 28.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.746 0.308 . . . . 0.0 110.503 -179.97 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.535 ' C ' ' H ' ' A' ' 13' ' ' ALA . 42.7 t60 -148.8 145.59 27.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.238 179.315 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.027 ' C ' ' N ' ' A' ' 14' ' ' LYS . . . 71.87 -31.42 0.23 Allowed 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 125.65 1.844 . . . . 0.0 109.521 -177.728 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 11' ' ' HIS . . . -62.53 2.32 0.29 Allowed 'General case' 0 N--CA 1.412 -2.348 1 N-CA-C 95.365 -5.791 . . . . 0.0 95.365 164.982 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.027 ' N ' ' C ' ' A' ' 12' ' ' ALA . 23.3 tttm -116.3 -169.53 1.63 Allowed 'General case' 0 C--N 1.394 2.512 0 CA-C-N 109.442 -3.526 . . . . 0.0 111.778 177.01 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' H ' ' CG ' ' A' ' 14' ' ' LYS . 7.4 m-70 34.1 19.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.812 178.2 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 14' ' ' LYS . 3.0 tt 174.8 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 CA-C-O 122.077 0.941 . . . . 0.0 109.641 179.836 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.62 -13.35 83.58 Favored Glycine 0 C--N 1.275 -2.855 0 N-CA-C 105.508 -3.037 . . . . 0.0 105.508 174.358 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -93.85 -45.91 7.43 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.483 178.046 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 18' ' ' HIS . . . 169.48 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.615 -179.787 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 19' ' ' ALA . . . 60.32 8.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.882 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 21' ' ' VAL . 50.5 t -147.08 -7.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.657 -179.866 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 4.8 m120 97.24 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.692 1.245 . . . . 0.0 109.835 -179.374 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.513 ' CG ' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -170.66 -113.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.513 ' H ' ' CG ' ' A' ' 23' ' ' HIS . 31.5 t80 64.64 -6.01 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.931 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 19' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 stop_ save_